Pathway_ID	Pathway_Name	Accession_Count	Accessions
Reactome: R-HSA-1614558	Degradation of cysteine and homocysteine	3	XP_050033399.1;XP_050023802.1;XP_050024957.1
MetaCyc: PWY-7347	Sucrose biosynthesis III	1	XP_050050068.1
Reactome: R-HSA-3214841	PKMTs methylate histone lysines	62	XP_050044775.1;XP_050024207.1;XP_050039389.1;XP_050030718.1;XP_050034065.1;XP_050034064.1;XP_050025266.1;XP_050045301.1;XP_050052258.1;XP_050044779.1;XP_050039385.1;XP_050028001.1;XP_050045170.1;XP_050044777.1;XP_050038199.1;XP_050029891.1;XP_050039391.1;XP_050024209.1;XP_050035110.1;XP_050034063.1;XP_050040703.1;XP_050048275.1;XP_050025243.1;XP_050024205.1;XP_050036268.1;XP_050026960.1;XP_050030716.1;XP_050026957.1;XP_050030717.1;XP_050034061.1;XP_050024208.1;XP_050051294.1;XP_050049068.1;XP_050044776.1;XP_050025244.1;XP_050034062.1;XP_050029889.1;XP_050026959.1;XP_050039388.1;XP_050034066.1;XP_050045285.1;XP_050045874.1;XP_050039387.1;XP_050044774.1;XP_050046300.1;XP_050030715.1;XP_050046969.1;XP_050039386.1;XP_050034060.1;XP_050034681.1;XP_050029887.1;XP_050026958.1;XP_050036655.1;XP_050045294.1;XP_050039390.1;XP_050040704.1;XP_050025248.1;XP_050045875.1;XP_050038213.1;XP_050029890.1;XP_050044780.1;XP_050040705.1
Reactome: R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	36	XP_050023570.1;XP_050035481.1;XP_050052687.1;XP_050048255.1;XP_050048723.1;XP_050050094.1;XP_050022472.1;XP_050023192.1;XP_050050095.1;XP_050035427.1;XP_050050096.1;XP_050041510.1;XP_050044597.1;XP_050050103.1;XP_050051240.1;XP_050023562.1;XP_050050105.1;XP_050050100.1;XP_050042077.1;XP_050050093.1;XP_050033021.1;XP_050027328.1;XP_050050098.1;XP_050050492.1;XP_050050107.1;XP_050048534.1;XP_050050102.1;XP_050050099.1;XP_050034171.1;XP_050030850.1;XP_050050101.1;XP_050041504.1;XP_050023575.1;XP_050050104.1;XP_050051751.1;XP_050050106.1
MetaCyc: PWYG-321		5	XP_050029751.1;XP_050049718.1;XP_050033008.1;XP_050033009.1;XP_050032773.1
Reactome: R-HSA-169911	Regulation of Apoptosis	1	XP_050031735.1
Reactome: R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	114	XP_050042714.1;XP_050039882.1;XP_050033913.1;XP_050040632.1;XP_050052117.1;XP_050048061.1;XP_050036558.1;XP_050044680.1;XP_050037013.1;XP_050027435.1;XP_050048060.1;XP_050049407.1;XP_050048534.1;XP_050041744.1;XP_050026721.1;XP_050041753.1;XP_050049826.1;XP_050035149.1;XP_050051837.1;XP_050041323.1;XP_050044689.1;XP_050035483.1;XP_050052195.1;XP_050029294.1;XP_050038626.1;XP_050043804.1;XP_050038747.1;XP_050029851.1;XP_050044122.1;XP_050043802.1;XP_050045264.1;XP_050028344.1;XP_050038550.1;XP_050028191.1;XP_050051304.1;XP_050039997.1;XP_050033573.1;XP_050029850.1;XP_050027693.1;XP_050049827.1;XP_050035484.1;XP_050036006.1;XP_050048062.1;XP_050032688.1;XP_050027463.1;XP_050043919.1;XP_050029508.1;XP_050031153.1;XP_050034780.1;XP_050026723.1;XP_050044593.1;XP_050023059.1;XP_050034409.1;XP_050046933.1;XP_050028318.1;XP_050032331.1;XP_050027728.1;XP_050024740.1;XP_050039285.1;XP_050032921.1;XP_050045196.1;XP_050044445.1;XP_050051569.1;XP_050039286.1;XP_050026722.1;XP_050044688.1;XP_050032528.1;XP_050037479.1;XP_050034868.1;XP_050045970.1;XP_050026103.1;XP_050023492.1;XP_050022748.1;XP_050032936.1;XP_050031861.1;XP_050049170.1;XP_050050516.1;XP_050025636.1;XP_050040648.1;XP_050027477.1;XP_050052130.1;XP_050042319.1;XP_050043916.1;XP_050036005.1;XP_050035213.1;XP_050046934.1;XP_050029380.1;XP_050049776.1;XP_050052816.1;XP_050043803.1;XP_050049830.1;XP_050032267.1;XP_050049831.1;XP_050035481.1;XP_050039340.1;XP_050023058.1;XP_050032598.1;XP_050050940.1;XP_050045969.1;XP_050027304.1;XP_050043918.1;XP_050026018.1;XP_050022853.1;XP_050043917.1;XP_050044875.1;XP_050032793.1;XP_050040677.1;XP_050032330.1;XP_050027305.1;XP_050052131.1;XP_050028604.1;XP_050032599.1;XP_050031230.1;XP_050047002.1
Reactome: R-HSA-196299	Beta-catenin phosphorylation cascade	9	XP_050048777.1;XP_050048776.1;XP_050047997.1;XP_050047996.1;XP_050047995.1;XP_050047994.1;XP_050048775.1;XP_050048357.1;XP_050047998.1
Reactome: R-HSA-2028269	Signaling by Hippo	8	XP_050044279.1;XP_050026976.1;XP_050044281.1;XP_050044282.1;XP_050036613.1;XP_050026975.1;XP_050044278.1;XP_050026974.1
Reactome: R-HSA-210990	PECAM1 interactions	1	XP_050025376.1
KEGG: 00720+1.5.1.5+3.5.4.9	Carbon fixation pathways in prokaryotes	3	XP_050052682.1;XP_050048637.1;XP_050052683.1
Reactome: R-HSA-166208	mTORC1-mediated signalling	37	XP_050029407.1;XP_050033999.1;XP_050029885.1;XP_050051080.1;XP_050029409.1;XP_050051098.1;XP_050029884.1;XP_050034000.1;XP_050025347.1;XP_050051087.1;XP_050043540.1;XP_050034700.1;XP_050050756.1;XP_050050754.1;XP_050043466.1;XP_050027195.1;XP_050034001.1;XP_050051109.1;XP_050051067.1;XP_050029406.1;XP_050032858.1;XP_050025348.1;XP_050029408.1;XP_050029883.1;XP_050050753.1;XP_050034809.1;XP_050032859.1;XP_050027194.1;XP_050044489.1;XP_050029405.1;XP_050044488.1;XP_050050757.1;XP_050041412.1;XP_050050752.1;XP_050024740.1;XP_050051073.1;XP_050040015.1
KEGG: 00010+2.3.1.12	Glycolysis / Gluconeogenesis	1	XP_050039504.1
MetaCyc: PWY-6619	Adenine and adenosine salvage VI	2	XP_050050828.1;XP_050050829.1
Reactome: R-HSA-4724325	Defective ALG8 causes ALG8-CDG (CDG-1h)	1	XP_050039242.1
Reactome: R-HSA-212300	PRC2 methylates histones and DNA	24	XP_050043471.1;XP_050026959.1;XP_050030757.1;XP_050043468.1;XP_050025266.1;XP_050043470.1;XP_050051703.1;XP_050051702.1;XP_050043469.1;XP_050042802.1;XP_050029889.1;XP_050025244.1;XP_050043472.1;XP_050038213.1;XP_050025248.1;XP_050026960.1;XP_050036268.1;XP_050029890.1;XP_050025243.1;XP_050026957.1;XP_050029887.1;XP_050038199.1;XP_050026958.1;XP_050029891.1
MetaCyc: PWY-3801	Sucrose degradation II (sucrose synthase)	5	XP_050037412.1;XP_050037411.1;XP_050050068.1;XP_050037410.1;XP_050037409.1
KEGG: 00720+4.2.1.17+1.1.1.35	Carbon fixation pathways in prokaryotes	6	XP_050041643.1;XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050026422.1;XP_050032010.1
KEGG: 00640+6.2.1.4	Propanoate metabolism	1	XP_050026352.1
Reactome: R-HSA-1614603	Cysteine formation from homocysteine	6	XP_050035465.1;XP_050035464.1;XP_050023802.1;XP_050035467.1;XP_050035466.1;XP_050035463.1
KEGG: 00785+2.3.1.181	Lipoic acid metabolism	3	XP_050036621.1;XP_050048152.1;XP_050045962.1
Reactome: R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	1	XP_050050751.1
Reactome: R-HSA-373080	Class B/2 (Secretin family receptors)	20	XP_050041327.1;XP_050033319.1;XP_050044971.1;XP_050044844.1;XP_050050021.1;XP_050044841.1;XP_050027547.1;XP_050026396.1;XP_050044843.1;XP_050034186.1;XP_050041328.1;XP_050051928.1;XP_050044842.1;XP_050050209.1;XP_050050429.1;XP_050025780.1;XP_050027890.1;XP_050027563.1;XP_050026181.1;XP_050027562.1
Reactome: R-HSA-1483101	Synthesis of PS	4	XP_050039465.1;XP_050039467.1;XP_050039464.1;XP_050039466.1
KEGG: 00650+2.6.1.19	Butanoate metabolism	1	XP_050041758.1
MetaCyc: PWY-6122	5-aminoimidazole ribonucleotide biosynthesis II	4	XP_050040275.1;XP_050048865.1;XP_050039987.1;XP_050039374.1
KEGG: 00790+2.10.1.1	Folate biosynthesis	1	XP_050036161.1
Reactome: R-HSA-5358346	Hedgehog ligand biogenesis	59	XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050045660.1;XP_050044478.1;XP_050025715.1;XP_050033319.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050034858.1;XP_050022938.1;XP_050040200.1;XP_050050209.1;XP_050048534.1;XP_050032477.1;XP_050050373.1;XP_050045785.1;XP_050047809.1;XP_050048719.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050044470.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050049124.1;XP_050034857.1;XP_050040198.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050027657.1;XP_050036580.1;XP_050036156.1;XP_050038140.1;XP_050033833.1;XP_050048824.1;XP_050036253.1;XP_050037399.1;XP_050044469.1;XP_050023192.1;XP_050047181.1
Reactome: R-HSA-1989781	PPARA activates gene expression	117	XP_050022818.1;XP_050039207.1;XP_050024679.1;XP_050042080.1;XP_050043924.1;XP_050025012.1;XP_050031330.1;XP_050042081.1;XP_050033232.1;XP_050033234.1;XP_050046034.1;XP_050036373.1;XP_050040984.1;XP_050040898.1;XP_050027825.1;XP_050033835.1;XP_050040909.1;XP_050033725.1;XP_050040906.1;XP_050041692.1;XP_050052316.1;XP_050040910.1;XP_050025006.1;XP_050045376.1;XP_050031490.1;XP_050027717.1;XP_050033834.1;XP_050040907.1;XP_050040900.1;XP_050035315.1;XP_050042828.1;XP_050046004.1;XP_050041691.1;XP_050051361.1;XP_050042141.1;XP_050040212.1;XP_050040899.1;XP_050042140.1;XP_050040982.1;XP_050040202.1;XP_050051362.1;XP_050040209.1;XP_050042719.1;XP_050041696.1;XP_050031742.1;XP_050040981.1;XP_050025020.1;XP_050051411.1;XP_050040897.1;XP_050040903.1;XP_050033836.1;XP_050050507.1;XP_050050590.1;XP_050032594.1;XP_050051363.1;XP_050038305.1;XP_050026045.1;XP_050047080.1;XP_050041694.1;XP_050022816.1;XP_050026623.1;XP_050033726.1;XP_050029499.1;XP_050026624.1;XP_050022815.1;XP_050040213.1;XP_050050591.1;XP_050040980.1;XP_050040905.1;XP_050022817.1;XP_050050589.1;XP_050042083.1;XP_050031529.1;XP_050026625.1;XP_050022814.1;XP_050051364.1;XP_050040214.1;XP_050042082.1;XP_050035019.1;XP_050028746.1;XP_050033724.1;XP_050036219.1;XP_050040986.1;XP_050036728.1;XP_050041886.1;XP_050040908.1;XP_050033233.1;XP_050047090.1;XP_050042722.1;XP_050040902.1;XP_050042721.1;XP_050041695.1;XP_050042079.1;XP_050051359.1;XP_050040901.1;XP_050027718.1;XP_050047091.1;XP_050048003.1;XP_050040983.1;XP_050051365.1;XP_050022569.1;XP_050040979.1;XP_050022560.1;XP_050041885.1;XP_050040210.1;XP_050051360.1;XP_050042723.1;XP_050038602.1;XP_050040904.1;XP_050026626.1;XP_050030834.1;XP_050047081.1;XP_050040985.1;XP_050025001.1;XP_050040211.1;XP_050046003.1;XP_050033235.1
KEGG: 00510+2.4.1.144	N-Glycan biosynthesis	8	XP_050035813.1;XP_050044773.1;XP_050037949.1;XP_050037186.1;XP_050026116.1;XP_050026853.1;XP_050037187.1;XP_050022524.1
Reactome: R-HSA-450341	Activation of the AP-1 family of transcription factors	4	XP_050047598.1;XP_050023625.1;XP_050051597.1;XP_050047606.1
Reactome: R-HSA-165158	Activation of AKT2	1	XP_050032548.1
Reactome: R-HSA-5689603	UCH proteinases	80	XP_050048719.1;XP_050050373.1;XP_050039300.1;XP_050045785.1;XP_050040200.1;XP_050039302.1;XP_050052711.1;XP_050039550.1;XP_050037401.1;XP_050047703.1;XP_050034772.1;XP_050025715.1;XP_050044478.1;XP_050048416.1;XP_050025848.1;XP_050048721.1;XP_050031479.1;XP_050047181.1;XP_050044069.1;XP_050050611.1;XP_050033833.1;XP_050040277.1;XP_050039301.1;XP_050022518.1;XP_050033318.1;XP_050024749.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050037135.1;XP_050040198.1;XP_050042025.1;XP_050035481.1;XP_050039549.1;XP_050040199.1;XP_050044470.1;XP_050033331.1;XP_050048417.1;XP_050049690.1;XP_050051964.1;XP_050025777.1;XP_050035472.1;XP_050049691.1;XP_050035016.1;XP_050047809.1;XP_050048534.1;XP_050032477.1;XP_050039299.1;XP_050022938.1;XP_050035017.1;XP_050035018.1;XP_050033237.1;XP_050047705.1;XP_050045660.1;XP_050040278.1;XP_050044476.1;XP_050044469.1;XP_050052710.1;XP_050027729.1;XP_050037399.1;XP_050048824.1;XP_050033317.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050042788.1;XP_050031869.1;XP_050027134.1;XP_050037398.1;XP_050040279.1;XP_050044475.1;XP_050048012.1;XP_050048720.1;XP_050049124.1;XP_050033832.1;XP_050048823.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050036567.1
Reactome: R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	4	XP_050040824.1;XP_050052687.1;XP_050032670.1;XP_050022594.1
Reactome: R-HSA-73856	RNA Polymerase II Transcription Termination	60	XP_050029351.1;XP_050049410.1;XP_050045424.1;XP_050036363.1;XP_050048361.1;XP_050038681.1;XP_050026402.1;XP_050030603.1;XP_050040805.1;XP_050040012.1;XP_050049052.1;XP_050049520.1;XP_050038682.1;XP_050044982.1;XP_050032816.1;XP_050049409.1;XP_050029910.1;XP_050045189.1;XP_050049051.1;XP_050038680.1;XP_050035497.1;XP_050035496.1;XP_050036364.1;XP_050049523.1;XP_050029327.1;XP_050049521.1;XP_050025576.1;XP_050029923.1;XP_050048351.1;XP_050029632.1;XP_050049522.1;XP_050036485.1;XP_050047758.1;XP_050040680.1;XP_050049519.1;XP_050023014.1;XP_050044983.1;XP_050052839.1;XP_050047729.1;XP_050029925.1;XP_050047733.1;XP_050045659.1;XP_050032814.1;XP_050047730.1;XP_050047731.1;XP_050029909.1;XP_050023742.1;XP_050039198.1;XP_050049411.1;XP_050032813.1;XP_050041352.1;XP_050052835.1;XP_050030410.1;XP_050048613.1;XP_050029924.1;XP_050027597.1;XP_050048350.1;XP_050038928.1;XP_050047732.1;XP_050032815.1
Reactome: R-HSA-354192	Integrin signaling	1	XP_050032548.1
KEGG: 00562+2.7.1.153	Inositol phosphate metabolism	2	XP_050052756.1;XP_050028399.1
KEGG: 00073+1.2.1.84	Cutin, suberine and wax biosynthesis	24	XP_050038859.1;XP_050041247.1;XP_050038845.1;XP_050038846.1;XP_050039370.1;XP_050037743.1;XP_050039376.1;XP_050038844.1;XP_050038848.1;XP_050040922.1;XP_050037742.1;XP_050039214.1;XP_050038858.1;XP_050038842.1;XP_050038847.1;XP_050039377.1;XP_050039371.1;XP_050038843.1;XP_050041248.1;XP_050038856.1;XP_050038855.1;XP_050039379.1;XP_050039378.1;XP_050039773.1
Reactome: R-HSA-8863795	Downregulation of ERBB2 signaling	12	XP_050044784.1;XP_050044786.1;XP_050044781.1;XP_050051864.1;XP_050035481.1;XP_050048534.1;XP_050051868.1;XP_050048200.1;XP_050051866.1;XP_050048201.1;XP_050032720.1;XP_050051865.1
Reactome: R-HSA-70688	Proline catabolism	3	XP_050043133.1;XP_050039753.1;XP_050029177.1
MetaCyc: PWY-4702	Phytate degradation I	1	XP_050048146.1
KEGG: 00310+1.2.4.2	Lysine degradation	2	XP_050022550.1;XP_050036622.1
MetaCyc: PWY-7803	Trna splicing II	2	XP_050040962.1;XP_050040740.1
KEGG: 00710+5.3.1.1	Carbon fixation in photosynthetic organisms	1	XP_050045451.1
MetaCyc: PWY-7356	Thiamine salvage IV (yeast)	1	XP_050034132.1
MetaCyc: PWY-6842	Glutathione-mediated detoxification II	61	XP_050025458.1;XP_050029071.1;XP_050031855.1;XP_050047698.1;XP_050029052.1;XP_050025490.1;XP_050031611.1;XP_050025491.1;XP_050029057.1;XP_050048247.1;XP_050025459.1;XP_050048256.1;XP_050024015.1;XP_050031589.1;XP_050025493.1;XP_050029305.1;XP_050025460.1;XP_050025650.1;XP_050029960.1;XP_050029053.1;XP_050029059.1;XP_050025461.1;XP_050047714.1;XP_050029072.1;XP_050027823.1;XP_050022874.1;XP_050043741.1;XP_050029055.1;XP_050030373.1;XP_050029056.1;XP_050024805.1;XP_050031599.1;XP_050043742.1;XP_050029240.1;XP_050048220.1;XP_050025508.1;XP_050050544.1;XP_050050545.1;XP_050047905.1;XP_050048233.1;XP_050052719.1;XP_050029054.1;XP_050024014.1;XP_050023398.1;XP_050031872.1;XP_050048267.1;XP_050052721.1;XP_050028992.1;XP_050025413.1;XP_050026762.1;XP_050029058.1;XP_050027833.1;XP_050047704.1;XP_050025457.1;XP_050025489.1;XP_050036058.1;XP_050025492.1;XP_050030014.1;XP_050030123.1;XP_050052715.1;XP_050052716.1
MetaCyc: PWY-2942	L-lysine biosynthesis III	1	XP_050045137.1
KEGG: 04150+2.7.11.24	mTOR signaling pathway	10	XP_050033244.1;XP_050051597.1;XP_050033239.1;XP_050033241.1;XP_050033240.1;XP_050033242.1;XP_050047606.1;XP_050045063.1;XP_050033243.1;XP_050047598.1
KEGG: 00190+3.6.1.1	Oxidative phosphorylation	7	XP_050052520.1;XP_050034244.1;XP_050052518.1;XP_050034243.1;XP_050034246.1;XP_050052521.1;XP_050034245.1
KEGG: 00130+2.6.1.5	Ubiquinone and other terpenoid-quinone biosynthesis	3	XP_050031962.1;XP_050049181.1;XP_050049182.1
Reactome: R-HSA-9027277	Erythropoietin activates Phospholipase C gamma (PLCG)	2	XP_050048141.1;XP_050048140.1
Reactome: R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	29	XP_050038469.1;XP_050023730.1;XP_050025563.1;XP_050045300.1;XP_050034643.1;XP_050047361.1;XP_050040427.1;XP_050040428.1;XP_050034644.1;XP_050023776.1;XP_050023729.1;XP_050037136.1;XP_050046063.1;XP_050023726.1;XP_050041013.1;XP_050046123.1;XP_050033368.1;XP_050033935.1;XP_050023728.1;XP_050044010.1;XP_050023779.1;XP_050023724.1;XP_050037137.1;XP_050043147.1;XP_050023777.1;XP_050035378.1;XP_050023725.1;XP_050023727.1;XP_050024189.1
Reactome: R-HSA-9613829	Chaperone Mediated Autophagy	3	XP_050023674.1;XP_050035481.1;XP_050048534.1
Reactome: R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	2	XP_050026573.1;XP_050026574.1
MetaCyc: PWY-5971	Palmitate biosynthesis II (bacteria and plant cytoplasm)	4	XP_050033009.1;XP_050032773.1;XP_050033008.1;XP_050029751.1
KEGG: 00250+4.3.2.2	Alanine, aspartate and glutamate metabolism	1	XP_050030286.1
Reactome: R-HSA-72764	Eukaryotic Translation Termination	96	XP_050045969.1;XP_050032598.1;XP_050050940.1;XP_050023058.1;XP_050039340.1;XP_050035481.1;XP_050049831.1;XP_050026018.1;XP_050043918.1;XP_050027304.1;XP_050032330.1;XP_050040677.1;XP_050032793.1;XP_050043917.1;XP_050022853.1;XP_050047002.1;XP_050031230.1;XP_050032599.1;XP_050028604.1;XP_050052131.1;XP_050027305.1;XP_050051569.1;XP_050044445.1;XP_050045196.1;XP_050032921.1;XP_050039285.1;XP_050024740.1;XP_050032331.1;XP_050049170.1;XP_050032936.1;XP_050031861.1;XP_050023492.1;XP_050022748.1;XP_050045970.1;XP_050026103.1;XP_050034868.1;XP_050032528.1;XP_050026722.1;XP_050039286.1;XP_050036005.1;XP_050043916.1;XP_050046934.1;XP_050052130.1;XP_050027477.1;XP_050042319.1;XP_050025636.1;XP_050050516.1;XP_050032267.1;XP_050049830.1;XP_050043803.1;XP_050049776.1;XP_050029380.1;XP_050038550.1;XP_050028344.1;XP_050044122.1;XP_050043802.1;XP_050029851.1;XP_050038626.1;XP_050043804.1;XP_050035484.1;XP_050029850.1;XP_050033573.1;XP_050039997.1;XP_050028191.1;XP_050031153.1;XP_050043919.1;XP_050032688.1;XP_050048062.1;XP_050036006.1;XP_050052202.1;XP_050046933.1;XP_050028318.1;XP_050049373.1;XP_050052201.1;XP_050023059.1;XP_050044593.1;XP_050026723.1;XP_050040632.1;XP_050033913.1;XP_050039882.1;XP_050042714.1;XP_050027435.1;XP_050048060.1;XP_050044680.1;XP_050048061.1;XP_050052117.1;XP_050039129.1;XP_050035149.1;XP_050041753.1;XP_050026721.1;XP_050041744.1;XP_050048534.1;XP_050029294.1;XP_050035483.1;XP_050052195.1;XP_050041323.1
KEGG: 00562+2.7.1.158	Inositol phosphate metabolism	1	XP_050026059.1
MetaCyc: PWY-381	Nitrate reduction II (assimilatory)	11	XP_050038621.1;XP_050038620.1;XP_050038619.1;XP_050038622.1;XP_050028873.1;XP_050051950.1;XP_050033588.1;XP_050038618.1;XP_050028874.1;XP_050028876.1;XP_050033589.1
MetaCyc: PWY-6692	Fe(II) oxidation	3	XP_050047841.1;YP_010283869.1;YP_010283878.1
Reactome: R-HSA-5683371	Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7)	1	XP_050043445.1
KEGG: 00400+1.14.16.1	Phenylalanine, tyrosine and tryptophan biosynthesis	1	XP_050047981.1
Reactome: R-HSA-3299685	Detoxification of Reactive Oxygen Species	42	XP_050027433.1;XP_050034716.1;XP_050047036.1;XP_050028343.1;XP_050042153.1;XP_050032053.1;XP_050052141.1;XP_050025841.1;XP_050044924.1;XP_050052134.1;XP_050048386.1;XP_050023553.1;XP_050047035.1;XP_050047553.1;XP_050042152.1;XP_050025838.1;XP_050052655.1;XP_050042018.1;XP_050026032.1;XP_050047038.1;XP_050052656.1;XP_050052142.1;XP_050045633.1;XP_050048385.1;XP_050047037.1;XP_050049549.1;XP_050047042.1;XP_050032314.1;XP_050025840.1;XP_050051422.1;XP_050047034.1;XP_050042154.1;XP_050047041.1;XP_050047040.1;XP_050032645.1;XP_050023549.1;XP_050048505.1;XP_050049354.1;XP_050052657.1;XP_050026849.1;XP_050047039.1;XP_050037110.1
Reactome: R-HSA-2024096	HS-GAG degradation	14	XP_050024093.1;XP_050034457.1;XP_050042169.1;XP_050045117.1;XP_050043439.1;XP_050029775.1;XP_050049087.1;XP_050043294.1;XP_050025072.1;XP_050040600.1;XP_050039341.1;XP_050040138.1;XP_050029774.1;XP_050028547.1
MetaCyc: PWY-801	Homocysteine and cysteine interconversion	11	XP_050052715.1;XP_050052716.1;XP_050052719.1;XP_050035467.1;XP_050050545.1;XP_050050544.1;XP_050035464.1;XP_050035465.1;XP_050052721.1;XP_050035463.1;XP_050035466.1
KEGG: 00970+6.1.1.2	Aminoacyl-tRNA biosynthesis	2	XP_050026443.1;XP_050047848.1
Reactome: R-HSA-9037629	Lewis blood group biosynthesis	47	XP_050039394.1;XP_050024273.1;XP_050048405.1;XP_050039399.1;XP_050039396.1;XP_050050343.1;XP_050028977.1;XP_050040650.1;XP_050032740.1;XP_050051471.1;XP_050049822.1;XP_050029741.1;XP_050048406.1;XP_050023275.1;XP_050050595.1;XP_050029740.1;XP_050043380.1;XP_050041796.1;XP_050039393.1;XP_050038327.1;XP_050023203.1;XP_050052631.1;XP_050052630.1;XP_050050606.1;XP_050050345.1;XP_050047475.1;XP_050041799.1;XP_050048919.1;XP_050028486.1;XP_050049823.1;XP_050049824.1;XP_050032741.1;XP_050041797.1;XP_050028752.1;XP_050039397.1;XP_050028967.1;XP_050052502.1;XP_050023445.1;XP_050040649.1;XP_050043378.1;XP_050039398.1;XP_050048407.1;XP_050044858.1;XP_050041798.1;XP_050039395.1;XP_050052632.1;XP_050046465.1
KEGG: 00051+2.7.1.105+3.1.3.46	Fructose and mannose metabolism	11	XP_050030795.1;XP_050030805.1;XP_050030802.1;XP_050030803.1;XP_050030801.1;XP_050030799.1;XP_050030798.1;XP_050030796.1;XP_050030797.1;XP_050030804.1;XP_050030800.1
Reactome: R-HSA-3000484	Scavenging by Class F Receptors	12	XP_050042260.1;XP_050042242.1;XP_050042262.1;XP_050042241.1;XP_050042261.1;XP_050023334.1;XP_050042454.1;XP_050023312.1;XP_050042240.1;XP_050023422.1;XP_050023796.1;XP_050023809.1
KEGG: 00900+4.1.1.33	Terpenoid backbone biosynthesis	2	XP_050051831.1;XP_050051832.1
Reactome: R-HSA-418592	ADP signalling through P2Y purinoceptor 1	7	XP_050035408.1;XP_050035407.1;XP_050025622.1;XP_050023177.1;XP_050042122.1;XP_050025623.1;XP_050044424.1
Reactome: R-HSA-5621575	CD209 (DC-SIGN) signaling	9	XP_050042105.1;XP_050042109.1;XP_050042112.1;XP_050038602.1;XP_050042111.1;XP_050042110.1;XP_050042106.1;XP_050042107.1;XP_050042108.1
Reactome: R-HSA-110329	Cleavage of the damaged pyrimidine	18	XP_050030582.1;XP_050026313.1;XP_050025266.1;XP_050030583.1;XP_050049035.1;XP_050025244.1;XP_050052047.1;XP_050049036.1;XP_050025248.1;XP_050034158.1;XP_050038213.1;XP_050034157.1;XP_050025243.1;XP_050036268.1;XP_050038199.1;XP_050025763.1;XP_050034159.1;XP_050030584.1
MetaCyc: PWY-6901	Superpathway of glucose and xylose degradation	9	XP_050038973.1;XP_050034255.1;XP_050038972.1;XP_050041668.1;XP_050034254.1;XP_050034253.1;XP_050041662.1;XP_050044976.1;XP_050051894.1
KEGG: 00950+2.6.1.5	Isoquinoline alkaloid biosynthesis	3	XP_050049181.1;XP_050049182.1;XP_050031962.1
Reactome: R-HSA-189483	Heme degradation	1	XP_050024072.1
Reactome: R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	40	XP_050026810.1;XP_050033146.1;XP_050046156.1;XP_050035932.1;XP_050026809.1;XP_050023718.1;XP_050038862.1;XP_050029516.1;XP_050044008.1;XP_050023476.1;XP_050038866.1;XP_050049051.1;XP_050045189.1;XP_050038968.1;XP_050030653.1;XP_050049377.1;XP_050042392.1;XP_050023475.1;XP_050049052.1;XP_050038865.1;XP_050035770.1;XP_050024518.1;XP_050038864.1;XP_050025064.1;XP_050036827.1;XP_050039240.1;XP_050038967.1;XP_050030652.1;XP_050030506.1;XP_050038969.1;XP_050030507.1;XP_050038966.1;XP_050036430.1;XP_050023474.1;XP_050030942.1;XP_050038863.1;XP_050038895.1;XP_050042391.1;XP_050035933.1;XP_050029515.1
Reactome: R-HSA-4641257	Degradation of AXIN	56	XP_050047181.1;XP_050044469.1;XP_050032733.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050033318.1;XP_050037398.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050031786.1;XP_050027118.1;XP_050040198.1;XP_050049124.1;XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050036567.1;XP_050033331.1;XP_050035472.1;XP_050051964.1;XP_050048719.1;XP_050047809.1;XP_050045785.1;XP_050050373.1;XP_050032477.1;XP_050048534.1;XP_050040200.1;XP_050049277.1;XP_050022938.1;XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050044478.1;XP_050031585.1;XP_050045660.1;XP_050031586.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050044476.1
Reactome: R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	21	XP_050043905.1;XP_050043904.1;XP_050044153.1;XP_050033575.1;XP_050048111.1;XP_050042485.1;XP_050041327.1;XP_050043907.1;XP_050049526.1;XP_050046782.1;XP_050043906.1;XP_050026292.1;XP_050033577.1;XP_050048112.1;XP_050033574.1;XP_050033576.1;XP_050041328.1;XP_050045149.1;XP_050036596.1;XP_050027462.1;XP_050037157.1
KEGG: 00511+3.2.1.23	Other glycan degradation	20	XP_050042181.1;XP_050042167.1;XP_050042180.1;XP_050042178.1;XP_050038798.1;XP_050039611.1;XP_050042438.1;XP_050042439.1;XP_050042437.1;XP_050042169.1;XP_050042179.1;XP_050039612.1;XP_050038908.1;XP_050042175.1;XP_050040162.1;XP_050040161.1;XP_050042436.1;XP_050042177.1;XP_050045117.1;XP_050042176.1
KEGG: 00062+4.2.1.134	Fatty acid elongation	2	XP_050042358.1;XP_050045032.1
Reactome: R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	76	XP_050031537.1;XP_050047372.1;XP_050022602.1;XP_050044530.1;XP_050046392.1;XP_050026954.1;XP_050042401.1;XP_050022603.1;XP_050037414.1;XP_050047375.1;XP_050047371.1;XP_050045373.1;XP_050023695.1;XP_050049295.1;XP_050022605.1;XP_050022604.1;XP_050049294.1;XP_050034960.1;XP_050029852.1;XP_050034518.1;XP_050042755.1;XP_050044807.1;XP_050047373.1;XP_050048896.1;XP_050038988.1;XP_050026955.1;XP_050036381.1;XP_050050532.1;XP_050034961.1;XP_050022980.1;XP_050034639.1;XP_050035481.1;XP_050046688.1;XP_050044213.1;XP_050031535.1;XP_050026035.1;XP_050038612.1;XP_050046062.1;XP_050046064.1;XP_050023494.1;XP_050044532.1;XP_050032647.1;XP_050045052.1;XP_050048534.1;XP_050044529.1;XP_050033903.1;XP_050049297.1;XP_050049296.1;XP_050050310.1;XP_050033904.1;XP_050051335.1;XP_050028292.1;XP_050051336.1;XP_050044525.1;XP_050025144.1;XP_050035537.1;XP_050051200.1;XP_050022606.1;XP_050032071.1;XP_050047374.1;XP_050031536.1;XP_050044528.1;XP_050045930.1;XP_050028323.1;XP_050022581.1;XP_050045372.1;XP_050051397.1;XP_050029342.1;XP_050048499.1;XP_050044695.1;XP_050044524.1;XP_050044531.1;XP_050044527.1;XP_050032478.1;XP_050042307.1;XP_050047551.1
Reactome: R-HSA-9664565	Signaling by ERBB2 KD Mutants	10	XP_050051865.1;XP_050048201.1;XP_050051866.1;XP_050048200.1;XP_050051868.1;XP_050032853.1;XP_050044781.1;XP_050051864.1;XP_050044786.1;XP_050044784.1
KEGG: 00270+6.3.2.2	Cysteine and methionine metabolism	2	XP_050027889.1;XP_050026350.1
Reactome: R-HSA-5173105	O-linked glycosylation	10	XP_050051992.1;XP_050051991.1;XP_050036875.1;XP_050037277.1;XP_050038650.1;XP_050027018.1;XP_050039591.1;XP_050028252.1;XP_050023266.1;XP_050047045.1
Reactome: R-HSA-350054	Notch-HLH transcription pathway	22	XP_050027120.1;XP_050050843.1;XP_050027119.1;XP_050051590.1;XP_050044796.1;XP_050031442.1;XP_050050621.1;XP_050041140.1;XP_050038799.1;XP_050031443.1;XP_050031360.1;XP_050023569.1;XP_050032607.1;XP_050027121.1;XP_050041139.1;XP_050044795.1;XP_050045588.1;XP_050044797.1;XP_050041141.1;XP_050051588.1;XP_050023568.1;XP_050045648.1
Reactome: R-HSA-2468052	Establishment of Sister Chromatid Cohesion	14	XP_050047136.1;XP_050028218.1;XP_050028217.1;XP_050040052.1;XP_050047138.1;XP_050047137.1;XP_050031575.1;XP_050040049.1;XP_050040054.1;XP_050040143.1;XP_050040050.1;XP_050040051.1;XP_050047139.1;XP_050052697.1
KEGG: 00052+3.2.1.23	Galactose metabolism	20	XP_050039612.1;XP_050042179.1;XP_050042169.1;XP_050042437.1;XP_050042439.1;XP_050042438.1;XP_050039611.1;XP_050038798.1;XP_050042178.1;XP_050042167.1;XP_050042180.1;XP_050042181.1;XP_050042176.1;XP_050045117.1;XP_050042436.1;XP_050042177.1;XP_050040161.1;XP_050040162.1;XP_050042175.1;XP_050038908.1
Reactome: R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	29	XP_050034644.1;XP_050023776.1;XP_050047361.1;XP_050040427.1;XP_050040428.1;XP_050023730.1;XP_050025563.1;XP_050045300.1;XP_050034643.1;XP_050038469.1;XP_050024189.1;XP_050037137.1;XP_050023724.1;XP_050043147.1;XP_050023777.1;XP_050035378.1;XP_050023725.1;XP_050023727.1;XP_050044010.1;XP_050023779.1;XP_050023729.1;XP_050046063.1;XP_050037136.1;XP_050023726.1;XP_050041013.1;XP_050046123.1;XP_050033368.1;XP_050033935.1;XP_050023728.1
Reactome: R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	44	XP_050045183.1;XP_050038335.1;XP_050045633.1;XP_050029578.1;XP_050045187.1;XP_050045185.1;XP_050032314.1;XP_050049130.1;XP_050045181.1;XP_050033235.1;XP_050045188.1;XP_050033233.1;XP_050042079.1;XP_050047090.1;XP_050045182.1;XP_050047091.1;XP_050048189.1;XP_050038333.1;XP_050045186.1;XP_050034501.1;XP_050030846.1;XP_050042082.1;XP_050040549.1;XP_050024400.1;XP_050048188.1;XP_050028343.1;XP_050050603.1;XP_050052134.1;XP_050031490.1;XP_050031832.1;XP_050042080.1;XP_050033234.1;XP_050033232.1;XP_050045180.1;XP_050047553.1;XP_050042081.1;XP_050031330.1;XP_050043924.1;XP_050042083.1;XP_050038334.1;XP_050051792.1;XP_050045184.1;XP_050031529.1;XP_050043887.1
KEGG: 00627+3.6.1.7	Aminobenzoate degradation	3	XP_050045973.1;XP_050045972.1;XP_050045971.1
Reactome: R-HSA-114508	Effects of PIP2 hydrolysis	23	XP_050048424.1;XP_050035431.1;XP_050026074.1;XP_050046068.1;XP_050044041.1;XP_050035430.1;XP_050035432.1;XP_050035434.1;XP_050033083.1;XP_050036247.1;XP_050035435.1;XP_050035433.1;XP_050026073.1;XP_050025879.1;XP_050046067.1;XP_050035429.1;XP_050048427.1;XP_050048423.1;XP_050036246.1;XP_050048426.1;XP_050033084.1;XP_050044042.1;XP_050048425.1
KEGG: 00330+3.5.3.11	Arginine and proline metabolism	1	XP_050047167.1
MetaCyc: PWY-7158	L-phenylalanine degradation V	2	XP_050034971.1;XP_050047981.1
MetaCyc: PWY-7082	Ammonia oxidation IV (autotrophic ammonia oxidizers)	1	XP_050047841.1
MetaCyc: PWY-7851	Coenzyme A biosynthesis II (eukaryotic)	3	XP_050044452.1;XP_050026513.1;XP_050044453.1
KEGG: 00240+2.4.2.1	Pyrimidine metabolism	3	XP_050035831.1;XP_050046554.1;XP_050046556.1
Reactome: R-HSA-427601	Multifunctional anion exchangers	5	XP_050046740.1;XP_050024653.1;XP_050024651.1;XP_050024652.1;XP_050024650.1
Reactome: R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	1	XP_050036540.1
MetaCyc: PWY-5497	Purine nucleobases degradation II (anaerobic)	7	XP_050052682.1;XP_050032637.1;XP_050048637.1;XP_050045421.1;XP_050034367.1;XP_050052683.1;XP_050032636.1
KEGG: 00908+2.5.1.75	Zeatin biosynthesis	1	XP_050031168.1
Reactome: R-HSA-390450	Folding of actin by CCT/TriC	9	XP_050044826.1;XP_050045149.1;XP_050048111.1;XP_050037157.1;XP_050034746.1;XP_050034156.1;XP_050026292.1;XP_050044153.1;XP_050048112.1
KEGG: 00040+2.7.7.9	Pentose and glucuronate interconversions	4	XP_050037411.1;XP_050037412.1;XP_050037409.1;XP_050037410.1
Reactome: R-HSA-156711	Polo-like kinase mediated events	7	XP_050027568.1;XP_050027567.1;XP_050027566.1;XP_050039527.1;XP_050026017.1;XP_050036138.1;XP_050039528.1
KEGG: 00514+2.4.1.109	Other types of O-glycan biosynthesis	12	XP_050051991.1;XP_050046831.1;XP_050023434.1;XP_050046070.1;XP_050051992.1;XP_050041249.1;XP_050024005.1;XP_050041250.1;XP_050024120.1;XP_050024010.1;XP_050037277.1;XP_050046071.1
MetaCyc: PWY-7077	N-acetyl-D-galactosamine degradation	3	XP_050038837.1;XP_050038836.1;XP_050038838.1
MetaCyc: PWY-7277	Sphingolipid biosynthesis (mammals)	1	XP_050028497.1
Reactome: R-HSA-111458	Formation of apoptosome	13	XP_050047553.1;XP_050030062.1;XP_050030063.1;XP_050040075.1;XP_050030255.1;XP_050030061.1;XP_050045633.1;XP_050030254.1;XP_050030252.1;XP_050030253.1;XP_050030251.1;XP_050052134.1;XP_050036557.1
Reactome: R-HSA-8866427	VLDLR internalisation and degradation	4	XP_050037100.1;XP_050028603.1;XP_050040246.1;XP_050048294.1
KEGG: 00561+3.1.1.3	Glycerolipid metabolism	7	XP_050047992.1;XP_050047989.1;XP_050023765.1;XP_050046664.1;XP_050023764.1;XP_050047993.1;XP_050047990.1
KEGG: 00760+2.4.2.19	Nicotinate and nicotinamide metabolism	4	XP_050042247.1;XP_050042256.1;XP_050042265.1;XP_050042238.1
MetaCyc: PWY-5133	Colupulone and cohumulone biosynthesis	3	XP_050040406.1;XP_050044794.1;XP_050030604.1
Reactome: R-HSA-1237112	Methionine salvage pathway	19	XP_050045631.1;XP_050038461.1;XP_050030253.1;XP_050030254.1;XP_050024914.1;XP_050024913.1;XP_050026779.1;XP_050038462.1;XP_050024912.1;XP_050030062.1;XP_050039079.1;XP_050030252.1;XP_050023175.1;XP_050030251.1;XP_050030255.1;XP_050030061.1;XP_050026778.1;XP_050030063.1;XP_050023174.1
KEGG: 00510+2.4.1.258	N-Glycan biosynthesis	1	XP_050025367.1
KEGG: 00860+1.16.3.1	Porphyrin and chlorophyll metabolism	2	XP_050045507.1;XP_050045508.1
Reactome: R-HSA-9610379	HCMV Late Events	59	XP_050044202.1;XP_050035933.1;XP_050038213.1;XP_050025248.1;XP_050029515.1;XP_050052234.1;XP_050052196.1;XP_050023474.1;XP_050051774.1;XP_050036430.1;XP_050042391.1;XP_050038895.1;XP_050030942.1;XP_050038863.1;XP_050038767.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050044203.1;XP_050050057.1;XP_050038966.1;XP_050030507.1;XP_050038967.1;XP_050036827.1;XP_050039240.1;XP_050025064.1;XP_050025244.1;XP_050040730.1;XP_050030675.1;XP_050050066.1;XP_050035770.1;XP_050038865.1;XP_050036268.1;XP_050025243.1;XP_050027404.1;XP_050038864.1;XP_050024518.1;XP_050023475.1;XP_050042392.1;XP_050038199.1;XP_050038989.1;XP_050023476.1;XP_050044008.1;XP_050030653.1;XP_050049377.1;XP_050025266.1;XP_050038968.1;XP_050038866.1;XP_050025018.1;XP_050033146.1;XP_050044204.1;XP_050026810.1;XP_050038862.1;XP_050029516.1;XP_050023718.1;XP_050046156.1;XP_050025017.1;XP_050035932.1;XP_050026809.1
Reactome: R-HSA-4655427	SUMOylation of DNA methylation proteins	8	XP_050042802.1;XP_050031628.1;XP_050043472.1;XP_050043471.1;XP_050030757.1;XP_050043468.1;XP_050043470.1;XP_050043469.1
Reactome: R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	1	XP_050036540.1
KEGG: 00620+1.8.1.4	Pyruvate metabolism	1	XP_050026566.1
MetaCyc: PWY-5744	Glyoxylate assimilation	22	XP_050048467.1;XP_050048461.1;XP_050034249.1;XP_050049116.1;XP_050049115.1;XP_050025446.1;XP_050048466.1;XP_050022903.1;XP_050048458.1;XP_050022906.1;XP_050038033.1;XP_050048468.1;XP_050048462.1;XP_050048456.1;XP_050045094.1;XP_050048457.1;XP_050048463.1;XP_050048460.1;XP_050048459.1;XP_050048465.1;XP_050022895.1;XP_050049114.1
KEGG: 00532+2.4.2.26	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3	XP_050032785.1;XP_050032783.1;XP_050032784.1
MetaCyc: PWY-7511	Protein ubiquitination	224	XP_050039428.1;XP_050049698.1;XP_050041907.1;XP_050037285.1;XP_050043143.1;XP_050024516.1;XP_050051233.1;XP_050051600.1;XP_050050488.1;XP_050031040.1;XP_050046084.1;XP_050032706.1;XP_050037313.1;XP_050048503.1;XP_050031035.1;XP_050031041.1;XP_050024301.1;XP_050050513.1;XP_050037722.1;XP_050026890.1;XP_050027443.1;XP_050038964.1;XP_050027436.1;XP_050040089.1;XP_050037844.1;XP_050045361.1;XP_050026808.1;XP_050027445.1;XP_050049433.1;XP_050032992.1;XP_050031585.1;XP_050037311.1;XP_050047794.1;XP_050032610.1;XP_050022746.1;XP_050023299.1;XP_050037314.1;XP_050050553.1;XP_050031586.1;XP_050047965.1;XP_050037316.1;XP_050024067.1;XP_050050492.1;XP_050046081.1;XP_050025877.1;XP_050052018.1;XP_050046077.1;XP_050041478.1;XP_050022757.1;XP_050022943.1;XP_050041504.1;XP_050041078.1;XP_050041483.1;XP_050041794.1;XP_050037315.1;XP_050049259.1;XP_050041080.1;XP_050045838.1;XP_050040090.1;XP_050027441.1;XP_050045012.1;XP_050049775.1;XP_050045358.1;XP_050032608.1;XP_050047461.1;XP_050032705.1;XP_050047793.1;XP_050050558.1;XP_050052025.1;XP_050045011.1;XP_050044211.1;XP_050031152.1;XP_050052022.1;XP_050032703.1;XP_050023745.1;XP_050048953.1;XP_050046970.1;XP_050027438.1;XP_050031904.1;XP_050029873.1;XP_050030381.1;XP_050026446.1;XP_050032065.1;XP_050046078.1;XP_050048419.1;XP_050045359.1;XP_050046076.1;XP_050040091.1;XP_050041491.1;XP_050026807.1;XP_050030321.1;XP_050028689.1;XP_050031043.1;XP_050025302.1;XP_050027437.1;XP_050052821.1;XP_050043144.1;XP_050050557.1;XP_050039971.1;XP_050044006.1;XP_050049399.1;XP_050050552.1;XP_050034959.1;XP_050027442.1;XP_050030330.1;XP_050023491.1;XP_050027439.1;XP_050025301.1;XP_050022942.1;XP_050047795.1;XP_050050921.1;XP_050046311.1;XP_050023285.1;XP_050031595.1;XP_050046075.1;XP_050035687.1;XP_050032704.1;XP_050038774.1;XP_050023046.1;XP_050040247.1;XP_050050561.1;XP_050051599.1;XP_050048420.1;XP_050051234.1;XP_050047955.1;XP_050044220.1;XP_050023531.1;XP_050046911.1;XP_050042966.1;XP_050041911.1;XP_050050509.1;XP_050034834.1;XP_050036253.1;XP_050052023.1;XP_050043145.1;XP_050045008.1;XP_050046080.1;XP_050024198.1;XP_050038032.1;XP_050051598.1;XP_050050560.1;XP_050025077.1;XP_050039353.1;XP_050052019.1;XP_050041909.1;XP_050023286.1;XP_050031158.1;XP_050040440.1;XP_050048137.1;XP_050023647.1;XP_050046475.1;XP_050031044.1;XP_050050511.1;XP_050023140.1;XP_050049030.1;XP_050022940.1;XP_050027440.1;XP_050050510.1;XP_050049349.1;XP_050041910.1;XP_050047840.1;XP_050022747.1;XP_050036741.1;XP_050052024.1;XP_050051602.1;XP_050038963.1;XP_050030331.1;XP_050023532.1;XP_050038965.1;XP_050052020.1;XP_050049837.1;XP_050023141.1;XP_050048132.1;XP_050028790.1;XP_050045360.1;XP_050044005.1;XP_050040110.1;XP_050029872.1;XP_050045014.1;XP_050023161.1;XP_050027602.1;XP_050034306.1;XP_050044212.1;XP_050051601.1;XP_050051387.1;XP_050046085.1;XP_050049355.1;XP_050041510.1;XP_050031905.1;XP_050031594.1;XP_050050551.1;XP_050032078.1;XP_050049432.1;XP_050043146.1;XP_050032720.1;XP_050032745.1;XP_050045013.1;XP_050047796.1;XP_050044007.1;XP_050051383.1;XP_050032609.1;XP_050049111.1;XP_050039437.1;XP_050022883.1;XP_050041495.1;XP_050024877.1;XP_050045009.1;XP_050040463.1;XP_050027444.1;XP_050023529.1;XP_050023637.1;XP_050022941.1;XP_050031628.1;XP_050052017.1;XP_050037310.1;XP_050023300.1;XP_050022888.1;XP_050026806.1;XP_050035101.1;XP_050049340.1;XP_050023284.1;XP_050037312.1;XP_050041079.1;XP_050048418.1
MetaCyc: PWY-5122	Geranyl diphosphate biosynthesis	1	XP_050023623.1
Reactome: R-HSA-2214320	Anchoring fibril formation	3	XP_050052132.1;XP_050051572.1;XP_050052245.1
Reactome: R-HSA-1855231	Synthesis of IPs in the ER lumen	3	XP_050029736.1;XP_050029737.1;XP_050029738.1
Reactome: R-HSA-72086	mRNA Capping	30	XP_050046063.1;XP_050037136.1;XP_050023729.1;XP_050023728.1;XP_050033935.1;XP_050033368.1;XP_050046123.1;XP_050041013.1;XP_050023726.1;XP_050023779.1;XP_050044010.1;XP_050035378.1;XP_050023777.1;XP_050043147.1;XP_050023725.1;XP_050023727.1;XP_050037137.1;XP_050023724.1;XP_050024189.1;XP_050038469.1;XP_050045300.1;XP_050023730.1;XP_050025563.1;XP_050034643.1;XP_050040427.1;XP_050047361.1;XP_050040428.1;XP_050034644.1;XP_050045189.1;XP_050023776.1
Reactome: R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	28	XP_050044695.1;XP_050047604.1;XP_050045274.1;XP_050032478.1;XP_050024885.1;XP_050022605.1;XP_050022604.1;XP_050046064.1;XP_050047551.1;XP_050048786.1;XP_050028323.1;XP_050022581.1;XP_050022603.1;XP_050028292.1;XP_050037414.1;XP_050044213.1;XP_050038612.1;XP_050048499.1;XP_050033903.1;XP_050039624.1;XP_050033904.1;XP_050041012.1;XP_050037711.1;XP_050045930.1;XP_050032647.1;XP_050022602.1;XP_050022606.1;XP_050048896.1
MetaCyc: PWY-5384	Sucrose degradation IV (sucrose phosphorylase)	1	XP_050050068.1
MetaCyc: PWY-7159	3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent)	2	XP_050034747.1;XP_050034748.1
Reactome: R-HSA-8939902	Regulation of RUNX2 expression and activity	58	XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050044478.1;XP_050045660.1;XP_050034772.1;XP_050025715.1;XP_050047670.1;XP_050037401.1;XP_050033237.1;XP_050022938.1;XP_050040200.1;XP_050050373.1;XP_050045785.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050048719.1;XP_050047809.1;XP_050036567.1;XP_050033331.1;XP_050040624.1;XP_050035472.1;XP_050051964.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050044470.1;XP_050052231.1;XP_050029802.1;XP_050050645.1;XP_050040198.1;XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050049124.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050027118.1;XP_050043507.1;XP_050031786.1;XP_050042788.1;XP_050047422.1;XP_050022518.1;XP_050027134.1;XP_050032720.1;XP_050037398.1;XP_050033318.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050044469.1;XP_050047181.1
Reactome: R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	13	XP_050024731.1;XP_050048357.1;XP_050047998.1;XP_050048775.1;XP_050047994.1;XP_050047995.1;XP_050047997.1;XP_050047996.1;XP_050048776.1;XP_050048777.1;XP_050044843.1;XP_050050021.1;XP_050024722.1
Reactome: R-HSA-418346	Platelet homeostasis	3	XP_050025123.1;XP_050025135.1;XP_050025138.1
Reactome: R-HSA-1475029	Reversible hydration of carbon dioxide	8	XP_050025446.1;XP_050049115.1;XP_050049116.1;XP_050049114.1;XP_050038033.1;XP_050022895.1;XP_050022906.1;XP_050022903.1
Reactome: R-HSA-9619483	Activation of AMPK downstream of NMDARs	28	XP_050043181.1;XP_050049758.1;XP_050034639.1;XP_050046735.1;XP_050042307.1;XP_050044532.1;XP_050049757.1;XP_050039380.1;XP_050044524.1;XP_050044525.1;XP_050051356.1;XP_050024840.1;XP_050051357.1;XP_050044531.1;XP_050044527.1;XP_050052420.1;XP_050049762.1;XP_050046734.1;XP_050051355.1;XP_050044530.1;XP_050052055.1;XP_050044529.1;XP_050039381.1;XP_050044528.1;XP_050047338.1;XP_050049759.1;XP_050024841.1;XP_050049761.1
MetaCyc: PWY-5826	Hypoglycin biosynthesis	42	XP_050024014.1;XP_050029054.1;XP_050031599.1;XP_050043742.1;XP_050024805.1;XP_050029240.1;XP_050029056.1;XP_050030373.1;XP_050025508.1;XP_050030014.1;XP_050025492.1;XP_050036058.1;XP_050025457.1;XP_050025489.1;XP_050030123.1;XP_050023398.1;XP_050029058.1;XP_050025413.1;XP_050028992.1;XP_050024015.1;XP_050031589.1;XP_050025459.1;XP_050029305.1;XP_050025460.1;XP_050025493.1;XP_050025458.1;XP_050029057.1;XP_050025491.1;XP_050025490.1;XP_050029052.1;XP_050031611.1;XP_050029071.1;XP_050029072.1;XP_050029055.1;XP_050043741.1;XP_050027823.1;XP_050022874.1;XP_050029059.1;XP_050029053.1;XP_050029960.1;XP_050025650.1;XP_050025461.1
Reactome: R-HSA-9022699	MECP2 regulates neuronal receptors and channels	3	XP_050035889.1;XP_050031707.1;XP_050035890.1
KEGG: 00230+2.7.1.20	Purine metabolism	2	XP_050050828.1;XP_050050829.1
KEGG: 00680+4.2.1.11	Methane metabolism	1	XP_050051894.1
Reactome: R-HSA-112412	SOS-mediated signalling	1	XP_050032853.1
Reactome: R-HSA-113418	Formation of the Early Elongation Complex	38	XP_050034644.1;XP_050045189.1;XP_050023776.1;XP_050047361.1;XP_050045300.1;XP_050030810.1;XP_050024189.1;XP_050030811.1;XP_050023777.1;XP_050023727.1;XP_050035378.1;XP_050023724.1;XP_050030280.1;XP_050039485.1;XP_050044010.1;XP_050023577.1;XP_050037136.1;XP_050047588.1;XP_050023728.1;XP_050046123.1;XP_050039484.1;XP_050040427.1;XP_050040428.1;XP_050043138.1;XP_050023730.1;XP_050025563.1;XP_050034643.1;XP_050038469.1;XP_050025635.1;XP_050023576.1;XP_050043147.1;XP_050023725.1;XP_050037137.1;XP_050023779.1;XP_050046063.1;XP_050023729.1;XP_050033368.1;XP_050023726.1
KEGG: 00970+6.1.1.17	Aminoacyl-tRNA biosynthesis	2	XP_050028841.1;XP_050044097.1
Reactome: R-HSA-392451	G beta:gamma signalling through PI3Kgamma	8	XP_050048619.1;XP_050025623.1;XP_050048621.1;XP_050048620.1;XP_050023177.1;XP_050032548.1;XP_050044424.1;XP_050025622.1
KEGG: 00750+2.6.1.52	Vitamin B6 metabolism	2	XP_050034258.1;XP_050034259.1
Reactome: R-HSA-9614657	FOXO-mediated transcription of cell death genes	9	XP_050040210.1;XP_050026954.1;XP_050040212.1;XP_050040214.1;XP_050040213.1;XP_050038602.1;XP_050040209.1;XP_050040211.1;XP_050026955.1
MetaCyc: PWY-6946	Cholesterol degradation to androstenedione II (cholesterol dehydrogenase)	6	XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1;XP_050041643.1
KEGG: 00513+2.4.1.142	Various types of N-glycan biosynthesis	1	XP_050029793.1
Reactome: R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	35	XP_050039068.1;XP_050039484.1;XP_050030634.1;XP_050043138.1;XP_050023730.1;XP_050034643.1;XP_050038469.1;XP_050023576.1;XP_050025635.1;XP_050048717.1;XP_050043147.1;XP_050023725.1;XP_050048718.1;XP_050023779.1;XP_050023729.1;XP_050046063.1;XP_050023714.1;XP_050023726.1;XP_050034644.1;XP_050023776.1;XP_050051335.1;XP_050051336.1;XP_050030810.1;XP_050024189.1;XP_050030811.1;XP_050023724.1;XP_050023727.1;XP_050023777.1;XP_050030280.1;XP_050045052.1;XP_050039485.1;XP_050023577.1;XP_050047588.1;XP_050046123.1;XP_050023728.1
Reactome: R-HSA-8963896	HDL assembly	8	XP_050042111.1;XP_050042112.1;XP_050042109.1;XP_050042105.1;XP_050042107.1;XP_050042106.1;XP_050042108.1;XP_050042110.1
Reactome: R-HSA-438066	Unblocking of NMDA receptors, glutamate binding and activation	28	XP_050050684.1;XP_050050681.1;XP_050050687.1;XP_050050680.1;XP_050050698.1;XP_050050699.1;XP_050050702.1;XP_050048383.1;XP_050048384.1;XP_050050685.1;XP_050050696.1;XP_050048382.1;XP_050050689.1;XP_050050697.1;XP_050050694.1;XP_050050691.1;XP_050050688.1;XP_050050700.1;XP_050050686.1;XP_050050690.1;XP_050050679.1;XP_050050693.1;XP_050050701.1;XP_050050692.1;XP_050050682.1;XP_050050683.1;XP_050048381.1;XP_050050695.1
Reactome: R-HSA-388479	Vasopressin-like receptors	6	XP_050030075.1;XP_050044943.1;XP_050030263.1;XP_050049422.1;XP_050045674.1;XP_050044449.1
MetaCyc: PWY-5367	Petroselinate biosynthesis	4	XP_050032773.1;XP_050033009.1;XP_050033008.1;XP_050029751.1
KEGG: 00790+3.4.19.9	Folate biosynthesis	1	XP_050032978.1
MetaCyc: PWY-5030	L-histidine degradation III	8	XP_050027712.1;XP_050052683.1;XP_050044610.1;XP_050027711.1;XP_050052374.1;XP_050052682.1;XP_050048637.1;XP_050045421.1
Reactome: R-HSA-1963642	PI3K events in ERBB2 signaling	8	XP_050051865.1;XP_050051866.1;XP_050051868.1;XP_050032853.1;XP_050051864.1;XP_050044781.1;XP_050044786.1;XP_050044784.1
Reactome: R-HSA-110331	Cleavage of the damaged purine	11	XP_050036268.1;XP_050025243.1;XP_050038213.1;XP_050049643.1;XP_050025248.1;XP_050025266.1;XP_050052047.1;XP_050025244.1;XP_050025763.1;XP_050043043.1;XP_050038199.1
MetaCyc: PWY-5353	Arachidonate biosynthesis I (6-desaturase, lower eukaryotes)	2	XP_050042358.1;XP_050045032.1
KEGG: 00480+4.3.2.7	Glutathione metabolism	3	XP_050047740.1;XP_050047739.1;XP_050048564.1
Reactome: R-HSA-5602636	IKBKB deficiency causes SCID	1	XP_050050758.1
KEGG: 00564+2.7.1.107	Glycerophospholipid metabolism	18	XP_050035432.1;XP_050035434.1;XP_050026074.1;XP_050035431.1;XP_050048424.1;XP_050035430.1;XP_050044041.1;XP_050046068.1;XP_050048426.1;XP_050048423.1;XP_050048427.1;XP_050048425.1;XP_050044042.1;XP_050026073.1;XP_050035433.1;XP_050035435.1;XP_050035429.1;XP_050046067.1
Reactome: R-HSA-68952	DNA replication initiation	11	XP_050043962.1;XP_050041995.1;XP_050041997.1;XP_050034506.1;XP_050032235.1;XP_050041996.1;XP_050049531.1;XP_050041998.1;XP_050028231.1;XP_050039359.1;XP_050041999.1
KEGG: 00564+3.1.1.32	Glycerophospholipid metabolism	1	XP_050039130.1
Reactome: R-HSA-9022707	MECP2 regulates transcription factors	1	XP_050031707.1
MetaCyc: PWY-7727	Docosahexaenoate biosynthesis IV (4-desaturase, mammals)	2	XP_050045032.1;XP_050042358.1
MetaCyc: PWY-7445	Luteolin triglucuronide degradation	18	XP_050030591.1;XP_050031815.1;XP_050037574.1;XP_050022520.1;XP_050032263.1;XP_050037576.1;XP_050052158.1;XP_050031834.1;XP_050037573.1;XP_050037575.1;XP_050022911.1;XP_050030590.1;XP_050052159.1;XP_050052157.1;XP_050031263.1;XP_050037572.1;XP_050033134.1;XP_050022517.1
Reactome: R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	24	XP_050023312.1;XP_050046840.1;XP_050042261.1;XP_050023422.1;XP_050023796.1;XP_050044540.1;XP_050029683.1;XP_050042241.1;XP_050040959.1;XP_050042262.1;XP_050042260.1;XP_050040960.1;XP_050046839.1;XP_050046184.1;XP_050023649.1;XP_050042454.1;XP_050023334.1;XP_050034595.1;XP_050023809.1;XP_050042240.1;XP_050042242.1;XP_050023648.1;XP_050051298.1;XP_050026869.1
Reactome: R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	20	XP_050051864.1;XP_050044781.1;XP_050047997.1;XP_050047065.1;XP_050044786.1;XP_050047606.1;XP_050048775.1;XP_050048776.1;XP_050047996.1;XP_050044784.1;XP_050047995.1;XP_050047994.1;XP_050032853.1;XP_050051868.1;XP_050047998.1;XP_050051866.1;XP_050047598.1;XP_050048777.1;XP_050024508.1;XP_050051865.1
MetaCyc: PWY-46	Putrescine biosynthesis III	2	XP_050036729.1;XP_050036726.1
Reactome: R-HSA-8948747	Regulation of PTEN localization	10	XP_050048534.1;XP_050035481.1;XP_050032514.1;XP_050032515.1;XP_050032516.1;XP_050032509.1;XP_050032511.1;XP_050032513.1;XP_050032512.1;XP_050032510.1
KEGG: 00052+2.7.1.11	Galactose metabolism	4	XP_050040645.1;XP_050040641.1;XP_050040643.1;XP_050040644.1
Reactome: R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	8	XP_050044773.1;XP_050037949.1;XP_050037186.1;XP_050026116.1;XP_050035813.1;XP_050022524.1;XP_050026853.1;XP_050037187.1
KEGG: 00330+2.5.1.22	Arginine and proline metabolism	2	XP_050027527.1;XP_050027526.1
Reactome: R-HSA-380259	Loss of Nlp from mitotic centrosomes	38	XP_050039261.1;XP_050049353.1;XP_050035880.1;XP_050024782.1;XP_050028813.1;XP_050036465.1;XP_050025351.1;XP_050043820.1;XP_050030429.1;XP_050038645.1;XP_050030428.1;XP_050038560.1;XP_050030430.1;XP_050038642.1;XP_050030424.1;XP_050035119.1;XP_050044095.1;XP_050044093.1;XP_050030425.1;XP_050025352.1;XP_050030426.1;XP_050043899.1;XP_050043821.1;XP_050045039.1;XP_050038643.1;XP_050035114.1;XP_050025353.1;XP_050038648.1;XP_050035116.1;XP_050034759.1;XP_050044094.1;XP_050045165.1;XP_050038561.1;XP_050045038.1;XP_050038644.1;XP_050044096.1;XP_050038646.1;XP_050038647.1
KEGG: 00260+2.6.1.52	Glycine, serine and threonine metabolism	2	XP_050034258.1;XP_050034259.1
Reactome: R-HSA-916853	Degradation of GABA	2	XP_050027290.1;XP_050041758.1
Reactome: R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	16	XP_050047338.1;XP_050026292.1;XP_050048112.1;XP_050052420.1;XP_050045149.1;XP_050052055.1;XP_050034746.1;XP_050037157.1;XP_050051355.1;XP_050049757.1;XP_050034156.1;XP_050051357.1;XP_050051356.1;XP_050044153.1;XP_050044826.1;XP_050048111.1
Reactome: R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	8	XP_050025941.1;XP_050029936.1;XP_050048534.1;XP_050035481.1;XP_050033094.1;XP_050025942.1;XP_050032293.1;XP_050033093.1
Reactome: R-HSA-6814848	Glycerophospholipid catabolism	5	XP_050027792.1;XP_050035084.1;XP_050051136.1;XP_050035083.1;XP_050051137.1
MetaCyc: PWY-5028	L-histidine degradation II	4	XP_050052374.1;XP_050044610.1;XP_050027711.1;XP_050027712.1
KEGG: 00130+2.1.1.222+2.1.1.64	Ubiquinone and other terpenoid-quinone biosynthesis	2	XP_050025937.1;XP_050025938.1
KEGG: 00330+1.14.13.39	Arginine and proline metabolism	3	XP_050048952.1;XP_050048936.1;XP_050048943.1
KEGG: 00230+2.4.2.7	Purine metabolism	1	XP_050049687.1
Reactome: R-HSA-977443	GABA receptor activation	6	XP_050040330.1;XP_050040332.1;XP_050040329.1;XP_050040327.1;XP_050039666.1;XP_050040334.1
Reactome: R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	27	XP_050047955.1;XP_050047965.1;XP_050049349.1;XP_050046640.1;XP_050049030.1;XP_050048893.1;XP_050048137.1;XP_050043649.1;XP_050035481.1;XP_050036365.1;XP_050026843.1;XP_050048132.1;XP_050035872.1;XP_050049340.1;XP_050031262.1;XP_050043659.1;XP_050031594.1;XP_050036502.1;XP_050026914.1;XP_050037416.1;XP_050023628.1;XP_050027801.1;XP_050034595.1;XP_050049355.1;XP_050048534.1;XP_050037415.1;XP_050034653.1
Reactome: R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	2	XP_050038602.1;XP_050036605.1
KEGG: 00620+4.2.1.2	Pyruvate metabolism	1	XP_050037417.1
MetaCyc: PWY-5849	Menaquinol-6 biosynthesis	1	XP_050045574.1
KEGG: 00230+2.7.4.3	Purine metabolism	9	XP_050050643.1;XP_050023196.1;XP_050046313.1;XP_050023197.1;XP_050040014.1;XP_050023199.1;XP_050038592.1;XP_050023195.1;XP_050039403.1
KEGG: 00230+2.7.6.1	Purine metabolism	5	XP_050038764.1;XP_050030167.1;XP_050038766.1;XP_050030166.1;XP_050038765.1
Reactome: R-HSA-425561	Sodium/Calcium exchangers	22	XP_050044603.1;XP_050048958.1;XP_050044604.1;XP_050051982.1;XP_050048629.1;XP_050032483.1;XP_050051987.1;XP_050049927.1;XP_050032484.1;XP_050044383.1;XP_050044888.1;XP_050037037.1;XP_050044887.1;XP_050037033.1;XP_050037034.1;XP_050037035.1;XP_050049003.1;XP_050044384.1;XP_050044605.1;XP_050051975.1;XP_050037405.1;XP_050037036.1
KEGG: 00513+2.4.1.143	Various types of N-glycan biosynthesis	3	XP_050036462.1;XP_050030754.1;XP_050030755.1
KEGG: 00230+6.3.5.3	Purine metabolism	1	XP_050040275.1
MetaCyc: PWY-5142	Acyl-[acyl-carrier protein] thioesterase pathway	4	XP_050033008.1;XP_050032773.1;XP_050033009.1;XP_050029751.1
MetaCyc: PWY-7456	Beta-(1,4)-mannan degradation	2	XP_050044364.1;XP_050044728.1
Reactome: R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	6	XP_050025696.1;XP_050028323.1;XP_050025697.1;XP_050040075.1;XP_050028292.1;XP_050052094.1
Reactome: R-HSA-6793080	rRNA modification in the mitochondrion	2	XP_050029102.1;XP_050031832.1
Reactome: R-HSA-5654712	FRS-mediated FGFR4 signaling	2	XP_050048507.1;XP_050032853.1
Reactome: R-HSA-442982	Ras activation upon Ca2+ influx through NMDA receptor	28	XP_050048384.1;XP_050050685.1;XP_050048383.1;XP_050050698.1;XP_050050680.1;XP_050050687.1;XP_050050684.1;XP_050050681.1;XP_050050702.1;XP_050050699.1;XP_050050689.1;XP_050048382.1;XP_050050691.1;XP_050050694.1;XP_050050697.1;XP_050050696.1;XP_050050693.1;XP_050050679.1;XP_050050701.1;XP_050050692.1;XP_050050686.1;XP_050050690.1;XP_050050700.1;XP_050050688.1;XP_050048381.1;XP_050050695.1;XP_050050683.1;XP_050050682.1
Reactome: R-HSA-163560	Triglyceride catabolism	17	XP_050034110.1;XP_050034933.1;XP_050042106.1;XP_050042107.1;XP_050034934.1;XP_050034395.1;XP_050028692.1;XP_050042110.1;XP_050042112.1;XP_050034114.1;XP_050036461.1;XP_050042108.1;XP_050034396.1;XP_050040576.1;XP_050042111.1;XP_050042109.1;XP_050042105.1
Reactome: R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	26	XP_050032578.1;XP_050027743.1;XP_050032523.1;XP_050034643.1;XP_050036394.1;XP_050037445.1;XP_050032546.1;XP_050028883.1;XP_050040020.1;XP_050045195.1;XP_050039785.1;XP_050040196.1;XP_050037088.1;XP_050034644.1;XP_050040013.1;XP_050046123.1;XP_050032579.1;XP_050023463.1;XP_050043822.1;XP_050027634.1;XP_050037081.1;XP_050033013.1;XP_050051719.1;XP_050040236.1;XP_050032577.1;XP_050024189.1
MetaCyc: PWY-6898	Thiamine salvage III	1	XP_050034132.1
KEGG: 00380+3.7.1.3	Tryptophan metabolism	5	XP_050025834.1;XP_050025835.1;XP_050025837.1;XP_050025836.1;XP_050026084.1
KEGG: 00510+2.4.1.265	N-Glycan biosynthesis	1	XP_050039242.1
Reactome: R-HSA-445355	Smooth Muscle Contraction	20	XP_050040873.1;XP_050040301.1;XP_050024180.1;XP_050024177.1;XP_050039290.1;XP_050044440.1;XP_050024178.1;XP_050052032.1;XP_050044441.1;XP_050024176.1;XP_050044438.1;XP_050039231.1;XP_050044437.1;XP_050039223.1;XP_050024175.1;XP_050024179.1;XP_050044435.1;XP_050044436.1;XP_050039234.1;XP_050040300.1
MetaCyc: PWY-6871	3-methylbutanol biosynthesis (engineered)	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
KEGG: 00561+3.1.1.23	Glycerolipid metabolism	4	XP_050038705.1;XP_050038706.1;XP_050038707.1;XP_050032596.1
Reactome: R-HSA-933542	TRAF6 mediated NF-kB activation	4	XP_050049501.1;XP_050050758.1;XP_050049499.1;XP_050049500.1
KEGG: 00380+4.2.1.17+1.1.1.35	Tryptophan metabolism	6	XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1;XP_050041643.1
MetaCyc: PWY-5136	Fatty acid beta-oxidation II (plant peroxisome)	8	XP_050041643.1;XP_050041635.1;XP_050026060.1;XP_050051194.1;XP_050041651.1;XP_050023456.1;XP_050026422.1;XP_050032010.1
Reactome: R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	52	XP_050022938.1;XP_050040200.1;XP_050048719.1;XP_050047809.1;XP_050050373.1;XP_050045785.1;XP_050048534.1;XP_050032477.1;XP_050044478.1;XP_050045660.1;XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050033237.1;XP_050037401.1;XP_050034772.1;XP_050025715.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050033318.1;XP_050037398.1;XP_050044469.1;XP_050047181.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050048823.1;XP_050033832.1;XP_050040199.1;XP_050044470.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050033331.1;XP_050036567.1;XP_050051964.1;XP_050035472.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050040198.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050049124.1
Reactome: R-HSA-8851805	MET activates RAS signaling	3	XP_050050151.1;XP_050050150.1;XP_050032853.1
Reactome: R-HSA-9022927	MECP2 regulates transcription of genes involved in GABA signaling	1	XP_050031707.1
MetaCyc: PWY-7238	Sucrose biosynthesis II	9	XP_050050068.1;XP_050037071.1;XP_050037412.1;XP_050037411.1;XP_050037070.1;XP_050037409.1;XP_050037069.1;XP_050037410.1;XP_050042052.1
Reactome: R-HSA-5467337	APC truncation mutants have impaired AXIN binding	8	XP_050048776.1;XP_050048777.1;XP_050047998.1;XP_050047994.1;XP_050048775.1;XP_050047996.1;XP_050047997.1;XP_050047995.1
Reactome: R-HSA-196757	Metabolism of folate and pterines	9	XP_050034367.1;XP_050032825.1;XP_050032636.1;XP_050051161.1;XP_050048637.1;XP_050052682.1;XP_050052683.1;XP_050032637.1;XP_050030635.1
Reactome: R-HSA-114608	Platelet degranulation	13	XP_050024180.1;XP_050033791.1;XP_050024176.1;XP_050045935.1;XP_050051286.1;XP_050033667.1;XP_050052627.1;XP_050045934.1;XP_050029683.1;XP_050024175.1;XP_050024177.1;XP_050024179.1;XP_050024178.1
Reactome: R-HSA-199220	Vitamin B5 (pantothenate) metabolism	27	XP_050030035.1;XP_050025114.1;XP_050041502.1;XP_050051929.1;XP_050033008.1;XP_050040326.1;XP_050032998.1;XP_050030138.1;XP_050032773.1;XP_050027845.1;XP_050032996.1;XP_050033002.1;XP_050030053.1;XP_050030055.1;XP_050025112.1;XP_050030085.1;XP_050030054.1;XP_050038921.1;XP_050030084.1;XP_050033009.1;XP_050038286.1;XP_050029751.1;XP_050028646.1;XP_050032997.1;XP_050041503.1;XP_050037610.1;XP_050028975.1
MetaCyc: PWY-7433	Mucin core 1 and core 2 O-glycosylation	3	XP_050042668.1;XP_050042669.1;XP_050042670.1
Reactome: R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	8	XP_050048777.1;XP_050048776.1;XP_050047998.1;XP_050047996.1;XP_050047997.1;XP_050047995.1;XP_050047994.1;XP_050048775.1
KEGG: 00190+7.1.1.2	Oxidative phosphorylation	2	YP_010283869.1;YP_010283878.1
Reactome: R-HSA-9657050	Defective OGG1 Localization	1	XP_050052047.1
Reactome: R-HSA-8856828	Clathrin-mediated endocytosis	74	XP_050025688.1;XP_050047655.1;XP_050042241.1;XP_050042260.1;XP_050040246.1;XP_050026078.1;XP_050027302.1;XP_050032853.1;XP_050041634.1;XP_050036756.1;XP_050025689.1;XP_050026080.1;XP_050047658.1;XP_050028603.1;XP_050032654.1;XP_050042454.1;XP_050023809.1;XP_050045760.1;XP_050032522.1;XP_050032518.1;XP_050042240.1;XP_050048518.1;XP_050047657.1;XP_050028884.1;XP_050042242.1;XP_050039510.1;XP_050036757.1;XP_050051710.1;XP_050044191.1;XP_050022836.1;XP_050026519.1;XP_050051708.1;XP_050037100.1;XP_050044608.1;XP_050048534.1;XP_050032521.1;XP_050023334.1;XP_050032519.1;XP_050023808.1;XP_050044192.1;XP_050023500.1;XP_050028745.1;XP_050022842.1;XP_050026079.1;XP_050044193.1;XP_050035481.1;XP_050023422.1;XP_050023796.1;XP_050044195.1;XP_050037400.1;XP_050027890.1;XP_050042262.1;XP_050039071.1;XP_050026076.1;XP_050023312.1;XP_050042261.1;XP_050044197.1;XP_050028849.1;XP_050050919.1;XP_050026075.1;XP_050051709.1;XP_050044199.1;XP_050036758.1;XP_050032517.1;XP_050026077.1;XP_050048294.1;XP_050025687.1;XP_050033511.1;XP_050032655.1;XP_050044198.1;XP_050023499.1;XP_050032520.1;XP_050039072.1;XP_050044194.1
Reactome: R-HSA-8941333	RUNX2 regulates genes involved in differentiation of myeloid cells	1	XP_050047422.1
Reactome: R-HSA-2428933	SHC-related events triggered by IGF1R	1	XP_050032853.1
Reactome: R-HSA-4086400	PCP/CE pathway	4	XP_050024731.1;XP_050044843.1;XP_050050021.1;XP_050024722.1
KEGG: 00480+3.4.11.1	Glutathione metabolism	8	XP_050049818.1;XP_050049469.1;XP_050049467.1;XP_050038122.1;XP_050049820.1;XP_050038137.1;XP_050049468.1;XP_050049819.1
Reactome: R-HSA-2682334	EPH-Ephrin signaling	5	XP_050023761.1;XP_050041704.1;XP_050023778.1;XP_050023786.1;XP_050023769.1
MetaCyc: PWY-3841	Folate transformations II (plants)	10	XP_050032637.1;XP_050052683.1;XP_050036540.1;XP_050048637.1;XP_050052682.1;XP_050027282.1;XP_050027283.1;XP_050032825.1;XP_050034367.1;XP_050032636.1
KEGG: 00230+2.1.2.2	Purine metabolism	1	XP_050048865.1
Reactome: R-HSA-171319	Telomere Extension By Telomerase	5	XP_050038700.1;XP_050046898.1;XP_050042954.1;XP_050027729.1;XP_050038701.1
Reactome: R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	6	XP_050046958.1;XP_050046054.1;XP_050026685.1;XP_050046055.1;XP_050037466.1;XP_050051772.1
Reactome: R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	7	XP_050050758.1;XP_050047769.1;XP_050047670.1;XP_050040624.1;XP_050035481.1;XP_050040623.1;XP_050048534.1
KEGG: 00564+2.7.8.5	Glycerophospholipid metabolism	2	XP_050029506.1;XP_050029507.1
KEGG: 00280+4.2.1.17	Valine, leucine and isoleucine degradation	1	XP_050032010.1
KEGG: 00260+2.1.2.10	Glycine, serine and threonine metabolism	7	XP_050045007.1;XP_050050950.1;XP_050052825.1;XP_050050895.1;XP_050045006.1;XP_050050949.1;XP_050030625.1
Reactome: R-HSA-168276	NS1 Mediated Effects on Host Pathways	41	XP_050044454.1;XP_050038967.1;XP_050039240.1;XP_050036827.1;XP_050025064.1;XP_050038966.1;XP_050030507.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050042391.1;XP_050038895.1;XP_050038863.1;XP_050030942.1;XP_050023474.1;XP_050036430.1;XP_050029515.1;XP_050035933.1;XP_050029516.1;XP_050038862.1;XP_050023718.1;XP_050046156.1;XP_050035932.1;XP_050026809.1;XP_050027366.1;XP_050033146.1;XP_050026810.1;XP_050030653.1;XP_050049377.1;XP_050026399.1;XP_050038968.1;XP_050038866.1;XP_050023476.1;XP_050044008.1;XP_050023475.1;XP_050042392.1;XP_050038864.1;XP_050024518.1;XP_050035770.1;XP_050038865.1;XP_050026400.1
MetaCyc: PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	9	XP_050030696.1;XP_050046343.1;XP_050050265.1;XP_050022865.1;XP_050050266.1;XP_050024735.1;XP_050047573.1;XP_050034682.1;XP_050050267.1
Reactome: R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	57	XP_050044470.1;XP_050052231.1;XP_050029802.1;XP_050050645.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050034857.1;XP_050040198.1;XP_050027657.1;XP_050036580.1;XP_050036156.1;XP_050038140.1;XP_050033318.1;XP_050037398.1;XP_050042788.1;XP_050022518.1;XP_050027134.1;XP_050023192.1;XP_050044469.1;XP_050047181.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050036253.1;XP_050045660.1;XP_050044478.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050037401.1;XP_050033237.1;XP_050034858.1;XP_050025715.1;XP_050034772.1;XP_050022938.1;XP_050040200.1;XP_050047809.1;XP_050048719.1;XP_050048534.1;XP_050032477.1;XP_050050373.1;XP_050045785.1
Reactome: R-HSA-9603505	NTRK3 as a dependence receptor	3	XP_050047588.1;XP_050023576.1;XP_050023577.1
Reactome: R-HSA-8854691	Interleukin-20 family signaling	6	XP_050034883.1;XP_050034885.1;XP_050034886.1;XP_050034887.1;XP_050044596.1;XP_050034884.1
Reactome: R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	10	XP_050032516.1;XP_050032515.1;XP_050032509.1;XP_050032511.1;XP_050032512.1;XP_050032513.1;XP_050032510.1;XP_050048534.1;XP_050035481.1;XP_050032514.1
Reactome: R-HSA-1234174	Cellular response to hypoxia	3	XP_050049860.1;XP_050049859.1;XP_050049858.1
MetaCyc: PWY-6277	Superpathway of 5-aminoimidazole ribonucleotide biosynthesis	4	XP_050040275.1;XP_050048865.1;XP_050039987.1;XP_050039374.1
KEGG: 04660+2.7.10.2	T cell receptor signaling pathway	16	XP_050024603.1;XP_050024595.1;XP_050024588.1;XP_050034360.1;XP_050026977.1;XP_050031022.1;XP_050031020.1;XP_050034361.1;XP_050031021.1;XP_050034359.1;XP_050031023.1;XP_050044596.1;XP_050047089.1;XP_050031019.1;XP_050052372.1;XP_050024580.1
Reactome: R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	46	XP_050023729.1;XP_050046063.1;XP_050023714.1;XP_050023726.1;XP_050033368.1;XP_050048718.1;XP_050023779.1;XP_050037137.1;XP_050048717.1;XP_050023725.1;XP_050043147.1;XP_050023576.1;XP_050025635.1;XP_050038469.1;XP_050023730.1;XP_050025563.1;XP_050034643.1;XP_050040427.1;XP_050030634.1;XP_050043138.1;XP_050040428.1;XP_050039068.1;XP_050039484.1;XP_050037136.1;XP_050047588.1;XP_050046123.1;XP_050023728.1;XP_050045052.1;XP_050044010.1;XP_050039485.1;XP_050023577.1;XP_050023724.1;XP_050023777.1;XP_050035378.1;XP_050023727.1;XP_050030280.1;XP_050024189.1;XP_050030811.1;XP_050051335.1;XP_050045300.1;XP_050051336.1;XP_050030810.1;XP_050047361.1;XP_050034644.1;XP_050023776.1;XP_050045189.1
Reactome: R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	15	XP_050051244.1;XP_050036268.1;XP_050025243.1;XP_050038213.1;XP_050043448.1;XP_050025266.1;XP_050025248.1;XP_050039518.1;XP_050032836.1;XP_050035482.1;XP_050025244.1;XP_050038199.1;XP_050027729.1;XP_050041693.1;XP_050041386.1
MetaCyc: PWY-5538	Pyruvate fermentation to acetate VI	8	XP_050049076.1;XP_050042703.1;XP_050043005.1;XP_050042702.1;XP_050049075.1;XP_050026352.1;XP_050042704.1;XP_050026353.1
KEGG: 00230+6.3.5.2	Purine metabolism	3	XP_050042205.1;XP_050042215.1;XP_050042202.1
KEGG: 00450+6.1.1.10	Selenocompound metabolism	2	XP_050043461.1;XP_050034442.1
Reactome: R-HSA-70350	Fructose catabolism	5	XP_050026967.1;XP_050026970.1;XP_050026969.1;XP_050026968.1;XP_050048268.1
KEGG: 00900+1.1.1.34	Terpenoid backbone biosynthesis	1	XP_050024679.1
KEGG: 00260+2.3.1.29	Glycine, serine and threonine metabolism	2	XP_050042563.1;XP_050042562.1
Reactome: R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	4	XP_050033785.1;XP_050033786.1;XP_050033672.1;XP_050033673.1
Reactome: R-HSA-1566948	Elastic fibre formation	1	XP_050022553.1
Reactome: R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	42	XP_050051710.1;XP_050026519.1;XP_050051708.1;XP_050051406.1;XP_050045030.1;XP_050029085.1;XP_050036570.1;XP_050029333.1;XP_050049233.1;XP_050040045.1;XP_050047029.1;XP_050025647.1;XP_050040044.1;XP_050023720.1;XP_050027434.1;XP_050029335.1;XP_050029817.1;XP_050050919.1;XP_050051709.1;XP_050050875.1;XP_050034917.1;XP_050032270.1;XP_050052248.1;XP_050049232.1;XP_050052249.1;XP_050046002.1;XP_050045029.1;XP_050047028.1;XP_050040046.1;XP_050043547.1;XP_050048257.1;XP_050036184.1;XP_050028605.1;XP_050022514.1;XP_050029819.1;XP_050050885.1;XP_050046114.1;XP_050029334.1;XP_050046113.1;XP_050045031.1;XP_050047207.1;XP_050029818.1
KEGG: 00561+2.3.1.20	Glycerolipid metabolism	7	XP_050046981.1;XP_050047364.1;XP_050047365.1;XP_050046979.1;XP_050046980.1;XP_050047472.1;XP_050047470.1
Reactome: R-HSA-392517	Rap1 signalling	9	XP_050042112.1;XP_050042111.1;XP_050042105.1;XP_050042109.1;XP_050051758.1;XP_050042107.1;XP_050042106.1;XP_050042108.1;XP_050042110.1
MetaCyc: PWY-6972	Oleandomycin activation/inactivation	1	XP_050024072.1
Reactome: R-HSA-2160916	Hyaluronan uptake and degradation	24	XP_050025615.1;XP_050025616.1;XP_050026984.1;XP_050025617.1;XP_050030479.1;XP_050026982.1;XP_050034457.1;XP_050030480.1;XP_050048293.1;XP_050045117.1;XP_050048290.1;XP_050043064.1;XP_050027975.1;XP_050036110.1;XP_050048292.1;XP_050026917.1;XP_050048291.1;XP_050026983.1;XP_050026981.1;XP_050026985.1;XP_050028195.1;XP_050025618.1;XP_050035570.1;XP_050030481.1
Reactome: R-HSA-1227986	Signaling by ERBB2	9	XP_050048200.1;XP_050051866.1;XP_050051868.1;XP_050044784.1;XP_050044786.1;XP_050051864.1;XP_050044781.1;XP_050051865.1;XP_050048201.1
MetaCyc: PWY-5844	Menaquinol-9 biosynthesis	1	XP_050045574.1
KEGG: 00630+6.4.1.3	Glyoxylate and dicarboxylate metabolism	1	XP_050049718.1
Reactome: R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	2	XP_050025879.1;XP_050032853.1
KEGG: 00240+1.17.4.1	Pyrimidine metabolism	2	XP_050038800.1;XP_050030600.1
Reactome: R-HSA-5655862	Translesion synthesis by POLK	19	XP_050027029.1;XP_050029852.1;XP_050049952.1;XP_050045557.1;XP_050025144.1;XP_050029342.1;XP_050046062.1;XP_050022980.1;XP_050051397.1;XP_050052687.1;XP_050035481.1;XP_050050532.1;XP_050042972.1;XP_050027026.1;XP_050027028.1;XP_050042755.1;XP_050022795.1;XP_050048534.1;XP_050045558.1
Reactome: R-HSA-6807004	Negative regulation of MET activity	19	XP_050044192.1;XP_050046497.1;XP_050044193.1;XP_050032853.1;XP_050044197.1;XP_050035481.1;XP_050023108.1;XP_050047867.1;XP_050047865.1;XP_050044199.1;XP_050044195.1;XP_050047866.1;XP_050032654.1;XP_050047570.1;XP_050032655.1;XP_050044191.1;XP_050044198.1;XP_050048534.1;XP_050044194.1
KEGG: 00515+2.4.1.109	Mannose type O-glycan biosynthesis	12	XP_050041250.1;XP_050024010.1;XP_050024120.1;XP_050051991.1;XP_050023434.1;XP_050046831.1;XP_050046070.1;XP_050041249.1;XP_050051992.1;XP_050024005.1;XP_050046071.1;XP_050037277.1
KEGG: 00240+2.7.1.21	Pyrimidine metabolism	1	XP_050032909.1
Reactome: R-HSA-3899300	SUMOylation of transcription cofactors	22	XP_050044405.1;XP_050044401.1;XP_050044403.1;XP_050051690.1;XP_050031628.1;XP_050034256.1;XP_050044404.1;XP_050044407.1;XP_050034257.1;XP_050044395.1;XP_050044406.1;XP_050044398.1;XP_050044397.1;XP_050035889.1;XP_050044396.1;XP_050044402.1;XP_050038602.1;XP_050044394.1;XP_050035890.1;XP_050044400.1;XP_050044408.1;XP_050023674.1
Reactome: R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	3	XP_050050504.1;XP_050047675.1;XP_050047668.1
Reactome: R-HSA-71064	Lysine catabolism	6	XP_050030793.1;XP_050030791.1;XP_050038813.1;XP_050030792.1;XP_050036844.1;XP_050026566.1
MetaCyc: PWY-3661	Glycine betaine degradation I	3	XP_050032637.1;XP_050032636.1;XP_050034367.1
Reactome: R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	11	XP_050051578.1;XP_050037869.1;XP_050038837.1;XP_050038836.1;XP_050050483.1;XP_050051577.1;XP_050049157.1;XP_050038838.1;XP_050051580.1;XP_050051579.1;XP_050051581.1
Reactome: R-HSA-5679001	Defective ABCC2 causes Dubin-Johnson syndrome	1	XP_050024072.1
Reactome: R-HSA-432720	Lysosome Vesicle Biogenesis	16	XP_050047330.1;XP_050027139.1;XP_050032654.1;XP_050039510.1;XP_050032655.1;XP_050047329.1;XP_050047332.1;XP_050045259.1;XP_050039072.1;XP_050045258.1;XP_050039071.1;XP_050027140.1;XP_050050919.1;XP_050045261.1;XP_050045260.1;XP_050047331.1
Reactome: R-HSA-2022854	Keratan sulfate biosynthesis	19	XP_050036875.1;XP_050049401.1;XP_050040302.1;XP_050045709.1;XP_050030575.1;XP_050027346.1;XP_050027345.1;XP_050046537.1;XP_050040309.1;XP_050040306.1;XP_050040307.1;XP_050041857.1;XP_050040304.1;XP_050040303.1;XP_050039591.1;XP_050038650.1;XP_050027344.1;XP_050027354.1;XP_050049413.1
Reactome: R-HSA-75153	Apoptotic execution phase	1	XP_050030639.1
MetaCyc: PWY-7659	Viridicatumtoxin biosynthesis	1	XP_050023623.1
Reactome: R-HSA-379716	Cytosolic tRNA aminoacylation	20	XP_050024514.1;XP_050040038.1;XP_050051668.1;XP_050050331.1;XP_050028841.1;XP_050052095.1;XP_050029927.1;XP_050031596.1;XP_050031115.1;XP_050034442.1;XP_050042092.1;XP_050038756.1;XP_050044543.1;XP_050034251.1;XP_050051666.1;XP_050049722.1;XP_050031025.1;XP_050026033.1;XP_050031592.1;XP_050031591.1
KEGG: 00062+4.2.1.17+1.1.1.211	Fatty acid elongation	1	XP_050032010.1
KEGG: 00730+3.6.1.15	Thiamine metabolism	1	XP_050051386.1
MetaCyc: PWY-5078	L-isoleucine degradation II	4	XP_050052301.1;XP_050052400.1;XP_050039540.1;XP_050052302.1
KEGG: 00010+4.1.2.13	Glycolysis / Gluconeogenesis	2	XP_050025560.1;XP_050025561.1
KEGG: 00564+4.1.1.65	Glycerophospholipid metabolism	3	XP_050022634.1;XP_050022630.1;XP_050022623.1
Reactome: R-HSA-2206292	MPS VII - Sly syndrome	2	XP_050034457.1;XP_050045117.1
MetaCyc: PWY-7049	Icosapentaenoate biosynthesis II (6-desaturase, mammals)	2	XP_050045032.1;XP_050042358.1
MetaCyc: PWY-7337	10-cis-heptadecenoyl-CoA degradation (yeast)	2	XP_050026060.1;XP_050023456.1
KEGG: 00900+2.3.3.10	Terpenoid backbone biosynthesis	5	XP_050041695.1;XP_050041692.1;XP_050041694.1;XP_050041696.1;XP_050041691.1
Reactome: R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	15	XP_050026115.1;XP_050026114.1;XP_050025644.1;XP_050038896.1;XP_050027409.1;XP_050050873.1;XP_050027421.1;XP_050027408.1;XP_050027422.1;XP_050027410.1;XP_050026113.1;XP_050028858.1;XP_050024513.1;XP_050050872.1;XP_050023375.1
Reactome: R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1	XP_050050758.1
Reactome: R-HSA-5687128	MAPK6/MAPK4 signaling	95	XP_050022518.1;XP_050042108.1;XP_050023418.1;XP_050029824.1;XP_050033318.1;XP_050042111.1;XP_050033833.1;XP_050047181.1;XP_050046838.1;XP_050033331.1;XP_050035472.1;XP_050051964.1;XP_050042106.1;XP_050052226.1;XP_050040199.1;XP_050042110.1;XP_050044470.1;XP_050040198.1;XP_050039235.1;XP_050042025.1;XP_050035481.1;XP_050037397.1;XP_050024749.1;XP_050031786.1;XP_050027118.1;XP_050029825.1;XP_050029859.1;XP_050040200.1;XP_050026047.1;XP_050046837.1;XP_050045785.1;XP_050050373.1;XP_050051917.1;XP_050042109.1;XP_050048719.1;XP_050042105.1;XP_050048721.1;XP_050023419.1;XP_050025848.1;XP_050031479.1;XP_050044478.1;XP_050034772.1;XP_050025715.1;XP_050037401.1;XP_050052225.1;XP_050027134.1;XP_050042788.1;XP_050037398.1;XP_050029827.1;XP_050038140.1;XP_050036156.1;XP_050049607.1;XP_050027657.1;XP_050029862.1;XP_050048824.1;XP_050037399.1;XP_050023625.1;XP_050029336.1;XP_050049606.1;XP_050044469.1;XP_050036567.1;XP_050028353.1;XP_050042107.1;XP_050048823.1;XP_050033832.1;XP_050051916.1;XP_050050645.1;XP_050029861.1;XP_050029802.1;XP_050026046.1;XP_050026223.1;XP_050025375.1;XP_050052231.1;XP_050029337.1;XP_050049124.1;XP_050032553.1;XP_050048720.1;XP_050044475.1;XP_050025374.1;XP_050029860.1;XP_050029858.1;XP_050022938.1;XP_050032477.1;XP_050048534.1;XP_050039236.1;XP_050029338.1;XP_050047809.1;XP_050044476.1;XP_050029826.1;XP_050023605.1;XP_050051915.1;XP_050045660.1;XP_050042112.1;XP_050052512.1;XP_050033237.1
MetaCyc: PWY-6453	Stigma estolide biosynthesis	15	XP_050037457.1;XP_050050583.1;XP_050047027.1;XP_050037775.1;XP_050037856.1;XP_050047026.1;XP_050037455.1;XP_050037458.1;XP_050027415.1;XP_050037456.1;XP_050037854.1;XP_050037855.1;XP_050027416.1;XP_050037857.1;XP_050032357.1
MetaCyc: PWY-7177	UTP and CTP dephosphorylation II	3	XP_050026501.1;XP_050026500.1;XP_050026502.1
Reactome: R-HSA-8934593	Regulation of RUNX1 Expression and Activity	32	XP_050047422.1;XP_050029824.1;XP_050029827.1;XP_050048388.1;XP_050029336.1;XP_050029862.1;XP_050048389.1;XP_050047674.1;XP_050028353.1;XP_050051916.1;XP_050052226.1;XP_050048387.1;XP_050026223.1;XP_050026046.1;XP_050029861.1;XP_050029337.1;XP_050039235.1;XP_050032553.1;XP_050029859.1;XP_050029825.1;XP_050029860.1;XP_050029858.1;XP_050026047.1;XP_050051917.1;XP_050039236.1;XP_050029338.1;XP_050047664.1;XP_050029826.1;XP_050051915.1;XP_050023605.1;XP_050052512.1;XP_050052225.1
KEGG: 00620+2.3.1.12	Pyruvate metabolism	1	XP_050039504.1
KEGG: 00983+2.7.1.48	Drug metabolism - other enzymes	6	XP_050031818.1;XP_050031820.1;XP_050031819.1;XP_050031817.1;XP_050024420.1;XP_050024419.1
Reactome: R-HSA-416476	G alpha (q) signalling events	53	XP_050038409.1;XP_050052126.1;XP_050042122.1;XP_050025622.1;XP_050049211.1;XP_050049205.1;XP_050051925.1;XP_050049293.1;XP_050048906.1;XP_050048217.1;XP_050049278.1;XP_050049264.1;XP_050049239.1;XP_050049220.1;XP_050045772.1;XP_050040292.1;XP_050040289.1;XP_050049308.1;XP_050049286.1;XP_050030075.1;XP_050025623.1;XP_050044449.1;XP_050042463.1;XP_050044424.1;XP_050040294.1;XP_050049248.1;XP_050039647.1;XP_050023177.1;XP_050049231.1;XP_050048905.1;XP_050049086.1;XP_050049422.1;XP_050049301.1;XP_050030263.1;XP_050049256.1;XP_050044943.1;XP_050039607.1;XP_050040293.1;XP_050045674.1;XP_050049292.1;XP_050038435.1;XP_050042308.1;XP_050029683.1;XP_050040288.1;XP_050035408.1;XP_050049270.1;XP_050027421.1;XP_050047359.1;XP_050027422.1;XP_050040290.1;XP_050022718.1;XP_050051924.1;XP_050035407.1
Reactome: R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	1	XP_050049439.1
Reactome: R-HSA-1482788	Acyl chain remodelling of PC	4	XP_050025400.1;XP_050025686.1;XP_050033390.1;XP_050050549.1
KEGG: 00410+4.1.1.9	beta-Alanine metabolism	3	XP_050025931.1;XP_050025930.1;XP_050025932.1
Reactome: R-HSA-5357905	Regulation of TNFR1 signaling	22	XP_050047215.1;XP_050047192.1;XP_050047193.1;XP_050035853.1;XP_050039209.1;XP_050050142.1;XP_050047191.1;XP_050047214.1;XP_050048534.1;XP_050050144.1;XP_050039211.1;XP_050046878.1;XP_050047213.1;XP_050039208.1;XP_050046879.1;XP_050035481.1;XP_050050758.1;XP_050050141.1;XP_050050140.1;XP_050050143.1;XP_050046877.1;XP_050039210.1
MetaCyc: PWY-7854	Crotonyl-coa/ethylmalonyl-coa/hydroxybutyryl-coa cycle (engineered)	3	XP_050023456.1;XP_050034236.1;XP_050026060.1
MetaCyc: PWY-6679	Jadomycin biosynthesis	12	XP_050048466.1;XP_050048463.1;XP_050048460.1;XP_050048459.1;XP_050048458.1;XP_050048465.1;XP_050048462.1;XP_050048468.1;XP_050048467.1;XP_050048456.1;XP_050048461.1;XP_050048457.1
MetaCyc: PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	3	XP_050047837.1;XP_050047839.1;XP_050047838.1
Reactome: R-HSA-6783310	Fanconi Anemia Pathway	67	XP_050046377.1;XP_050038352.1;XP_050033132.1;XP_050039837.1;XP_050030531.1;XP_050048534.1;XP_050042500.1;XP_050028088.1;XP_050039323.1;XP_050033073.1;XP_050022808.1;XP_050035482.1;XP_050049890.1;XP_050041016.1;XP_050033730.1;XP_050041114.1;XP_050030443.1;XP_050032850.1;XP_050039156.1;XP_050048503.1;XP_050035066.1;XP_050039871.1;XP_050023408.1;XP_050030365.1;XP_050038369.1;XP_050039324.1;XP_050029342.1;XP_050041498.1;XP_050044105.1;XP_050039148.1;XP_050035003.1;XP_050047064.1;XP_050041884.1;XP_050025131.1;XP_050047478.1;XP_050024862.1;XP_050047479.1;XP_050032576.1;XP_050036244.1;XP_050024989.1;XP_050023541.1;XP_050033516.1;XP_050043603.1;XP_050023413.1;XP_050035124.1;XP_050028341.1;XP_050029852.1;XP_050043463.1;XP_050026174.1;XP_050029205.1;XP_050023165.1;XP_050044923.1;XP_050044807.1;XP_050028048.1;XP_050042755.1;XP_050041386.1;XP_050035620.1;XP_050041725.1;XP_050039028.1;XP_050045145.1;XP_050050532.1;XP_050039872.1;XP_050037012.1;XP_050035033.1;XP_050022980.1;XP_050035481.1;XP_050039029.1
Reactome: R-HSA-380994	ATF4 activates genes in response to endoplasmic reticulum stress	23	XP_050040211.1;XP_050049165.1;XP_050049167.1;XP_050051195.1;XP_050040214.1;XP_050041683.1;XP_050039289.1;XP_050032757.1;XP_050041684.1;XP_050040640.1;XP_050049122.1;XP_050040210.1;XP_050035381.1;XP_050049123.1;XP_050037004.1;XP_050042417.1;XP_050040209.1;XP_050032756.1;XP_050023789.1;XP_050040213.1;XP_050040212.1;XP_050041682.1;XP_050049441.1
KEGG: 00052+2.7.7.9	Galactose metabolism	4	XP_050037410.1;XP_050037409.1;XP_050037412.1;XP_050037411.1
KEGG: 00330+1.2.1.41+2.7.2.11	Arginine and proline metabolism	1	XP_050049134.1
Reactome: R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	80	XP_050029644.1;XP_050029087.1;XP_050029649.1;XP_050047657.1;XP_050050506.1;XP_050029648.1;XP_050037100.1;XP_050051708.1;XP_050044191.1;XP_050051710.1;XP_050022836.1;XP_050026519.1;XP_050023334.1;XP_050032521.1;XP_050044608.1;XP_050048534.1;XP_050032519.1;XP_050049691.1;XP_050029647.1;XP_050042242.1;XP_050039510.1;XP_050036757.1;XP_050032853.1;XP_050041634.1;XP_050036756.1;XP_050047655.1;XP_050040246.1;XP_050042260.1;XP_050042241.1;XP_050026078.1;XP_050042454.1;XP_050032522.1;XP_050023809.1;XP_050042240.1;XP_050050820.1;XP_050032518.1;XP_050026080.1;XP_050028603.1;XP_050047658.1;XP_050032654.1;XP_050029370.1;XP_050026076.1;XP_050042261.1;XP_050044197.1;XP_050023312.1;XP_050026075.1;XP_050050919.1;XP_050028849.1;XP_050036758.1;XP_050044199.1;XP_050051709.1;XP_050050029.1;XP_050039071.1;XP_050050819.1;XP_050042262.1;XP_050032655.1;XP_050044198.1;XP_050032520.1;XP_050031823.1;XP_050044194.1;XP_050039072.1;XP_050029645.1;XP_050026077.1;XP_050044609.1;XP_050032517.1;XP_050029320.1;XP_050048294.1;XP_050044193.1;XP_050035481.1;XP_050023422.1;XP_050023796.1;XP_050048363.1;XP_050028745.1;XP_050049690.1;XP_050044192.1;XP_050022842.1;XP_050026079.1;XP_050029646.1;XP_050044195.1;XP_050027890.1
Reactome: R-HSA-1660661	Sphingolipid de novo biosynthesis	16	XP_050051836.1;XP_050051835.1;XP_050048818.1;XP_050035255.1;XP_050048816.1;XP_050041701.1;XP_050044090.1;XP_050022492.1;XP_050022494.1;XP_050022495.1;XP_050045406.1;XP_050043903.1;XP_050048815.1;XP_050037297.1;XP_050044091.1;XP_050022493.1
Reactome: R-HSA-9034864	Activated NTRK3 signals through RAS	1	XP_050032853.1
Reactome: R-HSA-2980766	Nuclear Envelope Breakdown	1	XP_050030707.1
Reactome: R-HSA-5693607	Processing of DNA double-strand break ends	58	XP_050030920.1;XP_050044695.1;XP_050032478.1;XP_050030939.1;XP_050047551.1;XP_050046064.1;XP_050023494.1;XP_050028323.1;XP_050022980.1;XP_050044213.1;XP_050051397.1;XP_050035481.1;XP_050022581.1;XP_050029342.1;XP_050025244.1;XP_050048499.1;XP_050046062.1;XP_050038612.1;XP_050050532.1;XP_050025248.1;XP_050038213.1;XP_050038964.1;XP_050034961.1;XP_050036675.1;XP_050045930.1;XP_050042755.1;XP_050022606.1;XP_050044807.1;XP_050036676.1;XP_050048896.1;XP_050034408.1;XP_050024165.1;XP_050025266.1;XP_050035537.1;XP_050025144.1;XP_050022604.1;XP_050022605.1;XP_050029852.1;XP_050034960.1;XP_050037414.1;XP_050028292.1;XP_050022603.1;XP_050033903.1;XP_050030921.1;XP_050033904.1;XP_050025243.1;XP_050043980.1;XP_050042401.1;XP_050038965.1;XP_050036268.1;XP_050038963.1;XP_050045121.1;XP_050038199.1;XP_050032647.1;XP_050022602.1;XP_050036207.1;XP_050048534.1;XP_050030938.1
Reactome: R-HSA-427652	Sodium-coupled phosphate cotransporters	4	XP_050039133.1;XP_050039135.1;XP_050039134.1;XP_050039132.1
MetaCyc: PWY-4041	Gamma-glutamyl cycle	43	XP_050030014.1;XP_050025492.1;XP_050041754.1;XP_050036058.1;XP_050025489.1;XP_050025457.1;XP_050030123.1;XP_050023398.1;XP_050029058.1;XP_050025413.1;XP_050028992.1;XP_050029054.1;XP_050024014.1;XP_050024805.1;XP_050043742.1;XP_050029240.1;XP_050031599.1;XP_050029056.1;XP_050030373.1;XP_050025508.1;XP_050029072.1;XP_050029055.1;XP_050043741.1;XP_050027823.1;XP_050022874.1;XP_050029059.1;XP_050029053.1;XP_050029960.1;XP_050025650.1;XP_050025461.1;XP_050024015.1;XP_050031589.1;XP_050025459.1;XP_050029305.1;XP_050025460.1;XP_050025493.1;XP_050025458.1;XP_050025491.1;XP_050029057.1;XP_050025490.1;XP_050029052.1;XP_050031611.1;XP_050029071.1
KEGG: 00380+3.5.1.9	Tryptophan metabolism	11	XP_050040581.1;XP_050035077.1;XP_050040577.1;XP_050040417.1;XP_050040584.1;XP_050040418.1;XP_050040583.1;XP_050040415.1;XP_050040416.1;XP_050040580.1;XP_050040419.1
KEGG: 00620+6.4.1.2	Pyruvate metabolism	12	XP_050048461.1;XP_050048456.1;XP_050048462.1;XP_050048468.1;XP_050048467.1;XP_050048457.1;XP_050048459.1;XP_050048460.1;XP_050048463.1;XP_050048466.1;XP_050048458.1;XP_050048465.1
MetaCyc: PWY-5265	Peptidoglycan biosynthesis II (staphylococci)	3	XP_050033583.1;XP_050033584.1;XP_050034973.1
MetaCyc: PWY-7411	Phosphatidate biosynthesis (yeast)	12	XP_050047027.1;XP_050037775.1;XP_050050583.1;XP_050047026.1;XP_050037856.1;XP_050027416.1;XP_050037855.1;XP_050037854.1;XP_050027415.1;XP_050032357.1;XP_050037857.1;XP_050034614.1
Reactome: R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	18	XP_050042105.1;XP_050042109.1;XP_050042111.1;XP_050023177.1;XP_050044424.1;XP_050029917.1;XP_050032121.1;XP_050025622.1;XP_050042108.1;XP_050032122.1;XP_050025623.1;XP_050029919.1;XP_050042112.1;XP_050042110.1;XP_050025879.1;XP_050029918.1;XP_050042107.1;XP_050042106.1
KEGG: 00670+4.3.1.4+2.1.2.5	One carbon pool by folate	1	XP_050045421.1
MetaCyc: PWY-3781	Aerobic respiration I (cytochrome c)	7	XP_050033843.1;XP_050033718.1;YP_010283869.1;YP_010283878.1;XP_050033719.1;XP_050038590.1;XP_050047841.1
MetaCyc: PWY-1801	Formaldehyde oxidation II (glutathione-dependent)	4	XP_050049682.1;XP_050052302.1;XP_050052400.1;XP_050052301.1
Reactome: R-HSA-2500257	Resolution of Sister Chromatid Cohesion	122	XP_050047338.1;XP_050040792.1;XP_050029374.1;XP_050025910.1;XP_050039305.1;XP_050033432.1;XP_050047136.1;XP_050026883.1;XP_050029375.1;XP_050035114.1;XP_050040143.1;XP_050035973.1;XP_050036430.1;XP_050035977.1;XP_050046838.1;XP_050052055.1;XP_050030509.1;XP_050035116.1;XP_050040054.1;XP_050037090.1;XP_050027083.1;XP_050035992.1;XP_050039380.1;XP_050029897.1;XP_050028218.1;XP_050051356.1;XP_050039518.1;XP_050043181.1;XP_050035989.1;XP_050047994.1;XP_050047996.1;XP_050048776.1;XP_050044509.1;XP_050033477.1;XP_050030513.1;XP_050049762.1;XP_050042732.1;XP_050047997.1;XP_050035988.1;XP_050035985.1;XP_050046837.1;XP_050027084.1;XP_050030515.1;XP_050044008.1;XP_050047137.1;XP_050049757.1;XP_050048777.1;XP_050035984.1;XP_050035982.1;XP_050027567.1;XP_050034683.1;XP_050035981.1;XP_050029297.1;XP_050035980.1;XP_050052697.1;XP_050030512.1;XP_050046735.1;XP_050039306.1;XP_050044467.1;XP_050035976.1;XP_050028217.1;XP_050027568.1;XP_050035933.1;XP_050035986.1;XP_050035978.1;XP_050040051.1;XP_050051355.1;XP_050035991.1;XP_050038895.1;XP_050029298.1;XP_050045597.1;XP_050042728.1;XP_050045443.1;XP_050029077.1;XP_050030511.1;XP_050024840.1;XP_050035974.1;XP_050035983.1;XP_050035987.1;XP_050042731.1;XP_050040049.1;XP_050042730.1;XP_050029076.1;XP_050041693.1;XP_050025911.1;XP_050039381.1;XP_050035990.1;XP_050042727.1;XP_050024518.1;XP_050047564.1;XP_050049761.1;XP_050042706.1;XP_050049759.1;XP_050024841.1;XP_050040050.1;XP_050028813.1;XP_050030514.1;XP_050052420.1;XP_050047139.1;XP_050027566.1;XP_050048775.1;XP_050046734.1;XP_050035993.1;XP_050047138.1;XP_050040052.1;XP_050038418.1;XP_050035979.1;XP_050049377.1;XP_050051357.1;XP_050029078.1;XP_050035119.1;XP_050035482.1;XP_050042726.1;XP_050033146.1;XP_050047998.1;XP_050049758.1;XP_050046156.1;XP_050035975.1;XP_050035932.1;XP_050047995.1;XP_050045051.1;XP_050023718.1
Reactome: R-HSA-170968	Frs2-mediated activation	2	XP_050047606.1;XP_050047598.1
Reactome: R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	20	XP_050049165.1;XP_050051195.1;XP_050049167.1;XP_050045480.1;XP_050039289.1;XP_050041683.1;XP_050041684.1;XP_050049122.1;XP_050040640.1;XP_050032479.1;XP_050035381.1;XP_050049123.1;XP_050037004.1;XP_050023789.1;XP_050045481.1;XP_050041682.1;XP_050031590.1;XP_050031163.1;XP_050045479.1;XP_050049441.1
Reactome: R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1	XP_050025879.1
KEGG: 00760+1.4.1.21	Nicotinate and nicotinamide metabolism	4	XP_050048789.1;XP_050048790.1;XP_050048791.1;XP_050048788.1
KEGG: 00240+4.1.1.23	Pyrimidine metabolism	1	XP_050023639.1
MetaCyc: PWY-8052	2-arachidonoylglycerol biosynthesis	14	XP_050042251.1;XP_050042250.1;XP_050037456.1;XP_050048141.1;XP_050037455.1;XP_050037458.1;XP_050042252.1;XP_050038435.1;XP_050047067.1;XP_050042253.1;XP_050038409.1;XP_050048140.1;XP_050037457.1;XP_050042022.1
KEGG: 05163+2.7.1.153	Human cytomegalovirus infection	2	XP_050052756.1;XP_050028399.1
Reactome: R-HSA-399719	Trafficking of AMPA receptors	27	XP_050026258.1;XP_050050696.1;XP_050050689.1;XP_050050694.1;XP_050050697.1;XP_050050691.1;XP_050050698.1;XP_050050680.1;XP_050050681.1;XP_050050684.1;XP_050050687.1;XP_050050702.1;XP_050050699.1;XP_050026259.1;XP_050050685.1;XP_050050682.1;XP_050050683.1;XP_050050695.1;XP_050026257.1;XP_050050686.1;XP_050050690.1;XP_050050700.1;XP_050050688.1;XP_050050679.1;XP_050050693.1;XP_050050692.1;XP_050050701.1
KEGG: 00051+4.1.2.13	Fructose and mannose metabolism	2	XP_050025560.1;XP_050025561.1
Reactome: R-HSA-1251985	Nuclear signaling by ERBB4	17	XP_050043659.1;XP_050031262.1;XP_050035872.1;XP_050026914.1;XP_050026551.1;XP_050037416.1;XP_050051864.1;XP_050023628.1;XP_050027801.1;XP_050037415.1;XP_050034653.1;XP_050048893.1;XP_050051865.1;XP_050043649.1;XP_050051866.1;XP_050026843.1;XP_050051868.1
KEGG: 00230+1.17.4.1	Purine metabolism	2	XP_050038800.1;XP_050030600.1
Reactome: R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1	XP_050045897.1
Reactome: R-HSA-6794361	Neurexins and neuroligins	22	XP_050051838.1;XP_050046951.1;XP_050040727.1;XP_050031828.1;XP_050051839.1;XP_050049319.1;XP_050027422.1;XP_050027421.1;XP_050047657.1;XP_050047655.1;XP_050034684.1;XP_050046869.1;XP_050048381.1;XP_050031827.1;XP_050040729.1;XP_050034685.1;XP_050048384.1;XP_050048383.1;XP_050031826.1;XP_050046952.1;XP_050047658.1;XP_050048382.1
MetaCyc: PWY-7193	Pyrimidine ribonucleosides salvage I	8	XP_050031817.1;XP_050025363.1;XP_050024419.1;XP_050024420.1;XP_050031819.1;XP_050031820.1;XP_050031818.1;XP_050025364.1
Reactome: R-HSA-211945	Phase I - Functionalization of compounds	2	XP_050028257.1;XP_050027825.1
Reactome: R-HSA-383280	Nuclear Receptor transcription pathway	74	XP_050027721.1;XP_050049454.1;XP_050049227.1;XP_050033344.1;XP_050047285.1;XP_050042257.1;XP_050029958.1;XP_050049229.1;XP_050027574.1;XP_050049228.1;XP_050049216.1;XP_050030943.1;XP_050049453.1;XP_050033371.1;XP_050027175.1;XP_050045237.1;XP_050033343.1;XP_050050374.1;XP_050049230.1;XP_050045295.1;XP_050049222.1;XP_050049533.1;XP_050044963.1;XP_050051156.1;XP_050027719.1;XP_050042255.1;XP_050049663.1;XP_050043924.1;XP_050027720.1;XP_050040259.1;XP_050027724.1;XP_050027575.1;XP_050049225.1;XP_050033345.1;XP_050030944.1;XP_050034681.1;XP_050043764.1;XP_050039558.1;XP_050027173.1;XP_050044962.1;XP_050052827.1;XP_050049224.1;XP_050033342.1;XP_050027576.1;XP_050049532.1;XP_050045296.1;XP_050045238.1;XP_050027959.1;XP_050049673.1;XP_050047284.1;XP_050027722.1;XP_050049226.1;XP_050049662.1;XP_050049452.1;XP_050047402.1;XP_050029940.1;XP_050027578.1;XP_050047287.1;XP_050027577.1;XP_050040258.1;XP_050047286.1;XP_050051155.1;XP_050033346.1;XP_050027573.1;XP_050049221.1;XP_050049217.1;XP_050049223.1;XP_050042258.1;XP_050027174.1;XP_050028145.1;XP_050049219.1;XP_050049218.1;XP_050027723.1;XP_050045239.1
KEGG: 00430+2.3.2.2	Taurine and hypotaurine metabolism	42	XP_050030123.1;XP_050030014.1;XP_050025492.1;XP_050036058.1;XP_050025489.1;XP_050025457.1;XP_050029058.1;XP_050025413.1;XP_050028992.1;XP_050023398.1;XP_050024014.1;XP_050029054.1;XP_050025508.1;XP_050031599.1;XP_050043742.1;XP_050024805.1;XP_050029240.1;XP_050029056.1;XP_050030373.1;XP_050029055.1;XP_050043741.1;XP_050027823.1;XP_050022874.1;XP_050029072.1;XP_050025461.1;XP_050029053.1;XP_050029059.1;XP_050025650.1;XP_050029960.1;XP_050029305.1;XP_050025460.1;XP_050025493.1;XP_050031589.1;XP_050024015.1;XP_050025459.1;XP_050029057.1;XP_050025491.1;XP_050029052.1;XP_050031611.1;XP_050025490.1;XP_050029071.1;XP_050025458.1
Reactome: R-HSA-1483148	Synthesis of PG	12	XP_050047862.1;XP_050034951.1;XP_050032863.1;XP_050050471.1;XP_050050470.1;XP_050047984.1;XP_050029506.1;XP_050034952.1;XP_050047861.1;XP_050047860.1;XP_050029507.1;XP_050050469.1
Reactome: R-HSA-2424491	DAP12 signaling	3	XP_050032853.1;XP_050048140.1;XP_050048141.1
Reactome: R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	2	XP_050048534.1;XP_050035481.1
Reactome: R-HSA-390648	Muscarinic acetylcholine receptors	4	XP_050034836.1;XP_050037497.1;XP_050037503.1;XP_050034835.1
KEGG: 00513+3.2.1.52	Various types of N-glycan biosynthesis	31	XP_050039363.1;XP_050026983.1;XP_050026917.1;XP_050026985.1;XP_050026981.1;XP_050049136.1;XP_050049366.1;XP_050028195.1;XP_050025618.1;XP_050035570.1;XP_050030481.1;XP_050028196.1;XP_050026984.1;XP_050025616.1;XP_050049140.1;XP_050038974.1;XP_050025615.1;XP_050049367.1;XP_050039361.1;XP_050030479.1;XP_050026982.1;XP_050025617.1;XP_050049137.1;XP_050049139.1;XP_050049141.1;XP_050030480.1;XP_050039362.1;XP_050049138.1;XP_050043064.1;XP_050027975.1;XP_050036110.1
Reactome: R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	22	XP_050027634.1;XP_050033013.1;XP_050051719.1;XP_050040236.1;XP_050024189.1;XP_050032577.1;XP_050032579.1;XP_050046123.1;XP_050023463.1;XP_050033431.1;XP_050032546.1;XP_050045195.1;XP_050044200.1;XP_050040196.1;XP_050034644.1;XP_050037088.1;XP_050036394.1;XP_050032523.1;XP_050034643.1;XP_050032578.1;XP_050033476.1;XP_050044013.1
Reactome: R-HSA-193692	Regulated proteolysis of p75NTR	13	XP_050023628.1;XP_050027801.1;XP_050037416.1;XP_050043649.1;XP_050034653.1;XP_050037415.1;XP_050026843.1;XP_050035872.1;XP_050043659.1;XP_050031262.1;XP_050026551.1;XP_050026914.1;XP_050048893.1
Reactome: R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	10	XP_050034001.1;XP_050033999.1;XP_050051087.1;XP_050051109.1;XP_050051067.1;XP_050051080.1;XP_050044965.1;XP_050051098.1;XP_050034000.1;XP_050051073.1
KEGG: 00670+1.5.1.5+3.5.4.9	One carbon pool by folate	3	XP_050048637.1;XP_050052682.1;XP_050052683.1
KEGG: 00500+2.4.1.11	Starch and sucrose metabolism	1	XP_050040570.1
MetaCyc: PWY-601	Glucosinolate biosynthesis from tryptophan	6	XP_050050545.1;XP_050052715.1;XP_050052716.1;XP_050050544.1;XP_050052719.1;XP_050052721.1
KEGG: 00030+1.1.1.44	Pentose phosphate pathway	2	XP_050051191.1;XP_050051182.1
Reactome: R-HSA-8847993	ERBB2 Activates PTK6 Signaling	7	XP_050044781.1;XP_050051864.1;XP_050044786.1;XP_050044784.1;XP_050051866.1;XP_050051865.1;XP_050051868.1
KEGG: 00534+2.4.2.26	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3	XP_050032785.1;XP_050032783.1;XP_050032784.1
MetaCyc: PWY-6700	Queuosine biosynthesis I (de novo)	2	XP_050051592.1;XP_050027731.1
MetaCyc: PWY-5154	L-arginine biosynthesis III (via N-acetyl-L-citrulline)	4	XP_050052351.1;XP_050032255.1;XP_050045223.1;XP_050045233.1
KEGG: 00480+6.3.2.3	Glutathione metabolism	3	XP_050042925.1;XP_050042926.1;XP_050042924.1
Reactome: R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	9	XP_050044784.1;XP_050044786.1;XP_050047065.1;XP_050051864.1;XP_050044781.1;XP_050032853.1;XP_050051868.1;XP_050051866.1;XP_050051865.1
MetaCyc: PWY-7420	Monoacylglycerol metabolism (yeast)	4	XP_050032596.1;XP_050038707.1;XP_050038705.1;XP_050038706.1
Reactome: R-HSA-5223345	Miscellaneous transport and binding events	16	XP_050027558.1;XP_050027551.1;XP_050027554.1;XP_050027556.1;XP_050027553.1;XP_050027555.1;XP_050027550.1;XP_050027557.1;XP_050040028.1;XP_050040029.1;XP_050040026.1;XP_050027559.1;XP_050040027.1;XP_050027560.1;XP_050048520.1;XP_050027552.1
KEGG: 00625+1.1.1.1	Chloroalkane and chloroalkene degradation	3	XP_050052400.1;XP_050052302.1;XP_050052301.1
Reactome: R-HSA-70268	Pyruvate metabolism	5	XP_050025621.1;XP_050036755.1;XP_050026566.1;XP_050027474.1;XP_050039504.1
KEGG: 00770+2.7.1.33	Pantothenate and CoA biosynthesis	5	XP_050042906.1;XP_050049381.1;XP_050049382.1;XP_050049380.1;XP_050049379.1
Reactome: R-HSA-5389840	Mitochondrial translation elongation	75	XP_050037838.1;XP_050041975.1;XP_050028163.1;XP_050032857.1;XP_050028096.1;XP_050026521.1;XP_050037279.1;XP_050044835.1;XP_050042718.1;XP_050043556.1;XP_050045126.1;XP_050050913.1;XP_050040023.1;XP_050039125.1;XP_050023640.1;XP_050039649.1;XP_050041219.1;XP_050039627.1;XP_050039616.1;XP_050023265.1;XP_050045057.1;XP_050044790.1;XP_050029104.1;XP_050027247.1;XP_050045271.1;XP_050045058.1;XP_050034817.1;XP_050030729.1;XP_050042030.1;XP_050027137.1;XP_050041163.1;XP_050036221.1;XP_050041976.1;XP_050027133.1;XP_050031801.1;XP_050026332.1;XP_050022527.1;XP_050036486.1;XP_050030728.1;XP_050046959.1;XP_050047641.1;XP_050036704.1;XP_050036878.1;XP_050047319.1;XP_050027066.1;XP_050049331.1;XP_050027321.1;XP_050045284.1;XP_050035998.1;XP_050052609.1;XP_050042269.1;XP_050031800.1;XP_050049763.1;XP_050025036.1;XP_050022476.1;XP_050038468.1;XP_050051717.1;XP_050051211.1;XP_050027420.1;XP_050047642.1;XP_050041220.1;XP_050033257.1;XP_050047054.1;XP_050042040.1;XP_050047314.1;XP_050035939.1;XP_050028172.1;XP_050027411.1;XP_050046197.1;XP_050035316.1;XP_050027674.1;XP_050029555.1;XP_050052189.1;XP_050042050.1;XP_050038683.1
Reactome: R-HSA-9665246	Resistance of ERBB2 KD mutants to neratinib	2	XP_050048201.1;XP_050048200.1
KEGG: 00510+2.4.1.267	N-Glycan biosynthesis	1	XP_050023594.1
Reactome: R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	3	XP_050027018.1;XP_050023266.1;XP_050028252.1
KEGG: 00240+3.6.1.12	Pyrimidine metabolism	1	XP_050049688.1
Reactome: R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1	XP_050045897.1
Reactome: R-HSA-1482922	Acyl chain remodelling of PI	4	XP_050050549.1;XP_050033390.1;XP_050025686.1;XP_050025400.1
MetaCyc: PWY-8072	Alanine racemization	1	XP_050026567.1
Reactome: R-HSA-5602498	MyD88 deficiency (TLR2/4)	1	XP_050024508.1
Reactome: R-HSA-196783	Coenzyme A biosynthesis	7	XP_050042906.1;XP_050035188.1;XP_050049381.1;XP_050049382.1;XP_050023905.1;XP_050049380.1;XP_050049379.1
MetaCyc: PWY-5316	Nicotine biosynthesis	4	XP_050042238.1;XP_050042265.1;XP_050042247.1;XP_050042256.1
MetaCyc: PWY-5690	TCA cycle II (plants and fungi)	24	XP_050037167.1;XP_050042702.1;XP_050037166.1;XP_050043005.1;XP_050037164.1;XP_050037417.1;XP_050026353.1;XP_050033719.1;XP_050045192.1;XP_050037925.1;XP_050033718.1;XP_050049076.1;XP_050035735.1;XP_050037172.1;XP_050042703.1;XP_050033843.1;XP_050037165.1;XP_050037169.1;XP_050037926.1;XP_050038590.1;XP_050037168.1;XP_050042704.1;XP_050026352.1;XP_050049075.1
MetaCyc: PWY-7799	Arg/N-end rule pathway (eukaryotic)	13	XP_050051770.1;XP_050030645.1;XP_050026685.1;XP_050051773.1;XP_050027670.1;XP_050027667.1;XP_050027669.1;XP_050051772.1;XP_050027668.1;XP_050032600.1;XP_050051771.1;XP_050033366.1;XP_050032601.1
Reactome: R-HSA-5205685	Pink/Parkin Mediated Mitophagy	10	XP_050035481.1;XP_050048534.1;XP_050029936.1;XP_050030100.1;XP_050025941.1;XP_050025942.1;XP_050024240.1;XP_050026264.1;XP_050025603.1;XP_050026263.1
KEGG: 00514+2.4.1.221	Other types of O-glycan biosynthesis	3	XP_050024357.1;XP_050024358.1;XP_050024359.1
KEGG: 00770+2.6.1.42	Pantothenate and CoA biosynthesis	1	XP_050039540.1
KEGG: 00640+2.6.1.19	Propanoate metabolism	1	XP_050041758.1
Reactome: R-HSA-9649948	Signaling downstream of RAS mutants	34	XP_050050684.1;XP_050050687.1;XP_050050681.1;XP_050050698.1;XP_050050685.1;XP_050050696.1;XP_050050697.1;XP_050024175.1;XP_050024179.1;XP_050050686.1;XP_050050700.1;XP_050050690.1;XP_050050701.1;XP_050023932.1;XP_050050679.1;XP_050050683.1;XP_050024178.1;XP_050050699.1;XP_050050702.1;XP_050047606.1;XP_050050680.1;XP_050024176.1;XP_050050691.1;XP_050050694.1;XP_050050689.1;XP_050050688.1;XP_050024180.1;XP_050050692.1;XP_050050693.1;XP_050047598.1;XP_050050682.1;XP_050039818.1;XP_050050695.1;XP_050024177.1
Reactome: R-HSA-6809371	Formation of the cornified envelope	35	XP_050027839.1;XP_050024791.1;XP_050026170.1;XP_050027840.1;XP_050027157.1;XP_050027650.1;XP_050023992.1;XP_050027965.1;XP_050042611.1;XP_050046753.1;XP_050023979.1;XP_050026168.1;XP_050048067.1;XP_050027966.1;XP_050027156.1;XP_050046595.1;XP_050046754.1;XP_050048066.1;XP_050042604.1;XP_050027769.1;XP_050050278.1;XP_050046692.1;XP_050026169.1;XP_050046752.1;XP_050046725.1;XP_050046755.1;XP_050046766.1;XP_050026240.1;XP_050046727.1;XP_050024785.1;XP_050024786.1;XP_050023964.1;XP_050042597.1;XP_050023985.1;XP_050023957.1
Reactome: R-HSA-6807505	RNA polymerase II transcribes snRNA genes	62	XP_050034031.1;XP_050038469.1;XP_050026414.1;XP_050049613.1;XP_050034643.1;XP_050034964.1;XP_050044013.1;XP_050023730.1;XP_050033476.1;XP_050046968.1;XP_050043036.1;XP_050033368.1;XP_050023726.1;XP_050026697.1;XP_050046063.1;XP_050050855.1;XP_050032071.1;XP_050023729.1;XP_050023313.1;XP_050033431.1;XP_050040107.1;XP_050023779.1;XP_050048718.1;XP_050034981.1;XP_050044947.1;XP_050043147.1;XP_050023725.1;XP_050048717.1;XP_050025635.1;XP_050034505.1;XP_050044948.1;XP_050040671.1;XP_050034965.1;XP_050041862.1;XP_050043035.1;XP_050044200.1;XP_050045189.1;XP_050023776.1;XP_050025920.1;XP_050025922.1;XP_050034644.1;XP_050043034.1;XP_050034030.1;XP_050023728.1;XP_050046123.1;XP_050030160.1;XP_050040647.1;XP_050041904.1;XP_050025923.1;XP_050043037.1;XP_050045116.1;XP_050044805.1;XP_050023777.1;XP_050044778.1;XP_050023727.1;XP_050025921.1;XP_050045910.1;XP_050023724.1;XP_050024153.1;XP_050025919.1;XP_050044812.1;XP_050024189.1
MetaCyc: PWY-5642	2,4-dinitrotoluene degradation	1	XP_050036825.1
Reactome: R-HSA-5250924	B-WICH complex positively regulates rRNA expression	27	XP_050038199.1;XP_050045531.1;XP_050028889.1;XP_050045588.1;XP_050046123.1;XP_050025248.1;XP_050045646.1;XP_050038213.1;XP_050024189.1;XP_050045040.1;XP_050023813.1;XP_050025243.1;XP_050030957.1;XP_050036268.1;XP_050045647.1;XP_050034643.1;XP_050032466.1;XP_050037436.1;XP_050024718.1;XP_050023814.1;XP_050025244.1;XP_050025266.1;XP_050034644.1;XP_050037088.1;XP_050045532.1;XP_050044393.1;XP_050045530.1
Reactome: R-HSA-1442490	Collagen degradation	15	XP_050024453.1;XP_050034209.1;XP_050052132.1;XP_050052730.1;XP_050044081.1;XP_050044654.1;XP_050024936.1;XP_050034595.1;XP_050024935.1;XP_050044129.1;XP_050026551.1;XP_050033321.1;XP_050044127.1;XP_050051572.1;XP_050044128.1
MetaCyc: PWY-7892	Trna-uridine 2-thiolation and selenation (bacteria)	3	XP_050033201.1;XP_050033199.1;XP_050033200.1
KEGG: 00630+4.2.1.3	Glyoxylate and dicarboxylate metabolism	3	XP_050033512.1;XP_050033513.1;XP_050032828.1
Reactome: R-HSA-5626978	TNFR1-mediated ceramide production	2	XP_050047118.1;XP_050047117.1
Reactome: R-HSA-6783984	Glycine degradation	9	XP_050023416.1;XP_050032566.1;XP_050032971.1;XP_050026566.1;XP_050049590.1;XP_050032565.1;XP_050032563.1;XP_050032564.1;XP_050030625.1
Reactome: R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	24	XP_050026017.1;XP_050036138.1;XP_050035378.1;XP_050050601.1;XP_050046148.1;XP_050024395.1;XP_050048621.1;XP_050031701.1;XP_050033368.1;XP_050037098.1;XP_050046150.1;XP_050037097.1;XP_050046147.1;XP_050039527.1;XP_050033968.1;XP_050037096.1;XP_050046149.1;XP_050037094.1;XP_050031698.1;XP_050048620.1;XP_050039528.1;XP_050045300.1;XP_050048619.1;XP_050037095.1
Reactome: R-HSA-5678520	Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2	4	XP_050042819.1;XP_050042593.1;XP_050042814.1;XP_050042821.1
Reactome: R-HSA-5362517	Signaling by Retinoic Acid	6	XP_050025621.1;XP_050026566.1;XP_050035176.1;XP_050028615.1;XP_050027474.1;XP_050039504.1
KEGG: 00730+2.8.1.7	Thiamine metabolism	3	XP_050025344.1;XP_050041676.1;XP_050025345.1
MetaCyc: PWY-7571	Ferrichrome A biosynthesis	5	XP_050041696.1;XP_050041691.1;XP_050041695.1;XP_050041694.1;XP_050041692.1
KEGG: 00900+2.1.1.100	Terpenoid backbone biosynthesis	1	XP_050025361.1
Reactome: R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	18	XP_050043181.1;XP_050049758.1;XP_050046735.1;XP_050049757.1;XP_050051356.1;XP_050051357.1;XP_050024840.1;XP_050039380.1;XP_050052420.1;XP_050049762.1;XP_050046734.1;XP_050052055.1;XP_050051355.1;XP_050039381.1;XP_050047338.1;XP_050049759.1;XP_050024841.1;XP_050049761.1
KEGG: 00730+2.2.1.7	Thiamine metabolism	2	XP_050027584.1;XP_050027585.1
MetaCyc: PWY-6606	Guanosine nucleotides degradation II	1	XP_050049541.1
Reactome: R-HSA-177504	Retrograde neurotrophin signalling	4	XP_050037100.1;XP_050028603.1;XP_050040246.1;XP_050048294.1
Reactome: R-HSA-8943723	Regulation of PTEN mRNA translation	26	XP_050028353.1;XP_050026046.1;XP_050026223.1;XP_050029861.1;XP_050023605.1;XP_050051915.1;XP_050029826.1;XP_050051916.1;XP_050052226.1;XP_050032553.1;XP_050052512.1;XP_050029337.1;XP_050039235.1;XP_050052225.1;XP_050029824.1;XP_050029860.1;XP_050029825.1;XP_050029859.1;XP_050026047.1;XP_050029827.1;XP_050029858.1;XP_050039236.1;XP_050051917.1;XP_050029862.1;XP_050029336.1;XP_050029338.1
Reactome: R-HSA-8943724	Regulation of PTEN gene transcription	49	XP_050046119.1;XP_050044957.1;XP_050029405.1;XP_050044488.1;XP_050044489.1;XP_050027194.1;XP_050032859.1;XP_050050753.1;XP_050048349.1;XP_050031736.1;XP_050040015.1;XP_050041412.1;XP_050050752.1;XP_050050757.1;XP_050048804.1;XP_050026960.1;XP_050026957.1;XP_050044956.1;XP_050027195.1;XP_050029891.1;XP_050051444.1;XP_050029408.1;XP_050025348.1;XP_050032858.1;XP_050029406.1;XP_050044958.1;XP_050031628.1;XP_050046120.1;XP_050050756.1;XP_050026959.1;XP_050043540.1;XP_050029831.1;XP_050025347.1;XP_050047598.1;XP_050029889.1;XP_050051442.1;XP_050050754.1;XP_050043466.1;XP_050029890.1;XP_050051443.1;XP_050029407.1;XP_050045444.1;XP_050051441.1;XP_050029887.1;XP_050044955.1;XP_050047606.1;XP_050026958.1;XP_050029409.1;XP_050023625.1
KEGG: 00980+1.1.1.1	Metabolism of xenobiotics by cytochrome P450	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
Reactome: R-HSA-193048	Androgen biosynthesis	2	XP_050050944.1;XP_050050945.1
Reactome: R-HSA-4570464	SUMOylation of RNA binding proteins	41	XP_050035770.1;XP_050038865.1;XP_050038864.1;XP_050024518.1;XP_050042392.1;XP_050023475.1;XP_050031628.1;XP_050023476.1;XP_050044008.1;XP_050030653.1;XP_050049377.1;XP_050038968.1;XP_050038866.1;XP_050033146.1;XP_050044204.1;XP_050026810.1;XP_050029516.1;XP_050038862.1;XP_050023718.1;XP_050046156.1;XP_050035932.1;XP_050026809.1;XP_050035933.1;XP_050044202.1;XP_050029515.1;XP_050023474.1;XP_050036430.1;XP_050042391.1;XP_050038895.1;XP_050030942.1;XP_050038863.1;XP_050038969.1;XP_050044203.1;XP_050030652.1;XP_050030506.1;XP_050038966.1;XP_050030507.1;XP_050038967.1;XP_050036827.1;XP_050039240.1;XP_050025064.1
Reactome: R-HSA-5654706	FRS-mediated FGFR3 signaling	2	XP_050032853.1;XP_050048507.1
KEGG: 00010+1.8.1.4	Glycolysis / Gluconeogenesis	1	XP_050026566.1
Reactome: R-HSA-375276	Peptide ligand-binding receptors	22	XP_050039607.1;XP_050040293.1;XP_050032774.1;XP_050046184.1;XP_050031300.1;XP_050030182.1;XP_050048217.1;XP_050052126.1;XP_050040294.1;XP_050039647.1;XP_050040290.1;XP_050030876.1;XP_050029589.1;XP_050040289.1;XP_050040292.1;XP_050042463.1;XP_050031301.1;XP_050032453.1;XP_050044540.1;XP_050029683.1;XP_050040288.1;XP_050042308.1
Reactome: R-HSA-674695	RNA Polymerase II Pre-transcription Events	75	XP_050044597.1;XP_050043147.1;XP_050023725.1;XP_050048717.1;XP_050031536.1;XP_050032071.1;XP_050023779.1;XP_050048718.1;XP_050045190.1;XP_050040428.1;XP_050043138.1;XP_050039068.1;XP_050039484.1;XP_050022472.1;XP_050026414.1;XP_050034031.1;XP_050045372.1;XP_050023777.1;XP_050030280.1;XP_050049297.1;XP_050049296.1;XP_050047588.1;XP_050023728.1;XP_050034030.1;XP_050039485.1;XP_050045052.1;XP_050023577.1;XP_050042077.1;XP_050034644.1;XP_050045189.1;XP_050045027.1;XP_050040671.1;XP_050045300.1;XP_050051335.1;XP_050030810.1;XP_050051336.1;XP_050037137.1;XP_050034505.1;XP_050025635.1;XP_050023576.1;XP_050036381.1;XP_050046063.1;XP_050023729.1;XP_050033368.1;XP_050038988.1;XP_050023714.1;XP_050023726.1;XP_050034518.1;XP_050040427.1;XP_050030634.1;XP_050048255.1;XP_050038469.1;XP_050026035.1;XP_050031535.1;XP_050044472.1;XP_050023730.1;XP_050025563.1;XP_050046688.1;XP_050034643.1;XP_050023727.1;XP_050035378.1;XP_050034171.1;XP_050023724.1;XP_050024189.1;XP_050030811.1;XP_050037136.1;XP_050044473.1;XP_050046123.1;XP_050044010.1;XP_050031537.1;XP_050049295.1;XP_050049294.1;XP_050047361.1;XP_050045373.1;XP_050023776.1
KEGG: 00480+2.5.1.16	Glutathione metabolism	4	XP_050027526.1;XP_050027527.1;XP_050041589.1;XP_050041583.1
MetaCyc: PWY-5738	GDP-6-deoxy-D-talose biosynthesis	3	XP_050047838.1;XP_050047837.1;XP_050047839.1
KEGG: 00220+4.3.2.1	Arginine biosynthesis	2	XP_050045233.1;XP_050045223.1
Reactome: R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	1	XP_050039865.1
Reactome: R-HSA-70263	Gluconeogenesis	34	XP_050038404.1;XP_050037164.1;XP_050041662.1;XP_050038972.1;XP_050034554.1;XP_050036164.1;XP_050038132.1;XP_050037168.1;XP_050037172.1;XP_050036163.1;XP_050038121.1;XP_050038118.1;XP_050036456.1;XP_050041668.1;XP_050025561.1;XP_050038117.1;XP_050034972.1;XP_050038973.1;XP_050037166.1;XP_050036162.1;XP_050038116.1;XP_050037165.1;XP_050031435.1;XP_050051894.1;XP_050037169.1;XP_050025560.1;XP_050038127.1;XP_050034452.1;XP_050045451.1;XP_050038119.1;XP_050044414.1;XP_050034437.1;XP_050045192.1;XP_050050068.1
MetaCyc: PWY-4981	L-proline biosynthesis II (from arginine)	3	XP_050039554.1;XP_050048960.1;XP_050040888.1
KEGG: 00330+1.2.1.88	Arginine and proline metabolism	1	XP_050029177.1
Reactome: R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	87	XP_050027718.1;XP_050040901.1;XP_050040902.1;XP_050042079.1;XP_050051359.1;XP_050040908.1;XP_050046003.1;XP_050025001.1;XP_050040985.1;XP_050047081.1;XP_050030834.1;XP_050040904.1;XP_050026626.1;XP_050038602.1;XP_050051360.1;XP_050044843.1;XP_050022560.1;XP_050041885.1;XP_050051365.1;XP_050022569.1;XP_050040979.1;XP_050040983.1;XP_050026625.1;XP_050031529.1;XP_050042083.1;XP_050022817.1;XP_050040905.1;XP_050040980.1;XP_050022815.1;XP_050026624.1;XP_050033726.1;XP_050041886.1;XP_050036219.1;XP_050040986.1;XP_050033724.1;XP_050028746.1;XP_050035019.1;XP_050042082.1;XP_050051364.1;XP_050022814.1;XP_050051411.1;XP_050025020.1;XP_050040981.1;XP_050051362.1;XP_050040202.1;XP_050040982.1;XP_050042140.1;XP_050040899.1;XP_050042141.1;XP_050051361.1;XP_050046004.1;XP_050026623.1;XP_050022816.1;XP_050047080.1;XP_050026045.1;XP_050051363.1;XP_050038305.1;XP_050032594.1;XP_050050507.1;XP_050033836.1;XP_050040903.1;XP_050040897.1;XP_050033725.1;XP_050040909.1;XP_050033835.1;XP_050040898.1;XP_050046034.1;XP_050036373.1;XP_050040984.1;XP_050042081.1;XP_050025012.1;XP_050031330.1;XP_050043924.1;XP_050042080.1;XP_050039207.1;XP_050022818.1;XP_050035315.1;XP_050040900.1;XP_050040907.1;XP_050033834.1;XP_050027717.1;XP_050031490.1;XP_050045376.1;XP_050025006.1;XP_050040910.1;XP_050052316.1;XP_050040906.1
Reactome: R-HSA-418990	Adherens junctions interactions	2	XP_050049527.1;XP_050030651.1
Reactome: R-HSA-9665247	Resistance of ERBB2 KD mutants to osimertinib	2	XP_050048200.1;XP_050048201.1
Reactome: R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	17	XP_050048305.1;XP_050032981.1;XP_050033583.1;XP_050042031.1;XP_050023465.1;XP_050023466.1;XP_050039004.1;XP_050033404.1;XP_050039005.1;XP_050044996.1;XP_050047336.1;XP_050033584.1;XP_050025367.1;XP_050034973.1;XP_050026303.1;XP_050023594.1;XP_050039242.1
Reactome: R-HSA-5663220	RHO GTPases Activate Formins	121	XP_050038895.1;XP_050029298.1;XP_050051355.1;XP_050035991.1;XP_050051946.1;XP_050035933.1;XP_050035986.1;XP_050035978.1;XP_050027568.1;XP_050042731.1;XP_050042730.1;XP_050029076.1;XP_050041693.1;XP_050035987.1;XP_050035974.1;XP_050035983.1;XP_050024840.1;XP_050030511.1;XP_050042728.1;XP_050045443.1;XP_050029077.1;XP_050051948.1;XP_050025375.1;XP_050045597.1;XP_050039327.1;XP_050046734.1;XP_050027566.1;XP_050048775.1;XP_050052420.1;XP_050028813.1;XP_050030514.1;XP_050049759.1;XP_050024841.1;XP_050024518.1;XP_050047564.1;XP_050025374.1;XP_050042727.1;XP_050049761.1;XP_050042706.1;XP_050039381.1;XP_050035990.1;XP_050025911.1;XP_050047995.1;XP_050045051.1;XP_050023718.1;XP_050035975.1;XP_050046156.1;XP_050035932.1;XP_050047998.1;XP_050033146.1;XP_050049758.1;XP_050035482.1;XP_050035119.1;XP_050029078.1;XP_050042726.1;XP_050035979.1;XP_050049377.1;XP_050051357.1;XP_050038418.1;XP_050035993.1;XP_050051949.1;XP_050046065.1;XP_050030509.1;XP_050035116.1;XP_050052055.1;XP_050035977.1;XP_050046838.1;XP_050035114.1;XP_050036430.1;XP_050035973.1;XP_050029375.1;XP_050026883.1;XP_050025910.1;XP_050033432.1;XP_050039305.1;XP_050029374.1;XP_050040792.1;XP_050047338.1;XP_050047996.1;XP_050035989.1;XP_050047994.1;XP_050039518.1;XP_050043181.1;XP_050039380.1;XP_050029897.1;XP_050051356.1;XP_050024722.1;XP_050035992.1;XP_050027083.1;XP_050037090.1;XP_050046837.1;XP_050035988.1;XP_050035985.1;XP_050047997.1;XP_050049762.1;XP_050042732.1;XP_050036805.1;XP_050030513.1;XP_050044509.1;XP_050033477.1;XP_050050158.1;XP_050048776.1;XP_050044467.1;XP_050039306.1;XP_050035976.1;XP_050030512.1;XP_050046735.1;XP_050051947.1;XP_050024731.1;XP_050035980.1;XP_050035981.1;XP_050029297.1;XP_050035984.1;XP_050035982.1;XP_050027567.1;XP_050034683.1;XP_050048777.1;XP_050027084.1;XP_050030515.1;XP_050044008.1;XP_050049757.1
KEGG: 00310+4.2.1.17+1.1.1.35	Lysine degradation	6	XP_050041651.1;XP_050041635.1;XP_050051194.1;XP_050032010.1;XP_050026422.1;XP_050041643.1
Reactome: R-HSA-917937	Iron uptake and transport	9	XP_050033512.1;XP_050049690.1;XP_050040624.1;XP_050047670.1;XP_050033513.1;XP_050049691.1;XP_050048534.1;XP_050040623.1;XP_050035481.1
MetaCyc: PWY-7902	Glucosylglycerol biosynthesis	1	XP_050034614.1
Reactome: R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	10	XP_050027464.1;XP_050044348.1;XP_050044346.1;XP_050052127.1;XP_050048032.1;XP_050044347.1;XP_050034022.1;XP_050052129.1;XP_050047548.1;XP_050052128.1
Reactome: R-HSA-9665249	Resistance of ERBB2 KD mutants to afatinib	2	XP_050048201.1;XP_050048200.1
MetaCyc: PWY-6545	Pyrimidine deoxyribonucleotides de novo biosynthesis III	13	XP_050041566.1;XP_050045218.1;XP_050030600.1;XP_050031510.1;XP_050034794.1;XP_050029492.1;XP_050038800.1;XP_050043296.1;XP_050029490.1;XP_050025198.1;XP_050038939.1;XP_050051386.1;XP_050031386.1
Reactome: R-HSA-5676934	Protein repair	8	XP_050049772.1;XP_050049774.1;XP_050032690.1;XP_050049773.1;XP_050047311.1;XP_050032691.1;XP_050047312.1;XP_050051509.1
Reactome: R-HSA-190861	Gap junction assembly	18	XP_050043181.1;XP_050049758.1;XP_050046735.1;XP_050049757.1;XP_050039380.1;XP_050051357.1;XP_050051356.1;XP_050024840.1;XP_050049762.1;XP_050052420.1;XP_050051355.1;XP_050052055.1;XP_050046734.1;XP_050047338.1;XP_050039381.1;XP_050049761.1;XP_050024841.1;XP_050049759.1
Reactome: R-HSA-189085	Digestion of dietary carbohydrate	105	XP_050042347.1;XP_050032571.1;XP_050033969.1;XP_050042738.1;XP_050049093.1;XP_050044714.1;XP_050029432.1;XP_050049094.1;XP_050033456.1;XP_050049805.1;XP_050030758.1;XP_050052474.1;XP_050037224.1;XP_050049095.1;XP_050049804.1;XP_050041043.1;XP_050046728.1;XP_050042713.1;XP_050027483.1;XP_050031249.1;XP_050044411.1;XP_050029424.1;XP_050029425.1;XP_050029437.1;XP_050026821.1;XP_050029436.1;XP_050029442.1;XP_050029423.1;XP_050030759.1;XP_050029735.1;XP_050042346.1;XP_050050224.1;XP_050028469.1;XP_050028630.1;XP_050049799.1;XP_050044043.1;XP_050027379.1;XP_050052548.1;XP_050029433.1;XP_050042739.1;XP_050029447.1;XP_050029430.1;XP_050049801.1;XP_050049096.1;XP_050049806.1;XP_050037727.1;XP_050038509.1;XP_050029445.1;XP_050037776.1;XP_050029435.1;XP_050040829.1;XP_050029429.1;XP_050042348.1;XP_050029428.1;XP_050034285.1;XP_050036918.1;XP_050026104.1;XP_050029438.1;XP_050025418.1;XP_050044049.1;XP_050029427.1;XP_050028738.1;XP_050044317.1;XP_050029446.1;XP_050033770.1;XP_050029426.1;XP_050037255.1;XP_050025609.1;XP_050037106.1;XP_050033660.1;XP_050048017.1;XP_050027480.1;XP_050037105.1;XP_050041044.1;XP_050037442.1;XP_050034534.1;XP_050027479.1;XP_050049803.1;XP_050030202.1;XP_050029439.1;XP_050032833.1;XP_050024457.1;XP_050029443.1;XP_050052495.1;XP_050044713.1;XP_050033454.1;XP_050042596.1;XP_050029431.1;XP_050052483.1;XP_050029441.1;XP_050029444.1;XP_050047354.1;XP_050037441.1;XP_050030760.1;XP_050033453.1;XP_050049835.1;XP_050024494.1;XP_050028102.1;XP_050029434.1;XP_050027378.1;XP_050029440.1;XP_050033455.1;XP_050049092.1;XP_050038331.1;XP_050025610.1
Reactome: R-HSA-5633231	Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)	3	XP_050042031.1;XP_050033583.1;XP_050033584.1
Reactome: R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	11	XP_050037015.1;XP_050026566.1;XP_050037017.1;XP_050039504.1;XP_050027474.1;XP_050037016.1;XP_050035176.1;XP_050028615.1;XP_050037281.1;XP_050025621.1;XP_050037282.1
KEGG: 00030+3.1.1.17	Pentose phosphate pathway	2	XP_050030744.1;XP_050030742.1
KEGG: 00010+5.4.2.12	Glycolysis / Gluconeogenesis	1	XP_050044976.1
KEGG: 00790+1.1.1.153	Folate biosynthesis	1	XP_050045374.1
MetaCyc: PWY-6146	Methanobacterium thermoautotrophicum biosynthetic metabolism	3	XP_050036163.1;XP_050036164.1;XP_050036162.1
Reactome: R-HSA-77111	Synthesis of Ketone Bodies	4	XP_050033708.1;XP_050033709.1;XP_050033707.1;XP_050033827.1
KEGG: 00500+2.4.1.1	Starch and sucrose metabolism	3	XP_050037069.1;XP_050037070.1;XP_050037071.1
MetaCyc: PWY-5138	Fatty acid beta-oxidation IV (unsaturated, even number)	6	XP_050041643.1;XP_050026422.1;XP_050032010.1;XP_050041635.1;XP_050051194.1;XP_050041651.1
KEGG: 00562+5.5.1.4	Inositol phosphate metabolism	2	XP_050052037.1;XP_050052036.1
MetaCyc: PWY-5480	Pyruvate fermentation to ethanol I	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
MetaCyc: PWY-3861	Mannitol degradation II	1	XP_050044364.1
Reactome: R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	2	XP_050044056.1;XP_050023324.1
KEGG: 00650+4.1.3.4	Butanoate metabolism	4	XP_050033707.1;XP_050033709.1;XP_050033827.1;XP_050033708.1
KEGG: 00220+1.14.13.39	Arginine biosynthesis	3	XP_050048936.1;XP_050048952.1;XP_050048943.1
Reactome: R-HSA-6803529	FGFR2 alternative splicing	15	XP_050023729.1;XP_050046063.1;XP_050038469.1;XP_050023726.1;XP_050046123.1;XP_050023728.1;XP_050023730.1;XP_050034643.1;XP_050023724.1;XP_050043147.1;XP_050023727.1;XP_050023725.1;XP_050034644.1;XP_050024189.1;XP_050045189.1
Reactome: R-HSA-381753	Olfactory Signaling Pathway	18	XP_050039690.1;XP_050038525.1;XP_050028645.1;XP_050047049.1;XP_050025729.1;XP_050040401.1;XP_050026279.1;XP_050034840.1;XP_050038897.1;XP_050047047.1;XP_050046086.1;XP_050026278.1;XP_050026281.1;XP_050047048.1;XP_050046897.1;XP_050038827.1;XP_050026280.1;XP_050047050.1
MetaCyc: PWY-6708	Ubiquinol-8 biosynthesis (prokaryotic)	4	XP_050040261.1;XP_050025937.1;XP_050025938.1;XP_050033250.1
Reactome: R-HSA-174437	Removal of the Flap Intermediate from the C-strand	11	XP_050029852.1;XP_050022594.1;XP_050050532.1;XP_050040824.1;XP_050029342.1;XP_050052687.1;XP_050032670.1;XP_050022581.1;XP_050042755.1;XP_050047548.1;XP_050022980.1
Reactome: R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	269	XP_050032227.1;XP_050049124.1;XP_050049557.1;XP_050042717.1;XP_050034247.1;XP_050030249.1;XP_050044345.1;XP_050038767.1;XP_050050645.1;XP_050048824.1;XP_050044823.1;XP_050026794.1;XP_050052023.1;XP_050023531.1;XP_050038630.1;XP_050040459.1;XP_050039353.1;XP_050052019.1;XP_050038140.1;XP_050048837.1;XP_050038778.1;XP_050041422.1;XP_050046475.1;XP_050027440.1;XP_050024092.1;XP_050038184.1;XP_050044188.1;XP_050036741.1;XP_050052024.1;XP_050052633.1;XP_050023146.1;XP_050027078.1;XP_050045360.1;XP_050044005.1;XP_050023664.1;XP_050023141.1;XP_050027118.1;XP_050031786.1;XP_050044212.1;XP_050035472.1;XP_050044470.1;XP_050029872.1;XP_050045014.1;XP_050047778.1;XP_050031905.1;XP_050030329.1;XP_050050414.1;XP_050051387.1;XP_050030937.1;XP_050023714.1;XP_050044189.1;XP_050033318.1;XP_050025715.1;XP_050039331.1;XP_050045013.1;XP_050047670.1;XP_050047796.1;XP_050044007.1;XP_050023115.1;XP_050025435.1;XP_050025424.1;XP_050025083.1;XP_050048817.1;XP_050051289.1;XP_050045785.1;XP_050043599.1;XP_050045009.1;XP_050048719.1;XP_050023637.1;XP_050025423.1;XP_050048418.1;XP_050023111.1;XP_050040200.1;XP_050052635.1;XP_050024516.1;XP_050044475.1;XP_050049698.1;XP_050024240.1;XP_050031830.1;XP_050045946.1;XP_050052231.1;XP_050031040.1;XP_050031041.1;XP_050043247.1;XP_050042788.1;XP_050027134.1;XP_050027443.1;XP_050027436.1;XP_050040089.1;XP_050037398.1;XP_050038964.1;XP_050037844.1;XP_050036156.1;XP_050027657.1;XP_050047517.1;XP_050041423.1;XP_050051381.1;XP_050023643.1;XP_050027445.1;XP_050033237.1;XP_050044476.1;XP_050047794.1;XP_050032610.1;XP_050041478.1;XP_050041424.1;XP_050048771.1;XP_050041483.1;XP_050047174.1;XP_050044416.1;XP_050051055.1;XP_050027441.1;XP_050022813.1;XP_050045358.1;XP_050045838.1;XP_050040090.1;XP_050045897.1;XP_050032608.1;XP_050043586.1;XP_050047793.1;XP_050041421.1;XP_050031904.1;XP_050027438.1;XP_050024941.1;XP_050044211.1;XP_050045011.1;XP_050031152.1;XP_050052022.1;XP_050025483.1;XP_050029873.1;XP_050029756.1;XP_050052684.1;XP_050047516.1;XP_050041491.1;XP_050039332.1;XP_050048801.1;XP_050027439.1;XP_050030330.1;XP_050027442.1;XP_050050921.1;XP_050046311.1;XP_050025482.1;XP_050030022.1;XP_050047795.1;XP_050038774.1;XP_050048720.1;XP_050049582.1;XP_050036567.1;XP_050048823.1;XP_050023046.1;XP_050048420.1;XP_050024082.1;XP_050045008.1;XP_050034248.1;XP_050040440.1;XP_050023647.1;XP_050050644.1;XP_050045660.1;XP_050023140.1;XP_050038963.1;XP_050030331.1;XP_050032477.1;XP_050047809.1;XP_050047547.1;XP_050027281.1;XP_050022938.1;XP_050023532.1;XP_050038965.1;XP_050039330.1;XP_050052020.1;XP_050028790.1;XP_050035481.1;XP_050024749.1;XP_050027602.1;XP_050043617.1;XP_050033833.1;XP_050047181.1;XP_050032720.1;XP_050023267.1;XP_050043606.1;XP_050032078.1;XP_050034772.1;XP_050026417.1;XP_050032745.1;XP_050025434.1;XP_050025848.1;XP_050048721.1;XP_050031479.1;XP_050032609.1;XP_050044478.1;XP_050022883.1;XP_050041495.1;XP_050026416.1;XP_050050373.1;XP_050031678.1;XP_050040463.1;XP_050027444.1;XP_050023529.1;XP_050031831.1;XP_050044970.1;XP_050026806.1;XP_050052017.1;XP_050047769.1;XP_050048807.1;XP_050051288.1;XP_050037285.1;XP_050040624.1;XP_050039329.1;XP_050033832.1;XP_050024087.1;XP_050029802.1;XP_050037399.1;XP_050024301.1;XP_050044469.1;XP_050024081.1;XP_050031035.1;XP_050025425.1;XP_050051056.1;XP_050032821.1;XP_050038628.1;XP_050026808.1;XP_050045361.1;XP_050024939.1;XP_050048534.1;XP_050028542.1;XP_050022757.1;XP_050040623.1;XP_050052018.1;XP_050025877.1;XP_050025426.1;XP_050049259.1;XP_050024349.1;XP_050045012.1;XP_050040198.1;XP_050049775.1;XP_050042025.1;XP_050037397.1;XP_050034623.1;XP_050033331.1;XP_050052025.1;XP_050051964.1;XP_050030634.1;XP_050040199.1;XP_050024348.1;XP_050048825.1;XP_050022518.1;XP_050048419.1;XP_050022593.1;XP_050045359.1;XP_050040091.1;XP_050051971.1;XP_050030381.1;XP_050026446.1;XP_050038738.1;XP_050052685.1;XP_050026807.1;XP_050025092.1;XP_050037401.1;XP_050044006.1;XP_050024098.1;XP_050027437.1;XP_050025302.1;XP_050052636.1;XP_050052821.1;XP_050051290.1;XP_050039971.1;XP_050022667.1;XP_050049612.1;XP_050029755.1;XP_050025301.1
Reactome: R-HSA-8964539	Glutamate and glutamine metabolism	15	XP_050051792.1;XP_050040888.1;XP_050052721.1;XP_050033589.1;XP_050039554.1;XP_050049134.1;XP_050033588.1;XP_050051950.1;XP_050052719.1;XP_050026388.1;XP_050030846.1;XP_050052716.1;XP_050052715.1;XP_050050545.1;XP_050048960.1
Reactome: R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	18	XP_050051381.1;XP_050035481.1;XP_050039331.1;XP_050039332.1;XP_050034247.1;XP_050039329.1;XP_050048801.1;XP_050040339.1;XP_050048534.1;XP_050040340.1;XP_050040341.1;XP_050047778.1;XP_050040338.1;XP_050038630.1;XP_050030937.1;XP_050039330.1;XP_050038628.1;XP_050034248.1
Reactome: R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1	XP_050032010.1
MetaCyc: PWY-7886	Cell-surface glycoconjugate-linked phosphocholine biosynthesis	6	XP_050039337.1;XP_050039333.1;XP_050039338.1;XP_050039334.1;XP_050039335.1;XP_050039336.1
KEGG: 00270+2.6.1.5	Cysteine and methionine metabolism	3	XP_050031962.1;XP_050049182.1;XP_050049181.1
Reactome: R-HSA-5675221	Negative regulation of MAPK pathway	18	XP_050039818.1;XP_050047387.1;XP_050048777.1;XP_050036586.1;XP_050047996.1;XP_050033089.1;XP_050047995.1;XP_050047994.1;XP_050035481.1;XP_050047998.1;XP_050047598.1;XP_050047386.1;XP_050048821.1;XP_050048776.1;XP_050047997.1;XP_050047606.1;XP_050048534.1;XP_050048775.1
Reactome: R-HSA-8941858	Regulation of RUNX3 expression and activity	52	XP_050040200.1;XP_050022938.1;XP_050047809.1;XP_050048719.1;XP_050032477.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050045660.1;XP_050044478.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050037401.1;XP_050033237.1;XP_050025715.1;XP_050034772.1;XP_050027657.1;XP_050038140.1;XP_050037398.1;XP_050033318.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050047422.1;XP_050047181.1;XP_050044469.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050044470.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050044475.1;XP_050024749.1;XP_050049124.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050040198.1
Reactome: R-HSA-9026519	Activated NTRK2 signals through RAS	1	XP_050032853.1
KEGG: 00760+6.3.4.21	Nicotinate and nicotinamide metabolism	8	XP_050042238.1;XP_050042265.1;XP_050039106.1;XP_050042256.1;XP_050039107.1;XP_050026192.1;XP_050039108.1;XP_050042247.1
Reactome: R-HSA-111464	SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes	7	XP_050052134.1;XP_050037104.1;XP_050040075.1;XP_050041785.1;XP_050045633.1;XP_050047553.1;XP_050037103.1
Reactome: R-HSA-3928662	EPHB-mediated forward signaling	17	XP_050025688.1;XP_050029842.1;XP_050027302.1;XP_050032102.1;XP_050048381.1;XP_050025375.1;XP_050045552.1;XP_050025689.1;XP_050025374.1;XP_050025687.1;XP_050037400.1;XP_050048382.1;XP_050029843.1;XP_050048384.1;XP_050045760.1;XP_050029841.1;XP_050048383.1
KEGG: 00053+1.1.1.22	Ascorbate and aldarate metabolism	2	XP_050040190.1;XP_050040189.1
KEGG: 00785+2.8.1.8	Lipoic acid metabolism	1	XP_050039804.1
Reactome: R-HSA-2206302	MPS I - Hurler syndrome	1	XP_050049087.1
KEGG: 00562+3.1.4.11	Inositol phosphate metabolism	10	XP_050042250.1;XP_050042251.1;XP_050042252.1;XP_050048141.1;XP_050038409.1;XP_050042253.1;XP_050047067.1;XP_050038435.1;XP_050042022.1;XP_050048140.1
KEGG: 00410+1.3.3.6	beta-Alanine metabolism	2	XP_050026060.1;XP_050023456.1
KEGG: 00520+5.1.3.2	Amino sugar and nucleotide sugar metabolism	3	XP_050031783.1;XP_050031782.1;XP_050042029.1
Reactome: R-HSA-163359	Glucagon signaling in metabolic regulation	11	XP_050045225.1;XP_050045739.1;XP_050025623.1;XP_050045741.1;XP_050045740.1;XP_050041325.1;XP_050025622.1;XP_050040744.1;XP_050051299.1;XP_050045224.1;XP_050044424.1
KEGG: 00983+2.7.4.14	Drug metabolism - other enzymes	4	XP_050023196.1;XP_050023195.1;XP_050023197.1;XP_050023199.1
Reactome: R-HSA-2206307	MPS IIIA - Sanfilippo syndrome A	2	XP_050029775.1;XP_050029774.1
Reactome: R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	6	XP_050043507.1;XP_050029322.1;XP_050029360.1;XP_050029361.1;XP_050029321.1;XP_050044596.1
MetaCyc: PWY-7342	Superpathway of nicotine biosynthesis	4	XP_050042247.1;XP_050042256.1;XP_050042238.1;XP_050042265.1
Reactome: R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	3	XP_050047964.1;XP_050047962.1;XP_050047963.1
Reactome: R-HSA-159740	Gamma-carboxylation of protein precursors	1	XP_050052424.1
Reactome: R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	10	XP_050041257.1;XP_050035405.1;XP_050035406.1;XP_050041259.1;XP_050026507.1;XP_050041258.1;XP_050035404.1;XP_050039551.1;XP_050039553.1;XP_050039552.1
KEGG: 00254+6.4.1.2	Aflatoxin biosynthesis	12	XP_050048458.1;XP_050048465.1;XP_050048460.1;XP_050048459.1;XP_050048463.1;XP_050048466.1;XP_050048457.1;XP_050048461.1;XP_050048456.1;XP_050048462.1;XP_050048468.1;XP_050048467.1
MetaCyc: PWY-6731	Starch degradation III	3	XP_050037069.1;XP_050037070.1;XP_050037071.1
KEGG: 00920+2.7.7.4	Sulfur metabolism	2	XP_050051797.1;XP_050051798.1
KEGG: 00860+1.3.3.4	Porphyrin and chlorophyll metabolism	2	XP_050034747.1;XP_050034748.1
KEGG: 00521+3.1.3.25	Streptomycin biosynthesis	1	XP_050048146.1
Reactome: R-HSA-212676	Dopamine Neurotransmitter Release Cycle	5	XP_050031247.1;XP_050039213.1;XP_050039212.1;XP_050040727.1;XP_050040729.1
KEGG: 00564+2.7.8.11	Glycerophospholipid metabolism	1	XP_050025335.1
MetaCyc: PWY-5973	Cis-vaccenate biosynthesis	4	XP_050033008.1;XP_050033009.1;XP_050032773.1;XP_050029751.1
MetaCyc: PWY-7979	Protein O-mannosylation III (mammals, core M3)	14	XP_050029180.1;XP_050037277.1;XP_050046071.1;XP_050047045.1;XP_050041249.1;XP_050046070.1;XP_050051992.1;XP_050051991.1;XP_050023434.1;XP_050046831.1;XP_050024005.1;XP_050041250.1;XP_050024120.1;XP_050024010.1
KEGG: 00250+4.3.2.1	Alanine, aspartate and glutamate metabolism	2	XP_050045233.1;XP_050045223.1
KEGG: 00983+2.1.1.67	Drug metabolism - other enzymes	10	XP_050028107.1;XP_050043008.1;XP_050037646.1;XP_050028103.1;XP_050028106.1;XP_050022501.1;XP_050032154.1;XP_050028104.1;XP_050028105.1;XP_050037649.1
Reactome: R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	67	XP_050027578.1;XP_050044469.1;XP_050027577.1;XP_050037399.1;XP_050048824.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050042788.1;XP_050047422.1;XP_050025248.1;XP_050027134.1;XP_050025244.1;XP_050044475.1;XP_050048720.1;XP_050049124.1;XP_050052231.1;XP_050029802.1;XP_050050645.1;XP_050048823.1;XP_050033832.1;XP_050036567.1;XP_050047809.1;XP_050048534.1;XP_050032477.1;XP_050022938.1;XP_050027576.1;XP_050033237.1;XP_050045300.1;XP_050045660.1;XP_050044476.1;XP_050033368.1;XP_050047181.1;XP_050033833.1;XP_050033318.1;XP_050038213.1;XP_050022518.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050037397.1;XP_050042025.1;XP_050035481.1;XP_050040198.1;XP_050044470.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050048719.1;XP_050038199.1;XP_050050373.1;XP_050045785.1;XP_050036268.1;XP_050052372.1;XP_050025243.1;XP_050035378.1;XP_050040200.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050044478.1;XP_050031479.1;XP_050025848.1;XP_050025266.1;XP_050048721.1
Reactome: R-HSA-8849932	Synaptic adhesion-like molecules	6	XP_050048382.1;XP_050022968.1;XP_050048381.1;XP_050048383.1;XP_050048384.1;XP_050050841.1
Reactome: R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	3	XP_050032293.1;XP_050048534.1;XP_050035481.1
KEGG: 04070+3.1.3.64	Phosphatidylinositol signaling system	1	XP_050040343.1
Reactome: R-HSA-68867	Assembly of the pre-replicative complex	21	XP_050050719.1;XP_050035183.1;XP_050045792.1;XP_050049554.1;XP_050040739.1;XP_050036167.1;XP_050041989.1;XP_050038751.1;XP_050023646.1;XP_050041990.1;XP_050049555.1;XP_050043900.1;XP_050046049.1;XP_050049723.1;XP_050049556.1;XP_050033374.1;XP_050033934.1;XP_050031078.1;XP_050027478.1;XP_050043901.1;XP_050031079.1
KEGG: 00760+3.6.1.9	Nicotinate and nicotinamide metabolism	3	XP_050041566.1;XP_050045218.1;XP_050025198.1
MetaCyc: PWY-8086	(S)-lactate fermentation to propanoate, acetate and hydrogen	16	XP_050037168.1;XP_050037169.1;XP_050037926.1;XP_050037165.1;XP_050037172.1;XP_050035735.1;XP_050045192.1;XP_050037925.1;XP_050037417.1;XP_050034236.1;XP_050037164.1;XP_050036163.1;XP_050036162.1;XP_050036164.1;XP_050037166.1;XP_050037167.1
KEGG: 00630+1.11.1.6	Glyoxylate and dicarboxylate metabolism	6	XP_050038506.1;XP_050038505.1;XP_050048385.1;XP_050029938.1;XP_050029373.1;XP_050048386.1
MetaCyc: PWY-5669	Phosphatidylserine and phosphatidylethanolamine biosynthesis I	3	XP_050022634.1;XP_050022623.1;XP_050022630.1
Reactome: R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	122	XP_050035149.1;XP_050041753.1;XP_050048534.1;XP_050041744.1;XP_050026721.1;XP_050030148.1;XP_050036709.1;XP_050035483.1;XP_050052195.1;XP_050051109.1;XP_050041323.1;XP_050051067.1;XP_050029294.1;XP_050039882.1;XP_050048967.1;XP_050042714.1;XP_050040632.1;XP_050033913.1;XP_050051491.1;XP_050027435.1;XP_050048060.1;XP_050044680.1;XP_050052117.1;XP_050048061.1;XP_050041428.1;XP_050044171.1;XP_050032688.1;XP_050051080.1;XP_050048062.1;XP_050036006.1;XP_050031153.1;XP_050043919.1;XP_050023059.1;XP_050044593.1;XP_050026723.1;XP_050028318.1;XP_050046933.1;XP_050045043.1;XP_050029851.1;XP_050038626.1;XP_050043804.1;XP_050028206.1;XP_050038550.1;XP_050028344.1;XP_050044122.1;XP_050043802.1;XP_050039997.1;XP_050051087.1;XP_050028191.1;XP_050035484.1;XP_050029850.1;XP_050036857.1;XP_050033573.1;XP_050050516.1;XP_050044965.1;XP_050046934.1;XP_050043916.1;XP_050036005.1;XP_050052130.1;XP_050027477.1;XP_050042319.1;XP_050025636.1;XP_050034001.1;XP_050049776.1;XP_050029380.1;XP_050046031.1;XP_050029801.1;XP_050032267.1;XP_050049830.1;XP_050046469.1;XP_050043803.1;XP_050039285.1;XP_050032921.1;XP_050024740.1;XP_050032331.1;XP_050051569.1;XP_050048965.1;XP_050044445.1;XP_050031169.1;XP_050045196.1;XP_050051073.1;XP_050045970.1;XP_050026103.1;XP_050034868.1;XP_050032528.1;XP_050026722.1;XP_050039286.1;XP_050031861.1;XP_050032936.1;XP_050049170.1;XP_050022748.1;XP_050023492.1;XP_050043917.1;XP_050022853.1;XP_050051098.1;XP_050032330.1;XP_050040677.1;XP_050044169.1;XP_050034000.1;XP_050032793.1;XP_050033999.1;XP_050052131.1;XP_050028604.1;XP_050044170.1;XP_050027305.1;XP_050032272.1;XP_050031230.1;XP_050047002.1;XP_050030630.1;XP_050032599.1;XP_050023058.1;XP_050039340.1;XP_050035481.1;XP_050049831.1;XP_050050940.1;XP_050032598.1;XP_050045969.1;XP_050043918.1;XP_050027304.1;XP_050036708.1;XP_050025476.1;XP_050026018.1
Reactome: R-HSA-8964208	Phenylalanine metabolism	7	XP_050038344.1;XP_050052721.1;XP_050052719.1;XP_050052716.1;XP_050052715.1;XP_050050545.1;XP_050047981.1
Reactome: R-HSA-8875555	MET activates RAP1 and RAC1	2	XP_050023708.1;XP_050032853.1
Reactome: R-HSA-203754	NOSIP mediated eNOS trafficking	2	XP_050041272.1;XP_050041270.1
KEGG: 00401+2.6.1.1	Novobiocin biosynthesis	3	XP_050026413.1;XP_050049203.1;XP_050049202.1
Reactome: R-HSA-5694530	Cargo concentration in the ER	15	XP_050051718.1;XP_050052700.1;XP_050044271.1;XP_050051715.1;XP_050049323.1;XP_050051716.1;XP_050051713.1;XP_050051711.1;XP_050038325.1;XP_050049325.1;XP_050051714.1;XP_050052701.1;XP_050025016.1;XP_050035507.1;XP_050051712.1
Reactome: R-HSA-6798695	Neutrophil degranulation	244	XP_050025566.1;XP_050028236.1;XP_050037700.1;XP_050043005.1;XP_050044292.1;XP_050040075.1;XP_050044127.1;XP_050024782.1;XP_050051733.1;XP_050048209.1;XP_050050137.1;XP_050048810.1;XP_050051735.1;XP_050045628.1;XP_050039108.1;XP_050051836.1;XP_050048205.1;XP_050044083.1;XP_050041849.1;XP_050051835.1;XP_050025874.1;XP_050049771.1;XP_050036812.1;XP_050047867.1;XP_050047570.1;XP_050037400.1;XP_050044294.1;XP_050039873.1;XP_050037699.1;XP_050051971.1;XP_050041309.1;XP_050041846.1;XP_050049919.1;XP_050024113.1;XP_050048953.1;XP_050048210.1;XP_050040199.1;XP_050027140.1;XP_050048212.1;XP_050044128.1;XP_050033331.1;XP_050032732.1;XP_050046554.1;XP_050052836.1;XP_050051964.1;XP_050049924.1;XP_050042936.1;XP_050037524.1;XP_050032588.1;XP_050040198.1;XP_050049713.1;XP_050048207.1;XP_050042025.1;XP_050041842.1;XP_050036464.1;XP_050028237.1;XP_050049923.1;XP_050040116.1;XP_050024175.1;XP_050028235.1;XP_050035709.1;XP_050039107.1;XP_050048112.1;XP_050040716.1;XP_050045758.1;XP_050034457.1;XP_050045406.1;XP_050049667.1;XP_050045117.1;XP_050026519.1;XP_050024661.1;XP_050032858.1;XP_050033958.1;XP_050041851.1;XP_050044082.1;XP_050036558.1;XP_050024114.1;XP_050046981.1;XP_050034717.1;XP_050040015.1;XP_050042052.1;XP_050050206.1;XP_050041843.1;XP_050033237.1;XP_050046979.1;XP_050050752.1;XP_050049725.1;XP_050052798.1;XP_050048126.1;XP_050049920.1;XP_050037525.1;XP_050027134.1;XP_050024323.1;XP_050037526.1;XP_050027139.1;XP_050047472.1;XP_050034459.1;XP_050024176.1;XP_050039106.1;XP_050030558.1;XP_050041844.1;XP_050049658.1;XP_050044086.1;XP_050051200.1;XP_050046184.1;XP_050041847.1;XP_050044654.1;XP_050030101.1;XP_050033832.1;XP_050041845.1;XP_050049651.1;XP_050032728.1;XP_050029802.1;XP_050050756.1;XP_050044540.1;XP_050026657.1;XP_050035732.1;XP_050043078.1;XP_050051705.1;XP_050023108.1;XP_050044865.1;XP_050025364.1;XP_050049676.1;XP_050037617.1;XP_050048127.1;XP_050040449.1;XP_050045786.1;XP_050048111.1;XP_050037530.1;XP_050041883.1;XP_050025363.1;XP_050036380.1;XP_050044129.1;XP_050040200.1;XP_050049738.1;XP_050043166.1;XP_050048211.1;XP_050028755.1;XP_050045149.1;XP_050035730.1;XP_050045785.1;XP_050026420.1;XP_050049261.1;XP_050024178.1;XP_050034749.1;XP_050027141.1;XP_050032978.1;XP_050037041.1;XP_050025848.1;XP_050050753.1;XP_050048385.1;XP_050038669.1;XP_050049917.1;XP_050049319.1;XP_050037522.1;XP_050049760.1;XP_050049747.1;XP_050050757.1;XP_050037521.1;XP_050025715.1;XP_050032078.1;XP_050038826.1;XP_050029847.1;XP_050048386.1;XP_050037618.1;XP_050033006.1;XP_050033318.1;XP_050048125.1;XP_050023192.1;XP_050034653.1;XP_050024666.1;XP_050040707.1;XP_050041348.1;XP_050033833.1;XP_050044081.1;XP_050048410.1;XP_050046497.1;XP_050024177.1;XP_050034460.1;XP_050047470.1;XP_050050175.1;XP_050049687.1;XP_050024749.1;XP_050037528.1;XP_050027118.1;XP_050051732.1;XP_050040119.1;XP_050032632.1;XP_050051734.1;XP_050022938.1;XP_050047866.1;XP_050040117.1;XP_050051981.1;XP_050024179.1;XP_050048208.1;XP_050040693.1;XP_050050134.1;XP_050049921.1;XP_050026581.1;XP_050047809.1;XP_050050138.1;XP_050034458.1;XP_050051837.1;XP_050038184.1;XP_050032859.1;XP_050039027.1;XP_050034867.1;XP_050029776.1;XP_050037529.1;XP_050044085.1;XP_050048206.1;XP_050050174.1;XP_050036466.1;XP_050044084.1;XP_050051980.1;XP_050037527.1;XP_050047865.1;XP_050046980.1;XP_050034507.1;XP_050043493.1;XP_050041850.1;XP_050024146.1;XP_050037523.1;XP_050031626.1;XP_050046556.1;XP_050050173.1;XP_050042812.1;XP_050034595.1;XP_050049481.1;XP_050042344.1;XP_050050645.1;XP_050025016.1;XP_050050068.1;XP_050030375.1;XP_050028756.1;XP_050046843.1;XP_050042169.1;XP_050041848.1;XP_050049918.1;XP_050050754.1;XP_050034475.1;XP_050024180.1;XP_050044293.1;XP_050051332.1
Reactome: R-HSA-2871809	FCERI mediated Ca+2 mobilization	8	XP_050025879.1;XP_050051316.1;XP_050048140.1;XP_050051315.1;XP_050051317.1;XP_050048141.1;XP_050051318.1;XP_050032853.1
Reactome: R-HSA-156902	Peptide chain elongation	92	XP_050027435.1;XP_050048060.1;XP_050044680.1;XP_050048061.1;XP_050052117.1;XP_050039882.1;XP_050042714.1;XP_050040632.1;XP_050033913.1;XP_050052195.1;XP_050035483.1;XP_050041323.1;XP_050029294.1;XP_050041753.1;XP_050035149.1;XP_050026721.1;XP_050041744.1;XP_050048534.1;XP_050039997.1;XP_050028191.1;XP_050035484.1;XP_050029850.1;XP_050033573.1;XP_050029851.1;XP_050043804.1;XP_050038626.1;XP_050038550.1;XP_050028344.1;XP_050043802.1;XP_050044122.1;XP_050023059.1;XP_050044593.1;XP_050026723.1;XP_050046933.1;XP_050028318.1;XP_050032688.1;XP_050048062.1;XP_050036006.1;XP_050031153.1;XP_050043919.1;XP_050026103.1;XP_050034868.1;XP_050045970.1;XP_050032528.1;XP_050026722.1;XP_050039286.1;XP_050032936.1;XP_050031861.1;XP_050049170.1;XP_050023492.1;XP_050022748.1;XP_050032921.1;XP_050039285.1;XP_050024740.1;XP_050032331.1;XP_050051569.1;XP_050044445.1;XP_050045196.1;XP_050049776.1;XP_050029380.1;XP_050032267.1;XP_050049830.1;XP_050043803.1;XP_050050516.1;XP_050046934.1;XP_050036005.1;XP_050043916.1;XP_050052130.1;XP_050027477.1;XP_050042319.1;XP_050025636.1;XP_050043918.1;XP_050027304.1;XP_050026018.1;XP_050023058.1;XP_050039340.1;XP_050049831.1;XP_050035481.1;XP_050045969.1;XP_050032598.1;XP_050050940.1;XP_050028604.1;XP_050052131.1;XP_050027305.1;XP_050047002.1;XP_050031230.1;XP_050032599.1;XP_050043917.1;XP_050022853.1;XP_050032330.1;XP_050040677.1;XP_050032793.1
Reactome: R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	3	XP_050025746.1;XP_050029683.1;XP_050025745.1
MetaCyc: PWY-5905	Hypusine biosynthesis	1	XP_050040886.1
KEGG: 00561+3.2.1.22	Glycerolipid metabolism	8	XP_050038831.1;XP_050038635.1;XP_050039867.1;XP_050038834.1;XP_050038830.1;XP_050038832.1;XP_050038829.1;XP_050038833.1
Reactome: R-HSA-8874081	MET activates PTK2 signaling	12	XP_050033321.1;XP_050025341.1;XP_050024362.1;XP_050024364.1;XP_050025338.1;XP_050024363.1;XP_050031326.1;XP_050025339.1;XP_050031395.1;XP_050030649.1;XP_050025342.1;XP_050052730.1
Reactome: R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	1	XP_050032010.1
Reactome: R-HSA-446203	Asparagine N-linked glycosylation	4	XP_050040648.1;XP_050027693.1;XP_050029754.1;XP_050051837.1
KEGG: 00592+1.3.3.6	alpha-Linolenic acid metabolism	2	XP_050023456.1;XP_050026060.1
KEGG: 00053+1.8.5.1	Ascorbate and aldarate metabolism	2	XP_050026762.1;XP_050027833.1
Reactome: R-HSA-192823	Viral mRNA Translation	92	XP_050029851.1;XP_050043804.1;XP_050038626.1;XP_050038550.1;XP_050028344.1;XP_050043802.1;XP_050044122.1;XP_050039997.1;XP_050028191.1;XP_050035484.1;XP_050029850.1;XP_050033573.1;XP_050032688.1;XP_050048062.1;XP_050036006.1;XP_050031153.1;XP_050043919.1;XP_050023059.1;XP_050044593.1;XP_050026723.1;XP_050028318.1;XP_050046933.1;XP_050039882.1;XP_050042714.1;XP_050040632.1;XP_050033913.1;XP_050027435.1;XP_050048060.1;XP_050044680.1;XP_050052117.1;XP_050048061.1;XP_050035149.1;XP_050041753.1;XP_050041744.1;XP_050048534.1;XP_050026721.1;XP_050035483.1;XP_050052195.1;XP_050041323.1;XP_050029294.1;XP_050023058.1;XP_050039340.1;XP_050049831.1;XP_050035481.1;XP_050032598.1;XP_050045969.1;XP_050050940.1;XP_050043918.1;XP_050027304.1;XP_050026018.1;XP_050043917.1;XP_050022853.1;XP_050032330.1;XP_050040677.1;XP_050032793.1;XP_050052131.1;XP_050028604.1;XP_050027305.1;XP_050047002.1;XP_050031230.1;XP_050032599.1;XP_050039285.1;XP_050032921.1;XP_050024740.1;XP_050032331.1;XP_050051569.1;XP_050044445.1;XP_050045196.1;XP_050034868.1;XP_050026103.1;XP_050045970.1;XP_050026722.1;XP_050032528.1;XP_050039286.1;XP_050032936.1;XP_050049170.1;XP_050031861.1;XP_050023492.1;XP_050022748.1;XP_050050516.1;XP_050046934.1;XP_050036005.1;XP_050043916.1;XP_050052130.1;XP_050027477.1;XP_050042319.1;XP_050025636.1;XP_050049776.1;XP_050029380.1;XP_050032267.1;XP_050049830.1;XP_050043803.1
KEGG: 00190+7.1.2.2	Oxidative phosphorylation	5	XP_050050217.1;XP_050047208.1;XP_050043887.1;XP_050034615.1;XP_050031579.1
MetaCyc: PWY-6883	Pyruvate fermentation to butanol II (engineered)	6	XP_050041643.1;XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1
Reactome: R-HSA-163765	ChREBP activates metabolic gene expression	42	XP_050033002.1;XP_050032773.1;XP_050030138.1;XP_050032998.1;XP_050048461.1;XP_050048467.1;XP_050035169.1;XP_050048458.1;XP_050051929.1;XP_050025114.1;XP_050032997.1;XP_050035168.1;XP_050048468.1;XP_050038921.1;XP_050035170.1;XP_050030054.1;XP_050030085.1;XP_050030055.1;XP_050048463.1;XP_050030053.1;XP_050032996.1;XP_050027845.1;XP_050033008.1;XP_050041502.1;XP_050043005.1;XP_050030035.1;XP_050048466.1;XP_050028975.1;XP_050048457.1;XP_050037610.1;XP_050041503.1;XP_050028646.1;XP_050048462.1;XP_050029751.1;XP_050048456.1;XP_050033009.1;XP_050038286.1;XP_050030084.1;XP_050048465.1;XP_050025112.1;XP_050048459.1;XP_050048460.1
KEGG: 00710+3.1.3.11	Carbon fixation in photosynthetic organisms	2	XP_050038404.1;XP_050044414.1
Reactome: R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	14	XP_050051705.1;XP_050030286.1;XP_050042215.1;XP_050042205.1;XP_050040275.1;XP_050034170.1;XP_050047718.1;XP_050039374.1;XP_050039987.1;XP_050039993.1;XP_050048865.1;XP_050039992.1;XP_050042202.1;XP_050026581.1
MetaCyc: PWY-5873	Ubiquinol-7 biosynthesis (eukaryotic)	4	XP_050033250.1;XP_050040261.1;XP_050025937.1;XP_050025938.1
KEGG: 04070+2.7.4.24+2.7.4.21	Phosphatidylinositol signaling system	19	XP_050034728.1;XP_050034727.1;XP_050034736.1;XP_050034725.1;XP_050034729.1;XP_050034740.1;XP_050034723.1;XP_050034732.1;XP_050034735.1;XP_050034738.1;XP_050034739.1;XP_050034726.1;XP_050034731.1;XP_050034724.1;XP_050034722.1;XP_050034733.1;XP_050034737.1;XP_050034734.1;XP_050034730.1
KEGG: 00534+2.4.1.224+2.4.1.225	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2	XP_050050426.1;XP_050036614.1
Reactome: R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	18	XP_050049036.1;XP_050025248.1;XP_050034158.1;XP_050038213.1;XP_050034157.1;XP_050025243.1;XP_050036268.1;XP_050038199.1;XP_050025763.1;XP_050034159.1;XP_050030584.1;XP_050026313.1;XP_050030582.1;XP_050025266.1;XP_050030583.1;XP_050049035.1;XP_050025244.1;XP_050052047.1
KEGG: 00062+3.1.2.22	Fatty acid elongation	1	XP_050051190.1
KEGG: 00670+1.5.1.3	One carbon pool by folate	1	XP_050032825.1
KEGG: 00071+5.1.2.3+4.2.1.17+1.1.1.35	Fatty acid degradation	2	XP_050032010.1;XP_050026422.1
MetaCyc: PWY-7437	Protein O-[N-acetyl]-glucosylation	6	XP_050049196.1;XP_050039300.1;XP_050039299.1;XP_050049195.1;XP_050039302.1;XP_050039301.1
KEGG: 00860+6.1.1.17	Porphyrin and chlorophyll metabolism	2	XP_050028841.1;XP_050044097.1
KEGG: 00643+3.7.1.2	Styrene degradation	1	XP_050034252.1
KEGG: 00340+4.3.1.3	Histidine metabolism	1	XP_050052374.1
Reactome: R-HSA-4085377	SUMOylation of SUMOylation proteins	37	XP_050038969.1;XP_050030652.1;XP_050030506.1;XP_050038966.1;XP_050030507.1;XP_050036827.1;XP_050039240.1;XP_050025064.1;XP_050038967.1;XP_050035933.1;XP_050029515.1;XP_050036430.1;XP_050023474.1;XP_050030942.1;XP_050038863.1;XP_050042391.1;XP_050038895.1;XP_050023476.1;XP_050044008.1;XP_050038968.1;XP_050038866.1;XP_050049377.1;XP_050030653.1;XP_050026810.1;XP_050033146.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050038862.1;XP_050029516.1;XP_050023718.1;XP_050035770.1;XP_050038865.1;XP_050024518.1;XP_050038864.1;XP_050023475.1;XP_050042392.1
Reactome: R-HSA-69166	Removal of the Flap Intermediate	20	XP_050041999.1;XP_050022581.1;XP_050032670.1;XP_050052687.1;XP_050022980.1;XP_050047548.1;XP_050029342.1;XP_050040824.1;XP_050029852.1;XP_050043962.1;XP_050041995.1;XP_050039359.1;XP_050042755.1;XP_050041998.1;XP_050049531.1;XP_050041996.1;XP_050032235.1;XP_050050532.1;XP_050041997.1;XP_050022594.1
Reactome: R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	8	XP_050048419.1;XP_050048418.1;XP_050048420.1;XP_050048620.1;XP_050035481.1;XP_050048534.1;XP_050048621.1;XP_050048619.1
Reactome: R-HSA-3214842	HDMs demethylate histones	30	XP_050045444.1;XP_050025979.1;XP_050025982.1;XP_050041930.1;XP_050038199.1;XP_050027688.1;XP_050025983.1;XP_050036268.1;XP_050049596.1;XP_050025243.1;XP_050049594.1;XP_050027690.1;XP_050041931.1;XP_050041926.1;XP_050041929.1;XP_050038213.1;XP_050025248.1;XP_050041925.1;XP_050031736.1;XP_050049595.1;XP_050025244.1;XP_050025981.1;XP_050041934.1;XP_050025980.1;XP_050041927.1;XP_050041932.1;XP_050041933.1;XP_050041928.1;XP_050027689.1;XP_050025266.1
Reactome: R-HSA-9627069	Regulation of the apoptosome activity	17	XP_050030252.1;XP_050047598.1;XP_050030251.1;XP_050052134.1;XP_050036557.1;XP_050030063.1;XP_050030255.1;XP_050030061.1;XP_050045633.1;XP_050030253.1;XP_050030254.1;XP_050037104.1;XP_050047606.1;XP_050047553.1;XP_050037103.1;XP_050030062.1;XP_050040075.1
Reactome: R-HSA-977225	Amyloid fiber formation	21	XP_050038199.1;XP_050023628.1;XP_050048534.1;XP_050034595.1;XP_050034653.1;XP_050038213.1;XP_050025248.1;XP_050035872.1;XP_050043659.1;XP_050032867.1;XP_050036268.1;XP_050025243.1;XP_050035481.1;XP_050043649.1;XP_050032868.1;XP_050024240.1;XP_050025244.1;XP_050025266.1;XP_050033921.1;XP_050033920.1;XP_050048893.1
MetaCyc: PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	4	XP_050036844.1;XP_050026566.1;XP_050036622.1;XP_050022550.1
KEGG: 00604+3.2.1.52	Glycosphingolipid biosynthesis - ganglio series	31	XP_050026981.1;XP_050026985.1;XP_050026917.1;XP_050026983.1;XP_050039363.1;XP_050028196.1;XP_050025618.1;XP_050030481.1;XP_050035570.1;XP_050049366.1;XP_050028195.1;XP_050049136.1;XP_050025617.1;XP_050030479.1;XP_050039361.1;XP_050026982.1;XP_050038974.1;XP_050025615.1;XP_050049367.1;XP_050025616.1;XP_050026984.1;XP_050049140.1;XP_050043064.1;XP_050027975.1;XP_050036110.1;XP_050049138.1;XP_050049137.1;XP_050049139.1;XP_050049141.1;XP_050030480.1;XP_050039362.1
Reactome: R-HSA-9608287	Defective MUTYH substrate binding	1	XP_050049643.1
Reactome: R-HSA-2672351	Stimuli-sensing channels	111	XP_050030763.1;XP_050046097.1;XP_050051082.1;XP_050031049.1;XP_050035481.1;XP_050040473.1;XP_050045119.1;XP_050039562.1;XP_050025184.1;XP_050036609.1;XP_050043355.1;XP_050036693.1;XP_050039295.1;XP_050030768.1;XP_050033593.1;XP_050029448.1;XP_050031050.1;XP_050048770.1;XP_050046815.1;XP_050039292.1;XP_050024929.1;XP_050030766.1;XP_050035835.1;XP_050029903.1;XP_050046518.1;XP_050047587.1;XP_050038594.1;XP_050045407.1;XP_050050276.1;XP_050038686.1;XP_050025197.1;XP_050029902.1;XP_050046816.1;XP_050030767.1;XP_050045409.1;XP_050034596.1;XP_050052119.1;XP_050026423.1;XP_050025801.1;XP_050045605.1;XP_050023397.1;XP_050040365.1;XP_050046514.1;XP_050040361.1;XP_050029900.1;XP_050031258.1;XP_050046404.1;XP_050024895.1;XP_050024459.1;XP_050029904.1;XP_050023304.1;XP_050031259.1;XP_050045385.1;XP_050038909.1;XP_050031221.1;XP_050045685.1;XP_050030762.1;XP_050039296.1;XP_050030765.1;XP_050039758.1;XP_050040366.1;XP_050038910.1;XP_050046709.1;XP_050027708.1;XP_050052133.1;XP_050047937.1;XP_050043726.1;XP_050041600.1;XP_050030771.1;XP_050030764.1;XP_050045120.1;XP_050046512.1;XP_050031048.1;XP_050047633.1;XP_050040460.1;XP_050029906.1;XP_050025800.1;XP_050028953.1;XP_050023067.1;XP_050040461.1;XP_050035844.1;XP_050052661.1;XP_050047239.1;XP_050030761.1;XP_050025512.1;XP_050046710.1;XP_050039606.1;XP_050050515.1;XP_050046817.1;XP_050039294.1;XP_050029898.1;XP_050038675.1;XP_050039768.1;XP_050025186.1;XP_050035667.1;XP_050029905.1;XP_050029899.1;XP_050025185.1;XP_050025193.1;XP_050043701.1;XP_050029901.1;XP_050046711.1;XP_050048534.1;XP_050035781.1;XP_050052662.1;XP_050029643.1;XP_050050378.1;XP_050043333.1;XP_050031619.1;XP_050045408.1;XP_050045410.1
KEGG: 00564+2.7.7.41	Glycerophospholipid metabolism	3	XP_050031896.1;XP_050031895.1;XP_050052679.1
Reactome: R-HSA-70370	Galactose catabolism	4	XP_050031782.1;XP_050042029.1;XP_050031783.1;XP_050045037.1
KEGG: 00710+1.2.1.12	Carbon fixation in photosynthetic organisms	2	XP_050041668.1;XP_050041662.1
Reactome: R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	3	XP_050039647.1;XP_050047598.1;XP_050047606.1
Reactome: R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	7	XP_050037100.1;XP_050039071.1;XP_050040246.1;XP_050028603.1;XP_050048294.1;XP_050039510.1;XP_050039072.1
Reactome: R-HSA-1592389	Activation of Matrix Metalloproteinases	2	XP_050024936.1;XP_050024935.1
Reactome: R-HSA-112043	PLC beta mediated events	5	XP_050038409.1;XP_050025879.1;XP_050038435.1;XP_050028241.1;XP_050050347.1
MetaCyc: PWY-5749	Itaconate degradation	1	XP_050026352.1
Reactome: R-HSA-5674135	MAP2K and MAPK activation	16	XP_050047598.1;XP_050023932.1;XP_050024180.1;XP_050050752.1;XP_050050754.1;XP_050050757.1;XP_050050756.1;XP_050024177.1;XP_050024178.1;XP_050032859.1;XP_050050753.1;XP_050024176.1;XP_050032858.1;XP_050047606.1;XP_050024175.1;XP_050024179.1
KEGG: 00480+1.17.4.1	Glutathione metabolism	2	XP_050030600.1;XP_050038800.1
KEGG: 04070+2.7.1.153	Phosphatidylinositol signaling system	2	XP_050052756.1;XP_050028399.1
KEGG: 00600+3.1.3.4	Sphingolipid metabolism	4	XP_050037456.1;XP_050037455.1;XP_050037457.1;XP_050037458.1
Reactome: R-HSA-139915	Activation of PUMA and translocation to mitochondria	7	XP_050025696.1;XP_050046150.1;XP_050025697.1;XP_050046149.1;XP_050052094.1;XP_050046147.1;XP_050046148.1
MetaCyc: PWY-0	Putrescine degradation III	5	XP_050051327.1;XP_050046955.1;XP_050045770.1;XP_050050999.1;XP_050045759.1
KEGG: 00900+2.5.1.10+2.5.1.1	Terpenoid backbone biosynthesis	1	XP_050023623.1
Reactome: R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	51	XP_050039381.1;XP_050035990.1;XP_050028330.1;XP_050049759.1;XP_050024841.1;XP_050049761.1;XP_050049353.1;XP_050052420.1;XP_050049762.1;XP_050046734.1;XP_050035988.1;XP_050035985.1;XP_050035993.1;XP_050049757.1;XP_050037041.1;XP_050035979.1;XP_050051357.1;XP_050035984.1;XP_050035982.1;XP_050035980.1;XP_050049758.1;XP_050035981.1;XP_050031039.1;XP_050035976.1;XP_050035975.1;XP_050046735.1;XP_050040551.1;XP_050035986.1;XP_050035978.1;XP_050047338.1;XP_050043899.1;XP_050026883.1;XP_050035977.1;XP_050050989.1;XP_050035973.1;XP_050034982.1;XP_050051355.1;XP_050035991.1;XP_050052055.1;XP_050035992.1;XP_050045597.1;XP_050039380.1;XP_050029897.1;XP_050024840.1;XP_050051356.1;XP_050045165.1;XP_050035987.1;XP_050043181.1;XP_050035974.1;XP_050035983.1;XP_050035989.1
KEGG: 00603+3.2.1.22	Glycosphingolipid biosynthesis - globo and isoglobo series	8	XP_050038833.1;XP_050038829.1;XP_050038832.1;XP_050038830.1;XP_050038834.1;XP_050039867.1;XP_050038635.1;XP_050038831.1
Reactome: R-HSA-5654704	SHC-mediated cascade:FGFR3	1	XP_050032853.1
Reactome: R-HSA-9013508	NOTCH3 Intracellular Domain Regulates Transcription	4	XP_050045588.1;XP_050038799.1;XP_050050843.1;XP_050038602.1
MetaCyc: PWY-7791	UMP biosynthesis III	2	XP_050023639.1;XP_050032255.1
Reactome: R-HSA-73728	RNA Polymerase I Promoter Opening	7	XP_050038199.1;XP_050038213.1;XP_050025248.1;XP_050025266.1;XP_050036268.1;XP_050025243.1;XP_050025244.1
Reactome: R-HSA-1963640	GRB2 events in ERBB2 signaling	5	XP_050051868.1;XP_050051866.1;XP_050051865.1;XP_050051864.1;XP_050032853.1
Reactome: R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	4	XP_050040600.1;XP_050043294.1;XP_050043439.1;XP_050039341.1
Reactome: R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	3	XP_050025696.1;XP_050052094.1;XP_050025697.1
Reactome: R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	16	XP_050039330.1;XP_050038628.1;XP_050034248.1;XP_050040338.1;XP_050038630.1;XP_050030937.1;XP_050040339.1;XP_050040340.1;XP_050047778.1;XP_050040341.1;XP_050048801.1;XP_050034247.1;XP_050039329.1;XP_050039331.1;XP_050039332.1;XP_050051381.1
MetaCyc: PWY-7290	Escherichia coli serotype O86 O-antigen biosynthesis	3	XP_050042669.1;XP_050042670.1;XP_050042668.1
KEGG: 00290+2.6.1.42	Valine, leucine and isoleucine biosynthesis	1	XP_050039540.1
Reactome: R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	13	XP_050043962.1;XP_050041995.1;XP_050041997.1;XP_050041996.1;XP_050046147.1;XP_050032235.1;XP_050046150.1;XP_050049531.1;XP_050041998.1;XP_050039359.1;XP_050046148.1;XP_050041999.1;XP_050046149.1
Reactome: R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	23	XP_050028231.1;XP_050042755.1;XP_050048534.1;XP_050042972.1;XP_050050532.1;XP_050039028.1;XP_050022594.1;XP_050046028.1;XP_050022980.1;XP_050035481.1;XP_050032670.1;XP_050052687.1;XP_050051397.1;XP_050029342.1;XP_050046062.1;XP_050040824.1;XP_050039029.1;XP_050025144.1;XP_050049952.1;XP_050039454.1;XP_050046029.1;XP_050034506.1;XP_050029852.1
Reactome: R-HSA-156582	Acetylation	6	XP_050027182.1;XP_050027935.1;XP_050027932.1;XP_050027934.1;XP_050027933.1;XP_050028265.1
Reactome: R-HSA-1912420	Pre-NOTCH Processing in Golgi	10	XP_050029080.1;XP_050029082.1;XP_050041141.1;XP_050051588.1;XP_050029083.1;XP_050029084.1;XP_050041139.1;XP_050051590.1;XP_050029081.1;XP_050041140.1
KEGG: 00020+2.3.3.8	Citrate cycle (TCA cycle)	1	XP_050043005.1
KEGG: 00590+5.3.99.3	Arachidonic acid metabolism	1	XP_050052798.1
Reactome: R-HSA-171007	p38MAPK events	7	XP_050033239.1;XP_050033241.1;XP_050033240.1;XP_050033242.1;XP_050033244.1;XP_050028233.1;XP_050033243.1
KEGG: 00680+4.1.2.13	Methane metabolism	2	XP_050025561.1;XP_050025560.1
MetaCyc: PWY-6317	D-galactose degradation I (Leloir pathway)	6	XP_050030095.1;XP_050031782.1;XP_050042029.1;XP_050040105.1;XP_050031783.1;XP_050045037.1
Reactome: R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1	XP_050032010.1
Reactome: R-HSA-202424	Downstream TCR signaling	60	XP_050044470.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050040624.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050049124.1;XP_050040198.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050033318.1;XP_050037398.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050044469.1;XP_050047181.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050045660.1;XP_050050758.1;XP_050028062.1;XP_050044478.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050047670.1;XP_050033237.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050032548.1;XP_050022938.1;XP_050047769.1;XP_050040200.1;XP_050047809.1;XP_050048719.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050028061.1;XP_050050373.1;XP_050045785.1
MetaCyc: PWY-6644	Fluoroacetate and fluorothreonine biosynthesis	3	XP_050035831.1;XP_050046554.1;XP_050046556.1
Reactome: R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	10	XP_050044529.1;XP_050044530.1;XP_050026955.1;XP_050044531.1;XP_050044527.1;XP_050044524.1;XP_050044525.1;XP_050044532.1;XP_050044528.1;XP_050026954.1
KEGG: 00620+6.2.1.1	Pyruvate metabolism	3	XP_050030604.1;XP_050044794.1;XP_050040406.1
KEGG: 00250+2.6.1.16	Alanine, aspartate and glutamate metabolism	5	XP_050051578.1;XP_050051579.1;XP_050051581.1;XP_050051580.1;XP_050051577.1
Reactome: R-HSA-426496	Post-transcriptional silencing by small RNAs	19	XP_050028353.1;XP_050029826.1;XP_050023605.1;XP_050029861.1;XP_050026046.1;XP_050026223.1;XP_050029337.1;XP_050052512.1;XP_050032553.1;XP_050029859.1;XP_050029825.1;XP_050029860.1;XP_050029824.1;XP_050029858.1;XP_050029827.1;XP_050026047.1;XP_050029336.1;XP_050029862.1;XP_050029338.1
Reactome: R-HSA-1614517	Sulfide oxidation to sulfate	3	XP_050034610.1;XP_050034609.1;XP_050025887.1
Reactome: R-HSA-73621	Pyrimidine catabolism	29	XP_050050866.1;XP_050045748.1;XP_050028325.1;XP_050036028.1;XP_050039684.1;XP_050032573.1;XP_050030473.1;XP_050050868.1;XP_050045749.1;XP_050050863.1;XP_050030474.1;XP_050045750.1;XP_050050864.1;XP_050050867.1;XP_050050862.1;XP_050050861.1;XP_050030478.1;XP_050045689.1;XP_050028326.1;XP_050028197.1;XP_050045147.1;XP_050030472.1;XP_050042341.1;XP_050045146.1;XP_050030475.1;XP_050050865.1;XP_050028296.1;XP_050045148.1;XP_050035831.1
Reactome: R-HSA-8986944	Transcriptional Regulation by MECP2	28	XP_050029337.1;XP_050039235.1;XP_050032553.1;XP_050052512.1;XP_050052225.1;XP_050028353.1;XP_050029826.1;XP_050052226.1;XP_050051916.1;XP_050026223.1;XP_050026046.1;XP_050029861.1;XP_050023605.1;XP_050051915.1;XP_050029862.1;XP_050029336.1;XP_050039236.1;XP_050051917.1;XP_050029338.1;XP_050031707.1;XP_050029825.1;XP_050029859.1;XP_050029824.1;XP_050029860.1;XP_050029827.1;XP_050044079.1;XP_050029858.1;XP_050026047.1
Reactome: R-HSA-1679131	Trafficking and processing of endosomal TLR	5	XP_050044127.1;XP_050044081.1;XP_050044654.1;XP_050044129.1;XP_050044128.1
MetaCyc: PWY-6074	Zymosterol biosynthesis	4	XP_050045363.1;XP_050045362.1;XP_050045365.1;XP_050045364.1
MetaCyc: PWY-7798	Protein S-nitrosylation and denitrosylation	3	XP_050052302.1;XP_050052400.1;XP_050052301.1
Reactome: R-HSA-6785470	tRNA processing in the mitochondrion	6	XP_050036853.1;XP_050036852.1;XP_050046343.1;XP_050030696.1;XP_050029880.1;XP_050031156.1
MetaCyc: PWY-6683	Assimilatory sulfate reduction III	2	XP_050051797.1;XP_050051798.1
MetaCyc: PWY-5079	L-phenylalanine degradation III	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
MetaCyc: PWY-6342	Noradrenaline and adrenaline degradation	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
Reactome: R-HSA-9645135	STAT5 Activation	1	XP_050032853.1
Reactome: R-HSA-8948751	Regulation of PTEN stability and activity	60	XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050052231.1;XP_050044470.1;XP_050050645.1;XP_050029802.1;XP_050033331.1;XP_050036567.1;XP_050035472.1;XP_050051964.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050048620.1;XP_050040198.1;XP_050042025.1;XP_050035481.1;XP_050048720.1;XP_050049124.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050042788.1;XP_050032720.1;XP_050022518.1;XP_050027134.1;XP_050037398.1;XP_050033318.1;XP_050044469.1;XP_050047181.1;XP_050051200.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050031585.1;XP_050044478.1;XP_050045660.1;XP_050025848.1;XP_050048721.1;XP_050031586.1;XP_050044476.1;XP_050031479.1;XP_050048619.1;XP_050033237.1;XP_050037401.1;XP_050034772.1;XP_050025715.1;XP_050049277.1;XP_050022938.1;XP_050040200.1;XP_050048719.1;XP_050047809.1;XP_050048621.1;XP_050050373.1;XP_050045785.1;XP_050048534.1;XP_050032477.1
KEGG: 00480+1.1.1.44	Glutathione metabolism	2	XP_050051182.1;XP_050051191.1
MetaCyc: PWY-6672	Cis-genanyl-coa degradation	3	XP_050044794.1;XP_050040406.1;XP_050030604.1
KEGG: 00332+2.7.2.11	Carbapenem biosynthesis	1	XP_050049134.1
Reactome: R-HSA-1483166	Synthesis of PA	30	XP_050050469.1;XP_050027415.1;XP_050024464.1;XP_050037855.1;XP_050027416.1;XP_050040576.1;XP_050032863.1;XP_050037856.1;XP_050024465.1;XP_050033390.1;XP_050037775.1;XP_050024467.1;XP_050034614.1;XP_050032357.1;XP_050037857.1;XP_050029507.1;XP_050037854.1;XP_050050470.1;XP_050050549.1;XP_050050471.1;XP_050024463.1;XP_050047026.1;XP_050029506.1;XP_050034933.1;XP_050050583.1;XP_050025686.1;XP_050025400.1;XP_050034934.1;XP_050047027.1;XP_050024466.1
KEGG: 00512+2.4.1.122	Mucin type O-glycan biosynthesis	3	XP_050042669.1;XP_050042670.1;XP_050042668.1
Reactome: R-HSA-167162	RNA Polymerase II HIV Promoter Escape	44	XP_050023726.1;XP_050038988.1;XP_050033368.1;XP_050023729.1;XP_050032071.1;XP_050046063.1;XP_050034518.1;XP_050037137.1;XP_050043147.1;XP_050023725.1;XP_050031536.1;XP_050036381.1;XP_050034505.1;XP_050034031.1;XP_050031535.1;XP_050026414.1;XP_050026035.1;XP_050038469.1;XP_050034643.1;XP_050046688.1;XP_050045372.1;XP_050023730.1;XP_050025563.1;XP_050040428.1;XP_050040427.1;XP_050046123.1;XP_050034030.1;XP_050023728.1;XP_050037136.1;XP_050031537.1;XP_050044010.1;XP_050023724.1;XP_050023727.1;XP_050035378.1;XP_050049296.1;XP_050024189.1;XP_050049297.1;XP_050040671.1;XP_050045300.1;XP_050049294.1;XP_050047361.1;XP_050049295.1;XP_050045373.1;XP_050034644.1
Reactome: R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	3	XP_050036144.1;XP_050036143.1;XP_050036145.1
MetaCyc: PWY-5913	Partial TCA cycle (obligate autotrophs)	29	XP_050037168.1;XP_050043069.1;XP_050049075.1;XP_050042704.1;XP_050026352.1;XP_050049202.1;XP_050037007.1;XP_050037165.1;XP_050026413.1;XP_050037169.1;XP_050037926.1;XP_050037396.1;XP_050035735.1;XP_050042703.1;XP_050037172.1;XP_050026123.1;XP_050045192.1;XP_050037925.1;XP_050049076.1;XP_050043076.1;XP_050037417.1;XP_050026353.1;XP_050049203.1;XP_050037164.1;XP_050041863.1;XP_050042702.1;XP_050037166.1;XP_050043005.1;XP_050037167.1
KEGG: 00565+3.1.4.4	Ether lipid metabolism	3	XP_050050469.1;XP_050050470.1;XP_050050471.1
KEGG: 00073+2.3.1.20	Cutin, suberine and wax biosynthesis	7	XP_050046981.1;XP_050047364.1;XP_050047365.1;XP_050046979.1;XP_050046980.1;XP_050047472.1;XP_050047470.1
KEGG: 00750+2.7.1.35	Vitamin B6 metabolism	2	XP_050026420.1;XP_050039873.1
KEGG: 00720+4.2.1.2	Carbon fixation pathways in prokaryotes	1	XP_050037417.1
KEGG: 00520+2.7.1.1	Amino sugar and nucleotide sugar metabolism	3	XP_050027343.1;XP_050047070.1;XP_050047071.1
Reactome: R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	13	XP_050049599.1;XP_050048534.1;XP_050035481.1;XP_050049608.1;XP_050049616.1;XP_050049592.1;XP_050049576.1;XP_050049552.1;XP_050049544.1;XP_050049584.1;XP_050049569.1;XP_050032293.1;XP_050049561.1
Reactome: R-HSA-8964315	G beta:gamma signalling through BTK	4	XP_050025623.1;XP_050023177.1;XP_050044424.1;XP_050025622.1
MetaCyc: PWY-6722	Candicidin biosynthesis	14	XP_050048466.1;XP_050048459.1;XP_050048460.1;XP_050048463.1;XP_050048465.1;XP_050048458.1;XP_050048456.1;XP_050048462.1;XP_050048468.1;XP_050048467.1;XP_050034249.1;XP_050048461.1;XP_050045094.1;XP_050048457.1
KEGG: 00562+5.3.1.1	Inositol phosphate metabolism	1	XP_050045451.1
MetaCyc: PWY-7664	Oleate biosynthesis IV (anaerobic)	4	XP_050029751.1;XP_050033008.1;XP_050032773.1;XP_050033009.1
KEGG: 00020+2.3.1.61	Citrate cycle (TCA cycle)	1	XP_050036844.1
KEGG: 00780+1.1.1.100+4.2.1.59+2.3.1.41	Biotin metabolism	4	XP_050029751.1;XP_050032773.1;XP_050033009.1;XP_050033008.1
KEGG: 00670+1.5.1.6	One carbon pool by folate	1	XP_050030635.1
MetaCyc: PWY-5751	Phenylethanol biosynthesis	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
KEGG: 00240+1.3.5.2	Pyrimidine metabolism	1	XP_050036053.1
MetaCyc: PWY-7494	Choline degradation IV	3	XP_050043945.1;XP_050030051.1;XP_050052743.1
Reactome: R-HSA-4085001	Sialic acid metabolism	13	XP_050034475.1;XP_050032545.1;XP_050030444.1;XP_050034507.1;XP_050041883.1;XP_050030445.1;XP_050024113.1;XP_050042169.1;XP_050031626.1;XP_050030375.1;XP_050024146.1;XP_050024114.1;XP_050046030.1
Reactome: R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	60	XP_050038469.1;XP_050029342.1;XP_050049837.1;XP_050046062.1;XP_050022980.1;XP_050025563.1;XP_050035481.1;XP_050052687.1;XP_050051397.1;XP_050034643.1;XP_050040427.1;XP_050032512.1;XP_050046029.1;XP_050040428.1;XP_050034506.1;XP_050040824.1;XP_050039454.1;XP_050045557.1;XP_050042972.1;XP_050033368.1;XP_050029505.1;XP_050042755.1;XP_050028231.1;XP_050045558.1;XP_050043147.1;XP_050022594.1;XP_050037137.1;XP_050034093.1;XP_050051314.1;XP_050050532.1;XP_050032516.1;XP_050032515.1;XP_050045300.1;XP_050026756.1;XP_050032670.1;XP_050049363.1;XP_050047361.1;XP_050032510.1;XP_050032511.1;XP_050029852.1;XP_050034644.1;XP_050049952.1;XP_050025144.1;XP_050037136.1;XP_050045758.1;XP_050046123.1;XP_050023148.1;XP_050044010.1;XP_050048534.1;XP_050032514.1;XP_050032513.1;XP_050035378.1;XP_050023147.1;XP_050026755.1;XP_050034094.1;XP_050023824.1;XP_050046028.1;XP_050049362.1;XP_050024189.1;XP_050032509.1
Reactome: R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	10	XP_050033368.1;XP_050046039.1;XP_050046838.1;XP_050046038.1;XP_050049009.1;XP_050045300.1;XP_050046837.1;XP_050049007.1;XP_050035378.1;XP_050049008.1
Reactome: R-HSA-72163	mRNA Splicing - Major Pathway	163	XP_050024189.1;XP_050039876.1;XP_050023727.1;XP_050049876.1;XP_050049874.1;XP_050045424.1;XP_050048361.1;XP_050033857.1;XP_050029341.1;XP_050023842.1;XP_050049410.1;XP_050046123.1;XP_050031253.1;XP_050025366.1;XP_050051446.1;XP_050048028.1;XP_050029923.1;XP_050039877.1;XP_050036364.1;XP_050026756.1;XP_050032701.1;XP_050051840.1;XP_050029925.1;XP_050045659.1;XP_050052839.1;XP_050023742.1;XP_050044202.1;XP_050043437.1;XP_050045647.1;XP_050047731.1;XP_050034802.1;XP_050044100.1;XP_050026737.1;XP_050023729.1;XP_050039128.1;XP_050023256.1;XP_050049519.1;XP_050032269.1;XP_050029924.1;XP_050026428.1;XP_050047732.1;XP_050050501.1;XP_050049870.1;XP_050039198.1;XP_050052835.1;XP_050030410.1;XP_050036382.1;XP_050040975.1;XP_050049877.1;XP_050049884.1;XP_050025921.1;XP_050036568.1;XP_050026755.1;XP_050049872.1;XP_050025923.1;XP_050049888.1;XP_050045758.1;XP_050023728.1;XP_050025920.1;XP_050034644.1;XP_050025068.1;XP_050049880.1;XP_050045189.1;XP_050026260.1;XP_050025576.1;XP_050023671.1;XP_050049523.1;XP_050049409.1;XP_050045577.1;XP_050044982.1;XP_050051314.1;XP_050033747.1;XP_050023725.1;XP_050031929.1;XP_050049522.1;XP_050044983.1;XP_050039480.1;XP_050050871.1;XP_050023844.1;XP_050029839.1;XP_050048350.1;XP_050038928.1;XP_050040109.1;XP_050036429.1;XP_050023638.1;XP_050049337.1;XP_050044033.1;XP_050050843.1;XP_050048613.1;XP_050023672.1;XP_050026402.1;XP_050030685.1;XP_050042354.1;XP_050049520.1;XP_050023724.1;XP_050049883.1;XP_050036363.1;XP_050044032.1;XP_050037072.1;XP_050025922.1;XP_050049932.1;XP_050050593.1;XP_050049521.1;XP_050049887.1;XP_050049882.1;XP_050032926.1;XP_050050869.1;XP_050044204.1;XP_050045646.1;XP_050023841.1;XP_050047729.1;XP_050023843.1;XP_050026261.1;XP_050047730.1;XP_050049886.1;XP_050029909.1;XP_050049885.1;XP_050046063.1;XP_050047758.1;XP_050040680.1;XP_050023726.1;XP_050045396.1;XP_050049875.1;XP_050052659.1;XP_050023840.1;XP_050040483.1;XP_050023730.1;XP_050034643.1;XP_050025066.1;XP_050038469.1;XP_050049837.1;XP_050032605.1;XP_050049411.1;XP_050032813.1;XP_050025843.1;XP_050025067.1;XP_050030686.1;XP_050025919.1;XP_050023824.1;XP_050029459.1;XP_050036801.1;XP_050048351.1;XP_050032816.1;XP_050029910.1;XP_050025978.1;XP_050047733.1;XP_050023845.1;XP_050049871.1;XP_050043147.1;XP_050032814.1;XP_050049879.1;XP_050048029.1;XP_050044866.1;XP_050023014.1;XP_050040482.1;XP_050027597.1;XP_050049881.1;XP_050032815.1;XP_050049878.1;XP_050044203.1;XP_050049626.1;XP_050040484.1;XP_050039472.1
Reactome: R-HSA-389957	Prefoldin mediated transfer of substrate to CCT/TriC	19	XP_050048913.1;XP_050048916.1;XP_050048112.1;XP_050026292.1;XP_050048915.1;XP_050045149.1;XP_050052058.1;XP_050037157.1;XP_050034746.1;XP_050026109.1;XP_050034156.1;XP_050035455.1;XP_050035428.1;XP_050051893.1;XP_050044153.1;XP_050048914.1;XP_050044826.1;XP_050047315.1;XP_050048111.1
MetaCyc: PWY-5486	Pyruvate fermentation to ethanol II	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
Reactome: R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	38	XP_050044096.1;XP_050045038.1;XP_050038644.1;XP_050038647.1;XP_050038646.1;XP_050044094.1;XP_050038561.1;XP_050045165.1;XP_050038648.1;XP_050035114.1;XP_050025353.1;XP_050035116.1;XP_050034759.1;XP_050025352.1;XP_050030425.1;XP_050030426.1;XP_050038643.1;XP_050045039.1;XP_050043821.1;XP_050043899.1;XP_050035119.1;XP_050030424.1;XP_050038642.1;XP_050044093.1;XP_050044095.1;XP_050030428.1;XP_050038645.1;XP_050043820.1;XP_050030429.1;XP_050030430.1;XP_050038560.1;XP_050025351.1;XP_050036465.1;XP_050028813.1;XP_050024782.1;XP_050049353.1;XP_050035880.1;XP_050039261.1
MetaCyc: PWY-7255	Ergothioneine biosynthesis I (bacteria)	2	XP_050027889.1;XP_050026350.1
KEGG: 00030+4.1.2.4	Pentose phosphate pathway	1	XP_050048410.1
Reactome: R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	7	XP_050040209.1;XP_050052627.1;XP_050040210.1;XP_050040214.1;XP_050040212.1;XP_050040211.1;XP_050040213.1
Reactome: R-HSA-352230	Amino acid transport across the plasma membrane	5	XP_050028080.1;XP_050028081.1;XP_050028083.1;XP_050036619.1;XP_050028082.1
Reactome: R-HSA-8941332	RUNX2 regulates genes involved in cell migration	4	XP_050048620.1;XP_050047422.1;XP_050048621.1;XP_050048619.1
MetaCyc: PWY-6281	L-selenocysteine biosynthesis II (archaea and eukaryotes)	7	XP_050031596.1;XP_050050114.1;XP_050036866.1;XP_050026752.1;XP_050023969.1;XP_050041755.1;XP_050030955.1
KEGG: 00450+2.1.1.13	Selenocompound metabolism	1	XP_050036540.1
KEGG: 00240+3.1.3.5	Pyrimidine metabolism	1	XP_050049541.1
MetaCyc: PWY-3385	Choline biosynthesis I	6	XP_050039338.1;XP_050039333.1;XP_050039337.1;XP_050039336.1;XP_050039335.1;XP_050039334.1
Reactome: R-HSA-5619061	Defective SLC33A1 causes spastic paraplegia 42 (SPG42)	3	XP_050051438.1;XP_050051440.1;XP_050051439.1
Reactome: R-HSA-9017802	Noncanonical activation of NOTCH3	12	XP_050023628.1;XP_050027801.1;XP_050037416.1;XP_050043649.1;XP_050034653.1;XP_050037415.1;XP_050026843.1;XP_050035872.1;XP_050031262.1;XP_050043659.1;XP_050026914.1;XP_050048893.1
KEGG: 04151+2.7.11.1	PI3K-Akt signaling pathway	141	XP_050031200.1;XP_050037625.1;XP_050026954.1;XP_050050723.1;XP_050048905.1;XP_050031206.1;XP_050026053.1;XP_050036226.1;XP_050048619.1;XP_050029303.1;XP_050042989.1;XP_050037630.1;XP_050041922.1;XP_050051647.1;XP_050034960.1;XP_050031198.1;XP_050036224.1;XP_050044446.1;XP_050026955.1;XP_050036225.1;XP_050032708.1;XP_050028233.1;XP_050027320.1;XP_050043308.1;XP_050031194.1;XP_050034932.1;XP_050036237.1;XP_050036232.1;XP_050026027.1;XP_050041921.1;XP_050028166.1;XP_050048621.1;XP_050037623.1;XP_050050734.1;XP_050050310.1;XP_050032548.1;XP_050043849.1;XP_050031207.1;XP_050045593.1;XP_050028292.1;XP_050050709.1;XP_050036131.1;XP_050051059.1;XP_050037629.1;XP_050036230.1;XP_050026555.1;XP_050037627.1;XP_050036239.1;XP_050048906.1;XP_050026976.1;XP_050032586.1;XP_050043130.1;XP_050036231.1;XP_050029160.1;XP_050026977.1;XP_050031209.1;XP_050050715.1;XP_050042307.1;XP_050049192.1;XP_050037622.1;XP_050026695.1;XP_050022875.1;XP_050032707.1;XP_050043304.1;XP_050049350.1;XP_050031202.1;XP_050041923.1;XP_050042990.1;XP_050025348.1;XP_050031205.1;XP_050031203.1;XP_050043303.1;XP_050043305.1;XP_050023932.1;XP_050032928.1;XP_050043302.1;XP_050033844.1;XP_050031197.1;XP_050037624.1;XP_050032102.1;XP_050042988.1;XP_050036238.1;XP_050028165.1;XP_050044807.1;XP_050031195.1;XP_050026974.1;XP_050036240.1;XP_050034961.1;XP_050043306.1;XP_050036228.1;XP_050050041.1;XP_050032927.1;XP_050036129.1;XP_050037621.1;XP_050031201.1;XP_050048620.1;XP_050035999.1;XP_050036236.1;XP_050030586.1;XP_050025347.1;XP_050043301.1;XP_050036142.1;XP_050031196.1;XP_050031204.1;XP_050026975.1;XP_050045265.1;XP_050046724.1;XP_050035462.1;XP_050036233.1;XP_050031199.1;XP_050041948.1;XP_050037628.1;XP_050036613.1;XP_050036223.1;XP_050036235.1;XP_050036234.1;XP_050029381.1;XP_050036227.1;XP_050049191.1;XP_050033720.1;XP_050033021.1;XP_050043307.1;XP_050042629.1;XP_050037631.1;XP_050036130.1;XP_050050042.1;XP_050045266.1;XP_050043129.1;XP_050043309.1;XP_050036229.1;XP_050028687.1;XP_050036241.1;XP_050034828.1;XP_050034829.1;XP_050026054.1;XP_050044080.1;XP_050037626.1;XP_050031208.1;XP_050028323.1;XP_050039865.1;XP_050041924.1
KEGG: 00562+3.1.3.36	Inositol phosphate metabolism	2	XP_050023808.1;XP_050025862.1
Reactome: R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	15	XP_050040824.1;XP_050050532.1;XP_050041261.1;XP_050029852.1;XP_050022594.1;XP_050031446.1;XP_050052687.1;XP_050032670.1;XP_050042225.1;XP_050027779.1;XP_050031345.1;XP_050042755.1;XP_050022980.1;XP_050048896.1;XP_050029342.1
MetaCyc: PWY-7887	Protein SAMPylation and SAMP-mediated thiolation	5	XP_050033200.1;XP_050033201.1;XP_050033199.1;XP_050050274.1;XP_050025634.1
KEGG: 00270+2.5.1.6	Cysteine and methionine metabolism	2	XP_050052167.1;XP_050052168.1
Reactome: R-HSA-1236394	Signaling by ERBB4	8	XP_050051865.1;XP_050040327.1;XP_050040329.1;XP_050040332.1;XP_050040330.1;XP_050051866.1;XP_050051868.1;XP_050051864.1
Reactome: R-HSA-445144	Signal transduction by L1	3	XP_050051200.1;XP_050047606.1;XP_050047598.1
KEGG: 00230+2.7.4.8	Purine metabolism	23	XP_050050200.1;XP_050049241.1;XP_050048546.1;XP_050050203.1;XP_050048547.1;XP_050050199.1;XP_050050204.1;XP_050043318.1;XP_050043319.1;XP_050049240.1;XP_050050201.1;XP_050048545.1;XP_050043320.1;XP_050050202.1;XP_050036821.1;XP_050036822.1;XP_050044277.1;XP_050049238.1;XP_050036823.1;XP_050027671.1;XP_050049242.1;XP_050048548.1;XP_050043321.1
Reactome: R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	68	XP_050045785.1;XP_050050373.1;XP_050048719.1;XP_050040200.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050039332.1;XP_050039331.1;XP_050031479.1;XP_050048721.1;XP_050025848.1;XP_050044478.1;XP_050048801.1;XP_050047778.1;XP_050040341.1;XP_050033833.1;XP_050030937.1;XP_050040338.1;XP_050047181.1;XP_050033318.1;XP_050022518.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050044470.1;XP_050040199.1;XP_050032477.1;XP_050040340.1;XP_050048534.1;XP_050040339.1;XP_050047809.1;XP_050039330.1;XP_050022938.1;XP_050051381.1;XP_050033237.1;XP_050044476.1;XP_050045660.1;XP_050048824.1;XP_050037399.1;XP_050038630.1;XP_050044469.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050034248.1;XP_050038628.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050049124.1;XP_050048720.1;XP_050044475.1;XP_050039329.1;XP_050034247.1;XP_050036567.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050048823.1;XP_050033832.1
MetaCyc: PWY-7269	NAD/NADP-NADH/NADPH mitochondrial interconversion (yeast)	5	XP_050025547.1;XP_050025550.1;XP_050025548.1;XP_050025549.1;XP_050023815.1
KEGG: 00515+2.7.1.183	Mannose type O-glycan biosynthesis	1	XP_050047045.1
MetaCyc: PWY-6333	Acetaldehyde biosynthesis I	3	XP_050052302.1;XP_050052400.1;XP_050052301.1
KEGG: 00020+1.2.4.2	Citrate cycle (TCA cycle)	2	XP_050036622.1;XP_050022550.1
MetaCyc: PWY-5083	NAD/NADH phosphorylation and dephosphorylation	7	XP_050025548.1;XP_050025549.1;XP_050023815.1;YP_010283869.1;YP_010283878.1;XP_050025547.1;XP_050025550.1
Reactome: R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	191	XP_050039557.1;XP_050027305.1;XP_050034567.1;XP_050052131.1;XP_050041313.1;XP_050038432.1;XP_050047002.1;XP_050031230.1;XP_050043917.1;XP_050026792.1;XP_050044078.1;XP_050044446.1;XP_050032330.1;XP_050030466.1;XP_050026018.1;XP_050052267.1;XP_050032840.1;XP_050039340.1;XP_050023058.1;XP_050050940.1;XP_050032598.1;XP_050045969.1;XP_050052268.1;XP_050050655.1;XP_050049776.1;XP_050039582.1;XP_050042306.1;XP_050043803.1;XP_050032267.1;XP_050050516.1;XP_050049123.1;XP_050025636.1;XP_050027477.1;XP_050052130.1;XP_050042319.1;XP_050043916.1;XP_050039286.1;XP_050026722.1;XP_050032528.1;XP_050045970.1;XP_050034868.1;XP_050022748.1;XP_050031861.1;XP_050032936.1;XP_050045470.1;XP_050032331.1;XP_050049167.1;XP_050039285.1;XP_050032921.1;XP_050051569.1;XP_050044445.1;XP_050023059.1;XP_050030467.1;XP_050028318.1;XP_050041682.1;XP_050052269.1;XP_050036006.1;XP_050048853.1;XP_050046987.1;XP_050032353.1;XP_050022875.1;XP_050041143.1;XP_050033573.1;XP_050029850.1;XP_050025206.1;XP_050041312.1;XP_050035484.1;XP_050043804.1;XP_050034659.1;XP_050049165.1;XP_050025176.1;XP_050044122.1;XP_050043802.1;XP_050028344.1;XP_050034757.1;XP_050049441.1;XP_050035483.1;XP_050029294.1;XP_050048534.1;XP_050041744.1;XP_050035149.1;XP_050041753.1;XP_050041314.1;XP_050052117.1;XP_050048061.1;XP_050032347.1;XP_050048060.1;XP_050033847.1;XP_050027435.1;XP_050038433.1;XP_050034620.1;XP_050037446.1;XP_050039882.1;XP_050036830.1;XP_050026185.1;XP_050034770.1;XP_050033723.1;XP_050028604.1;XP_050032599.1;XP_050027514.1;XP_050022853.1;XP_050045601.1;XP_050023381.1;XP_050032793.1;XP_050040677.1;XP_050027304.1;XP_050034745.1;XP_050043918.1;XP_050026793.1;XP_050052296.1;XP_050026008.1;XP_050035481.1;XP_050049831.1;XP_050034721.1;XP_050024013.1;XP_050039349.1;XP_050048049.1;XP_050050490.1;XP_050029380.1;XP_050026498.1;XP_050049830.1;XP_050032634.1;XP_050023789.1;XP_050046746.1;XP_050027512.1;XP_050046934.1;XP_050036005.1;XP_050029607.1;XP_050026103.1;XP_050049122.1;XP_050023492.1;XP_050049170.1;XP_050030468.1;XP_050024740.1;XP_050033844.1;XP_050044114.1;XP_050041311.1;XP_050045196.1;XP_050026723.1;XP_050044593.1;XP_050023767.1;XP_050034633.1;XP_050027513.1;XP_050041315.1;XP_050046933.1;XP_050047864.1;XP_050049624.1;XP_050042950.1;XP_050048062.1;XP_050025612.1;XP_050037004.1;XP_050032688.1;XP_050036431.1;XP_050035381.1;XP_050043919.1;XP_050031153.1;XP_050047808.1;XP_050028191.1;XP_050039997.1;XP_050040640.1;XP_050039289.1;XP_050023588.1;XP_050052060.1;XP_050051195.1;XP_050038626.1;XP_050049769.1;XP_050029851.1;XP_050025209.1;XP_050034628.1;XP_050038550.1;XP_050041323.1;XP_050025213.1;XP_050052195.1;XP_050032689.1;XP_050026721.1;XP_050041310.1;XP_050026988.1;XP_050048805.1;XP_050050654.1;XP_050025611.1;XP_050044680.1;XP_050030710.1;XP_050041684.1;XP_050033720.1;XP_050041683.1;XP_050042714.1;XP_050027710.1;XP_050030959.1;XP_050036543.1;XP_050033913.1;XP_050040632.1
Reactome: R-HSA-3371571	HSF1-dependent transactivation	34	XP_050050697.1;XP_050050696.1;XP_050050685.1;XP_050050687.1;XP_050050684.1;XP_050050681.1;XP_050029406.1;XP_050029408.1;XP_050050698.1;XP_050025348.1;XP_050029405.1;XP_050050683.1;XP_050034809.1;XP_050050701.1;XP_050050679.1;XP_050050700.1;XP_050050686.1;XP_050050690.1;XP_050041412.1;XP_050050694.1;XP_050050691.1;XP_050050689.1;XP_050029407.1;XP_050050699.1;XP_050029409.1;XP_050050702.1;XP_050050680.1;XP_050050695.1;XP_050034700.1;XP_050025347.1;XP_050050682.1;XP_050050692.1;XP_050050693.1;XP_050050688.1
Reactome: R-HSA-5578995	Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)	10	XP_050028105.1;XP_050037649.1;XP_050032154.1;XP_050028104.1;XP_050028103.1;XP_050028106.1;XP_050022501.1;XP_050028107.1;XP_050043008.1;XP_050037646.1
MetaCyc: PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	5	XP_050050236.1;XP_050050237.1;XP_050050239.1;XP_050050240.1;XP_050050241.1
Reactome: R-HSA-5576886	Phase 4 - resting membrane potential	12	XP_050036145.1;XP_050050090.1;XP_050036143.1;XP_050046299.1;XP_050028600.1;XP_050044911.1;XP_050046722.1;XP_050036338.1;XP_050028602.1;XP_050036144.1;XP_050023480.1;XP_050037464.1
KEGG: 00531+3.1.6.14	Glycosaminoglycan degradation	2	XP_050027139.1;XP_050027140.1
KEGG: 00670+2.1.1.13	One carbon pool by folate	1	XP_050036540.1
MetaCyc: PWY-6733	Sporopollenin precursors biosynthesis	24	XP_050038843.1;XP_050041248.1;XP_050038856.1;XP_050038855.1;XP_050039379.1;XP_050039378.1;XP_050039773.1;XP_050038859.1;XP_050038845.1;XP_050041247.1;XP_050039370.1;XP_050038846.1;XP_050039376.1;XP_050037743.1;XP_050037742.1;XP_050038844.1;XP_050038848.1;XP_050040922.1;XP_050038847.1;XP_050038842.1;XP_050039214.1;XP_050038858.1;XP_050039371.1;XP_050039377.1
MetaCyc: PWY-6892	Thiazole biosynthesis I (facultative anaerobic bacteria)	2	XP_050027584.1;XP_050027585.1
Reactome: R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	8	XP_050032478.1;XP_050048032.1;XP_050033903.1;XP_050044695.1;XP_050033904.1;XP_050047551.1;XP_050029505.1;XP_050047548.1
MetaCyc: PWY-6922	L-Ndelta-acetylornithine biosynthesis	6	XP_050043133.1;XP_050048960.1;XP_050036729.1;XP_050049134.1;XP_050036726.1;XP_050039753.1
MetaCyc: PWY-7230	Ubiquinol-6 biosynthesis from 4-aminobenzoate (yeast)	3	XP_050025938.1;XP_050025937.1;XP_050033250.1
MetaCyc: PWY-2541	Phytosterol biosynthesis (plants)	4	XP_050045365.1;XP_050045364.1;XP_050045363.1;XP_050045362.1
MetaCyc: PWY-7279	Aerobic respiration II (cytochrome c) (yeast)	5	XP_050033843.1;XP_050033718.1;XP_050038590.1;XP_050033719.1;XP_050047841.1
MetaCyc: PWY-2781	Cis-zeatin biosynthesis	1	XP_050031168.1
Reactome: R-HSA-8963888	Chylomicron assembly	15	XP_050023809.1;XP_050042240.1;XP_050023796.1;XP_050023422.1;XP_050024095.1;XP_050023334.1;XP_050042454.1;XP_050042261.1;XP_050023312.1;XP_050042242.1;XP_050052147.1;XP_050052148.1;XP_050042262.1;XP_050042260.1;XP_050042241.1
Reactome: R-HSA-6782135	Dual incision in TC-NER	63	XP_050046027.1;XP_050049362.1;XP_050032509.1;XP_050024189.1;XP_050046028.1;XP_050023824.1;XP_050023147.1;XP_050026755.1;XP_050034094.1;XP_050032513.1;XP_050046026.1;XP_050035378.1;XP_050032514.1;XP_050048534.1;XP_050032576.1;XP_050044010.1;XP_050023148.1;XP_050046123.1;XP_050044656.1;XP_050037136.1;XP_050045758.1;XP_050025144.1;XP_050049952.1;XP_050034644.1;XP_050029852.1;XP_050032511.1;XP_050047361.1;XP_050032510.1;XP_050049363.1;XP_050032670.1;XP_050026756.1;XP_050045300.1;XP_050032516.1;XP_050032515.1;XP_050050532.1;XP_050051314.1;XP_050034093.1;XP_050022594.1;XP_050037137.1;XP_050043147.1;XP_050045558.1;XP_050028231.1;XP_050042755.1;XP_050033368.1;XP_050042972.1;XP_050039454.1;XP_050045557.1;XP_050040824.1;XP_050040428.1;XP_050034506.1;XP_050046029.1;XP_050040427.1;XP_050032512.1;XP_050052687.1;XP_050051397.1;XP_050034643.1;XP_050035481.1;XP_050025563.1;XP_050022980.1;XP_050046062.1;XP_050029342.1;XP_050049837.1;XP_050038469.1
MetaCyc: PWY-7919	Protein N-glycosylation processing phase (plants and animals)	3	XP_050050234.1;XP_050050233.1;XP_050050232.1
KEGG: 00052+3.2.1.22	Galactose metabolism	8	XP_050038831.1;XP_050038635.1;XP_050039867.1;XP_050038834.1;XP_050038830.1;XP_050038832.1;XP_050038829.1;XP_050038833.1
Reactome: R-HSA-2871796	FCERI mediated MAPK activation	11	XP_050048140.1;XP_050051315.1;XP_050051316.1;XP_050032853.1;XP_050051318.1;XP_050048141.1;XP_050047606.1;XP_050051597.1;XP_050023625.1;XP_050047598.1;XP_050051317.1
MetaCyc: PWY-7820	Teichuronic acid biosynthesis (B. subtilis 168)	2	XP_050040190.1;XP_050040189.1
MetaCyc: PWY-5537	Pyruvate fermentation to acetate V	8	XP_050049076.1;XP_050043005.1;XP_050042703.1;XP_050042702.1;XP_050042704.1;XP_050026352.1;XP_050049075.1;XP_050026353.1
MetaCyc: PWY-735	Jasmonic acid biosynthesis	2	XP_050023456.1;XP_050026060.1
KEGG: 00540+2.7.7.38	Lipopolysaccharide biosynthesis	1	XP_050032545.1
MetaCyc: PWY-31	Canavanine degradation	2	XP_050036726.1;XP_050036729.1
KEGG: 00730+2.7.6.2	Thiamine metabolism	1	XP_050034132.1
MetaCyc: PWY-5659	GDP-mannose biosynthesis	3	XP_050050068.1;XP_050044728.1;XP_050044364.1
Reactome: R-HSA-73863	RNA Polymerase I Transcription Termination	26	XP_050028889.1;XP_050037136.1;XP_050046123.1;XP_050033368.1;XP_050044010.1;XP_050045531.1;XP_050037137.1;XP_050035378.1;XP_050023813.1;XP_050030957.1;XP_050024189.1;XP_050037436.1;XP_050024718.1;XP_050023814.1;XP_050025563.1;XP_050045300.1;XP_050032466.1;XP_050034643.1;XP_050047361.1;XP_050045532.1;XP_050040427.1;XP_050044393.1;XP_050045530.1;XP_050040428.1;XP_050034644.1;XP_050037088.1
MetaCyc: PWY-6857	Retinol biosynthesis	7	XP_050023764.1;XP_050046664.1;XP_050047992.1;XP_050023765.1;XP_050047989.1;XP_050047990.1;XP_050047993.1
Reactome: R-HSA-9010553	Regulation of expression of SLITs and ROBOs	174	XP_050032936.1;XP_050031861.1;XP_050022748.1;XP_050029923.1;XP_050044355.1;XP_050026722.1;XP_050032528.1;XP_050039286.1;XP_050045970.1;XP_050034868.1;XP_050037401.1;XP_050051073.1;XP_050051569.1;XP_050044445.1;XP_050032331.1;XP_050032921.1;XP_050039285.1;XP_050043803.1;XP_050032267.1;XP_050049776.1;XP_050025636.1;XP_050043916.1;XP_050044356.1;XP_050052130.1;XP_050042319.1;XP_050027477.1;XP_050050516.1;XP_050026018.1;XP_050040199.1;XP_050030634.1;XP_050051964.1;XP_050029924.1;XP_050033331.1;XP_050045969.1;XP_050032598.1;XP_050050940.1;XP_050037397.1;XP_050030410.1;XP_050042025.1;XP_050023058.1;XP_050040198.1;XP_050039340.1;XP_050031230.1;XP_050047002.1;XP_050023742.1;XP_050052131.1;XP_050022518.1;XP_050027305.1;XP_050029925.1;XP_050049519.1;XP_050032330.1;XP_050043917.1;XP_050049523.1;XP_050028252.1;XP_050044476.1;XP_050045189.1;XP_050048061.1;XP_050052117.1;XP_050048060.1;XP_050027435.1;XP_050033237.1;XP_050044982.1;XP_050039882.1;XP_050051067.1;XP_050029294.1;XP_050051109.1;XP_050035483.1;XP_050041744.1;XP_050048534.1;XP_050035149.1;XP_050041753.1;XP_050029850.1;XP_050029802.1;XP_050052231.1;XP_050033573.1;XP_050035484.1;XP_050033832.1;XP_050044122.1;XP_050043802.1;XP_050044475.1;XP_050028344.1;XP_050043804.1;XP_050028318.1;XP_050027657.1;XP_050036156.1;XP_050037398.1;XP_050023059.1;XP_050027134.1;XP_050042788.1;XP_050044983.1;XP_050044469.1;XP_050036006.1;XP_050037399.1;XP_050049522.1;XP_050049170.1;XP_050023492.1;XP_050044478.1;XP_050049521.1;XP_050031479.1;XP_050026103.1;XP_050048721.1;XP_050025848.1;XP_050045196.1;XP_050024740.1;XP_050025715.1;XP_050034772.1;XP_050044360.1;XP_050049830.1;XP_050049520.1;XP_050040200.1;XP_050029380.1;XP_050048719.1;XP_050046934.1;XP_050036005.1;XP_050045785.1;XP_050050373.1;XP_050026674.1;XP_050044470.1;XP_050035472.1;XP_050027304.1;XP_050043918.1;XP_050031786.1;XP_050027118.1;XP_050024749.1;XP_050049831.1;XP_050035481.1;XP_050032599.1;XP_050033318.1;XP_050028604.1;XP_050023714.1;XP_050032793.1;XP_050026675.1;XP_050047181.1;XP_050051098.1;XP_050040677.1;XP_050033833.1;XP_050022853.1;XP_050044359.1;XP_050045660.1;XP_050044680.1;XP_050040632.1;XP_050033913.1;XP_050042714.1;XP_050044357.1;XP_050022938.1;XP_050041323.1;XP_050052195.1;XP_050047809.1;XP_050032477.1;XP_050026721.1;XP_050050645.1;XP_050048823.1;XP_050027018.1;XP_050039997.1;XP_050051087.1;XP_050036567.1;XP_050028191.1;XP_050038550.1;XP_050044358.1;XP_050038626.1;XP_050049124.1;XP_050048720.1;XP_050029851.1;XP_050046933.1;XP_050049373.1;XP_050038140.1;XP_050044593.1;XP_050026723.1;XP_050031153.1;XP_050043919.1;XP_050048062.1;XP_050032688.1;XP_050048824.1;XP_050051080.1
Reactome: R-HSA-2395516	Electron transport from NADPH to Ferredoxin	3	XP_050026269.1;XP_050032712.1;XP_050041743.1
Reactome: R-HSA-8853659	RET signaling	11	XP_050042110.1;XP_050042107.1;XP_050042106.1;XP_050045015.1;XP_050042108.1;XP_050042105.1;XP_050042109.1;XP_050032853.1;XP_050045016.1;XP_050042112.1;XP_050042111.1
KEGG: 00230+3.6.1.6	Purine metabolism	1	XP_050029776.1
MetaCyc: PWY-7592	Arachidonate biosynthesis III (6-desaturase, mammals)	2	XP_050042358.1;XP_050045032.1
MetaCyc: PWY-6142	Gluconeogenesis II (Methanobacterium thermoautotrophicum)	20	XP_050044976.1;XP_050051894.1;XP_050025560.1;XP_050034253.1;XP_050049114.1;XP_050034255.1;XP_050022895.1;XP_050045451.1;XP_050050068.1;XP_050025446.1;XP_050036163.1;XP_050049115.1;XP_050034254.1;XP_050049116.1;XP_050038033.1;XP_050025561.1;XP_050022906.1;XP_050036162.1;XP_050036164.1;XP_050022903.1
KEGG: 00510+2.7.1.108	N-Glycan biosynthesis	1	XP_050039374.1
KEGG: 00564+3.1.1.4	Glycerophospholipid metabolism	27	XP_050037151.1;XP_050033390.1;XP_050035198.1;XP_050037140.1;XP_050037142.1;XP_050035199.1;XP_050037148.1;XP_050037146.1;XP_050037145.1;XP_050035192.1;XP_050035193.1;XP_050037147.1;XP_050031256.1;XP_050030747.1;XP_050025686.1;XP_050037661.1;XP_050037143.1;XP_050025400.1;XP_050035194.1;XP_050050549.1;XP_050037150.1;XP_050035195.1;XP_050037139.1;XP_050035197.1;XP_050037144.1;XP_050035196.1;XP_050037141.1
KEGG: 00970+6.1.1.10	Aminoacyl-tRNA biosynthesis	2	XP_050043461.1;XP_050034442.1
Reactome: R-HSA-3270619	IRF3-mediated induction of type I IFN	7	XP_050028237.1;XP_050028236.1;XP_050033021.1;XP_050039027.1;XP_050028235.1;XP_050040449.1;XP_050032478.1
Reactome: R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	37	XP_050044008.1;XP_050023476.1;XP_050030653.1;XP_050049377.1;XP_050038866.1;XP_050038968.1;XP_050033146.1;XP_050026810.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050046156.1;XP_050035932.1;XP_050026809.1;XP_050038865.1;XP_050035770.1;XP_050038864.1;XP_050024518.1;XP_050023475.1;XP_050042392.1;XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050030507.1;XP_050038966.1;XP_050038967.1;XP_050025064.1;XP_050039240.1;XP_050036827.1;XP_050035933.1;XP_050029515.1;XP_050023474.1;XP_050036430.1;XP_050038895.1;XP_050042391.1;XP_050038863.1;XP_050030942.1
MetaCyc: PWY-6608	Guanosine nucleotides degradation III	4	XP_050035831.1;XP_050049541.1;XP_050046556.1;XP_050046554.1
Reactome: R-HSA-3238698	WNT ligand biogenesis and trafficking	13	XP_050027563.1;XP_050050512.1;XP_050044844.1;XP_050044841.1;XP_050026181.1;XP_050027547.1;XP_050044843.1;XP_050027562.1;XP_050042201.1;XP_050050069.1;XP_050044971.1;XP_050051928.1;XP_050044842.1
KEGG: 00510+2.4.1.131	N-Glycan biosynthesis	2	XP_050039004.1;XP_050039005.1
MetaCyc: PWY-6891	Thiazole biosynthesis II (aerobic bacteria)	2	XP_050027584.1;XP_050027585.1
Reactome: R-HSA-3359471	Defective MMAB causes methylmalonic aciduria type cblB	1	XP_050028834.1
KEGG: 00680+1.1.1.95	Methane metabolism	1	XP_050045348.1
MetaCyc: PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	18	XP_050040418.1;XP_050040584.1;XP_050040415.1;XP_050040583.1;XP_050025836.1;XP_050040580.1;XP_050026084.1;XP_050035077.1;XP_050040577.1;XP_050025835.1;XP_050025837.1;XP_050040419.1;XP_050040416.1;XP_050045561.1;XP_050040581.1;XP_050025834.1;XP_050040417.1;XP_050048623.1
Reactome: R-HSA-376176	Signaling by ROBO receptors	7	XP_050037480.1;XP_050046065.1;XP_050037482.1;XP_050037484.1;XP_050050158.1;XP_050037483.1;XP_050037481.1
KEGG: 00330+2.6.1.1	Arginine and proline metabolism	3	XP_050049203.1;XP_050049202.1;XP_050026413.1
MetaCyc: PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	6	XP_050050239.1;XP_050050237.1;XP_050050236.1;XP_050048146.1;XP_050050241.1;XP_050050240.1
MetaCyc: PWY-7282	4-amino-2-methyl-5-phosphomethylpyrimidine biosynthesis	4	XP_050039873.1;XP_050039987.1;XP_050044537.1;XP_050026420.1
KEGG: 00460+3.5.1.1	Cyanoamino acid metabolism	3	XP_050035272.1;XP_050036428.1;XP_050038344.1
Reactome: R-HSA-381070	IRE1alpha activates chaperones	1	XP_050052627.1
KEGG: 00640+4.2.1.17	Propanoate metabolism	6	XP_050041643.1;XP_050041635.1;XP_050051194.1;XP_050041651.1;XP_050026422.1;XP_050032010.1
KEGG: 00480+2.5.1.22	Glutathione metabolism	2	XP_050027527.1;XP_050027526.1
KEGG: 00020+1.8.1.4	Citrate cycle (TCA cycle)	1	XP_050026566.1
Reactome: R-HSA-4717374	Defective DPM1 causes DPM1-CDG (CDG-1e)	3	XP_050029180.1;XP_050030816.1;XP_050030815.1
KEGG: 00340+2.1.2.5	Histidine metabolism	1	XP_050045421.1
Reactome: R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	21	XP_050048806.1;XP_050034733.1;XP_050034730.1;XP_050034734.1;XP_050034737.1;XP_050034735.1;XP_050034738.1;XP_050034731.1;XP_050034726.1;XP_050034739.1;XP_050034722.1;XP_050034724.1;XP_050034723.1;XP_050034740.1;XP_050034732.1;XP_050034736.1;XP_050034728.1;XP_050026059.1;XP_050034727.1;XP_050034725.1;XP_050034729.1
MetaCyc: PWY-4983	Nitric oxide biosynthesis II (mammals)	6	XP_050048952.1;XP_050045233.1;XP_050045223.1;XP_050048936.1;XP_050052351.1;XP_050048943.1
MetaCyc: PWY-5392	Reductive TCA cycle II	20	XP_050026353.1;XP_050037417.1;XP_050037164.1;XP_050042702.1;XP_050037166.1;XP_050043005.1;XP_050037167.1;XP_050037168.1;XP_050049075.1;XP_050026352.1;XP_050042704.1;XP_050037165.1;XP_050037926.1;XP_050037169.1;XP_050035735.1;XP_050042703.1;XP_050037172.1;XP_050037925.1;XP_050045192.1;XP_050049076.1
KEGG: 00270+2.6.1.1	Cysteine and methionine metabolism	3	XP_050026413.1;XP_050049202.1;XP_050049203.1
Reactome: R-HSA-6784531	tRNA processing in the nucleus	63	XP_050035933.1;XP_050029418.1;XP_050029515.1;XP_050045659.1;XP_050049540.1;XP_050036430.1;XP_050023474.1;XP_050046987.1;XP_050038863.1;XP_050030942.1;XP_050038895.1;XP_050044078.1;XP_050042391.1;XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050026011.1;XP_050030507.1;XP_050040962.1;XP_050038966.1;XP_050030695.1;XP_050025064.1;XP_050039240.1;XP_050036827.1;XP_050029882.1;XP_050038967.1;XP_050038596.1;XP_050032322.1;XP_050046770.1;XP_050038865.1;XP_050032689.1;XP_050035770.1;XP_050028068.1;XP_050024518.1;XP_050026402.1;XP_050026812.1;XP_050038864.1;XP_050023475.1;XP_050042392.1;XP_050029880.1;XP_050028248.1;XP_050026010.1;XP_050045470.1;XP_050040740.1;XP_050044008.1;XP_050026009.1;XP_050023476.1;XP_050038595.1;XP_050047656.1;XP_050038866.1;XP_050038968.1;XP_050030653.1;XP_050028275.1;XP_050049377.1;XP_050026810.1;XP_050033146.1;XP_050031156.1;XP_050046156.1;XP_050035932.1;XP_050026809.1;XP_050023718.1;XP_050038862.1;XP_050029516.1
MetaCyc: PWY-6958	Icosapentaenoate biosynthesis I (lower eukaryotes)	2	XP_050042358.1;XP_050045032.1
Reactome: R-HSA-159227	Transport of the SLBP independent Mature mRNA	38	XP_050045189.1;XP_050038968.1;XP_050038866.1;XP_050030653.1;XP_050049377.1;XP_050023476.1;XP_050044008.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050029516.1;XP_050038862.1;XP_050023718.1;XP_050026810.1;XP_050033146.1;XP_050024518.1;XP_050038864.1;XP_050035770.1;XP_050038865.1;XP_050042392.1;XP_050023475.1;XP_050038966.1;XP_050030507.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050036827.1;XP_050039240.1;XP_050025064.1;XP_050038967.1;XP_050029515.1;XP_050035933.1;XP_050038863.1;XP_050030942.1;XP_050042391.1;XP_050038895.1;XP_050036430.1;XP_050023474.1
Reactome: R-HSA-5620912	Anchoring of the basal body to the plasma membrane	56	XP_050031414.1;XP_050046455.1;XP_050039261.1;XP_050024782.1;XP_050035880.1;XP_050049353.1;XP_050036465.1;XP_050025351.1;XP_050048265.1;XP_050028813.1;XP_050036027.1;XP_050043820.1;XP_050030429.1;XP_050030428.1;XP_050050657.1;XP_050038645.1;XP_050038560.1;XP_050030430.1;XP_050030424.1;XP_050026503.1;XP_050038642.1;XP_050035119.1;XP_050044095.1;XP_050044093.1;XP_050030426.1;XP_050030425.1;XP_050025352.1;XP_050039998.1;XP_050043821.1;XP_050045039.1;XP_050043899.1;XP_050030155.1;XP_050038643.1;XP_050035114.1;XP_050025353.1;XP_050038648.1;XP_050048244.1;XP_050031422.1;XP_050035116.1;XP_050034759.1;XP_050030156.1;XP_050030157.1;XP_050050659.1;XP_050036102.1;XP_050044094.1;XP_050031383.1;XP_050050658.1;XP_050038561.1;XP_050045165.1;XP_050044096.1;XP_050045038.1;XP_050030154.1;XP_050038644.1;XP_050047755.1;XP_050038647.1;XP_050038646.1
Reactome: R-HSA-416482	G alpha (12/13) signalling events	50	XP_050044252.1;XP_050035529.1;XP_050048906.1;XP_050035528.1;XP_050051317.1;XP_050027594.1;XP_050025622.1;XP_050044088.1;XP_050035530.1;XP_050027589.1;XP_050027587.1;XP_050027590.1;XP_050035532.1;XP_050035531.1;XP_050044089.1;XP_050045914.1;XP_050025623.1;XP_050027592.1;XP_050032614.1;XP_050027586.1;XP_050044251.1;XP_050025973.1;XP_050051316.1;XP_050035527.1;XP_050051318.1;XP_050027591.1;XP_050049086.1;XP_050027593.1;XP_050035526.1;XP_050048905.1;XP_050035533.1;XP_050051315.1;XP_050044424.1;XP_050023177.1;XP_050038532.1;XP_050042817.1;XP_050032615.1;XP_050027596.1;XP_050027588.1;XP_050047807.1;XP_050045915.1;XP_050025974.1;XP_050047816.1;XP_050027595.1;XP_050047799.1;XP_050044253.1;XP_050041946.1;XP_050047821.1;XP_050032102.1;XP_050038531.1
KEGG: 00640+1.8.1.4	Propanoate metabolism	1	XP_050026566.1
Reactome: R-HSA-9637628	Modulation by Mtb of host immune system	2	XP_050035481.1;XP_050048534.1
MetaCyc: PWY-5870	Ubiquinol-8 biosynthesis (eukaryotic)	4	XP_050040261.1;XP_050025937.1;XP_050025938.1;XP_050033250.1
MetaCyc: PWY-5686	UMP biosynthesis I	3	XP_050023639.1;XP_050036053.1;XP_050032255.1
Reactome: R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	51	XP_050045648.1;XP_050031594.1;XP_050036502.1;XP_050026914.1;XP_050023568.1;XP_050044797.1;XP_050035872.1;XP_050031262.1;XP_050037415.1;XP_050034653.1;XP_050036373.1;XP_050023628.1;XP_050027801.1;XP_050027121.1;XP_050034595.1;XP_050049355.1;XP_050047955.1;XP_050040624.1;XP_050031443.1;XP_050048132.1;XP_050026843.1;XP_050044796.1;XP_050027120.1;XP_050050843.1;XP_050035481.1;XP_050026551.1;XP_050049340.1;XP_050043659.1;XP_050045588.1;XP_050044795.1;XP_050037416.1;XP_050048534.1;XP_050040623.1;XP_050046640.1;XP_050049030.1;XP_050048893.1;XP_050032607.1;XP_050023569.1;XP_050031360.1;XP_050049349.1;XP_050047965.1;XP_050038799.1;XP_050034209.1;XP_050050621.1;XP_050047670.1;XP_050038602.1;XP_050031442.1;XP_050048137.1;XP_050027119.1;XP_050043649.1;XP_050036365.1
MetaCyc: PWY-3722	Glycine betaine biosynthesis II (Gram-positive bacteria)	3	XP_050043945.1;XP_050052743.1;XP_050030051.1
Reactome: R-HSA-162588	Budding and maturation of HIV virion	10	XP_050038767.1;XP_050050057.1;XP_050052234.1;XP_050025018.1;XP_050027715.1;XP_050050066.1;XP_050025017.1;XP_050048534.1;XP_050030675.1;XP_050035481.1
KEGG: 00520+2.7.1.59	Amino sugar and nucleotide sugar metabolism	1	XP_050049157.1
Reactome: R-HSA-2995383	Initiation of Nuclear Envelope Reformation	2	XP_050030707.1;XP_050039951.1
KEGG: 00332+1.2.1.41+2.7.2.11	Carbapenem biosynthesis	1	XP_050049134.1
Reactome: R-HSA-9022702	MECP2 regulates transcription of neuronal ligands	3	XP_050035890.1;XP_050031707.1;XP_050035889.1
MetaCyc: PWY-7779	Methyl tert-butyl ether degradation	6	XP_050041643.1;XP_050026422.1;XP_050032010.1;XP_050041635.1;XP_050051194.1;XP_050041651.1
MetaCyc: PWY-5740	GDP-L-colitose biosynthesis	3	XP_050047839.1;XP_050047837.1;XP_050047838.1
Reactome: R-HSA-419771	Opsins	2	XP_050046019.1;XP_050051869.1
Reactome: R-HSA-1482925	Acyl chain remodelling of PG	4	XP_050050549.1;XP_050025400.1;XP_050033390.1;XP_050025686.1
Reactome: R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	5	XP_050027741.1;XP_050047770.1;XP_050051298.1;XP_050047771.1;XP_050040711.1
MetaCyc: PWY-5695	Inosine 5'-phosphate degradation	6	XP_050035831.1;XP_050026581.1;XP_050049541.1;XP_050046556.1;XP_050051705.1;XP_050046554.1
Reactome: R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	2	XP_050044089.1;XP_050044088.1
Reactome: R-HSA-69473	G2/M DNA damage checkpoint	49	XP_050024165.1;XP_050048896.1;XP_050036676.1;XP_050044807.1;XP_050022606.1;XP_050042755.1;XP_050045930.1;XP_050036675.1;XP_050034961.1;XP_050038964.1;XP_050038213.1;XP_050025248.1;XP_050050532.1;XP_050038612.1;XP_050046062.1;XP_050048499.1;XP_050025244.1;XP_050029342.1;XP_050022581.1;XP_050051397.1;XP_050044213.1;XP_050022980.1;XP_050028323.1;XP_050023494.1;XP_050046064.1;XP_050047551.1;XP_050032478.1;XP_050044695.1;XP_050036207.1;XP_050022602.1;XP_050032647.1;XP_050038199.1;XP_050038963.1;XP_050038965.1;XP_050036268.1;XP_050025243.1;XP_050042401.1;XP_050033904.1;XP_050033903.1;XP_050028292.1;XP_050022603.1;XP_050037414.1;XP_050029852.1;XP_050034960.1;XP_050022605.1;XP_050022604.1;XP_050025144.1;XP_050035537.1;XP_050025266.1
Reactome: R-HSA-445095	Interaction between L1 and Ankyrins	52	XP_050052574.1;XP_050052565.1;XP_050052577.1;XP_050036849.1;XP_050052559.1;XP_050052567.1;XP_050051732.1;XP_050045174.1;XP_050052585.1;XP_050036850.1;XP_050052573.1;XP_050052561.1;XP_050045172.1;XP_050052556.1;XP_050052557.1;XP_050052551.1;XP_050052546.1;XP_050052560.1;XP_050052580.1;XP_050052550.1;XP_050052576.1;XP_050052562.1;XP_050052563.1;XP_050052568.1;XP_050052578.1;XP_050052583.1;XP_050052569.1;XP_050052584.1;XP_050052547.1;XP_050052555.1;XP_050052586.1;XP_050052558.1;XP_050052579.1;XP_050052552.1;XP_050052566.1;XP_050052545.1;XP_050051734.1;XP_050045173.1;XP_050036851.1;XP_050052544.1;XP_050052570.1;XP_050045171.1;XP_050052554.1;XP_050051733.1;XP_050052587.1;XP_050036848.1;XP_050052549.1;XP_050052571.1;XP_050051735.1;XP_050052582.1;XP_050052553.1;XP_050052572.1
KEGG: 00380+1.8.1.4	Tryptophan metabolism	1	XP_050026566.1
KEGG: 00680+5.4.2.12	Methane metabolism	1	XP_050044976.1
KEGG: 00010+2.7.1.40	Glycolysis / Gluconeogenesis	3	XP_050034253.1;XP_050034254.1;XP_050034255.1
Reactome: R-HSA-8964616	G beta:gamma signalling through CDC42	8	XP_050044089.1;XP_050025623.1;XP_050044424.1;XP_050023177.1;XP_050025375.1;XP_050025622.1;XP_050025374.1;XP_050044088.1
KEGG: 00630+6.3.1.2	Glyoxylate and dicarboxylate metabolism	11	XP_050038621.1;XP_050038619.1;XP_050038620.1;XP_050038622.1;XP_050028873.1;XP_050033588.1;XP_050051950.1;XP_050038618.1;XP_050028874.1;XP_050028876.1;XP_050033589.1
MetaCyc: PWY-5054	D-sorbitol biosynthesis I	1	XP_050050068.1
Reactome: R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	4	XP_050025622.1;XP_050044424.1;XP_050025623.1;XP_050023177.1
Reactome: R-HSA-190373	FGFR1c ligand binding and activation	4	XP_050047847.1;XP_050047846.1;XP_050047716.1;XP_050034235.1
Reactome: R-HSA-6791055	TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P	1	XP_050047377.1
Reactome: R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	17	XP_050049167.1;XP_050051195.1;XP_050049165.1;XP_050049122.1;XP_050040640.1;XP_050032757.1;XP_050041684.1;XP_050041683.1;XP_050039289.1;XP_050032756.1;XP_050023789.1;XP_050042417.1;XP_050037004.1;XP_050049123.1;XP_050035381.1;XP_050049441.1;XP_050041682.1
KEGG: 00220+3.5.3.1	Arginine biosynthesis	2	XP_050036729.1;XP_050036726.1
Reactome: R-HSA-167172	Transcription of the HIV genome	44	XP_050034518.1;XP_050038988.1;XP_050023726.1;XP_050033368.1;XP_050023729.1;XP_050046063.1;XP_050032071.1;XP_050031536.1;XP_050036381.1;XP_050034505.1;XP_050037137.1;XP_050023725.1;XP_050043147.1;XP_050034643.1;XP_050046688.1;XP_050045372.1;XP_050023730.1;XP_050025563.1;XP_050034031.1;XP_050031535.1;XP_050026414.1;XP_050026035.1;XP_050038469.1;XP_050040428.1;XP_050040427.1;XP_050031537.1;XP_050044010.1;XP_050046123.1;XP_050023728.1;XP_050034030.1;XP_050037136.1;XP_050049296.1;XP_050024189.1;XP_050049297.1;XP_050023724.1;XP_050035378.1;XP_050023727.1;XP_050045300.1;XP_050040671.1;XP_050045373.1;XP_050034644.1;XP_050047361.1;XP_050049294.1;XP_050049295.1
KEGG: 00290+4.2.1.33	Valine, leucine and isoleucine biosynthesis	3	XP_050033512.1;XP_050033513.1;XP_050032828.1
KEGG: 04070+2.7.11.13	Phosphatidylinositol signaling system	15	XP_050036247.1;XP_050048818.1;XP_050033083.1;XP_050048815.1;XP_050048816.1;XP_050049843.1;XP_050049845.1;XP_050033084.1;XP_050030242.1;XP_050049842.1;XP_050036246.1;XP_050051435.1;XP_050051436.1;XP_050049844.1;XP_050030241.1
MetaCyc: PWY-6902	Chitin degradation II (Vibrio)	46	XP_050044411.1;XP_050036110.1;XP_050043064.1;XP_050049139.1;XP_050049141.1;XP_050049138.1;XP_050049140.1;XP_050038974.1;XP_050044714.1;XP_050044831.1;XP_050044317.1;XP_050044830.1;XP_050049136.1;XP_050051568.1;XP_050026981.1;XP_050032571.1;XP_050027975.1;XP_050039362.1;XP_050030480.1;XP_050049137.1;XP_050026982.1;XP_050039361.1;XP_050030479.1;XP_050025617.1;XP_050026984.1;XP_050025616.1;XP_050049367.1;XP_050025615.1;XP_050035570.1;XP_050030481.1;XP_050044832.1;XP_050044043.1;XP_050025618.1;XP_050044667.1;XP_050028196.1;XP_050028195.1;XP_050049366.1;XP_050026985.1;XP_050051567.1;XP_050044713.1;XP_050026983.1;XP_050039363.1;XP_050026917.1;XP_050043208.1;XP_050029822.1;XP_050032833.1
Reactome: R-HSA-5682910	LGI-ADAM interactions	3	XP_050050504.1;XP_050047675.1;XP_050047668.1
KEGG: 00230+4.6.1.1	Purine metabolism	11	XP_050045741.1;XP_050045740.1;XP_050045225.1;XP_050045739.1;XP_050041282.1;XP_050045224.1;XP_050051299.1;XP_050041283.1;XP_050040744.1;XP_050041281.1;XP_050041325.1
Reactome: R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	3	XP_050035213.1;XP_050038747.1;XP_050044875.1
Reactome: R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	3	XP_050037110.1;XP_050051798.1;XP_050051797.1
MetaCyc: PWY-7180	2-deoxy-alpha-D-ribose 1-phosphate degradation	1	XP_050048410.1
Reactome: R-HSA-72702	Ribosomal scanning and start codon recognition	72	XP_050046988.1;XP_050030148.1;XP_050048534.1;XP_050051067.1;XP_050029294.1;XP_050036709.1;XP_050035483.1;XP_050052195.1;XP_050051109.1;XP_050046989.1;XP_050033913.1;XP_050051491.1;XP_050048967.1;XP_050041428.1;XP_050027435.1;XP_050031153.1;XP_050044171.1;XP_050051080.1;XP_050036006.1;XP_050045043.1;XP_050028344.1;XP_050038550.1;XP_050028206.1;XP_050029851.1;XP_050038626.1;XP_050035484.1;XP_050029850.1;XP_050036857.1;XP_050028191.1;XP_050051087.1;XP_050036005.1;XP_050052130.1;XP_050044965.1;XP_050029801.1;XP_050032267.1;XP_050037583.1;XP_050046469.1;XP_050034001.1;XP_050049776.1;XP_050029380.1;XP_050046031.1;XP_050044445.1;XP_050051569.1;XP_050048965.1;XP_050031169.1;XP_050045196.1;XP_050051073.1;XP_050032921.1;XP_050024740.1;XP_050032331.1;XP_050031861.1;XP_050026103.1;XP_050034868.1;XP_050045970.1;XP_050032528.1;XP_050051098.1;XP_050032330.1;XP_050044169.1;XP_050037582.1;XP_050032793.1;XP_050034000.1;XP_050030630.1;XP_050032599.1;XP_050052131.1;XP_050044170.1;XP_050033999.1;XP_050032272.1;XP_050032598.1;XP_050045969.1;XP_050036708.1;XP_050025476.1;XP_050027304.1
Reactome: R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	11	XP_050033532.1;XP_050043078.1;XP_050033555.1;XP_050030213.1;XP_050033614.1;XP_050033565.1;XP_050033554.1;XP_050035779.1;XP_050033967.1;XP_050033553.1;XP_050033613.1
KEGG: 00983+6.3.5.2	Drug metabolism - other enzymes	3	XP_050042215.1;XP_050042205.1;XP_050042202.1
Reactome: R-HSA-9009391	Extra-nuclear estrogen signaling	4	XP_050025622.1;XP_050044424.1;XP_050025623.1;XP_050023177.1
Reactome: R-HSA-1369007	Mitochondrial ABC transporters	1	XP_050043445.1
KEGG: 00030+3.1.3.11	Pentose phosphate pathway	2	XP_050038404.1;XP_050044414.1
Reactome: R-HSA-426486	Small interfering RNA (siRNA) biogenesis	20	XP_050026047.1;XP_050029827.1;XP_050029824.1;XP_050036491.1;XP_050029825.1;XP_050035499.1;XP_050029338.1;XP_050029336.1;XP_050026223.1;XP_050026046.1;XP_050023605.1;XP_050037107.1;XP_050037062.1;XP_050029826.1;XP_050028353.1;XP_050037108.1;XP_050032553.1;XP_050036400.1;XP_050052512.1;XP_050029337.1
Reactome: R-HSA-9665245	Resistance of ERBB2 KD mutants to tesevatinib	2	XP_050048200.1;XP_050048201.1
Reactome: R-HSA-8949215	Mitochondrial calcium ion transport	18	XP_050022864.1;XP_050029164.1;XP_050025945.1;XP_050025947.1;XP_050029787.1;XP_050050910.1;XP_050025948.1;XP_050029168.1;XP_050029163.1;XP_050050911.1;XP_050025949.1;XP_050025946.1;XP_050029165.1;XP_050029167.1;XP_050031600.1;XP_050025944.1;XP_050050909.1;XP_050029166.1
MetaCyc: PWY-7821	Tunicamycin biosynthesis	4	XP_050049541.1;XP_050041566.1;XP_050025198.1;XP_050045218.1
Reactome: R-HSA-167161	HIV Transcription Initiation	44	XP_050034031.1;XP_050026035.1;XP_050026414.1;XP_050031535.1;XP_050038469.1;XP_050034643.1;XP_050045372.1;XP_050046688.1;XP_050023730.1;XP_050025563.1;XP_050040428.1;XP_050040427.1;XP_050038988.1;XP_050023726.1;XP_050033368.1;XP_050023729.1;XP_050032071.1;XP_050046063.1;XP_050034518.1;XP_050037137.1;XP_050023725.1;XP_050043147.1;XP_050031536.1;XP_050036381.1;XP_050034505.1;XP_050040671.1;XP_050045300.1;XP_050047361.1;XP_050049294.1;XP_050049295.1;XP_050045373.1;XP_050034644.1;XP_050046123.1;XP_050023728.1;XP_050034030.1;XP_050037136.1;XP_050031537.1;XP_050044010.1;XP_050023724.1;XP_050035378.1;XP_050023727.1;XP_050049296.1;XP_050024189.1;XP_050049297.1
MetaCyc: PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	7	XP_050046832.1;XP_050042256.1;XP_050032111.1;XP_050042247.1;XP_050046833.1;XP_050042265.1;XP_050042238.1
KEGG: 00640+6.4.1.2	Propanoate metabolism	12	XP_050048466.1;XP_050048459.1;XP_050048460.1;XP_050048463.1;XP_050048458.1;XP_050048465.1;XP_050048456.1;XP_050048467.1;XP_050048462.1;XP_050048468.1;XP_050048461.1;XP_050048457.1
MetaCyc: PWY-6863	Pyruvate fermentation to hexanol (engineered)	6	XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
Reactome: R-HSA-174362	Transport and synthesis of PAPS	2	XP_050051797.1;XP_050051798.1
MetaCyc: PWY-7118	Chitin degradation to ethanol	6	XP_050030604.1;XP_050052400.1;XP_050052302.1;XP_050052301.1;XP_050044794.1;XP_050040406.1
KEGG: 00770+2.7.1.24	Pantothenate and CoA biosynthesis	3	XP_050044453.1;XP_050044452.1;XP_050026513.1
KEGG: 00620+6.4.1.1	Pyruvate metabolism	3	XP_050036162.1;XP_050036164.1;XP_050036163.1
Reactome: R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	3	XP_050030451.1;XP_050024508.1;XP_050030452.1
Reactome: R-HSA-69481	G2/M Checkpoints	52	XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050045660.1;XP_050044478.1;XP_050032477.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050047809.1;XP_050048719.1;XP_050040200.1;XP_050022938.1;XP_050049124.1;XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050036567.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050044470.1;XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050047181.1;XP_050044469.1;XP_050037398.1;XP_050033318.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050027657.1;XP_050038140.1;XP_050036156.1
KEGG: 00630+2.1.2.1	Glyoxylate and dicarboxylate metabolism	3	XP_050034367.1;XP_050032636.1;XP_050032637.1
Reactome: R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1	XP_050052798.1
KEGG: 00670+2.1.2.5	One carbon pool by folate	1	XP_050045421.1
KEGG: 00030+5.3.1.9	Pentose phosphate pathway	1	XP_050050068.1
MetaCyc: PWY-7210	Pyrimidine deoxyribonucleotides biosynthesis from CTP	14	XP_050029488.1;XP_050051386.1;XP_050031386.1;XP_050029490.1;XP_050027283.1;XP_050027282.1;XP_050038939.1;XP_050038800.1;XP_050043296.1;XP_050029776.1;XP_050029492.1;XP_050031510.1;XP_050030600.1;XP_050034794.1
MetaCyc: PWY-5941	Glycogen degradation II	4	XP_050037069.1;XP_050042052.1;XP_050037070.1;XP_050037071.1
MetaCyc: PWY-7112	4-hydroxy-2-nonenal detoxification	55	XP_050029071.1;XP_050031855.1;XP_050047698.1;XP_050029057.1;XP_050025491.1;XP_050048247.1;XP_050029052.1;XP_050025490.1;XP_050031611.1;XP_050025458.1;XP_050025493.1;XP_050025460.1;XP_050029305.1;XP_050024015.1;XP_050048256.1;XP_050031589.1;XP_050025459.1;XP_050025461.1;XP_050047714.1;XP_050029059.1;XP_050029053.1;XP_050025650.1;XP_050029960.1;XP_050027823.1;XP_050022874.1;XP_050029055.1;XP_050043741.1;XP_050029072.1;XP_050025508.1;XP_050029056.1;XP_050030373.1;XP_050048220.1;XP_050029240.1;XP_050031599.1;XP_050043742.1;XP_050024805.1;XP_050029054.1;XP_050024014.1;XP_050048233.1;XP_050047905.1;XP_050028992.1;XP_050029058.1;XP_050027833.1;XP_050026762.1;XP_050025413.1;XP_050048267.1;XP_050023398.1;XP_050031872.1;XP_050030123.1;XP_050036058.1;XP_050047704.1;XP_050025457.1;XP_050025489.1;XP_050030014.1;XP_050025492.1
Reactome: R-HSA-9645722	Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function	2	XP_050025745.1;XP_050025746.1
Reactome: R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	4	XP_050050843.1;XP_050038602.1;XP_050045588.1;XP_050038799.1
Reactome: R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	2	XP_050048534.1;XP_050035481.1
Reactome: R-HSA-1369062	ABC transporters in lipid homeostasis	33	XP_050035418.1;XP_050034903.1;XP_050034910.1;XP_050023523.1;XP_050036050.1;XP_050037000.1;XP_050028031.1;XP_050034333.1;XP_050044027.1;XP_050034332.1;XP_050034902.1;XP_050044028.1;XP_050035816.1;XP_050035787.1;XP_050024286.1;XP_050044026.1;XP_050034905.1;XP_050034672.1;XP_050034901.1;XP_050036997.1;XP_050028035.1;XP_050036999.1;XP_050036049.1;XP_050035957.1;XP_050024282.1;XP_050034904.1;XP_050023461.1;XP_050035421.1;XP_050031037.1;XP_050035419.1;XP_050036998.1;XP_050042875.1;XP_050035420.1
MetaCyc: PWY-7416	Phospholipid remodeling (phosphatidylcholine, yeast)	27	XP_050035194.1;XP_050050549.1;XP_050037150.1;XP_050025686.1;XP_050037143.1;XP_050037661.1;XP_050025400.1;XP_050037141.1;XP_050037139.1;XP_050035195.1;XP_050035197.1;XP_050037144.1;XP_050035196.1;XP_050037140.1;XP_050035199.1;XP_050037142.1;XP_050037148.1;XP_050037146.1;XP_050037151.1;XP_050033390.1;XP_050035198.1;XP_050035193.1;XP_050031256.1;XP_050037147.1;XP_050030747.1;XP_050037145.1;XP_050035192.1
KEGG: 00983+3.5.4.5	Drug metabolism - other enzymes	2	XP_050025364.1;XP_050025363.1
KEGG: 00860+2.5.1.141	Porphyrin and chlorophyll metabolism	1	XP_050032875.1
Reactome: R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	3	XP_050033588.1;XP_050051950.1;XP_050033589.1
Reactome: R-HSA-933541	TRAF6 mediated IRF7 activation	2	XP_050038602.1;XP_050032293.1
Reactome: R-HSA-164378	PKA activation in glucagon signalling	21	XP_050029918.1;XP_050042110.1;XP_050042106.1;XP_050042107.1;XP_050045741.1;XP_050045740.1;XP_050032122.1;XP_050045225.1;XP_050042112.1;XP_050029919.1;XP_050029917.1;XP_050045224.1;XP_050051299.1;XP_050040744.1;XP_050042108.1;XP_050041325.1;XP_050032121.1;XP_050042109.1;XP_050042105.1;XP_050042111.1;XP_050045739.1
KEGG: 00720+2.3.3.8	Carbon fixation pathways in prokaryotes	1	XP_050043005.1
Reactome: R-HSA-913709	O-linked glycosylation of mucins	23	XP_050046052.1;XP_050048638.1;XP_050029180.1;XP_050038994.1;XP_050037471.1;XP_050042670.1;XP_050046051.1;XP_050042668.1;XP_050039888.1;XP_050043528.1;XP_050040257.1;XP_050046050.1;XP_050042669.1;XP_050037469.1;XP_050046053.1;XP_050037470.1;XP_050045111.1;XP_050043541.1;XP_050045112.1;XP_050045709.1;XP_050038993.1;XP_050032817.1;XP_050043001.1
Reactome: R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	2	XP_050034022.1;XP_050027464.1
Reactome: R-HSA-164843	2-LTR circle formation	4	XP_050023852.1;XP_050039027.1;XP_050040449.1;XP_050048803.1
KEGG: 00020+4.1.1.32	Citrate cycle (TCA cycle)	11	XP_050038117.1;XP_050034437.1;XP_050038119.1;XP_050038118.1;XP_050034554.1;XP_050034972.1;XP_050031435.1;XP_050038116.1;XP_050038127.1;XP_050038121.1;XP_050038132.1
KEGG: 00010+5.1.3.15	Glycolysis / Gluconeogenesis	1	XP_050037648.1
Reactome: R-HSA-5626467	RHO GTPases activate IQGAPs	26	XP_050049762.1;XP_050052420.1;XP_050051355.1;XP_050052055.1;XP_050046734.1;XP_050047338.1;XP_050039381.1;XP_050032711.1;XP_050025374.1;XP_050049761.1;XP_050024841.1;XP_050049759.1;XP_050029078.1;XP_050049758.1;XP_050043181.1;XP_050029076.1;XP_050046840.1;XP_050046735.1;XP_050025375.1;XP_050046839.1;XP_050049757.1;XP_050029077.1;XP_050039380.1;XP_050051356.1;XP_050024840.1;XP_050051357.1
Reactome: R-HSA-140342	Apoptosis induced DNA fragmentation	2	XP_050050899.1;XP_050050908.1
KEGG: 00521+2.7.1.1	Streptomycin biosynthesis	3	XP_050047070.1;XP_050027343.1;XP_050047071.1
Reactome: R-HSA-3322077	Glycogen synthesis	8	XP_050040570.1;XP_050037409.1;XP_050048534.1;XP_050035481.1;XP_050037410.1;XP_050042400.1;XP_050037412.1;XP_050037411.1
MetaCyc: PWY-5668	Cardiolipin biosynthesis I	4	XP_050034951.1;XP_050029506.1;XP_050029507.1;XP_050034952.1
Reactome: R-HSA-9648025	EML4 and NUDC in mitotic spindle formation	109	XP_050047996.1;XP_050035989.1;XP_050047994.1;XP_050039518.1;XP_050043181.1;XP_050039380.1;XP_050029897.1;XP_050051356.1;XP_050035992.1;XP_050027083.1;XP_050037090.1;XP_050035116.1;XP_050030509.1;XP_050052055.1;XP_050035977.1;XP_050046838.1;XP_050035114.1;XP_050036430.1;XP_050035973.1;XP_050029375.1;XP_050026883.1;XP_050025910.1;XP_050039305.1;XP_050033432.1;XP_050029374.1;XP_050040792.1;XP_050047338.1;XP_050039306.1;XP_050044467.1;XP_050035976.1;XP_050030512.1;XP_050046735.1;XP_050035980.1;XP_050035981.1;XP_050029297.1;XP_050035984.1;XP_050035982.1;XP_050027567.1;XP_050034683.1;XP_050048777.1;XP_050027084.1;XP_050030515.1;XP_050044008.1;XP_050049757.1;XP_050035988.1;XP_050047997.1;XP_050035985.1;XP_050046837.1;XP_050042732.1;XP_050049762.1;XP_050030513.1;XP_050033477.1;XP_050044509.1;XP_050048776.1;XP_050042731.1;XP_050041693.1;XP_050029076.1;XP_050042730.1;XP_050035987.1;XP_050035974.1;XP_050035983.1;XP_050030511.1;XP_050024840.1;XP_050045443.1;XP_050042728.1;XP_050029077.1;XP_050045597.1;XP_050038895.1;XP_050029298.1;XP_050051355.1;XP_050035991.1;XP_050035933.1;XP_050035978.1;XP_050035986.1;XP_050027568.1;XP_050047995.1;XP_050023718.1;XP_050045051.1;XP_050046156.1;XP_050035975.1;XP_050035932.1;XP_050033146.1;XP_050047998.1;XP_050049758.1;XP_050029078.1;XP_050035119.1;XP_050042726.1;XP_050035482.1;XP_050049377.1;XP_050035979.1;XP_050051357.1;XP_050038418.1;XP_050035993.1;XP_050046734.1;XP_050048775.1;XP_050027566.1;XP_050052420.1;XP_050028813.1;XP_050030514.1;XP_050024841.1;XP_050049759.1;XP_050024518.1;XP_050042727.1;XP_050047564.1;XP_050049761.1;XP_050042706.1;XP_050039381.1;XP_050035990.1;XP_050025911.1
MetaCyc: PWY-5872	Ubiquinol-10 biosynthesis (eukaryotic)	4	XP_050025938.1;XP_050025937.1;XP_050040261.1;XP_050033250.1
KEGG: 04070+3.1.3.78	Phosphatidylinositol signaling system	5	XP_050047184.1;XP_050047313.1;XP_050047183.1;XP_050047182.1;XP_050047185.1
KEGG: 00520+3.5.1.25	Amino sugar and nucleotide sugar metabolism	3	XP_050038837.1;XP_050038836.1;XP_050038838.1
Reactome: R-HSA-1296052	Ca2+ activated K+ channels	9	XP_050050755.1;XP_050050805.1;XP_050050764.1;XP_050050797.1;XP_050050782.1;XP_050050788.1;XP_050050773.1;XP_050052373.1;XP_050050748.1
Reactome: R-HSA-419812	Calcitonin-like ligand receptors	5	XP_050043190.1;XP_050043344.1;XP_050042923.1;XP_050042920.1;XP_050042922.1
Reactome: R-HSA-3371568	Attenuation phase	2	XP_050038602.1;XP_050040551.1
Reactome: R-HSA-5603041	IRAK4 deficiency (TLR2/4)	1	XP_050024508.1
Reactome: R-HSA-389948	PD-1 signaling	1	XP_050025376.1
KEGG: 00640+1.2.4.4	Propanoate metabolism	3	XP_050036446.1;XP_050036449.1;XP_050036448.1
Reactome: R-HSA-69205	G1/S-Specific Transcription	19	XP_050043962.1;XP_050027282.1;XP_050050719.1;XP_050046147.1;XP_050039527.1;XP_050032909.1;XP_050039528.1;XP_050052687.1;XP_050046149.1;XP_050023646.1;XP_050049723.1;XP_050027283.1;XP_050026017.1;XP_050036138.1;XP_050032825.1;XP_050046150.1;XP_050049483.1;XP_050046148.1;XP_050049497.1
Reactome: R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	6	XP_050037850.1;XP_050037849.1;XP_050043467.1;XP_050044419.1;XP_050044420.1;XP_050025997.1
Reactome: R-HSA-8951911	RUNX3 regulates RUNX1-mediated transcription	1	XP_050047422.1
KEGG: 00471+3.5.1.2	D-Glutamine and D-glutamate metabolism	1	XP_050026388.1
KEGG: 04070+3.1.3.25	Phosphatidylinositol signaling system	1	XP_050048146.1
Reactome: R-HSA-5362798	Release of Hh-Np from the secreting cell	4	XP_050033319.1;XP_050050209.1;XP_050026869.1;XP_050026551.1
Reactome: R-HSA-195253	Degradation of beta-catenin by the destruction complex	66	XP_050048824.1;XP_050037399.1;XP_050044469.1;XP_050037398.1;XP_050042788.1;XP_050027134.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050048720.1;XP_050049124.1;XP_050044475.1;XP_050040624.1;XP_050036567.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050048823.1;XP_050033832.1;XP_050048775.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050047809.1;XP_050022938.1;XP_050047995.1;XP_050049197.1;XP_050033237.1;XP_050047998.1;XP_050044476.1;XP_050049198.1;XP_050045660.1;XP_050033833.1;XP_050047181.1;XP_050033318.1;XP_050022518.1;XP_050035481.1;XP_050042025.1;XP_050047994.1;XP_050047996.1;XP_050040198.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050037397.1;XP_050035472.1;XP_050051964.1;XP_050033331.1;XP_050044470.1;XP_050040199.1;XP_050050373.1;XP_050047997.1;XP_050045785.1;XP_050048719.1;XP_050048776.1;XP_050040200.1;XP_050025715.1;XP_050049199.1;XP_050034772.1;XP_050047670.1;XP_050037401.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050044478.1;XP_050048777.1
Reactome: R-HSA-3371453	Regulation of HSF1-mediated heat shock response	80	XP_050038966.1;XP_050023495.1;XP_050052627.1;XP_050033167.1;XP_050028323.1;XP_050032317.1;XP_050029342.1;XP_050032562.1;XP_050038967.1;XP_050025064.1;XP_050039240.1;XP_050034762.1;XP_050029515.1;XP_050035933.1;XP_050023298.1;XP_050038895.1;XP_050029319.1;XP_050042391.1;XP_050047606.1;XP_050030942.1;XP_050029369.1;XP_050047777.1;XP_050049377.1;XP_050030653.1;XP_050023361.1;XP_050049449.1;XP_050023718.1;XP_050035113.1;XP_050035932.1;XP_050046156.1;XP_050028292.1;XP_050033146.1;XP_050049306.1;XP_050038864.1;XP_050034760.1;XP_050024518.1;XP_050038865.1;XP_050035770.1;XP_050023887.1;XP_050049304.1;XP_050049305.1;XP_050023782.1;XP_050023362.1;XP_050030507.1;XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050022980.1;XP_050047598.1;XP_050036827.1;XP_050034761.1;XP_050050532.1;XP_050032316.1;XP_050042755.1;XP_050023870.1;XP_050038863.1;XP_050044807.1;XP_050023474.1;XP_050023364.1;XP_050036430.1;XP_050038866.1;XP_050038968.1;XP_050039297.1;XP_050034450.1;XP_050029852.1;XP_050044008.1;XP_050023476.1;XP_050029516.1;XP_050038862.1;XP_050023869.1;XP_050023297.1;XP_050026809.1;XP_050028030.1;XP_050026810.1;XP_050046880.1;XP_050049307.1;XP_050023363.1;XP_050023475.1;XP_050042392.1;XP_050023360.1
Reactome: R-HSA-1250196	SHC1 events in ERBB2 signaling	10	XP_050051864.1;XP_050044781.1;XP_050044786.1;XP_050036246.1;XP_050044784.1;XP_050032853.1;XP_050051868.1;XP_050036247.1;XP_050051866.1;XP_050051865.1
KEGG: 00514+2.4.1.255	Other types of O-glycan biosynthesis	4	XP_050039299.1;XP_050039300.1;XP_050039301.1;XP_050039302.1
Reactome: R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	37	XP_050049156.1;XP_050045191.1;XP_050045235.1;XP_050038514.1;XP_050041874.1;XP_050028872.1;XP_050042263.1;XP_050031946.1;XP_050049155.1;XP_050044087.1;XP_050042266.1;XP_050031949.1;XP_050045179.1;XP_050045194.1;XP_050045178.1;XP_050045177.1;XP_050042270.1;XP_050030699.1;XP_050037106.1;XP_050048401.1;XP_050037902.1;XP_050042271.1;XP_050037105.1;XP_050031948.1;XP_050048711.1;XP_050027798.1;XP_050042264.1;XP_050042294.1;XP_050045234.1;XP_050045176.1;XP_050031947.1;XP_050041873.1;XP_050045175.1;XP_050030700.1;XP_050048399.1;XP_050045193.1;XP_050048400.1
Reactome: R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	33	XP_050044105.1;XP_050048499.1;XP_050038612.1;XP_050044213.1;XP_050022581.1;XP_050028323.1;XP_050046064.1;XP_050047551.1;XP_050048786.1;XP_050032478.1;XP_050045274.1;XP_050044695.1;XP_050032850.1;XP_050048896.1;XP_050022606.1;XP_050037711.1;XP_050045930.1;XP_050039324.1;XP_050039323.1;XP_050037414.1;XP_050022603.1;XP_050028292.1;XP_050022604.1;XP_050022605.1;XP_050024885.1;XP_050047604.1;XP_050022602.1;XP_050024123.1;XP_050032647.1;XP_050041012.1;XP_050033904.1;XP_050039624.1;XP_050033903.1
MetaCyc: PWY-7291	Oleate beta-oxidation (isomerase-dependent, yeast)	2	XP_050026060.1;XP_050023456.1
KEGG: 00720+1.1.1.37	Carbon fixation pathways in prokaryotes	11	XP_050037167.1;XP_050037925.1;XP_050045192.1;XP_050037172.1;XP_050037166.1;XP_050035735.1;XP_050037169.1;XP_050037926.1;XP_050037164.1;XP_050037165.1;XP_050037168.1
Reactome: R-HSA-2173788	Downregulation of TGF-beta receptor signaling	12	XP_050046837.1;XP_050048534.1;XP_050035481.1;XP_050046838.1;XP_050023721.1;XP_050052710.1;XP_050036461.1;XP_050032720.1;XP_050052711.1;XP_050045247.1;XP_050044544.1;XP_050028692.1
MetaCyc: PWY-6174	Mevalonate pathway II (archaea)	9	XP_050041694.1;XP_050028850.1;XP_050041696.1;XP_050041692.1;XP_050045766.1;XP_050041695.1;XP_050041691.1;XP_050024679.1;XP_050045765.1
Reactome: R-HSA-4086398	Ca2+ pathway	42	XP_050051915.1;XP_050023605.1;XP_050029826.1;XP_050028062.1;XP_050052764.1;XP_050052225.1;XP_050052763.1;XP_050052512.1;XP_050023177.1;XP_050026047.1;XP_050024343.1;XP_050029858.1;XP_050044424.1;XP_050029860.1;XP_050029825.1;XP_050029859.1;XP_050029338.1;XP_050051917.1;XP_050039236.1;XP_050028061.1;XP_050029861.1;XP_050026046.1;XP_050026223.1;XP_050051757.1;XP_050025879.1;XP_050052226.1;XP_050051916.1;XP_050028353.1;XP_050025623.1;XP_050032553.1;XP_050052762.1;XP_050051756.1;XP_050039235.1;XP_050029337.1;XP_050027890.1;XP_050038409.1;XP_050029827.1;XP_050029824.1;XP_050025622.1;XP_050051758.1;XP_050029862.1;XP_050029336.1
KEGG: 00240+3.6.1.23	Pyrimidine metabolism	1	XP_050034827.1
Reactome: R-HSA-8851708	Signaling by FGFR2 IIIa TM	15	XP_050023728.1;XP_050046123.1;XP_050023726.1;XP_050038469.1;XP_050046063.1;XP_050023729.1;XP_050034643.1;XP_050023730.1;XP_050043147.1;XP_050023727.1;XP_050023725.1;XP_050023724.1;XP_050045189.1;XP_050024189.1;XP_050034644.1
KEGG: 00983+2.4.2.8	Drug metabolism - other enzymes	2	XP_050045960.1;XP_050045961.1
Reactome: R-HSA-5632684	Hedgehog 'on' state	58	XP_050040200.1;XP_050022938.1;XP_050032477.1;XP_050050209.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050047809.1;XP_050048719.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050045660.1;XP_050044478.1;XP_050025715.1;XP_050033319.1;XP_050034772.1;XP_050033237.1;XP_050037401.1;XP_050037398.1;XP_050033318.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050041328.1;XP_050047181.1;XP_050044469.1;XP_050035472.1;XP_050022472.1;XP_050051964.1;XP_050033331.1;XP_050036567.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050044470.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050049124.1;XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050048935.1;XP_050041327.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050044475.1
Reactome: R-HSA-111931	PKA-mediated phosphorylation of CREB	8	XP_050042105.1;XP_050042109.1;XP_050042112.1;XP_050042111.1;XP_050042110.1;XP_050042106.1;XP_050042107.1;XP_050042108.1
KEGG: 00010+2.7.1.1	Glycolysis / Gluconeogenesis	3	XP_050047071.1;XP_050047070.1;XP_050027343.1
KEGG: 00520+5.4.2.10	Amino sugar and nucleotide sugar metabolism	4	XP_050050483.1;XP_050023606.1;XP_050023928.1;XP_050040092.1
Reactome: R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1	XP_050045552.1
Reactome: R-HSA-5099900	WNT5A-dependent internalization of FZD4	10	XP_050037100.1;XP_050030242.1;XP_050039072.1;XP_050030241.1;XP_050040246.1;XP_050028603.1;XP_050039071.1;XP_050027890.1;XP_050048294.1;XP_050039510.1
Reactome: R-HSA-156842	Eukaryotic Translation Elongation	7	XP_050040455.1;XP_050036820.1;XP_050042949.1;XP_050039184.1;XP_050039185.1;XP_050050959.1;XP_050040456.1
MetaCyc: PWY-5466	Matairesinol biosynthesis	18	XP_050052158.1;XP_050037576.1;XP_050037575.1;XP_050037573.1;XP_050031834.1;XP_050022911.1;XP_050037574.1;XP_050022520.1;XP_050030591.1;XP_050031815.1;XP_050032263.1;XP_050033134.1;XP_050037572.1;XP_050022517.1;XP_050052159.1;XP_050030590.1;XP_050031263.1;XP_050052157.1
Reactome: R-HSA-8949613	Cristae formation	29	XP_050029368.1;XP_050035944.1;XP_050026549.1;XP_050031579.1;XP_050034504.1;XP_050029317.1;XP_050034502.1;XP_050030318.1;XP_050026550.1;XP_050045431.1;XP_050047208.1;XP_050023597.1;XP_050023244.1;XP_050030910.1;XP_050049449.1;XP_050030121.1;XP_050033401.1;XP_050049314.1;XP_050032502.1;XP_050049173.1;XP_050033403.1;YP_010283873.1;XP_050040553.1;XP_050043887.1;XP_050033402.1;XP_050042316.1;XP_050034503.1;XP_050042317.1;XP_050026328.1
KEGG: 00051+5.3.1.1	Fructose and mannose metabolism	1	XP_050045451.1
MetaCyc: PWY-7391	Isoprene biosynthesis II (engineered)	12	XP_050051832.1;XP_050041691.1;XP_050024679.1;XP_050045765.1;XP_050041695.1;XP_050045766.1;XP_050041692.1;XP_050041696.1;XP_050028850.1;XP_050044825.1;XP_050051831.1;XP_050041694.1
Reactome: R-HSA-8951936	RUNX3 regulates p14-ARF	1	XP_050047422.1
KEGG: 00565+3.1.1.4	Ether lipid metabolism	27	XP_050035194.1;XP_050050549.1;XP_050037150.1;XP_050025686.1;XP_050037143.1;XP_050037661.1;XP_050025400.1;XP_050037141.1;XP_050035195.1;XP_050037139.1;XP_050035197.1;XP_050037144.1;XP_050035196.1;XP_050037140.1;XP_050037142.1;XP_050035199.1;XP_050037146.1;XP_050037148.1;XP_050037151.1;XP_050033390.1;XP_050035198.1;XP_050035193.1;XP_050031256.1;XP_050037147.1;XP_050030747.1;XP_050037145.1;XP_050035192.1
MetaCyc: PWY-6855	Chitin degradation I (archaea)	19	XP_050040346.1;XP_050040348.1;XP_050040347.1;XP_050049839.1;XP_050044411.1;XP_050029822.1;XP_050032833.1;XP_050043208.1;XP_050032571.1;XP_050044713.1;XP_050051567.1;XP_050051568.1;XP_050044830.1;XP_050044667.1;XP_050044317.1;XP_050044831.1;XP_050044714.1;XP_050044043.1;XP_050044832.1
Reactome: R-HSA-5628897	TP53 Regulates Metabolic Genes	91	YP_010283874.1;XP_050029337.1;XP_050050754.1;XP_050043466.1;XP_050032553.1;XP_050042307.1;XP_050051916.1;XP_050026046.1;XP_050033752.1;XP_050050756.1;XP_050026223.1;XP_050029861.1;XP_050037102.1;XP_050050068.1;XP_050044524.1;XP_050044527.1;XP_050044531.1;XP_050028353.1;XP_050033751.1;XP_050029862.1;XP_050029336.1;XP_050022910.1;XP_050029827.1;XP_050025102.1;XP_050044528.1;XP_050047857.1;XP_050029407.1;XP_050024428.1;XP_050040015.1;XP_050033750.1;XP_050050752.1;XP_050041412.1;XP_050052512.1;XP_050051460.1;XP_050032859.1;XP_050029826.1;XP_050027194.1;XP_050044488.1;XP_050051915.1;XP_050023605.1;XP_050045633.1;XP_050044525.1;XP_050038791.1;XP_050029338.1;XP_050048621.1;XP_050037110.1;XP_050036569.1;XP_050044529.1;XP_050029406.1;XP_050039236.1;XP_050032858.1;XP_050029858.1;XP_050027195.1;YP_010283871.1;XP_050029860.1;XP_050045279.1;XP_050038789.1;XP_050034639.1;XP_050048620.1;XP_050039235.1;XP_050052134.1;XP_050030178.1;XP_050052226.1;XP_050044532.1;XP_050043540.1;XP_050025347.1;XP_050026388.1;XP_050029409.1;XP_050047553.1;XP_050045053.1;XP_050026164.1;XP_050029824.1;XP_050052225.1;XP_050048619.1;XP_050050757.1;XP_050042233.1;XP_050029405.1;XP_050044489.1;XP_050050753.1;XP_050025568.1;XP_050031824.1;XP_050025348.1;XP_050029408.1;XP_050044530.1;XP_050051917.1;XP_050038790.1;XP_050026047.1;YP_010283870.1;XP_050029825.1;XP_050029859.1;XP_050022909.1
MetaCyc: PWY-5723	Rubisco shunt	8	XP_050034254.1;XP_050034253.1;XP_050044976.1;XP_050033946.1;XP_050047377.1;XP_050051894.1;XP_050049438.1;XP_050034255.1
Reactome: R-HSA-193648	NRAGE signals death through JNK	45	XP_050038532.1;XP_050042817.1;XP_050048905.1;XP_050035526.1;XP_050051315.1;XP_050035533.1;XP_050027591.1;XP_050027593.1;XP_050035527.1;XP_050051318.1;XP_050023604.1;XP_050047821.1;XP_050038531.1;XP_050044253.1;XP_050041946.1;XP_050045915.1;XP_050025974.1;XP_050047816.1;XP_050027595.1;XP_050047799.1;XP_050023603.1;XP_050027596.1;XP_050027588.1;XP_050047807.1;XP_050027587.1;XP_050035530.1;XP_050027589.1;XP_050044088.1;XP_050035528.1;XP_050051317.1;XP_050027594.1;XP_050044252.1;XP_050035529.1;XP_050048906.1;XP_050044251.1;XP_050025973.1;XP_050051316.1;XP_050027592.1;XP_050027586.1;XP_050044089.1;XP_050023602.1;XP_050045914.1;XP_050027590.1;XP_050035531.1;XP_050035532.1
KEGG: 00521+5.5.1.4	Streptomycin biosynthesis	2	XP_050052037.1;XP_050052036.1
KEGG: 00900+2.7.7.60	Terpenoid backbone biosynthesis	1	XP_050046883.1
Reactome: R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	93	XP_050032742.1;XP_050049757.1;XP_050047797.1;XP_050045529.1;XP_050052462.1;XP_050042211.1;XP_050050272.1;XP_050046735.1;XP_050044509.1;XP_050038146.1;XP_050042302.1;XP_050030784.1;XP_050047757.1;XP_050033494.1;XP_050030681.1;XP_050032496.1;XP_050049762.1;XP_050042301.1;XP_050049233.1;XP_050050238.1;XP_050048810.1;XP_050033500.1;XP_050034282.1;XP_050052733.1;XP_050039380.1;XP_050051356.1;XP_050033627.1;XP_050043181.1;XP_050039959.1;XP_050038147.1;XP_050030783.1;XP_050049777.1;XP_050047338.1;XP_050045595.1;XP_050035971.1;XP_050048257.1;XP_050042789.1;XP_050048644.1;XP_050042243.1;XP_050035850.1;XP_050044767.1;XP_050033964.1;XP_050050216.1;XP_050036828.1;XP_050025646.1;XP_050052055.1;XP_050050256.1;XP_050038148.1;XP_050030785.1;XP_050050207.1;XP_050049232.1;XP_050034918.1;XP_050050246.1;XP_050051357.1;XP_050023886.1;XP_050050264.1;XP_050030787.1;XP_050049758.1;XP_050030786.1;XP_050029540.1;XP_050050230.1;XP_050036861.1;XP_050025401.1;XP_050039381.1;XP_050044598.1;XP_050049759.1;XP_050024841.1;XP_050027921.1;XP_050049761.1;XP_050042210.1;XP_050052420.1;XP_050050223.1;XP_050043791.1;XP_050045596.1;XP_050046734.1;XP_050051406.1;XP_050050573.1;XP_050026207.1;XP_050024840.1;XP_050035540.1;XP_050036862.1;XP_050042479.1;XP_050042300.1;XP_050048645.1;XP_050038145.1;XP_050022722.1;XP_050051130.1;XP_050024323.1;XP_050032743.1;XP_050038144.1;XP_050042212.1;XP_050038149.1;XP_050051355.1
Reactome: R-HSA-5607764	CLEC7A (Dectin-1) signaling	60	XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050049124.1;XP_050040198.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050051964.1;XP_050035472.1;XP_050040624.1;XP_050033331.1;XP_050036567.1;XP_050052231.1;XP_050044470.1;XP_050029802.1;XP_050050645.1;XP_050048823.1;XP_050033832.1;XP_050040199.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050044469.1;XP_050047181.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050025715.1;XP_050034772.1;XP_050047670.1;XP_050033237.1;XP_050037401.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050045660.1;XP_050028062.1;XP_050050758.1;XP_050044478.1;XP_050040623.1;XP_050048534.1;XP_050032477.1;XP_050050373.1;XP_050028061.1;XP_050045785.1;XP_050047809.1;XP_050048719.1;XP_050032548.1;XP_050022938.1;XP_050047769.1;XP_050040200.1
MetaCyc: PWY-6614	Tetrahydrofolate biosynthesis	1	XP_050032825.1
MetaCyc: PWY-7805	(aminomethyl)phosphonate degradation	8	XP_050034244.1;XP_050052518.1;XP_050052520.1;XP_050034245.1;XP_050049687.1;XP_050034243.1;XP_050034246.1;XP_050052521.1
KEGG: 00650+4.2.1.17	Butanoate metabolism	1	XP_050032010.1
KEGG: 00513+2.4.1.261	Various types of N-glycan biosynthesis	1	XP_050048305.1
Reactome: R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	43	XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050030507.1;XP_050038928.1;XP_050038966.1;XP_050025064.1;XP_050039240.1;XP_050036827.1;XP_050048613.1;XP_050038967.1;XP_050035933.1;XP_050029515.1;XP_050040680.1;XP_050036430.1;XP_050023474.1;XP_050030942.1;XP_050038863.1;XP_050038895.1;XP_050042391.1;XP_050044008.1;XP_050023476.1;XP_050036364.1;XP_050038866.1;XP_050045189.1;XP_050038968.1;XP_050049377.1;XP_050030653.1;XP_050026810.1;XP_050033146.1;XP_050046156.1;XP_050026809.1;XP_050035932.1;XP_050023718.1;XP_050038862.1;XP_050029516.1;XP_050038865.1;XP_050035770.1;XP_050024518.1;XP_050038864.1;XP_050042392.1;XP_050023475.1;XP_050036363.1
KEGG: 00380+2.3.1.61	Tryptophan metabolism	1	XP_050036844.1
Reactome: R-HSA-111469	SMAC, XIAP-regulated apoptotic response	3	XP_050037103.1;XP_050041785.1;XP_050037104.1
KEGG: 00280+5.1.99.1	Valine, leucine and isoleucine degradation	1	XP_050034236.1
KEGG: 00720+6.4.1.1	Carbon fixation pathways in prokaryotes	3	XP_050036162.1;XP_050036164.1;XP_050036163.1
Reactome: R-HSA-166166	MyD88-independent TLR4 cascade	10	XP_050049561.1;XP_050049569.1;XP_050049584.1;XP_050049544.1;XP_050049576.1;XP_050049552.1;XP_050049592.1;XP_050049608.1;XP_050049616.1;XP_050049599.1
MetaCyc: PWY-7746	Mycobacterial sulfolipid biosynthesis	4	XP_050033009.1;XP_050032773.1;XP_050033008.1;XP_050029751.1
MetaCyc: PWY-7124	Ethylene biosynthesis V (engineered)	8	XP_050043069.1;XP_050043076.1;XP_050037007.1;XP_050051894.1;XP_050044976.1;XP_050037396.1;XP_050041863.1;XP_050026123.1
KEGG: 00230+2.4.2.1	Purine metabolism	3	XP_050046556.1;XP_050046554.1;XP_050035831.1
KEGG: 00900+2.5.1.58	Terpenoid backbone biosynthesis	1	XP_050037466.1
Reactome: R-HSA-2428928	IRS-related events triggered by IGF1R	1	XP_050026814.1
MetaCyc: PWY-6549	L-glutamine biosynthesis III	17	XP_050043076.1;XP_050033589.1;XP_050028874.1;XP_050028876.1;XP_050038620.1;XP_050038619.1;XP_050041863.1;XP_050033588.1;XP_050028873.1;XP_050043069.1;XP_050037007.1;XP_050038618.1;XP_050037396.1;XP_050038622.1;XP_050051950.1;XP_050026123.1;XP_050038621.1
Reactome: R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	1	XP_050047422.1
Reactome: R-HSA-9604323	Negative regulation of NOTCH4 signaling	54	XP_050047809.1;XP_050048719.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050050373.1;XP_050045785.1;XP_050022938.1;XP_050040200.1;XP_050047670.1;XP_050037401.1;XP_050033237.1;XP_050025715.1;XP_050034772.1;XP_050045660.1;XP_050044478.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050044469.1;XP_050047181.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050027657.1;XP_050038140.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050022518.1;XP_050027134.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050049124.1;XP_050040198.1;XP_050052231.1;XP_050044470.1;XP_050050645.1;XP_050029802.1;XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050035472.1;XP_050051964.1;XP_050036567.1;XP_050033331.1;XP_050040624.1
Reactome: R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	11	XP_050038199.1;XP_050025763.1;XP_050043043.1;XP_050052047.1;XP_050025244.1;XP_050038213.1;XP_050049643.1;XP_050025266.1;XP_050025248.1;XP_050036268.1;XP_050025243.1
Reactome: R-HSA-165159	mTOR signalling	24	XP_050029407.1;XP_050027195.1;XP_050029409.1;XP_050029406.1;XP_050032858.1;XP_050029408.1;XP_050025348.1;XP_050025347.1;XP_050050753.1;XP_050043540.1;XP_050034809.1;XP_050034700.1;XP_050032859.1;XP_050027194.1;XP_050044489.1;XP_050029405.1;XP_050050756.1;XP_050044488.1;XP_050050754.1;XP_050043466.1;XP_050050757.1;XP_050041412.1;XP_050050752.1;XP_050040015.1
MetaCyc: PWY-6129	Dolichol and dolichyl phosphate biosynthesis	6	XP_050039374.1;XP_050038668.1;XP_050038667.1;XP_050050944.1;XP_050025956.1;XP_050050945.1
KEGG: 00561+2.7.1.107	Glycerolipid metabolism	18	XP_050035431.1;XP_050048424.1;XP_050026074.1;XP_050035430.1;XP_050044041.1;XP_050046068.1;XP_050035432.1;XP_050035434.1;XP_050035433.1;XP_050035435.1;XP_050026073.1;XP_050046067.1;XP_050035429.1;XP_050048427.1;XP_050048426.1;XP_050048423.1;XP_050044042.1;XP_050048425.1
Reactome: R-HSA-1614635	Sulfur amino acid metabolism	4	XP_050045028.1;XP_050046841.1;XP_050042638.1;XP_050036540.1
KEGG: 00460+2.3.2.2	Cyanoamino acid metabolism	42	XP_050027823.1;XP_050022874.1;XP_050043741.1;XP_050029055.1;XP_050029072.1;XP_050025461.1;XP_050029960.1;XP_050025650.1;XP_050029053.1;XP_050029059.1;XP_050025493.1;XP_050025460.1;XP_050029305.1;XP_050025459.1;XP_050024015.1;XP_050031589.1;XP_050029071.1;XP_050025490.1;XP_050029052.1;XP_050031611.1;XP_050025491.1;XP_050029057.1;XP_050025458.1;XP_050030123.1;XP_050025457.1;XP_050025489.1;XP_050036058.1;XP_050025492.1;XP_050030014.1;XP_050028992.1;XP_050025413.1;XP_050029058.1;XP_050023398.1;XP_050029054.1;XP_050024014.1;XP_050025508.1;XP_050030373.1;XP_050029056.1;XP_050024805.1;XP_050043742.1;XP_050031599.1;XP_050029240.1
Reactome: R-HSA-163615	PKA activation	21	XP_050042111.1;XP_050045739.1;XP_050042105.1;XP_050042109.1;XP_050032121.1;XP_050041325.1;XP_050042108.1;XP_050040744.1;XP_050045224.1;XP_050051299.1;XP_050029917.1;XP_050029919.1;XP_050042112.1;XP_050045225.1;XP_050032122.1;XP_050045741.1;XP_050045740.1;XP_050042107.1;XP_050042106.1;XP_050042110.1;XP_050029918.1
Reactome: R-HSA-2129379	Molecules associated with elastic fibres	9	XP_050026336.1;XP_050026339.1;XP_050043548.1;XP_050026337.1;XP_050026342.1;XP_050041702.1;XP_050026340.1;XP_050026341.1;XP_050026338.1
Reactome: R-HSA-5696400	Dual Incision in GG-NER	36	XP_050049952.1;XP_050025144.1;XP_050029852.1;XP_050047361.1;XP_050032670.1;XP_050046027.1;XP_050046028.1;XP_050046026.1;XP_050048534.1;XP_050032576.1;XP_050044010.1;XP_050044656.1;XP_050037136.1;XP_050039454.1;XP_050045557.1;XP_050048032.1;XP_050040824.1;XP_050040428.1;XP_050034506.1;XP_050040427.1;XP_050046029.1;XP_050035481.1;XP_050052687.1;XP_050051397.1;XP_050022980.1;XP_050025563.1;XP_050046062.1;XP_050029342.1;XP_050050532.1;XP_050037137.1;XP_050022594.1;XP_050045558.1;XP_050024696.1;XP_050028231.1;XP_050042755.1;XP_050042972.1
Reactome: R-HSA-192456	Digestion of dietary lipid	7	XP_050047993.1;XP_050047990.1;XP_050047992.1;XP_050023765.1;XP_050047989.1;XP_050023764.1;XP_050046664.1
KEGG: 00966+2.6.1.42	Glucosinolate biosynthesis	1	XP_050039540.1
KEGG: 00950+2.6.1.1	Isoquinoline alkaloid biosynthesis	3	XP_050026413.1;XP_050049202.1;XP_050049203.1
Reactome: R-HSA-5619055	Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)	1	XP_050037405.1
MetaCyc: PWY-7900	Glycogen biosynthesis III (from alpha-maltose 1-phosphate)	3	XP_050028738.1;XP_050042400.1;XP_050028469.1
Reactome: R-HSA-110357	Displacement of DNA glycosylase by APEX1	14	XP_050034157.1;XP_050027464.1;XP_050034158.1;XP_050049643.1;XP_050026313.1;XP_050030582.1;XP_050049036.1;XP_050030583.1;XP_050034022.1;XP_050049035.1;XP_050030584.1;XP_050052047.1;XP_050034159.1;XP_050043043.1
Reactome: R-HSA-73772	RNA Polymerase I Promoter Escape	34	XP_050045300.1;XP_050037436.1;XP_050024718.1;XP_050023814.1;XP_050034644.1;XP_050025266.1;XP_050037088.1;XP_050045530.1;XP_050047361.1;XP_050045532.1;XP_050044010.1;XP_050038199.1;XP_050046123.1;XP_050037136.1;XP_050024189.1;XP_050025243.1;XP_050036268.1;XP_050035378.1;XP_050034643.1;XP_050032466.1;XP_050025563.1;XP_050025244.1;XP_050040428.1;XP_050040427.1;XP_050044393.1;XP_050045531.1;XP_050033368.1;XP_050028889.1;XP_050046963.1;XP_050025248.1;XP_050038213.1;XP_050030957.1;XP_050037137.1;XP_050023813.1
KEGG: 00030+2.7.1.11	Pentose phosphate pathway	4	XP_050040643.1;XP_050040641.1;XP_050040645.1;XP_050040644.1
KEGG: 00513+2.4.1.257+2.4.1.132	Various types of N-glycan biosynthesis	2	XP_050023466.1;XP_050023465.1
KEGG: 00730+3.1.3.1	Thiamine metabolism	8	XP_050045710.1;XP_050041543.1;XP_050042681.1;XP_050042679.1;XP_050042678.1;XP_050047231.1;XP_050041544.1;XP_050041542.1
MetaCyc: PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	4	XP_050036449.1;XP_050036446.1;XP_050026566.1;XP_050036448.1
Reactome: R-HSA-3000170	Syndecan interactions	2	XP_050040600.1;XP_050043548.1
Reactome: R-HSA-210500	Glutamate Neurotransmitter Release Cycle	3	XP_050026388.1;XP_050039212.1;XP_050039213.1
Reactome: R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	14	XP_050028061.1;XP_050049592.1;XP_050049616.1;XP_050049608.1;XP_050048534.1;XP_050035481.1;XP_050049599.1;XP_050049561.1;XP_050049569.1;XP_050049584.1;XP_050028062.1;XP_050049544.1;XP_050049576.1;XP_050049552.1
KEGG: 00400+2.6.1.1	Phenylalanine, tyrosine and tryptophan biosynthesis	3	XP_050049202.1;XP_050049203.1;XP_050026413.1
Reactome: R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	1	XP_050023721.1
Reactome: R-HSA-1474244	Extracellular matrix organization	2	XP_050051572.1;XP_050052132.1
KEGG: 00860+2.5.1.17	Porphyrin and chlorophyll metabolism	1	XP_050028834.1
Reactome: R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	27	XP_050037415.1;XP_050034653.1;XP_050034595.1;XP_050049355.1;XP_050048534.1;XP_050037416.1;XP_050027801.1;XP_050023628.1;XP_050036502.1;XP_050026914.1;XP_050031594.1;XP_050031262.1;XP_050049340.1;XP_050043659.1;XP_050035872.1;XP_050026843.1;XP_050048132.1;XP_050048137.1;XP_050043649.1;XP_050035481.1;XP_050036365.1;XP_050049030.1;XP_050048893.1;XP_050046640.1;XP_050047965.1;XP_050049349.1;XP_050047955.1
Reactome: R-HSA-901042	Calnexin/calreticulin cycle	4	XP_050023649.1;XP_050040959.1;XP_050023648.1;XP_050040960.1
MetaCyc: PWY-1269	CMP-3-deoxy-D-manno-octulosonate biosynthesis	1	XP_050032545.1
MetaCyc: PWY-7182	Linalool biosynthesis I	1	XP_050023623.1
Reactome: R-HSA-1483255	PI Metabolism	2	XP_050045167.1;XP_050045166.1
KEGG: 00130+2.1.1.163	Ubiquinone and other terpenoid-quinone biosynthesis	1	XP_050045574.1
Reactome: R-HSA-419037	NCAM1 interactions	10	XP_050032585.1;XP_050051572.1;XP_050045827.1;XP_050045823.1;XP_050045824.1;XP_050045825.1;XP_050039341.1;XP_050045826.1;XP_050045828.1;XP_050052132.1
Reactome: R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	6	XP_050032853.1;XP_050040512.1;XP_050040511.1;XP_050040510.1;XP_050040509.1;XP_050040507.1
Reactome: R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	9	XP_050036138.1;XP_050026017.1;XP_050046147.1;XP_050039527.1;XP_050046149.1;XP_050046148.1;XP_050039528.1;XP_050046150.1;XP_050049483.1
KEGG: 00340+3.5.2.7	Histidine metabolism	1	XP_050044610.1
Reactome: R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	7	XP_050023173.1;XP_050047573.1;XP_050024735.1;XP_050034682.1;XP_050025373.1;XP_050025371.1;XP_050025370.1
Reactome: R-HSA-9609690	HCMV Early Events	101	XP_050038213.1;XP_050026883.1;XP_050047338.1;XP_050038863.1;XP_050029887.1;XP_050052055.1;XP_050036430.1;XP_050035973.1;XP_050035977.1;XP_050023474.1;XP_050029897.1;XP_050039380.1;XP_050030507.1;XP_050051356.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050035992.1;XP_050035989.1;XP_050029889.1;XP_050036827.1;XP_050043181.1;XP_050036268.1;XP_050025243.1;XP_050026957.1;XP_050038199.1;XP_050035988.1;XP_050035985.1;XP_050049762.1;XP_050029891.1;XP_050031742.1;XP_050042392.1;XP_050023475.1;XP_050050590.1;XP_050035984.1;XP_050038968.1;XP_050035982.1;XP_050038866.1;XP_050025266.1;XP_050023476.1;XP_050049757.1;XP_050044008.1;XP_050026809.1;XP_050046735.1;XP_050029516.1;XP_050038862.1;XP_050035976.1;XP_050035981.1;XP_050026810.1;XP_050035980.1;XP_050029515.1;XP_050029499.1;XP_050025248.1;XP_050051690.1;XP_050050591.1;XP_050029890.1;XP_050035933.1;XP_050035978.1;XP_050035986.1;XP_050051355.1;XP_050050589.1;XP_050030942.1;XP_050035991.1;XP_050042391.1;XP_050026958.1;XP_050038895.1;XP_050026959.1;XP_050038966.1;XP_050024840.1;XP_050045597.1;XP_050039240.1;XP_050035974.1;XP_050025244.1;XP_050035983.1;XP_050025064.1;XP_050035987.1;XP_050038967.1;XP_050036728.1;XP_050024518.1;XP_050049761.1;XP_050038864.1;XP_050049759.1;XP_050024841.1;XP_050026960.1;XP_050039381.1;XP_050035770.1;XP_050035990.1;XP_050038865.1;XP_050046734.1;XP_050052420.1;XP_050030653.1;XP_050035979.1;XP_050049377.1;XP_050051357.1;XP_050035993.1;XP_050035932.1;XP_050046156.1;XP_050035975.1;XP_050023718.1;XP_050033146.1;XP_050049758.1
MetaCyc: PWY-6372	1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)	3	XP_050026059.1;XP_050052036.1;XP_050052037.1
Reactome: R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	1	XP_050043127.1
KEGG: 00330+1.2.1.41	Arginine and proline metabolism	1	XP_050049134.1
MetaCyc: PWY-7909	Formaldehyde oxidation VII (THF pathway)	3	XP_050052682.1;XP_050048637.1;XP_050052683.1
Reactome: R-HSA-5637810	Constitutive Signaling by EGFRvIII	3	XP_050048201.1;XP_050032853.1;XP_050048200.1
Reactome: R-HSA-186797	Signaling by PDGF	3	XP_050052132.1;XP_050050472.1;XP_050051572.1
KEGG: 00510+2.4.1.256	N-Glycan biosynthesis	2	XP_050033404.1;XP_050032981.1
Reactome: R-HSA-5610783	Degradation of GLI2 by the proteasome	64	XP_050032477.1;XP_050048534.1;XP_050040623.1;XP_050047809.1;XP_050022938.1;XP_050042112.1;XP_050033237.1;XP_050044476.1;XP_050045660.1;XP_050048824.1;XP_050037399.1;XP_050044469.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050049124.1;XP_050048720.1;XP_050044475.1;XP_050042107.1;XP_050036567.1;XP_050040624.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050048823.1;XP_050033832.1;XP_050045785.1;XP_050050373.1;XP_050048719.1;XP_050042109.1;XP_050042105.1;XP_050040200.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050047670.1;XP_050031479.1;XP_050048721.1;XP_050025848.1;XP_050044478.1;XP_050033833.1;XP_050042111.1;XP_050047181.1;XP_050033318.1;XP_050042108.1;XP_050022518.1;XP_050035481.1;XP_050042025.1;XP_050048935.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050051964.1;XP_050035472.1;XP_050042106.1;XP_050033331.1;XP_050044470.1;XP_050042110.1;XP_050040199.1
Reactome: R-HSA-5654688	SHC-mediated cascade:FGFR1	1	XP_050032853.1
Reactome: R-HSA-8868766	rRNA processing in the mitochondrion	5	XP_050029880.1;XP_050046343.1;XP_050030696.1;XP_050036852.1;XP_050036853.1
Reactome: R-HSA-6804758	Regulation of TP53 Activity through Acetylation	14	XP_050050904.1;XP_050044956.1;XP_050027158.1;XP_050044957.1;XP_050046119.1;XP_050046120.1;XP_050048620.1;XP_050044958.1;XP_050044955.1;XP_050030609.1;XP_050030608.1;XP_050048619.1;XP_050030610.1;XP_050048621.1
Reactome: R-HSA-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	34	XP_050050590.1;XP_050029826.1;XP_050023605.1;XP_050051915.1;XP_050052512.1;XP_050031736.1;XP_050052225.1;XP_050029825.1;XP_050029859.1;XP_050029860.1;XP_050029858.1;XP_050026047.1;XP_050051917.1;XP_050039236.1;XP_050029338.1;XP_050031742.1;XP_050028353.1;XP_050051916.1;XP_050052226.1;XP_050026046.1;XP_050029861.1;XP_050026223.1;XP_050039235.1;XP_050029337.1;XP_050032553.1;XP_050036728.1;XP_050029499.1;XP_050029824.1;XP_050029827.1;XP_050050591.1;XP_050029336.1;XP_050029862.1;XP_050050589.1;XP_050045444.1
KEGG: 00053+3.1.1.17	Ascorbate and aldarate metabolism	2	XP_050030742.1;XP_050030744.1
Reactome: R-HSA-5655302	Signaling by FGFR1 in disease	6	XP_050032853.1;XP_050040511.1;XP_050040510.1;XP_050040512.1;XP_050040509.1;XP_050040507.1
MetaCyc: PWY-7709	(3R)-linalool biosynthesis	1	XP_050023623.1
Reactome: R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	10	XP_050049599.1;XP_050049608.1;XP_050049616.1;XP_050049592.1;XP_050049552.1;XP_050049576.1;XP_050049544.1;XP_050049584.1;XP_050049569.1;XP_050049561.1
Reactome: R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	6	XP_050032314.1;XP_050049009.1;XP_050023625.1;XP_050049007.1;XP_050028343.1;XP_050049008.1
KEGG: 00281+4.2.1.17+1.1.1.35	Geraniol degradation	6	XP_050026422.1;XP_050032010.1;XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050041643.1
KEGG: 00270+1.1.1.37	Cysteine and methionine metabolism	11	XP_050037925.1;XP_050045192.1;XP_050037167.1;XP_050035735.1;XP_050037166.1;XP_050037172.1;XP_050037164.1;XP_050037165.1;XP_050037926.1;XP_050037169.1;XP_050037168.1
Reactome: R-HSA-69541	Stabilization of p53	9	XP_050047371.1;XP_050028323.1;XP_050048534.1;XP_050047372.1;XP_050028292.1;XP_050035481.1;XP_050047374.1;XP_050047373.1;XP_050047375.1
Reactome: R-HSA-9022535	Loss of phosphorylation of MECP2 at T308	1	XP_050031707.1
Reactome: R-HSA-5627117	RHO GTPases Activate ROCKs	1	XP_050032102.1
Reactome: R-HSA-2408557	Selenocysteine synthesis	94	XP_050038550.1;XP_050028344.1;XP_050044122.1;XP_050043802.1;XP_050029851.1;XP_050043804.1;XP_050038626.1;XP_050035484.1;XP_050029850.1;XP_050033573.1;XP_050039997.1;XP_050028191.1;XP_050031153.1;XP_050043919.1;XP_050032688.1;XP_050036866.1;XP_050048062.1;XP_050036006.1;XP_050046933.1;XP_050028318.1;XP_050023059.1;XP_050044593.1;XP_050026723.1;XP_050040632.1;XP_050033913.1;XP_050039882.1;XP_050042714.1;XP_050048060.1;XP_050027435.1;XP_050044680.1;XP_050052117.1;XP_050048061.1;XP_050035149.1;XP_050041753.1;XP_050026721.1;XP_050041744.1;XP_050048534.1;XP_050029294.1;XP_050052195.1;XP_050035483.1;XP_050041323.1;XP_050050940.1;XP_050032598.1;XP_050045969.1;XP_050023058.1;XP_050039340.1;XP_050049831.1;XP_050035481.1;XP_050026018.1;XP_050043918.1;XP_050027304.1;XP_050032330.1;XP_050040677.1;XP_050032793.1;XP_050043917.1;XP_050022853.1;XP_050047002.1;XP_050031230.1;XP_050032599.1;XP_050028604.1;XP_050052131.1;XP_050027305.1;XP_050051569.1;XP_050044445.1;XP_050045196.1;XP_050039285.1;XP_050032921.1;XP_050024740.1;XP_050032331.1;XP_050049170.1;XP_050032936.1;XP_050031861.1;XP_050022748.1;XP_050023492.1;XP_050031596.1;XP_050045970.1;XP_050026103.1;XP_050034868.1;XP_050032528.1;XP_050026722.1;XP_050039286.1;XP_050036005.1;XP_050046934.1;XP_050043916.1;XP_050027477.1;XP_050052130.1;XP_050042319.1;XP_050025636.1;XP_050050516.1;XP_050032267.1;XP_050049830.1;XP_050043803.1;XP_050049776.1;XP_050029380.1
KEGG: 00564+2.3.1.15	Glycerophospholipid metabolism	3	XP_050047026.1;XP_050047027.1;XP_050037775.1
Reactome: R-HSA-2206282	MPS IIIB - Sanfilippo syndrome B	2	XP_050025072.1;XP_050024093.1
KEGG: 00250+2.6.1.1	Alanine, aspartate and glutamate metabolism	3	XP_050049203.1;XP_050049202.1;XP_050026413.1
KEGG: 00730+2.7.4.3	Thiamine metabolism	9	XP_050050643.1;XP_050046313.1;XP_050023197.1;XP_050023196.1;XP_050023199.1;XP_050040014.1;XP_050039403.1;XP_050023195.1;XP_050038592.1
Reactome: R-HSA-5619078	Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)	1	XP_050047421.1
Reactome: R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	2	XP_050026711.1;XP_050045005.1
MetaCyc: PWY-6908	Thiamine diphosphate biosynthesis IV (eukaryotes)	1	XP_050034132.1
KEGG: 00450+2.7.7.4	Selenocompound metabolism	2	XP_050051798.1;XP_050051797.1
KEGG: 00640+6.4.1.3	Propanoate metabolism	1	XP_050049718.1
Reactome: R-HSA-2142789	Ubiquinol biosynthesis	7	XP_050037268.1;XP_050033250.1;XP_050049568.1;XP_050045574.1;XP_050025937.1;XP_050025938.1;XP_050040261.1
Reactome: R-HSA-4720489	Defective ALG12 causes ALG12-CDG (CDG-1g)	1	XP_050026303.1
Reactome: R-HSA-264876	Insulin processing	14	XP_050049357.1;XP_050048972.1;XP_050048921.1;XP_050031593.1;XP_050051846.1;XP_050047029.1;XP_050023282.1;XP_050048971.1;XP_050029834.1;XP_050036270.1;XP_050049755.1;XP_050049358.1;XP_050048431.1;XP_050046646.1
MetaCyc: PWY-4841	UDP-alpha-D-glucuronate biosynthesis (from myo-inositol)	1	XP_050027273.1
Reactome: R-HSA-418885	DCC mediated attractive signaling	4	XP_050025375.1;XP_050048906.1;XP_050025374.1;XP_050048905.1
MetaCyc: PWY-6724	Starch degradation II	1	XP_050042052.1
KEGG: 00670+6.3.4.3	One carbon pool by folate	1	XP_050048637.1
KEGG: 05165+2.7.1.153	Human papillomavirus infection	2	XP_050052756.1;XP_050028399.1
Reactome: R-HSA-1170546	Prolactin receptor signaling	4	XP_050022944.1;XP_050047670.1;XP_050040623.1;XP_050040624.1
MetaCyc: PWY-5704	Urea degradation II	2	XP_050024276.1;XP_050024271.1
KEGG: 00520+5.4.2.3	Amino sugar and nucleotide sugar metabolism	1	XP_050050483.1
Reactome: R-HSA-418594	G alpha (i) signalling events	44	XP_050031300.1;XP_050032774.1;XP_050045739.1;XP_050047974.1;XP_050030182.1;XP_050022995.1;XP_050052179.1;XP_050032012.1;XP_050028241.1;XP_050041325.1;XP_050044424.1;XP_050023177.1;XP_050045224.1;XP_050045225.1;XP_050047991.1;XP_050050347.1;XP_050045740.1;XP_050045741.1;XP_050032011.1;XP_050029589.1;XP_050042308.1;XP_050029602.1;XP_050029683.1;XP_050051869.1;XP_050046184.1;XP_050032733.1;XP_050048217.1;XP_050029601.1;XP_050025622.1;XP_050040744.1;XP_050037418.1;XP_050051299.1;XP_050022993.1;XP_050042463.1;XP_050032453.1;XP_050031301.1;XP_050037419.1;XP_050050229.1;XP_050030876.1;XP_050025623.1;XP_050032013.1;XP_050052180.1;XP_050044540.1;XP_050047982.1
Reactome: R-HSA-167290	Pausing and recovery of HIV elongation	35	XP_050025635.1;XP_050023576.1;XP_050023725.1;XP_050043147.1;XP_050048717.1;XP_050023779.1;XP_050048718.1;XP_050023714.1;XP_050023726.1;XP_050046063.1;XP_050023729.1;XP_050039484.1;XP_050039068.1;XP_050043138.1;XP_050030634.1;XP_050034643.1;XP_050023730.1;XP_050038469.1;XP_050030811.1;XP_050024189.1;XP_050030280.1;XP_050023777.1;XP_050023727.1;XP_050023724.1;XP_050023577.1;XP_050039485.1;XP_050045052.1;XP_050023728.1;XP_050046123.1;XP_050047588.1;XP_050023776.1;XP_050034644.1;XP_050030810.1;XP_050051336.1;XP_050051335.1
KEGG: 00650+2.3.3.10	Butanoate metabolism	5	XP_050041696.1;XP_050041691.1;XP_050041695.1;XP_050041692.1;XP_050041694.1
KEGG: 00970+6.1.1.11	Aminoacyl-tRNA biosynthesis	3	XP_050031596.1;XP_050050114.1;XP_050026752.1
KEGG: 00240+2.4.2.10	Pyrimidine metabolism	1	XP_050023639.1
MetaCyc: PWY-6907	Thiamine diphosphate biosynthesis III (Staphylococcus)	1	XP_050034132.1
MetaCyc: PWY-7218	Photosynthetic 3-hydroxybutanoate biosynthesis (engineered)	5	XP_050051894.1;XP_050044976.1;XP_050034255.1;XP_050034253.1;XP_050034254.1
KEGG: 00623+1.1.1.35	Toluene degradation	6	XP_050026422.1;XP_050032010.1;XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050041643.1
Reactome: R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	4	XP_050040600.1;XP_050043294.1;XP_050043439.1;XP_050039341.1
Reactome: R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	3	XP_050032712.1;XP_050041743.1;XP_050026269.1
Reactome: R-HSA-437239	Recycling pathway of L1	25	XP_050048294.1;XP_050039381.1;XP_050047338.1;XP_050049759.1;XP_050024841.1;XP_050049761.1;XP_050028603.1;XP_050043040.1;XP_050052420.1;XP_050049762.1;XP_050037100.1;XP_050046734.1;XP_050052055.1;XP_050051355.1;XP_050049757.1;XP_050051356.1;XP_050024840.1;XP_050051357.1;XP_050039380.1;XP_050040246.1;XP_050026027.1;XP_050049758.1;XP_050043038.1;XP_050043181.1;XP_050046735.1
Reactome: R-HSA-1474228	Degradation of the extracellular matrix	20	XP_050046601.1;XP_050044584.1;XP_050036157.1;XP_050049873.1;XP_050049856.1;XP_050045831.1;XP_050050641.1;XP_050039846.1;XP_050044586.1;XP_050039847.1;XP_050046592.1;XP_050042953.1;XP_050049864.1;XP_050034653.1;XP_050024936.1;XP_050034595.1;XP_050024935.1;XP_050052245.1;XP_050043121.1;XP_050044585.1
Reactome: R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1	XP_050024508.1
Reactome: R-HSA-4719360	Defective DPM3 causes DPM3-CDG (CDG-1o)	3	XP_050030816.1;XP_050029180.1;XP_050030815.1
MetaCyc: PWY-7802	N-end rule pathway II (prokaryotic)	4	XP_050027668.1;XP_050027670.1;XP_050027667.1;XP_050027669.1
Reactome: R-HSA-5654720	PI-3K cascade:FGFR4	1	XP_050032853.1
Reactome: R-HSA-418217	G beta:gamma signalling through PLC beta	5	XP_050025623.1;XP_050023177.1;XP_050038409.1;XP_050044424.1;XP_050025622.1
MetaCyc: PWY-7013	(S)-propane-1,2-diol degradation	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
Reactome: R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	16	XP_050039330.1;XP_050034248.1;XP_050038628.1;XP_050040339.1;XP_050040340.1;XP_050047778.1;XP_050040341.1;XP_050038630.1;XP_050040338.1;XP_050030937.1;XP_050039329.1;XP_050034247.1;XP_050048801.1;XP_050051381.1;XP_050039331.1;XP_050039332.1
MetaCyc: PWY-6385	Peptidoglycan biosynthesis III (mycobacteria)	2	XP_050033584.1;XP_050033583.1
KEGG: 00520+3.2.1.52	Amino sugar and nucleotide sugar metabolism	31	XP_050036110.1;XP_050027975.1;XP_050043064.1;XP_050039362.1;XP_050049137.1;XP_050030480.1;XP_050049141.1;XP_050049139.1;XP_050049138.1;XP_050026982.1;XP_050039361.1;XP_050030479.1;XP_050025617.1;XP_050049140.1;XP_050025616.1;XP_050026984.1;XP_050049367.1;XP_050025615.1;XP_050038974.1;XP_050035570.1;XP_050030481.1;XP_050025618.1;XP_050028196.1;XP_050049136.1;XP_050028195.1;XP_050049366.1;XP_050026985.1;XP_050026981.1;XP_050039363.1;XP_050026983.1;XP_050026917.1
KEGG: 00603+3.2.1.52	Glycosphingolipid biosynthesis - globo and isoglobo series	31	XP_050028196.1;XP_050025618.1;XP_050030481.1;XP_050035570.1;XP_050049366.1;XP_050028195.1;XP_050049136.1;XP_050026981.1;XP_050026985.1;XP_050026917.1;XP_050026983.1;XP_050039363.1;XP_050043064.1;XP_050027975.1;XP_050036110.1;XP_050049138.1;XP_050030480.1;XP_050049137.1;XP_050049141.1;XP_050049139.1;XP_050039362.1;XP_050025617.1;XP_050039361.1;XP_050030479.1;XP_050026982.1;XP_050025615.1;XP_050038974.1;XP_050049367.1;XP_050026984.1;XP_050025616.1;XP_050049140.1
MetaCyc: PWY-621	Sucrose degradation III (sucrose invertase)	1	XP_050050068.1
KEGG: 00380+2.6.1.7	Tryptophan metabolism	6	XP_050052719.1;XP_050052721.1;XP_050050544.1;XP_050052715.1;XP_050052716.1;XP_050050545.1
Reactome: R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	34	XP_050024180.1;XP_050050688.1;XP_050050693.1;XP_050047598.1;XP_050050692.1;XP_050050682.1;XP_050039818.1;XP_050024177.1;XP_050050695.1;XP_050047606.1;XP_050050680.1;XP_050050699.1;XP_050050702.1;XP_050024176.1;XP_050050689.1;XP_050050694.1;XP_050050691.1;XP_050050700.1;XP_050050686.1;XP_050050690.1;XP_050050679.1;XP_050050701.1;XP_050023932.1;XP_050050683.1;XP_050024178.1;XP_050050684.1;XP_050050681.1;XP_050050687.1;XP_050050698.1;XP_050050685.1;XP_050050696.1;XP_050024179.1;XP_050024175.1;XP_050050697.1
Reactome: R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	31	XP_050036268.1;XP_050038965.1;XP_050048821.1;XP_050052372.1;XP_050025243.1;XP_050030697.1;XP_050036675.1;XP_050038964.1;XP_050038213.1;XP_050025248.1;XP_050024165.1;XP_050036676.1;XP_050048534.1;XP_050036207.1;XP_050022606.1;XP_050022602.1;XP_050038199.1;XP_050038963.1;XP_050022605.1;XP_050047551.1;XP_050022604.1;XP_050032478.1;XP_050044695.1;XP_050025266.1;XP_050030698.1;XP_050025244.1;XP_050028292.1;XP_050022603.1;XP_050035481.1;XP_050037414.1;XP_050028323.1
Reactome: R-HSA-5689880	Ub-specific processing proteases	126	XP_050031035.1;XP_050024814.1;XP_050044469.1;XP_050047374.1;XP_050048824.1;XP_050032733.1;XP_050037399.1;XP_050027729.1;XP_050027657.1;XP_050032654.1;XP_050038140.1;XP_050030425.1;XP_050036156.1;XP_050036372.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050023317.1;XP_050044475.1;XP_050049124.1;XP_050048720.1;XP_050029802.1;XP_050050645.1;XP_050050488.1;XP_050052231.1;XP_050048823.1;XP_050024847.1;XP_050032512.1;XP_050033832.1;XP_050030939.1;XP_050025600.1;XP_050036567.1;XP_050024842.1;XP_050047809.1;XP_050032514.1;XP_050032477.1;XP_050048534.1;XP_050024808.1;XP_050028061.1;XP_050023316.1;XP_050022938.1;XP_050032513.1;XP_050023319.1;XP_050031045.1;XP_050032509.1;XP_050024803.1;XP_050025608.1;XP_050033237.1;XP_050030424.1;XP_050030428.1;XP_050032511.1;XP_050045660.1;XP_050032510.1;XP_050031585.1;XP_050028062.1;XP_050030430.1;XP_050044476.1;XP_050031586.1;XP_050047373.1;XP_050027285.1;XP_050047181.1;XP_050024696.1;XP_050024825.1;XP_050033833.1;XP_050025606.1;XP_050030426.1;XP_050039028.1;XP_050032515.1;XP_050032516.1;XP_050033318.1;XP_050036381.1;XP_050022518.1;XP_050031786.1;XP_050024819.1;XP_050027118.1;XP_050037397.1;XP_050024830.1;XP_050051844.1;XP_050024749.1;XP_050039549.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050025599.1;XP_050023320.1;XP_050044470.1;XP_050040199.1;XP_050051843.1;XP_050051964.1;XP_050037023.1;XP_050035472.1;XP_050039029.1;XP_050033331.1;XP_050023734.1;XP_050030938.1;XP_050048719.1;XP_050027284.1;XP_050042990.1;XP_050039955.1;XP_050047372.1;XP_050032655.1;XP_050024833.1;XP_050045785.1;XP_050050373.1;XP_050036447.1;XP_050040200.1;XP_050024858.1;XP_050049277.1;XP_050047375.1;XP_050037401.1;XP_050023219.1;XP_050025607.1;XP_050039550.1;XP_050025715.1;XP_050042989.1;XP_050031600.1;XP_050034772.1;XP_050042988.1;XP_050023168.1;XP_050044478.1;XP_050030429.1;XP_050031479.1;XP_050025183.1;XP_050047371.1;XP_050048721.1;XP_050025848.1
Reactome: R-HSA-180746	Nuclear import of Rev protein	38	XP_050023474.1;XP_050036430.1;XP_050042391.1;XP_050038895.1;XP_050038863.1;XP_050030942.1;XP_050035933.1;XP_050029515.1;XP_050038967.1;XP_050036827.1;XP_050039240.1;XP_050025064.1;XP_050038969.1;XP_050030652.1;XP_050030506.1;XP_050038966.1;XP_050030507.1;XP_050042392.1;XP_050023475.1;XP_050035770.1;XP_050038865.1;XP_050038864.1;XP_050024518.1;XP_050033146.1;XP_050026810.1;XP_050029516.1;XP_050038862.1;XP_050023718.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050047656.1;XP_050023476.1;XP_050044008.1;XP_050030653.1;XP_050049377.1;XP_050038968.1;XP_050038866.1
Reactome: R-HSA-4641263	Regulation of FZD by ubiquitination	3	XP_050027890.1;XP_050048534.1;XP_050035481.1
KEGG: 00510+3.6.1.43	N-Glycan biosynthesis	1	XP_050051593.1
Reactome: R-HSA-912446	Meiotic recombination	30	XP_050025244.1;XP_050029342.1;XP_050045461.1;XP_050028292.1;XP_050031345.1;XP_050028323.1;XP_050036133.1;XP_050022980.1;XP_050029156.1;XP_050029852.1;XP_050047551.1;XP_050048786.1;XP_050032478.1;XP_050025266.1;XP_050047604.1;XP_050044695.1;XP_050036132.1;XP_050024172.1;XP_050042755.1;XP_050038199.1;XP_050025243.1;XP_050036268.1;XP_050024167.1;XP_050033904.1;XP_050031446.1;XP_050039624.1;XP_050050532.1;XP_050025248.1;XP_050038213.1;XP_050033903.1
Reactome: R-HSA-196836	Vitamin C (ascorbate) metabolism	2	XP_050027833.1;XP_050026762.1
Reactome: R-HSA-156590	Glutathione conjugation	20	XP_050047698.1;XP_050031855.1;XP_050048247.1;XP_050048220.1;XP_050032744.1;XP_050037017.1;XP_050037015.1;XP_050048256.1;XP_050049682.1;XP_050047905.1;XP_050048233.1;XP_050047714.1;XP_050026762.1;XP_050037281.1;XP_050027833.1;XP_050031872.1;XP_050037282.1;XP_050048267.1;XP_050047704.1;XP_050037016.1
KEGG: 00970+2.1.2.9	Aminoacyl-tRNA biosynthesis	5	XP_050034845.1;XP_050030635.1;XP_050034847.1;XP_050034846.1;XP_050048865.1
KEGG: 00261+4.3.3.7	Monobactam biosynthesis	1	XP_050045137.1
Reactome: R-HSA-9633012	Response of EIF2AK4 (GCN2) to amino acid deficiency	96	XP_050032688.1;XP_050048062.1;XP_050036006.1;XP_050031153.1;XP_050043919.1;XP_050023059.1;XP_050044593.1;XP_050048187.1;XP_050026723.1;XP_050046933.1;XP_050028318.1;XP_050029851.1;XP_050038626.1;XP_050043804.1;XP_050038550.1;XP_050028344.1;XP_050043802.1;XP_050044122.1;XP_050039997.1;XP_050028191.1;XP_050035484.1;XP_050029850.1;XP_050033573.1;XP_050041753.1;XP_050035149.1;XP_050041744.1;XP_050026721.1;XP_050048534.1;XP_050052195.1;XP_050035483.1;XP_050041323.1;XP_050029294.1;XP_050039882.1;XP_050042714.1;XP_050040632.1;XP_050033913.1;XP_050048060.1;XP_050027435.1;XP_050044680.1;XP_050048061.1;XP_050052117.1;XP_050043917.1;XP_050022853.1;XP_050032330.1;XP_050040677.1;XP_050032793.1;XP_050052131.1;XP_050028604.1;XP_050027305.1;XP_050032272.1;XP_050047002.1;XP_050031230.1;XP_050032599.1;XP_050023058.1;XP_050039340.1;XP_050049831.1;XP_050035481.1;XP_050032598.1;XP_050045969.1;XP_050050940.1;XP_050043918.1;XP_050027304.1;XP_050026018.1;XP_050050516.1;XP_050036005.1;XP_050043916.1;XP_050046934.1;XP_050052130.1;XP_050049350.1;XP_050042319.1;XP_050027477.1;XP_050025636.1;XP_050049776.1;XP_050029380.1;XP_050032267.1;XP_050049830.1;XP_050043803.1;XP_050032921.1;XP_050039285.1;XP_050024740.1;XP_050032331.1;XP_050044445.1;XP_050051569.1;XP_050045196.1;XP_050028637.1;XP_050026103.1;XP_050034868.1;XP_050045970.1;XP_050026722.1;XP_050032528.1;XP_050039286.1;XP_050032936.1;XP_050031861.1;XP_050049170.1;XP_050022748.1;XP_050023492.1
Reactome: R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	8	XP_050052809.1;XP_050051033.1;XP_050025696.1;XP_050051035.1;XP_050052094.1;XP_050025697.1;XP_050051032.1;XP_050052808.1
Reactome: R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	3	XP_050040624.1;XP_050040623.1;XP_050047670.1
KEGG: 00071+2.3.1.21	Fatty acid degradation	3	XP_050048736.1;XP_050048737.1;XP_050048738.1
KEGG: 00030+2.2.1.2	Pentose phosphate pathway	1	XP_050047377.1
Reactome: R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	3	XP_050038764.1;XP_050038765.1;XP_050038766.1
Reactome: R-HSA-391160	Signal regulatory protein family interactions	7	XP_050031019.1;XP_050031023.1;XP_050031020.1;XP_050031022.1;XP_050031021.1;XP_050032853.1;XP_050025376.1
Reactome: R-HSA-982772	Growth hormone receptor signaling	4	XP_050047606.1;XP_050022944.1;XP_050047598.1;XP_050026551.1
Reactome: R-HSA-6785631	ERBB2 Regulates Cell Motility	8	XP_050051868.1;XP_050051866.1;XP_050044784.1;XP_050044786.1;XP_050051864.1;XP_050044781.1;XP_050051865.1;XP_050048885.1
KEGG: 00520+2.4.1.16	Amino sugar and nucleotide sugar metabolism	3	XP_050044850.1;XP_050044851.1;XP_050044852.1
MetaCyc: PWY-8051	Anandamide biosynthesis I	43	XP_050037139.1;XP_050037854.1;XP_050037144.1;XP_050035196.1;XP_050037141.1;XP_050037457.1;XP_050037143.1;XP_050025400.1;XP_050037661.1;XP_050035194.1;XP_050050549.1;XP_050047026.1;XP_050037150.1;XP_050035192.1;XP_050027416.1;XP_050037855.1;XP_050037151.1;XP_050035198.1;XP_050037775.1;XP_050037140.1;XP_050035199.1;XP_050037146.1;XP_050037148.1;XP_050035195.1;XP_050035197.1;XP_050032357.1;XP_050037857.1;XP_050039130.1;XP_050050583.1;XP_050025686.1;XP_050047027.1;XP_050037145.1;XP_050027415.1;XP_050037455.1;XP_050037458.1;XP_050037456.1;XP_050035193.1;XP_050031256.1;XP_050037147.1;XP_050030747.1;XP_050033390.1;XP_050037856.1;XP_050037142.1
Reactome: R-HSA-977606	Regulation of Complement cascade	7	XP_050031301.1;XP_050044540.1;XP_050031300.1;XP_050046184.1;XP_050028047.1;XP_050030876.1;XP_050045926.1
KEGG: 00030+5.3.1.6	Pentose phosphate pathway	1	XP_050049438.1
KEGG: 00270+4.2.1.22	Cysteine and methionine metabolism	5	XP_050035467.1;XP_050035466.1;XP_050035463.1;XP_050035464.1;XP_050035465.1
MetaCyc: PWY-1722	Formate assimilation into 5,10-methylenetetrahydrofolate	3	XP_050052682.1;XP_050048637.1;XP_050052683.1
Reactome: R-HSA-211976	Endogenous sterols	4	XP_050026269.1;XP_050041743.1;XP_050027825.1;XP_050032712.1
Reactome: R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	2	XP_050026533.1;XP_050038736.1
MetaCyc: PWY-7184	Pyrimidine deoxyribonucleotides de novo biosynthesis I	15	XP_050038939.1;XP_050027283.1;XP_050029490.1;XP_050027282.1;XP_050025198.1;XP_050043296.1;XP_050038800.1;XP_050031386.1;XP_050051386.1;XP_050045218.1;XP_050041566.1;XP_050029492.1;XP_050034794.1;XP_050031510.1;XP_050030600.1
KEGG: 00900+2.5.1.87	Terpenoid backbone biosynthesis	3	XP_050038668.1;XP_050038667.1;XP_050025956.1
Reactome: R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	26	XP_050046123.1;XP_050032579.1;XP_050040013.1;XP_050043822.1;XP_050023463.1;XP_050037081.1;XP_050033013.1;XP_050027634.1;XP_050032577.1;XP_050024189.1;XP_050040236.1;XP_050051719.1;XP_050037445.1;XP_050034643.1;XP_050032523.1;XP_050036394.1;XP_050032578.1;XP_050027743.1;XP_050039785.1;XP_050045195.1;XP_050040020.1;XP_050028883.1;XP_050032546.1;XP_050034644.1;XP_050037088.1;XP_050040196.1
MetaCyc: PWY-7179-1	Purine deoxyribonucleosides degradation II	3	XP_050035831.1;XP_050046554.1;XP_050046556.1
KEGG: 00562+3.1.3.66	Inositol phosphate metabolism	4	XP_050040159.1;XP_050040160.1;XP_050040158.1;XP_050040157.1
Reactome: R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	19	XP_050040824.1;XP_050025144.1;XP_050049952.1;XP_050029852.1;XP_050027464.1;XP_050034506.1;XP_050047548.1;XP_050022980.1;XP_050052687.1;XP_050032670.1;XP_050051397.1;XP_050029342.1;XP_050034022.1;XP_050046062.1;XP_050050532.1;XP_050022594.1;XP_050042755.1;XP_050028231.1;XP_050042972.1
MetaCyc: PWY-7625	Phosphatidylinositol biosynthesis II (eukaryotes)	1	XP_050025335.1
KEGG: 00670+2.1.2.3	One carbon pool by folate	1	XP_050034170.1
Reactome: R-HSA-170670	Adenylate cyclase inhibitory pathway	8	XP_050040744.1;XP_050041325.1;XP_050045224.1;XP_050051299.1;XP_050045225.1;XP_050045739.1;XP_050045741.1;XP_050045740.1
KEGG: 00680+2.1.2.1	Methane metabolism	3	XP_050034367.1;XP_050032636.1;XP_050032637.1
Reactome: R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	1	XP_050042395.1
Reactome: R-HSA-70895	Branched-chain amino acid catabolism	14	XP_050033422.1;XP_050036448.1;XP_050034049.1;XP_050048930.1;XP_050026566.1;XP_050051624.1;XP_050036825.1;XP_050048931.1;XP_050048932.1;XP_050036446.1;XP_050039540.1;XP_050039587.1;XP_050039588.1;XP_050036449.1
KEGG: 00500+5.3.1.9	Starch and sucrose metabolism	1	XP_050050068.1
Reactome: R-HSA-937041	IKK complex recruitment mediated by RIP1	13	XP_050049552.1;XP_050049576.1;XP_050049544.1;XP_050049584.1;XP_050049569.1;XP_050050758.1;XP_050049561.1;XP_050049599.1;XP_050035481.1;XP_050048534.1;XP_050049608.1;XP_050049616.1;XP_050049592.1
Reactome: R-HSA-427413	NoRC negatively regulates rRNA expression	51	XP_050024189.1;XP_050035378.1;XP_050036268.1;XP_050025243.1;XP_050038199.1;XP_050044010.1;XP_050037136.1;XP_050046123.1;XP_050037088.1;XP_050025266.1;XP_050034644.1;XP_050035889.1;XP_050043471.1;XP_050045532.1;XP_050047361.1;XP_050045530.1;XP_050043470.1;XP_050027309.1;XP_050045300.1;XP_050035890.1;XP_050042802.1;XP_050023814.1;XP_050043472.1;XP_050039889.1;XP_050024718.1;XP_050037436.1;XP_050044238.1;XP_050038213.1;XP_050044239.1;XP_050044237.1;XP_050025248.1;XP_050023813.1;XP_050037137.1;XP_050030957.1;XP_050042565.1;XP_050022610.1;XP_050045531.1;XP_050028889.1;XP_050033368.1;XP_050044240.1;XP_050030757.1;XP_050043468.1;XP_050040427.1;XP_050044393.1;XP_050043469.1;XP_050040428.1;XP_050044236.1;XP_050025563.1;XP_050034643.1;XP_050032466.1;XP_050025244.1
MetaCyc: PWY-1861	Formaldehyde assimilation II (assimilatory RuMP Cycle)	9	XP_050033946.1;XP_050047377.1;XP_050040644.1;XP_050025560.1;XP_050025561.1;XP_050040641.1;XP_050040645.1;XP_050049438.1;XP_050040643.1
Reactome: R-HSA-5696394	DNA Damage Recognition in GG-NER	38	XP_050046029.1;XP_050048417.1;XP_050039454.1;XP_050048032.1;XP_050025777.1;XP_050048012.1;XP_050037135.1;XP_050035481.1;XP_050040226.1;XP_050029370.1;XP_050029646.1;XP_050045755.1;XP_050050820.1;XP_050045753.1;XP_050044069.1;XP_050027729.1;XP_050050611.1;XP_050033317.1;XP_050024696.1;XP_050048416.1;XP_050029648.1;XP_050050029.1;XP_050050506.1;XP_050050819.1;XP_050029644.1;XP_050029087.1;XP_050029649.1;XP_050047703.1;XP_050023321.1;XP_050047705.1;XP_050029320.1;XP_050046028.1;XP_050044609.1;XP_050031823.1;XP_050029645.1;XP_050029647.1;XP_050045754.1;XP_050048534.1
KEGG: 00480+2.3.2.2+3.4.19.13	Glutathione metabolism	42	XP_050029053.1;XP_050029059.1;XP_050029960.1;XP_050025650.1;XP_050025461.1;XP_050029072.1;XP_050029055.1;XP_050043741.1;XP_050022874.1;XP_050027823.1;XP_050025458.1;XP_050029057.1;XP_050025491.1;XP_050029052.1;XP_050025490.1;XP_050031611.1;XP_050029071.1;XP_050024015.1;XP_050031589.1;XP_050025459.1;XP_050029305.1;XP_050025460.1;XP_050025493.1;XP_050023398.1;XP_050029058.1;XP_050025413.1;XP_050028992.1;XP_050030014.1;XP_050025492.1;XP_050036058.1;XP_050025457.1;XP_050025489.1;XP_050030123.1;XP_050024805.1;XP_050031599.1;XP_050043742.1;XP_050029240.1;XP_050029056.1;XP_050030373.1;XP_050025508.1;XP_050024014.1;XP_050029054.1
KEGG: 00281+4.2.1.17	Geraniol degradation	1	XP_050032010.1
MetaCyc: PWY-2821	Glucosinolate biosynthesis from phenylalanine	6	XP_050050545.1;XP_050052715.1;XP_050052716.1;XP_050052721.1;XP_050052719.1;XP_050050544.1
KEGG: 04070+2.7.1.107	Phosphatidylinositol signaling system	18	XP_050035430.1;XP_050044041.1;XP_050046068.1;XP_050035431.1;XP_050048424.1;XP_050026074.1;XP_050035434.1;XP_050035432.1;XP_050046067.1;XP_050035429.1;XP_050035433.1;XP_050035435.1;XP_050026073.1;XP_050044042.1;XP_050048425.1;XP_050048427.1;XP_050048426.1;XP_050048423.1
KEGG: 00592+3.1.1.32	alpha-Linolenic acid metabolism	1	XP_050039130.1
Reactome: R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	16	XP_050040340.1;XP_050040341.1;XP_050047778.1;XP_050040339.1;XP_050030937.1;XP_050038630.1;XP_050040338.1;XP_050039330.1;XP_050034248.1;XP_050038628.1;XP_050051381.1;XP_050039332.1;XP_050039331.1;XP_050034247.1;XP_050039329.1;XP_050048801.1
Reactome: R-HSA-9013700	NOTCH4 Activation and Transmission of Signal to the Nucleus	13	XP_050035872.1;XP_050043659.1;XP_050031262.1;XP_050026914.1;XP_050048893.1;XP_050027801.1;XP_050023628.1;XP_050037416.1;XP_050043649.1;XP_050034595.1;XP_050034653.1;XP_050037415.1;XP_050026843.1
MetaCyc: PWY-5177	Glutaryl-coa degradation	6	XP_050041635.1;XP_050051194.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
Reactome: R-HSA-8964572	Lipid particle organization	1	XP_050047264.1
Reactome: R-HSA-8963684	Tyrosine catabolism	10	XP_050037282.1;XP_050027257.1;XP_050049182.1;XP_050031962.1;XP_050037281.1;XP_050037016.1;XP_050049181.1;XP_050034252.1;XP_050037017.1;XP_050037015.1
Reactome: R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	5	XP_050051992.1;XP_050037277.1;XP_050051991.1;XP_050027018.1;XP_050028252.1
MetaCyc: PWY-8047	Bryostatin biosynthesis	4	XP_050029751.1;XP_050033009.1;XP_050032773.1;XP_050033008.1
KEGG: 00680+2.6.1.52	Methane metabolism	2	XP_050034259.1;XP_050034258.1
Reactome: R-HSA-8964011	HDL clearance	2	XP_050036189.1;XP_050036188.1
Reactome: R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	6	XP_050043294.1;XP_050040600.1;XP_050050426.1;XP_050036614.1;XP_050039341.1;XP_050043439.1
KEGG: 00510+1.3.1.94	N-Glycan biosynthesis	2	XP_050050944.1;XP_050050945.1
KEGG: 00230+3.5.4.6	Purine metabolism	9	XP_050035323.1;XP_050035322.1;XP_050035321.1;XP_050035320.1;XP_050035325.1;XP_050035327.1;XP_050035324.1;XP_050035326.1;XP_050035328.1
Reactome: R-HSA-181429	Serotonin Neurotransmitter Release Cycle	3	XP_050039213.1;XP_050031247.1;XP_050039212.1
Reactome: R-HSA-180292	GAB1 signalosome	1	XP_050032853.1
MetaCyc: PWY-7219	Adenosine ribonucleotides de novo biosynthesis	11	XP_050050643.1;XP_050046313.1;XP_050023197.1;XP_050023196.1;XP_050023199.1;XP_050047718.1;XP_050040014.1;XP_050039403.1;XP_050030286.1;XP_050023195.1;XP_050038592.1
Reactome: R-HSA-975871	MyD88 cascade initiated on plasma membrane	3	XP_050030451.1;XP_050024508.1;XP_050030452.1
MetaCyc: PWY-7800	Ac/N-end rule pathway	6	XP_050026685.1;XP_050051770.1;XP_050051773.1;XP_050051771.1;XP_050033366.1;XP_050051772.1
Reactome: R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	8	XP_050048776.1;XP_050048777.1;XP_050047994.1;XP_050048775.1;XP_050047997.1;XP_050047996.1;XP_050047995.1;XP_050047998.1
MetaCyc: PWY-6587	Pyruvate fermentation to ethanol III	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
Reactome: R-HSA-1660662	Glycosphingolipid metabolism	74	XP_050028755.1;XP_050043064.1;XP_050050137.1;XP_050048209.1;XP_050036110.1;XP_050045335.1;XP_050045336.1;XP_050048211.1;XP_050034362.1;XP_050045339.1;XP_050048005.1;XP_050045340.1;XP_050028051.1;XP_050048205.1;XP_050038669.1;XP_050024113.1;XP_050023783.1;XP_050033540.1;XP_050027775.1;XP_050048210.1;XP_050027990.1;XP_050026984.1;XP_050025616.1;XP_050028497.1;XP_050025617.1;XP_050023504.1;XP_050050175.1;XP_050028195.1;XP_050040119.1;XP_050025618.1;XP_050048207.1;XP_050030481.1;XP_050035570.1;XP_050048212.1;XP_050026917.1;XP_050026983.1;XP_050045704.1;XP_050026985.1;XP_050047118.1;XP_050050138.1;XP_050027925.1;XP_050040117.1;XP_050028050.1;XP_050040116.1;XP_050048208.1;XP_050050134.1;XP_050050206.1;XP_050045333.1;XP_050045337.1;XP_050045705.1;XP_050034507.1;XP_050045331.1;XP_050048206.1;XP_050026981.1;XP_050024114.1;XP_050050174.1;XP_050045334.1;XP_050045342.1;XP_050030480.1;XP_050027975.1;XP_050025615.1;XP_050045341.1;XP_050031626.1;XP_050045332.1;XP_050024146.1;XP_050030479.1;XP_050026982.1;XP_050050173.1;XP_050047117.1;XP_050042169.1;XP_050034475.1;XP_050041883.1;XP_050030375.1;XP_050028756.1
MetaCyc: PWY-5737	(5R)-carbapenem carboxylate biosynthesis	2	XP_050043133.1;XP_050039753.1
KEGG: 00640+1.3.3.6	Propanoate metabolism	2	XP_050023456.1;XP_050026060.1
MetaCyc: PWY-7039	Phosphatidate metabolism, as a signaling molecule	31	XP_050046068.1;XP_050035430.1;XP_050047067.1;XP_050044041.1;XP_050042253.1;XP_050038409.1;XP_050048424.1;XP_050035431.1;XP_050042022.1;XP_050026074.1;XP_050035434.1;XP_050042251.1;XP_050035432.1;XP_050042252.1;XP_050050469.1;XP_050046067.1;XP_050038435.1;XP_050035429.1;XP_050050470.1;XP_050050471.1;XP_050035435.1;XP_050048140.1;XP_050035433.1;XP_050026073.1;XP_050044042.1;XP_050048425.1;XP_050042250.1;XP_050048427.1;XP_050048141.1;XP_050048423.1;XP_050048426.1
Reactome: R-HSA-1221632	Meiotic synapsis	24	XP_050038213.1;XP_050047136.1;XP_050025248.1;XP_050036268.1;XP_050028217.1;XP_050025243.1;XP_050035858.1;XP_050025763.1;XP_050038199.1;XP_050039547.1;XP_050047139.1;XP_050044807.1;XP_050050408.1;XP_050028218.1;XP_050025266.1;XP_050047138.1;XP_050047137.1;XP_050039546.1;XP_050035556.1;XP_050041511.1;XP_050025244.1;XP_050031697.1;XP_050035555.1;XP_050051043.1
Reactome: R-HSA-6791462	TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P	1	XP_050047377.1
Reactome: R-HSA-5662702	Melanin biosynthesis	7	XP_050039958.1;XP_050046058.1;XP_050029972.1;XP_050046016.1;XP_050032146.1;XP_050026749.1;XP_050025499.1
Reactome: R-HSA-110320	Translesion Synthesis by POLH	19	XP_050050532.1;XP_050027281.1;XP_050048534.1;XP_050042755.1;XP_050044823.1;XP_050042972.1;XP_050023192.1;XP_050025144.1;XP_050049952.1;XP_050023168.1;XP_050029852.1;XP_050023241.1;XP_050035481.1;XP_050051397.1;XP_050052687.1;XP_050022980.1;XP_050032805.1;XP_050046062.1;XP_050029342.1
KEGG: 04714+2.7.11.1	Thermogenesis	141	XP_050043306.1;XP_050034961.1;XP_050032927.1;XP_050050041.1;XP_050036228.1;XP_050031195.1;XP_050044807.1;XP_050036240.1;XP_050026974.1;XP_050036236.1;XP_050025347.1;XP_050030586.1;XP_050043301.1;XP_050036129.1;XP_050037621.1;XP_050035999.1;XP_050031201.1;XP_050048620.1;XP_050031203.1;XP_050031205.1;XP_050043305.1;XP_050043303.1;XP_050049350.1;XP_050031202.1;XP_050025348.1;XP_050042990.1;XP_050041923.1;XP_050032102.1;XP_050042988.1;XP_050036238.1;XP_050037624.1;XP_050031197.1;XP_050028165.1;XP_050023932.1;XP_050033844.1;XP_050032928.1;XP_050043302.1;XP_050036241.1;XP_050028687.1;XP_050044080.1;XP_050034828.1;XP_050034829.1;XP_050026054.1;XP_050050042.1;XP_050045266.1;XP_050036130.1;XP_050036229.1;XP_050043129.1;XP_050043309.1;XP_050039865.1;XP_050041924.1;XP_050031208.1;XP_050037626.1;XP_050028323.1;XP_050036233.1;XP_050041948.1;XP_050031199.1;XP_050031196.1;XP_050036142.1;XP_050026975.1;XP_050045265.1;XP_050046724.1;XP_050035462.1;XP_050031204.1;XP_050033021.1;XP_050033720.1;XP_050036227.1;XP_050049191.1;XP_050037631.1;XP_050043307.1;XP_050042629.1;XP_050036613.1;XP_050036223.1;XP_050037628.1;XP_050036234.1;XP_050029381.1;XP_050036235.1;XP_050032708.1;XP_050036225.1;XP_050028233.1;XP_050026955.1;XP_050044446.1;XP_050036232.1;XP_050036237.1;XP_050026027.1;XP_050027320.1;XP_050031194.1;XP_050034932.1;XP_050043308.1;XP_050026954.1;XP_050050723.1;XP_050048905.1;XP_050031206.1;XP_050026053.1;XP_050031200.1;XP_050037625.1;XP_050051647.1;XP_050034960.1;XP_050036224.1;XP_050031198.1;XP_050048619.1;XP_050029303.1;XP_050036226.1;XP_050042989.1;XP_050037630.1;XP_050041922.1;XP_050026976.1;XP_050032586.1;XP_050036231.1;XP_050043130.1;XP_050037627.1;XP_050036230.1;XP_050026555.1;XP_050048906.1;XP_050036239.1;XP_050049192.1;XP_050037622.1;XP_050042307.1;XP_050022875.1;XP_050026695.1;XP_050043304.1;XP_050032707.1;XP_050026977.1;XP_050029160.1;XP_050050715.1;XP_050031209.1;XP_050032548.1;XP_050050310.1;XP_050043849.1;XP_050028166.1;XP_050048621.1;XP_050041921.1;XP_050037623.1;XP_050050734.1;XP_050050709.1;XP_050037629.1;XP_050036131.1;XP_050051059.1;XP_050031207.1;XP_050028292.1;XP_050045593.1
Reactome: R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	3	XP_050038747.1;XP_050044875.1;XP_050035213.1
MetaCyc: PWY-7606	Docosahexaenoate biosynthesis III (6-desaturase, mammals)	10	XP_050051194.1;XP_050041651.1;XP_050023456.1;XP_050026422.1;XP_050032010.1;XP_050041643.1;XP_050041635.1;XP_050045032.1;XP_050026060.1;XP_050042358.1
Reactome: R-HSA-182218	Nef Mediated CD8 Down-regulation	8	XP_050037100.1;XP_050045458.1;XP_050045457.1;XP_050049787.1;XP_050045459.1;XP_050040246.1;XP_050028603.1;XP_050048294.1
Reactome: R-HSA-71262	Carnitine synthesis	3	XP_050034537.1;XP_050034536.1;XP_050033753.1
KEGG: 00983+3.6.1.23	Drug metabolism - other enzymes	1	XP_050034827.1
KEGG: 00362+4.2.1.17	Benzoate degradation	1	XP_050032010.1
KEGG: 00250+1.4.1.14	Alanine, aspartate and glutamate metabolism	1	XP_050028197.1
KEGG: 00250+6.3.4.4	Alanine, aspartate and glutamate metabolism	1	XP_050047718.1
Reactome: R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	15	XP_050051718.1;XP_050052700.1;XP_050044271.1;XP_050051715.1;XP_050051716.1;XP_050051713.1;XP_050044303.1;XP_050051711.1;XP_050047656.1;XP_050044556.1;XP_050027741.1;XP_050051714.1;XP_050052701.1;XP_050051712.1;XP_050051298.1
MetaCyc: PWY-922	Mevalonate pathway I	12	XP_050041694.1;XP_050051831.1;XP_050044825.1;XP_050028850.1;XP_050041696.1;XP_050041692.1;XP_050041695.1;XP_050045766.1;XP_050045765.1;XP_050041691.1;XP_050024679.1;XP_050051832.1
Reactome: R-HSA-446353	Cell-extracellular matrix interactions	1	XP_050039865.1
MetaCyc: PWY-6749	CMP-legionaminate biosynthesis I	9	XP_050051579.1;XP_050051581.1;XP_050051580.1;XP_050040092.1;XP_050023928.1;XP_050051578.1;XP_050051577.1;XP_050050483.1;XP_050023606.1
Reactome: R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	29	XP_050034643.1;XP_050038602.1;XP_050029889.1;XP_050025244.1;XP_050038469.1;XP_050044338.1;XP_050026959.1;XP_050025266.1;XP_050034644.1;XP_050052258.1;XP_050044337.1;XP_050029887.1;XP_050038199.1;XP_050023625.1;XP_050026958.1;XP_050029891.1;XP_050046123.1;XP_050031529.1;XP_050044295.1;XP_050024189.1;XP_050038213.1;XP_050035110.1;XP_050025248.1;XP_050026960.1;XP_050036268.1;XP_050029890.1;XP_050025243.1;XP_050043147.1;XP_050026957.1
KEGG: 00030+3.1.1.31	Pentose phosphate pathway	1	XP_050049839.1
MetaCyc: PWY-7221	Guanosine ribonucleotides de novo biosynthesis	34	XP_050049242.1;XP_050038939.1;XP_050042215.1;XP_050031386.1;XP_050048548.1;XP_050026581.1;XP_050031510.1;XP_050050199.1;XP_050043296.1;XP_050048547.1;XP_050029490.1;XP_050048546.1;XP_050042205.1;XP_050048545.1;XP_050042202.1;XP_050049238.1;XP_050036823.1;XP_050036822.1;XP_050027671.1;XP_050043321.1;XP_050029492.1;XP_050050203.1;XP_050050200.1;XP_050049241.1;XP_050043319.1;XP_050050204.1;XP_050043318.1;XP_050051705.1;XP_050043320.1;XP_050049240.1;XP_050050201.1;XP_050044277.1;XP_050036821.1;XP_050050202.1
Reactome: R-HSA-390247	Beta-oxidation of very long chain fatty acids	5	XP_050031037.1;XP_050025932.1;XP_050025930.1;XP_050044392.1;XP_050025931.1
KEGG: 00040+1.1.1.22	Pentose and glucuronate interconversions	2	XP_050040190.1;XP_050040189.1
Reactome: R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	4	XP_050040026.1;XP_050040028.1;XP_050040027.1;XP_050040029.1
Reactome: R-HSA-4549356	Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2	1	XP_050034973.1
Reactome: R-HSA-392170	ADP signalling through P2Y purinoceptor 12	4	XP_050044424.1;XP_050023177.1;XP_050025623.1;XP_050025622.1
Reactome: R-HSA-877312	Regulation of IFNG signaling	1	XP_050025376.1
Reactome: R-HSA-8866423	VLDL assembly	15	XP_050042242.1;XP_050052148.1;XP_050052147.1;XP_050042262.1;XP_050042260.1;XP_050042241.1;XP_050023422.1;XP_050023796.1;XP_050042240.1;XP_050023809.1;XP_050023312.1;XP_050023334.1;XP_050042261.1;XP_050042454.1;XP_050024095.1
Reactome: R-HSA-73762	RNA Polymerase I Transcription Initiation	34	XP_050034643.1;XP_050032466.1;XP_050025563.1;XP_050040428.1;XP_050040427.1;XP_050044393.1;XP_050044955.1;XP_050045531.1;XP_050033368.1;XP_050028889.1;XP_050030957.1;XP_050037137.1;XP_050023813.1;XP_050048804.1;XP_050045300.1;XP_050024718.1;XP_050037436.1;XP_050023814.1;XP_050034644.1;XP_050037088.1;XP_050046119.1;XP_050044957.1;XP_050045530.1;XP_050045532.1;XP_050047361.1;XP_050044958.1;XP_050044010.1;XP_050046120.1;XP_050046123.1;XP_050045588.1;XP_050037136.1;XP_050024189.1;XP_050044956.1;XP_050035378.1
Reactome: R-HSA-5675482	Regulation of necroptotic cell death	2	XP_050035481.1;XP_050048534.1
Reactome: R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	36	XP_050024521.1;XP_050022515.1;XP_050024523.1;XP_050047269.1;XP_050046125.1;XP_050034545.1;XP_050037757.1;XP_050047298.1;XP_050025495.1;XP_050043896.1;XP_050047259.1;XP_050047280.1;XP_050039662.1;XP_050046136.1;XP_050039783.1;XP_050024535.1;XP_050042930.1;XP_050043920.1;XP_050029068.1;XP_050025412.1;XP_050040372.1;XP_050045776.1;XP_050045983.1;XP_050039827.1;XP_050046083.1;XP_050046032.1;XP_050034544.1;XP_050043062.1;XP_050025480.1;XP_050028966.1;XP_050046045.1;XP_050047249.1;XP_050042277.1;XP_050025496.1;XP_050047289.1;XP_050047126.1
MetaCyc: PWY-7205	CMP phosphorylation	6	XP_050043296.1;XP_050029490.1;XP_050038939.1;XP_050031510.1;XP_050031386.1;XP_050029492.1
MetaCyc: PWY-6383	Mono-trans, poly-cis decaprenyl phosphate biosynthesis	3	XP_050045766.1;XP_050023623.1;XP_050045765.1
Reactome: R-HSA-3000497	Scavenging by Class H Receptors	12	XP_050023809.1;XP_050042240.1;XP_050023422.1;XP_050023796.1;XP_050042454.1;XP_050023334.1;XP_050042261.1;XP_050023312.1;XP_050042262.1;XP_050042242.1;XP_050042260.1;XP_050042241.1
MetaCyc: PWY-2261	Ascorbate glutathione cycle	2	XP_050027833.1;XP_050026762.1
Reactome: R-HSA-5689896	Ovarian tumor domain proteases	13	XP_050030629.1;XP_050037023.1;XP_050049198.1;XP_050033093.1;XP_050049197.1;XP_050030628.1;XP_050033094.1;XP_050023752.1;XP_050049199.1;XP_050048534.1;XP_050035481.1;XP_050023751.1;XP_050023192.1
Reactome: R-HSA-428890	Role of ABL in ROBO-SLIT signaling	7	XP_050035116.1;XP_050040735.1;XP_050035119.1;XP_050040734.1;XP_050035114.1;XP_050052372.1;XP_050040736.1
KEGG: 00510+2.4.1.141	N-Glycan biosynthesis	2	XP_050033584.1;XP_050033583.1
KEGG: 00480+4.3.2.9	Glutathione metabolism	1	XP_050041754.1
MetaCyc: PWY-6829	Trna methylation (yeast)	19	XP_050038336.1;XP_050030696.1;XP_050037317.1;XP_050022865.1;XP_050050265.1;XP_050029388.1;XP_050029894.1;XP_050042353.1;XP_050029816.1;XP_050038338.1;XP_050024735.1;XP_050050266.1;XP_050041916.1;XP_050038337.1;XP_050046343.1;XP_050029387.1;XP_050050267.1;XP_050038339.1;XP_050038357.1
KEGG: 00720+4.2.1.17	Carbon fixation pathways in prokaryotes	1	XP_050032010.1
Reactome: R-HSA-112409	RAF-independent MAPK1/3 activation	6	XP_050047387.1;XP_050033089.1;XP_050047606.1;XP_050047386.1;XP_050047598.1;XP_050036586.1
KEGG: 00360+1.14.16.1	Phenylalanine metabolism	1	XP_050047981.1
Reactome: R-HSA-2046105	Linoleic acid (LA) metabolism	1	XP_050031037.1
KEGG: 00970+6.1.1.1	Aminoacyl-tRNA biosynthesis	2	XP_050032528.1;XP_050049722.1
Reactome: R-HSA-9634285	Constitutive Signaling by Overexpressed ERBB2	3	XP_050048200.1;XP_050032853.1;XP_050048201.1
Reactome: R-HSA-9609523	Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	11	XP_050051936.1;XP_050045264.1;XP_050026655.1;XP_050023469.1;XP_050032675.1;XP_050051937.1;XP_050051836.1;XP_050031171.1;XP_050038325.1;XP_050051835.1;XP_050052194.1
Reactome: R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	4	XP_050035408.1;XP_050035407.1;XP_050038409.1;XP_050042122.1
KEGG: 00970+6.1.1.19	Aminoacyl-tRNA biosynthesis	3	XP_050026082.1;XP_050038756.1;XP_050026081.1
Reactome: R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	19	XP_050041412.1;XP_050048620.1;XP_050048619.1;XP_050038789.1;XP_050042304.1;XP_050038791.1;XP_050034809.1;XP_050052241.1;XP_050025347.1;XP_050026421.1;XP_050034700.1;XP_050025348.1;XP_050048621.1;XP_050052242.1;XP_050034829.1;XP_050034828.1;XP_050032548.1;XP_050032586.1;XP_050038790.1
Reactome: R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	1	XP_050029505.1
Reactome: R-HSA-1632852	Macroautophagy	81	XP_050050757.1;XP_050038362.1;XP_050043348.1;XP_050031141.1;XP_050044489.1;XP_050029405.1;XP_050032811.1;XP_050050753.1;XP_050025942.1;XP_050032808.1;XP_050032810.1;XP_050029408.1;XP_050025348.1;XP_050044530.1;XP_050036447.1;XP_050038790.1;XP_050023914.1;XP_050038789.1;XP_050024142.1;XP_050023676.1;XP_050023913.1;XP_050034639.1;XP_050044532.1;XP_050043812.1;XP_050025347.1;XP_050043540.1;XP_050043349.1;XP_050029409.1;XP_050032809.1;XP_050042901.1;XP_050051796.1;XP_050025941.1;XP_050044482.1;XP_050043350.1;XP_050032008.1;XP_050026883.1;XP_050041958.1;XP_050038361.1;XP_050040015.1;XP_050042902.1;XP_050042900.1;XP_050044483.1;XP_050029936.1;XP_050041412.1;XP_050050752.1;XP_050051460.1;XP_050032859.1;XP_050027194.1;XP_050032807.1;XP_050044488.1;XP_050044525.1;XP_050038791.1;XP_050036220.1;XP_050023915.1;XP_050051051.1;XP_050038583.1;XP_050038184.1;XP_050029406.1;XP_050032858.1;XP_050044529.1;XP_050027195.1;XP_050032009.1;XP_050050754.1;XP_050043466.1;XP_050042307.1;XP_050050756.1;XP_050045597.1;XP_050044524.1;XP_050023912.1;XP_050044531.1;XP_050044527.1;XP_050031140.1;XP_050022977.1;XP_050045005.1;XP_050043351.1;XP_050038584.1;XP_050038581.1;XP_050031139.1;XP_050051050.1;XP_050044528.1;XP_050029407.1
Reactome: R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	78	XP_050051765.1;XP_050039769.1;XP_050027470.1;XP_050043402.1;XP_050039080.1;XP_050039016.1;XP_050039126.1;XP_050039699.1;XP_050027496.1;XP_050039365.1;XP_050039772.1;XP_050039364.1;XP_050039085.1;XP_050047366.1;XP_050026205.1;XP_050051763.1;XP_050028129.1;XP_050026888.1;XP_050039706.1;XP_050039709.1;XP_050039770.1;XP_050039711.1;XP_050039710.1;XP_050039084.1;XP_050039707.1;XP_050039088.1;XP_050026206.1;XP_050041192.1;XP_050039705.1;XP_050039712.1;XP_050027469.1;XP_050039087.1;XP_050027497.1;XP_050026887.1;XP_050039704.1;XP_050039703.1;XP_050039186.1;XP_050039015.1;XP_050039426.1;XP_050041191.1;XP_050036659.1;XP_050039086.1;XP_050036658.1;XP_050039701.1;XP_050033896.1;XP_050048344.1;XP_050039702.1;XP_050039183.1;XP_050025916.1;XP_050039191.1;XP_050039082.1;XP_050026935.1;XP_050039081.1;XP_050027024.1;XP_050039366.1;XP_050039698.1;XP_050026425.1;XP_050039555.1;XP_050039083.1;XP_050039545.1;XP_050039017.1;XP_050039722.1;XP_050033799.1;XP_050033894.1;XP_050041128.1;XP_050042219.1;XP_050045032.1;XP_050039708.1;XP_050039189.1;XP_050039263.1;XP_050051766.1;XP_050042358.1;XP_050025917.1;XP_050036103.1;XP_050039700.1;XP_050036636.1;XP_050051764.1;XP_050027502.1
KEGG: 00310+4.2.1.17	Lysine degradation	1	XP_050032010.1
Reactome: R-HSA-196108	Pregnenolone biosynthesis	6	XP_050035447.1;XP_050026269.1;XP_050035446.1;XP_050035448.1;XP_050041743.1;XP_050032712.1
Reactome: R-HSA-1482798	Acyl chain remodeling of CL	3	XP_050027699.1;XP_050032010.1;XP_050027700.1
Reactome: R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	10	XP_050025374.1;XP_050026292.1;XP_050025375.1;XP_050023174.1;XP_050028343.1;XP_050032314.1;XP_050049449.1;XP_050023175.1;XP_050047377.1;XP_050050242.1
Reactome: R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	34	XP_050044797.1;XP_050025236.1;XP_050045648.1;XP_050023568.1;XP_050036373.1;XP_050025232.1;XP_050027121.1;XP_050040624.1;XP_050025231.1;XP_050044796.1;XP_050050843.1;XP_050027120.1;XP_050035481.1;XP_050031443.1;XP_050025223.1;XP_050025229.1;XP_050025217.1;XP_050025230.1;XP_050025227.1;XP_050040623.1;XP_050048534.1;XP_050045588.1;XP_050044795.1;XP_050025220.1;XP_050025215.1;XP_050023569.1;XP_050031360.1;XP_050032607.1;XP_050038602.1;XP_050031442.1;XP_050027119.1;XP_050038799.1;XP_050050621.1;XP_050047670.1
Reactome: R-HSA-72731	Recycling of eIF2:GDP	4	XP_050039041.1;XP_050043425.1;XP_050050027.1;XP_050032272.1
KEGG: 00511+3.2.1.24	Other glycan degradation	8	XP_050030714.1;XP_050033519.1;XP_050028838.1;XP_050052209.1;XP_050052205.1;XP_050052177.1;XP_050052207.1;XP_050052206.1
Reactome: R-HSA-165181	Inhibition of TSC complex formation by PKB	4	XP_050051460.1;XP_050038789.1;XP_050038790.1;XP_050038791.1
MetaCyc: PWY-6837	Fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)	2	XP_050026060.1;XP_050023456.1
MetaCyc: PWY-6580	Phosphatidylinositol biosynthesis I (bacteria)	3	XP_050052037.1;XP_050052036.1;XP_050040343.1
KEGG: 00220+2.6.1.1	Arginine biosynthesis	3	XP_050049202.1;XP_050049203.1;XP_050026413.1
Reactome: R-HSA-5657655	MGMT-mediated DNA damage reversal	2	XP_050032823.1;XP_050032822.1
KEGG: 00230+2.7.1.25	Purine metabolism	2	XP_050051797.1;XP_050051798.1
Reactome: R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	21	XP_050037094.1;XP_050046149.1;XP_050052687.1;XP_050031698.1;XP_050039528.1;XP_050037095.1;XP_050037097.1;XP_050046147.1;XP_050039527.1;XP_050033968.1;XP_050037096.1;XP_050024395.1;XP_050050601.1;XP_050046148.1;XP_050031701.1;XP_050037098.1;XP_050046150.1;XP_050049483.1;XP_050026017.1;XP_050036138.1;XP_050049723.1
Reactome: R-HSA-193681	Ceramide signalling	2	XP_050047117.1;XP_050047118.1
Reactome: R-HSA-5658442	Regulation of RAS by GAPs	60	XP_050044470.1;XP_050052231.1;XP_050029802.1;XP_050050645.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050048000.1;XP_050047999.1;XP_050048001.1;XP_050045411.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050036567.1;XP_050027118.1;XP_050031786.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050040198.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050045552.1;XP_050044469.1;XP_050047181.1;XP_050037462.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050045660.1;XP_050044478.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050033237.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050037461.1;XP_050022938.1;XP_050040200.1;XP_050028748.1;XP_050047809.1;XP_050048719.1;XP_050048534.1;XP_050032477.1;XP_050050373.1;XP_050045785.1
KEGG: 00740+3.6.1.9	Riboflavin metabolism	3	XP_050041566.1;XP_050025198.1;XP_050045218.1
Reactome: R-HSA-9665244	Resistance of ERBB2 KD mutants to sapitinib	2	XP_050048200.1;XP_050048201.1
Reactome: R-HSA-1169091	Activation of NF-kappaB in B cells	59	XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050052231.1;XP_050044470.1;XP_050050645.1;XP_050029802.1;XP_050036567.1;XP_050033331.1;XP_050040624.1;XP_050035472.1;XP_050051964.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050040198.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050049124.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050042788.1;XP_050022518.1;XP_050027134.1;XP_050033318.1;XP_050037398.1;XP_050044469.1;XP_050047181.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050050758.1;XP_050028062.1;XP_050044478.1;XP_050045660.1;XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050047670.1;XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050022938.1;XP_050047769.1;XP_050040200.1;XP_050048719.1;XP_050047809.1;XP_050028061.1;XP_050050373.1;XP_050045785.1;XP_050040623.1;XP_050048534.1;XP_050032477.1
KEGG: 00240+6.3.5.5	Pyrimidine metabolism	1	XP_050032255.1
KEGG: 00970+6.1.1.7	Aminoacyl-tRNA biosynthesis	5	XP_050050331.1;XP_050046188.1;XP_050046186.1;XP_050025343.1;XP_050046185.1
KEGG: 00230+3.6.1.29	Purine metabolism	1	XP_050031607.1
Reactome: R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	9	XP_050041676.1;XP_050041743.1;XP_050046122.1;XP_050045508.1;XP_050027425.1;XP_050026269.1;XP_050048798.1;XP_050045507.1;XP_050045958.1
KEGG: 00010+2.7.1.11	Glycolysis / Gluconeogenesis	4	XP_050040644.1;XP_050040641.1;XP_050040645.1;XP_050040643.1
MetaCyc: PWY-5381	Pyridine nucleotide cycling (plants)	12	XP_050032111.1;XP_050042247.1;XP_050039108.1;XP_050049541.1;XP_050026192.1;XP_050039107.1;XP_050046832.1;XP_050042256.1;XP_050039106.1;XP_050046833.1;XP_050042238.1;XP_050042265.1
MetaCyc: PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	2	XP_050026059.1;XP_050048806.1
MetaCyc: PWY-7999	Vitamin K-epoxide cycle	2	XP_050025573.1;XP_050052424.1
KEGG: 00640+6.2.1.1	Propanoate metabolism	3	XP_050030604.1;XP_050040406.1;XP_050044794.1
Reactome: R-HSA-9020702	Interleukin-1 signaling	71	XP_050047670.1;XP_050037401.1;XP_050034772.1;XP_050025715.1;XP_050044478.1;XP_050025848.1;XP_050048721.1;XP_050031479.1;XP_050048719.1;XP_050050373.1;XP_050045785.1;XP_050037310.1;XP_050040200.1;XP_050026263.1;XP_050037312.1;XP_050024749.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050040198.1;XP_050042025.1;XP_050035481.1;XP_050040199.1;XP_050044470.1;XP_050033331.1;XP_050035472.1;XP_050051964.1;XP_050047181.1;XP_050033833.1;XP_050022518.1;XP_050033318.1;XP_050048125.1;XP_050033237.1;XP_050050758.1;XP_050028062.1;XP_050045660.1;XP_050037311.1;XP_050037314.1;XP_050044476.1;XP_050037316.1;XP_050047809.1;XP_050028061.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050022938.1;XP_050037315.1;XP_050026264.1;XP_050044475.1;XP_050048127.1;XP_050048720.1;XP_050049124.1;XP_050048823.1;XP_050033832.1;XP_050052231.1;XP_050050645.1;XP_050024508.1;XP_050029802.1;XP_050040624.1;XP_050036567.1;XP_050044469.1;XP_050037313.1;XP_050048824.1;XP_050037399.1;XP_050038140.1;XP_050048126.1;XP_050036156.1;XP_050027657.1;XP_050042788.1;XP_050027134.1;XP_050037398.1
Reactome: R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	8	XP_050042110.1;XP_050042108.1;XP_050042107.1;XP_050042106.1;XP_050042109.1;XP_050042105.1;XP_050042111.1;XP_050042112.1
MetaCyc: PWY-7222	Guanosine deoxyribonucleotides de novo biosynthesis II	8	XP_050030600.1;XP_050031510.1;XP_050029492.1;XP_050043296.1;XP_050038800.1;XP_050029490.1;XP_050038939.1;XP_050031386.1
MetaCyc: PWY-3961	Phosphopantothenate biosynthesis II	5	XP_050049379.1;XP_050049380.1;XP_050049382.1;XP_050049381.1;XP_050042906.1
KEGG: 00051+5.3.1.8	Fructose and mannose metabolism	1	XP_050044364.1
Reactome: R-HSA-4641265	Repression of WNT target genes	17	XP_050025229.1;XP_050025217.1;XP_050025230.1;XP_050025236.1;XP_050049374.1;XP_050025223.1;XP_050049378.1;XP_050049376.1;XP_050025227.1;XP_050025232.1;XP_050025231.1;XP_050025215.1;XP_050025220.1;XP_050052764.1;XP_050049375.1;XP_050052763.1;XP_050052762.1
MetaCyc: PWY-8026	Sterol biosynthesis (methylotrophs)	4	XP_050045362.1;XP_050045363.1;XP_050045364.1;XP_050045365.1
Reactome: R-HSA-1483226	Synthesis of PI	1	XP_050025335.1
KEGG: 00010+4.1.1.32	Glycolysis / Gluconeogenesis	11	XP_050031435.1;XP_050038116.1;XP_050038121.1;XP_050038132.1;XP_050038127.1;XP_050034437.1;XP_050038119.1;XP_050038118.1;XP_050038117.1;XP_050034554.1;XP_050034972.1
MetaCyc: PWY-5667	CDP-diacylglycerol biosynthesis I	15	XP_050037856.1;XP_050047026.1;XP_050052679.1;XP_050050583.1;XP_050037775.1;XP_050047027.1;XP_050034614.1;XP_050037857.1;XP_050032357.1;XP_050027415.1;XP_050027416.1;XP_050031896.1;XP_050037854.1;XP_050037855.1;XP_050031895.1
Reactome: R-HSA-9630222	Defective NTHL1 substrate binding	1	XP_050026313.1
Reactome: R-HSA-189451	Heme biosynthesis	6	XP_050049384.1;XP_050032875.1;XP_050035135.1;XP_050049383.1;XP_050034747.1;XP_050034748.1
Reactome: R-HSA-8964026	Chylomicron clearance	12	XP_050023422.1;XP_050023796.1;XP_050042240.1;XP_050023809.1;XP_050023312.1;XP_050023334.1;XP_050042261.1;XP_050042454.1;XP_050042242.1;XP_050042260.1;XP_050042262.1;XP_050042241.1
Reactome: R-HSA-1433559	Regulation of KIT signaling	2	XP_050049563.1;XP_050032853.1
KEGG: 00270+1.1.1.95	Cysteine and methionine metabolism	1	XP_050045348.1
Reactome: R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	18	XP_050039329.1;XP_050034247.1;XP_050023419.1;XP_050048801.1;XP_050051381.1;XP_050039331.1;XP_050039332.1;XP_050023418.1;XP_050039330.1;XP_050038628.1;XP_050034248.1;XP_050040339.1;XP_050040340.1;XP_050047778.1;XP_050040341.1;XP_050040338.1;XP_050038630.1;XP_050030937.1
Reactome: R-HSA-399997	Acetylcholine regulates insulin secretion	4	XP_050038409.1;XP_050042122.1;XP_050035408.1;XP_050035407.1
Reactome: R-HSA-8939247	RUNX1 regulates transcription of genes involved in interleukin signaling	1	XP_050047422.1
Reactome: R-HSA-176412	Phosphorylation of the APC/C	16	XP_050040339.1;XP_050040340.1;XP_050040341.1;XP_050047778.1;XP_050040338.1;XP_050038630.1;XP_050030937.1;XP_050039330.1;XP_050034248.1;XP_050038628.1;XP_050051381.1;XP_050039331.1;XP_050039332.1;XP_050039329.1;XP_050034247.1;XP_050048801.1
Reactome: R-HSA-418890	Role of second messengers in netrin-1 signaling	7	XP_050038754.1;XP_050038949.1;XP_050035761.1;XP_050038950.1;XP_050039259.1;XP_050038883.1;XP_050028895.1
KEGG: 00564+1.1.1.94	Glycerophospholipid metabolism	1	XP_050034614.1
KEGG: 00564+3.1.4.4	Glycerophospholipid metabolism	3	XP_050050470.1;XP_050050471.1;XP_050050469.1
KEGG: 00564+3.1.3.4	Glycerophospholipid metabolism	4	XP_050037455.1;XP_050037457.1;XP_050037458.1;XP_050037456.1
KEGG: 00270+4.2.1.109	Cysteine and methionine metabolism	8	XP_050030063.1;XP_050030062.1;XP_050030061.1;XP_050030255.1;XP_050030251.1;XP_050030252.1;XP_050030253.1;XP_050030254.1
Reactome: R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	1	XP_050032010.1
Reactome: R-HSA-1368082	RORA activates gene expression	10	XP_050031529.1;XP_050042083.1;XP_050038602.1;XP_050031490.1;XP_050042082.1;XP_050042079.1;XP_050042081.1;XP_050043924.1;XP_050031330.1;XP_050042080.1
MetaCyc: PWY-7807	Glyphosate degradation III	8	XP_050034243.1;XP_050034246.1;XP_050052521.1;XP_050034244.1;XP_050052518.1;XP_050052520.1;XP_050034245.1;XP_050049687.1
Reactome: R-HSA-71737	Pyrophosphate hydrolysis	3	XP_050052521.1;XP_050052518.1;XP_050052520.1
MetaCyc: PWY-5188	Tetrapyrrole biosynthesis I (from glutamate)	2	XP_050044097.1;XP_050028841.1
Reactome: R-HSA-9027284	Erythropoietin activates RAS	1	XP_050032853.1
MetaCyc: PWY-7733	3-hydroxyquinaldate biosynthesis	11	XP_050040584.1;XP_050040418.1;XP_050040415.1;XP_050040583.1;XP_050040580.1;XP_050040419.1;XP_050040416.1;XP_050040581.1;XP_050035077.1;XP_050040577.1;XP_050040417.1
Reactome: R-HSA-5625740	RHO GTPases activate PKNs	9	XP_050033751.1;XP_050049845.1;XP_050049843.1;XP_050049842.1;XP_050033750.1;XP_050033752.1;XP_050032548.1;XP_050025568.1;XP_050049844.1
MetaCyc: PWY-6348	Phosphate acquisition	8	XP_050035094.1;XP_050030520.1;XP_050023380.1;XP_050042536.1;XP_050027424.1;XP_050027405.1;XP_050034778.1;XP_050049985.1
MetaCyc: PWY-6019	Pseudouridine degradation	2	XP_050041147.1;XP_050041182.1
Reactome: R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	35	XP_050032579.1;XP_050046123.1;XP_050023272.1;XP_050023463.1;XP_050043822.1;XP_050027634.1;XP_050033013.1;XP_050051719.1;XP_050024189.1;XP_050027743.1;XP_050032578.1;XP_050023274.1;XP_050037445.1;XP_050040020.1;XP_050028883.1;XP_050039785.1;XP_050044200.1;XP_050040196.1;XP_050034644.1;XP_050037088.1;XP_050040013.1;XP_050023271.1;XP_050033431.1;XP_050037081.1;XP_050040236.1;XP_050023273.1;XP_050032577.1;XP_050034643.1;XP_050032523.1;XP_050036394.1;XP_050033476.1;XP_050023270.1;XP_050044013.1;XP_050032546.1;XP_050045195.1
Reactome: R-HSA-9665233	Resistance of ERBB2 KD mutants to trastuzumab	2	XP_050048200.1;XP_050048201.1
Reactome: R-HSA-202670	ERKs are inactivated	2	XP_050047606.1;XP_050047598.1
MetaCyc: PWY-7141	(3S)-linalool biosynthesis	1	XP_050023623.1
Reactome: R-HSA-200425	Carnitine metabolism	21	XP_050048467.1;XP_050044529.1;XP_050044530.1;XP_050048461.1;XP_050048458.1;XP_050044528.1;XP_050048466.1;XP_050048457.1;XP_050048462.1;XP_050048468.1;XP_050048456.1;XP_050048465.1;XP_050044532.1;XP_050043506.1;XP_050044531.1;XP_050044527.1;XP_050044525.1;XP_050048459.1;XP_050044524.1;XP_050048460.1;XP_050048463.1
Reactome: R-HSA-6802952	Signaling by BRAF and RAF fusions	40	XP_050050686.1;XP_050050700.1;XP_050050690.1;XP_050023932.1;XP_050050701.1;XP_050050679.1;XP_050050683.1;XP_050024178.1;XP_050050698.1;XP_050023719.1;XP_050050684.1;XP_050038184.1;XP_050025900.1;XP_050050681.1;XP_050050687.1;XP_050050685.1;XP_050044712.1;XP_050050696.1;XP_050050697.1;XP_050024175.1;XP_050024179.1;XP_050044711.1;XP_050050688.1;XP_050024180.1;XP_050047245.1;XP_050050692.1;XP_050047598.1;XP_050050693.1;XP_050050682.1;XP_050050695.1;XP_050024177.1;XP_050050702.1;XP_050050699.1;XP_050050680.1;XP_050047606.1;XP_050024176.1;XP_050025899.1;XP_050050694.1;XP_050050691.1;XP_050050689.1
Reactome: R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	3	XP_050052627.1;XP_050051298.1;XP_050027741.1
Reactome: R-HSA-176974	Unwinding of DNA	17	XP_050040739.1;XP_050036167.1;XP_050049554.1;XP_050045792.1;XP_050050222.1;XP_050035183.1;XP_050025383.1;XP_050041990.1;XP_050041989.1;XP_050049443.1;XP_050049556.1;XP_050036578.1;XP_050049555.1;XP_050046049.1;XP_050049497.1;XP_050031079.1;XP_050031078.1
KEGG: 00600+2.4.1.80	Sphingolipid metabolism	1	XP_050023783.1
MetaCyc: PWY-7663	Gondoate biosynthesis (anaerobic)	4	XP_050032773.1;XP_050033009.1;XP_050033008.1;XP_050029751.1
MetaCyc: PWY-5123	Trans, trans-farnesyl diphosphate biosynthesis	3	XP_050045766.1;XP_050023623.1;XP_050045765.1
KEGG: 00650+5.1.2.3+4.2.1.17+1.1.1.35	Butanoate metabolism	2	XP_050032010.1;XP_050026422.1
Reactome: R-HSA-5661270	Formation of xylulose-5-phosphate	1	XP_050044168.1
MetaCyc: PWY-6596	Adenosine nucleotides degradation I	12	XP_050051705.1;XP_050035320.1;XP_050035321.1;XP_050035322.1;XP_050035323.1;XP_050049541.1;XP_050035328.1;XP_050035326.1;XP_050035324.1;XP_050035327.1;XP_050026581.1;XP_050035325.1
MetaCyc: PWY-6527	Stachyose degradation	18	XP_050030095.1;XP_050031782.1;XP_050042029.1;XP_050038635.1;XP_050039867.1;XP_050038834.1;XP_050037412.1;XP_050037411.1;XP_050037409.1;XP_050038833.1;XP_050045037.1;XP_050038831.1;XP_050031783.1;XP_050038830.1;XP_050038832.1;XP_050037410.1;XP_050040105.1;XP_050038829.1
Reactome: R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	11	XP_050035408.1;XP_050032614.1;XP_050025622.1;XP_050023177.1;XP_050042122.1;XP_050044424.1;XP_050047606.1;XP_050035407.1;XP_050032615.1;XP_050025623.1;XP_050047598.1
MetaCyc: PWY-7619	Juniperonate biosynthesis	78	XP_050028129.1;XP_050051763.1;XP_050026205.1;XP_050039710.1;XP_050039711.1;XP_050039770.1;XP_050039706.1;XP_050039709.1;XP_050026888.1;XP_050039088.1;XP_050039707.1;XP_050039084.1;XP_050039087.1;XP_050027469.1;XP_050039712.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039080.1;XP_050043402.1;XP_050027470.1;XP_050039769.1;XP_050051765.1;XP_050039016.1;XP_050039772.1;XP_050039365.1;XP_050027496.1;XP_050039699.1;XP_050039126.1;XP_050047366.1;XP_050039085.1;XP_050039364.1;XP_050039083.1;XP_050039555.1;XP_050026425.1;XP_050039698.1;XP_050039366.1;XP_050027024.1;XP_050041128.1;XP_050033894.1;XP_050033799.1;XP_050039722.1;XP_050039017.1;XP_050039545.1;XP_050036103.1;XP_050042358.1;XP_050051766.1;XP_050025917.1;XP_050039263.1;XP_050045032.1;XP_050039189.1;XP_050039708.1;XP_050042219.1;XP_050027502.1;XP_050051764.1;XP_050036636.1;XP_050039700.1;XP_050039186.1;XP_050039703.1;XP_050039704.1;XP_050026887.1;XP_050027497.1;XP_050039701.1;XP_050036658.1;XP_050039086.1;XP_050036659.1;XP_050039426.1;XP_050041191.1;XP_050039015.1;XP_050039191.1;XP_050025916.1;XP_050039183.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050039081.1;XP_050026935.1;XP_050039082.1
KEGG: 04660+3.1.3.16	T cell receptor signaling pathway	59	XP_050040107.1;XP_050034952.1;XP_050047404.1;XP_050039894.1;XP_050023143.1;XP_050025672.1;XP_050023189.1;XP_050051674.1;XP_050050072.1;XP_050024310.1;XP_050047386.1;XP_050024316.1;XP_050029847.1;XP_050025720.1;XP_050023418.1;XP_050037472.1;XP_050025670.1;XP_050034951.1;XP_050048821.1;XP_050033089.1;XP_050025671.1;XP_050036461.1;XP_050043539.1;XP_050051673.1;XP_050050372.1;XP_050032919.1;XP_050024313.1;XP_050038926.1;XP_050028692.1;XP_050024512.1;XP_050025673.1;XP_050035479.1;XP_050022996.1;XP_050039893.1;XP_050027367.1;XP_050024315.1;XP_050049023.1;XP_050042483.1;XP_050024311.1;XP_050052813.1;XP_050050842.1;XP_050035478.1;XP_050050370.1;XP_050030280.1;XP_050024314.1;XP_050046743.1;XP_050024153.1;XP_050025562.1;XP_050042946.1;XP_050035477.1;XP_050030913.1;XP_050039895.1;XP_050045668.1;XP_050051183.1;XP_050025719.1;XP_050047387.1;XP_050023419.1;XP_050036586.1;XP_050038927.1
Reactome: R-HSA-168638	NOD1/2 Signaling Pathway	11	XP_050048534.1;XP_050033242.1;XP_050035481.1;XP_050033241.1;XP_050033240.1;XP_050028061.1;XP_050033239.1;XP_050033243.1;XP_050033244.1;XP_050028062.1;XP_050050758.1
Reactome: R-HSA-442720	CREB1 phosphorylation through the activation of Adenylate Cyclase	13	XP_050029918.1;XP_050029917.1;XP_050042110.1;XP_050042108.1;XP_050042107.1;XP_050032121.1;XP_050042106.1;XP_050042109.1;XP_050042105.1;XP_050032122.1;XP_050042111.1;XP_050042112.1;XP_050029919.1
Reactome: R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	54	XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050045660.1;XP_050044478.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050047670.1;XP_050040200.1;XP_050022938.1;XP_050032477.1;XP_050048534.1;XP_050040623.1;XP_050045785.1;XP_050050373.1;XP_050047809.1;XP_050048719.1;XP_050035472.1;XP_050051964.1;XP_050036567.1;XP_050033331.1;XP_050040624.1;XP_050029802.1;XP_050050645.1;XP_050044470.1;XP_050052231.1;XP_050048823.1;XP_050033832.1;XP_050040199.1;XP_050049124.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050037398.1;XP_050033318.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050027657.1;XP_050038140.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050047181.1;XP_050044469.1
MetaCyc: PWY-882	L-ascorbate biosynthesis I (L-galactose pathway)	2	XP_050044728.1;XP_050044364.1
Reactome: R-HSA-4719377	Defective DPM2 causes DPM2-CDG (CDG-1u)	3	XP_050030816.1;XP_050029180.1;XP_050030815.1
KEGG: 00970+6.1.1.9	Aminoacyl-tRNA biosynthesis	6	XP_050022584.1;XP_050022582.1;XP_050022583.1;XP_050022585.1;XP_050022742.1;XP_050022586.1
Reactome: R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	44	XP_050034644.1;XP_050045373.1;XP_050049295.1;XP_050049294.1;XP_050047361.1;XP_050045300.1;XP_050040671.1;XP_050049297.1;XP_050024189.1;XP_050049296.1;XP_050023727.1;XP_050035378.1;XP_050023724.1;XP_050044010.1;XP_050031537.1;XP_050037136.1;XP_050034030.1;XP_050023728.1;XP_050046123.1;XP_050040427.1;XP_050040428.1;XP_050025563.1;XP_050023730.1;XP_050045372.1;XP_050046688.1;XP_050034643.1;XP_050038469.1;XP_050031535.1;XP_050026414.1;XP_050026035.1;XP_050034031.1;XP_050034505.1;XP_050036381.1;XP_050031536.1;XP_050023725.1;XP_050043147.1;XP_050037137.1;XP_050034518.1;XP_050032071.1;XP_050046063.1;XP_050023729.1;XP_050033368.1;XP_050038988.1;XP_050023726.1
MetaCyc: PWY-7852	6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)	3	XP_050048632.1;XP_050048633.1;XP_050048631.1
KEGG: 00330+1.14.11.2	Arginine and proline metabolism	13	XP_050025756.1;XP_050048008.1;XP_050032373.1;XP_050030411.1;XP_050031909.1;XP_050032372.1;XP_050031906.1;XP_050031908.1;XP_050038099.1;XP_050031911.1;XP_050031907.1;XP_050048009.1;XP_050048007.1
MetaCyc: PWY-7656	Spodoptera littoralis pheromone biosynthesis	30	XP_050041643.1;XP_050041248.1;XP_050038843.1;XP_050039378.1;XP_050039379.1;XP_050039773.1;XP_050038856.1;XP_050051194.1;XP_050041651.1;XP_050038855.1;XP_050038846.1;XP_050039370.1;XP_050037743.1;XP_050039376.1;XP_050038859.1;XP_050041247.1;XP_050041635.1;XP_050038845.1;XP_050038842.1;XP_050039214.1;XP_050038858.1;XP_050038847.1;XP_050039377.1;XP_050039371.1;XP_050038844.1;XP_050038848.1;XP_050026422.1;XP_050040922.1;XP_050037742.1;XP_050032010.1
Reactome: R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	13	XP_050042252.1;XP_050025862.1;XP_050048141.1;XP_050042250.1;XP_050042251.1;XP_050048806.1;XP_050023808.1;XP_050042022.1;XP_050048140.1;XP_050038409.1;XP_050042253.1;XP_050047067.1;XP_050038435.1
Reactome: R-HSA-194840	Rho GTPase cycle	153	XP_050038532.1;XP_050024733.1;XP_050042817.1;XP_050048905.1;XP_050023611.1;XP_050048785.1;XP_050025862.1;XP_050035527.1;XP_050045602.1;XP_050051318.1;XP_050047821.1;XP_050038531.1;XP_050023772.1;XP_050023614.1;XP_050041413.1;XP_050027500.1;XP_050043782.1;XP_050024734.1;XP_050024732.1;XP_050034198.1;XP_050023610.1;XP_050047799.1;XP_050044583.1;XP_050049309.1;XP_050034930.1;XP_050045665.1;XP_050039311.1;XP_050049311.1;XP_050027587.1;XP_050045664.1;XP_050035530.1;XP_050047122.1;XP_050035529.1;XP_050023609.1;XP_050034801.1;XP_050025973.1;XP_050024145.1;XP_050027586.1;XP_050030611.1;XP_050027498.1;XP_050023867.1;XP_050039799.1;XP_050045914.1;XP_050023774.1;XP_050038952.1;XP_050043184.1;XP_050051315.1;XP_050031106.1;XP_050046316.1;XP_050027591.1;XP_050042709.1;XP_050027593.1;XP_050032721.1;XP_050042707.1;XP_050034800.1;XP_050024091.1;XP_050050907.1;XP_050027595.1;XP_050031902.1;XP_050047807.1;XP_050023608.1;XP_050051418.1;XP_050032804.1;XP_050042489.1;XP_050039304.1;XP_050044088.1;XP_050039793.1;XP_050027594.1;XP_050051317.1;XP_050039794.1;XP_050039303.1;XP_050051416.1;XP_050048906.1;XP_050044251.1;XP_050043787.1;XP_050043790.1;XP_050026696.1;XP_050031113.1;XP_050035533.1;XP_050041548.1;XP_050043789.1;XP_050043781.1;XP_050043785.1;XP_050039796.1;XP_050041946.1;XP_050023775.1;XP_050044253.1;XP_050051415.1;XP_050047123.1;XP_050030291.1;XP_050031114.1;XP_050043783.1;XP_050051419.1;XP_050051414.1;XP_050027596.1;XP_050027588.1;XP_050027501.1;XP_050035528.1;XP_050049310.1;XP_050032722.1;XP_050036710.1;XP_050043786.1;XP_050051316.1;XP_050031110.1;XP_050027592.1;XP_050023773.1;XP_050032802.1;XP_050023616.1;XP_050042708.1;XP_050044089.1;XP_050032803.1;XP_050035532.1;XP_050027590.1;XP_050034928.1;XP_050051420.1;XP_050031111.1;XP_050027499.1;XP_050045603.1;XP_050035526.1;XP_050045667.1;XP_050025374.1;XP_050043788.1;XP_050031901.1;XP_050034931.1;XP_050039310.1;XP_050032801.1;XP_050044580.1;XP_050041414.1;XP_050031112.1;XP_050051417.1;XP_050049312.1;XP_050044582.1;XP_050023868.1;XP_050045915.1;XP_050025974.1;XP_050047816.1;XP_050044581.1;XP_050023615.1;XP_050027589.1;XP_050038951.1;XP_050038746.1;XP_050034799.1;XP_050039797.1;XP_050044252.1;XP_050045666.1;XP_050033197.1;XP_050034927.1;XP_050025375.1;XP_050031108.1;XP_050034929.1;XP_050031109.1;XP_050035531.1;XP_050039798.1
Reactome: R-HSA-168325	Viral Messenger RNA Synthesis	51	XP_050038865.1;XP_050023724.1;XP_050035770.1;XP_050023727.1;XP_050024189.1;XP_050038864.1;XP_050024518.1;XP_050042392.1;XP_050023475.1;XP_050046123.1;XP_050023728.1;XP_050044008.1;XP_050023476.1;XP_050034644.1;XP_050049377.1;XP_050030653.1;XP_050038866.1;XP_050038968.1;XP_050033146.1;XP_050026810.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050046156.1;XP_050026809.1;XP_050035932.1;XP_050043147.1;XP_050023725.1;XP_050035933.1;XP_050029515.1;XP_050023474.1;XP_050023729.1;XP_050046063.1;XP_050023726.1;XP_050036430.1;XP_050038895.1;XP_050042391.1;XP_050030942.1;XP_050038863.1;XP_050030652.1;XP_050030506.1;XP_050038969.1;XP_050030507.1;XP_050038966.1;XP_050038967.1;XP_050038469.1;XP_050025064.1;XP_050036827.1;XP_050039240.1;XP_050023730.1;XP_050034643.1
KEGG: 00590+3.1.1.4	Arachidonic acid metabolism	27	XP_050030747.1;XP_050035193.1;XP_050037147.1;XP_050031256.1;XP_050035192.1;XP_050037145.1;XP_050035199.1;XP_050037142.1;XP_050037148.1;XP_050037146.1;XP_050037140.1;XP_050035198.1;XP_050037151.1;XP_050033390.1;XP_050037141.1;XP_050037144.1;XP_050035196.1;XP_050035195.1;XP_050037139.1;XP_050035197.1;XP_050037150.1;XP_050035194.1;XP_050050549.1;XP_050037143.1;XP_050037661.1;XP_050025400.1;XP_050025686.1
KEGG: 00970+2.9.1.2	Aminoacyl-tRNA biosynthesis	1	XP_050036866.1
Reactome: R-HSA-70171	Glycolysis	23	XP_050040644.1;XP_050051894.1;XP_050048436.1;XP_050047071.1;XP_050025560.1;XP_050034253.1;XP_050034255.1;XP_050047070.1;XP_050045451.1;XP_050040641.1;XP_050040645.1;XP_050050068.1;XP_050027343.1;XP_050040346.1;XP_050040348.1;XP_050034254.1;XP_050040347.1;XP_050041662.1;XP_050025561.1;XP_050041668.1;XP_050038972.1;XP_050040643.1;XP_050038973.1
Reactome: R-HSA-5579006	Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)	3	XP_050042925.1;XP_050042926.1;XP_050042924.1
MetaCyc: PWY-4984	Urea cycle	5	XP_050052351.1;XP_050036726.1;XP_050045223.1;XP_050036729.1;XP_050045233.1
Reactome: R-HSA-71403	Citric acid cycle (TCA cycle)	34	XP_050037396.1;XP_050033718.1;XP_050045192.1;XP_050044834.1;XP_050026352.1;XP_050037007.1;XP_050047044.1;XP_050034954.1;XP_050032828.1;XP_050042268.1;XP_050041863.1;XP_050023889.1;XP_050036002.1;XP_050037417.1;XP_050026353.1;XP_050033719.1;XP_050027292.1;XP_050042703.1;XP_050043228.1;XP_050049076.1;XP_050026122.1;XP_050026123.1;XP_050036003.1;XP_050042704.1;XP_050049075.1;XP_050038590.1;XP_050043069.1;XP_050033843.1;XP_050043005.1;XP_050026566.1;XP_050042702.1;XP_050036844.1;XP_050043076.1;XP_050036004.1
Reactome: R-HSA-68616	Assembly of the ORC complex at the origin of replication	7	XP_050038751.1;XP_050043900.1;XP_050043901.1;XP_050027478.1;XP_050023646.1;XP_050033374.1;XP_050033934.1
MetaCyc: PWY-5103	L-isoleucine biosynthesis III	1	XP_050039540.1
MetaCyc: PWY-7921	Protein O-mannosylation I (yeast)	13	XP_050024005.1;XP_050046070.1;XP_050041249.1;XP_050051992.1;XP_050051991.1;XP_050023434.1;XP_050046831.1;XP_050024120.1;XP_050024010.1;XP_050041250.1;XP_050029180.1;XP_050037277.1;XP_050046071.1
Reactome: R-HSA-77595	Processing of Intronless Pre-mRNAs	12	XP_050048613.1;XP_050036363.1;XP_050052835.1;XP_050040680.1;XP_050048351.1;XP_050036364.1;XP_050045659.1;XP_050038928.1;XP_050048350.1;XP_050052839.1;XP_050045189.1;XP_050026402.1
KEGG: 00270+2.6.1.52	Cysteine and methionine metabolism	2	XP_050034259.1;XP_050034258.1
KEGG: 00680+3.1.3.3	Methane metabolism	1	XP_050025381.1
MetaCyc: PWY-6367	D-myo-inositol-5-phosphate metabolism	15	XP_050042022.1;XP_050047313.1;XP_050047183.1;XP_050048140.1;XP_050038409.1;XP_050042253.1;XP_050047067.1;XP_050038435.1;XP_050047184.1;XP_050042252.1;XP_050048141.1;XP_050042250.1;XP_050047185.1;XP_050042251.1;XP_050047182.1
KEGG: 00680+2.7.1.11	Methane metabolism	4	XP_050040644.1;XP_050040643.1;XP_050040641.1;XP_050040645.1
KEGG: 00230+6.3.3.1	Purine metabolism	1	XP_050048865.1
MetaCyc: PWY-5074	Mevalonate degradation	4	XP_050033709.1;XP_050033707.1;XP_050033827.1;XP_050033708.1
KEGG: 00670+2.1.2.2	One carbon pool by folate	1	XP_050048865.1
Reactome: R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	13	XP_050048717.1;XP_050046839.1;XP_050046147.1;XP_050049483.1;XP_050046150.1;XP_050046148.1;XP_050048718.1;XP_050036373.1;XP_050048534.1;XP_050035481.1;XP_050050843.1;XP_050046149.1;XP_050046840.1
Reactome: R-HSA-196780	Biotin transport and metabolism	21	XP_050048463.1;XP_050048460.1;XP_050048459.1;XP_050045657.1;XP_050048465.1;XP_050048456.1;XP_050048468.1;XP_050048462.1;XP_050049718.1;XP_050045094.1;XP_050048152.1;XP_050048457.1;XP_050048466.1;XP_050036162.1;XP_050036164.1;XP_050048458.1;XP_050048467.1;XP_050034249.1;XP_050048865.1;XP_050048461.1;XP_050036163.1
KEGG: 00250+2.6.1.19	Alanine, aspartate and glutamate metabolism	1	XP_050041758.1
KEGG: 00020+6.4.1.1	Citrate cycle (TCA cycle)	3	XP_050036163.1;XP_050036164.1;XP_050036162.1
Reactome: R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	28	XP_050051381.1;XP_050035481.1;XP_050039331.1;XP_050025244.1;XP_050047598.1;XP_050039332.1;XP_050025266.1;XP_050034247.1;XP_050039329.1;XP_050048801.1;XP_050040339.1;XP_050038199.1;XP_050023625.1;XP_050040341.1;XP_050047606.1;XP_050047778.1;XP_050048534.1;XP_050040340.1;XP_050038630.1;XP_050040338.1;XP_050030937.1;XP_050025248.1;XP_050038213.1;XP_050038628.1;XP_050034248.1;XP_050025243.1;XP_050036268.1;XP_050039330.1
Reactome: R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	8	XP_050047998.1;XP_050047997.1;XP_050047996.1;XP_050047995.1;XP_050047994.1;XP_050048775.1;XP_050048777.1;XP_050048776.1
Reactome: R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	2	XP_050036261.1;XP_050039888.1
Reactome: R-HSA-3247509	Chromatin modifying enzymes	3	XP_050023897.1;XP_050023896.1;XP_050023898.1
Reactome: R-HSA-159418	Recycling of bile acids and salts	4	XP_050042821.1;XP_050042814.1;XP_050042819.1;XP_050042593.1
Reactome: R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	4	XP_050025623.1;XP_050023177.1;XP_050044424.1;XP_050025622.1
MetaCyc: PWY-6435	4-hydroxybenzoate biosynthesis III (plants)	6	XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
MetaCyc: PWY-8043	Ophthalmate biosynthesis	5	XP_050042925.1;XP_050042926.1;XP_050026350.1;XP_050042924.1;XP_050027889.1
MetaCyc: PWY-7817	Type I lipoteichoic acid biosynthesis (S. aureus)	29	XP_050035432.1;XP_050034952.1;XP_050031896.1;XP_050037410.1;XP_050031895.1;XP_050035434.1;XP_050026074.1;XP_050035431.1;XP_050048424.1;XP_050034951.1;XP_050044041.1;XP_050035430.1;XP_050046068.1;XP_050048426.1;XP_050048423.1;XP_050048427.1;XP_050037409.1;XP_050029507.1;XP_050048425.1;XP_050044042.1;XP_050026073.1;XP_050052679.1;XP_050029506.1;XP_050035433.1;XP_050035435.1;XP_050037412.1;XP_050035429.1;XP_050046067.1;XP_050037411.1
KEGG: 00051+1.1.1.271	Fructose and mannose metabolism	1	XP_050048517.1
Reactome: R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	30	XP_050047787.1;XP_050047785.1;XP_050051749.1;XP_050047786.1;XP_050047789.1;XP_050048221.1;XP_050029773.1;XP_050029769.1;XP_050025352.1;XP_050047788.1;XP_050051746.1;XP_050044337.1;XP_050051750.1;XP_050038768.1;XP_050027992.1;XP_050025351.1;XP_050025353.1;XP_050051747.1;XP_050029772.1;XP_050029771.1;XP_050051745.1;XP_050038769.1;XP_050045482.1;XP_050051744.1;XP_050051748.1;XP_050048485.1;XP_050029770.1;XP_050048486.1;XP_050038770.1;XP_050044338.1
Reactome: R-HSA-5625900	RHO GTPases activate CIT	4	XP_050033713.1;XP_050042467.1;XP_050035581.1;XP_050027821.1
MetaCyc: PWY-6886	1-butanol autotrophic biosynthesis (engineered)	7	XP_050034253.1;XP_050038973.1;XP_050034254.1;XP_050038972.1;XP_050051894.1;XP_050034255.1;XP_050044976.1
MetaCyc: PWY-5386	Methylglyoxal degradation I	2	XP_050036755.1;XP_050032575.1
Reactome: R-HSA-176187	Activation of ATR in response to replication stress	38	XP_050043900.1;XP_050046049.1;XP_050049723.1;XP_050034961.1;XP_050033374.1;XP_050050532.1;XP_050044807.1;XP_050049497.1;XP_050031079.1;XP_050042755.1;XP_050023494.1;XP_050030939.1;XP_050049554.1;XP_050036167.1;XP_050046062.1;XP_050041989.1;XP_050029342.1;XP_050041990.1;XP_050051397.1;XP_050023646.1;XP_050022980.1;XP_050049555.1;XP_050042401.1;XP_050049556.1;XP_050033934.1;XP_050030938.1;XP_050031078.1;XP_050027478.1;XP_050043901.1;XP_050035183.1;XP_050034960.1;XP_050029852.1;XP_050045792.1;XP_050025144.1;XP_050035537.1;XP_050040739.1;XP_050038751.1;XP_050026673.1
KEGG: 00531+3.2.1.52	Glycosaminoglycan degradation	31	XP_050027975.1;XP_050043064.1;XP_050036110.1;XP_050049138.1;XP_050049137.1;XP_050030480.1;XP_050049139.1;XP_050049141.1;XP_050039362.1;XP_050025617.1;XP_050030479.1;XP_050039361.1;XP_050026982.1;XP_050038974.1;XP_050025615.1;XP_050049367.1;XP_050025616.1;XP_050026984.1;XP_050049140.1;XP_050028196.1;XP_050025618.1;XP_050030481.1;XP_050035570.1;XP_050049366.1;XP_050028195.1;XP_050049136.1;XP_050026981.1;XP_050026985.1;XP_050026917.1;XP_050039363.1;XP_050026983.1
KEGG: 00620+3.6.1.7	Pyruvate metabolism	3	XP_050045973.1;XP_050045972.1;XP_050045971.1
KEGG: 00562+2.7.1.134+2.7.1.159	Inositol phosphate metabolism	1	XP_050048806.1
KEGG: 00280+2.3.3.10	Valine, leucine and isoleucine degradation	5	XP_050041695.1;XP_050041694.1;XP_050041692.1;XP_050041696.1;XP_050041691.1
MetaCyc: PWY-6840	Homoglutathione biosynthesis	2	XP_050026350.1;XP_050027889.1
MetaCyc: PWY-40	Putrescine biosynthesis I	1	XP_050047167.1
Reactome: R-HSA-5619039	Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)	4	XP_050050303.1;XP_050050302.1;XP_050050306.1;XP_050050304.1
Reactome: R-HSA-141444	Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal	91	XP_050029297.1;XP_050035981.1;XP_050035980.1;XP_050030512.1;XP_050035976.1;XP_050039306.1;XP_050044467.1;XP_050044008.1;XP_050027084.1;XP_050030515.1;XP_050048777.1;XP_050034683.1;XP_050027567.1;XP_050035982.1;XP_050035984.1;XP_050042732.1;XP_050035985.1;XP_050035988.1;XP_050047997.1;XP_050046837.1;XP_050048776.1;XP_050033477.1;XP_050044509.1;XP_050030513.1;XP_050039518.1;XP_050047994.1;XP_050035989.1;XP_050047996.1;XP_050037090.1;XP_050027083.1;XP_050035992.1;XP_050029897.1;XP_050036430.1;XP_050035973.1;XP_050035114.1;XP_050046838.1;XP_050035977.1;XP_050035116.1;XP_050030509.1;XP_050029374.1;XP_050040792.1;XP_050039305.1;XP_050033432.1;XP_050025910.1;XP_050029375.1;XP_050026883.1;XP_050035482.1;XP_050035119.1;XP_050042726.1;XP_050029078.1;XP_050047998.1;XP_050033146.1;XP_050035975.1;XP_050046156.1;XP_050035932.1;XP_050023718.1;XP_050045051.1;XP_050047995.1;XP_050035993.1;XP_050038418.1;XP_050049377.1;XP_050035979.1;XP_050030514.1;XP_050028813.1;XP_050027566.1;XP_050048775.1;XP_050025911.1;XP_050035990.1;XP_050042706.1;XP_050042727.1;XP_050024518.1;XP_050047564.1;XP_050035974.1;XP_050035983.1;XP_050035987.1;XP_050041693.1;XP_050029076.1;XP_050042730.1;XP_050042731.1;XP_050045597.1;XP_050029077.1;XP_050045443.1;XP_050042728.1;XP_050030511.1;XP_050035991.1;XP_050038895.1;XP_050029298.1;XP_050027568.1;XP_050035986.1;XP_050035978.1;XP_050035933.1
KEGG: 00790+4.1.99.22	Folate biosynthesis	4	XP_050027387.1;XP_050027385.1;XP_050027388.1;XP_050027386.1
Reactome: R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	2	XP_050037462.1;XP_050037461.1
KEGG: 00310+2.3.1.61	Lysine degradation	1	XP_050036844.1
Reactome: R-HSA-198323	AKT phosphorylates targets in the cytosol	11	XP_050038789.1;XP_050048619.1;XP_050048621.1;XP_050048620.1;XP_050034700.1;XP_050038790.1;XP_050032586.1;XP_050034829.1;XP_050034828.1;XP_050038791.1;XP_050034809.1
Reactome: R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	58	XP_050032598.1;XP_050045969.1;XP_050038550.1;XP_050028206.1;XP_050028344.1;XP_050038626.1;XP_050029851.1;XP_050036857.1;XP_050029850.1;XP_050025476.1;XP_050036708.1;XP_050035484.1;XP_050027304.1;XP_050028191.1;XP_050032793.1;XP_050044169.1;XP_050032330.1;XP_050031153.1;XP_050036006.1;XP_050044171.1;XP_050045043.1;XP_050032599.1;XP_050030630.1;XP_050032272.1;XP_050044170.1;XP_050052131.1;XP_050051491.1;XP_050045196.1;XP_050031169.1;XP_050033913.1;XP_050048965.1;XP_050044445.1;XP_050051569.1;XP_050032331.1;XP_050048967.1;XP_050024740.1;XP_050032921.1;XP_050041428.1;XP_050031861.1;XP_050032528.1;XP_050027435.1;XP_050045970.1;XP_050034868.1;XP_050026103.1;XP_050030148.1;XP_050052130.1;XP_050036005.1;XP_050048534.1;XP_050029294.1;XP_050046469.1;XP_050029801.1;XP_050032267.1;XP_050046031.1;XP_050029380.1;XP_050049776.1;XP_050035483.1;XP_050052195.1;XP_050036709.1
KEGG: 00500+3.6.1.9	Starch and sucrose metabolism	3	XP_050041566.1;XP_050025198.1;XP_050045218.1
Reactome: R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	20	XP_050037157.1;XP_050034746.1;XP_050051200.1;XP_050045149.1;XP_050029601.1;XP_050028241.1;XP_050048112.1;XP_050025622.1;XP_050026292.1;XP_050023177.1;XP_050037418.1;XP_050044424.1;XP_050050347.1;XP_050048111.1;XP_050025623.1;XP_050037419.1;XP_050044826.1;XP_050044153.1;XP_050029602.1;XP_050034156.1
Reactome: R-HSA-111448	Activation of NOXA and translocation to mitochondria	4	XP_050046149.1;XP_050046147.1;XP_050046148.1;XP_050046150.1
Reactome: R-HSA-9630221	Defective NTHL1 substrate processing	1	XP_050026313.1
MetaCyc: PWY-7790	UMP biosynthesis II	2	XP_050032255.1;XP_050023639.1
KEGG: 00511+3.2.1.52	Other glycan degradation	31	XP_050026917.1;XP_050039363.1;XP_050026983.1;XP_050026981.1;XP_050026985.1;XP_050049366.1;XP_050028195.1;XP_050049136.1;XP_050028196.1;XP_050025618.1;XP_050030481.1;XP_050035570.1;XP_050038974.1;XP_050025615.1;XP_050049367.1;XP_050026984.1;XP_050025616.1;XP_050049140.1;XP_050025617.1;XP_050039361.1;XP_050030479.1;XP_050026982.1;XP_050049138.1;XP_050049137.1;XP_050049139.1;XP_050049141.1;XP_050030480.1;XP_050039362.1;XP_050043064.1;XP_050027975.1;XP_050036110.1
Reactome: R-HSA-203927	MicroRNA (miRNA) biogenesis	36	XP_050028353.1;XP_050032364.1;XP_050028042.1;XP_050037107.1;XP_050026046.1;XP_050026223.1;XP_050029337.1;XP_050045940.1;XP_050034643.1;XP_050032553.1;XP_050038469.1;XP_050036692.1;XP_050029824.1;XP_050043147.1;XP_050029827.1;XP_050029336.1;XP_050050508.1;XP_050037108.1;XP_050034644.1;XP_050047656.1;XP_050037062.1;XP_050029826.1;XP_050023605.1;XP_050052512.1;XP_050032017.1;XP_050031871.1;XP_050024189.1;XP_050029825.1;XP_050052287.1;XP_050044079.1;XP_050042592.1;XP_050032018.1;XP_050026047.1;XP_050052288.1;XP_050029338.1;XP_050046123.1
Reactome: R-HSA-8948216	Collagen chain trimerization	5	XP_050051572.1;XP_050052730.1;XP_050052132.1;XP_050033321.1;XP_050024453.1
KEGG: 00750+1.4.3.5	Vitamin B6 metabolism	1	XP_050044537.1
Reactome: R-HSA-420092	Glucagon-type ligand receptors	4	XP_050044424.1;XP_050023177.1;XP_050025623.1;XP_050025622.1
Reactome: R-HSA-5654733	Negative regulation of FGFR4 signaling	5	XP_050047598.1;XP_050035481.1;XP_050048534.1;XP_050032853.1;XP_050047606.1
MetaCyc: PWY-2161	Folate polyglutamylation	5	XP_050034367.1;XP_050032636.1;XP_050051161.1;XP_050032637.1;XP_050048637.1
KEGG: 00300+4.3.3.7	Lysine biosynthesis	1	XP_050045137.1
MetaCyc: PWY-4321	L-glutamate degradation IV	1	XP_050041758.1
Reactome: R-HSA-111465	Apoptotic cleavage of cellular proteins	7	XP_050035870.1;XP_050030939.1;XP_050041785.1;XP_050035718.1;XP_050046798.1;XP_050031403.1;XP_050030938.1
Reactome: R-HSA-6791461	RPIA deficiency: failed conversion of RU5P to R5P	1	XP_050049438.1
MetaCyc: PWY-5	Canavanine biosynthesis	3	XP_050052351.1;XP_050045233.1;XP_050045223.1
Reactome: R-HSA-2559585	Oncogene Induced Senescence	25	XP_050052225.1;XP_050047598.1;XP_050047375.1;XP_050035481.1;XP_050046149.1;XP_050039235.1;XP_050051915.1;XP_050029861.1;XP_050051916.1;XP_050052226.1;XP_050047371.1;XP_050046147.1;XP_050047373.1;XP_050047374.1;XP_050046150.1;XP_050051917.1;XP_050039236.1;XP_050048534.1;XP_050047372.1;XP_050047606.1;XP_050046148.1;XP_050029862.1;XP_050029858.1;XP_050029860.1;XP_050029859.1
Reactome: R-HSA-162699	Synthesis of dolichyl-phosphate mannose	3	XP_050030815.1;XP_050029180.1;XP_050030816.1
KEGG: 00230+2.7.1.40	Purine metabolism	3	XP_050034255.1;XP_050034254.1;XP_050034253.1
Reactome: R-HSA-209560	NF-kB is activated and signals survival	4	XP_050026263.1;XP_050026264.1;XP_050035481.1;XP_050048534.1
Reactome: R-HSA-68884	Mitotic Telophase/Cytokinesis	1	XP_050033964.1
Reactome: R-HSA-1300642	Sperm Motility And Taxes	3	XP_050024661.1;XP_050024666.1;XP_050044865.1
Reactome: R-HSA-9033241	Peroxisomal protein import	66	XP_050039563.1;XP_050041369.1;XP_050043000.1;XP_050029953.1;XP_050033709.1;XP_050030300.1;XP_050029838.1;XP_050051751.1;XP_050050796.1;XP_050051502.1;XP_050030850.1;XP_050025931.1;XP_050025930.1;XP_050029837.1;XP_050033787.1;XP_050028430.1;XP_050041399.1;XP_050048385.1;XP_050041439.1;XP_050050793.1;XP_050050795.1;XP_050048386.1;XP_050051508.1;XP_050051507.1;XP_050041368.1;XP_050051240.1;XP_050039519.1;XP_050050794.1;XP_050026060.1;XP_050043614.1;XP_050029844.1;XP_050029026.1;XP_050035481.1;XP_050025932.1;XP_050029836.1;XP_050028763.1;XP_050043612.1;XP_050031675.1;XP_050033708.1;XP_050033827.1;XP_050048534.1;XP_050051503.1;XP_050023456.1;XP_050032248.1;XP_050038368.1;XP_050043613.1;XP_050039526.1;XP_050033661.1;XP_050023575.1;XP_050044270.1;XP_050032424.1;XP_050051504.1;XP_050033707.1;XP_050044392.1;XP_050027328.1;XP_050031674.1;XP_050030299.1;XP_050031673.1;XP_050032249.1;XP_050030021.1;XP_050032744.1;XP_050051506.1;XP_050023562.1;XP_050046467.1;XP_050023570.1;XP_050048723.1
Reactome: R-HSA-6799198	Complex I biogenesis	47	XP_050030853.1;XP_050048413.1;XP_050048359.1;XP_050023883.1;XP_050049627.1;XP_050026961.1;XP_050050818.1;XP_050048792.1;YP_010283869.1;YP_010283878.1;XP_050023713.1;XP_050047293.1;XP_050044448.1;XP_050029753.1;YP_010283875.1;XP_050042222.1;XP_050033980.1;XP_050032473.1;XP_050034521.1;XP_050030648.1;XP_050045244.1;YP_010283877.1;XP_050030733.1;XP_050027280.1;XP_050041760.1;XP_050030451.1;XP_050029504.1;XP_050031998.1;XP_050043511.1;XP_050044788.1;XP_050030732.1;XP_050049591.1;XP_050030452.1;XP_050031032.1;XP_050036254.1;XP_050042155.1;XP_050047891.1;XP_050045538.1;XP_050030734.1;XP_050028250.1;YP_010283876.1;XP_050042156.1;XP_050049630.1;XP_050047701.1;XP_050048772.1;XP_050033249.1;XP_050045575.1
MetaCyc: PWY-5469	Sesamin biosynthesis	18	XP_050052158.1;XP_050037576.1;XP_050022911.1;XP_050037573.1;XP_050037575.1;XP_050031834.1;XP_050037574.1;XP_050022520.1;XP_050030591.1;XP_050031815.1;XP_050032263.1;XP_050033134.1;XP_050037572.1;XP_050022517.1;XP_050052159.1;XP_050030590.1;XP_050031263.1;XP_050052157.1
Reactome: R-HSA-5654700	FRS-mediated FGFR2 signaling	2	XP_050048507.1;XP_050032853.1
Reactome: R-HSA-179812	GRB2 events in EGFR signaling	1	XP_050032853.1
Reactome: R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	37	XP_050042294.1;XP_050045234.1;XP_050048711.1;XP_050027798.1;XP_050042264.1;XP_050031948.1;XP_050048401.1;XP_050037106.1;XP_050042271.1;XP_050037902.1;XP_050037105.1;XP_050030699.1;XP_050048400.1;XP_050045193.1;XP_050048399.1;XP_050030700.1;XP_050041873.1;XP_050045175.1;XP_050031947.1;XP_050045176.1;XP_050042266.1;XP_050044087.1;XP_050031946.1;XP_050049155.1;XP_050041874.1;XP_050028872.1;XP_050042263.1;XP_050045235.1;XP_050038514.1;XP_050045191.1;XP_050049156.1;XP_050042270.1;XP_050045177.1;XP_050045194.1;XP_050045178.1;XP_050031949.1;XP_050045179.1
KEGG: 00410+2.6.1.19	beta-Alanine metabolism	1	XP_050041758.1
KEGG: 00040+2.7.1.17	Pentose and glucuronate interconversions	1	XP_050044168.1
KEGG: 00564+2.3.1.51	Glycerophospholipid metabolism	8	XP_050050583.1;XP_050037856.1;XP_050027415.1;XP_050037854.1;XP_050027416.1;XP_050037855.1;XP_050032357.1;XP_050037857.1
Reactome: R-HSA-9645460	Alpha-protein kinase 1 signaling pathway	4	XP_050028061.1;XP_050035481.1;XP_050048534.1;XP_050028062.1
KEGG: 00790+2.8.1.12	Folate biosynthesis	2	XP_050025634.1;XP_050050274.1
Reactome: R-HSA-5654710	PI-3K cascade:FGFR3	1	XP_050032853.1
Reactome: R-HSA-72649	Translation initiation complex formation	68	XP_050051491.1;XP_050033913.1;XP_050048967.1;XP_050041428.1;XP_050027435.1;XP_050030148.1;XP_050048534.1;XP_050029294.1;XP_050051067.1;XP_050051109.1;XP_050035483.1;XP_050052195.1;XP_050036709.1;XP_050038550.1;XP_050028206.1;XP_050028344.1;XP_050038626.1;XP_050029851.1;XP_050036857.1;XP_050029850.1;XP_050035484.1;XP_050051087.1;XP_050028191.1;XP_050031153.1;XP_050036006.1;XP_050051080.1;XP_050044171.1;XP_050045043.1;XP_050051073.1;XP_050045196.1;XP_050031169.1;XP_050044445.1;XP_050051569.1;XP_050048965.1;XP_050032331.1;XP_050024740.1;XP_050032921.1;XP_050031861.1;XP_050032528.1;XP_050034868.1;XP_050026103.1;XP_050045970.1;XP_050052130.1;XP_050036005.1;XP_050044965.1;XP_050046469.1;XP_050029801.1;XP_050032267.1;XP_050046031.1;XP_050029380.1;XP_050049776.1;XP_050034001.1;XP_050045969.1;XP_050032598.1;XP_050025476.1;XP_050036708.1;XP_050027304.1;XP_050032793.1;XP_050034000.1;XP_050044169.1;XP_050051098.1;XP_050032330.1;XP_050032599.1;XP_050030630.1;XP_050032272.1;XP_050052131.1;XP_050044170.1;XP_050033999.1
Reactome: R-HSA-8854518	AURKA Activation by TPX2	43	XP_050035114.1;XP_050038648.1;XP_050025353.1;XP_050034759.1;XP_050035116.1;XP_050025352.1;XP_050030425.1;XP_050030426.1;XP_050043821.1;XP_050045039.1;XP_050043899.1;XP_050038643.1;XP_050044096.1;XP_050045038.1;XP_050038644.1;XP_050038647.1;XP_050038646.1;XP_050048292.1;XP_050044094.1;XP_050038561.1;XP_050045165.1;XP_050024782.1;XP_050035880.1;XP_050049353.1;XP_050036465.1;XP_050025351.1;XP_050048293.1;XP_050028813.1;XP_050046392.1;XP_050048290.1;XP_050039261.1;XP_050030424.1;XP_050038642.1;XP_050035119.1;XP_050044095.1;XP_050044093.1;XP_050030429.1;XP_050043820.1;XP_050048291.1;XP_050030428.1;XP_050038645.1;XP_050038560.1;XP_050030430.1
KEGG: 00565+2.5.1.26	Ether lipid metabolism	2	XP_050030300.1;XP_050030299.1
MetaCyc: PWY-7035	(9Z)-tricosene biosynthesis	78	XP_050039364.1;XP_050047366.1;XP_050039085.1;XP_050027496.1;XP_050039126.1;XP_050039699.1;XP_050039772.1;XP_050039365.1;XP_050039016.1;XP_050051765.1;XP_050039769.1;XP_050027470.1;XP_050039080.1;XP_050043402.1;XP_050039705.1;XP_050041192.1;XP_050026206.1;XP_050039712.1;XP_050039087.1;XP_050027469.1;XP_050039084.1;XP_050039088.1;XP_050039707.1;XP_050026888.1;XP_050039710.1;XP_050039706.1;XP_050039709.1;XP_050039770.1;XP_050039711.1;XP_050026205.1;XP_050028129.1;XP_050051763.1;XP_050026935.1;XP_050039082.1;XP_050039081.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050025916.1;XP_050039191.1;XP_050039183.1;XP_050039015.1;XP_050041191.1;XP_050039426.1;XP_050036658.1;XP_050039701.1;XP_050039086.1;XP_050036659.1;XP_050027497.1;XP_050026887.1;XP_050039704.1;XP_050039703.1;XP_050039186.1;XP_050039700.1;XP_050051764.1;XP_050027502.1;XP_050036636.1;XP_050042219.1;XP_050039263.1;XP_050051766.1;XP_050042358.1;XP_050025917.1;XP_050036103.1;XP_050039708.1;XP_050045032.1;XP_050039189.1;XP_050039017.1;XP_050039545.1;XP_050033894.1;XP_050041128.1;XP_050039722.1;XP_050033799.1;XP_050039698.1;XP_050027024.1;XP_050039366.1;XP_050039083.1;XP_050026425.1;XP_050039555.1
Reactome: R-HSA-186763	Downstream signal transduction	5	XP_050043898.1;XP_050043897.1;XP_050045552.1;XP_050023708.1;XP_050032853.1
Reactome: R-HSA-3000480	Scavenging by Class A Receptors	12	XP_050042242.1;XP_050042262.1;XP_050042260.1;XP_050042241.1;XP_050023422.1;XP_050023796.1;XP_050042240.1;XP_050023809.1;XP_050023312.1;XP_050023334.1;XP_050042261.1;XP_050042454.1
Reactome: R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	11	XP_050049729.1;XP_050047598.1;XP_050049727.1;XP_050046174.1;XP_050046173.1;XP_050051141.1;XP_050047606.1;XP_050049728.1;XP_050051139.1;XP_050051138.1;XP_050051140.1
Reactome: R-HSA-446205	Synthesis of GDP-mannose	5	XP_050044364.1;XP_050051540.1;XP_050044728.1;XP_050050517.1;XP_050047157.1
Reactome: R-HSA-202040	G-protein activation	6	XP_050044424.1;XP_050025623.1;XP_050023177.1;XP_050025622.1;XP_050050347.1;XP_050028241.1
Reactome: R-HSA-180585	Vif-mediated degradation of APOBEC3G	54	XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050044475.1;XP_050024749.1;XP_050049124.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050040198.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050044470.1;XP_050048823.1;XP_050030634.1;XP_050040199.1;XP_050033832.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050036567.1;XP_050023714.1;XP_050047181.1;XP_050044469.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050033318.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050033237.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050045660.1;XP_050044478.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050047809.1;XP_050048719.1;XP_050032477.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050040200.1;XP_050022938.1
Reactome: R-HSA-1482839	Acyl chain remodelling of PE	4	XP_050025686.1;XP_050033390.1;XP_050025400.1;XP_050050549.1
Reactome: R-HSA-429947	Deadenylation of mRNA	42	XP_050051748.1;XP_050048485.1;XP_050038770.1;XP_050044338.1;XP_050029772.1;XP_050029771.1;XP_050051087.1;XP_050038566.1;XP_050045482.1;XP_050051744.1;XP_050051746.1;XP_050044337.1;XP_050051080.1;XP_050027992.1;XP_050034000.1;XP_050038768.1;XP_050051098.1;XP_050048221.1;XP_050033999.1;XP_050043316.1;XP_050048486.1;XP_050038567.1;XP_050029770.1;XP_050051073.1;XP_050051745.1;XP_050051747.1;XP_050032757.1;XP_050043317.1;XP_050038769.1;XP_050032756.1;XP_050051750.1;XP_050051109.1;XP_050047789.1;XP_050029769.1;XP_050029773.1;XP_050047787.1;XP_050047785.1;XP_050051749.1;XP_050034001.1;XP_050047786.1;XP_050047788.1;XP_050051067.1
Reactome: R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	8	XP_050050766.1;XP_050050765.1;XP_050030583.1;XP_050050761.1;XP_050030582.1;XP_050030584.1;XP_050050762.1;XP_050050763.1
MetaCyc: PWY-5108	L-isoleucine biosynthesis V	4	XP_050039540.1;XP_050030604.1;XP_050044794.1;XP_050040406.1
Reactome: R-HSA-9617629	Regulation of FOXO transcriptional activity by acetylation	1	XP_050038602.1
Reactome: R-HSA-4755583	Defective DOLK causes DOLK-CDG (CDG-1m)	1	XP_050039374.1
Reactome: R-HSA-4641258	Degradation of DVL	54	XP_050049124.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050035472.1;XP_050051964.1;XP_050024722.1;XP_050036567.1;XP_050033331.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050047181.1;XP_050044469.1;XP_050033318.1;XP_050037398.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050024731.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050045660.1;XP_050044478.1;XP_050032477.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050047809.1;XP_050048719.1;XP_050040200.1;XP_050022938.1
KEGG: 00240+3.1.3.89	Pyrimidine metabolism	1	XP_050027419.1
KEGG: 00710+2.6.1.1	Carbon fixation in photosynthetic organisms	3	XP_050026413.1;XP_050049203.1;XP_050049202.1
Reactome: R-HSA-212436	Generic Transcription Pathway	53	XP_050052316.1;XP_050035019.1;XP_050051364.1;XP_050022814.1;XP_050035315.1;XP_050033834.1;XP_050041886.1;XP_050027717.1;XP_050033724.1;XP_050040986.1;XP_050045376.1;XP_050048526.1;XP_050043924.1;XP_050026442.1;XP_050022815.1;XP_050026624.1;XP_050022818.1;XP_050033726.1;XP_050026625.1;XP_050033725.1;XP_050033835.1;XP_050040980.1;XP_050036373.1;XP_050040984.1;XP_050022817.1;XP_050051360.1;XP_050033836.1;XP_050041885.1;XP_050022560.1;XP_050040983.1;XP_050051365.1;XP_050040979.1;XP_050022569.1;XP_050026623.1;XP_050038305.1;XP_050051363.1;XP_050026045.1;XP_050046003.1;XP_050022816.1;XP_050030834.1;XP_050040985.1;XP_050026626.1;XP_050042140.1;XP_050040982.1;XP_050051359.1;XP_050051362.1;XP_050051361.1;XP_050042141.1;XP_050046004.1;XP_050051411.1;XP_050040981.1;XP_050048525.1;XP_050027718.1
KEGG: 00280+1.2.1.27	Valine, leucine and isoleucine degradation	1	XP_050036825.1
Reactome: R-HSA-3656237	Defective EXT2 causes exostoses 2	6	XP_050043294.1;XP_050050426.1;XP_050036614.1;XP_050040600.1;XP_050039341.1;XP_050043439.1
KEGG: 00460+2.1.2.1	Cyanoamino acid metabolism	3	XP_050032636.1;XP_050034367.1;XP_050032637.1
KEGG: 00710+5.3.1.6	Carbon fixation in photosynthetic organisms	1	XP_050049438.1
KEGG: 00680+6.2.1.1	Methane metabolism	3	XP_050044794.1;XP_050040406.1;XP_050030604.1
MetaCyc: PWY-5104	L-isoleucine biosynthesis IV	1	XP_050039540.1
MetaCyc: PWY-8040	Ansatrienin biosynthesis	1	XP_050026567.1
KEGG: 00760+2.7.7.18	Nicotinate and nicotinamide metabolism	1	XP_050032111.1
Reactome: R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	8	XP_050048776.1;XP_050048777.1;XP_050047998.1;XP_050047994.1;XP_050048775.1;XP_050047997.1;XP_050047996.1;XP_050047995.1
Reactome: R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1	XP_050045768.1
Reactome: R-HSA-8865999	MET activates PTPN11	1	XP_050032853.1
Reactome: R-HSA-76005	Response to elevated platelet cytosolic Ca2+	2	XP_050030242.1;XP_050030241.1
KEGG: 00740+3.1.3.2	Riboflavin metabolism	8	XP_050027424.1;XP_050027405.1;XP_050034778.1;XP_050049985.1;XP_050035094.1;XP_050030520.1;XP_050042536.1;XP_050023380.1
Reactome: R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	25	XP_050042110.1;XP_050029918.1;XP_050042107.1;XP_050042106.1;XP_050025623.1;XP_050032122.1;XP_050045741.1;XP_050045740.1;XP_050029919.1;XP_050045225.1;XP_050042112.1;XP_050051299.1;XP_050045224.1;XP_050023177.1;XP_050044424.1;XP_050029917.1;XP_050041325.1;XP_050032121.1;XP_050042108.1;XP_050040744.1;XP_050025622.1;XP_050042109.1;XP_050042105.1;XP_050045739.1;XP_050042111.1
MetaCyc: PWY-6963	Ammonia assimilation cycle I	12	XP_050028197.1;XP_050028873.1;XP_050051950.1;XP_050033588.1;XP_050038620.1;XP_050038619.1;XP_050038622.1;XP_050038621.1;XP_050033589.1;XP_050028876.1;XP_050028874.1;XP_050038618.1
KEGG: 00250+3.5.1.1	Alanine, aspartate and glutamate metabolism	3	XP_050038344.1;XP_050035272.1;XP_050036428.1
KEGG: 00970+6.1.1.14	Aminoacyl-tRNA biosynthesis	2	XP_050029578.1;XP_050044543.1
KEGG: 00270+2.6.1.42	Cysteine and methionine metabolism	1	XP_050039540.1
MetaCyc: PWY-7224	Purine deoxyribonucleosides salvage	6	XP_050029490.1;XP_050038939.1;XP_050043296.1;XP_050029492.1;XP_050031510.1;XP_050031386.1
Reactome: R-HSA-390918	Peroxisomal lipid metabolism	5	XP_050050793.1;XP_050050796.1;XP_050046467.1;XP_050050795.1;XP_050050794.1
Reactome: R-HSA-73933	Resolution of Abasic Sites (AP sites)	2	XP_050034022.1;XP_050027464.1
Reactome: R-HSA-2299718	Condensation of Prophase Chromosomes	15	XP_050025244.1;XP_050027734.1;XP_050040708.1;XP_050023899.1;XP_050045170.1;XP_050035801.1;XP_050038199.1;XP_050040710.1;XP_050025243.1;XP_050036268.1;XP_050040709.1;XP_050030621.1;XP_050025266.1;XP_050025248.1;XP_050038213.1
Reactome: R-HSA-73980	RNA Polymerase III Transcription Termination	22	XP_050023271.1;XP_050032579.1;XP_050046123.1;XP_050023272.1;XP_050051719.1;XP_050040236.1;XP_050024189.1;XP_050032577.1;XP_050023273.1;XP_050027634.1;XP_050033013.1;XP_050032578.1;XP_050036394.1;XP_050032523.1;XP_050034643.1;XP_050023270.1;XP_050023274.1;XP_050040196.1;XP_050037088.1;XP_050034644.1;XP_050032546.1;XP_050045195.1
KEGG: 00562+3.1.3.64	Inositol phosphate metabolism	1	XP_050040343.1
Reactome: R-HSA-197264	Nicotinamide salvaging	6	XP_050039107.1;XP_050026192.1;XP_050042259.1;XP_050039108.1;XP_050039106.1;XP_050048787.1
Reactome: R-HSA-5674499	Negative feedback regulation of MAPK pathway	2	XP_050047606.1;XP_050047598.1
Reactome: R-HSA-74259	Purine catabolism	31	XP_050050867.1;XP_050050862.1;XP_050028326.1;XP_050030478.1;XP_050041566.1;XP_050045689.1;XP_050050861.1;XP_050038110.1;XP_050050865.1;XP_050045148.1;XP_050028296.1;XP_050045147.1;XP_050046556.1;XP_050030472.1;XP_050030475.1;XP_050045146.1;XP_050028325.1;XP_050039684.1;XP_050050866.1;XP_050045748.1;XP_050025198.1;XP_050030474.1;XP_050050864.1;XP_050045750.1;XP_050030473.1;XP_050046554.1;XP_050030111.1;XP_050050868.1;XP_050045749.1;XP_050038111.1;XP_050050863.1
MetaCyc: PWY-7918	Protein N-glycosylation processing phase (yeast)	3	XP_050050232.1;XP_050050234.1;XP_050050233.1
KEGG: 00970+6.1.1.5	Aminoacyl-tRNA biosynthesis	2	XP_050026033.1;XP_050048047.1
MetaCyc: PWY-7117	C4 photosynthetic carbon assimilation cycle, PEPCK type	11	XP_050049202.1;XP_050049203.1;XP_050049116.1;XP_050049115.1;XP_050025446.1;XP_050026413.1;XP_050022903.1;XP_050022895.1;XP_050022906.1;XP_050038033.1;XP_050049114.1
Reactome: R-HSA-499943	Interconversion of nucleotide di- and triphosphates	36	XP_050026500.1;XP_050046313.1;XP_050023197.1;XP_050029492.1;XP_050027283.1;XP_050052798.1;XP_050023196.1;XP_050049688.1;XP_050050202.1;XP_050050643.1;XP_050050201.1;XP_050052639.1;XP_050038592.1;XP_050023195.1;XP_050050204.1;XP_050040014.1;XP_050038800.1;XP_050050203.1;XP_050050200.1;XP_050031510.1;XP_050030600.1;XP_050034794.1;XP_050052640.1;XP_050026502.1;XP_050043088.1;XP_050037110.1;XP_050029488.1;XP_050031386.1;XP_050026501.1;XP_050039403.1;XP_050023199.1;XP_050038939.1;XP_050026762.1;XP_050050199.1;XP_050027282.1;XP_050029490.1
KEGG: 00640+1.2.1.27	Propanoate metabolism	1	XP_050036825.1
Reactome: R-HSA-9634635	Estrogen-stimulated signaling through PRKCZ	1	XP_050032548.1
MetaCyc: PWY-5532	Nucleoside and nucleotide degradation (archaea)	5	XP_050036028.1;XP_050035831.1;XP_050032573.1;XP_050046554.1;XP_050046556.1
Reactome: R-HSA-189200	Cellular hexose transport	36	XP_050029266.1;XP_050052270.1;XP_050034317.1;XP_050036085.1;XP_050052271.1;XP_050035815.1;XP_050025267.1;XP_050041599.1;XP_050041728.1;XP_050041727.1;XP_050025263.1;XP_050043538.1;XP_050024090.1;XP_050046257.1;XP_050034318.1;XP_050034323.1;XP_050052272.1;XP_050034322.1;XP_050034315.1;XP_050034319.1;XP_050034316.1;XP_050034320.1;XP_050029216.1;XP_050032082.1;XP_050025274.1;XP_050034321.1;XP_050025277.1;XP_050031038.1;XP_050052273.1;XP_050034326.1;XP_050032081.1;XP_050022608.1;XP_050041726.1;XP_050029265.1;XP_050025281.1;XP_050034331.1
Reactome: R-HSA-2467813	Separation of Sister Chromatids	191	XP_050048719.1;XP_050047997.1;XP_050045785.1;XP_050050373.1;XP_050048776.1;XP_050040200.1;XP_050033477.1;XP_050044509.1;XP_050030513.1;XP_050035981.1;XP_050052697.1;XP_050039331.1;XP_050035980.1;XP_050025715.1;XP_050030512.1;XP_050035976.1;XP_050034772.1;XP_050047137.1;XP_050044008.1;XP_050027084.1;XP_050030515.1;XP_050044478.1;XP_050031479.1;XP_050034683.1;XP_050048721.1;XP_050025848.1;XP_050035973.1;XP_050030937.1;XP_050047181.1;XP_050040338.1;XP_050047778.1;XP_050040341.1;XP_050033833.1;XP_050035116.1;XP_050030509.1;XP_050040054.1;XP_050040792.1;XP_050033432.1;XP_050033318.1;XP_050025910.1;XP_050047136.1;XP_050031786.1;XP_050027118.1;XP_050043181.1;XP_050039518.1;XP_050024749.1;XP_050035481.1;XP_050047996.1;XP_050037090.1;XP_050044470.1;XP_050027083.1;XP_050035992.1;XP_050035472.1;XP_050029897.1;XP_050030514.1;XP_050047809.1;XP_050040050.1;XP_050032477.1;XP_050027566.1;XP_050048775.1;XP_050046734.1;XP_050025911.1;XP_050039330.1;XP_050035990.1;XP_050022938.1;XP_050042706.1;XP_050049761.1;XP_050042727.1;XP_050024518.1;XP_050049759.1;XP_050042726.1;XP_050035482.1;XP_050049758.1;XP_050047998.1;XP_050033146.1;XP_050035975.1;XP_050035932.1;XP_050023718.1;XP_050045660.1;XP_050035993.1;XP_050049377.1;XP_050038630.1;XP_050040051.1;XP_050035991.1;XP_050048824.1;XP_050029298.1;XP_050034248.1;XP_050028217.1;XP_050038140.1;XP_050035983.1;XP_050035987.1;XP_050049124.1;XP_050041693.1;XP_050042731.1;XP_050048720.1;XP_050050645.1;XP_050048823.1;XP_050029077.1;XP_050045443.1;XP_050042728.1;XP_050030511.1;XP_050024840.1;XP_050036567.1;XP_050034247.1;XP_050042732.1;XP_050049762.1;XP_050035988.1;XP_050046837.1;XP_050035985.1;XP_050037401.1;XP_050029297.1;XP_050039332.1;XP_050046735.1;XP_050039306.1;XP_050044467.1;XP_050049757.1;XP_050048777.1;XP_050048801.1;XP_050035982.1;XP_050027567.1;XP_050035984.1;XP_050036430.1;XP_050040143.1;XP_050035114.1;XP_050046838.1;XP_050035977.1;XP_050052055.1;XP_050047338.1;XP_050029374.1;XP_050039305.1;XP_050029375.1;XP_050026883.1;XP_050022518.1;XP_050037397.1;XP_050047994.1;XP_050042025.1;XP_050035989.1;XP_050040198.1;XP_050040199.1;XP_050051964.1;XP_050051356.1;XP_050028218.1;XP_050039380.1;XP_050033331.1;XP_050028813.1;XP_050047139.1;XP_050052420.1;XP_050040340.1;XP_050048534.1;XP_050040339.1;XP_050039381.1;XP_050047564.1;XP_050024841.1;XP_050033237.1;XP_050035119.1;XP_050029078.1;XP_050046156.1;XP_050051381.1;XP_050045051.1;XP_050047995.1;XP_050047138.1;XP_050040052.1;XP_050038418.1;XP_050044476.1;XP_050051357.1;XP_050035979.1;XP_050044469.1;XP_050051355.1;XP_050038895.1;XP_050037399.1;XP_050038628.1;XP_050027568.1;XP_050027657.1;XP_050035978.1;XP_050035986.1;XP_050036156.1;XP_050035933.1;XP_050037398.1;XP_050027134.1;XP_050034447.1;XP_050042788.1;XP_050035974.1;XP_050044475.1;XP_050040049.1;XP_050029076.1;XP_050042730.1;XP_050045597.1;XP_050029802.1;XP_050052231.1;XP_050033832.1;XP_050039329.1
Reactome: R-HSA-74751	Insulin receptor signalling cascade	1	XP_050032853.1
Reactome: R-HSA-1253288	Downregulation of ERBB4 signaling	2	XP_050035481.1;XP_050048534.1
KEGG: 00930+4.2.1.17+1.1.1.35	Caprolactam degradation	6	XP_050041643.1;XP_050032010.1;XP_050026422.1;XP_050041651.1;XP_050041635.1;XP_050051194.1
MetaCyc: PWY-7883	Anhydromuropeptides recycling II	32	XP_050049136.1;XP_050026981.1;XP_050049138.1;XP_050049139.1;XP_050049141.1;XP_050043064.1;XP_050036110.1;XP_050038974.1;XP_050049140.1;XP_050049366.1;XP_050028195.1;XP_050028196.1;XP_050025618.1;XP_050030481.1;XP_050035570.1;XP_050026917.1;XP_050026983.1;XP_050039363.1;XP_050026985.1;XP_050030480.1;XP_050049137.1;XP_050039362.1;XP_050027975.1;XP_050025615.1;XP_050026191.1;XP_050049367.1;XP_050025616.1;XP_050026984.1;XP_050025617.1;XP_050039361.1;XP_050030479.1;XP_050026982.1
Reactome: R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	3	XP_050030452.1;XP_050024508.1;XP_050030451.1
Reactome: R-HSA-1296061	HCN channels	5	XP_050044691.1;XP_050043473.1;XP_050043474.1;XP_050044690.1;XP_050044692.1
KEGG: 00960+2.6.1.1	Tropane, piperidine and pyridine alkaloid biosynthesis	3	XP_050026413.1;XP_050049203.1;XP_050049202.1
KEGG: 00790+4.2.1.96	Folate biosynthesis	1	XP_050034971.1
KEGG: 00061+1.1.1.100+2.3.1.85+4.2.1.59+2.3.1.39+2.3.1.41+3.1.2.14	Fatty acid biosynthesis	4	XP_050033008.1;XP_050032773.1;XP_050033009.1;XP_050029751.1
Reactome: R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	52	XP_050047809.1;XP_050048719.1;XP_050048534.1;XP_050032477.1;XP_050050373.1;XP_050045785.1;XP_050022938.1;XP_050040200.1;XP_050037401.1;XP_050033237.1;XP_050025715.1;XP_050034772.1;XP_050045660.1;XP_050044478.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050044469.1;XP_050047181.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050027118.1;XP_050031786.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050040198.1;XP_050052231.1;XP_050044470.1;XP_050050645.1;XP_050029802.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1
KEGG: 00785+6.3.1.20	Lipoic acid metabolism	1	XP_050036621.1
MetaCyc: PWY-5172	Acetyl-coa biosynthesis III (from citrate)	1	XP_050043005.1
MetaCyc: PWY-622	Starch biosynthesis	4	XP_050050068.1;XP_050028738.1;XP_050042400.1;XP_050028469.1
MetaCyc: PWY-5994	Palmitate biosynthesis (animals and fungi, cytoplasm)	4	XP_050029751.1;XP_050033009.1;XP_050032773.1;XP_050033008.1
Reactome: R-HSA-174403	Glutathione synthesis and recycling	11	XP_050048564.1;XP_050042926.1;XP_050041754.1;XP_050027889.1;XP_050051979.1;XP_050026350.1;XP_050049815.1;XP_050042924.1;XP_050047739.1;XP_050047740.1;XP_050042925.1
Reactome: R-HSA-5632968	Defective Mismatch Repair Associated With MSH6	3	XP_050027779.1;XP_050042225.1;XP_050041261.1
KEGG: 00280+1.3.8.4	Valine, leucine and isoleucine degradation	1	XP_050051624.1
Reactome: R-HSA-201688	WNT mediated activation of DVL	3	XP_050024731.1;XP_050051200.1;XP_050024722.1
MetaCyc: PWY-5080	Very long chain fatty acid biosynthesis I	78	XP_050051765.1;XP_050039080.1;XP_050043402.1;XP_050027470.1;XP_050039769.1;XP_050039016.1;XP_050039699.1;XP_050039126.1;XP_050027496.1;XP_050039365.1;XP_050039772.1;XP_050039364.1;XP_050039085.1;XP_050047366.1;XP_050026205.1;XP_050051763.1;XP_050028129.1;XP_050026888.1;XP_050039711.1;XP_050039770.1;XP_050039706.1;XP_050039709.1;XP_050039710.1;XP_050039084.1;XP_050039707.1;XP_050039088.1;XP_050026206.1;XP_050041192.1;XP_050039705.1;XP_050039087.1;XP_050027469.1;XP_050039712.1;XP_050026887.1;XP_050027497.1;XP_050039186.1;XP_050039704.1;XP_050039703.1;XP_050041191.1;XP_050039426.1;XP_050039015.1;XP_050039086.1;XP_050036659.1;XP_050036658.1;XP_050039701.1;XP_050033896.1;XP_050039702.1;XP_050048344.1;XP_050039183.1;XP_050039191.1;XP_050025916.1;XP_050039082.1;XP_050026935.1;XP_050039081.1;XP_050039366.1;XP_050027024.1;XP_050039698.1;XP_050039555.1;XP_050026425.1;XP_050039083.1;XP_050039545.1;XP_050039017.1;XP_050033799.1;XP_050039722.1;XP_050041128.1;XP_050033894.1;XP_050042219.1;XP_050039708.1;XP_050045032.1;XP_050039189.1;XP_050036103.1;XP_050039263.1;XP_050042358.1;XP_050051766.1;XP_050025917.1;XP_050039700.1;XP_050036636.1;XP_050027502.1;XP_050051764.1
Reactome: R-HSA-8873719	RAB geranylgeranylation	17	XP_050047671.1;XP_050039139.1;XP_050038679.1;XP_050051980.1;XP_050023598.1;XP_050036585.1;XP_050037432.1;XP_050051035.1;XP_050052808.1;XP_050038732.1;XP_050051033.1;XP_050052809.1;XP_050038731.1;XP_050037431.1;XP_050039138.1;XP_050051981.1;XP_050051032.1
Reactome: R-HSA-1660499	Synthesis of PIPs at the plasma membrane	19	XP_050051980.1;XP_050052756.1;XP_050031141.1;XP_050040160.1;XP_050039358.1;XP_050039456.1;XP_050040157.1;XP_050031140.1;XP_050040158.1;XP_050022977.1;XP_050040159.1;XP_050045005.1;XP_050023808.1;XP_050039357.1;XP_050031139.1;XP_050039455.1;XP_050051981.1;XP_050049284.1;XP_050028399.1
MetaCyc: PWY-6470	Peptidoglycan biosynthesis V (beta-lactam resistance)	3	XP_050033584.1;XP_050033583.1;XP_050034973.1
Reactome: R-HSA-156581	Methylation	18	XP_050028105.1;XP_050052168.1;XP_050032154.1;XP_050022501.1;XP_050028107.1;XP_050052167.1;XP_050052201.1;XP_050036540.1;XP_050052202.1;XP_050037649.1;XP_050028104.1;XP_050028103.1;XP_050028106.1;XP_050039129.1;XP_050039955.1;XP_050043008.1;XP_050023004.1;XP_050037646.1
Reactome: R-HSA-9648895	Response of EIF2AK1 (HRI) to heme deficiency	1	XP_050032272.1
KEGG: 00230+2.4.2.8	Purine metabolism	2	XP_050045961.1;XP_050045960.1
KEGG: 00340+2.1.1.22	Histidine metabolism	1	XP_050034614.1
MetaCyc: PWY-8013	UDP-N-acetyl-D-galactosamine biosynthesis III	6	XP_050051578.1;XP_050051580.1;XP_050051577.1;XP_050050068.1;XP_050051579.1;XP_050051581.1
KEGG: 00591+3.1.1.4	Linoleic acid metabolism	27	XP_050035192.1;XP_050037145.1;XP_050030747.1;XP_050031256.1;XP_050037147.1;XP_050035193.1;XP_050035198.1;XP_050033390.1;XP_050037151.1;XP_050037148.1;XP_050037146.1;XP_050035199.1;XP_050037142.1;XP_050037140.1;XP_050035196.1;XP_050037144.1;XP_050035197.1;XP_050035195.1;XP_050037139.1;XP_050037141.1;XP_050037661.1;XP_050025400.1;XP_050037143.1;XP_050025686.1;XP_050037150.1;XP_050050549.1;XP_050035194.1
Reactome: R-HSA-72165	mRNA Splicing - Minor Pathway	50	XP_050024189.1;XP_050023727.1;XP_050036568.1;XP_050023724.1;XP_050044032.1;XP_050048361.1;XP_050048565.1;XP_050023728.1;XP_050041971.1;XP_050046123.1;XP_050025366.1;XP_050031253.1;XP_050025914.1;XP_050034644.1;XP_050023028.1;XP_050030935.1;XP_050045189.1;XP_050025576.1;XP_050032816.1;XP_050029910.1;XP_050045646.1;XP_050043147.1;XP_050023725.1;XP_050045647.1;XP_050032814.1;XP_050029909.1;XP_050025915.1;XP_050023014.1;XP_050046063.1;XP_050023729.1;XP_050039480.1;XP_050023726.1;XP_050039128.1;XP_050040482.1;XP_050041973.1;XP_050036429.1;XP_050032815.1;XP_050049626.1;XP_050040483.1;XP_050023730.1;XP_050023638.1;XP_050041972.1;XP_050040484.1;XP_050044033.1;XP_050034643.1;XP_050045525.1;XP_050038469.1;XP_050039472.1;XP_050040975.1;XP_050032813.1
MetaCyc: PWY-7841	Neolacto-series glycosphingolipids biosynthesis	1	XP_050023783.1
KEGG: 00071+1.1.1.1	Fatty acid degradation	3	XP_050052400.1;XP_050052302.1;XP_050052301.1
MetaCyc: PWY-5856	Ubiquinol-9 biosynthesis (prokaryotic)	4	XP_050033250.1;XP_050025937.1;XP_050040261.1;XP_050025938.1
MetaCyc: PWY-7346	UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)	2	XP_050040190.1;XP_050040189.1
Reactome: R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1	XP_050032010.1
Reactome: R-HSA-8953750	Transcriptional Regulation by E2F6	33	XP_050037097.1;XP_050034960.1;XP_050031698.1;XP_050032145.1;XP_050037094.1;XP_050030856.1;XP_050033903.1;XP_050040075.1;XP_050033904.1;XP_050026957.1;XP_050026960.1;XP_050031628.1;XP_050046148.1;XP_050029891.1;XP_050046147.1;XP_050033968.1;XP_050026959.1;XP_050048786.1;XP_050037096.1;XP_050046149.1;XP_050037095.1;XP_050029889.1;XP_050046963.1;XP_050034961.1;XP_050030855.1;XP_050029890.1;XP_050026958.1;XP_050024395.1;XP_050050601.1;XP_050029887.1;XP_050046150.1;XP_050031701.1;XP_050037098.1
KEGG: 04658+3.1.3.16	Th1 and Th2 cell differentiation	59	XP_050030913.1;XP_050039895.1;XP_050035477.1;XP_050042946.1;XP_050025562.1;XP_050038927.1;XP_050036586.1;XP_050023419.1;XP_050047387.1;XP_050025719.1;XP_050051183.1;XP_050045668.1;XP_050042483.1;XP_050049023.1;XP_050024315.1;XP_050027367.1;XP_050039893.1;XP_050024153.1;XP_050046743.1;XP_050024314.1;XP_050030280.1;XP_050050370.1;XP_050052813.1;XP_050035478.1;XP_050050842.1;XP_050024311.1;XP_050043539.1;XP_050036461.1;XP_050025671.1;XP_050033089.1;XP_050022996.1;XP_050035479.1;XP_050025673.1;XP_050028692.1;XP_050024512.1;XP_050038926.1;XP_050050372.1;XP_050024313.1;XP_050032919.1;XP_050051673.1;XP_050051674.1;XP_050023189.1;XP_050023143.1;XP_050025672.1;XP_050039894.1;XP_050034952.1;XP_050047404.1;XP_050040107.1;XP_050034951.1;XP_050048821.1;XP_050025670.1;XP_050037472.1;XP_050023418.1;XP_050029847.1;XP_050024316.1;XP_050025720.1;XP_050050072.1;XP_050024310.1;XP_050047386.1
Reactome: R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	3	XP_050031011.1;XP_050031013.1;XP_050031012.1
MetaCyc: PWY-3162	L-tryptophan degradation V (side chain pathway)	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
MetaCyc: PWY-7761	NAD salvage pathway II (PNC IV cycle)	3	XP_050046832.1;XP_050032111.1;XP_050046833.1
KEGG: 00270+1.13.11.20	Cysteine and methionine metabolism	1	XP_050033399.1
MetaCyc: PWY-5966-1	Fatty acid biosynthesis initiation (animals and fungi, cytoplasm)	16	XP_050048459.1;XP_050048460.1;XP_050048463.1;XP_050048465.1;XP_050033009.1;XP_050048462.1;XP_050048468.1;XP_050048456.1;XP_050029751.1;XP_050048457.1;XP_050048466.1;XP_050033008.1;XP_050048458.1;XP_050048467.1;XP_050048461.1;XP_050032773.1
Reactome: R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	5	XP_050032256.1;XP_050033086.1;XP_050032128.1;XP_050029504.1;XP_050044905.1
Reactome: R-HSA-375165	NCAM signaling for neurite out-growth	11	XP_050051732.1;XP_050047598.1;XP_050051733.1;XP_050036850.1;XP_050036848.1;XP_050047606.1;XP_050032853.1;XP_050051735.1;XP_050051734.1;XP_050036851.1;XP_050036849.1
KEGG: 00520+5.4.2.8	Amino sugar and nucleotide sugar metabolism	1	XP_050044728.1
KEGG: 00520+2.7.7.9	Amino sugar and nucleotide sugar metabolism	4	XP_050037409.1;XP_050037410.1;XP_050037411.1;XP_050037412.1
KEGG: 00473+5.1.1.1	D-Alanine metabolism	1	XP_050026567.1
Reactome: R-HSA-5083627	Defective LARGE causes MDDGA6 and MDDGB6	3	XP_050038650.1;XP_050039591.1;XP_050036875.1
Reactome: R-HSA-975634	Retinoid metabolism and transport	16	XP_050042242.1;XP_050043439.1;XP_050042240.1;XP_050023809.1;XP_050040600.1;XP_050042454.1;XP_050023334.1;XP_050043294.1;XP_050039341.1;XP_050042262.1;XP_050042260.1;XP_050042241.1;XP_050023796.1;XP_050023422.1;XP_050023312.1;XP_050042261.1
KEGG: 00480+3.4.11.2	Glutathione metabolism	7	XP_050026344.1;XP_050033316.1;XP_050035778.1;XP_050035822.1;XP_050026186.1;XP_050035204.1;XP_050034720.1
MetaCyc: PWY-5484	Glycolysis II (from fructose 6-phosphate)	18	XP_050041662.1;XP_050034254.1;XP_050038404.1;XP_050038973.1;XP_050040643.1;XP_050038972.1;XP_050041668.1;XP_050025561.1;XP_050034253.1;XP_050025560.1;XP_050051894.1;XP_050044976.1;XP_050040644.1;XP_050040641.1;XP_050040645.1;XP_050045451.1;XP_050044414.1;XP_050034255.1
MetaCyc: PWY-2301	Myo-inositol biosynthesis	3	XP_050052036.1;XP_050052037.1;XP_050048146.1
KEGG: 00533+2.4.1.68	Glycosaminoglycan biosynthesis - keratan sulfate	1	XP_050036571.1
Reactome: R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	19	XP_050036644.1;XP_050036551.1;XP_050040875.1;XP_050036546.1;XP_050043647.1;XP_050042413.1;XP_050030414.1;XP_050036548.1;XP_050040874.1;XP_050033609.1;XP_050036552.1;XP_050022643.1;XP_050045998.1;XP_050043194.1;XP_050043710.1;XP_050036547.1;XP_050042414.1;XP_050036549.1;XP_050031894.1
KEGG: 00350+3.7.1.2	Tyrosine metabolism	1	XP_050034252.1
MetaCyc: PWY-5972	Stearate biosynthesis I (animals)	76	XP_050039191.1;XP_050025916.1;XP_050039183.1;XP_050048344.1;XP_050039702.1;XP_050033896.1;XP_050039081.1;XP_050026935.1;XP_050039082.1;XP_050039186.1;XP_050039704.1;XP_050039703.1;XP_050026887.1;XP_050027497.1;XP_050036658.1;XP_050039701.1;XP_050039086.1;XP_050036659.1;XP_050039426.1;XP_050041191.1;XP_050039015.1;XP_050036103.1;XP_050039263.1;XP_050025917.1;XP_050051766.1;XP_050039708.1;XP_050039189.1;XP_050042219.1;XP_050027502.1;XP_050051764.1;XP_050036636.1;XP_050039700.1;XP_050039083.1;XP_050039555.1;XP_050026425.1;XP_050039698.1;XP_050039366.1;XP_050027024.1;XP_050041128.1;XP_050033894.1;XP_050033799.1;XP_050039722.1;XP_050039017.1;XP_050039545.1;XP_050039772.1;XP_050039365.1;XP_050027496.1;XP_050039699.1;XP_050039126.1;XP_050047366.1;XP_050039085.1;XP_050039364.1;XP_050043402.1;XP_050039080.1;XP_050027470.1;XP_050039769.1;XP_050051765.1;XP_050039016.1;XP_050039088.1;XP_050039707.1;XP_050039084.1;XP_050039087.1;XP_050027469.1;XP_050039712.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050028129.1;XP_050051763.1;XP_050026205.1;XP_050039710.1;XP_050039711.1;XP_050039770.1;XP_050039709.1;XP_050039706.1;XP_050026888.1
MetaCyc: PWY-7165	L-ascorbate biosynthesis VI (engineered pathway)	2	XP_050030744.1;XP_050030742.1
Reactome: R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	2	XP_050025376.1;XP_050032853.1
KEGG: 00230+4.1.1.21	Purine metabolism	2	XP_050039993.1;XP_050039992.1
MetaCyc: PWY-7395	D-galactosamine and N-acetyl-D-galactosamine degradation	3	XP_050038837.1;XP_050038836.1;XP_050038838.1
KEGG: 00970+6.1.1.18	Aminoacyl-tRNA biosynthesis	2	XP_050031592.1;XP_050031591.1
Reactome: R-HSA-444257	RSK activation	4	XP_050032548.1;XP_050047598.1;XP_050026027.1;XP_050047606.1
KEGG: 00562+3.1.3.56	Inositol phosphate metabolism	5	XP_050050241.1;XP_050050240.1;XP_050050236.1;XP_050050239.1;XP_050050237.1
MetaCyc: PWY-7382	Lipoate biosynthesis and incorporation IV (yeast)	4	XP_050039804.1;XP_050045962.1;XP_050036621.1;XP_050048152.1
MetaCyc: PWY-8010	L-cysteine biosynthesis IX (Trichomonas vaginalis)	3	XP_050034258.1;XP_050045348.1;XP_050034259.1
KEGG: 00232+2.3.1.5	Caffeine metabolism	6	XP_050027182.1;XP_050027934.1;XP_050027933.1;XP_050028265.1;XP_050027932.1;XP_050027935.1
Reactome: R-HSA-74749	Signal attenuation	3	XP_050047598.1;XP_050047606.1;XP_050032853.1
MetaCyc: PWY-5057	L-valine degradation II	4	XP_050052301.1;XP_050052400.1;XP_050052302.1;XP_050039540.1
Reactome: R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	6	XP_050046497.1;XP_050047866.1;XP_050023108.1;XP_050047570.1;XP_050047867.1;XP_050047865.1
Reactome: R-HSA-5654689	PI-3K cascade:FGFR1	1	XP_050032853.1
MetaCyc: PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	6	XP_050040348.1;XP_050040346.1;XP_050040347.1;XP_050050068.1;XP_050049839.1;XP_050050483.1
MetaCyc: PWY-5675	Nitrate reduction V (assimilatory)	11	XP_050033589.1;XP_050028876.1;XP_050038618.1;XP_050028874.1;XP_050033588.1;XP_050051950.1;XP_050028873.1;XP_050038622.1;XP_050038620.1;XP_050038619.1;XP_050038621.1
KEGG: 00250+2.1.3.2	Alanine, aspartate and glutamate metabolism	1	XP_050032255.1
KEGG: 00130+1.17.4.4	Ubiquinone and other terpenoid-quinone biosynthesis	1	XP_050025573.1
KEGG: 00520+1.1.1.22	Amino sugar and nucleotide sugar metabolism	2	XP_050040190.1;XP_050040189.1
Reactome: R-HSA-5603029	IkBA variant leads to EDA-ID	1	XP_050050758.1
MetaCyc: PWY-6556	Pyrimidine ribonucleosides salvage II	2	XP_050025364.1;XP_050025363.1
KEGG: 00780+6.3.4.15	Biotin metabolism	1	XP_050048152.1
MetaCyc: PWY-2201	Folate transformations I	7	XP_050052683.1;XP_050032636.1;XP_050034367.1;XP_050032637.1;XP_050048637.1;XP_050036540.1;XP_050052682.1
MetaCyc: PWY-6535	4-aminobutanoate degradation I	1	XP_050041758.1
KEGG: 00970+6.3.5.7	Aminoacyl-tRNA biosynthesis	16	XP_050040991.1;XP_050044966.1;XP_050028159.1;XP_050040998.1;XP_050040994.1;XP_050040799.1;XP_050028879.1;XP_050027048.1;XP_050028158.1;XP_050040995.1;XP_050028060.1;XP_050040996.1;XP_050028160.1;XP_050040997.1;XP_050040999.1;XP_050040993.1
Reactome: R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	9	XP_050038199.1;XP_050031736.1;XP_050045444.1;XP_050025244.1;XP_050038213.1;XP_050025266.1;XP_050025248.1;XP_050036268.1;XP_050025243.1
KEGG: 00062+4.2.1.17+1.1.1.35	Fatty acid elongation	6	XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
KEGG: 00240+6.3.4.2	Pyrimidine metabolism	3	XP_050026501.1;XP_050026500.1;XP_050026502.1
Reactome: R-HSA-69183	Processive synthesis on the lagging strand	13	XP_050041996.1;XP_050032235.1;XP_050040824.1;XP_050022594.1;XP_050043962.1;XP_050041995.1;XP_050041997.1;XP_050039359.1;XP_050041999.1;XP_050052687.1;XP_050032670.1;XP_050049531.1;XP_050041998.1
Reactome: R-HSA-71384	Ethanol oxidation	7	XP_050044794.1;XP_050052301.1;XP_050031784.1;XP_050052400.1;XP_050052302.1;XP_050030604.1;XP_050031785.1
MetaCyc: PWY-6123	Inosine-5'-phosphate biosynthesis I	4	XP_050039993.1;XP_050030286.1;XP_050039992.1;XP_050034170.1
Reactome: R-HSA-9652282	Drug-mediated inhibition of ERBB2 signaling	2	XP_050048200.1;XP_050048201.1
Reactome: R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	2	XP_050024731.1;XP_050024722.1
KEGG: 00982+1.1.1.1	Drug metabolism - cytochrome P450	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
Reactome: R-HSA-9018519	Estrogen-dependent gene expression	89	XP_050040909.1;XP_050023726.1;XP_050046063.1;XP_050023729.1;XP_050040898.1;XP_050042081.1;XP_050043924.1;XP_050029824.1;XP_050042080.1;XP_050034505.1;XP_050047136.1;XP_050038213.1;XP_050040900.1;XP_050038469.1;XP_050040907.1;XP_050034643.1;XP_050039235.1;XP_050023730.1;XP_050040910.1;XP_050052226.1;XP_050040906.1;XP_050028218.1;XP_050046123.1;XP_050051917.1;XP_050022602.1;XP_050038199.1;XP_050036268.1;XP_050026047.1;XP_050025243.1;XP_050040899.1;XP_050023727.1;XP_050023724.1;XP_050024189.1;XP_050029825.1;XP_050029859.1;XP_050052225.1;XP_050022603.1;XP_050037414.1;XP_050040958.1;XP_050047137.1;XP_050022605.1;XP_050022604.1;XP_050040897.1;XP_050040903.1;XP_050025266.1;XP_050045444.1;XP_050042083.1;XP_050022606.1;XP_050029336.1;XP_050023625.1;XP_050048718.1;XP_050029862.1;XP_050040905.1;XP_050028217.1;XP_050023725.1;XP_050043147.1;XP_050040551.1;XP_050048717.1;XP_050029827.1;XP_050047422.1;XP_050025248.1;XP_050025244.1;XP_050032553.1;XP_050029337.1;XP_050042082.1;XP_050026046.1;XP_050026223.1;XP_050029861.1;XP_050051916.1;XP_050028353.1;XP_050023728.1;XP_050047139.1;XP_050029338.1;XP_050039236.1;XP_050040901.1;XP_050042079.1;XP_050040902.1;XP_050029858.1;XP_050029860.1;XP_050040908.1;XP_050031736.1;XP_050052512.1;XP_050040904.1;XP_050038602.1;XP_050051915.1;XP_050023605.1;XP_050047138.1;XP_050029826.1;XP_050034644.1
Reactome: R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	3	XP_050052309.1;XP_050044540.1;XP_050046184.1
Reactome: R-HSA-351143	Agmatine biosynthesis	1	XP_050047167.1
Reactome: R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	8	XP_050041140.1;XP_050041139.1;XP_050051590.1;XP_050024357.1;XP_050051588.1;XP_050041141.1;XP_050024358.1;XP_050024359.1
Reactome: R-HSA-9603798	Class I peroxisomal membrane protein import	12	XP_050034672.1;XP_050045397.1;XP_050051751.1;XP_050048723.1;XP_050036049.1;XP_050030850.1;XP_050033662.1;XP_050036050.1;XP_050031037.1;XP_050033771.1;XP_050023461.1;XP_050039626.1
Reactome: R-HSA-901032	ER Quality Control Compartment (ERQC)	11	XP_050043327.1;XP_050043324.1;XP_050049433.1;XP_050048534.1;XP_050035481.1;XP_050036253.1;XP_050043325.1;XP_050043328.1;XP_050043329.1;XP_050049432.1;XP_050043326.1
Reactome: R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	34	XP_050025556.1;XP_050030856.1;XP_050044385.1;XP_050035922.1;XP_050044386.1;XP_050035921.1;XP_050042766.1;XP_050023898.1;XP_050035918.1;XP_050034278.1;XP_050035917.1;XP_050031628.1;XP_050044387.1;XP_050049421.1;XP_050044388.1;XP_050044890.1;XP_050034279.1;XP_050025557.1;XP_050023897.1;XP_050027684.1;XP_050034280.1;XP_050025555.1;XP_050023896.1;XP_050029831.1;XP_050034281.1;XP_050035920.1;XP_050034277.1;XP_050035919.1;XP_050051200.1;XP_050042768.1;XP_050030855.1;XP_050027315.1;XP_050027316.1;XP_050047422.1
Reactome: R-HSA-983231	Factors involved in megakaryocyte development and platelet production	67	XP_050025603.1;XP_050029167.1;XP_050029165.1;XP_050042112.1;XP_050027722.1;XP_050050652.1;XP_050031736.1;XP_050025374.1;XP_050029164.1;XP_050027576.1;XP_050031738.1;XP_050028705.1;XP_050050650.1;XP_050022944.1;XP_050028562.1;XP_050031737.1;XP_050042107.1;XP_050025375.1;XP_050027723.1;XP_050027174.1;XP_050043115.1;XP_050027573.1;XP_050042295.1;XP_050028210.1;XP_050027577.1;XP_050027578.1;XP_050045444.1;XP_050035889.1;XP_050027175.1;XP_050029918.1;XP_050035890.1;XP_050029919.1;XP_050046875.1;XP_050029166.1;XP_050050653.1;XP_050028563.1;XP_050043114.1;XP_050027574.1;XP_050029917.1;XP_050052372.1;XP_050042296.1;XP_050043113.1;XP_050027721.1;XP_050042105.1;XP_050042109.1;XP_050029163.1;XP_050043116.1;XP_050027173.1;XP_050046873.1;XP_050042106.1;XP_050042110.1;XP_050050651.1;XP_050027575.1;XP_050043117.1;XP_050048806.1;XP_050032122.1;XP_050026711.1;XP_050042108.1;XP_050027724.1;XP_050032121.1;XP_050046874.1;XP_050028706.1;XP_050029168.1;XP_050027720.1;XP_050042111.1;XP_050027719.1;XP_050050989.1
KEGG: 00480+2.5.1.18+1.8.5.1	Glutathione metabolism	2	XP_050027833.1;XP_050026762.1
MetaCyc: PWY-5857	Ubiquinol-10 biosynthesis (prokaryotic)	4	XP_050033250.1;XP_050025937.1;XP_050040261.1;XP_050025938.1
KEGG: 00520+1.1.1.271	Amino sugar and nucleotide sugar metabolism	1	XP_050048517.1
MetaCyc: PWY-5890	Menaquinol-10 biosynthesis	1	XP_050045574.1
MetaCyc: PWY-7734	Quinoxaline-2-carboxylate biosynthesis	11	XP_050035077.1;XP_050040581.1;XP_050040417.1;XP_050040577.1;XP_050040415.1;XP_050040583.1;XP_050040584.1;XP_050040418.1;XP_050040419.1;XP_050040580.1;XP_050040416.1
Reactome: R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	5	XP_050049499.1;XP_050050758.1;XP_050049500.1;XP_050049501.1;XP_050024508.1
Reactome: R-HSA-167044	Signalling to RAS	3	XP_050032853.1;XP_050045015.1;XP_050045016.1
MetaCyc: PWY-7586	Beta-1,4-d-mannosyl-n-acetyl-d-glucosamine degradation	2	XP_050044728.1;XP_050044364.1
MetaCyc: PWY-5101	L-isoleucine biosynthesis II	1	XP_050039540.1
Reactome: R-HSA-9609736	Assembly and cell surface presentation of NMDA receptors	48	XP_050050696.1;XP_050049759.1;XP_050024841.1;XP_050049761.1;XP_050050697.1;XP_050039381.1;XP_050048382.1;XP_050046734.1;XP_050040729.1;XP_050050684.1;XP_050050681.1;XP_050050687.1;XP_050050698.1;XP_050052420.1;XP_050050685.1;XP_050049762.1;XP_050050683.1;XP_050051357.1;XP_050049757.1;XP_050048381.1;XP_050050686.1;XP_050050700.1;XP_050050690.1;XP_050046735.1;XP_050040727.1;XP_050050701.1;XP_050049758.1;XP_050050679.1;XP_050050694.1;XP_050050691.1;XP_050047338.1;XP_050050689.1;XP_050050699.1;XP_050050702.1;XP_050051355.1;XP_050052055.1;XP_050050680.1;XP_050048383.1;XP_050048384.1;XP_050039380.1;XP_050050682.1;XP_050051356.1;XP_050024840.1;XP_050050695.1;XP_050050688.1;XP_050050692.1;XP_050043181.1;XP_050050693.1
Reactome: R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	13	XP_050044191.1;XP_050032655.1;XP_050044193.1;XP_050048534.1;XP_050035481.1;XP_050044198.1;XP_050044197.1;XP_050032853.1;XP_050044199.1;XP_050044194.1;XP_050044192.1;XP_050044195.1;XP_050032654.1
MetaCyc: PWY-7723	Bacterial bioluminescence	4	XP_050029751.1;XP_050032773.1;XP_050033009.1;XP_050033008.1
KEGG: 00330+2.5.1.16	Arginine and proline metabolism	4	XP_050041583.1;XP_050041589.1;XP_050027527.1;XP_050027526.1
Reactome: R-HSA-167590	Nef Mediated CD4 Down-regulation	8	XP_050045457.1;XP_050049787.1;XP_050045458.1;XP_050037100.1;XP_050048294.1;XP_050028603.1;XP_050040246.1;XP_050045459.1
Reactome: R-HSA-111457	Release of apoptotic factors from the mitochondria	5	XP_050037104.1;XP_050052134.1;XP_050045633.1;XP_050047553.1;XP_050037103.1
Reactome: R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	8	XP_050048777.1;XP_050048776.1;XP_050047997.1;XP_050047996.1;XP_050047995.1;XP_050047994.1;XP_050048775.1;XP_050047998.1
Reactome: R-HSA-381042	PERK regulates gene expression	2	XP_050032272.1;XP_050052627.1
Reactome: R-HSA-2029485	Role of phospholipids in phagocytosis	8	XP_050025879.1;XP_050050471.1;XP_050050470.1;XP_050048140.1;XP_050036247.1;XP_050048141.1;XP_050036246.1;XP_050050469.1
MetaCyc: PWY-7214	Baicalein degradation (hydrogen peroxide detoxification)	18	XP_050037576.1;XP_050052158.1;XP_050031834.1;XP_050037573.1;XP_050037575.1;XP_050022911.1;XP_050031815.1;XP_050030591.1;XP_050022520.1;XP_050037574.1;XP_050032263.1;XP_050037572.1;XP_050033134.1;XP_050022517.1;XP_050052159.1;XP_050030590.1;XP_050052157.1;XP_050031263.1
Reactome: R-HSA-4720454	Defective ALG9 causes ALG9-CDG (CDG-1l)	1	XP_050048305.1
MetaCyc: PWY-561	Superpathway of glyoxylate cycle and fatty acid degradation	16	XP_050037169.1;XP_050037926.1;XP_050033843.1;XP_050037165.1;XP_050038590.1;XP_050037168.1;XP_050045192.1;XP_050037925.1;XP_050033718.1;XP_050037172.1;XP_050035735.1;XP_050037164.1;XP_050033719.1;XP_050037417.1;XP_050037167.1;XP_050037166.1
Reactome: R-HSA-918233	TRAF3-dependent IRF activation pathway	2	XP_050038602.1;XP_050032293.1
KEGG: 00220+6.3.4.5	Arginine biosynthesis	1	XP_050052351.1
KEGG: 00860+4.99.1.1	Porphyrin and chlorophyll metabolism	1	XP_050035135.1
MetaCyc: PWY-5884	Wax esters biosynthesis I	24	XP_050039377.1;XP_050039371.1;XP_050038842.1;XP_050039214.1;XP_050038858.1;XP_050038847.1;XP_050040922.1;XP_050038844.1;XP_050038848.1;XP_050037742.1;XP_050037743.1;XP_050039376.1;XP_050038846.1;XP_050039370.1;XP_050041247.1;XP_050038845.1;XP_050038859.1;XP_050039773.1;XP_050039379.1;XP_050039378.1;XP_050038855.1;XP_050038856.1;XP_050041248.1;XP_050038843.1
Reactome: R-HSA-5654699	SHC-mediated cascade:FGFR2	1	XP_050032853.1
MetaCyc: PWY-6664	Di-myo-inositol phosphate biosynthesis	2	XP_050052036.1;XP_050052037.1
Reactome: R-HSA-9608290	Defective MUTYH substrate processing	1	XP_050049643.1
Reactome: R-HSA-444821	Relaxin receptors	3	XP_050027255.1;XP_050040115.1;XP_050026830.1
KEGG: 00052+2.7.1.6	Galactose metabolism	2	XP_050030095.1;XP_050040105.1
KEGG: 00630+3.5.1.9	Glyoxylate and dicarboxylate metabolism	11	XP_050040417.1;XP_050040577.1;XP_050035077.1;XP_050040581.1;XP_050040419.1;XP_050040580.1;XP_050040416.1;XP_050040415.1;XP_050040583.1;XP_050040584.1;XP_050040418.1
KEGG: 00790+3.5.4.16	Folate biosynthesis	3	XP_050048631.1;XP_050048632.1;XP_050048633.1
Reactome: R-HSA-389661	Glyoxylate metabolism and glycine degradation	28	XP_050027474.1;XP_050051507.1;XP_050036449.1;XP_050051506.1;XP_050026566.1;XP_050051502.1;XP_050051508.1;XP_050032248.1;XP_050042361.1;XP_050029504.1;XP_050033336.1;XP_050049590.1;XP_050025621.1;XP_050051503.1;XP_050039804.1;XP_050036844.1;XP_050045962.1;XP_050032249.1;XP_050039504.1;XP_050036446.1;XP_050036621.1;XP_050036622.1;XP_050029177.1;XP_050051504.1;XP_050036448.1;XP_050022550.1;XP_050045137.1;XP_050037114.1
Reactome: R-HSA-427589	Type II Na+/Pi cotransporters	5	XP_050033592.1;XP_050033610.1;XP_050033541.1;XP_050033591.1;XP_050033634.1
Reactome: R-HSA-196843	Vitamin B2 (riboflavin) metabolism	11	XP_050037558.1;XP_050030520.1;XP_050037560.1;XP_050042682.1;XP_050034819.1;XP_050037563.1;XP_050042683.1;XP_050044362.1;XP_050037559.1;XP_050037562.1;XP_050037561.1
Reactome: R-HSA-73776	RNA Polymerase II Promoter Escape	44	XP_050049296.1;XP_050024189.1;XP_050049297.1;XP_050035378.1;XP_050023727.1;XP_050023724.1;XP_050044010.1;XP_050031537.1;XP_050023728.1;XP_050034030.1;XP_050046123.1;XP_050037136.1;XP_050045373.1;XP_050034644.1;XP_050049295.1;XP_050049294.1;XP_050047361.1;XP_050045300.1;XP_050040671.1;XP_050031536.1;XP_050034505.1;XP_050036381.1;XP_050043147.1;XP_050023725.1;XP_050037137.1;XP_050034518.1;XP_050033368.1;XP_050023726.1;XP_050038988.1;XP_050032071.1;XP_050046063.1;XP_050023729.1;XP_050040428.1;XP_050040427.1;XP_050045372.1;XP_050046688.1;XP_050034643.1;XP_050025563.1;XP_050023730.1;XP_050034031.1;XP_050038469.1;XP_050026414.1;XP_050031535.1;XP_050026035.1
Reactome: R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	41	XP_050026756.1;XP_050045300.1;XP_050034644.1;XP_050032510.1;XP_050047361.1;XP_050049363.1;XP_050032511.1;XP_050044010.1;XP_050032514.1;XP_050048534.1;XP_050045758.1;XP_050037136.1;XP_050046123.1;XP_050023148.1;XP_050049362.1;XP_050024189.1;XP_050032509.1;XP_050026755.1;XP_050034094.1;XP_050023147.1;XP_050035378.1;XP_050032513.1;XP_050046028.1;XP_050023824.1;XP_050025563.1;XP_050034643.1;XP_050035481.1;XP_050049837.1;XP_050038469.1;XP_050039454.1;XP_050046029.1;XP_050032512.1;XP_050040427.1;XP_050040428.1;XP_050033368.1;XP_050051314.1;XP_050032515.1;XP_050032516.1;XP_050037137.1;XP_050043147.1;XP_050034093.1
Reactome: R-HSA-389357	CD28 dependent PI3K/Akt signaling	10	XP_050042304.1;XP_050048619.1;XP_050048621.1;XP_050048620.1;XP_050025348.1;XP_050041412.1;XP_050032548.1;XP_050025347.1;XP_050052242.1;XP_050052241.1
MetaCyc: PWY-6620	Guanine and guanosine salvage	5	XP_050045960.1;XP_050035831.1;XP_050046556.1;XP_050045961.1;XP_050046554.1
KEGG: 04070+2.7.8.11	Phosphatidylinositol signaling system	1	XP_050025335.1
Reactome: R-HSA-427359	SIRT1 negatively regulates rRNA expression	13	XP_050045532.1;XP_050025243.1;XP_050045530.1;XP_050036268.1;XP_050025248.1;XP_050025266.1;XP_050038213.1;XP_050028889.1;XP_050024718.1;XP_050025244.1;XP_050038199.1;XP_050045531.1;XP_050039589.1
MetaCyc: PWY-6920	6-gingerol analog biosynthesis (engineered)	2	XP_050023456.1;XP_050026060.1
MetaCyc: PWY-7838	Globo-series glycosphingolipids biosynthesis	1	XP_050023783.1
Reactome: R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	1	XP_050049365.1
KEGG: 00790+3.1.3.1	Folate biosynthesis	8	XP_050041543.1;XP_050045710.1;XP_050042681.1;XP_050042678.1;XP_050042679.1;XP_050047231.1;XP_050041544.1;XP_050041542.1
KEGG: 00534+5.1.3.17	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2	XP_050025613.1;XP_050025614.1
MetaCyc: PWY-7384	Anaerobic energy metabolism (invertebrates, mitochondrial)	11	XP_050042703.1;XP_050043005.1;XP_050042702.1;XP_050049076.1;XP_050026352.1;XP_050049718.1;XP_050042704.1;XP_050049075.1;XP_050026353.1;XP_050037417.1;XP_050034236.1
Reactome: R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	3	XP_050048534.1;XP_050035481.1;XP_050024508.1
KEGG: 00620+4.4.1.5	Pyruvate metabolism	1	XP_050036755.1
Reactome: R-HSA-1650814	Collagen biosynthesis and modifying enzymes	23	XP_050030411.1;XP_050033321.1;XP_050048008.1;XP_050025756.1;XP_050038099.1;XP_050032372.1;XP_050048009.1;XP_050052245.1;XP_050052730.1;XP_050031909.1;XP_050032373.1;XP_050023094.1;XP_050031908.1;XP_050031906.1;XP_050031911.1;XP_050051572.1;XP_050052132.1;XP_050031907.1;XP_050041690.1;XP_050024453.1;XP_050048007.1;XP_050032389.1;XP_050023095.1
KEGG: 04070+3.1.3.36	Phosphatidylinositol signaling system	2	XP_050023808.1;XP_050025862.1
KEGG: 00220+3.5.1.2	Arginine biosynthesis	1	XP_050026388.1
KEGG: 00240+3.5.4.5	Pyrimidine metabolism	2	XP_050025363.1;XP_050025364.1
KEGG: 00513+2.4.1.258	Various types of N-glycan biosynthesis	1	XP_050025367.1
MetaCyc: PWY-6361	1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3)	1	XP_050026059.1
Reactome: R-HSA-5685942	HDR through Homologous Recombination (HRR)	49	XP_050035481.1;XP_050022581.1;XP_050052687.1;XP_050051397.1;XP_050044213.1;XP_050022980.1;XP_050028323.1;XP_050038612.1;XP_050046062.1;XP_050048499.1;XP_050029342.1;XP_050045557.1;XP_050032478.1;XP_050044695.1;XP_050045274.1;XP_050040824.1;XP_050034506.1;XP_050023241.1;XP_050048786.1;XP_050046064.1;XP_050047551.1;XP_050045558.1;XP_050022606.1;XP_050042755.1;XP_050028231.1;XP_050048896.1;XP_050042972.1;XP_050050532.1;XP_050037711.1;XP_050045930.1;XP_050022594.1;XP_050022603.1;XP_050028292.1;XP_050032670.1;XP_050037414.1;XP_050025144.1;XP_050049952.1;XP_050024885.1;XP_050047604.1;XP_050029852.1;XP_050022605.1;XP_050022604.1;XP_050048534.1;XP_050022602.1;XP_050032647.1;XP_050039624.1;XP_050033903.1;XP_050041012.1;XP_050033904.1
MetaCyc: PWY-7546	Diphthamide biosynthesis II (eukaryotes)	3	XP_050048261.1;XP_050029390.1;XP_050023816.1
MetaCyc: PWY-7410	Ipsdienol biosynthesis	1	XP_050023623.1
Reactome: R-HSA-8964041	LDL remodeling	12	XP_050023334.1;XP_050042454.1;XP_050042261.1;XP_050023312.1;XP_050042240.1;XP_050023422.1;XP_050023796.1;XP_050023809.1;XP_050042262.1;XP_050042242.1;XP_050042260.1;XP_050042241.1
Reactome: R-HSA-877300	Interferon gamma signaling	46	XP_050031170.1;XP_050041002.1;XP_050050698.1;XP_050050684.1;XP_050050687.1;XP_050050681.1;XP_050050685.1;XP_050041652.1;XP_050041005.1;XP_050050696.1;XP_050031956.1;XP_050041001.1;XP_050041736.1;XP_050050697.1;XP_050050323.1;XP_050050700.1;XP_050041739.1;XP_050050686.1;XP_050050690.1;XP_050041734.1;XP_050031304.1;XP_050041737.1;XP_050050701.1;XP_050024450.1;XP_050050679.1;XP_050050324.1;XP_050050683.1;XP_050041741.1;XP_050050702.1;XP_050050699.1;XP_050050680.1;XP_050041738.1;XP_050046345.1;XP_050050694.1;XP_050050691.1;XP_050050689.1;XP_050050688.1;XP_050050692.1;XP_050031957.1;XP_050050693.1;XP_050031305.1;XP_050050682.1;XP_050041003.1;XP_050031398.1;XP_050050695.1;XP_050041740.1
MetaCyc: PWY-5871	Ubiquinol-9 biosynthesis (eukaryotic)	4	XP_050033250.1;XP_050025938.1;XP_050025937.1;XP_050040261.1
KEGG: 00072+4.1.3.4	Synthesis and degradation of ketone bodies	4	XP_050033827.1;XP_050033709.1;XP_050033707.1;XP_050033708.1
Reactome: R-HSA-5656121	Translesion synthesis by POLI	17	XP_050050532.1;XP_050042755.1;XP_050022795.1;XP_050048534.1;XP_050042972.1;XP_050027026.1;XP_050027028.1;XP_050049952.1;XP_050025144.1;XP_050027029.1;XP_050029852.1;XP_050022980.1;XP_050051397.1;XP_050052687.1;XP_050035481.1;XP_050029342.1;XP_050046062.1
MetaCyc: PWY-7721	Methyl phomopsenoate biosynthesis	1	XP_050023623.1
KEGG: 00720+4.2.1.3	Carbon fixation pathways in prokaryotes	3	XP_050032828.1;XP_050033513.1;XP_050033512.1
MetaCyc: PWY-7119	Ceramide and sphingolipid recycling and degradation (yeast)	1	XP_050048005.1
KEGG: 00230+4.6.1.2	Purine metabolism	12	XP_050039290.1;XP_050046277.1;XP_050039223.1;XP_050039234.1;XP_050040300.1;XP_050035632.1;XP_050052032.1;XP_050045386.1;XP_050040873.1;XP_050040301.1;XP_050039231.1;XP_050029992.1
MetaCyc: PWY-8012	Mupirocin biosynthesis	4	XP_050029751.1;XP_050033008.1;XP_050032773.1;XP_050033009.1
Reactome: R-HSA-432142	Platelet sensitization by LDL	21	XP_050047994.1;XP_050042261.1;XP_050025376.1;XP_050023312.1;XP_050047996.1;XP_050047995.1;XP_050023796.1;XP_050023422.1;XP_050047998.1;XP_050042262.1;XP_050042260.1;XP_050042241.1;XP_050048777.1;XP_050042454.1;XP_050023334.1;XP_050048775.1;XP_050047997.1;XP_050042240.1;XP_050023809.1;XP_050042242.1;XP_050048776.1
KEGG: 00760+2.3.1.286	Nicotinate and nicotinamide metabolism	19	XP_050051483.1;XP_050038319.1;XP_050051480.1;XP_050038321.1;XP_050048189.1;XP_050038324.1;XP_050038323.1;XP_050032595.1;XP_050038317.1;XP_050051482.1;XP_050051481.1;XP_050022773.1;XP_050036457.1;XP_050048188.1;XP_050038316.1;XP_050038315.1;XP_050038322.1;XP_050038318.1;XP_050038320.1
Reactome: R-HSA-77108	Utilization of Ketone Bodies	1	XP_050039373.1
KEGG: 00100+1.3.1.70	Steroid biosynthesis	4	XP_050045364.1;XP_050045365.1;XP_050045362.1;XP_050045363.1
KEGG: 00270+4.1.1.50	Cysteine and methionine metabolism	1	XP_050027983.1
Reactome: R-HSA-69091	Polymerase switching	18	XP_050042972.1;XP_050049531.1;XP_050041998.1;XP_050039359.1;XP_050022594.1;XP_050041997.1;XP_050041996.1;XP_050032235.1;XP_050046062.1;XP_050041999.1;XP_050032670.1;XP_050051397.1;XP_050052687.1;XP_050043962.1;XP_050041995.1;XP_050040824.1;XP_050025144.1;XP_050049952.1
KEGG: 00860+4.4.1.17	Porphyrin and chlorophyll metabolism	1	XP_050023768.1
MetaCyc: PWY-7726	(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)	10	XP_050041643.1;XP_050041635.1;XP_050045032.1;XP_050026060.1;XP_050042358.1;XP_050051194.1;XP_050041651.1;XP_050023456.1;XP_050026422.1;XP_050032010.1
Reactome: R-HSA-111471	Apoptotic factor-mediated response	2	XP_050025745.1;XP_050025746.1
KEGG: 00620+2.7.1.40	Pyruvate metabolism	3	XP_050034255.1;XP_050034253.1;XP_050034254.1
KEGG: 00260+1.1.1.1	Glycine, serine and threonine metabolism	3	XP_050052400.1;XP_050052302.1;XP_050052301.1
MetaCyc: PWY-5331	Taurine biosynthesis I	1	XP_050033399.1
Reactome: R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	40	XP_050038790.1;XP_050026954.1;XP_050027195.1;XP_050044529.1;XP_050044530.1;XP_050029408.1;XP_050025348.1;XP_050029406.1;XP_050032858.1;XP_050044488.1;XP_050029405.1;XP_050044489.1;XP_050027194.1;XP_050051460.1;XP_050032859.1;XP_050038791.1;XP_050050753.1;XP_050044525.1;XP_050040015.1;XP_050050752.1;XP_050041412.1;XP_050050757.1;XP_050046172.1;XP_050044528.1;XP_050046171.1;XP_050029407.1;XP_050026955.1;XP_050029409.1;XP_050050756.1;XP_050044532.1;XP_050042307.1;XP_050044531.1;XP_050044527.1;XP_050043540.1;XP_050025347.1;XP_050044524.1;XP_050038789.1;XP_050034639.1;XP_050050754.1;XP_050043466.1
KEGG: 00020+1.2.4.1	Citrate cycle (TCA cycle)	2	XP_050025621.1;XP_050027474.1
KEGG: 00710+2.7.2.3	Carbon fixation in photosynthetic organisms	2	XP_050038972.1;XP_050038973.1
Reactome: R-HSA-936837	Ion transport by P-type ATPases	95	XP_050037204.1;XP_050029083.1;XP_050044083.1;XP_050026494.1;XP_050052065.1;XP_050029082.1;XP_050026481.1;XP_050050679.1;XP_050022596.1;XP_050029081.1;XP_050028628.1;XP_050050700.1;XP_050050690.1;XP_050038788.1;XP_050029084.1;XP_050052064.1;XP_050040153.1;XP_050051478.1;XP_050040149.1;XP_050034674.1;XP_050050685.1;XP_050039039.1;XP_050051487.1;XP_050032730.1;XP_050032731.1;XP_050038640.1;XP_050050687.1;XP_050050698.1;XP_050040155.1;XP_050039040.1;XP_050044552.1;XP_050049102.1;XP_050026485.1;XP_050038557.1;XP_050050682.1;XP_050052063.1;XP_050026489.1;XP_050050694.1;XP_050049099.1;XP_050050689.1;XP_050026486.1;XP_050051807.1;XP_050040154.1;XP_050051808.1;XP_050040152.1;XP_050034679.1;XP_050050702.1;XP_050050680.1;XP_050040151.1;XP_050050683.1;XP_050044082.1;XP_050044085.1;XP_050026483.1;XP_050026492.1;XP_050050701.1;XP_050032729.1;XP_050044084.1;XP_050026484.1;XP_050051806.1;XP_050050686.1;XP_050038555.1;XP_050040150.1;XP_050050697.1;XP_050026493.1;XP_050050696.1;XP_050051492.1;XP_050026495.1;XP_050051472.1;XP_050034676.1;XP_050034383.1;XP_050026491.1;XP_050026487.1;XP_050050684.1;XP_050050681.1;XP_050026490.1;XP_050050695.1;XP_050026482.1;XP_050040156.1;XP_050049100.1;XP_050044553.1;XP_050029080.1;XP_050050692.1;XP_050050693.1;XP_050050688.1;XP_050037205.1;XP_050034675.1;XP_050050691.1;XP_050034680.1;XP_050034678.1;XP_050049098.1;XP_050026488.1;XP_050040148.1;XP_050044086.1;XP_050050699.1;XP_050036504.1
KEGG: 00230+3.1.3.5	Purine metabolism	1	XP_050049541.1
MetaCyc: PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation I	18	XP_050030063.1;XP_050026778.1;XP_050030061.1;XP_050030255.1;XP_050030251.1;XP_050030252.1;XP_050039041.1;XP_050039079.1;XP_050030062.1;XP_050024912.1;XP_050050027.1;XP_050026779.1;XP_050024913.1;XP_050030254.1;XP_050030253.1;XP_050024914.1;XP_050031848.1;XP_050045631.1
Reactome: R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	3	XP_050051440.1;XP_050051438.1;XP_050051439.1
KEGG: 00330+1.5.1.2	Arginine and proline metabolism	2	XP_050040888.1;XP_050039554.1
KEGG: 00770+2.7.8.7	Pantothenate and CoA biosynthesis	1	XP_050040326.1
MetaCyc: PWY-2941	L-lysine biosynthesis II	1	XP_050045137.1
KEGG: 00010+3.1.3.9	Glycolysis / Gluconeogenesis	2	XP_050036456.1;XP_050034452.1
Reactome: R-HSA-112311	Neurotransmitter clearance	90	XP_050035848.1;XP_050035553.1;XP_050024880.1;XP_050031349.1;XP_050035763.1;XP_050043179.1;XP_050035966.1;XP_050035847.1;XP_050035956.1;XP_050046803.1;XP_050024748.1;XP_050024898.1;XP_050027888.1;XP_050035217.1;XP_050035952.1;XP_050035948.1;XP_050043638.1;XP_050024746.1;XP_050034860.1;XP_050031348.1;XP_050035705.1;XP_050024723.1;XP_050035951.1;XP_050034469.1;XP_050045420.1;XP_050045695.1;XP_050031477.1;XP_050035791.1;XP_050044647.1;XP_050031482.1;XP_050024741.1;XP_050024784.1;XP_050031346.1;XP_050035762.1;XP_050035829.1;XP_050046242.1;XP_050036094.1;XP_050035967.1;XP_050035823.1;XP_050035826.1;XP_050024721.1;XP_050035958.1;XP_050035955.1;XP_050043177.1;XP_050041992.1;XP_050034967.1;XP_050024745.1;XP_050024724.1;XP_050046804.1;XP_050031480.1;XP_050041659.1;XP_050040139.1;XP_050034468.1;XP_050035314.1;XP_050035954.1;XP_050043180.1;XP_050024743.1;XP_050046806.1;XP_050035552.1;XP_050024747.1;XP_050024879.1;XP_050023509.1;XP_050034533.1;XP_050025028.1;XP_050024504.1;XP_050029239.1;XP_050031476.1;XP_050024744.1;XP_050024742.1;XP_050034984.1;XP_050035403.1;XP_050034966.1;XP_050022871.1;XP_050024720.1;XP_050034433.1;XP_050031483.1;XP_050035422.1;XP_050034983.1;XP_050034396.1;XP_050035554.1;XP_050025319.1;XP_050031347.1;XP_050035845.1;XP_050034532.1;XP_050031481.1;XP_050046807.1;XP_050034395.1;XP_050034768.1;XP_050024865.1;XP_050031478.1
MetaCyc: PWY-6964	Ammonia assimilation cycle II	11	XP_050038621.1;XP_050038620.1;XP_050038619.1;XP_050038622.1;XP_050028873.1;XP_050033588.1;XP_050051950.1;XP_050028874.1;XP_050038618.1;XP_050028876.1;XP_050033589.1
KEGG: 00513+2.4.1.131	Various types of N-glycan biosynthesis	2	XP_050039004.1;XP_050039005.1
MetaCyc: PWY-7654	(8E,10E)-dodeca-8,10-dienol biosynthesis	6	XP_050041643.1;XP_050032010.1;XP_050026422.1;XP_050041651.1;XP_050051194.1;XP_050041635.1
Reactome: R-HSA-425986	Sodium/Proton exchangers	25	XP_050025590.1;XP_050033611.1;XP_050033612.1;XP_050035685.1;XP_050046729.1;XP_050034169.1;XP_050037063.1;XP_050033594.1;XP_050037728.1;XP_050051338.1;XP_050039483.1;XP_050051251.1;XP_050046350.1;XP_050025591.1;XP_050037064.1;XP_050025587.1;XP_050033593.1;XP_050044254.1;XP_050025592.1;XP_050040626.1;XP_050025588.1;XP_050025589.1;XP_050050276.1;XP_050033633.1;XP_050047633.1
Reactome: R-HSA-948021	Transport to the Golgi and subsequent modification	1	XP_050035507.1
Reactome: R-HSA-2206308	MPS IV - Morquio syndrome B	1	XP_050042169.1
MetaCyc: PWY-7115	C4 photosynthetic carbon assimilation cycle, NAD-ME type	22	XP_050022895.1;XP_050049114.1;XP_050037925.1;XP_050045192.1;XP_050035735.1;XP_050037172.1;XP_050037165.1;XP_050037926.1;XP_050026413.1;XP_050037169.1;XP_050037168.1;XP_050049202.1;XP_050022906.1;XP_050037167.1;XP_050038033.1;XP_050037166.1;XP_050022903.1;XP_050037164.1;XP_050049115.1;XP_050025446.1;XP_050049116.1;XP_050049203.1
MetaCyc: PWY-7856	Heme a biosynthesis	1	XP_050032875.1
Reactome: R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	25	XP_050023728.1;XP_050028332.1;XP_050023726.1;XP_050046123.1;XP_050046063.1;XP_050023729.1;XP_050043147.1;XP_050044202.1;XP_050023727.1;XP_050023725.1;XP_050023724.1;XP_050028333.1;XP_050024189.1;XP_050028335.1;XP_050038469.1;XP_050028337.1;XP_050044204.1;XP_050026202.1;XP_050034643.1;XP_050023730.1;XP_050028336.1;XP_050044203.1;XP_050045189.1;XP_050028334.1;XP_050034644.1
Reactome: R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	1	XP_050032853.1
MetaCyc: PWY-1361	Benzoyl-coa degradation I (aerobic)	6	XP_050041643.1;XP_050026422.1;XP_050032010.1;XP_050051194.1;XP_050041635.1;XP_050041651.1
Reactome: R-HSA-2142753	Arachidonic acid metabolism	14	XP_050040996.1;XP_050028060.1;XP_050040991.1;XP_050028879.1;XP_050028158.1;XP_050027048.1;XP_050040995.1;XP_050040993.1;XP_050040999.1;XP_050040799.1;XP_050040994.1;XP_050040998.1;XP_050040997.1;XP_050028159.1
Reactome: R-HSA-71336	Pentose phosphate pathway	10	XP_050033946.1;XP_050051191.1;XP_050047377.1;XP_050048527.1;XP_050049839.1;XP_050051182.1;XP_050048528.1;XP_050048410.1;XP_050028579.1;XP_050049438.1
Reactome: R-HSA-6804754	Regulation of TP53 Expression	3	XP_050027639.1;XP_050027638.1;XP_050027640.1
KEGG: 00520+4.2.1.47	Amino sugar and nucleotide sugar metabolism	3	XP_050047838.1;XP_050047837.1;XP_050047839.1
KEGG: 00561+2.3.1.15	Glycerolipid metabolism	3	XP_050047027.1;XP_050037775.1;XP_050047026.1
Reactome: R-HSA-381038	XBP1(S) activates chaperone genes	7	XP_050043492.1;XP_050049827.1;XP_050049353.1;XP_050049826.1;XP_050036253.1;XP_050034409.1;XP_050052816.1
Reactome: R-HSA-68962	Activation of the pre-replicative complex	40	XP_050041999.1;XP_050026673.1;XP_050038751.1;XP_050040739.1;XP_050050719.1;XP_050035183.1;XP_050029852.1;XP_050045792.1;XP_050039359.1;XP_050041998.1;XP_050031078.1;XP_050027478.1;XP_050043901.1;XP_050049556.1;XP_050033934.1;XP_050041996.1;XP_050049555.1;XP_050041997.1;XP_050041990.1;XP_050023646.1;XP_050044213.1;XP_050022980.1;XP_050041989.1;XP_050029342.1;XP_050049554.1;XP_050036167.1;XP_050034506.1;XP_050041995.1;XP_050043962.1;XP_050049497.1;XP_050031079.1;XP_050042755.1;XP_050028231.1;XP_050049531.1;XP_050033374.1;XP_050050532.1;XP_050032235.1;XP_050046049.1;XP_050043900.1;XP_050049723.1
MetaCyc: PWY-5109	Fermentation to 2-methylbutanoate	6	XP_050032010.1;XP_050026422.1;XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050041643.1
KEGG: 00240+2.7.1.48	Pyrimidine metabolism	6	XP_050031819.1;XP_050031820.1;XP_050031818.1;XP_050024419.1;XP_050024420.1;XP_050031817.1
MetaCyc: PWY-6537	4-aminobutanoate degradation II	1	XP_050041758.1
Reactome: R-HSA-4570571	Defective RFT1 causes RFT1-CDG (CDG-1n)	1	XP_050047336.1
Reactome: R-HSA-426117	Cation-coupled Chloride cotransporters	21	XP_050044997.1;XP_050050302.1;XP_050045002.1;XP_050038207.1;XP_050045001.1;XP_050050304.1;XP_050038216.1;XP_050045000.1;XP_050051515.1;XP_050051505.1;XP_050050306.1;XP_050051535.1;XP_050045003.1;XP_050038226.1;XP_050045059.1;XP_050051524.1;XP_050044998.1;XP_050045004.1;XP_050044999.1;XP_050044995.1;XP_050050303.1
KEGG: 00630+1.1.1.37	Glyoxylate and dicarboxylate metabolism	11	XP_050037166.1;XP_050035735.1;XP_050037172.1;XP_050037167.1;XP_050037925.1;XP_050045192.1;XP_050037168.1;XP_050037164.1;XP_050037165.1;XP_050037926.1;XP_050037169.1
Reactome: R-HSA-425381	Bicarbonate transporters	19	XP_050045548.1;XP_050049712.1;XP_050045546.1;XP_050045541.1;XP_050049707.1;XP_050049714.1;XP_050049710.1;XP_050049711.1;XP_050045544.1;XP_050049709.1;XP_050049715.1;XP_050045545.1;XP_050023644.1;XP_050045547.1;XP_050045540.1;XP_050023190.1;XP_050045542.1;XP_050045543.1;XP_050049708.1
KEGG: 00270+2.5.1.22	Cysteine and methionine metabolism	2	XP_050027527.1;XP_050027526.1
KEGG: 00480+1.8.1.7	Glutathione metabolism	1	XP_050037110.1
Reactome: R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	1	XP_050023668.1
KEGG: 00071+4.2.1.17+1.1.1.35	Fatty acid degradation	6	XP_050041643.1;XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1
KEGG: 00520+2.7.1.6	Amino sugar and nucleotide sugar metabolism	2	XP_050030095.1;XP_050040105.1
Reactome: R-HSA-1268020	Mitochondrial protein import	47	XP_050025909.1;XP_050027700.1;XP_050049907.1;XP_050038350.1;XP_050045958.1;XP_050043005.1;XP_050025779.1;XP_050042655.1;XP_050030100.1;XP_050051211.1;XP_050030678.1;XP_050049909.1;XP_050026606.1;XP_050022491.1;XP_050043228.1;XP_050045507.1;XP_050048413.1;XP_050049908.1;XP_050049449.1;XP_050049459.1;XP_050048147.1;XP_050040022.1;XP_050031873.1;XP_050040553.1;XP_050032828.1;XP_050042691.1;XP_050033466.1;XP_050047553.1;XP_050029581.1;XP_050022490.1;XP_050045508.1;XP_050036353.1;XP_050036384.1;XP_050043887.1;XP_050022551.1;XP_050031579.1;XP_050038513.1;XP_050036354.1;XP_050040261.1;XP_050033447.1;XP_050030676.1;XP_050022543.1;XP_050030677.1;XP_050042654.1;XP_050027699.1;XP_050038351.1;XP_050047208.1
Reactome: R-HSA-1169408	ISG15 antiviral mechanism	51	XP_050035933.1;XP_050029515.1;XP_050036430.1;XP_050051098.1;XP_050023474.1;XP_050038863.1;XP_050026370.1;XP_050030942.1;XP_050038895.1;XP_050026369.1;XP_050042391.1;XP_050051080.1;XP_050030652.1;XP_050030506.1;XP_050038969.1;XP_050030507.1;XP_050038966.1;XP_050051087.1;XP_050025064.1;XP_050039240.1;XP_050036827.1;XP_050038967.1;XP_050044454.1;XP_050035481.1;XP_050051067.1;XP_050026400.1;XP_050038865.1;XP_050035770.1;XP_050051109.1;XP_050024518.1;XP_050038864.1;XP_050042392.1;XP_050023475.1;XP_050048534.1;XP_050044008.1;XP_050023476.1;XP_050038866.1;XP_050038968.1;XP_050026399.1;XP_050030653.1;XP_050049377.1;XP_050026810.1;XP_050051073.1;XP_050033146.1;XP_050027366.1;XP_050046156.1;XP_050026809.1;XP_050035932.1;XP_050023718.1;XP_050029516.1;XP_050038862.1
MetaCyc: PWY-6969	TCA cycle V (2-oxoglutarate:ferredoxin oxidoreductase)	30	XP_050037396.1;XP_050035735.1;XP_050042703.1;XP_050037172.1;XP_050026123.1;XP_050045192.1;XP_050037925.1;XP_050049076.1;XP_050033718.1;XP_050038590.1;XP_050043069.1;XP_050037168.1;XP_050049075.1;XP_050042704.1;XP_050037007.1;XP_050026352.1;XP_050037165.1;XP_050033843.1;XP_050037926.1;XP_050037169.1;XP_050037166.1;XP_050042702.1;XP_050041863.1;XP_050043005.1;XP_050037167.1;XP_050033719.1;XP_050037417.1;XP_050026353.1;XP_050043076.1;XP_050037164.1
MetaCyc: PWY-6981	Chitin biosynthesis	4	XP_050044850.1;XP_050050068.1;XP_050044851.1;XP_050044852.1
Reactome: R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	58	XP_050041503.1;XP_050048457.1;XP_050028975.1;XP_050040211.1;XP_050037610.1;XP_050028646.1;XP_050048462.1;XP_050048456.1;XP_050029751.1;XP_050028850.1;XP_050048465.1;XP_050038286.1;XP_050033009.1;XP_050030084.1;XP_050040210.1;XP_050025112.1;XP_050048460.1;XP_050048459.1;XP_050032996.1;XP_050027845.1;XP_050040209.1;XP_050042079.1;XP_050033008.1;XP_050040212.1;XP_050048466.1;XP_050041502.1;XP_050030035.1;XP_050048468.1;XP_050032997.1;XP_050031490.1;XP_050042082.1;XP_050030054.1;XP_050040214.1;XP_050038921.1;XP_050030053.1;XP_050030085.1;XP_050030055.1;XP_050048463.1;XP_050032998.1;XP_050033002.1;XP_050030138.1;XP_050031529.1;XP_050032773.1;XP_050048467.1;XP_050042083.1;XP_050048461.1;XP_050044825.1;XP_050051831.1;XP_050048458.1;XP_050051929.1;XP_050042081.1;XP_050043924.1;XP_050040213.1;XP_050031330.1;XP_050042080.1;XP_050051832.1;XP_050024679.1;XP_050025114.1
MetaCyc: PWY-1042	Glycolysis IV (plant cytosol)	16	XP_050038973.1;XP_050040643.1;XP_050025561.1;XP_050041668.1;XP_050038972.1;XP_050034254.1;XP_050041662.1;XP_050040641.1;XP_050040645.1;XP_050034255.1;XP_050045451.1;XP_050025560.1;XP_050034253.1;XP_050044976.1;XP_050040644.1;XP_050051894.1
Reactome: R-HSA-162791	Attachment of GPI anchor to uPAR	8	XP_050051490.1;XP_050051489.1;XP_050029988.1;XP_050049984.1;XP_050047473.1;XP_050049600.1;XP_050040191.1;XP_050022952.1
KEGG: 00020+6.2.1.4	Citrate cycle (TCA cycle)	1	XP_050026352.1
MetaCyc: PWY-6802	Salidroside biosynthesis	3	XP_050052302.1;XP_050052400.1;XP_050052301.1
Reactome: R-HSA-428930	Thromboxane signalling through TP receptor	7	XP_050044424.1;XP_050025623.1;XP_050042122.1;XP_050023177.1;XP_050025622.1;XP_050035408.1;XP_050035407.1
MetaCyc: PWY-5097	L-lysine biosynthesis VI	1	XP_050045137.1
MetaCyc: PWY-6433	Hydroxylated fatty acid biosynthesis (plants)	78	XP_050039712.1;XP_050027469.1;XP_050039087.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039088.1;XP_050039707.1;XP_050039084.1;XP_050039710.1;XP_050039709.1;XP_050039706.1;XP_050039770.1;XP_050039711.1;XP_050026888.1;XP_050028129.1;XP_050051763.1;XP_050026205.1;XP_050047366.1;XP_050039085.1;XP_050039364.1;XP_050039772.1;XP_050039365.1;XP_050027496.1;XP_050039126.1;XP_050039699.1;XP_050039016.1;XP_050039769.1;XP_050027470.1;XP_050043402.1;XP_050039080.1;XP_050051765.1;XP_050051764.1;XP_050027502.1;XP_050036636.1;XP_050039700.1;XP_050039263.1;XP_050051766.1;XP_050025917.1;XP_050042358.1;XP_050036103.1;XP_050039189.1;XP_050045032.1;XP_050039708.1;XP_050042219.1;XP_050033894.1;XP_050041128.1;XP_050033799.1;XP_050039722.1;XP_050039017.1;XP_050039545.1;XP_050039083.1;XP_050026425.1;XP_050039555.1;XP_050039698.1;XP_050027024.1;XP_050039366.1;XP_050039081.1;XP_050026935.1;XP_050039082.1;XP_050025916.1;XP_050039191.1;XP_050039183.1;XP_050048344.1;XP_050039702.1;XP_050033896.1;XP_050039701.1;XP_050036658.1;XP_050039086.1;XP_050036659.1;XP_050039015.1;XP_050041191.1;XP_050039426.1;XP_050039703.1;XP_050039704.1;XP_050039186.1;XP_050027497.1;XP_050026887.1
KEGG: 00514+2.4.1.122	Other types of O-glycan biosynthesis	3	XP_050042668.1;XP_050042669.1;XP_050042670.1
Reactome: R-HSA-2514853	Condensation of Prometaphase Chromosomes	7	XP_050025414.1;XP_050023899.1;XP_050051200.1;XP_050047030.1;XP_050047031.1;XP_050035075.1;XP_050027734.1
Reactome: R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	1	XP_050044595.1
MetaCyc: PWY-6370	Ascorbate recycling (cytosolic)	2	XP_050026762.1;XP_050027833.1
Reactome: R-HSA-390696	Adrenoceptors	3	XP_050049086.1;XP_050049471.1;XP_050049472.1
Reactome: R-HSA-75102	C6 deamination of adenosine	1	XP_050023331.1
KEGG: 00600+3.1.4.12	Sphingolipid metabolism	1	XP_050028497.1
Reactome: R-HSA-9029558	NR1H2 & NR1H3 regulate gene expression linked to lipogenesis	26	XP_050033009.1;XP_050038286.1;XP_050030084.1;XP_050038921.1;XP_050030054.1;XP_050030085.1;XP_050025112.1;XP_050030055.1;XP_050030053.1;XP_050028975.1;XP_050037610.1;XP_050041503.1;XP_050032997.1;XP_050028646.1;XP_050029751.1;XP_050033008.1;XP_050051929.1;XP_050041502.1;XP_050030035.1;XP_050025114.1;XP_050032996.1;XP_050033002.1;XP_050030138.1;XP_050027845.1;XP_050032773.1;XP_050032998.1
MetaCyc: PWY-241	C4 photosynthetic carbon assimilation cycle, NADP-ME type	8	XP_050038033.1;XP_050049114.1;XP_050022895.1;XP_050022906.1;XP_050022903.1;XP_050025446.1;XP_050049115.1;XP_050049116.1
KEGG: 00903+4.2.1.17	Limonene and pinene degradation	6	XP_050041643.1;XP_050041635.1;XP_050051194.1;XP_050041651.1;XP_050026422.1;XP_050032010.1
KEGG: 00281+4.1.3.4	Geraniol degradation	4	XP_050033707.1;XP_050033709.1;XP_050033827.1;XP_050033708.1
Reactome: R-HSA-975155	MyD88 dependent cascade initiated on endosome	1	XP_050024508.1
Reactome: R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	8	XP_050047998.1;XP_050047997.1;XP_050047996.1;XP_050047995.1;XP_050047994.1;XP_050048775.1;XP_050048777.1;XP_050048776.1
Reactome: R-HSA-917977	Transferrin endocytosis and recycling	26	XP_050045459.1;XP_050032732.1;XP_050042150.1;XP_050034125.1;XP_050044696.1;XP_050032728.1;XP_050034072.1;XP_050045457.1;XP_050049787.1;XP_050034127.1;XP_050048793.1;XP_050037617.1;XP_050034615.1;XP_050044697.1;XP_050037618.1;XP_050049937.1;XP_050038826.1;XP_050050217.1;XP_050049057.1;XP_050049586.1;XP_050034126.1;XP_050045458.1;XP_050044699.1;XP_050041324.1;XP_050023172.1;XP_050041945.1
KEGG: 00510+2.7.8.15	N-Glycan biosynthesis	1	XP_050034973.1
KEGG: 00240+2.1.1.45	Pyrimidine metabolism	2	XP_050027283.1;XP_050027282.1
Reactome: R-HSA-2408522	Selenoamino acid metabolism	12	XP_050038756.1;XP_050051668.1;XP_050034442.1;XP_050051666.1;XP_050034251.1;XP_050028841.1;XP_050031115.1;XP_050031591.1;XP_050031592.1;XP_050029927.1;XP_050031025.1;XP_050026033.1
MetaCyc: PWY-7901	Glucosinolate biosynthesis from tyrosine	6	XP_050052715.1;XP_050052716.1;XP_050052719.1;XP_050052721.1;XP_050050544.1;XP_050050545.1
MetaCyc: PWY-7396	Butanol and isobutanol biosynthesis (engineered)	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
Reactome: R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	29	XP_050023628.1;XP_050027801.1;XP_050037416.1;XP_050048534.1;XP_050049355.1;XP_050034595.1;XP_050034653.1;XP_050037415.1;XP_050035872.1;XP_050049340.1;XP_050031262.1;XP_050043659.1;XP_050026551.1;XP_050031594.1;XP_050026914.1;XP_050036502.1;XP_050043649.1;XP_050035481.1;XP_050036365.1;XP_050048137.1;XP_050034209.1;XP_050048132.1;XP_050026843.1;XP_050047955.1;XP_050047965.1;XP_050049349.1;XP_050046640.1;XP_050048893.1;XP_050049030.1
Reactome: R-HSA-8853383	Lysosomal oligosaccharide catabolism	15	XP_050034457.1;XP_050052207.1;XP_050035730.1;XP_050052206.1;XP_050034458.1;XP_050033519.1;XP_050030714.1;XP_050052209.1;XP_050052205.1;XP_050035732.1;XP_050034460.1;XP_050028838.1;XP_050052177.1;XP_050034459.1;XP_050035709.1
KEGG: 00760+2.4.2.1	Nicotinate and nicotinamide metabolism	3	XP_050035831.1;XP_050046554.1;XP_050046556.1
Reactome: R-HSA-5654693	FRS-mediated FGFR1 signaling	2	XP_050032853.1;XP_050048507.1
MetaCyc: PWY-4661	1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)	4	XP_050026059.1;XP_050048806.1;XP_050052037.1;XP_050052036.1
Reactome: R-HSA-196807	Nicotinate metabolism	36	XP_050046833.1;XP_050050861.1;XP_050030478.1;XP_050050867.1;XP_050050862.1;XP_050030475.1;XP_050025548.1;XP_050042247.1;XP_050050865.1;XP_050032111.1;XP_050050866.1;XP_050030473.1;XP_050050868.1;XP_050045750.1;XP_050050864.1;XP_050042265.1;XP_050045689.1;XP_050025547.1;XP_050028326.1;XP_050042256.1;XP_050023815.1;XP_050030472.1;XP_050025549.1;XP_050045146.1;XP_050045147.1;XP_050028296.1;XP_050045148.1;XP_050045748.1;XP_050042238.1;XP_050039684.1;XP_050046832.1;XP_050028325.1;XP_050050863.1;XP_050045749.1;XP_050025550.1;XP_050030474.1
Reactome: R-HSA-3295583	TRP channels	17	XP_050033759.1;XP_050041146.1;XP_050038754.1;XP_050026579.1;XP_050049902.1;XP_050035761.1;XP_050049901.1;XP_050038949.1;XP_050041184.1;XP_050038950.1;XP_050038883.1;XP_050037920.1;XP_050044937.1;XP_050039259.1;XP_050028895.1;XP_050026580.1;XP_050033760.1
Reactome: R-HSA-418555	G alpha (s) signalling events	20	XP_050025623.1;XP_050045741.1;XP_050045740.1;XP_050040115.1;XP_050045225.1;XP_050042923.1;XP_050042920.1;XP_050027255.1;XP_050043344.1;XP_050043190.1;XP_050045739.1;XP_050045224.1;XP_050051299.1;XP_050023177.1;XP_050044424.1;XP_050041325.1;XP_050026830.1;XP_050040744.1;XP_050042922.1;XP_050025622.1
Reactome: R-HSA-5673000	RAF activation	33	XP_050050699.1;XP_050050702.1;XP_050050680.1;XP_050050694.1;XP_050050691.1;XP_050050689.1;XP_050050688.1;XP_050047996.1;XP_050047994.1;XP_050050692.1;XP_050050693.1;XP_050050682.1;XP_050039818.1;XP_050050695.1;XP_050047997.1;XP_050050684.1;XP_050048775.1;XP_050050687.1;XP_050050681.1;XP_050050698.1;XP_050050685.1;XP_050050696.1;XP_050050697.1;XP_050048776.1;XP_050047995.1;XP_050050686.1;XP_050050690.1;XP_050050700.1;XP_050050701.1;XP_050047998.1;XP_050050679.1;XP_050050683.1;XP_050048777.1
MetaCyc: PWY-6611	Adenine and adenosine salvage V	3	XP_050046554.1;XP_050046556.1;XP_050035831.1
KEGG: 00020+1.3.5.1	Citrate cycle (TCA cycle)	4	XP_050033719.1;XP_050038590.1;XP_050033718.1;XP_050033843.1
Reactome: R-HSA-3928663	EPHA-mediated growth cone collapse	1	XP_050032102.1
KEGG: 00982+2.5.1.18	Drug metabolism - cytochrome P450	13	XP_050047704.1;XP_050048256.1;XP_050047905.1;XP_050048233.1;XP_050031855.1;XP_050047698.1;XP_050026762.1;XP_050047714.1;XP_050027833.1;XP_050048247.1;XP_050031872.1;XP_050048267.1;XP_050048220.1
Reactome: R-HSA-389513	CTLA4 inhibitory signaling	11	XP_050047998.1;XP_050048619.1;XP_050048621.1;XP_050047995.1;XP_050047996.1;XP_050047997.1;XP_050048620.1;XP_050048775.1;XP_050047994.1;XP_050048777.1;XP_050048776.1
KEGG: 00983+2.4.2.3	Drug metabolism - other enzymes	3	XP_050035831.1;XP_050032573.1;XP_050036028.1
Reactome: R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	10	XP_050037314.1;XP_050037315.1;XP_050037312.1;XP_050037310.1;XP_050050758.1;XP_050037311.1;XP_050048534.1;XP_050035481.1;XP_050037313.1;XP_050037316.1
Reactome: R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	33	XP_050025244.1;XP_050040449.1;XP_050028323.1;XP_050047551.1;XP_050044695.1;XP_050048803.1;XP_050032478.1;XP_050036676.1;XP_050042599.1;XP_050024165.1;XP_050022606.1;XP_050036675.1;XP_050038213.1;XP_050025248.1;XP_050038964.1;XP_050039031.1;XP_050023852.1;XP_050028292.1;XP_050022603.1;XP_050037414.1;XP_050022605.1;XP_050022604.1;XP_050039027.1;XP_050033021.1;XP_050025266.1;XP_050034302.1;XP_050038199.1;XP_050038963.1;XP_050036207.1;XP_050022602.1;XP_050036268.1;XP_050038965.1;XP_050025243.1
KEGG: 00562+2.7.1.137	Inositol phosphate metabolism	1	XP_050045005.1
Reactome: R-HSA-163282	Mitochondrial transcription initiation	4	XP_050038335.1;XP_050038334.1;XP_050038333.1;XP_050024400.1
Reactome: R-HSA-5625970	RHO GTPases activate KTN1	8	XP_050038149.1;XP_050038147.1;XP_050038144.1;XP_050025374.1;XP_050025375.1;XP_050038146.1;XP_050038148.1;XP_050038145.1
Reactome: R-HSA-1445148	Translocation of SLC2A4 (GLUT4) to the plasma membrane	56	XP_050048921.1;XP_050031593.1;XP_050039381.1;XP_050051981.1;XP_050047029.1;XP_050049759.1;XP_050024841.1;XP_050030681.1;XP_050049761.1;XP_050052420.1;XP_050049762.1;XP_050046646.1;XP_050040055.1;XP_050046734.1;XP_050044530.1;XP_050044529.1;XP_050049358.1;XP_050049757.1;XP_050051357.1;XP_050048971.1;XP_050039852.1;XP_050044525.1;XP_050025568.1;XP_050051846.1;XP_050039851.1;XP_050049758.1;XP_050051980.1;XP_050033750.1;XP_050046735.1;XP_050029698.1;XP_050047338.1;XP_050044528.1;XP_050023282.1;XP_050049755.1;XP_050033751.1;XP_050039850.1;XP_050048431.1;XP_050052055.1;XP_050051355.1;XP_050049357.1;XP_050048972.1;XP_050033752.1;XP_050040056.1;XP_050044532.1;XP_050051356.1;XP_050024840.1;XP_050044524.1;XP_050039380.1;XP_050048155.1;XP_050044531.1;XP_050048157.1;XP_050044527.1;XP_050043181.1;XP_050034639.1;XP_050029699.1;XP_050048158.1
MetaCyc: PWY-7778	2-methylpropene degradation	6	XP_050041635.1;XP_050051194.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
Reactome: R-HSA-5358493	Synthesis of diphthamide-EEF2	4	XP_050030162.1;XP_050029390.1;XP_050048261.1;XP_050023816.1
MetaCyc: PWY-6352	3-phosphoinositide biosynthesis	5	XP_050045005.1;XP_050025335.1;XP_050028399.1;XP_050052756.1;XP_050049284.1
Reactome: R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	2	XP_050036188.1;XP_050036189.1
Reactome: R-HSA-3371511	HSF1 activation	6	XP_050022980.1;XP_050042755.1;XP_050050532.1;XP_050029852.1;XP_050023192.1;XP_050029342.1
MetaCyc: PWY-7920	Complex N-linked glycan biosynthesis (plants)	3	XP_050030755.1;XP_050036462.1;XP_050030754.1
Reactome: R-HSA-373752	Netrin-1 signaling	6	XP_050034240.1;XP_050034242.1;XP_050044814.1;XP_050034239.1;XP_050044813.1;XP_050034241.1
KEGG: 00330+3.5.3.1	Arginine and proline metabolism	2	XP_050036729.1;XP_050036726.1
KEGG: 04926+2.7.11.1	Relaxin signaling pathway	141	XP_050048905.1;XP_050026053.1;XP_050031206.1;XP_050026954.1;XP_050050723.1;XP_050037625.1;XP_050031200.1;XP_050031198.1;XP_050036224.1;XP_050051647.1;XP_050034960.1;XP_050042989.1;XP_050037630.1;XP_050041922.1;XP_050036226.1;XP_050048619.1;XP_050029303.1;XP_050028233.1;XP_050036225.1;XP_050032708.1;XP_050044446.1;XP_050026955.1;XP_050026027.1;XP_050036237.1;XP_050036232.1;XP_050043308.1;XP_050031194.1;XP_050034932.1;XP_050027320.1;XP_050043849.1;XP_050050310.1;XP_050032548.1;XP_050037623.1;XP_050050734.1;XP_050041921.1;XP_050028166.1;XP_050048621.1;XP_050036131.1;XP_050051059.1;XP_050037629.1;XP_050050709.1;XP_050045593.1;XP_050028292.1;XP_050031207.1;XP_050043130.1;XP_050036231.1;XP_050026976.1;XP_050032586.1;XP_050036239.1;XP_050048906.1;XP_050026555.1;XP_050036230.1;XP_050037627.1;XP_050026695.1;XP_050022875.1;XP_050032707.1;XP_050043304.1;XP_050042307.1;XP_050049192.1;XP_050037622.1;XP_050031209.1;XP_050050715.1;XP_050029160.1;XP_050026977.1;XP_050043303.1;XP_050043305.1;XP_050031205.1;XP_050031203.1;XP_050041923.1;XP_050025348.1;XP_050042990.1;XP_050049350.1;XP_050031202.1;XP_050028165.1;XP_050031197.1;XP_050037624.1;XP_050036238.1;XP_050042988.1;XP_050032102.1;XP_050043302.1;XP_050032928.1;XP_050033844.1;XP_050023932.1;XP_050050041.1;XP_050036228.1;XP_050032927.1;XP_050034961.1;XP_050043306.1;XP_050026974.1;XP_050036240.1;XP_050044807.1;XP_050031195.1;XP_050030586.1;XP_050025347.1;XP_050043301.1;XP_050036236.1;XP_050048620.1;XP_050031201.1;XP_050035999.1;XP_050036129.1;XP_050037621.1;XP_050031199.1;XP_050041948.1;XP_050036233.1;XP_050031204.1;XP_050046724.1;XP_050045265.1;XP_050026975.1;XP_050035462.1;XP_050036142.1;XP_050031196.1;XP_050043307.1;XP_050042629.1;XP_050037631.1;XP_050036227.1;XP_050049191.1;XP_050033720.1;XP_050033021.1;XP_050036235.1;XP_050036234.1;XP_050029381.1;XP_050037628.1;XP_050036613.1;XP_050036223.1;XP_050034829.1;XP_050034828.1;XP_050026054.1;XP_050044080.1;XP_050028687.1;XP_050036241.1;XP_050043129.1;XP_050043309.1;XP_050036229.1;XP_050036130.1;XP_050050042.1;XP_050045266.1;XP_050041924.1;XP_050039865.1;XP_050028323.1;XP_050031208.1;XP_050037626.1
KEGG: 00260+1.4.4.2	Glycine, serine and threonine metabolism	1	XP_050023416.1
MetaCyc: PWY-7036	Very long chain fatty acid biosynthesis II	78	XP_050039015.1;XP_050041191.1;XP_050039426.1;XP_050036658.1;XP_050039701.1;XP_050036659.1;XP_050039086.1;XP_050027497.1;XP_050026887.1;XP_050039703.1;XP_050039704.1;XP_050039186.1;XP_050026935.1;XP_050039082.1;XP_050039081.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050025916.1;XP_050039191.1;XP_050039183.1;XP_050039017.1;XP_050039545.1;XP_050033894.1;XP_050041128.1;XP_050033799.1;XP_050039722.1;XP_050039698.1;XP_050027024.1;XP_050039366.1;XP_050039083.1;XP_050026425.1;XP_050039555.1;XP_050039700.1;XP_050051764.1;XP_050027502.1;XP_050036636.1;XP_050042219.1;XP_050039263.1;XP_050025917.1;XP_050051766.1;XP_050042358.1;XP_050036103.1;XP_050045032.1;XP_050039708.1;XP_050039189.1;XP_050039016.1;XP_050051765.1;XP_050027470.1;XP_050039769.1;XP_050039080.1;XP_050043402.1;XP_050039364.1;XP_050047366.1;XP_050039085.1;XP_050027496.1;XP_050039126.1;XP_050039699.1;XP_050039772.1;XP_050039365.1;XP_050026888.1;XP_050039710.1;XP_050039706.1;XP_050039709.1;XP_050039770.1;XP_050039711.1;XP_050026205.1;XP_050028129.1;XP_050051763.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039712.1;XP_050027469.1;XP_050039087.1;XP_050039084.1;XP_050039088.1;XP_050039707.1
KEGG: 00511+3.2.1.96	Other glycan degradation	8	XP_050028519.1;XP_050032662.1;XP_050032649.1;XP_050032661.1;XP_050032650.1;XP_050032679.1;XP_050032648.1;XP_050032988.1
KEGG: 00250+6.3.5.5	Alanine, aspartate and glutamate metabolism	1	XP_050032255.1
KEGG: 00511+3.2.1.25	Other glycan degradation	7	XP_050034460.1;XP_050035732.1;XP_050034458.1;XP_050034459.1;XP_050035709.1;XP_050034457.1;XP_050035730.1
Reactome: R-HSA-3249367	STAT6-mediated induction of chemokines	3	XP_050028237.1;XP_050028236.1;XP_050028235.1
MetaCyc: PWY-4302	Aerobic respiration III (alternative oxidase pathway)	6	XP_050033843.1;YP_010283869.1;XP_050033718.1;YP_010283878.1;XP_050038590.1;XP_050033719.1
KEGG: 00260+3.1.3.3	Glycine, serine and threonine metabolism	1	XP_050025381.1
KEGG: 00790+6.3.2.17	Folate biosynthesis	1	XP_050051161.1
KEGG: 00620+1.2.4.1	Pyruvate metabolism	2	XP_050027474.1;XP_050025621.1
KEGG: 00270+2.1.1.37	Cysteine and methionine metabolism	9	XP_050042802.1;XP_050022710.1;XP_050043472.1;XP_050043471.1;XP_050043468.1;XP_050030757.1;XP_050043470.1;XP_050036607.1;XP_050043469.1
Reactome: R-HSA-9617324	Negative regulation of NMDA receptor-mediated neuronal transmission	28	XP_050050695.1;XP_050048381.1;XP_050050683.1;XP_050050682.1;XP_050050701.1;XP_050050692.1;XP_050050679.1;XP_050050693.1;XP_050050690.1;XP_050050700.1;XP_050050686.1;XP_050050688.1;XP_050050691.1;XP_050050694.1;XP_050050697.1;XP_050050689.1;XP_050048382.1;XP_050050696.1;XP_050048384.1;XP_050050685.1;XP_050048383.1;XP_050050702.1;XP_050050699.1;XP_050050698.1;XP_050050680.1;XP_050050681.1;XP_050050684.1;XP_050050687.1
MetaCyc: PWY-6599	Guanine and guanosine salvage II	2	XP_050045961.1;XP_050045960.1
Reactome: R-HSA-1236974	ER-Phagosome pathway	56	XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050052231.1;XP_050044470.1;XP_050024508.1;XP_050050645.1;XP_050029802.1;XP_050033331.1;XP_050036567.1;XP_050035472.1;XP_050051964.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050027118.1;XP_050045264.1;XP_050031786.1;XP_050040198.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050042788.1;XP_050022518.1;XP_050027134.1;XP_050033318.1;XP_050037398.1;XP_050044469.1;XP_050047181.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050050758.1;XP_050044478.1;XP_050045660.1;XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050027728.1;XP_050022938.1;XP_050040200.1;XP_050048719.1;XP_050047809.1;XP_050050373.1;XP_050045785.1;XP_050048534.1;XP_050032477.1
Reactome: R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	1	XP_050047422.1
MetaCyc: PWY-7822	Chitin degradation III (Serratia)	46	XP_050049366.1;XP_050028195.1;XP_050028196.1;XP_050044667.1;XP_050044832.1;XP_050044043.1;XP_050025618.1;XP_050035570.1;XP_050030481.1;XP_050029822.1;XP_050032833.1;XP_050043208.1;XP_050026917.1;XP_050039363.1;XP_050026983.1;XP_050044713.1;XP_050051567.1;XP_050026985.1;XP_050030480.1;XP_050049137.1;XP_050039362.1;XP_050027975.1;XP_050025615.1;XP_050049367.1;XP_050026984.1;XP_050025616.1;XP_050025617.1;XP_050030479.1;XP_050039361.1;XP_050026982.1;XP_050051568.1;XP_050044830.1;XP_050049136.1;XP_050044317.1;XP_050044831.1;XP_050044714.1;XP_050032571.1;XP_050026981.1;XP_050049138.1;XP_050049141.1;XP_050049139.1;XP_050043064.1;XP_050036110.1;XP_050044411.1;XP_050038974.1;XP_050049140.1
Reactome: R-HSA-2243919	Crosslinking of collagen fibrils	4	XP_050052132.1;XP_050051572.1;XP_050022553.1;XP_050052245.1
KEGG: 00052+5.1.3.2	Galactose metabolism	3	XP_050031782.1;XP_050042029.1;XP_050031783.1
KEGG: 00330+2.7.2.11	Arginine and proline metabolism	1	XP_050049134.1
Reactome: R-HSA-376172	DSCAM interactions	6	XP_050033239.1;XP_050033240.1;XP_050033241.1;XP_050033242.1;XP_050033244.1;XP_050033243.1
MetaCyc: PWY-7199	Pyrimidine deoxyribonucleosides salvage	5	XP_050025363.1;XP_050032909.1;XP_050025364.1;XP_050027282.1;XP_050027283.1
Reactome: R-HSA-9022538	Loss of MECP2 binding ability to 5mC-DNA	3	XP_050035890.1;XP_050031707.1;XP_050035889.1
KEGG: 00970+6.1.1.3	Aminoacyl-tRNA biosynthesis	6	XP_050051286.1;XP_050024312.1;XP_050050321.1;XP_050045469.1;XP_050041431.1;XP_050045468.1
MetaCyc: PWY-6557	Glycosaminoglycan-protein linkage region biosynthesis	3	XP_050032783.1;XP_050032784.1;XP_050032785.1
Reactome: R-HSA-1482801	Acyl chain remodelling of PS	4	XP_050025400.1;XP_050033390.1;XP_050025686.1;XP_050050549.1
MetaCyc: PWY-6368	3-phosphoinositide degradation	12	XP_050047182.1;XP_050047185.1;XP_050040343.1;XP_050023808.1;XP_050040159.1;XP_050047184.1;XP_050025862.1;XP_050040160.1;XP_050047183.1;XP_050047313.1;XP_050040157.1;XP_050040158.1
Reactome: R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	11	XP_050042082.1;XP_050042079.1;XP_050042081.1;XP_050042080.1;XP_050046147.1;XP_050046150.1;XP_050049483.1;XP_050046149.1;XP_050052687.1;XP_050042083.1;XP_050046148.1
KEGG: 00350+2.6.1.5	Tyrosine metabolism	3	XP_050031962.1;XP_050049182.1;XP_050049181.1
MetaCyc: PWY-6598	Sciadonate biosynthesis	78	XP_050039088.1;XP_050039707.1;XP_050039084.1;XP_050039712.1;XP_050039087.1;XP_050027469.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050028129.1;XP_050051763.1;XP_050026205.1;XP_050039710.1;XP_050039709.1;XP_050039706.1;XP_050039770.1;XP_050039711.1;XP_050026888.1;XP_050039772.1;XP_050039365.1;XP_050027496.1;XP_050039126.1;XP_050039699.1;XP_050047366.1;XP_050039085.1;XP_050039364.1;XP_050027470.1;XP_050039769.1;XP_050043402.1;XP_050039080.1;XP_050051765.1;XP_050039016.1;XP_050042358.1;XP_050051766.1;XP_050039263.1;XP_050025917.1;XP_050036103.1;XP_050039708.1;XP_050039189.1;XP_050045032.1;XP_050042219.1;XP_050051764.1;XP_050027502.1;XP_050036636.1;XP_050039700.1;XP_050039083.1;XP_050026425.1;XP_050039555.1;XP_050039698.1;XP_050027024.1;XP_050039366.1;XP_050033894.1;XP_050041128.1;XP_050033799.1;XP_050039722.1;XP_050039017.1;XP_050039545.1;XP_050025916.1;XP_050039191.1;XP_050039183.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050039081.1;XP_050026935.1;XP_050039082.1;XP_050039703.1;XP_050039704.1;XP_050039186.1;XP_050027497.1;XP_050026887.1;XP_050036658.1;XP_050039701.1;XP_050039086.1;XP_050036659.1;XP_050039015.1;XP_050041191.1;XP_050039426.1
MetaCyc: PWY-6483	Ceramide degradation (generic)	1	XP_050048005.1
MetaCyc: PWY-7340	9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)	2	XP_050026060.1;XP_050023456.1
KEGG: 00040+5.1.3.1	Pentose and glucuronate interconversions	1	XP_050033946.1
Reactome: R-HSA-73614	Pyrimidine salvage	12	XP_050036028.1;XP_050025364.1;XP_050031818.1;XP_050032573.1;XP_050031819.1;XP_050031820.1;XP_050024420.1;XP_050024419.1;XP_050025363.1;XP_050031817.1;XP_050035831.1;XP_050032909.1
MetaCyc: PWY-7996	Menaquinol-4 biosynthesis I	1	XP_050045574.1
MetaCyc: PWY-6605	Adenine and adenosine salvage II	1	XP_050049687.1
MetaCyc: PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	4	XP_050040275.1;XP_050048865.1;XP_050039987.1;XP_050039374.1
MetaCyc: PWY-3821	D-galactose detoxification	5	XP_050031782.1;XP_050030095.1;XP_050040105.1;XP_050042029.1;XP_050031783.1
MetaCyc: PWY-6638	Sulfolactate degradation III	3	XP_050049202.1;XP_050049203.1;XP_050026413.1
KEGG: 05170+2.7.1.153	Human immunodeficiency virus 1 infection	2	XP_050052756.1;XP_050028399.1
KEGG: 00010+4.2.1.11	Glycolysis / Gluconeogenesis	1	XP_050051894.1
Reactome: R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	7	XP_050036571.1;XP_050035882.1;XP_050030754.1;XP_050036462.1;XP_050033625.1;XP_050030755.1;XP_050048063.1
Reactome: R-HSA-426048	Arachidonate production from DAG	8	XP_050024687.1;XP_050038705.1;XP_050024686.1;XP_050038707.1;XP_050024689.1;XP_050038706.1;XP_050032596.1;XP_050032656.1
Reactome: R-HSA-5609978	Defective GALT can cause Galactosemia	1	XP_050045037.1
KEGG: 00930+3.1.1.17	Caprolactam degradation	2	XP_050030742.1;XP_050030744.1
KEGG: 00053+1.13.99.1	Ascorbate and aldarate metabolism	1	XP_050027273.1
Reactome: R-HSA-8940973	RUNX2 regulates osteoblast differentiation	4	XP_050052372.1;XP_050047598.1;XP_050047422.1;XP_050047606.1
Reactome: R-HSA-2160456	Phenylketonuria	1	XP_050047981.1
KEGG: 00770+3.6.1.9	Pantothenate and CoA biosynthesis	3	XP_050025198.1;XP_050045218.1;XP_050041566.1
MetaCyc: PWY-7717	3-hydroxy-4-methyl-anthranilate biosynthesis I	12	XP_050040418.1;XP_050040584.1;XP_050040415.1;XP_050040583.1;XP_050040419.1;XP_050040580.1;XP_050040416.1;XP_050040581.1;XP_050035077.1;XP_050040577.1;XP_050040417.1;XP_050048623.1
KEGG: 00592+3.1.1.4	alpha-Linolenic acid metabolism	27	XP_050035194.1;XP_050050549.1;XP_050037150.1;XP_050025686.1;XP_050025400.1;XP_050037661.1;XP_050037143.1;XP_050037141.1;XP_050037139.1;XP_050035195.1;XP_050035197.1;XP_050037144.1;XP_050035196.1;XP_050037140.1;XP_050037142.1;XP_050035199.1;XP_050037146.1;XP_050037148.1;XP_050037151.1;XP_050033390.1;XP_050035198.1;XP_050035193.1;XP_050037147.1;XP_050031256.1;XP_050030747.1;XP_050037145.1;XP_050035192.1
Reactome: R-HSA-68877	Mitotic Prometaphase	109	XP_050042728.1;XP_050045443.1;XP_050029077.1;XP_050030511.1;XP_050024840.1;XP_050045597.1;XP_050042731.1;XP_050029076.1;XP_050041693.1;XP_050042730.1;XP_050035983.1;XP_050035974.1;XP_050035987.1;XP_050027568.1;XP_050035933.1;XP_050035986.1;XP_050035978.1;XP_050051355.1;XP_050035991.1;XP_050038895.1;XP_050029298.1;XP_050049377.1;XP_050035979.1;XP_050051357.1;XP_050035993.1;XP_050038418.1;XP_050046156.1;XP_050035975.1;XP_050035932.1;XP_050047995.1;XP_050045051.1;XP_050023718.1;XP_050042726.1;XP_050035119.1;XP_050029078.1;XP_050035482.1;XP_050033146.1;XP_050047998.1;XP_050049758.1;XP_050024518.1;XP_050042727.1;XP_050047564.1;XP_050042706.1;XP_050049761.1;XP_050024841.1;XP_050049759.1;XP_050025911.1;XP_050039381.1;XP_050035990.1;XP_050027566.1;XP_050048775.1;XP_050046734.1;XP_050028813.1;XP_050030514.1;XP_050052420.1;XP_050029897.1;XP_050039380.1;XP_050051356.1;XP_050037090.1;XP_050035992.1;XP_050027083.1;XP_050035989.1;XP_050047994.1;XP_050047996.1;XP_050039518.1;XP_050043181.1;XP_050025910.1;XP_050039305.1;XP_050033432.1;XP_050029375.1;XP_050026883.1;XP_050047338.1;XP_050040792.1;XP_050029374.1;XP_050052055.1;XP_050035116.1;XP_050030509.1;XP_050035114.1;XP_050036430.1;XP_050035973.1;XP_050035977.1;XP_050046838.1;XP_050035984.1;XP_050027567.1;XP_050034683.1;XP_050035982.1;XP_050027084.1;XP_050030515.1;XP_050049757.1;XP_050044008.1;XP_050048777.1;XP_050030512.1;XP_050046735.1;XP_050039306.1;XP_050044467.1;XP_050035976.1;XP_050035981.1;XP_050029297.1;XP_050035980.1;XP_050030513.1;XP_050048776.1;XP_050044509.1;XP_050033477.1;XP_050035988.1;XP_050035985.1;XP_050046837.1;XP_050047997.1;XP_050049762.1;XP_050042732.1
KEGG: 00010+1.2.4.1	Glycolysis / Gluconeogenesis	2	XP_050025621.1;XP_050027474.1
Reactome: R-HSA-3000178	ECM proteoglycans	7	XP_050051572.1;XP_050027018.1;XP_050030649.1;XP_050028252.1;XP_050043548.1;XP_050039341.1;XP_050052132.1
MetaCyc: PWY-7344	UDP-alpha-D-galactose biosynthesis	3	XP_050031783.1;XP_050031782.1;XP_050042029.1
KEGG: 00980+2.5.1.18	Metabolism of xenobiotics by cytochrome P450	13	XP_050047905.1;XP_050048233.1;XP_050047704.1;XP_050048256.1;XP_050048220.1;XP_050048267.1;XP_050031872.1;XP_050047714.1;XP_050026762.1;XP_050027833.1;XP_050048247.1;XP_050047698.1;XP_050031855.1
KEGG: 00020+1.1.1.42	Citrate cycle (TCA cycle)	6	XP_050037396.1;XP_050043069.1;XP_050043076.1;XP_050041863.1;XP_050037007.1;XP_050026123.1
KEGG: 00640+5.1.99.1	Propanoate metabolism	1	XP_050034236.1
Reactome: R-HSA-8951430	RUNX3 regulates WNT signaling	3	XP_050052763.1;XP_050052762.1;XP_050052764.1
Reactome: R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	58	XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050045660.1;XP_050044478.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050051073.1;XP_050051109.1;XP_050051067.1;XP_050040200.1;XP_050022938.1;XP_050032477.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050047809.1;XP_050048719.1;XP_050035472.1;XP_050051964.1;XP_050051087.1;XP_050033331.1;XP_050036567.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050048823.1;XP_050033832.1;XP_050040199.1;XP_050049124.1;XP_050048720.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050037398.1;XP_050033318.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050051080.1;XP_050047181.1;XP_050051098.1;XP_050044469.1
KEGG: 00230+3.6.1.15	Purine metabolism	1	XP_050051386.1
MetaCyc: PWY-5523	5,6-dimethylbenzimidazole biosynthesis I (aerobic)	1	XP_050034819.1
Reactome: R-HSA-912631	Regulation of signaling by CBL	4	XP_050023708.1;XP_050048534.1;XP_050035481.1;XP_050032853.1
Reactome: R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	7	XP_050040160.1;XP_050045005.1;XP_050040159.1;XP_050049284.1;XP_050040157.1;XP_050040158.1;XP_050037178.1
MetaCyc: PWY-6803	Phosphatidylcholine acyl editing	28	XP_050025686.1;XP_050039130.1;XP_050025400.1;XP_050037661.1;XP_050037143.1;XP_050050549.1;XP_050035194.1;XP_050037150.1;XP_050035197.1;XP_050037139.1;XP_050035195.1;XP_050035196.1;XP_050037144.1;XP_050037141.1;XP_050033390.1;XP_050037151.1;XP_050035198.1;XP_050037140.1;XP_050037146.1;XP_050037148.1;XP_050035199.1;XP_050037142.1;XP_050037145.1;XP_050035192.1;XP_050037147.1;XP_050031256.1;XP_050035193.1;XP_050030747.1
MetaCyc: PWY-6308	L-cysteine biosynthesis II (tRNA-dependent)	3	XP_050027033.1;XP_050051243.1;XP_050040627.1
Reactome: R-HSA-174490	Membrane binding and targetting of GAG proteins	9	XP_050025017.1;XP_050035481.1;XP_050048534.1;XP_050030675.1;XP_050050066.1;XP_050025018.1;XP_050050057.1;XP_050052234.1;XP_050038767.1
MetaCyc: PWY-6854	Ethylene biosynthesis III (microbes)	14	XP_050049354.1;XP_050025841.1;XP_050028343.1;XP_050048505.1;XP_050023549.1;XP_050052656.1;XP_050026032.1;XP_050052655.1;XP_050026849.1;XP_050025840.1;XP_050025838.1;XP_050032314.1;XP_050052657.1;XP_050044924.1
Reactome: R-HSA-5676590	NIK-->noncanonical NF-kB signaling	57	XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050044475.1;XP_050024749.1;XP_050049124.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050040198.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050040624.1;XP_050036567.1;XP_050047181.1;XP_050044469.1;XP_050050414.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050033318.1;XP_050037398.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050033237.1;XP_050037401.1;XP_050047670.1;XP_050025715.1;XP_050034772.1;XP_050045660.1;XP_050044478.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1;XP_050047809.1;XP_050048719.1;XP_050032477.1;XP_050040623.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050047769.1;XP_050040200.1;XP_050022938.1
Reactome: R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	5	XP_050028252.1;XP_050051992.1;XP_050051991.1;XP_050027018.1;XP_050037277.1
KEGG: 00760+3.1.3.5	Nicotinate and nicotinamide metabolism	1	XP_050049541.1
MetaCyc: PWY-6313	Serotonin degradation	3	XP_050052400.1;XP_050052302.1;XP_050052301.1
MetaCyc: PWY-6799	Fatty acid biosynthesis initiation (plant mitochondria)	4	XP_050029751.1;XP_050033008.1;XP_050032773.1;XP_050033009.1
KEGG: 00450+1.8.1.9	Selenocompound metabolism	5	XP_050024925.1;XP_050026799.1;XP_050026797.1;XP_050026798.1;XP_050026800.1
KEGG: 00680+1.1.1.284	Methane metabolism	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
Reactome: R-HSA-418457	cGMP effects	5	XP_050051756.1;XP_050052373.1;XP_050051758.1;XP_050024343.1;XP_050051757.1
Reactome: R-HSA-5678895	Defective CFTR causes cystic fibrosis	65	XP_050037401.1;XP_050034858.1;XP_050025715.1;XP_050034772.1;XP_050044478.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050048719.1;XP_050050373.1;XP_050045785.1;XP_050040200.1;XP_050050833.1;XP_050050834.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050037397.1;XP_050035481.1;XP_050042025.1;XP_050034857.1;XP_050040198.1;XP_050050831.1;XP_050044470.1;XP_050027752.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050023192.1;XP_050047181.1;XP_050033833.1;XP_050027064.1;XP_050033318.1;XP_050022518.1;XP_050033237.1;XP_050025395.1;XP_050050832.1;XP_050045660.1;XP_050044476.1;XP_050025393.1;XP_050047809.1;XP_050048534.1;XP_050032477.1;XP_050022938.1;XP_050044475.1;XP_050048720.1;XP_050049124.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050033832.1;XP_050048823.1;XP_050025394.1;XP_050036567.1;XP_050044469.1;XP_050048824.1;XP_050037399.1;XP_050027657.1;XP_050036580.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050042788.1;XP_050027134.1
KEGG: 00680+3.1.3.11	Methane metabolism	2	XP_050038404.1;XP_050044414.1
MetaCyc: PWY-6558	Heparan sulfate biosynthesis (late stages)	5	XP_050052149.1;XP_050025613.1;XP_050050426.1;XP_050036614.1;XP_050025614.1
KEGG: 00550+2.4.1.227	Peptidoglycan biosynthesis	2	XP_050033584.1;XP_050033583.1
KEGG: 00280+2.6.1.42	Valine, leucine and isoleucine degradation	1	XP_050039540.1
MetaCyc: PWY-7922	Protein O-mannosylation II (mammals, core M1 and core M2)	13	XP_050024005.1;XP_050023434.1;XP_050051991.1;XP_050046831.1;XP_050041249.1;XP_050046070.1;XP_050051992.1;XP_050024120.1;XP_050024010.1;XP_050041250.1;XP_050037277.1;XP_050029180.1;XP_050046071.1
Reactome: R-HSA-879415	Advanced glycosylation endproduct receptor signaling	7	XP_050047598.1;XP_050040960.1;XP_050047606.1;XP_050040959.1;XP_050023648.1;XP_050051837.1;XP_050023649.1
KEGG: 00480+1.1.1.42	Glutathione metabolism	6	XP_050026123.1;XP_050043069.1;XP_050043076.1;XP_050037396.1;XP_050041863.1;XP_050037007.1
Reactome: R-HSA-4551295	Defective ALG11 causes ALG11-CDG (CDG-1p)	2	XP_050039004.1;XP_050039005.1
MetaCyc: PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	7	XP_050026059.1;XP_050048806.1;XP_050050239.1;XP_050050237.1;XP_050050236.1;XP_050050240.1;XP_050050241.1
Reactome: R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	15	XP_050052094.1;XP_050050077.1;XP_050025697.1;XP_050048619.1;XP_050047163.1;XP_050025696.1;XP_050050080.1;XP_050050081.1;XP_050048621.1;XP_050047165.1;XP_050047164.1;XP_050050079.1;XP_050048620.1;XP_050050082.1;XP_050047166.1
Reactome: R-HSA-425410	Metal ion SLC transporters	4	XP_050044573.1;XP_050044575.1;XP_050044574.1;XP_050044576.1
KEGG: 00500+2.4.1.25	Starch and sucrose metabolism	1	XP_050042052.1
Reactome: R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	55	XP_050037041.1;XP_050049757.1;XP_050035993.1;XP_050035982.1;XP_050046822.1;XP_050035984.1;XP_050051357.1;XP_050035979.1;XP_050035981.1;XP_050049758.1;XP_050035980.1;XP_050046735.1;XP_050035975.1;XP_050031039.1;XP_050035976.1;XP_050035990.1;XP_050039381.1;XP_050049761.1;XP_050024841.1;XP_050028330.1;XP_050049759.1;XP_050028813.1;XP_050049762.1;XP_050052420.1;XP_050049353.1;XP_050035985.1;XP_050035988.1;XP_050046734.1;XP_050045597.1;XP_050031914.1;XP_050035992.1;XP_050045165.1;XP_050051356.1;XP_050024840.1;XP_050029897.1;XP_050039380.1;XP_050035974.1;XP_050035983.1;XP_050043181.1;XP_050035987.1;XP_050046689.1;XP_050035989.1;XP_050047338.1;XP_050035986.1;XP_050035978.1;XP_050046821.1;XP_050026883.1;XP_050043899.1;XP_050035973.1;XP_050050989.1;XP_050035977.1;XP_050035991.1;XP_050052055.1;XP_050051355.1;XP_050034982.1
MetaCyc: PWY-7174	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation II	8	XP_050024914.1;XP_050039041.1;XP_050024913.1;XP_050031848.1;XP_050026778.1;XP_050024912.1;XP_050026779.1;XP_050050027.1
Reactome: R-HSA-71240	Tryptophan catabolism	17	XP_050052719.1;XP_050050545.1;XP_050026084.1;XP_050050544.1;XP_050025836.1;XP_050052715.1;XP_050052716.1;XP_050048623.1;XP_050025834.1;XP_050043059.1;XP_050043060.1;XP_050036619.1;XP_050045561.1;XP_050052721.1;XP_050025837.1;XP_050038809.1;XP_050025835.1
MetaCyc: PWY-7863	Roseoflavin biosynthesis	1	XP_050034819.1
Reactome: R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	52	XP_050040200.1;XP_050022938.1;XP_050048719.1;XP_050047809.1;XP_050045785.1;XP_050050373.1;XP_050032477.1;XP_050048534.1;XP_050044478.1;XP_050045660.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050044476.1;XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050033318.1;XP_050037398.1;XP_050047181.1;XP_050044469.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050033331.1;XP_050036567.1;XP_050035472.1;XP_050051964.1;XP_050037397.1;XP_050044475.1;XP_050024749.1;XP_050031786.1;XP_050027118.1;XP_050040198.1;XP_050049124.1;XP_050048720.1;XP_050035481.1;XP_050042025.1
MetaCyc: PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	1	XP_050048806.1
Reactome: R-HSA-937039	IRAK1 recruits IKK complex	10	XP_050037315.1;XP_050037312.1;XP_050037314.1;XP_050037311.1;XP_050050758.1;XP_050037310.1;XP_050035481.1;XP_050048534.1;XP_050037316.1;XP_050037313.1
MetaCyc: PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	12	XP_050042253.1;XP_050038409.1;XP_050047067.1;XP_050038435.1;XP_050049284.1;XP_050042022.1;XP_050048140.1;XP_050042251.1;XP_050042250.1;XP_050025335.1;XP_050042252.1;XP_050048141.1
MetaCyc: PWY-3341	L-proline biosynthesis III (from L-ornithine)	3	XP_050040888.1;XP_050048960.1;XP_050039554.1
KEGG: 00510+2.4.1.259+2.4.1.261	N-Glycan biosynthesis	1	XP_050048305.1
Reactome: R-HSA-1296072	Voltage gated Potassium channels	19	XP_050026118.1;XP_050041332.1;XP_050050156.1;XP_050027031.1;XP_050026117.1;XP_050044541.1;XP_050044542.1;XP_050026574.1;XP_050027030.1;XP_050044660.1;XP_050046507.1;XP_050026120.1;XP_050026121.1;XP_050041330.1;XP_050041331.1;XP_050026573.1;XP_050030659.1;XP_050026119.1;XP_050036881.1
KEGG: 00380+1.13.11.11	Tryptophan metabolism	1	XP_050038809.1
Reactome: R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	12	XP_050035287.1;XP_050040600.1;XP_050033884.1;XP_050026876.1;XP_050043294.1;XP_050043439.1;XP_050036371.1;XP_050032785.1;XP_050032783.1;XP_050027767.1;XP_050039341.1;XP_050032784.1
Reactome: R-HSA-9607240	FLT3 Signaling	1	XP_050032853.1
KEGG: 00130+1.14.99.60	Ubiquinone and other terpenoid-quinone biosynthesis	1	XP_050033250.1
MetaCyc: PWY-5891	Menaquinol-11 biosynthesis	1	XP_050045574.1
MetaCyc: PWY-3661-1	Glycine betaine degradation II (mammalian)	3	XP_050032636.1;XP_050034367.1;XP_050032637.1
Reactome: R-HSA-9656255	Defective OGG1 Substrate Binding	1	XP_050052047.1
Reactome: R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	17	XP_050046640.1;XP_050049030.1;XP_050047955.1;XP_050047965.1;XP_050049349.1;XP_050034209.1;XP_050048132.1;XP_050048137.1;XP_050035481.1;XP_050036365.1;XP_050026551.1;XP_050031594.1;XP_050036502.1;XP_050049340.1;XP_050034595.1;XP_050048534.1;XP_050049355.1
Reactome: R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	20	XP_050036379.1;XP_050042095.1;XP_050036357.1;XP_050044051.1;XP_050029511.1;XP_050049983.1;XP_050029929.1;XP_050045441.1;XP_050049681.1;XP_050042371.1;XP_050049680.1;XP_050049982.1;XP_050044986.1;XP_050042097.1;XP_050042094.1;XP_050023900.1;XP_050043794.1;XP_050046971.1;XP_050042093.1;XP_050042096.1
Reactome: R-HSA-9008059	Interleukin-37 signaling	1	XP_050025376.1
MetaCyc: PWY-5989	Stearate biosynthesis II (bacteria and plants)	4	XP_050033008.1;XP_050032773.1;XP_050033009.1;XP_050029751.1
Reactome: R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	40	XP_050038966.1;XP_050030507.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050038967.1;XP_050036827.1;XP_050039240.1;XP_050025064.1;XP_050029515.1;XP_050035933.1;XP_050042391.1;XP_050038895.1;XP_050030942.1;XP_050038863.1;XP_050046838.1;XP_050023474.1;XP_050036430.1;XP_050049377.1;XP_050030653.1;XP_050038968.1;XP_050038866.1;XP_050047656.1;XP_050023476.1;XP_050044008.1;XP_050038862.1;XP_050029516.1;XP_050023718.1;XP_050026809.1;XP_050046156.1;XP_050035932.1;XP_050033146.1;XP_050026810.1;XP_050038864.1;XP_050024518.1;XP_050035770.1;XP_050038865.1;XP_050046837.1;XP_050042392.1;XP_050023475.1
Reactome: R-HSA-4419969	Depolymerisation of the Nuclear Lamina	6	XP_050037457.1;XP_050037455.1;XP_050037458.1;XP_050050943.1;XP_050037456.1;XP_050030707.1
Reactome: R-HSA-2871837	FCERI mediated NF-kB activation	60	XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050044476.1;XP_050044478.1;XP_050050758.1;XP_050028062.1;XP_050045660.1;XP_050034772.1;XP_050025715.1;XP_050037401.1;XP_050033237.1;XP_050047670.1;XP_050047769.1;XP_050040200.1;XP_050022938.1;XP_050032548.1;XP_050045785.1;XP_050028061.1;XP_050050373.1;XP_050032477.1;XP_050040623.1;XP_050048534.1;XP_050048719.1;XP_050047809.1;XP_050040624.1;XP_050033331.1;XP_050036567.1;XP_050035472.1;XP_050051964.1;XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050029802.1;XP_050050645.1;XP_050044470.1;XP_050052231.1;XP_050040198.1;XP_050049124.1;XP_050042025.1;XP_050035481.1;XP_050048720.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050031786.1;XP_050027118.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050033318.1;XP_050037398.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050047181.1;XP_050044469.1
Reactome: R-HSA-500753	Pyrimidine biosynthesis	3	XP_050032255.1;XP_050023639.1;XP_050036053.1
Reactome: R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	2	XP_050044392.1;XP_050031037.1
Reactome: R-HSA-77042	Formation of editosomes by ADAR proteins	1	XP_050023331.1
Reactome: R-HSA-5685938	HDR through Single Strand Annealing (SSA)	36	XP_050028292.1;XP_050022603.1;XP_050037414.1;XP_050025144.1;XP_050035537.1;XP_050022605.1;XP_050022604.1;XP_050029852.1;XP_050032647.1;XP_050032576.1;XP_050022602.1;XP_050033903.1;XP_050033904.1;XP_050052372.1;XP_050042401.1;XP_050022980.1;XP_050028323.1;XP_050022581.1;XP_050051397.1;XP_050044213.1;XP_050029342.1;XP_050038612.1;XP_050048499.1;XP_050046062.1;XP_050044695.1;XP_050032478.1;XP_050047551.1;XP_050046064.1;XP_050048786.1;XP_050023494.1;XP_050042755.1;XP_050022606.1;XP_050044807.1;XP_050048896.1;XP_050050532.1;XP_050045930.1
Reactome: R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	4	XP_050039341.1;XP_050043439.1;XP_050043294.1;XP_050040600.1
Reactome: R-HSA-6806664	Metabolism of vitamin K	1	XP_050025573.1
Reactome: R-HSA-9616222	Transcriptional regulation of granulopoiesis	12	XP_050046149.1;XP_050038199.1;XP_050046148.1;XP_050025244.1;XP_050046150.1;XP_050025248.1;XP_050025266.1;XP_050046147.1;XP_050047422.1;XP_050038213.1;XP_050025243.1;XP_050036268.1
KEGG: 00592+1.1.1.1	alpha-Linolenic acid metabolism	3	XP_050052400.1;XP_050052302.1;XP_050052301.1
Reactome: R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	17	XP_050027755.1;XP_050027790.1;XP_050046143.1;XP_050027176.1;XP_050042130.1;XP_050027179.1;XP_050027180.1;XP_050042127.1;XP_050046904.1;XP_050023596.1;XP_050027177.1;XP_050042128.1;XP_050027178.1;XP_050042129.1;XP_050027941.1;XP_050027937.1;XP_050027181.1
Reactome: R-HSA-180534	Vpu mediated degradation of CD4	55	XP_050040198.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050033331.1;XP_050040624.1;XP_050036567.1;XP_050051964.1;XP_050035472.1;XP_050048823.1;XP_050033832.1;XP_050040199.1;XP_050044470.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050044469.1;XP_050047181.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050033318.1;XP_050037398.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050034772.1;XP_050025715.1;XP_050047670.1;XP_050033237.1;XP_050037401.1;XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050044478.1;XP_050045660.1;XP_050050373.1;XP_050045785.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050048719.1;XP_050047809.1;XP_050022938.1;XP_050040200.1
Reactome: R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	4	XP_050050843.1;XP_050038602.1;XP_050045588.1;XP_050038799.1
KEGG: 00720+1.1.1.42	Carbon fixation pathways in prokaryotes	6	XP_050026123.1;XP_050037007.1;XP_050037396.1;XP_050043069.1;XP_050043076.1;XP_050041863.1
KEGG: 04070+2.7.1.137	Phosphatidylinositol signaling system	1	XP_050045005.1
KEGG: 00230+2.4.2.14	Purine metabolism	1	XP_050039987.1
KEGG: 00760+2.7.1.23	Nicotinate and nicotinamide metabolism	5	XP_050025547.1;XP_050025550.1;XP_050025549.1;XP_050023815.1;XP_050025548.1
KEGG: 00531+3.2.1.50	Glycosaminoglycan degradation	2	XP_050024093.1;XP_050025072.1
Reactome: R-HSA-5620924	Intraflagellar transport	35	XP_050032638.1;XP_050037790.1;XP_050036213.1;XP_050023136.1;XP_050035319.1;XP_050037791.1;XP_050024307.1;XP_050032848.1;XP_050030922.1;XP_050033502.1;XP_050030923.1;XP_050030175.1;XP_050033363.1;XP_050030924.1;XP_050030681.1;XP_050036212.1;XP_050033446.1;XP_050030176.1;XP_050036113.1;XP_050048963.1;XP_050032085.1;XP_050033362.1;XP_050032107.1;XP_050045597.1;XP_050038179.1;XP_050031370.1;XP_050025094.1;XP_050026883.1;XP_050032639.1;XP_050040396.1;XP_050032233.1;XP_050049593.1;XP_050042818.1;XP_050037789.1;XP_050036388.1
Reactome: R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	46	XP_050025635.1;XP_050023576.1;XP_050043147.1;XP_050023725.1;XP_050037137.1;XP_050048717.1;XP_050023779.1;XP_050048718.1;XP_050033368.1;XP_050023714.1;XP_050023726.1;XP_050046063.1;XP_050023729.1;XP_050039484.1;XP_050039068.1;XP_050040428.1;XP_050043138.1;XP_050030634.1;XP_050040427.1;XP_050034643.1;XP_050025563.1;XP_050023730.1;XP_050038469.1;XP_050030811.1;XP_050024189.1;XP_050030280.1;XP_050023777.1;XP_050035378.1;XP_050023727.1;XP_050023724.1;XP_050023577.1;XP_050039485.1;XP_050044010.1;XP_050045052.1;XP_050023728.1;XP_050046123.1;XP_050037136.1;XP_050047588.1;XP_050045189.1;XP_050023776.1;XP_050034644.1;XP_050047361.1;XP_050030810.1;XP_050051336.1;XP_050045300.1;XP_050051335.1
Reactome: R-HSA-4755609	Defective DHDDS causes retinitis pigmentosa 59	15	XP_050024030.1;XP_050047428.1;XP_050025956.1;XP_050035210.1;XP_050038668.1;XP_050035211.1;XP_050026424.1;XP_050046583.1;XP_050038667.1;XP_050028887.1;XP_050035212.1;XP_050024028.1;XP_050038737.1;XP_050024031.1;XP_050035209.1
Reactome: R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	55	XP_050022938.1;XP_050040200.1;XP_050047809.1;XP_050048719.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050050373.1;XP_050045785.1;XP_050045660.1;XP_050044478.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050047670.1;XP_050037401.1;XP_050033237.1;XP_050025715.1;XP_050034772.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050044469.1;XP_050047181.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050052231.1;XP_050044470.1;XP_050029802.1;XP_050050645.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050040624.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050040198.1
MetaCyc: PWY-7839	Lacto-series glycosphingolipids biosynthesis	1	XP_050023783.1
KEGG: 05163+2.7.11.1	Human cytomegalovirus infection	141	XP_050031198.1;XP_050036224.1;XP_050034960.1;XP_050051647.1;XP_050041922.1;XP_050042989.1;XP_050037630.1;XP_050036226.1;XP_050029303.1;XP_050048619.1;XP_050026053.1;XP_050031206.1;XP_050048905.1;XP_050050723.1;XP_050026954.1;XP_050037625.1;XP_050031200.1;XP_050026027.1;XP_050036232.1;XP_050036237.1;XP_050043308.1;XP_050034932.1;XP_050031194.1;XP_050027320.1;XP_050028233.1;XP_050036225.1;XP_050032708.1;XP_050044446.1;XP_050026955.1;XP_050051059.1;XP_050036131.1;XP_050037629.1;XP_050050709.1;XP_050045593.1;XP_050028292.1;XP_050031207.1;XP_050043849.1;XP_050050310.1;XP_050032548.1;XP_050050734.1;XP_050037623.1;XP_050041921.1;XP_050048621.1;XP_050028166.1;XP_050032707.1;XP_050043304.1;XP_050026695.1;XP_050022875.1;XP_050042307.1;XP_050049192.1;XP_050037622.1;XP_050031209.1;XP_050050715.1;XP_050029160.1;XP_050026977.1;XP_050043130.1;XP_050036231.1;XP_050032586.1;XP_050026976.1;XP_050036239.1;XP_050048906.1;XP_050026555.1;XP_050036230.1;XP_050037627.1;XP_050028165.1;XP_050037624.1;XP_050031197.1;XP_050032102.1;XP_050036238.1;XP_050042988.1;XP_050032928.1;XP_050043302.1;XP_050033844.1;XP_050023932.1;XP_050043303.1;XP_050043305.1;XP_050031205.1;XP_050031203.1;XP_050041923.1;XP_050025348.1;XP_050042990.1;XP_050031202.1;XP_050049350.1;XP_050043301.1;XP_050030586.1;XP_050025347.1;XP_050036236.1;XP_050031201.1;XP_050048620.1;XP_050035999.1;XP_050037621.1;XP_050036129.1;XP_050050041.1;XP_050036228.1;XP_050032927.1;XP_050034961.1;XP_050043306.1;XP_050026974.1;XP_050036240.1;XP_050044807.1;XP_050031195.1;XP_050043307.1;XP_050042629.1;XP_050037631.1;XP_050036227.1;XP_050049191.1;XP_050033021.1;XP_050033720.1;XP_050036235.1;XP_050029381.1;XP_050036234.1;XP_050037628.1;XP_050036223.1;XP_050036613.1;XP_050031199.1;XP_050041948.1;XP_050036233.1;XP_050031204.1;XP_050035462.1;XP_050045265.1;XP_050026975.1;XP_050046724.1;XP_050036142.1;XP_050031196.1;XP_050041924.1;XP_050039865.1;XP_050028323.1;XP_050037626.1;XP_050031208.1;XP_050026054.1;XP_050034829.1;XP_050034828.1;XP_050044080.1;XP_050036241.1;XP_050028687.1;XP_050043309.1;XP_050043129.1;XP_050036229.1;XP_050036130.1;XP_050045266.1;XP_050050042.1
MetaCyc: PWY-6938	NADH repair	4	XP_050045591.1;XP_050035041.1;XP_050035042.1;XP_050045592.1
KEGG: 00450+4.4.1.13	Selenocompound metabolism	6	XP_050050545.1;XP_050052715.1;XP_050052716.1;XP_050050544.1;XP_050052721.1;XP_050052719.1
Reactome: R-HSA-190873	Gap junction degradation	9	XP_050026257.1;XP_050039510.1;XP_050026258.1;XP_050028745.1;XP_050028603.1;XP_050039071.1;XP_050039072.1;XP_050026259.1;XP_050028849.1
Reactome: R-HSA-9639288	Amino acids regulate mTORC1	71	XP_050049057.1;XP_050029409.1;XP_050049586.1;XP_050050528.1;XP_050041945.1;XP_050037618.1;XP_050038826.1;XP_050036413.1;XP_050050529.1;XP_050049787.1;XP_050049335.1;XP_050043540.1;XP_050025347.1;XP_050032732.1;XP_050045459.1;XP_050036169.1;XP_050044696.1;XP_050036415.1;XP_050045458.1;XP_050025348.1;XP_050029408.1;XP_050050757.1;XP_050034072.1;XP_050050753.1;XP_050036416.1;XP_050029405.1;XP_050044489.1;XP_050041324.1;XP_050023172.1;XP_050024204.1;XP_050029407.1;XP_050041409.1;XP_050035933.1;XP_050043466.1;XP_050050754.1;XP_050024202.1;XP_050037617.1;XP_050034615.1;XP_050050525.1;XP_050042150.1;XP_050042621.1;XP_050050527.1;XP_050050526.1;XP_050050756.1;XP_050032728.1;XP_050050217.1;XP_050044699.1;XP_050029406.1;XP_050032858.1;XP_050043175.1;XP_050036417.1;XP_050040935.1;XP_050027195.1;XP_050044697.1;XP_050039093.1;XP_050047383.1;XP_050049937.1;XP_050036414.1;XP_050049336.1;XP_050050752.1;XP_050041412.1;XP_050046156.1;XP_050035932.1;XP_050045457.1;XP_050033146.1;XP_050048793.1;XP_050024203.1;XP_050040015.1;XP_050032859.1;XP_050027194.1;XP_050044488.1
Reactome: R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	5	XP_050047553.1;XP_050045633.1;XP_050041785.1;XP_050040075.1;XP_050052134.1
KEGG: 00513+2.4.1.68	Various types of N-glycan biosynthesis	1	XP_050036571.1
Reactome: R-HSA-450302	activated TAK1 mediates p38 MAPK activation	5	XP_050028062.1;XP_050028061.1;XP_050035481.1;XP_050048534.1;XP_050028233.1
MetaCyc: PWY-7426	Complex N-linked glycan biosynthesis (vertebrates)	12	XP_050035813.1;XP_050037186.1;XP_050030755.1;XP_050026116.1;XP_050044773.1;XP_050037949.1;XP_050037187.1;XP_050036571.1;XP_050036462.1;XP_050026853.1;XP_050030754.1;XP_050022524.1
Reactome: R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	1	XP_050032102.1
Reactome: R-HSA-2022857	Keratan sulfate degradation	21	XP_050043064.1;XP_050027975.1;XP_050036110.1;XP_050030480.1;XP_050025617.1;XP_050030479.1;XP_050027139.1;XP_050026982.1;XP_050025615.1;XP_050025616.1;XP_050026984.1;XP_050025618.1;XP_050035570.1;XP_050030481.1;XP_050028195.1;XP_050042169.1;XP_050026981.1;XP_050026985.1;XP_050026917.1;XP_050027140.1;XP_050026983.1
Reactome: R-HSA-937042	IRAK2 mediated activation of TAK1 complex	4	XP_050028062.1;XP_050048534.1;XP_050035481.1;XP_050028061.1
Reactome: R-HSA-6787639	GDP-fucose biosynthesis	8	XP_050047421.1;XP_050046830.1;XP_050038995.1;XP_050048517.1;XP_050046829.1;XP_050047837.1;XP_050047839.1;XP_050047838.1
MetaCyc: PWY-7216	(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)	6	XP_050041643.1;XP_050032010.1;XP_050026422.1;XP_050041651.1;XP_050041635.1;XP_050051194.1
KEGG: 00410+4.2.1.17	beta-Alanine metabolism	6	XP_050041643.1;XP_050041651.1;XP_050041635.1;XP_050051194.1;XP_050032010.1;XP_050026422.1
Reactome: R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	16	XP_050023789.1;XP_050037004.1;XP_050042417.1;XP_050049123.1;XP_050035381.1;XP_050049441.1;XP_050044765.1;XP_050041682.1;XP_050051195.1;XP_050049167.1;XP_050049165.1;XP_050049122.1;XP_050040640.1;XP_050041684.1;XP_050039289.1;XP_050041683.1
Reactome: R-HSA-422356	Regulation of insulin secretion	9	XP_050042108.1;XP_050042106.1;XP_050042107.1;XP_050025879.1;XP_050042110.1;XP_050042111.1;XP_050042112.1;XP_050042109.1;XP_050042105.1
KEGG: 00280+1.1.1.31	Valine, leucine and isoleucine degradation	1	XP_050034049.1
Reactome: R-HSA-8853334	Signaling by FGFR3 fusions in cancer	1	XP_050032853.1
Reactome: R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	5	XP_050044392.1;XP_050042593.1;XP_050042819.1;XP_050042814.1;XP_050042821.1
KEGG: 00071+1.3.3.6	Fatty acid degradation	2	XP_050026060.1;XP_050023456.1
Reactome: R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	14	XP_050030781.1;XP_050032269.1;XP_050051802.1;XP_050028857.1;XP_050044765.1;XP_050031253.1;XP_050030782.1;XP_050031929.1;XP_050045591.1;XP_050042354.1;XP_050051803.1;XP_050042417.1;XP_050051801.1;XP_050023256.1
Reactome: R-HSA-166663	Initial triggering of complement	1	XP_050045926.1
KEGG: 00071+4.2.1.17+1.1.1.211	Fatty acid degradation	1	XP_050032010.1
Reactome: R-HSA-6798163	Choline catabolism	38	XP_050043833.1;XP_050043724.1;XP_050043832.1;XP_050038719.1;XP_050035865.1;XP_050038125.1;XP_050030051.1;XP_050043944.1;XP_050038062.1;XP_050029419.1;XP_050047302.1;XP_050026760.1;XP_050038139.1;XP_050041472.1;XP_050046589.1;XP_050029420.1;XP_050039446.1;XP_050052743.1;XP_050033801.1;XP_050033687.1;XP_050043945.1;XP_050043404.1;XP_050038124.1;XP_050030346.1;XP_050043826.1;XP_050050338.1;XP_050048094.1;XP_050022985.1;XP_050052742.1;XP_050030080.1;XP_050028550.1;XP_050030050.1;XP_050024649.1;XP_050046542.1;XP_050043810.1;XP_050043827.1;XP_050043725.1;XP_050050337.1
Reactome: R-HSA-174430	Telomere C-strand synthesis initiation	11	XP_050032235.1;XP_050041996.1;XP_050043962.1;XP_050041995.1;XP_050041997.1;XP_050034506.1;XP_050028231.1;XP_050039359.1;XP_050041999.1;XP_050049531.1;XP_050041998.1
Reactome: R-HSA-4615885	SUMOylation of DNA replication proteins	46	XP_050038866.1;XP_050038968.1;XP_050030653.1;XP_050049377.1;XP_050044008.1;XP_050027084.1;XP_050023476.1;XP_050046156.1;XP_050026809.1;XP_050035932.1;XP_050023718.1;XP_050038862.1;XP_050044467.1;XP_050039306.1;XP_050029516.1;XP_050047055.1;XP_050026810.1;XP_050033146.1;XP_050024518.1;XP_050038864.1;XP_050047066.1;XP_050038865.1;XP_050035770.1;XP_050042392.1;XP_050023475.1;XP_050030507.1;XP_050038966.1;XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050027083.1;XP_050052687.1;XP_050025064.1;XP_050029404.1;XP_050039240.1;XP_050036827.1;XP_050038967.1;XP_050039305.1;XP_050029515.1;XP_050035933.1;XP_050030942.1;XP_050038863.1;XP_050038895.1;XP_050042391.1;XP_050036430.1;XP_050023474.1
Reactome: R-HSA-5682294	Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B	3	XP_050044027.1;XP_050044026.1;XP_050044028.1
KEGG: 00520+3.2.1.14	Amino sugar and nucleotide sugar metabolism	15	XP_050051568.1;XP_050044830.1;XP_050044667.1;XP_050044317.1;XP_050044831.1;XP_050044043.1;XP_050044714.1;XP_050044832.1;XP_050044411.1;XP_050029822.1;XP_050032833.1;XP_050043208.1;XP_050044713.1;XP_050032571.1;XP_050051567.1
KEGG: 00230+3.5.1.5	Purine metabolism	2	XP_050024276.1;XP_050024271.1
Reactome: R-HSA-73780	RNA Polymerase III Chain Elongation	17	XP_050032579.1;XP_050046123.1;XP_050033013.1;XP_050027634.1;XP_050024189.1;XP_050032577.1;XP_050051719.1;XP_050040236.1;XP_050032523.1;XP_050034643.1;XP_050036394.1;XP_050032578.1;XP_050045195.1;XP_050032546.1;XP_050034644.1;XP_050037088.1;XP_050040196.1
KEGG: 00562+2.7.8.11	Inositol phosphate metabolism	1	XP_050025335.1
Reactome: R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	28	XP_050032648.1;XP_050032679.1;XP_050035481.1;XP_050048720.1;XP_050050234.1;XP_050049433.1;XP_050032650.1;XP_050032988.1;XP_050050232.1;XP_050050233.1;XP_050040959.1;XP_050036730.1;XP_050028519.1;XP_050048721.1;XP_050040960.1;XP_050048534.1;XP_050023649.1;XP_050045753.1;XP_050045754.1;XP_050023192.1;XP_050048719.1;XP_050023648.1;XP_050032662.1;XP_050045755.1;XP_050049432.1;XP_050032649.1;XP_050025566.1;XP_050032661.1
Reactome: R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1	XP_050038602.1
Reactome: R-HSA-162594	Early Phase of HIV Life Cycle	1	XP_050047548.1
Reactome: R-HSA-70221	Glycogen breakdown (glycogenolysis)	25	XP_050027511.1;XP_050052173.1;XP_050047528.1;XP_050027508.1;XP_050027203.1;XP_050047533.1;XP_050025356.1;XP_050047529.1;XP_050037071.1;XP_050025357.1;XP_050047531.1;XP_050037069.1;XP_050047532.1;XP_050047534.1;XP_050027202.1;XP_050042052.1;XP_050027509.1;XP_050052174.1;XP_050025358.1;XP_050025359.1;XP_050052175.1;XP_050047530.1;XP_050037070.1;XP_050030952.1;XP_050027510.1
Reactome: R-HSA-8983711	OAS antiviral response	1	XP_050039986.1
MetaCyc: PWY-6397	Mycolyl-arabinogalactan-peptidoglycan complex biosynthesis	3	XP_050031783.1;XP_050031782.1;XP_050042029.1
KEGG: 00230+6.3.4.4	Purine metabolism	1	XP_050047718.1
KEGG: 00670+2.1.2.1	One carbon pool by folate	3	XP_050032636.1;XP_050034367.1;XP_050032637.1
Reactome: R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	2	XP_050032548.1;XP_050032853.1
Reactome: R-HSA-75109	Triglyceride biosynthesis	11	XP_050046981.1;XP_050037456.1;XP_050046979.1;XP_050046980.1;XP_050037455.1;XP_050037458.1;XP_050034559.1;XP_050047472.1;XP_050047470.1;XP_050034558.1;XP_050037457.1
MetaCyc: PWY-7400	L-arginine biosynthesis IV (archaebacteria)	4	XP_050045223.1;XP_050045233.1;XP_050032255.1;XP_050052351.1
MetaCyc: PWY-7111	Pyruvate fermentation to isobutanol (engineered)	3	XP_050052302.1;XP_050052400.1;XP_050052301.1
MetaCyc: PWY-5741	Ethylmalonyl-coa pathway	1	XP_050034236.1
Reactome: R-HSA-392154	Nitric oxide stimulates guanylate cyclase	11	XP_050039234.1;XP_050040300.1;XP_050052032.1;XP_050039290.1;XP_050039223.1;XP_050048943.1;XP_050048936.1;XP_050039231.1;XP_050048952.1;XP_050040873.1;XP_050040301.1
KEGG: 00240+3.6.1.6	Pyrimidine metabolism	1	XP_050029776.1
Reactome: R-HSA-1483152	Hydrolysis of LPE	1	XP_050022770.1
Reactome: R-HSA-198753	ERK/MAPK targets	2	XP_050047606.1;XP_050047598.1
Reactome: R-HSA-8935964	RUNX1 regulates expression of components of tight junctions	1	XP_050047422.1
Reactome: R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	6	XP_050025568.1;XP_050033750.1;XP_050033752.1;XP_050034960.1;XP_050033751.1;XP_050034961.1
KEGG: 00020+2.3.1.12	Citrate cycle (TCA cycle)	1	XP_050039504.1
Reactome: R-HSA-3785653	Myoclonic epilepsy of Lafora	2	XP_050035481.1;XP_050048534.1
MetaCyc: PWY-5461	Betanidin degradation	18	XP_050031834.1;XP_050037573.1;XP_050037575.1;XP_050022911.1;XP_050037576.1;XP_050052158.1;XP_050032263.1;XP_050030591.1;XP_050031815.1;XP_050037574.1;XP_050022520.1;XP_050022517.1;XP_050037572.1;XP_050033134.1;XP_050052157.1;XP_050031263.1;XP_050052159.1;XP_050030590.1
KEGG: 00052+2.7.7.12	Galactose metabolism	1	XP_050045037.1
KEGG: 00330+2.3.1.57	Arginine and proline metabolism	5	XP_050046955.1;XP_050051327.1;XP_050045759.1;XP_050050999.1;XP_050045770.1
KEGG: 00626+1.1.1.1	Naphthalene degradation	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
Reactome: R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	13	XP_050051714.1;XP_050052701.1;XP_050052627.1;XP_050051712.1;XP_050051715.1;XP_050044271.1;XP_050051716.1;XP_050051713.1;XP_050046156.1;XP_050051711.1;XP_050033146.1;XP_050051718.1;XP_050052700.1
Reactome: R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	67	XP_050033237.1;XP_050051381.1;XP_050045660.1;XP_050044476.1;XP_050047809.1;XP_050040340.1;XP_050048534.1;XP_050032477.1;XP_050040339.1;XP_050039330.1;XP_050022938.1;XP_050044475.1;XP_050048720.1;XP_050049124.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050033832.1;XP_050048823.1;XP_050039329.1;XP_050036567.1;XP_050034247.1;XP_050044469.1;XP_050038630.1;XP_050037399.1;XP_050048824.1;XP_050027657.1;XP_050038628.1;XP_050034248.1;XP_050038140.1;XP_050037398.1;XP_050042788.1;XP_050027134.1;XP_050039332.1;XP_050037401.1;XP_050039331.1;XP_050025715.1;XP_050034772.1;XP_050048801.1;XP_050044478.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050048719.1;XP_050050373.1;XP_050045785.1;XP_050040200.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050037397.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050044470.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050030937.1;XP_050040338.1;XP_050047181.1;XP_050033833.1;XP_050047778.1;XP_050040341.1;XP_050033318.1;XP_050022518.1
Reactome: R-HSA-5603037	IRAK4 deficiency (TLR5)	1	XP_050024508.1
MetaCyc: PWY-7185	UTP and CTP dephosphorylation I	6	XP_050029776.1;XP_050049541.1;XP_050026502.1;XP_050026501.1;XP_050026500.1;XP_050051386.1
Reactome: R-HSA-8939256	RUNX1 regulates transcription of genes involved in WNT signaling	1	XP_050047422.1
Reactome: R-HSA-5545483	Defective Mismatch Repair Associated With MLH1	2	XP_050031446.1;XP_050031345.1
MetaCyc: PWY-7102	Bisabolene biosynthesis (engineered)	3	XP_050045766.1;XP_050023623.1;XP_050045765.1
KEGG: 00900+2.2.1.7	Terpenoid backbone biosynthesis	2	XP_050027585.1;XP_050027584.1
KEGG: 00510+2.4.1.260	N-Glycan biosynthesis	1	XP_050026303.1
Reactome: R-HSA-4793952	Defective MGAT2 causes MGAT2-CDG (CDG-2a)	3	XP_050030755.1;XP_050036462.1;XP_050030754.1
MetaCyc: PWY-7601	Arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)	78	XP_050039084.1;XP_050039707.1;XP_050039088.1;XP_050041192.1;XP_050026206.1;XP_050039705.1;XP_050039712.1;XP_050027469.1;XP_050039087.1;XP_050026205.1;XP_050051763.1;XP_050028129.1;XP_050026888.1;XP_050039709.1;XP_050039706.1;XP_050039711.1;XP_050039770.1;XP_050039710.1;XP_050039126.1;XP_050039699.1;XP_050027496.1;XP_050039365.1;XP_050039772.1;XP_050039364.1;XP_050039085.1;XP_050047366.1;XP_050051765.1;XP_050027470.1;XP_050039769.1;XP_050039080.1;XP_050043402.1;XP_050039016.1;XP_050042219.1;XP_050045032.1;XP_050039708.1;XP_050039189.1;XP_050039263.1;XP_050051766.1;XP_050042358.1;XP_050025917.1;XP_050036103.1;XP_050039700.1;XP_050036636.1;XP_050051764.1;XP_050027502.1;XP_050027024.1;XP_050039366.1;XP_050039698.1;XP_050026425.1;XP_050039555.1;XP_050039083.1;XP_050039545.1;XP_050039017.1;XP_050039722.1;XP_050033799.1;XP_050033894.1;XP_050041128.1;XP_050033896.1;XP_050039702.1;XP_050048344.1;XP_050039183.1;XP_050025916.1;XP_050039191.1;XP_050039082.1;XP_050026935.1;XP_050039081.1;XP_050027497.1;XP_050026887.1;XP_050039703.1;XP_050039704.1;XP_050039186.1;XP_050039015.1;XP_050039426.1;XP_050041191.1;XP_050036659.1;XP_050039086.1;XP_050039701.1;XP_050036658.1
Reactome: R-HSA-205043	NRIF signals cell death from the nucleus	16	XP_050026263.1;XP_050026914.1;XP_050026264.1;XP_050043659.1;XP_050031262.1;XP_050035872.1;XP_050037415.1;XP_050034653.1;XP_050048534.1;XP_050037416.1;XP_050023628.1;XP_050027801.1;XP_050048893.1;XP_050026843.1;XP_050043649.1;XP_050035481.1
Reactome: R-HSA-432722	Golgi Associated Vesicle Biogenesis	13	XP_050052238.1;XP_050026519.1;XP_050035249.1;XP_050045259.1;XP_050034841.1;XP_050051162.1;XP_050045260.1;XP_050045261.1;XP_050024867.1;XP_050022976.1;XP_050045258.1;XP_050050799.1;XP_050049368.1
Reactome: R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	1	XP_050032853.1
KEGG: 00620+4.1.1.32	Pyruvate metabolism	11	XP_050038132.1;XP_050038121.1;XP_050038127.1;XP_050038116.1;XP_050031435.1;XP_050034972.1;XP_050034554.1;XP_050038119.1;XP_050038118.1;XP_050034437.1;XP_050038117.1
MetaCyc: PWY-6728	Methylaspartate cycle	32	XP_050037168.1;XP_050038590.1;XP_050043069.1;XP_050049075.1;XP_050042704.1;XP_050033843.1;XP_050042703.1;XP_050037172.1;XP_050026123.1;XP_050049076.1;XP_050037925.1;XP_050043076.1;XP_050037164.1;XP_050042702.1;XP_050043005.1;XP_050049718.1;XP_050026352.1;XP_050037007.1;XP_050037165.1;XP_050037926.1;XP_050037169.1;XP_050037396.1;XP_050035735.1;XP_050045192.1;XP_050033718.1;XP_050033719.1;XP_050037417.1;XP_050026353.1;XP_050034236.1;XP_050041863.1;XP_050037166.1;XP_050037167.1
MetaCyc: PWY-6834	Spermidine biosynthesis III	1	XP_050027983.1
Reactome: R-HSA-9635465	Suppression of apoptosis	2	XP_050047606.1;XP_050047598.1
MetaCyc: PWY-6952	Glycerophosphodiester degradation	3	XP_050040576.1;XP_050034933.1;XP_050034934.1
Reactome: R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	21	XP_050045195.1;XP_050032546.1;XP_050039027.1;XP_050033021.1;XP_050037088.1;XP_050034644.1;XP_050032478.1;XP_050040196.1;XP_050040449.1;XP_050032578.1;XP_050034643.1;XP_050032523.1;XP_050036394.1;XP_050033013.1;XP_050027634.1;XP_050024189.1;XP_050032577.1;XP_050051719.1;XP_050040236.1;XP_050046123.1;XP_050032579.1
MetaCyc: PWY-7388	Octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)	4	XP_050029751.1;XP_050033008.1;XP_050032773.1;XP_050033009.1
Reactome: R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	70	XP_050049329.1;XP_050047138.1;XP_050049377.1;XP_050030653.1;XP_050033146.1;XP_050023718.1;XP_050046156.1;XP_050035932.1;XP_050035770.1;XP_050038865.1;XP_050038965.1;XP_050038864.1;XP_050024518.1;XP_050047139.1;XP_050045754.1;XP_050032647.1;XP_050038963.1;XP_050038966.1;XP_050048032.1;XP_050038967.1;XP_050029342.1;XP_050049346.1;XP_050039240.1;XP_050025064.1;XP_050048499.1;XP_050035933.1;XP_050040226.1;XP_050028217.1;XP_050038964.1;XP_050029515.1;XP_050045755.1;XP_050042391.1;XP_050038895.1;XP_050030942.1;XP_050023476.1;XP_050049347.1;XP_050029852.1;XP_050044008.1;XP_050047137.1;XP_050030582.1;XP_050038968.1;XP_050038866.1;XP_050049345.1;XP_050026810.1;XP_050029516.1;XP_050038862.1;XP_050026809.1;XP_050023877.1;XP_050042392.1;XP_050023475.1;XP_050031628.1;XP_050046064.1;XP_050038969.1;XP_050030652.1;XP_050030506.1;XP_050030507.1;XP_050028218.1;XP_050048803.1;XP_050030583.1;XP_050036827.1;XP_050049348.1;XP_050026811.1;XP_050032065.1;XP_050047136.1;XP_050050532.1;XP_050023474.1;XP_050030584.1;XP_050045753.1;XP_050036430.1;XP_050038863.1
KEGG: 00240+2.7.4.14	Pyrimidine metabolism	4	XP_050023199.1;XP_050023197.1;XP_050023196.1;XP_050023195.1
KEGG: 00970+6.1.1.21	Aminoacyl-tRNA biosynthesis	2	XP_050040038.1;XP_050040037.1
KEGG: 00260+1.2.1.8+1.1.99.1	Glycine, serine and threonine metabolism	3	XP_050030051.1;XP_050052743.1;XP_050043945.1
Reactome: R-HSA-9656256	Defective OGG1 Substrate Processing	1	XP_050052047.1
KEGG: 00062+2.3.1.199	Fatty acid elongation	76	XP_050039083.1;XP_050039555.1;XP_050026425.1;XP_050039698.1;XP_050039366.1;XP_050027024.1;XP_050041128.1;XP_050033894.1;XP_050039722.1;XP_050033799.1;XP_050039017.1;XP_050039545.1;XP_050036103.1;XP_050039263.1;XP_050025917.1;XP_050051766.1;XP_050039708.1;XP_050039189.1;XP_050042219.1;XP_050027502.1;XP_050051764.1;XP_050036636.1;XP_050039700.1;XP_050039186.1;XP_050039704.1;XP_050039703.1;XP_050026887.1;XP_050027497.1;XP_050036658.1;XP_050039701.1;XP_050036659.1;XP_050039086.1;XP_050039426.1;XP_050041191.1;XP_050039015.1;XP_050039191.1;XP_050025916.1;XP_050039183.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050039081.1;XP_050026935.1;XP_050039082.1;XP_050028129.1;XP_050051763.1;XP_050026205.1;XP_050039710.1;XP_050039770.1;XP_050039711.1;XP_050039706.1;XP_050039709.1;XP_050026888.1;XP_050039088.1;XP_050039707.1;XP_050039084.1;XP_050039087.1;XP_050027469.1;XP_050039712.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039080.1;XP_050043402.1;XP_050027470.1;XP_050039769.1;XP_050051765.1;XP_050039016.1;XP_050039772.1;XP_050039365.1;XP_050027496.1;XP_050039699.1;XP_050039126.1;XP_050047366.1;XP_050039085.1;XP_050039364.1
KEGG: 00230+2.7.7.4	Purine metabolism	2	XP_050051798.1;XP_050051797.1
KEGG: 00670+2.1.1.45	One carbon pool by folate	2	XP_050027282.1;XP_050027283.1
Reactome: R-HSA-8964046	VLDL clearance	12	XP_050042242.1;XP_050042260.1;XP_050042262.1;XP_050042241.1;XP_050042240.1;XP_050023422.1;XP_050023796.1;XP_050023809.1;XP_050023334.1;XP_050042261.1;XP_050042454.1;XP_050023312.1
Reactome: R-HSA-6803157	Antimicrobial peptides	7	XP_050037699.1;XP_050037700.1;XP_050037701.1;XP_050043104.1;XP_050043109.1;XP_050036508.1;XP_050036263.1
Reactome: R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	2	XP_050031026.1;XP_050043542.1
Reactome: R-HSA-3214858	RMTs methylate histone arginines	64	XP_050035921.1;XP_050023898.1;XP_050025266.1;XP_050046574.1;XP_050044386.1;XP_050044385.1;XP_050029380.1;XP_050036268.1;XP_050025243.1;XP_050037289.1;XP_050038199.1;XP_050035917.1;XP_050034278.1;XP_050035918.1;XP_050036559.1;XP_050034280.1;XP_050034279.1;XP_050048018.1;XP_050044388.1;XP_050042080.1;XP_050038213.1;XP_050042768.1;XP_050042081.1;XP_050049812.1;XP_050044464.1;XP_050034281.1;XP_050042303.1;XP_050035919.1;XP_050034277.1;XP_050050546.1;XP_050035920.1;XP_050042766.1;XP_050051813.1;XP_050028556.1;XP_050025262.1;XP_050035922.1;XP_050025556.1;XP_050037290.1;XP_050049421.1;XP_050029294.1;XP_050042079.1;XP_050044387.1;XP_050051688.1;XP_050042290.1;XP_050023896.1;XP_050025555.1;XP_050036266.1;XP_050042082.1;XP_050027684.1;XP_050025261.1;XP_050025244.1;XP_050023897.1;XP_050025557.1;XP_050049813.1;XP_050044890.1;XP_050025248.1;XP_050027316.1;XP_050027315.1;XP_050038206.1;XP_050042083.1;XP_050051812.1;XP_050038200.1;XP_050051570.1;XP_050038212.1
Reactome: R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	6	XP_050031027.1;XP_050039561.1;XP_050031029.1;XP_050048414.1;XP_050031028.1;XP_050048422.1
Reactome: R-HSA-8963901	Chylomicron remodeling	12	XP_050042242.1;XP_050042262.1;XP_050042260.1;XP_050042241.1;XP_050023809.1;XP_050023796.1;XP_050023422.1;XP_050042240.1;XP_050023312.1;XP_050042454.1;XP_050023334.1;XP_050042261.1
MetaCyc: PWY-7187	Pyrimidine deoxyribonucleotides de novo biosynthesis II	12	XP_050045218.1;XP_050041566.1;XP_050029492.1;XP_050031510.1;XP_050034794.1;XP_050029490.1;XP_050027283.1;XP_050027282.1;XP_050025198.1;XP_050038939.1;XP_050043296.1;XP_050031386.1
Reactome: R-HSA-204005	COPII-mediated vesicle transport	55	XP_050027485.1;XP_050049163.1;XP_050051715.1;XP_050051711.1;XP_050051139.1;XP_050036813.1;XP_050052700.1;XP_050051718.1;XP_050027659.1;XP_050023187.1;XP_050038347.1;XP_050027094.1;XP_050048257.1;XP_050051140.1;XP_050027484.1;XP_050052053.1;XP_050051138.1;XP_050024480.1;XP_050049323.1;XP_050027095.1;XP_050038349.1;XP_050025016.1;XP_050052701.1;XP_050035507.1;XP_050051695.1;XP_050038348.1;XP_050051406.1;XP_050051141.1;XP_050031488.1;XP_050051691.1;XP_050045632.1;XP_050049233.1;XP_050051714.1;XP_050049164.1;XP_050049254.1;XP_050051694.1;XP_050049325.1;XP_050051693.1;XP_050038325.1;XP_050036814.1;XP_050042299.1;XP_050051716.1;XP_050044271.1;XP_050023186.1;XP_050046156.1;XP_050051696.1;XP_050022595.1;XP_050051713.1;XP_050033146.1;XP_050051697.1;XP_050052235.1;XP_050051712.1;XP_050049232.1;XP_050031377.1;XP_050049253.1
KEGG: 04070+3.1.4.11	Phosphatidylinositol signaling system	10	XP_050042250.1;XP_050042251.1;XP_050042252.1;XP_050048141.1;XP_050038409.1;XP_050042253.1;XP_050038435.1;XP_050047067.1;XP_050042022.1;XP_050048140.1
KEGG: 00240+4.2.1.70	Pyrimidine metabolism	2	XP_050041182.1;XP_050041147.1
Reactome: R-HSA-5576892	Phase 0 - rapid depolarisation	39	XP_050050695.1;XP_050050682.1;XP_050050692.1;XP_050045828.1;XP_050045174.1;XP_050050693.1;XP_050050688.1;XP_050026451.1;XP_050045172.1;XP_050045825.1;XP_050050691.1;XP_050050694.1;XP_050050689.1;XP_050045827.1;XP_050050699.1;XP_050050702.1;XP_050050680.1;XP_050050683.1;XP_050041731.1;XP_050045823.1;XP_050050701.1;XP_050050679.1;XP_050050700.1;XP_050050686.1;XP_050050690.1;XP_050045824.1;XP_050050697.1;XP_050045171.1;XP_050050696.1;XP_050032079.1;XP_050045173.1;XP_050050685.1;XP_050045826.1;XP_050026855.1;XP_050050684.1;XP_050050687.1;XP_050033136.1;XP_050050681.1;XP_050050698.1
Reactome: R-HSA-382556	ABC-family proteins mediated transport	77	XP_050036156.1;XP_050038140.1;XP_050036580.1;XP_050027657.1;XP_050027134.1;XP_050042788.1;XP_050037398.1;XP_050044469.1;XP_050048824.1;XP_050037399.1;XP_050048823.1;XP_050033832.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050036567.1;XP_050025394.1;XP_050044475.1;XP_050049124.1;XP_050048720.1;XP_050022938.1;XP_050042722.1;XP_050042721.1;XP_050047809.1;XP_050032477.1;XP_050048534.1;XP_050042723.1;XP_050045660.1;XP_050025393.1;XP_050044476.1;XP_050050832.1;XP_050046921.1;XP_050033237.1;XP_050025395.1;XP_050022518.1;XP_050033318.1;XP_050032272.1;XP_050047181.1;XP_050023192.1;XP_050027064.1;XP_050033833.1;XP_050040199.1;XP_050044470.1;XP_050027752.1;XP_050050831.1;XP_050033331.1;XP_050051964.1;XP_050035472.1;XP_050037397.1;XP_050024749.1;XP_050048216.1;XP_050031786.1;XP_050027118.1;XP_050042828.1;XP_050050834.1;XP_050024072.1;XP_050040198.1;XP_050034857.1;XP_050042025.1;XP_050035481.1;XP_050040200.1;XP_050050833.1;XP_050048719.1;XP_050045785.1;XP_050050373.1;XP_050042719.1;XP_050046922.1;XP_050044478.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050024739.1;XP_050034858.1;XP_050037401.1;XP_050034772.1;XP_050046920.1;XP_050025715.1
MetaCyc: PWY-1622	Formaldehyde assimilation I (serine pathway)	15	XP_050037167.1;XP_050037925.1;XP_050045192.1;XP_050032636.1;XP_050037172.1;XP_050037166.1;XP_050034367.1;XP_050035735.1;XP_050037169.1;XP_050037926.1;XP_050051894.1;XP_050037164.1;XP_050037165.1;XP_050032637.1;XP_050037168.1
MetaCyc: PWY-6703	Preq0 biosynthesis	3	XP_050048631.1;XP_050048632.1;XP_050048633.1
Reactome: R-HSA-5083630	Defective LFNG causes SCDO3	5	XP_050051590.1;XP_050041139.1;XP_050041140.1;XP_050051588.1;XP_050041141.1
MetaCyc: PWY-6012	Acyl carrier protein metabolism	1	XP_050040326.1
MetaCyc: PWY-6610	Adenine salvage	3	XP_050049687.1;XP_050045960.1;XP_050045961.1
Reactome: R-HSA-912694	Regulation of IFNA signaling	1	XP_050025376.1
KEGG: 00020+1.1.1.37	Citrate cycle (TCA cycle)	11	XP_050037164.1;XP_050037165.1;XP_050037926.1;XP_050037169.1;XP_050037168.1;XP_050045192.1;XP_050037925.1;XP_050037167.1;XP_050035735.1;XP_050037166.1;XP_050037172.1
Reactome: R-HSA-5620916	VxPx cargo-targeting to cilium	12	XP_050048921.1;XP_050031593.1;XP_050049357.1;XP_050048972.1;XP_050051846.1;XP_050023282.1;XP_050048971.1;XP_050047029.1;XP_050049755.1;XP_050048431.1;XP_050049358.1;XP_050046646.1
Reactome: R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	126	XP_050039340.1;XP_050023058.1;XP_050035481.1;XP_050049831.1;XP_050050940.1;XP_050032598.1;XP_050045969.1;XP_050043918.1;XP_050027304.1;XP_050025476.1;XP_050036708.1;XP_050026018.1;XP_050022853.1;XP_050043917.1;XP_050037582.1;XP_050044169.1;XP_050040677.1;XP_050051098.1;XP_050032330.1;XP_050032793.1;XP_050034000.1;XP_050027305.1;XP_050052131.1;XP_050033999.1;XP_050044170.1;XP_050028604.1;XP_050032272.1;XP_050030630.1;XP_050047002.1;XP_050031230.1;XP_050032599.1;XP_050032921.1;XP_050039285.1;XP_050032331.1;XP_050024740.1;XP_050048965.1;XP_050051569.1;XP_050044445.1;XP_050051073.1;XP_050031169.1;XP_050045196.1;XP_050034868.1;XP_050045970.1;XP_050026103.1;XP_050039286.1;XP_050026722.1;XP_050032528.1;XP_050023492.1;XP_050022748.1;XP_050049170.1;XP_050032936.1;XP_050031861.1;XP_050050516.1;XP_050044965.1;XP_050052130.1;XP_050042319.1;XP_050027477.1;XP_050046934.1;XP_050036005.1;XP_050043916.1;XP_050025636.1;XP_050049776.1;XP_050034001.1;XP_050046031.1;XP_050029380.1;XP_050029801.1;XP_050032267.1;XP_050043803.1;XP_050049830.1;XP_050037583.1;XP_050046469.1;XP_050029851.1;XP_050043804.1;XP_050038626.1;XP_050028344.1;XP_050038550.1;XP_050028206.1;XP_050044122.1;XP_050043802.1;XP_050051087.1;XP_050028191.1;XP_050039997.1;XP_050035484.1;XP_050033573.1;XP_050036857.1;XP_050029850.1;XP_050051080.1;XP_050032688.1;XP_050044171.1;XP_050036006.1;XP_050048062.1;XP_050043919.1;XP_050031153.1;XP_050023059.1;XP_050026723.1;XP_050044593.1;XP_050045043.1;XP_050046933.1;XP_050028318.1;XP_050039882.1;XP_050042714.1;XP_050048967.1;XP_050033913.1;XP_050040632.1;XP_050046989.1;XP_050051491.1;XP_050044680.1;XP_050048060.1;XP_050027435.1;XP_050048061.1;XP_050052117.1;XP_050041428.1;XP_050041753.1;XP_050035149.1;XP_050041744.1;XP_050048534.1;XP_050026721.1;XP_050046988.1;XP_050030148.1;XP_050035483.1;XP_050052195.1;XP_050036709.1;XP_050041323.1;XP_050051109.1;XP_050029294.1;XP_050051067.1
KEGG: 00230+6.3.4.13	Purine metabolism	2	XP_050048865.1;XP_050039374.1
KEGG: 00030+2.7.6.1	Pentose phosphate pathway	5	XP_050038764.1;XP_050038765.1;XP_050030166.1;XP_050030167.1;XP_050038766.1
MetaCyc: PWY-7401	Crotonate fermentation (to acetate and cyclohexane carboxylate)	6	XP_050041643.1;XP_050026422.1;XP_050032010.1;XP_050051194.1;XP_050041635.1;XP_050041651.1
Reactome: R-HSA-204626	Hypusine synthesis from eIF5A-lysine	2	XP_050051954.1;XP_050040886.1
MetaCyc: PWY-4261	Glycerol degradation I	9	XP_050023601.1;XP_050044168.1;XP_050023583.1;XP_050034558.1;XP_050034933.1;XP_050034934.1;XP_050040576.1;XP_050043007.1;XP_050034559.1
MetaCyc: PWY-5981	CDP-diacylglycerol biosynthesis III	12	XP_050037856.1;XP_050050583.1;XP_050052679.1;XP_050034614.1;XP_050032357.1;XP_050037857.1;XP_050027415.1;XP_050031895.1;XP_050031896.1;XP_050027416.1;XP_050037855.1;XP_050037854.1
Reactome: R-HSA-111463	SMAC (DIABLO) binds to IAPs	7	XP_050047553.1;XP_050037103.1;XP_050041785.1;XP_050040075.1;XP_050037104.1;XP_050052134.1;XP_050045633.1
Reactome: R-HSA-75105	Fatty acyl-CoA biosynthesis	38	XP_050051514.1;XP_050033002.1;XP_050030138.1;XP_050032773.1;XP_050051516.1;XP_050032998.1;XP_050025114.1;XP_050051190.1;XP_050051929.1;XP_050032997.1;XP_050030085.1;XP_050030055.1;XP_050030053.1;XP_050051513.1;XP_050038921.1;XP_050030054.1;XP_050049665.1;XP_050051512.1;XP_050032996.1;XP_050027845.1;XP_050051511.1;XP_050041502.1;XP_050030035.1;XP_050043005.1;XP_050052359.1;XP_050033008.1;XP_050052410.1;XP_050049666.1;XP_050028646.1;XP_050049664.1;XP_050029751.1;XP_050028975.1;XP_050037610.1;XP_050041503.1;XP_050025112.1;XP_050033009.1;XP_050038286.1;XP_050030084.1
KEGG: 00563+3.5.1.89	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1	XP_050044051.1
Reactome: R-HSA-180910	Vpr-mediated nuclear import of PICs	37	XP_050038864.1;XP_050024518.1;XP_050035770.1;XP_050038865.1;XP_050042392.1;XP_050023475.1;XP_050030653.1;XP_050049377.1;XP_050038968.1;XP_050038866.1;XP_050023476.1;XP_050044008.1;XP_050038862.1;XP_050029516.1;XP_050023718.1;XP_050026809.1;XP_050046156.1;XP_050035932.1;XP_050033146.1;XP_050026810.1;XP_050029515.1;XP_050035933.1;XP_050042391.1;XP_050038895.1;XP_050030942.1;XP_050038863.1;XP_050023474.1;XP_050036430.1;XP_050038966.1;XP_050030507.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050038967.1;XP_050039240.1;XP_050036827.1;XP_050025064.1
Reactome: R-HSA-71032	Propionyl-CoA catabolism	4	XP_050049718.1;XP_050034236.1;XP_050026533.1;XP_050038736.1
MetaCyc: PWY-6124	Inosine-5'-phosphate biosynthesis II	4	XP_050039993.1;XP_050030286.1;XP_050039992.1;XP_050034170.1
Reactome: R-HSA-191273	Cholesterol biosynthesis	14	XP_050045765.1;XP_050024679.1;XP_050051832.1;XP_050045363.1;XP_050036811.1;XP_050045766.1;XP_050045362.1;XP_050045365.1;XP_050051831.1;XP_050044825.1;XP_050028850.1;XP_050045364.1;XP_050036809.1;XP_050036810.1
Reactome: R-HSA-4549349	Defective ALG2 causes ALG2-CDG (CDG-1i)	3	XP_050044996.1;XP_050023466.1;XP_050023465.1
Reactome: R-HSA-9033500	TYSND1 cleaves peroxisomal proteins	3	XP_050030300.1;XP_050044392.1;XP_050030299.1
Reactome: R-HSA-8939245	RUNX1 regulates transcription of genes involved in BCR signaling	1	XP_050047422.1
KEGG: 00260+4.2.1.22	Glycine, serine and threonine metabolism	5	XP_050035465.1;XP_050035464.1;XP_050035467.1;XP_050035466.1;XP_050035463.1
Reactome: R-HSA-3214815	HDACs deacetylate histones	33	XP_050045444.1;XP_050050589.1;XP_050044955.1;XP_050023568.1;XP_050050591.1;XP_050038213.1;XP_050029499.1;XP_050025248.1;XP_050044797.1;XP_050024845.1;XP_050031443.1;XP_050036728.1;XP_050025244.1;XP_050044796.1;XP_050031742.1;XP_050046120.1;XP_050038199.1;XP_050044958.1;XP_050044956.1;XP_050036268.1;XP_050025243.1;XP_050039889.1;XP_050031736.1;XP_050050621.1;XP_050048804.1;XP_050027309.1;XP_050031442.1;XP_050023569.1;XP_050031360.1;XP_050046119.1;XP_050044957.1;XP_050025266.1;XP_050050590.1
MetaCyc: PWY-6505	L-tryptophan degradation XII (Geobacillus)	1	XP_050045561.1
Reactome: R-HSA-9620244	Long-term potentiation	28	XP_050050696.1;XP_050050694.1;XP_050050697.1;XP_050050691.1;XP_050048382.1;XP_050050689.1;XP_050050699.1;XP_050050702.1;XP_050050681.1;XP_050050684.1;XP_050050687.1;XP_050050680.1;XP_050050698.1;XP_050048383.1;XP_050050685.1;XP_050048384.1;XP_050050683.1;XP_050050682.1;XP_050050695.1;XP_050048381.1;XP_050050688.1;XP_050050686.1;XP_050050700.1;XP_050050690.1;XP_050050692.1;XP_050050701.1;XP_050050679.1;XP_050050693.1
KEGG: 00360+4.2.1.17	Phenylalanine metabolism	6	XP_050041635.1;XP_050051194.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
Reactome: R-HSA-1250347	SHC1 events in ERBB4 signaling	5	XP_050032853.1;XP_050051864.1;XP_050051866.1;XP_050051865.1;XP_050051868.1
Reactome: R-HSA-6782315	tRNA modification in the nucleus and cytosol	42	XP_050037111.1;XP_050024076.1;XP_050044456.1;XP_050052646.1;XP_050035535.1;XP_050041821.1;XP_050031168.1;XP_050048642.1;XP_050035536.1;XP_050044729.1;XP_050048328.1;XP_050040715.1;XP_050029894.1;XP_050042353.1;XP_050023621.1;XP_050027731.1;XP_050041822.1;XP_050041916.1;XP_050031351.1;XP_050048643.1;XP_050049339.1;XP_050050310.1;XP_050041823.1;XP_050022865.1;XP_050023620.1;XP_050051592.1;XP_050038336.1;XP_050049014.1;XP_050048327.1;XP_050028841.1;XP_050031350.1;XP_050031484.1;XP_050052616.1;XP_050038337.1;XP_050052617.1;XP_050038338.1;XP_050039580.1;XP_050038357.1;XP_050036524.1;XP_050038339.1;XP_050052202.1;XP_050052201.1
Reactome: R-HSA-8874211	CREB3 factors activate genes	3	XP_050049072.1;XP_050027741.1;XP_050051298.1
Reactome: R-HSA-8878166	Transcriptional regulation by RUNX2	2	XP_050047422.1;XP_050043507.1
KEGG: 00380+1.13.11.6	Tryptophan metabolism	1	XP_050045561.1
Reactome: R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	30	XP_050046735.1;XP_050045464.1;XP_050024953.1;XP_050049758.1;XP_050043181.1;XP_050045467.1;XP_050026777.1;XP_050051356.1;XP_050051357.1;XP_050024840.1;XP_050045465.1;XP_050039380.1;XP_050043436.1;XP_050049757.1;XP_050027815.1;XP_050045466.1;XP_050052055.1;XP_050051355.1;XP_050026776.1;XP_050046734.1;XP_050049762.1;XP_050052420.1;XP_050049761.1;XP_050025278.1;XP_050049759.1;XP_050024841.1;XP_050047338.1;XP_050024952.1;XP_050036026.1;XP_050039381.1
Reactome: R-HSA-8937144	Aryl hydrocarbon receptor signalling	1	XP_050027825.1
Reactome: R-HSA-180024	DARPP-32 events	29	XP_050029918.1;XP_050042110.1;XP_050042038.1;XP_050024313.1;XP_050042107.1;XP_050042106.1;XP_050042037.1;XP_050042035.1;XP_050042042.1;XP_050032122.1;XP_050042112.1;XP_050029919.1;XP_050029917.1;XP_050042039.1;XP_050024314.1;XP_050042044.1;XP_050042108.1;XP_050024316.1;XP_050024310.1;XP_050032121.1;XP_050024311.1;XP_050042109.1;XP_050042105.1;XP_050042045.1;XP_050042043.1;XP_050024315.1;XP_050042111.1;XP_050042041.1;XP_050042036.1
Reactome: R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	50	XP_050047181.1;XP_050044469.1;XP_050033833.1;XP_050037399.1;XP_050048824.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050033318.1;XP_050037398.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050049124.1;XP_050042025.1;XP_050048720.1;XP_050040198.1;XP_050029802.1;XP_050050645.1;XP_050044470.1;XP_050052231.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050047809.1;XP_050048719.1;XP_050032477.1;XP_050045785.1;XP_050050373.1;XP_050040200.1;XP_050022938.1;XP_050033237.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050045660.1;XP_050044478.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050025848.1
Reactome: R-HSA-611105	Respiratory electron transport	72	XP_050025102.1;XP_050047857.1;XP_050024428.1;XP_050022910.1;XP_050049630.1;XP_050030732.1;XP_050033718.1;XP_050049591.1;XP_050044788.1;XP_050037102.1;YP_010283874.1;XP_050039258.1;YP_010283881.1;XP_050030648.1;XP_050034521.1;XP_050033980.1;YP_010283875.1;XP_050042222.1;YP_010283877.1;XP_050045244.1;YP_010283871.1;XP_050029504.1;XP_050041760.1;XP_050036569.1;XP_050043511.1;XP_050025577.1;XP_050030853.1;XP_050045633.1;YP_010283878.1;XP_050023713.1;XP_050048792.1;XP_050033843.1;XP_050044448.1;XP_050038590.1;XP_050028250.1;XP_050047553.1;XP_050030734.1;XP_050045053.1;XP_050034948.1;YP_010283876.1;XP_050034954.1;XP_050044722.1;XP_050045575.1;XP_050033719.1;XP_050048772.1;XP_050047701.1;XP_050036002.1;XP_050030178.1;XP_050042899.1;XP_050031032.1;XP_050045279.1;XP_050047891.1;XP_050045538.1;XP_050052134.1;XP_050032473.1;YP_010283870.1;XP_050023711.1;XP_050030733.1;XP_050022909.1;XP_050036004.1;XP_050031998.1;XP_050048413.1;XP_050042233.1;XP_050036003.1;XP_050023883.1;XP_050049627.1;XP_050031824.1;XP_050048359.1;YP_010283869.1;XP_050050818.1;XP_050029753.1;XP_050039241.1
KEGG: 00600+1.14.19.17	Sphingolipid metabolism	1	XP_050037297.1
KEGG: 00230+2.7.4.6	Purine metabolism	6	XP_050038939.1;XP_050029490.1;XP_050043296.1;XP_050029492.1;XP_050031386.1;XP_050031510.1
KEGG: 00190+7.1.1.8	Oxidative phosphorylation	1	XP_050047841.1
MetaCyc: PWY-7858	(5Z)-dodecenoate biosynthesis II	6	XP_050026060.1;XP_050033008.1;XP_050033009.1;XP_050032773.1;XP_050023456.1;XP_050029751.1
KEGG: 00030+5.1.3.1	Pentose phosphate pathway	1	XP_050033946.1
Reactome: R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription	3	XP_050047964.1;XP_050047962.1;XP_050047963.1
MetaCyc: PWY-7234	Inosine-5'-phosphate biosynthesis III	4	XP_050030286.1;XP_050039993.1;XP_050034170.1;XP_050039992.1
MetaCyc: PWY-7254	TCA cycle VII (acetate-producers)	11	XP_050033843.1;XP_050043076.1;XP_050038590.1;XP_050033719.1;XP_050037417.1;XP_050043069.1;XP_050037007.1;XP_050026123.1;XP_050033718.1;XP_050041863.1;XP_050037396.1
Reactome: R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	10	XP_050029921.1;XP_050048329.1;XP_050037137.1;XP_050034592.1;XP_050047068.1;XP_050037136.1;XP_050048331.1;XP_050049414.1;XP_050032851.1;XP_050026397.1
KEGG: 00940+1.11.1.7	Phenylpropanoid biosynthesis	18	XP_050022517.1;XP_050037572.1;XP_050033134.1;XP_050052157.1;XP_050031263.1;XP_050052159.1;XP_050030590.1;XP_050037575.1;XP_050037573.1;XP_050022911.1;XP_050031834.1;XP_050037576.1;XP_050052158.1;XP_050032263.1;XP_050030591.1;XP_050031815.1;XP_050037574.1;XP_050022520.1
KEGG: 00061+6.4.1.2	Fatty acid biosynthesis	12	XP_050048457.1;XP_050048456.1;XP_050048462.1;XP_050048467.1;XP_050048468.1;XP_050048461.1;XP_050048458.1;XP_050048465.1;XP_050048466.1;XP_050048463.1;XP_050048460.1;XP_050048459.1
Reactome: R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment	3	XP_050050758.1;XP_050035481.1;XP_050048534.1
MetaCyc: PWY-7197	Pyrimidine deoxyribonucleotide phosphorylation	7	XP_050029492.1;XP_050031510.1;XP_050034794.1;XP_050031386.1;XP_050029490.1;XP_050038939.1;XP_050043296.1
MetaCyc: PWY-4202	Arsenate detoxification I (mammalian)	3	XP_050035831.1;XP_050046554.1;XP_050046556.1
Reactome: R-HSA-5619107	Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)	37	XP_050049377.1;XP_050030653.1;XP_050038866.1;XP_050038968.1;XP_050044008.1;XP_050023476.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050033146.1;XP_050026810.1;XP_050038864.1;XP_050024518.1;XP_050038865.1;XP_050035770.1;XP_050023475.1;XP_050042392.1;XP_050030507.1;XP_050038966.1;XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050038967.1;XP_050025064.1;XP_050039240.1;XP_050036827.1;XP_050029515.1;XP_050035933.1;XP_050038895.1;XP_050042391.1;XP_050030942.1;XP_050038863.1;XP_050023474.1;XP_050036430.1
Reactome: R-HSA-173736	Alternative complement activation	2	XP_050046184.1;XP_050044540.1
Reactome: R-HSA-171306	Packaging Of Telomere Ends	8	XP_050025244.1;XP_050025763.1;XP_050038199.1;XP_050025243.1;XP_050036268.1;XP_050025248.1;XP_050025266.1;XP_050038213.1
MetaCyc: PWY-7736	Stellatic acid biosynthesis	1	XP_050023623.1
Reactome: R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	19	XP_050028061.1;XP_050050142.1;XP_050047214.1;XP_050048534.1;XP_050047191.1;XP_050047215.1;XP_050047193.1;XP_050047192.1;XP_050047213.1;XP_050050144.1;XP_050046878.1;XP_050046879.1;XP_050035481.1;XP_050046877.1;XP_050028062.1;XP_050050758.1;XP_050050141.1;XP_050050140.1;XP_050050143.1
Reactome: R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	28	XP_050045342.1;XP_050045334.1;XP_050045149.1;XP_050036828.1;XP_050034746.1;XP_050037157.1;XP_050051056.1;XP_050045335.1;XP_050045336.1;XP_050045341.1;XP_050026292.1;XP_050045332.1;XP_050045339.1;XP_050034362.1;XP_050048112.1;XP_050024013.1;XP_050044826.1;XP_050045333.1;XP_050051055.1;XP_050045340.1;XP_050048111.1;XP_050037446.1;XP_050045705.1;XP_050045337.1;XP_050034156.1;XP_050045704.1;XP_050045331.1;XP_050044153.1
KEGG: 00730+3.6.1.28	Thiamine metabolism	1	XP_050030314.1
Reactome: R-HSA-390522	Striated Muscle Contraction	13	XP_050039431.1;XP_050044438.1;XP_050039424.1;XP_050044441.1;XP_050039425.1;XP_050039432.1;XP_050039430.1;XP_050044437.1;XP_050044440.1;XP_050044435.1;XP_050039427.1;XP_050039429.1;XP_050044436.1
Reactome: R-HSA-9615710	Late endosomal microautophagy	10	XP_050023674.1;XP_050025018.1;XP_050048534.1;XP_050025017.1;XP_050035481.1;XP_050030675.1;XP_050050066.1;XP_050038767.1;XP_050052234.1;XP_050050057.1
Reactome: R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	18	XP_050045657.1;XP_050048460.1;XP_050048459.1;XP_050048463.1;XP_050048465.1;XP_050049718.1;XP_050048462.1;XP_050048468.1;XP_050048456.1;XP_050048457.1;XP_050048152.1;XP_050036164.1;XP_050036162.1;XP_050048466.1;XP_050048458.1;XP_050048461.1;XP_050048467.1;XP_050036163.1
MetaCyc: PWY-8106	Queuosine biosynthesis III (queuosine salvage)	2	XP_050027731.1;XP_050051592.1
KEGG: 00240+3.5.2.3	Pyrimidine metabolism	1	XP_050032255.1
Reactome: R-HSA-75893	TNF signaling	1	XP_050026551.1
Reactome: R-HSA-420029	Tight junction interactions	5	XP_050036824.1;XP_050049988.1;XP_050036823.1;XP_050036821.1;XP_050036822.1
Reactome: R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	3	XP_050048534.1;XP_050035481.1;XP_050048032.1
KEGG: 00280+1.2.4.4	Valine, leucine and isoleucine degradation	3	XP_050036448.1;XP_050036446.1;XP_050036449.1
MetaCyc: PWY-5067	Glycogen biosynthesis II (from UDP-D-Glucose)	4	XP_050028469.1;XP_050042400.1;XP_050040570.1;XP_050028738.1
KEGG: 00052+3.5.1.25	Galactose metabolism	3	XP_050038838.1;XP_050038837.1;XP_050038836.1
Reactome: R-HSA-1257604	PIP3 activates AKT signaling	20	XP_050032548.1;XP_050052242.1;XP_050048621.1;XP_050044786.1;XP_050047065.1;XP_050051864.1;XP_050044781.1;XP_050025348.1;XP_050051865.1;XP_050024508.1;XP_050025347.1;XP_050052241.1;XP_050051868.1;XP_050042304.1;XP_050048619.1;XP_050051866.1;XP_050044784.1;XP_050048620.1;XP_050032853.1;XP_050041412.1
KEGG: 00983+1.17.4.1	Drug metabolism - other enzymes	2	XP_050038800.1;XP_050030600.1
Reactome: R-HSA-4793954	Defective MOGS causes MOGS-CDG (CDG-2b)	3	XP_050050232.1;XP_050050234.1;XP_050050233.1
Reactome: R-HSA-1483213	Synthesis of PE	13	XP_050039335.1;XP_050037458.1;XP_050022623.1;XP_050037455.1;XP_050039338.1;XP_050037456.1;XP_050039337.1;XP_050022630.1;XP_050039333.1;XP_050022634.1;XP_050039336.1;XP_050039334.1;XP_050037457.1
KEGG: 00030+1.1.1.49	Pentose phosphate pathway	5	XP_050026013.1;XP_050026014.1;XP_050026016.1;XP_050026015.1;XP_050026012.1
Reactome: R-HSA-2132295	MHC class II antigen presentation	121	XP_050049759.1;XP_050024841.1;XP_050027218.1;XP_050049761.1;XP_050041736.1;XP_050039381.1;XP_050035990.1;XP_050032250.1;XP_050041002.1;XP_050046734.1;XP_050037100.1;XP_050027250.1;XP_050041005.1;XP_050052420.1;XP_050035979.1;XP_050051357.1;XP_050024114.1;XP_050038148.1;XP_050035993.1;XP_050041734.1;XP_050051716.1;XP_050031304.1;XP_050044271.1;XP_050031039.1;XP_050046156.1;XP_050034507.1;XP_050035975.1;XP_050033146.1;XP_050049758.1;XP_050024146.1;XP_050043899.1;XP_050031626.1;XP_050028603.1;XP_050038144.1;XP_050038145.1;XP_050035986.1;XP_050035978.1;XP_050030709.1;XP_050022889.1;XP_050051715.1;XP_050038149.1;XP_050034982.1;XP_050051355.1;XP_050044654.1;XP_050051711.1;XP_050035991.1;XP_050052700.1;XP_050036544.1;XP_050051718.1;XP_050025016.1;XP_050031305.1;XP_050052701.1;XP_050030375.1;XP_050024840.1;XP_050045165.1;XP_050040246.1;XP_050041003.1;XP_050026207.1;XP_050041740.1;XP_050045597.1;XP_050034475.1;XP_050041883.1;XP_050044129.1;XP_050027216.1;XP_050035987.1;XP_050035983.1;XP_050035974.1;XP_050028330.1;XP_050051714.1;XP_050044127.1;XP_050030681.1;XP_050041001.1;XP_050048294.1;XP_050038146.1;XP_050051006.1;XP_050035988.1;XP_050035985.1;XP_050027217.1;XP_050031170.1;XP_050027251.1;XP_050041652.1;XP_050049353.1;XP_050049762.1;XP_050035984.1;XP_050027252.1;XP_050051712.1;XP_050041741.1;XP_050035982.1;XP_050049757.1;XP_050037041.1;XP_050035976.1;XP_050041739.1;XP_050027249.1;XP_050046735.1;XP_050051713.1;XP_050035980.1;XP_050041737.1;XP_050035981.1;XP_050026883.1;XP_050026823.1;XP_050030327.1;XP_050047338.1;XP_050044081.1;XP_050041738.1;XP_050052055.1;XP_050035977.1;XP_050024113.1;XP_050050989.1;XP_050033964.1;XP_050035973.1;XP_050027253.1;XP_050039380.1;XP_050044128.1;XP_050029897.1;XP_050051356.1;XP_050035992.1;XP_050050837.1;XP_050035989.1;XP_050032251.1;XP_050043181.1;XP_050038147.1
KEGG: 00510+2.4.1.117	N-Glycan biosynthesis	1	XP_050039888.1
MetaCyc: PWY-5921	Glutaminyl-trnagln biosynthesis via transamidation	1	XP_050026388.1
Reactome: R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	10	XP_050024453.1;XP_050052132.1;XP_050044129.1;XP_050044654.1;XP_050052730.1;XP_050044081.1;XP_050033321.1;XP_050044127.1;XP_050051572.1;XP_050044128.1
KEGG: 00051+4.2.1.47	Fructose and mannose metabolism	3	XP_050047838.1;XP_050047839.1;XP_050047837.1
Reactome: R-HSA-525793	Myogenesis	15	XP_050052372.1;XP_050034239.1;XP_050025375.1;XP_050044799.1;XP_050034241.1;XP_050044801.1;XP_050034242.1;XP_050025374.1;XP_050044798.1;XP_050036805.1;XP_050044800.1;XP_050044802.1;XP_050044803.1;XP_050034240.1;XP_050024699.1
MetaCyc: PWY-7385	1,3-propanediol biosynthesis (engineered)	8	XP_050025560.1;XP_050034614.1;XP_050040644.1;XP_050040643.1;XP_050040641.1;XP_050050068.1;XP_050040645.1;XP_050025561.1
Reactome: R-HSA-5654695	PI-3K cascade:FGFR2	1	XP_050032853.1
MetaCyc: PWY-7220	Adenosine deoxyribonucleotides de novo biosynthesis II	8	XP_050031386.1;XP_050029490.1;XP_050038939.1;XP_050038800.1;XP_050043296.1;XP_050029492.1;XP_050031510.1;XP_050030600.1
MetaCyc: PWY-7560	Methylerythritol phosphate pathway II	5	XP_050027584.1;XP_050045766.1;XP_050045765.1;XP_050046883.1;XP_050027585.1
KEGG: 00270+4.4.1.13	Cysteine and methionine metabolism	6	XP_050050545.1;XP_050050544.1;XP_050052721.1;XP_050052719.1;XP_050052715.1;XP_050052716.1
Reactome: R-HSA-5660862	Defective SLC7A7 causes lysinuric protein intolerance (LPI)	1	XP_050036619.1
Reactome: R-HSA-8951664	Neddylation	158	XP_050029802.1;XP_050052231.1;XP_050033832.1;XP_050039985.1;XP_050039454.1;XP_050040624.1;XP_050026845.1;XP_050029781.1;XP_050044475.1;XP_050052635.1;XP_050038839.1;XP_050027657.1;XP_050029370.1;XP_050046059.1;XP_050051056.1;XP_050036156.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050044219.1;XP_050044469.1;XP_050037399.1;XP_050039779.1;XP_050044476.1;XP_050033847.1;XP_050050553.1;XP_050033237.1;XP_050029644.1;XP_050049767.1;XP_050046028.1;XP_050023147.1;XP_050045055.1;XP_050024349.1;XP_050029647.1;XP_050031954.1;XP_050048771.1;XP_050049691.1;XP_050048534.1;XP_050040623.1;XP_050024348.1;XP_050030634.1;XP_050040199.1;XP_050051964.1;XP_050047290.1;XP_050043447.1;XP_050033331.1;XP_050049142.1;XP_050037397.1;XP_050034382.1;XP_050042025.1;XP_050040198.1;XP_050051055.1;XP_050036347.1;XP_050044451.1;XP_050049143.1;XP_050038738.1;XP_050022518.1;XP_050029646.1;XP_050049146.1;XP_050024696.1;XP_050038825.1;XP_050052636.1;XP_050050819.1;XP_050050029.1;XP_050037401.1;XP_050025092.1;XP_050052685.1;XP_050047288.1;XP_050029320.1;XP_050039776.1;XP_050035110.1;XP_050023148.1;XP_050036605.1;XP_050031823.1;XP_050050552.1;XP_050049612.1;XP_050050645.1;XP_050048823.1;XP_050044345.1;XP_050034844.1;XP_050030249.1;XP_050036567.1;XP_050034247.1;XP_050042787.1;XP_050045056.1;XP_050036346.1;XP_050049124.1;XP_050048720.1;XP_050049582.1;XP_050036560.1;XP_050034248.1;XP_050038778.1;XP_050044806.1;XP_050038140.1;XP_050032549.1;XP_050029421.1;XP_050050820.1;XP_050040111.1;XP_050032550.1;XP_050040459.1;XP_050048824.1;XP_050029648.1;XP_050045660.1;XP_050026547.1;XP_050050506.1;XP_050029649.1;XP_050029087.1;XP_050022938.1;XP_050052633.1;XP_050025293.1;XP_050047809.1;XP_050049563.1;XP_050032477.1;XP_050044470.1;XP_050046029.1;XP_050027605.1;XP_050049690.1;XP_050035472.1;XP_050035219.1;XP_050031786.1;XP_050027118.1;XP_050049766.1;XP_050026607.1;XP_050024749.1;XP_050032632.1;XP_050035481.1;XP_050050551.1;XP_050023267.1;XP_050023585.1;XP_050033318.1;XP_050033723.1;XP_050039965.1;XP_050023714.1;XP_050047181.1;XP_050050414.1;XP_050033833.1;XP_050038815.1;XP_050049144.1;XP_050044478.1;XP_050031479.1;XP_050047291.1;XP_050048721.1;XP_050025848.1;XP_050047670.1;XP_050025715.1;XP_050029780.1;XP_050034772.1;XP_050040200.1;XP_050047769.1;XP_050023111.1;XP_050044609.1;XP_050038814.1;XP_050022843.1;XP_050029645.1;XP_050048719.1;XP_050052314.1;XP_050045785.1;XP_050050373.1
Reactome: R-HSA-5673001	RAF/MAP kinase cascade	50	XP_050050687.1;XP_050050684.1;XP_050050681.1;XP_050051735.1;XP_050050698.1;XP_050044781.1;XP_050036848.1;XP_050050685.1;XP_050051733.1;XP_050036851.1;XP_050050696.1;XP_050045015.1;XP_050048382.1;XP_050050697.1;XP_050051734.1;XP_050050690.1;XP_050050700.1;XP_050050686.1;XP_050050679.1;XP_050050701.1;XP_050051868.1;XP_050050683.1;XP_050051865.1;XP_050048381.1;XP_050047606.1;XP_050050680.1;XP_050044786.1;XP_050050699.1;XP_050047065.1;XP_050050702.1;XP_050051864.1;XP_050048507.1;XP_050048383.1;XP_050048384.1;XP_050050689.1;XP_050050694.1;XP_050050691.1;XP_050032853.1;XP_050050688.1;XP_050044784.1;XP_050045016.1;XP_050050693.1;XP_050051866.1;XP_050051732.1;XP_050047598.1;XP_050050692.1;XP_050036850.1;XP_050050682.1;XP_050036849.1;XP_050050695.1
Reactome: R-HSA-139853	Elevation of cytosolic Ca2+ levels	4	XP_050025123.1;XP_050025135.1;XP_050025879.1;XP_050025138.1
Reactome: R-HSA-418359	Reduction of cytosolic Ca++ levels	28	XP_050037037.1;XP_050044887.1;XP_050029081.1;XP_050037034.1;XP_050037033.1;XP_050037035.1;XP_050026489.1;XP_050026484.1;XP_050029080.1;XP_050026481.1;XP_050026492.1;XP_050026483.1;XP_050029082.1;XP_050026485.1;XP_050037036.1;XP_050026494.1;XP_050026482.1;XP_050029083.1;XP_050026490.1;XP_050026491.1;XP_050026487.1;XP_050032483.1;XP_050026488.1;XP_050026495.1;XP_050032484.1;XP_050026486.1;XP_050029084.1;XP_050026493.1
KEGG: 00010+6.2.1.1	Glycolysis / Gluconeogenesis	3	XP_050030604.1;XP_050044794.1;XP_050040406.1
Reactome: R-HSA-191859	snRNP Assembly	58	XP_050033146.1;XP_050026810.1;XP_050043912.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050025576.1;XP_050044008.1;XP_050023476.1;XP_050030653.1;XP_050049377.1;XP_050038866.1;XP_050038968.1;XP_050045189.1;XP_050042392.1;XP_050023475.1;XP_050048361.1;XP_050038865.1;XP_050036568.1;XP_050035770.1;XP_050043913.1;XP_050038864.1;XP_050026024.1;XP_050044812.1;XP_050045329.1;XP_050024518.1;XP_050049813.1;XP_050036395.1;XP_050038776.1;XP_050038967.1;XP_050026022.1;XP_050038775.1;XP_050025064.1;XP_050039240.1;XP_050036827.1;XP_050031490.1;XP_050030506.1;XP_050049626.1;XP_050030652.1;XP_050038969.1;XP_050030507.1;XP_050038966.1;XP_050023474.1;XP_050036430.1;XP_050026021.1;XP_050038895.1;XP_050038777.1;XP_050042391.1;XP_050038863.1;XP_050026023.1;XP_050030942.1;XP_050049812.1;XP_050035933.1;XP_050031330.1;XP_050029515.1
Reactome: R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	84	XP_050029515.1;XP_050047733.1;XP_050032814.1;XP_050036670.1;XP_050035933.1;XP_050030942.1;XP_050042391.1;XP_050029632.1;XP_050049522.1;XP_050038895.1;XP_050023014.1;XP_050044983.1;XP_050027597.1;XP_050038966.1;XP_050032815.1;XP_050039240.1;XP_050041352.1;XP_050025064.1;XP_050038967.1;XP_050024518.1;XP_050030603.1;XP_050038864.1;XP_050040805.1;XP_050035770.1;XP_050038865.1;XP_050029351.1;XP_050045189.1;XP_050030653.1;XP_050049377.1;XP_050035497.1;XP_050035496.1;XP_050049523.1;XP_050029327.1;XP_050035932.1;XP_050046156.1;XP_050044982.1;XP_050049409.1;XP_050032816.1;XP_050023718.1;XP_050029910.1;XP_050033146.1;XP_050047729.1;XP_050029925.1;XP_050047730.1;XP_050047731.1;XP_050029909.1;XP_050023742.1;XP_050038863.1;XP_050036485.1;XP_050036430.1;XP_050049519.1;XP_050047758.1;XP_050023474.1;XP_050029924.1;XP_050030507.1;XP_050041538.1;XP_050047732.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050039198.1;XP_050049411.1;XP_050036827.1;XP_050032813.1;XP_050030410.1;XP_050038681.1;XP_050049520.1;XP_050038682.1;XP_050049410.1;XP_050036662.1;XP_050045424.1;XP_050042392.1;XP_050023475.1;XP_050038968.1;XP_050038680.1;XP_050038866.1;XP_050023476.1;XP_050044008.1;XP_050029923.1;XP_050049521.1;XP_050026809.1;XP_050038862.1;XP_050029516.1;XP_050026810.1
MetaCyc: PWY-7343	UDP-alpha-D-glucose biosynthesis I	4	XP_050037411.1;XP_050037412.1;XP_050037410.1;XP_050037409.1
KEGG: 00510+2.4.1.83	N-Glycan biosynthesis	1	XP_050029180.1
KEGG: 00220+6.3.1.2	Arginine biosynthesis	11	XP_050038621.1;XP_050038622.1;XP_050038620.1;XP_050038619.1;XP_050033588.1;XP_050051950.1;XP_050028873.1;XP_050038618.1;XP_050028874.1;XP_050028876.1;XP_050033589.1
Reactome: R-HSA-8934903	Receptor Mediated Mitophagy	4	XP_050025942.1;XP_050029936.1;XP_050025941.1;XP_050051200.1
MetaCyc: PWY-5041	S-adenosyl-L-methionine cycle II	18	XP_050030829.1;XP_050030819.1;XP_050052167.1;XP_050030822.1;XP_050030831.1;XP_050030821.1;XP_050030823.1;XP_050030827.1;XP_050030820.1;XP_050052168.1;XP_050030828.1;XP_050030824.1;XP_050048145.1;XP_050030825.1;XP_050030818.1;XP_050030826.1;XP_050030830.1;XP_050030832.1
KEGG: 00710+4.1.2.13	Carbon fixation in photosynthetic organisms	2	XP_050025560.1;XP_050025561.1
Reactome: R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	4	XP_050048534.1;XP_050035481.1;XP_050028061.1;XP_050028062.1
MetaCyc: PWY-7268	NAD/NADP-NADH/NADPH cytosolic interconversion (yeast)	16	XP_050026012.1;XP_050025550.1;XP_050026123.1;XP_050026016.1;XP_050037396.1;XP_050037007.1;XP_050043069.1;XP_050026013.1;XP_050025548.1;XP_050023815.1;XP_050041863.1;XP_050025549.1;XP_050026015.1;XP_050025547.1;XP_050026014.1;XP_050043076.1
Reactome: R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	6	XP_050051735.1;XP_050041785.1;XP_050051732.1;XP_050051733.1;XP_050049319.1;XP_050051734.1
Reactome: R-HSA-8851907	MET activates PI3K/AKT signaling	1	XP_050032853.1
KEGG: 00524+2.7.1.1	Neomycin, kanamycin and gentamicin biosynthesis	3	XP_050047071.1;XP_050027343.1;XP_050047070.1
KEGG: 00030+4.1.2.13	Pentose phosphate pathway	2	XP_050025561.1;XP_050025560.1
Reactome: R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	28	XP_050022605.1;XP_050048786.1;XP_050046064.1;XP_050047551.1;XP_050022604.1;XP_050044695.1;XP_050045274.1;XP_050047604.1;XP_050032478.1;XP_050024885.1;XP_050038612.1;XP_050048499.1;XP_050028323.1;XP_050028292.1;XP_050022603.1;XP_050022581.1;XP_050037414.1;XP_050044213.1;XP_050033904.1;XP_050041012.1;XP_050037711.1;XP_050045930.1;XP_050033903.1;XP_050039624.1;XP_050048896.1;XP_050032647.1;XP_050022606.1;XP_050022602.1
Reactome: R-HSA-983189	Kinesins	68	XP_050050272.1;XP_050046735.1;XP_050042211.1;XP_050052462.1;XP_050045529.1;XP_050049757.1;XP_050050238.1;XP_050033500.1;XP_050032496.1;XP_050049762.1;XP_050042301.1;XP_050047757.1;XP_050033494.1;XP_050030681.1;XP_050038146.1;XP_050042302.1;XP_050033627.1;XP_050039959.1;XP_050043181.1;XP_050038147.1;XP_050052733.1;XP_050039380.1;XP_050051356.1;XP_050036828.1;XP_050025646.1;XP_050050256.1;XP_050052055.1;XP_050035850.1;XP_050050216.1;XP_050033964.1;XP_050035971.1;XP_050042789.1;XP_050048644.1;XP_050047338.1;XP_050050230.1;XP_050036861.1;XP_050050264.1;XP_050049758.1;XP_050050246.1;XP_050051357.1;XP_050023886.1;XP_050038148.1;XP_050050207.1;XP_050046734.1;XP_050052420.1;XP_050050223.1;XP_050043791.1;XP_050049759.1;XP_050024841.1;XP_050027921.1;XP_050049761.1;XP_050042210.1;XP_050039381.1;XP_050025401.1;XP_050048645.1;XP_050036862.1;XP_050042479.1;XP_050042300.1;XP_050024840.1;XP_050026207.1;XP_050050573.1;XP_050038149.1;XP_050051355.1;XP_050042212.1;XP_050038144.1;XP_050038145.1;XP_050022722.1;XP_050051130.1
Reactome: R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	19	XP_050032478.1;XP_050025266.1;XP_050044695.1;XP_050047551.1;XP_050022604.1;XP_050022605.1;XP_050037414.1;XP_050022603.1;XP_050028292.1;XP_050028323.1;XP_050025244.1;XP_050025248.1;XP_050038213.1;XP_050025243.1;XP_050036268.1;XP_050022606.1;XP_050022602.1;XP_050025763.1;XP_050038199.1
KEGG: 00640+4.1.1.9	Propanoate metabolism	3	XP_050025931.1;XP_050025932.1;XP_050025930.1
Reactome: R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	15	XP_050026192.1;XP_050042080.1;XP_050039107.1;XP_050039279.1;XP_050031330.1;XP_050043924.1;XP_050039108.1;XP_050042081.1;XP_050042082.1;XP_050042079.1;XP_050031490.1;XP_050042083.1;XP_050039278.1;XP_050039106.1;XP_050031529.1
Reactome: R-HSA-182971	EGFR downregulation	15	XP_050032654.1;XP_050025375.1;XP_050044192.1;XP_050044195.1;XP_050025374.1;XP_050044194.1;XP_050044199.1;XP_050044193.1;XP_050032655.1;XP_050044191.1;XP_050044197.1;XP_050032853.1;XP_050048534.1;XP_050044198.1;XP_050035481.1
KEGG: 00720+1.3.5.1	Carbon fixation pathways in prokaryotes	4	XP_050038590.1;XP_050033719.1;XP_050033843.1;XP_050033718.1
Reactome: R-HSA-8957275	Post-translational protein phosphorylation	24	XP_050051298.1;XP_050023648.1;XP_050042242.1;XP_050026869.1;XP_050042454.1;XP_050023334.1;XP_050034595.1;XP_050023649.1;XP_050046184.1;XP_050042240.1;XP_050023809.1;XP_050040959.1;XP_050042262.1;XP_050042241.1;XP_050042260.1;XP_050044540.1;XP_050029683.1;XP_050046839.1;XP_050040960.1;XP_050046840.1;XP_050042261.1;XP_050023312.1;XP_050023796.1;XP_050023422.1
Reactome: R-HSA-5368286	Mitochondrial translation initiation	77	XP_050027321.1;XP_050045284.1;XP_050049331.1;XP_050047319.1;XP_050027066.1;XP_050031800.1;XP_050025036.1;XP_050049763.1;XP_050035998.1;XP_050052609.1;XP_050042269.1;XP_050040040.1;XP_050026332.1;XP_050031801.1;XP_050027133.1;XP_050036704.1;XP_050036878.1;XP_050030728.1;XP_050047641.1;XP_050046959.1;XP_050036486.1;XP_050035939.1;XP_050047314.1;XP_050042040.1;XP_050047054.1;XP_050033257.1;XP_050052189.1;XP_050029555.1;XP_050038683.1;XP_050042050.1;XP_050027674.1;XP_050035316.1;XP_050046197.1;XP_050028172.1;XP_050027411.1;XP_050034847.1;XP_050051717.1;XP_050051211.1;XP_050022476.1;XP_050038468.1;XP_050041220.1;XP_050047642.1;XP_050027420.1;XP_050050913.1;XP_050034846.1;XP_050040023.1;XP_050043556.1;XP_050045126.1;XP_050032857.1;XP_050028096.1;XP_050041975.1;XP_050037838.1;XP_050044835.1;XP_050026521.1;XP_050037279.1;XP_050036366.1;XP_050027247.1;XP_050034817.1;XP_050045271.1;XP_050045058.1;XP_050044790.1;XP_050029104.1;XP_050045057.1;XP_050041976.1;XP_050036221.1;XP_050041163.1;XP_050027137.1;XP_050042030.1;XP_050030729.1;XP_050023640.1;XP_050039125.1;XP_050039616.1;XP_050023265.1;XP_050039627.1;XP_050034845.1;XP_050039649.1;XP_050041219.1
Reactome: R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	44	XP_050040671.1;XP_050045300.1;XP_050049294.1;XP_050047361.1;XP_050049295.1;XP_050045373.1;XP_050034644.1;XP_050046123.1;XP_050034030.1;XP_050023728.1;XP_050037136.1;XP_050031537.1;XP_050044010.1;XP_050023724.1;XP_050035378.1;XP_050023727.1;XP_050049296.1;XP_050024189.1;XP_050049297.1;XP_050034031.1;XP_050026035.1;XP_050026414.1;XP_050031535.1;XP_050038469.1;XP_050034643.1;XP_050046688.1;XP_050045372.1;XP_050025563.1;XP_050023730.1;XP_050040428.1;XP_050040427.1;XP_050038988.1;XP_050023726.1;XP_050033368.1;XP_050023729.1;XP_050046063.1;XP_050032071.1;XP_050034518.1;XP_050037137.1;XP_050023725.1;XP_050043147.1;XP_050031536.1;XP_050036381.1;XP_050034505.1
KEGG: 00790+1.14.16.1	Folate biosynthesis	1	XP_050047981.1
Reactome: R-HSA-5696395	Formation of Incision Complex in GG-NER	31	XP_050023321.1;XP_050029342.1;XP_050035481.1;XP_050045300.1;XP_050022980.1;XP_050025563.1;XP_050040428.1;XP_050029852.1;XP_050040427.1;XP_050047361.1;XP_050046029.1;XP_050039454.1;XP_050048032.1;XP_050033368.1;XP_050044656.1;XP_050045753.1;XP_050045754.1;XP_050037136.1;XP_050032576.1;XP_050048534.1;XP_050024696.1;XP_050042755.1;XP_050044010.1;XP_050046028.1;XP_050046026.1;XP_050035378.1;XP_050037137.1;XP_050040226.1;XP_050046027.1;XP_050045755.1;XP_050050532.1
KEGG: 00230+1.1.1.205	Purine metabolism	2	XP_050051705.1;XP_050026581.1
Reactome: R-HSA-75896	Plasmalogen biosynthesis	2	XP_050030299.1;XP_050030300.1
KEGG: 00250+1.2.1.88	Alanine, aspartate and glutamate metabolism	1	XP_050029177.1
MetaCyc: PWY-6689	Trna splicing I	2	XP_050040962.1;XP_050040740.1
KEGG: 00020+4.2.1.3	Citrate cycle (TCA cycle)	3	XP_050032828.1;XP_050033513.1;XP_050033512.1
KEGG: 00051+4.2.1.68	Fructose and mannose metabolism	1	XP_050031793.1
Reactome: R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	3	XP_050033246.1;XP_050033245.1;XP_050033247.1
Reactome: R-HSA-4608870	Asymmetric localization of PCP proteins	54	XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050031786.1;XP_050027118.1;XP_050040198.1;XP_050049124.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050029802.1;XP_050050645.1;XP_050044470.1;XP_050052231.1;XP_050036567.1;XP_050033331.1;XP_050051964.1;XP_050035472.1;XP_050047181.1;XP_050044469.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050038140.1;XP_050036156.1;XP_050027890.1;XP_050027657.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050037398.1;XP_050033318.1;XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050044478.1;XP_050045660.1;XP_050050021.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050044476.1;XP_050048719.1;XP_050047809.1;XP_050045785.1;XP_050050373.1;XP_050032477.1;XP_050048534.1;XP_050040200.1;XP_050022938.1
Reactome: R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	3	XP_050047658.1;XP_050047655.1;XP_050047657.1
KEGG: 00450+2.7.9.3	Selenocompound metabolism	3	XP_050041755.1;XP_050023969.1;XP_050030955.1
Reactome: R-HSA-5419276	Mitochondrial translation termination	74	XP_050027133.1;XP_050031801.1;XP_050026332.1;XP_050036486.1;XP_050030728.1;XP_050046959.1;XP_050047641.1;XP_050036704.1;XP_050036878.1;XP_050047319.1;XP_050027066.1;XP_050049331.1;XP_050027321.1;XP_050045284.1;XP_050035998.1;XP_050042269.1;XP_050052609.1;XP_050031800.1;XP_050049763.1;XP_050025036.1;XP_050022476.1;XP_050038468.1;XP_050051717.1;XP_050051211.1;XP_050027420.1;XP_050051246.1;XP_050047642.1;XP_050041220.1;XP_050033257.1;XP_050047054.1;XP_050042040.1;XP_050047314.1;XP_050035939.1;XP_050028172.1;XP_050027411.1;XP_050035316.1;XP_050046197.1;XP_050027674.1;XP_050029555.1;XP_050052189.1;XP_050042050.1;XP_050038683.1;XP_050041975.1;XP_050037838.1;XP_050028096.1;XP_050032857.1;XP_050037279.1;XP_050026521.1;XP_050044835.1;XP_050043556.1;XP_050045126.1;XP_050050913.1;XP_050040023.1;XP_050039125.1;XP_050023640.1;XP_050051245.1;XP_050039649.1;XP_050041219.1;XP_050039627.1;XP_050039616.1;XP_050023265.1;XP_050045057.1;XP_050044790.1;XP_050029104.1;XP_050027247.1;XP_050034817.1;XP_050045271.1;XP_050045058.1;XP_050030729.1;XP_050042030.1;XP_050027137.1;XP_050036221.1;XP_050041163.1;XP_050041976.1
Reactome: R-HSA-2559580	Oxidative Stress Induced Senescence	45	XP_050047598.1;XP_050025244.1;XP_050029889.1;XP_050039235.1;XP_050046149.1;XP_050035481.1;XP_050051916.1;XP_050052226.1;XP_050029861.1;XP_050029831.1;XP_050046147.1;XP_050026959.1;XP_050047374.1;XP_050046150.1;XP_050047373.1;XP_050029862.1;XP_050026958.1;XP_050023625.1;XP_050051597.1;XP_050047606.1;XP_050029887.1;XP_050029890.1;XP_050025248.1;XP_050038213.1;XP_050028233.1;XP_050052225.1;XP_050047375.1;XP_050051915.1;XP_050025266.1;XP_050047371.1;XP_050029891.1;XP_050031628.1;XP_050038199.1;XP_050046148.1;XP_050047372.1;XP_050039236.1;XP_050048534.1;XP_050051917.1;XP_050026957.1;XP_050029858.1;XP_050025243.1;XP_050036268.1;XP_050026960.1;XP_050029859.1;XP_050029860.1
MetaCyc: PWY-6906	Chitin derivatives degradation	9	XP_050050483.1;XP_050049839.1;XP_050040347.1;XP_050040348.1;XP_050040346.1;XP_050038836.1;XP_050038837.1;XP_050049157.1;XP_050038838.1
Reactome: R-HSA-2024101	CS/DS degradation	20	XP_050028195.1;XP_050030481.1;XP_050035570.1;XP_050025618.1;XP_050026917.1;XP_050026983.1;XP_050026981.1;XP_050026985.1;XP_050030480.1;XP_050049087.1;XP_050036110.1;XP_050027975.1;XP_050043064.1;XP_050040138.1;XP_050025615.1;XP_050025616.1;XP_050026984.1;XP_050025617.1;XP_050026982.1;XP_050030479.1
KEGG: 04070+2.7.1.158	Phosphatidylinositol signaling system	1	XP_050026059.1
KEGG: 00900+3.4.24.84	Terpenoid backbone biosynthesis	1	XP_050025991.1
MetaCyc: PWY-4061	Glutathione-mediated detoxification I	55	XP_050029056.1;XP_050030373.1;XP_050048220.1;XP_050031599.1;XP_050029240.1;XP_050024805.1;XP_050043742.1;XP_050025508.1;XP_050048233.1;XP_050047905.1;XP_050024014.1;XP_050029054.1;XP_050048267.1;XP_050023398.1;XP_050031872.1;XP_050028992.1;XP_050029058.1;XP_050027833.1;XP_050025413.1;XP_050026762.1;XP_050036058.1;XP_050025457.1;XP_050047704.1;XP_050025489.1;XP_050030014.1;XP_050025492.1;XP_050030123.1;XP_050025458.1;XP_050031855.1;XP_050029071.1;XP_050047698.1;XP_050048247.1;XP_050025491.1;XP_050029057.1;XP_050029052.1;XP_050025490.1;XP_050031611.1;XP_050024015.1;XP_050048256.1;XP_050031589.1;XP_050025459.1;XP_050025493.1;XP_050025460.1;XP_050029305.1;XP_050029059.1;XP_050029053.1;XP_050025650.1;XP_050029960.1;XP_050025461.1;XP_050047714.1;XP_050029072.1;XP_050027823.1;XP_050022874.1;XP_050029055.1;XP_050043741.1
Reactome: R-HSA-174411	Polymerase switching on the C-strand of the telomere	18	XP_050039359.1;XP_050049531.1;XP_050042972.1;XP_050041998.1;XP_050032235.1;XP_050041996.1;XP_050022594.1;XP_050041997.1;XP_050032670.1;XP_050052687.1;XP_050051397.1;XP_050041999.1;XP_050046062.1;XP_050040824.1;XP_050025144.1;XP_050049952.1;XP_050043962.1;XP_050041995.1
KEGG: 00310+1.8.1.4	Lysine degradation	1	XP_050026566.1
MetaCyc: PWY-7179	Purine deoxyribonucleosides degradation I	3	XP_050035831.1;XP_050046556.1;XP_050046554.1
Reactome: R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	57	XP_050022938.1;XP_050047769.1;XP_050040200.1;XP_050050373.1;XP_050045785.1;XP_050040623.1;XP_050048534.1;XP_050032477.1;XP_050048719.1;XP_050047809.1;XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050044478.1;XP_050045660.1;XP_050034772.1;XP_050025715.1;XP_050047670.1;XP_050037401.1;XP_050033237.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050033318.1;XP_050037398.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050050414.1;XP_050044469.1;XP_050047181.1;XP_050036567.1;XP_050033331.1;XP_050040624.1;XP_050035472.1;XP_050051964.1;XP_050048823.1;XP_050033832.1;XP_050040199.1;XP_050044470.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050040198.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050027118.1;XP_050031786.1
KEGG: 00051+5.4.2.8	Fructose and mannose metabolism	1	XP_050044728.1
Reactome: R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	54	XP_050048719.1;XP_050047809.1;XP_050045785.1;XP_050050373.1;XP_050032477.1;XP_050048534.1;XP_050040200.1;XP_050022938.1;XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050044478.1;XP_050034960.1;XP_050045660.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050044476.1;XP_050047181.1;XP_050044469.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050034961.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050033318.1;XP_050037398.1;XP_050037397.1;XP_050044475.1;XP_050024749.1;XP_050031786.1;XP_050027118.1;XP_050040198.1;XP_050049124.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050048823.1;XP_050040199.1;XP_050033832.1;XP_050029802.1;XP_050050645.1;XP_050044470.1;XP_050052231.1;XP_050036567.1;XP_050033331.1;XP_050035472.1;XP_050051964.1
Reactome: R-HSA-70921	Histidine catabolism	6	XP_050045421.1;XP_050034614.1;XP_050027711.1;XP_050044610.1;XP_050052374.1;XP_050027712.1
Reactome: R-HSA-177929	Signaling by EGFR	3	XP_050034595.1;XP_050034209.1;XP_050026551.1
Reactome: R-HSA-9028335	Activated NTRK2 signals through PI3K	1	XP_050032853.1
KEGG: 00983+1.1.1.205	Drug metabolism - other enzymes	2	XP_050051705.1;XP_050026581.1
Reactome: R-HSA-5609977	Defective GALE can cause Epimerase-deficiency galactosemia (EDG)	3	XP_050031783.1;XP_050042029.1;XP_050031782.1
Reactome: R-HSA-163210	Formation of ATP by chemiosmotic coupling	19	XP_050030318.1;XP_050034502.1;XP_050034504.1;XP_050031579.1;XP_050033401.1;XP_050030121.1;XP_050030910.1;XP_050045431.1;XP_050047208.1;YP_010283873.1;XP_050033403.1;XP_050049173.1;XP_050032502.1;XP_050026328.1;XP_050042317.1;XP_050034503.1;XP_050042316.1;XP_050033402.1;XP_050043887.1
MetaCyc: PWY-7977	L-methionine biosynthesis IV (archaea)	1	XP_050036540.1
MetaCyc: PWY-5739	GDP-D-perosamine biosynthesis	3	XP_050047838.1;XP_050047839.1;XP_050047837.1
KEGG: 00330+4.1.1.50	Arginine and proline metabolism	1	XP_050027983.1
MetaCyc: PWY-2221	Entner-Doudoroff pathway III (semi-phosphorylative)	7	XP_050051894.1;XP_050030742.1;XP_050044976.1;XP_050030744.1;XP_050034255.1;XP_050034253.1;XP_050034254.1
Reactome: R-HSA-2470946	Cohesin Loading onto Chromatin	19	XP_050040054.1;XP_050040051.1;XP_050047139.1;XP_050040050.1;XP_050040143.1;XP_050047136.1;XP_050045916.1;XP_050047220.1;XP_050028217.1;XP_050047221.1;XP_050045113.1;XP_050039318.1;XP_050040049.1;XP_050052697.1;XP_050028218.1;XP_050047137.1;XP_050047138.1;XP_050040052.1;XP_050039319.1
MetaCyc: PWY-8049	Pederin biosynthesis	4	XP_050032773.1;XP_050033009.1;XP_050033008.1;XP_050029751.1
MetaCyc: PWY-7942	5-oxo-L-proline metabolism	7	XP_050047740.1;XP_050044217.1;XP_050048564.1;XP_050038429.1;XP_050047739.1;XP_050038428.1;XP_050038430.1
MetaCyc: PWY-5895	Menaquinol-13 biosynthesis	1	XP_050045574.1
Reactome: R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	8	XP_050024903.1;XP_050032133.1;XP_050031245.1;XP_050024488.1;XP_050024487.1;XP_050024486.1;XP_050031637.1;XP_050024489.1
Reactome: R-HSA-5693548	Sensing of DNA Double Strand Breaks	11	XP_050047551.1;XP_050022604.1;XP_050022605.1;XP_050032478.1;XP_050044695.1;XP_050022606.1;XP_050037414.1;XP_050022602.1;XP_050028292.1;XP_050022603.1;XP_050028323.1
KEGG: 00500+3.1.3.9	Starch and sucrose metabolism	2	XP_050034452.1;XP_050036456.1
Reactome: R-HSA-2179392	EGFR Transactivation by Gastrin	1	XP_050032853.1
KEGG: 00561+2.7.7.9	Glycerolipid metabolism	4	XP_050037411.1;XP_050037412.1;XP_050037409.1;XP_050037410.1
Reactome: R-HSA-209968	Thyroxine biosynthesis	2	XP_050044992.1;XP_050042569.1
KEGG: 00520+5.3.1.8	Amino sugar and nucleotide sugar metabolism	1	XP_050044364.1
Reactome: R-HSA-5218920	VEGFR2 mediated vascular permeability	15	XP_050052241.1;XP_050051315.1;XP_050052242.1;XP_050025347.1;XP_050051316.1;XP_050032548.1;XP_050041412.1;XP_050051318.1;XP_050025348.1;XP_050048620.1;XP_050049527.1;XP_050048621.1;XP_050051317.1;XP_050048619.1;XP_050042304.1
MetaCyc: PWY-7524	Mevalonate pathway III (archaea)	8	XP_050041694.1;XP_050041696.1;XP_050045766.1;XP_050041695.1;XP_050041692.1;XP_050045765.1;XP_050024679.1;XP_050041691.1
KEGG: 00051+5.3.1.6	Fructose and mannose metabolism	1	XP_050049438.1
Reactome: R-HSA-9636383	Prevention of phagosomal-lysosomal fusion	4	XP_050032654.1;XP_050032655.1;XP_050048534.1;XP_050035481.1
KEGG: 00240+2.7.4.9	Pyrimidine metabolism	1	XP_050034794.1
KEGG: 00970+6.1.1.16	Aminoacyl-tRNA biosynthesis	2	XP_050033356.1;XP_050036368.1
KEGG: 00010+3.1.3.11	Glycolysis / Gluconeogenesis	2	XP_050044414.1;XP_050038404.1
KEGG: 00720+6.4.1.2	Carbon fixation pathways in prokaryotes	12	XP_050048463.1;XP_050048460.1;XP_050048459.1;XP_050048466.1;XP_050048458.1;XP_050048465.1;XP_050048461.1;XP_050048462.1;XP_050048468.1;XP_050048467.1;XP_050048456.1;XP_050048457.1
KEGG: 00564+1.1.1.8	Glycerophospholipid metabolism	1	XP_050034614.1
Reactome: R-HSA-68949	Orc1 removal from chromatin	76	XP_050048719.1;XP_050031078.1;XP_050050373.1;XP_050045785.1;XP_050040200.1;XP_050049556.1;XP_050033934.1;XP_050038751.1;XP_050047670.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050050719.1;XP_050045792.1;XP_050044478.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050047181.1;XP_050033833.1;XP_050031079.1;XP_050046049.1;XP_050033318.1;XP_050022518.1;XP_050027118.1;XP_050041989.1;XP_050031786.1;XP_050024749.1;XP_050037397.1;XP_050035481.1;XP_050041990.1;XP_050042025.1;XP_050040198.1;XP_050044470.1;XP_050040199.1;XP_050035472.1;XP_050051964.1;XP_050049554.1;XP_050033331.1;XP_050036167.1;XP_050047809.1;XP_050043901.1;XP_050027478.1;XP_050040623.1;XP_050048534.1;XP_050032477.1;XP_050049555.1;XP_050022938.1;XP_050033237.1;XP_050035183.1;XP_050045660.1;XP_050044476.1;XP_050040739.1;XP_050044469.1;XP_050048824.1;XP_050037399.1;XP_050027657.1;XP_050043900.1;XP_050049723.1;XP_050038140.1;XP_050036156.1;XP_050037398.1;XP_050033374.1;XP_050042788.1;XP_050027134.1;XP_050044475.1;XP_050048720.1;XP_050049124.1;XP_050023646.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050048823.1;XP_050033832.1;XP_050036567.1;XP_050040624.1
MetaCyc: PWY-8053	Anandamide biosynthesis II	42	XP_050047027.1;XP_050050583.1;XP_050025686.1;XP_050032357.1;XP_050037857.1;XP_050035197.1;XP_050035195.1;XP_050037142.1;XP_050037856.1;XP_050033390.1;XP_050030747.1;XP_050037147.1;XP_050031256.1;XP_050035193.1;XP_050037456.1;XP_050037455.1;XP_050037458.1;XP_050037145.1;XP_050027415.1;XP_050037150.1;XP_050047026.1;XP_050050549.1;XP_050035194.1;XP_050037661.1;XP_050037143.1;XP_050025400.1;XP_050037457.1;XP_050037141.1;XP_050035196.1;XP_050037144.1;XP_050037854.1;XP_050037139.1;XP_050037148.1;XP_050037146.1;XP_050035199.1;XP_050037140.1;XP_050037775.1;XP_050035198.1;XP_050037151.1;XP_050035192.1;XP_050027416.1;XP_050037855.1
Reactome: R-HSA-4341670	Defective NEU1 causes sialidosis	9	XP_050041883.1;XP_050034507.1;XP_050034475.1;XP_050042169.1;XP_050024113.1;XP_050024114.1;XP_050024146.1;XP_050031626.1;XP_050030375.1
MetaCyc: PWY-5664	Erythro-tetrahydrobiopterin biosynthesis II	4	XP_050045129.1;XP_050048633.1;XP_050048632.1;XP_050048631.1
Reactome: R-HSA-3214847	HATs acetylate histones	110	XP_050044009.1;XP_050026700.1;XP_050044748.1;XP_050050026.1;XP_050039299.1;XP_050024326.1;XP_050026318.1;XP_050024034.1;XP_050044793.1;XP_050041565.1;XP_050038701.1;XP_050047333.1;XP_050033582.1;XP_050037421.1;XP_050034479.1;XP_050038602.1;XP_050031369.1;XP_050026316.1;XP_050031496.1;XP_050038787.1;XP_050044747.1;XP_050050898.1;XP_050037420.1;XP_050030610.1;XP_050037422.1;XP_050033581.1;XP_050022606.1;XP_050050901.1;XP_050024499.1;XP_050027729.1;XP_050027326.1;XP_050050904.1;XP_050024325.1;XP_050025248.1;XP_050044239.1;XP_050034478.1;XP_050025244.1;XP_050034083.1;XP_050051310.1;XP_050030608.1;XP_050025728.1;XP_050026320.1;XP_050030609.1;XP_050051309.1;XP_050044236.1;XP_050026322.1;XP_050044792.1;XP_050026321.1;XP_050039593.1;XP_050048977.1;XP_050023734.1;XP_050030711.1;XP_050031222.1;XP_050038700.1;XP_050045588.1;XP_050042990.1;XP_050022602.1;XP_050026317.1;XP_050034480.1;XP_050038199.1;XP_050039300.1;XP_050025243.1;XP_050036268.1;XP_050024500.1;XP_050035523.1;XP_050039302.1;XP_050042945.1;XP_050044238.1;XP_050048974.1;XP_050050900.1;XP_050025379.1;XP_050037414.1;XP_050022603.1;XP_050042989.1;XP_050042988.1;XP_050036627.1;XP_050022604.1;XP_050048416.1;XP_050022605.1;XP_050036629.1;XP_050026323.1;XP_050025266.1;XP_050035136.1;XP_050050902.1;XP_050044240.1;XP_050035524.1;XP_050048973.1;XP_050036626.1;XP_050043295.1;XP_050048975.1;XP_050039592.1;XP_050026319.1;XP_050027158.1;XP_050051311.1;XP_050039301.1;XP_050038786.1;XP_050036381.1;XP_050044237.1;XP_050050903.1;XP_050038213.1;XP_050048976.1;XP_050030956.1;XP_050036628.1;XP_050026035.1;XP_050024498.1;XP_050034477.1;XP_050048978.1;XP_050052312.1;XP_050048417.1;XP_050039075.1
KEGG: 00900+2.7.1.36	Terpenoid backbone biosynthesis	1	XP_050028850.1
KEGG: 00620+1.1.1.37	Pyruvate metabolism	11	XP_050037169.1;XP_050037926.1;XP_050037164.1;XP_050037165.1;XP_050037168.1;XP_050037167.1;XP_050045192.1;XP_050037925.1;XP_050037172.1;XP_050037166.1;XP_050035735.1
Reactome: R-HSA-8983432	Interleukin-15 signaling	1	XP_050032853.1
KEGG: 00710+5.1.3.1	Carbon fixation in photosynthetic organisms	1	XP_050033946.1
KEGG: 00513+2.4.1.260	Various types of N-glycan biosynthesis	1	XP_050026303.1
Reactome: R-HSA-399956	CRMPs in Sema3A signaling	5	XP_050041903.1;XP_050041902.1;XP_050023263.1;XP_050023261.1;XP_050023262.1
Reactome: R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	37	XP_050023476.1;XP_050044008.1;XP_050038968.1;XP_050038866.1;XP_050049377.1;XP_050030653.1;XP_050026810.1;XP_050033146.1;XP_050046156.1;XP_050035932.1;XP_050026809.1;XP_050029516.1;XP_050038862.1;XP_050023718.1;XP_050035770.1;XP_050038865.1;XP_050024518.1;XP_050038864.1;XP_050023475.1;XP_050042392.1;XP_050038969.1;XP_050030506.1;XP_050030652.1;XP_050038966.1;XP_050030507.1;XP_050039240.1;XP_050036827.1;XP_050025064.1;XP_050038967.1;XP_050035933.1;XP_050029515.1;XP_050036430.1;XP_050023474.1;XP_050038863.1;XP_050030942.1;XP_050042391.1;XP_050038895.1
MetaCyc: PWY-6859	All-trans-farnesol biosynthesis	3	XP_050045766.1;XP_050023623.1;XP_050045765.1
Reactome: R-HSA-5635838	Activation of SMO	7	XP_050033319.1;XP_050037704.1;XP_050050209.1;XP_050044750.1;XP_050041327.1;XP_050044749.1;XP_050041328.1
KEGG: 00770+6.3.2.5	Pantothenate and CoA biosynthesis	1	XP_050035188.1
Reactome: R-HSA-3000157	Laminin interactions	12	XP_050024362.1;XP_050024364.1;XP_050025338.1;XP_050025341.1;XP_050031326.1;XP_050051572.1;XP_050024363.1;XP_050030649.1;XP_050025339.1;XP_050031395.1;XP_050052132.1;XP_050025342.1
KEGG: 00620+3.1.2.6	Pyruvate metabolism	1	XP_050032575.1
MetaCyc: PWY-7154	Ergosterol biosynthesis II	4	XP_050045362.1;XP_050045363.1;XP_050045364.1;XP_050045365.1
MetaCyc: PWY-7094	Fatty acid salvage	6	XP_050041643.1;XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1
MetaCyc: PWY-5855	Ubiquinol-7 biosynthesis (prokaryotic)	4	XP_050033250.1;XP_050040261.1;XP_050025937.1;XP_050025938.1
Reactome: R-HSA-380095	Tachykinin receptors bind tachykinins	4	XP_050047359.1;XP_050051925.1;XP_050051924.1;XP_050022718.1
Reactome: R-HSA-1663150	The activation of arylsulfatases	1	XP_050027990.1
Reactome: R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	1	XP_050028603.1
MetaCyc: PWY-7894	Procollagen hydroxylation and glycosylation	17	XP_050023095.1;XP_050032389.1;XP_050048007.1;XP_050031907.1;XP_050041690.1;XP_050023094.1;XP_050031906.1;XP_050031908.1;XP_050031911.1;XP_050032373.1;XP_050031909.1;XP_050048009.1;XP_050032372.1;XP_050038099.1;XP_050048008.1;XP_050025756.1;XP_050030411.1
Reactome: R-HSA-201681	TCF dependent signaling in response to WNT	14	XP_050045658.1;XP_050035481.1;XP_050048534.1;XP_050032733.1;XP_050024731.1;XP_050044843.1;XP_050050021.1;XP_050024722.1;XP_050031586.1;XP_050033247.1;XP_050033245.1;XP_050049277.1;XP_050033246.1;XP_050031585.1
Reactome: R-HSA-9022534	Loss of MECP2 binding ability to 5hmC-DNA	1	XP_050031707.1
MetaCyc: PWY-6609	Adenine and adenosine salvage III	5	XP_050035831.1;XP_050045960.1;XP_050046554.1;XP_050045961.1;XP_050046556.1
Reactome: R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	3	XP_050047598.1;XP_050045005.1;XP_050047606.1
KEGG: 00230+1.7.1.7	Purine metabolism	2	XP_050051074.1;XP_050051072.1
Reactome: R-HSA-199418	Negative regulation of the PI3K/AKT network	3	XP_050048619.1;XP_050048621.1;XP_050048620.1
Reactome: R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1	XP_050038799.1
Reactome: R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	68	XP_050044478.1;XP_050048801.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050039331.1;XP_050037401.1;XP_050039332.1;XP_050034772.1;XP_050025715.1;XP_050040200.1;XP_050048719.1;XP_050045785.1;XP_050050373.1;XP_050040199.1;XP_050044470.1;XP_050033331.1;XP_050051964.1;XP_050035472.1;XP_050037397.1;XP_050024749.1;XP_050031786.1;XP_050027118.1;XP_050040198.1;XP_050042025.1;XP_050035481.1;XP_050022518.1;XP_050033318.1;XP_050047181.1;XP_050040338.1;XP_050030937.1;XP_050040341.1;XP_050047778.1;XP_050033833.1;XP_050045660.1;XP_050044476.1;XP_050033237.1;XP_050051381.1;XP_050022938.1;XP_050039330.1;XP_050047809.1;XP_050040339.1;XP_050032477.1;XP_050048534.1;XP_050040340.1;XP_050048823.1;XP_050033832.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050039329.1;XP_050034247.1;XP_050036567.1;XP_050044475.1;XP_050049124.1;XP_050048720.1;XP_050038140.1;XP_050036156.1;XP_050034248.1;XP_050038628.1;XP_050027657.1;XP_050027134.1;XP_050042788.1;XP_050037398.1;XP_050038630.1;XP_050044469.1;XP_050037399.1;XP_050048824.1
Reactome: R-HSA-8854214	TBC/RABGAPs	13	XP_050023250.1;XP_050038790.1;XP_050032867.1;XP_050051460.1;XP_050023500.1;XP_050038791.1;XP_050052030.1;XP_050052031.1;XP_050038679.1;XP_050052029.1;XP_050032868.1;XP_050023499.1;XP_050038789.1
Reactome: R-HSA-165054	Rev-mediated nuclear export of HIV RNA	42	XP_050025064.1;XP_050036827.1;XP_050039240.1;XP_050038967.1;XP_050030506.1;XP_050030652.1;XP_050038969.1;XP_050030507.1;XP_050038966.1;XP_050036430.1;XP_050023474.1;XP_050046838.1;XP_050038863.1;XP_050030942.1;XP_050038895.1;XP_050042391.1;XP_050035933.1;XP_050039305.1;XP_050029515.1;XP_050026810.1;XP_050033146.1;XP_050046156.1;XP_050026809.1;XP_050035932.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050039306.1;XP_050044008.1;XP_050023476.1;XP_050047656.1;XP_050038866.1;XP_050038968.1;XP_050049377.1;XP_050030653.1;XP_050023475.1;XP_050042392.1;XP_050046837.1;XP_050038865.1;XP_050035770.1;XP_050024518.1;XP_050038864.1
Reactome: R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	64	XP_050044469.1;XP_050037399.1;XP_050048824.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050037398.1;XP_050042788.1;XP_050027134.1;XP_050044475.1;XP_050048720.1;XP_050049124.1;XP_050052231.1;XP_050029802.1;XP_050050645.1;XP_050048823.1;XP_050033832.1;XP_050042107.1;XP_050040624.1;XP_050036567.1;XP_050047809.1;XP_050048534.1;XP_050040623.1;XP_050032477.1;XP_050022938.1;XP_050033237.1;XP_050042112.1;XP_050045660.1;XP_050044476.1;XP_050047181.1;XP_050033833.1;XP_050042111.1;XP_050033318.1;XP_050022518.1;XP_050042108.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050037397.1;XP_050035481.1;XP_050042025.1;XP_050048935.1;XP_050040198.1;XP_050042110.1;XP_050044470.1;XP_050040199.1;XP_050042106.1;XP_050051964.1;XP_050035472.1;XP_050033331.1;XP_050042105.1;XP_050048719.1;XP_050042109.1;XP_050050373.1;XP_050045785.1;XP_050040200.1;XP_050047670.1;XP_050037401.1;XP_050025715.1;XP_050034772.1;XP_050044478.1;XP_050031479.1;XP_050025848.1;XP_050048721.1
KEGG: 00562+3.1.3.25	Inositol phosphate metabolism	1	XP_050048146.1
KEGG: 00627+4.2.1.17	Aminobenzoate degradation	6	XP_050041643.1;XP_050041651.1;XP_050041635.1;XP_050051194.1;XP_050032010.1;XP_050026422.1
MetaCyc: PWY-7176	UTP and CTP de novo biosynthesis	13	XP_050031510.1;XP_050026502.1;XP_050029492.1;XP_050023197.1;XP_050023196.1;XP_050026500.1;XP_050031386.1;XP_050026501.1;XP_050023195.1;XP_050043296.1;XP_050038939.1;XP_050023199.1;XP_050029490.1
Reactome: R-HSA-9615017	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	7	XP_050035890.1;XP_050048386.1;XP_050035889.1;XP_050048385.1;XP_050032314.1;XP_050026421.1;XP_050028343.1
Reactome: R-HSA-1489509	DAG and IP3 signaling	3	XP_050025879.1;XP_050036247.1;XP_050036246.1
KEGG: 00195+7.1.2.2	Photosynthesis	5	XP_050050217.1;XP_050043887.1;XP_050047208.1;XP_050031579.1;XP_050034615.1
KEGG: 00983+2.4.2.10	Drug metabolism - other enzymes	1	XP_050023639.1
Reactome: R-HSA-727802	Transport of nucleotide sugars	1	XP_050047421.1
Reactome: R-HSA-69231	Cyclin D associated events in G1	26	XP_050046148.1;XP_050048539.1;XP_050048534.1;XP_050040623.1;XP_050049483.1;XP_050046150.1;XP_050033755.1;XP_050048389.1;XP_050048829.1;XP_050033368.1;XP_050035378.1;XP_050048388.1;XP_050052372.1;XP_050033754.1;XP_050049484.1;XP_050045300.1;XP_050036919.1;XP_050046149.1;XP_050035481.1;XP_050047670.1;XP_050046147.1;XP_050047674.1;XP_050048542.1;XP_050040624.1;XP_050047664.1;XP_050048387.1
MetaCyc: PWY-7725	Arachidonate biosynthesis V (8-detaturase, mammals)	78	XP_050039017.1;XP_050039545.1;XP_050033894.1;XP_050041128.1;XP_050039722.1;XP_050033799.1;XP_050039698.1;XP_050027024.1;XP_050039366.1;XP_050039083.1;XP_050026425.1;XP_050039555.1;XP_050039700.1;XP_050051764.1;XP_050027502.1;XP_050036636.1;XP_050042219.1;XP_050039263.1;XP_050051766.1;XP_050042358.1;XP_050025917.1;XP_050036103.1;XP_050045032.1;XP_050039708.1;XP_050039189.1;XP_050039015.1;XP_050041191.1;XP_050039426.1;XP_050036658.1;XP_050039701.1;XP_050039086.1;XP_050036659.1;XP_050027497.1;XP_050026887.1;XP_050039704.1;XP_050039703.1;XP_050039186.1;XP_050026935.1;XP_050039082.1;XP_050039081.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050025916.1;XP_050039191.1;XP_050039183.1;XP_050026888.1;XP_050039710.1;XP_050039709.1;XP_050039706.1;XP_050039711.1;XP_050039770.1;XP_050026205.1;XP_050028129.1;XP_050051763.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039712.1;XP_050027469.1;XP_050039087.1;XP_050039084.1;XP_050039088.1;XP_050039707.1;XP_050039016.1;XP_050051765.1;XP_050039769.1;XP_050027470.1;XP_050039080.1;XP_050043402.1;XP_050039364.1;XP_050047366.1;XP_050039085.1;XP_050027496.1;XP_050039126.1;XP_050039699.1;XP_050039772.1;XP_050039365.1
KEGG: 00330+1.5.5.2	Arginine and proline metabolism	2	XP_050039753.1;XP_050043133.1
KEGG: 00604+3.2.1.23	Glycosphingolipid biosynthesis - ganglio series	20	XP_050045117.1;XP_050042176.1;XP_050040161.1;XP_050042436.1;XP_050042177.1;XP_050042175.1;XP_050040162.1;XP_050038908.1;XP_050042169.1;XP_050042179.1;XP_050039612.1;XP_050042439.1;XP_050042438.1;XP_050042437.1;XP_050042167.1;XP_050042180.1;XP_050042178.1;XP_050038798.1;XP_050039611.1;XP_050042181.1
Reactome: R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	10	XP_050036189.1;XP_050028834.1;XP_050023324.1;XP_050038736.1;XP_050026533.1;XP_050036188.1;XP_050036540.1;XP_050044056.1;XP_050052091.1;XP_050052093.1
Reactome: R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	4	XP_050040012.1;XP_050045189.1;XP_050025576.1;XP_050048361.1
MetaCyc: PWY-6134	L-tyrosine biosynthesis IV	1	XP_050047981.1
KEGG: 00633+2.3.1.5	Nitrotoluene degradation	6	XP_050027934.1;XP_050027933.1;XP_050028265.1;XP_050027932.1;XP_050027935.1;XP_050027182.1
MetaCyc: PWY-3561	Choline biosynthesis III	3	XP_050050470.1;XP_050050471.1;XP_050050469.1
Reactome: R-HSA-9613354	Lipophagy	9	XP_050044529.1;XP_050044530.1;XP_050034639.1;XP_050044527.1;XP_050044531.1;XP_050044525.1;XP_050044524.1;XP_050044532.1;XP_050044528.1
Reactome: R-HSA-167287	HIV elongation arrest and recovery	35	XP_050023577.1;XP_050045052.1;XP_050039485.1;XP_050046123.1;XP_050023728.1;XP_050047588.1;XP_050030811.1;XP_050024189.1;XP_050030280.1;XP_050023724.1;XP_050023777.1;XP_050023727.1;XP_050051336.1;XP_050030810.1;XP_050051335.1;XP_050023776.1;XP_050034644.1;XP_050048718.1;XP_050023779.1;XP_050023714.1;XP_050023726.1;XP_050023729.1;XP_050046063.1;XP_050023576.1;XP_050025635.1;XP_050048717.1;XP_050043147.1;XP_050023725.1;XP_050034643.1;XP_050023730.1;XP_050038469.1;XP_050039484.1;XP_050039068.1;XP_050043138.1;XP_050030634.1
Reactome: R-HSA-5578775	Ion homeostasis	60	XP_050026488.1;XP_050046815.1;XP_050032483.1;XP_050050702.1;XP_050050699.1;XP_050050680.1;XP_050050691.1;XP_050050694.1;XP_050050689.1;XP_050026486.1;XP_050025800.1;XP_050050692.1;XP_050037035.1;XP_050050693.1;XP_050026489.1;XP_050050688.1;XP_050050695.1;XP_050026482.1;XP_050025879.1;XP_050050682.1;XP_050026485.1;XP_050029080.1;XP_050050685.1;XP_050025801.1;XP_050026491.1;XP_050026487.1;XP_050026490.1;XP_050050698.1;XP_050050684.1;XP_050050687.1;XP_050050681.1;XP_050029084.1;XP_050026493.1;XP_050050697.1;XP_050032484.1;XP_050050696.1;XP_050026495.1;XP_050050701.1;XP_050037034.1;XP_050047239.1;XP_050037033.1;XP_050026484.1;XP_050050679.1;XP_050050700.1;XP_050050690.1;XP_050050686.1;XP_050029081.1;XP_050037037.1;XP_050046816.1;XP_050044887.1;XP_050034596.1;XP_050029083.1;XP_050026494.1;XP_050037036.1;XP_050046817.1;XP_050029082.1;XP_050050683.1;XP_050026481.1;XP_050026483.1;XP_050026492.1
Reactome: R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	25	XP_050052258.1;XP_050046839.1;XP_050042364.1;XP_050025231.1;XP_050025215.1;XP_050025220.1;XP_050052764.1;XP_050042366.1;XP_050052763.1;XP_050042363.1;XP_050046840.1;XP_050035481.1;XP_050052762.1;XP_050025229.1;XP_050025230.1;XP_050025217.1;XP_050025236.1;XP_050025223.1;XP_050035110.1;XP_050042367.1;XP_050046838.1;XP_050025227.1;XP_050048534.1;XP_050046837.1;XP_050025232.1
Reactome: R-HSA-389887	Beta-oxidation of pristanoyl-CoA	1	XP_050044392.1
MetaCyc: PWY-5147	Oleate biosynthesis I (plants)	4	XP_050029751.1;XP_050033008.1;XP_050033009.1;XP_050032773.1
KEGG: 00350+2.6.1.1	Tyrosine metabolism	3	XP_050049203.1;XP_050049202.1;XP_050026413.1
MetaCyc: PWY-7288	Fatty acid beta-oxidation VII (yeast peroxisome)	2	XP_050026060.1;XP_050023456.1
KEGG: 05170+2.7.11.1	Human immunodeficiency virus 1 infection	141	XP_050033720.1;XP_050033021.1;XP_050049191.1;XP_050036227.1;XP_050037631.1;XP_050042629.1;XP_050043307.1;XP_050036223.1;XP_050036613.1;XP_050037628.1;XP_050029381.1;XP_050036234.1;XP_050036235.1;XP_050036233.1;XP_050041948.1;XP_050031199.1;XP_050031196.1;XP_050036142.1;XP_050035462.1;XP_050046724.1;XP_050045265.1;XP_050026975.1;XP_050031204.1;XP_050039865.1;XP_050041924.1;XP_050031208.1;XP_050037626.1;XP_050028323.1;XP_050028687.1;XP_050036241.1;XP_050044080.1;XP_050026054.1;XP_050034829.1;XP_050034828.1;XP_050045266.1;XP_050050042.1;XP_050036130.1;XP_050036229.1;XP_050043129.1;XP_050043309.1;XP_050042988.1;XP_050036238.1;XP_050032102.1;XP_050037624.1;XP_050031197.1;XP_050028165.1;XP_050023932.1;XP_050033844.1;XP_050032928.1;XP_050043302.1;XP_050031203.1;XP_050031205.1;XP_050043305.1;XP_050043303.1;XP_050031202.1;XP_050049350.1;XP_050025348.1;XP_050042990.1;XP_050041923.1;XP_050036236.1;XP_050043301.1;XP_050030586.1;XP_050025347.1;XP_050037621.1;XP_050036129.1;XP_050035999.1;XP_050048620.1;XP_050031201.1;XP_050043306.1;XP_050034961.1;XP_050032927.1;XP_050036228.1;XP_050050041.1;XP_050031195.1;XP_050044807.1;XP_050036240.1;XP_050026974.1;XP_050050709.1;XP_050037629.1;XP_050051059.1;XP_050036131.1;XP_050031207.1;XP_050028292.1;XP_050045593.1;XP_050032548.1;XP_050050310.1;XP_050043849.1;XP_050048621.1;XP_050028166.1;XP_050041921.1;XP_050050734.1;XP_050037623.1;XP_050049192.1;XP_050037622.1;XP_050042307.1;XP_050032707.1;XP_050043304.1;XP_050022875.1;XP_050026695.1;XP_050026977.1;XP_050029160.1;XP_050050715.1;XP_050031209.1;XP_050032586.1;XP_050026976.1;XP_050036231.1;XP_050043130.1;XP_050037627.1;XP_050036230.1;XP_050026555.1;XP_050048906.1;XP_050036239.1;XP_050034960.1;XP_050051647.1;XP_050036224.1;XP_050031198.1;XP_050029303.1;XP_050048619.1;XP_050036226.1;XP_050041922.1;XP_050042989.1;XP_050037630.1;XP_050050723.1;XP_050026954.1;XP_050026053.1;XP_050031206.1;XP_050048905.1;XP_050031200.1;XP_050037625.1;XP_050036232.1;XP_050036237.1;XP_050026027.1;XP_050027320.1;XP_050034932.1;XP_050031194.1;XP_050043308.1;XP_050032708.1;XP_050036225.1;XP_050028233.1;XP_050026955.1;XP_050044446.1
KEGG: 00730+3.1.3.2	Thiamine metabolism	8	XP_050023380.1;XP_050042536.1;XP_050035094.1;XP_050030520.1;XP_050034778.1;XP_050049985.1;XP_050027405.1;XP_050027424.1
MetaCyc: PWY-6583	Pyruvate fermentation to butanol I	6	XP_050051194.1;XP_050041635.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041643.1
KEGG: 00400+2.6.1.5	Phenylalanine, tyrosine and tryptophan biosynthesis	3	XP_050031962.1;XP_050049182.1;XP_050049181.1
Reactome: R-HSA-5334118	DNA methylation	14	XP_050025244.1;XP_050043472.1;XP_050042802.1;XP_050038199.1;XP_050036268.1;XP_050025243.1;XP_050043470.1;XP_050043469.1;XP_050043471.1;XP_050038213.1;XP_050025266.1;XP_050043468.1;XP_050030757.1;XP_050025248.1
Reactome: R-HSA-1295596	Spry regulation of FGF signaling	5	XP_050047598.1;XP_050047606.1;XP_050032853.1;XP_050035481.1;XP_050048534.1
KEGG: 00250+2.4.2.14	Alanine, aspartate and glutamate metabolism	1	XP_050039987.1
MetaCyc: PWY-7417	Phospholipid remodeling (phosphatidate, yeast)	35	XP_050033390.1;XP_050037142.1;XP_050037856.1;XP_050027415.1;XP_050037145.1;XP_050030747.1;XP_050031256.1;XP_050037147.1;XP_050035193.1;XP_050025686.1;XP_050050583.1;XP_050035197.1;XP_050035195.1;XP_050037857.1;XP_050032357.1;XP_050035198.1;XP_050037151.1;XP_050037148.1;XP_050037146.1;XP_050035199.1;XP_050037140.1;XP_050035192.1;XP_050027416.1;XP_050037855.1;XP_050037661.1;XP_050025400.1;XP_050037143.1;XP_050037150.1;XP_050050549.1;XP_050035194.1;XP_050035196.1;XP_050037144.1;XP_050037854.1;XP_050037139.1;XP_050037141.1
KEGG: 00830+1.1.1.1	Retinol metabolism	3	XP_050052301.1;XP_050052400.1;XP_050052302.1
MetaCyc: PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	1	XP_050048806.1
MetaCyc: PWY-4381	Fatty acid biosynthesis initiation (bacteria and plants)	18	XP_050048459.1;XP_050048460.1;XP_050048463.1;XP_050033009.1;XP_050048465.1;XP_050048468.1;XP_050048462.1;XP_050048456.1;XP_050029751.1;XP_050048457.1;XP_050045094.1;XP_050048466.1;XP_050048458.1;XP_050033008.1;XP_050048461.1;XP_050034249.1;XP_050048467.1;XP_050032773.1
Reactome: R-HSA-8941326	RUNX2 regulates bone development	1	XP_050047422.1
Reactome: R-HSA-5627083	RHO GTPases regulate CFTR trafficking	2	XP_050026050.1;XP_050026049.1
Reactome: R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	2	XP_050034022.1;XP_050027464.1
Reactome: R-HSA-5684045	Defective ABCD1 causes adrenoleukodystrophy (ALD)	1	XP_050031037.1
MetaCyc: PWY-4081	Glutathione-peroxide redox reactions	1	XP_050037110.1
KEGG: 00280+4.2.1.17+1.1.1.35	Valine, leucine and isoleucine degradation	6	XP_050041643.1;XP_050032010.1;XP_050026422.1;XP_050041651.1;XP_050051194.1;XP_050041635.1
MetaCyc: PWY-6627	Salinosporamide A biosynthesis	3	XP_050035831.1;XP_050046556.1;XP_050046554.1
Reactome: R-HSA-388841	Costimulation by the CD28 family	2	XP_050025376.1;XP_050032853.1
KEGG: 00983+2.3.1.5	Drug metabolism - other enzymes	6	XP_050027935.1;XP_050027933.1;XP_050028265.1;XP_050027934.1;XP_050027932.1;XP_050027182.1
MetaCyc: PWY-5278	Sulfite oxidation III	2	XP_050051798.1;XP_050051797.1
MetaCyc: PWY-6168	Flavin biosynthesis III (fungi)	1	XP_050034819.1
MetaCyc: PWY-6471	Peptidoglycan biosynthesis IV (Enterococcus faecium)	3	XP_050034973.1;XP_050033584.1;XP_050033583.1
KEGG: 00970+6.1.1.15	Aminoacyl-tRNA biosynthesis	3	XP_050036769.1;XP_050028841.1;XP_050036768.1
KEGG: 00250+3.5.1.2	Alanine, aspartate and glutamate metabolism	1	XP_050026388.1
Reactome: R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	4	XP_050036269.1;XP_050052047.1;XP_050031324.1;XP_050029505.1
Reactome: R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	1	XP_050047377.1
KEGG: 00720+6.2.1.1	Carbon fixation pathways in prokaryotes	3	XP_050030604.1;XP_050044794.1;XP_050040406.1
MetaCyc: PWY-8088	Dipicolinate biosynthesis	1	XP_050045137.1
MetaCyc: PWY-1187	Glucosinolate biosynthesis from homomethionine	6	XP_050052715.1;XP_050052716.1;XP_050052719.1;XP_050052721.1;XP_050050544.1;XP_050050545.1
KEGG: 00740+2.7.1.26	Riboflavin metabolism	1	XP_050034819.1
MetaCyc: PWY-6945	Cholesterol degradation to androstenedione I (cholesterol oxidase)	6	XP_050041643.1;XP_050026422.1;XP_050032010.1;XP_050041635.1;XP_050051194.1;XP_050041651.1
MetaCyc: PWY-5647	2-nitrobenzoate degradation I	1	XP_050045561.1
Reactome: R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	3	XP_050048268.1;XP_050035481.1;XP_050048534.1
KEGG: 00072+2.3.3.10	Synthesis and degradation of ketone bodies	5	XP_050041696.1;XP_050041691.1;XP_050041695.1;XP_050041692.1;XP_050041694.1
Reactome: R-HSA-500657	Presynaptic function of Kainate receptors	5	XP_050025622.1;XP_050025623.1;XP_050023177.1;XP_050038409.1;XP_050044424.1
KEGG: 00670+2.1.2.10	One carbon pool by folate	7	XP_050030625.1;XP_050050949.1;XP_050045007.1;XP_050050950.1;XP_050045006.1;XP_050052825.1;XP_050050895.1
Reactome: R-HSA-388844	Receptor-type tyrosine-protein phosphatases	7	XP_050041344.1;XP_050039213.1;XP_050041343.1;XP_050041339.1;XP_050041341.1;XP_050039212.1;XP_050041342.1
MetaCyc: PWY-7206	Pyrimidine deoxyribonucleotides dephosphorylation	3	XP_050025198.1;XP_050045218.1;XP_050041566.1
Reactome: R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	37	XP_050038864.1;XP_050024518.1;XP_050035770.1;XP_050038865.1;XP_050042392.1;XP_050023475.1;XP_050030653.1;XP_050049377.1;XP_050038968.1;XP_050038866.1;XP_050023476.1;XP_050044008.1;XP_050038862.1;XP_050029516.1;XP_050023718.1;XP_050026809.1;XP_050046156.1;XP_050035932.1;XP_050033146.1;XP_050026810.1;XP_050029515.1;XP_050035933.1;XP_050042391.1;XP_050038895.1;XP_050038863.1;XP_050030942.1;XP_050023474.1;XP_050036430.1;XP_050038966.1;XP_050030507.1;XP_050038969.1;XP_050030652.1;XP_050030506.1;XP_050038967.1;XP_050039240.1;XP_050036827.1;XP_050025064.1
KEGG: 00510+2.4.1.257+2.4.1.132	N-Glycan biosynthesis	2	XP_050023465.1;XP_050023466.1
Reactome: R-HSA-8875656	MET receptor recycling	6	XP_050023499.1;XP_050037431.1;XP_050023500.1;XP_050032853.1;XP_050037432.1;XP_050023708.1
KEGG: 00260+2.1.2.1	Glycine, serine and threonine metabolism	3	XP_050032637.1;XP_050032636.1;XP_050034367.1
Reactome: R-HSA-211163	AKT-mediated inactivation of FOXO1A	3	XP_050048620.1;XP_050048621.1;XP_050048619.1
Reactome: R-HSA-72689	Formation of a pool of free 40S subunits	111	XP_050035484.1;XP_050029850.1;XP_050033573.1;XP_050036857.1;XP_050039997.1;XP_050028191.1;XP_050038550.1;XP_050028206.1;XP_050028344.1;XP_050044122.1;XP_050043802.1;XP_050029851.1;XP_050043804.1;XP_050038626.1;XP_050046933.1;XP_050028318.1;XP_050045043.1;XP_050023059.1;XP_050044593.1;XP_050026723.1;XP_050031153.1;XP_050043919.1;XP_050044171.1;XP_050032688.1;XP_050048062.1;XP_050036006.1;XP_050041428.1;XP_050027435.1;XP_050048060.1;XP_050044680.1;XP_050052117.1;XP_050048061.1;XP_050040632.1;XP_050033913.1;XP_050051491.1;XP_050039882.1;XP_050048967.1;XP_050042714.1;XP_050029294.1;XP_050036709.1;XP_050052195.1;XP_050035483.1;XP_050041323.1;XP_050030148.1;XP_050035149.1;XP_050041753.1;XP_050026721.1;XP_050041744.1;XP_050048534.1;XP_050036708.1;XP_050025476.1;XP_050026018.1;XP_050043918.1;XP_050027304.1;XP_050032598.1;XP_050050940.1;XP_050045969.1;XP_050023058.1;XP_050039340.1;XP_050035481.1;XP_050049831.1;XP_050047002.1;XP_050031230.1;XP_050030630.1;XP_050032599.1;XP_050044170.1;XP_050052131.1;XP_050028604.1;XP_050027305.1;XP_050032330.1;XP_050040677.1;XP_050044169.1;XP_050032793.1;XP_050043917.1;XP_050022853.1;XP_050049170.1;XP_050032936.1;XP_050031861.1;XP_050023492.1;XP_050022748.1;XP_050026103.1;XP_050045970.1;XP_050034868.1;XP_050026722.1;XP_050032528.1;XP_050039286.1;XP_050051569.1;XP_050048965.1;XP_050044445.1;XP_050031169.1;XP_050045196.1;XP_050039285.1;XP_050032921.1;XP_050024740.1;XP_050032331.1;XP_050032267.1;XP_050029801.1;XP_050046469.1;XP_050049830.1;XP_050043803.1;XP_050049776.1;XP_050029380.1;XP_050046031.1;XP_050046934.1;XP_050043916.1;XP_050036005.1;XP_050042319.1;XP_050052130.1;XP_050027477.1;XP_050025636.1;XP_050050516.1
Reactome: R-HSA-1483191	Synthesis of PC	110	XP_050036094.1;XP_050035829.1;XP_050046242.1;XP_050031346.1;XP_050035762.1;XP_050024784.1;XP_050024741.1;XP_050032133.1;XP_050043177.1;XP_050035955.1;XP_050035958.1;XP_050024721.1;XP_050035823.1;XP_050035826.1;XP_050024489.1;XP_050035967.1;XP_050035951.1;XP_050024723.1;XP_050035705.1;XP_050034860.1;XP_050031348.1;XP_050037456.1;XP_050031482.1;XP_050044647.1;XP_050035791.1;XP_050031477.1;XP_050045695.1;XP_050045420.1;XP_050034469.1;XP_050024748.1;XP_050046803.1;XP_050035956.1;XP_050035847.1;XP_050039337.1;XP_050024746.1;XP_050035952.1;XP_050035948.1;XP_050043638.1;XP_050037457.1;XP_050035217.1;XP_050027888.1;XP_050024898.1;XP_050031349.1;XP_050024880.1;XP_050035848.1;XP_050035553.1;XP_050035966.1;XP_050043179.1;XP_050024487.1;XP_050035763.1;XP_050035845.1;XP_050039338.1;XP_050031347.1;XP_050025319.1;XP_050024903.1;XP_050035554.1;XP_050031478.1;XP_050039336.1;XP_050024865.1;XP_050034768.1;XP_050034395.1;XP_050046807.1;XP_050031481.1;XP_050034532.1;XP_050031476.1;XP_050024744.1;XP_050034984.1;XP_050024742.1;XP_050035403.1;XP_050022871.1;XP_050034966.1;XP_050029239.1;XP_050037455.1;XP_050051200.1;XP_050037458.1;XP_050025028.1;XP_050024504.1;XP_050039317.1;XP_050034396.1;XP_050034983.1;XP_050031245.1;XP_050035422.1;XP_050039334.1;XP_050024486.1;XP_050034433.1;XP_050031483.1;XP_050024720.1;XP_050035314.1;XP_050034468.1;XP_050039335.1;XP_050041659.1;XP_050040139.1;XP_050031480.1;XP_050023509.1;XP_050034533.1;XP_050024747.1;XP_050024879.1;XP_050035552.1;XP_050024743.1;XP_050046806.1;XP_050043180.1;XP_050035954.1;XP_050024724.1;XP_050024745.1;XP_050034967.1;XP_050041992.1;XP_050039333.1;XP_050024488.1;XP_050046804.1;XP_050031637.1
Reactome: R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	7	XP_050036750.1;XP_050032825.1;XP_050048631.1;XP_050045374.1;XP_050048633.1;XP_050048632.1;XP_050045129.1
Reactome: R-HSA-5578998	Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)	1	XP_050049815.1
Reactome: R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	45	XP_050038469.1;XP_050034643.1;XP_050023730.1;XP_050025563.1;XP_050040428.1;XP_050043138.1;XP_050030634.1;XP_050040427.1;XP_050039484.1;XP_050039068.1;XP_050033368.1;XP_050023726.1;XP_050023714.1;XP_050046063.1;XP_050023729.1;XP_050023779.1;XP_050048718.1;XP_050043147.1;XP_050023725.1;XP_050037137.1;XP_050048717.1;XP_050025635.1;XP_050023576.1;XP_050030810.1;XP_050051336.1;XP_050045300.1;XP_050051335.1;XP_050047361.1;XP_050023776.1;XP_050034644.1;XP_050023728.1;XP_050046123.1;XP_050047588.1;XP_050037136.1;XP_050023577.1;XP_050039485.1;XP_050045052.1;XP_050044010.1;XP_050030280.1;XP_050023727.1;XP_050023777.1;XP_050035378.1;XP_050023724.1;XP_050030811.1;XP_050024189.1
KEGG: 00270+6.3.2.3	Cysteine and methionine metabolism	3	XP_050042926.1;XP_050042924.1;XP_050042925.1
Reactome: R-HSA-114604	GPVI-mediated activation cascade	8	XP_050025376.1;XP_050051318.1;XP_050051317.1;XP_050051315.1;XP_050025374.1;XP_050025375.1;XP_050051316.1;XP_050032548.1
KEGG: 00670+2.1.2.9	One carbon pool by folate	5	XP_050030635.1;XP_050034845.1;XP_050048865.1;XP_050034846.1;XP_050034847.1
Reactome: R-HSA-6804760	Regulation of TP53 Activity through Methylation	13	XP_050047375.1;XP_050047373.1;XP_050049813.1;XP_050050319.1;XP_050047374.1;XP_050035481.1;XP_050028292.1;XP_050048534.1;XP_050047372.1;XP_050045170.1;XP_050028323.1;XP_050049812.1;XP_050047371.1
Reactome: R-HSA-70635	Urea cycle	5	XP_050052351.1;XP_050036729.1;XP_050045233.1;XP_050045223.1;XP_050036726.1
KEGG: 00900+5.3.3.2	Terpenoid backbone biosynthesis	2	XP_050045766.1;XP_050045765.1
Reactome: R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	57	XP_050037401.1;XP_050033237.1;XP_050034772.1;XP_050025715.1;XP_050044478.1;XP_050045660.1;XP_050048721.1;XP_050025848.1;XP_050031479.1;XP_050044476.1;XP_050048719.1;XP_050036605.1;XP_050047809.1;XP_050045785.1;XP_050050373.1;XP_050032477.1;XP_050048534.1;XP_050040200.1;XP_050022938.1;XP_050024349.1;XP_050037397.1;XP_050024749.1;XP_050044475.1;XP_050031786.1;XP_050027118.1;XP_050040198.1;XP_050049124.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050024348.1;XP_050030634.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050033331.1;XP_050036567.1;XP_050035472.1;XP_050051964.1;XP_050047181.1;XP_050044469.1;XP_050023714.1;XP_050048824.1;XP_050037399.1;XP_050033833.1;XP_050036156.1;XP_050038140.1;XP_050027657.1;XP_050022518.1;XP_050027134.1;XP_050042788.1;XP_050033318.1;XP_050037398.1
Reactome: R-HSA-5632987	Defective Mismatch Repair Associated With PMS2	2	XP_050031446.1;XP_050031345.1
MetaCyc: PWY-7765	3-hydroxy-4-methyl-anthranilate biosynthesis II	12	XP_050040581.1;XP_050035077.1;XP_050040577.1;XP_050048623.1;XP_050040417.1;XP_050040584.1;XP_050040418.1;XP_050040415.1;XP_050040583.1;XP_050040419.1;XP_050040580.1;XP_050040416.1
MetaCyc: PWY-2161B	Glutamate removal from folates	1	XP_050032978.1
Reactome: R-HSA-9634638	Estrogen-dependent nuclear events downstream of ESR-membrane signaling	8	XP_050047606.1;XP_050048620.1;XP_050046837.1;XP_050048619.1;XP_050036805.1;XP_050048621.1;XP_050047598.1;XP_050046838.1
KEGG: 00500+2.4.1.18	Starch and sucrose metabolism	3	XP_050042400.1;XP_050028738.1;XP_050028469.1
MetaCyc: PWY-5366	Palmitoleate biosynthesis II (plants and bacteria)	4	XP_050029751.1;XP_050033009.1;XP_050032773.1;XP_050033008.1
Reactome: R-HSA-400253	Circadian Clock	27	XP_050042082.1;XP_050028692.1;XP_050045185.1;XP_050045187.1;XP_050045183.1;XP_050040624.1;XP_050036461.1;XP_050047670.1;XP_050045188.1;XP_050035481.1;XP_050038602.1;XP_050045181.1;XP_050031490.1;XP_050042079.1;XP_050042081.1;XP_050045180.1;XP_050043924.1;XP_050031330.1;XP_050042080.1;XP_050045184.1;XP_050044106.1;XP_050045186.1;XP_050031529.1;XP_050045182.1;XP_050048534.1;XP_050042083.1;XP_050040623.1
Reactome: R-HSA-201451	Signaling by BMP	1	XP_050029785.1
KEGG: 00710+1.1.1.37	Carbon fixation in photosynthetic organisms	11	XP_050037168.1;XP_050037164.1;XP_050037165.1;XP_050037169.1;XP_050037926.1;XP_050035735.1;XP_050037166.1;XP_050037172.1;XP_050037925.1;XP_050045192.1;XP_050037167.1
MetaCyc: PWY-7589	Palmitoleate biosynthesis III (cyanobacteria)	8	XP_050037857.1;XP_050032357.1;XP_050027415.1;XP_050027416.1;XP_050037855.1;XP_050037854.1;XP_050037856.1;XP_050050583.1
Reactome: R-HSA-3000171	Non-integrin membrane-ECM interactions	17	XP_050052730.1;XP_050025342.1;XP_050031326.1;XP_050024363.1;XP_050024362.1;XP_050033321.1;XP_050030649.1;XP_050025339.1;XP_050052132.1;XP_050031395.1;XP_050051572.1;XP_050027018.1;XP_050024364.1;XP_050028252.1;XP_050025338.1;XP_050025341.1;XP_050039341.1
KEGG: 00520+3.5.99.6	Amino sugar and nucleotide sugar metabolism	4	XP_050040346.1;XP_050040348.1;XP_050040347.1;XP_050049839.1
Reactome: R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	6	XP_050036365.1;XP_050034595.1;XP_050036502.1;XP_050046640.1;XP_050026551.1;XP_050034209.1
MetaCyc: PWY-7661	Protein N-glycosylation (Haloferax volcanii)	1	XP_050029180.1
KEGG: 00480+2.5.1.18	Glutathione metabolism	11	XP_050048233.1;XP_050047905.1;XP_050048256.1;XP_050047704.1;XP_050048220.1;XP_050048267.1;XP_050031872.1;XP_050048247.1;XP_050047714.1;XP_050047698.1;XP_050031855.1
Reactome: R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	5	XP_050028236.1;XP_050028237.1;XP_050048534.1;XP_050035481.1;XP_050028235.1
MetaCyc: PWY-7980	ATP biosynthesis	5	XP_050050217.1;XP_050043887.1;XP_050047208.1;XP_050034615.1;XP_050031579.1
Reactome: R-HSA-210745	Regulation of gene expression in beta cells	2	XP_050049439.1;XP_050045768.1
KEGG: 04151+2.7.1.153	PI3K-Akt signaling pathway	2	XP_050028399.1;XP_050052756.1
MetaCyc: PWY-8055	Palmitoyl ethanolamide biosynthesis	15	XP_050047026.1;XP_050037856.1;XP_050037775.1;XP_050047027.1;XP_050037457.1;XP_050050583.1;XP_050032357.1;XP_050037857.1;XP_050037855.1;XP_050037854.1;XP_050027416.1;XP_050037456.1;XP_050027415.1;XP_050037455.1;XP_050037458.1
MetaCyc: PWY-7227	Adenosine deoxyribonucleotides de novo biosynthesis	8	XP_050031386.1;XP_050038939.1;XP_050029490.1;XP_050038800.1;XP_050043296.1;XP_050029492.1;XP_050030600.1;XP_050031510.1
Reactome: R-HSA-211981	Xenobiotics	1	XP_050027825.1
KEGG: 04070+2.7.1.67	Phosphatidylinositol signaling system	1	XP_050049284.1
MetaCyc: PWY-7204	Pyridoxal 5'-phosphate salvage II (plants)	3	XP_050044537.1;XP_050039873.1;XP_050026420.1
KEGG: 00910+6.3.1.2	Nitrogen metabolism	11	XP_050038621.1;XP_050033588.1;XP_050051950.1;XP_050028873.1;XP_050038622.1;XP_050038620.1;XP_050038619.1;XP_050028876.1;XP_050028874.1;XP_050038618.1;XP_050033589.1
Reactome: R-HSA-216083	Integrin cell surface interactions	12	XP_050043548.1;XP_050052132.1;XP_050042816.1;XP_050044946.1;XP_050043549.1;XP_050043550.1;XP_050039341.1;XP_050043884.1;XP_050044944.1;XP_050044945.1;XP_050046048.1;XP_050051572.1
Reactome: R-HSA-2586552	Signaling by Leptin	1	XP_050022944.1
KEGG: 00360+2.6.1.5	Phenylalanine metabolism	3	XP_050049181.1;XP_050049182.1;XP_050031962.1
Reactome: R-HSA-5654732	Negative regulation of FGFR3 signaling	5	XP_050047598.1;XP_050032853.1;XP_050047606.1;XP_050048534.1;XP_050035481.1
Reactome: R-HSA-3656532	TGFBR1 KD Mutants in Cancer	1	XP_050023721.1
Reactome: R-HSA-351202	Metabolism of polyamines	5	XP_050041583.1;XP_050041589.1;XP_050027527.1;XP_050027983.1;XP_050027526.1
MetaCyc: PWY-6482	Diphthamide biosynthesis I (archaea)	3	XP_050029390.1;XP_050048261.1;XP_050023816.1
KEGG: 00270+2.1.1.13	Cysteine and methionine metabolism	1	XP_050036540.1
Reactome: R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	38	XP_050040427.1;XP_050040428.1;XP_050043138.1;XP_050039484.1;XP_050038469.1;XP_050025563.1;XP_050023730.1;XP_050034643.1;XP_050023725.1;XP_050043147.1;XP_050037137.1;XP_050025635.1;XP_050023576.1;XP_050046063.1;XP_050023729.1;XP_050033368.1;XP_050023726.1;XP_050023779.1;XP_050047361.1;XP_050034644.1;XP_050045189.1;XP_050023776.1;XP_050045300.1;XP_050030810.1;XP_050035378.1;XP_050023727.1;XP_050023777.1;XP_050023724.1;XP_050030280.1;XP_050024189.1;XP_050030811.1;XP_050047588.1;XP_050037136.1;XP_050023728.1;XP_050046123.1;XP_050039485.1;XP_050044010.1;XP_050023577.1
MetaCyc: PWY-7818	Type IV lipoteichoic acid biosynthesis (S. pneumoniae)	6	XP_050039337.1;XP_050039333.1;XP_050039338.1;XP_050039334.1;XP_050039335.1;XP_050039336.1
KEGG: 00910+1.4.1.14	Nitrogen metabolism	1	XP_050028197.1
Reactome: R-HSA-3232142	SUMOylation of ubiquitinylation proteins	39	XP_050024518.1;XP_050024349.1;XP_050038864.1;XP_050038865.1;XP_050035770.1;XP_050023475.1;XP_050042392.1;XP_050038866.1;XP_050038968.1;XP_050049377.1;XP_050030653.1;XP_050044008.1;XP_050023476.1;XP_050046156.1;XP_050026809.1;XP_050035932.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050026810.1;XP_050033146.1;XP_050029515.1;XP_050035933.1;XP_050038863.1;XP_050030942.1;XP_050038895.1;XP_050042391.1;XP_050036430.1;XP_050023474.1;XP_050030507.1;XP_050038966.1;XP_050030652.1;XP_050030506.1;XP_050038969.1;XP_050024348.1;XP_050025064.1;XP_050036827.1;XP_050039240.1;XP_050038967.1
Reactome: R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	4	XP_050035481.1;XP_050048534.1;XP_050028061.1;XP_050028062.1
Reactome: R-HSA-5654726	Negative regulation of FGFR1 signaling	9	XP_050047716.1;XP_050047847.1;XP_050048534.1;XP_050035481.1;XP_050034235.1;XP_050047606.1;XP_050032853.1;XP_050047846.1;XP_050047598.1
Reactome: R-HSA-75955	RNA Polymerase II Transcription Elongation	54	XP_050040428.1;XP_050043138.1;XP_050040427.1;XP_050030634.1;XP_050048255.1;XP_050039484.1;XP_050022472.1;XP_050039068.1;XP_050044472.1;XP_050038469.1;XP_050034643.1;XP_050023730.1;XP_050025563.1;XP_050044597.1;XP_050043147.1;XP_050023725.1;XP_050037137.1;XP_050048717.1;XP_050025635.1;XP_050023576.1;XP_050033368.1;XP_050023726.1;XP_050023714.1;XP_050046063.1;XP_050023729.1;XP_050045190.1;XP_050023779.1;XP_050048718.1;XP_050042077.1;XP_050047361.1;XP_050023776.1;XP_050034644.1;XP_050045027.1;XP_050030810.1;XP_050051336.1;XP_050045300.1;XP_050051335.1;XP_050030280.1;XP_050023777.1;XP_050035378.1;XP_050023727.1;XP_050034171.1;XP_050023724.1;XP_050030811.1;XP_050024189.1;XP_050023728.1;XP_050046123.1;XP_050044473.1;XP_050047588.1;XP_050037136.1;XP_050023577.1;XP_050039485.1;XP_050045052.1;XP_050044010.1
Reactome: R-HSA-8963693	Aspartate and asparagine metabolism	3	XP_050035272.1;XP_050036428.1;XP_050035830.1
Reactome: R-HSA-9665250	Resistance of ERBB2 KD mutants to AEE788	2	XP_050048201.1;XP_050048200.1
Reactome: R-HSA-8849175	Threonine catabolism	4	XP_050042563.1;XP_050042562.1;XP_050031278.1;XP_050031016.1
KEGG: 00270+5.3.1.23	Cysteine and methionine metabolism	8	XP_050031848.1;XP_050024914.1;XP_050039041.1;XP_050024913.1;XP_050026779.1;XP_050050027.1;XP_050026778.1;XP_050024912.1
Reactome: R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	6	XP_050037412.1;XP_050040190.1;XP_050037411.1;XP_050040189.1;XP_050037409.1;XP_050037410.1
KEGG: 04070+3.1.3.66	Phosphatidylinositol signaling system	4	XP_050040160.1;XP_050040159.1;XP_050040157.1;XP_050040158.1
Reactome: R-HSA-209543	p75NTR recruits signalling complexes	5	XP_050026264.1;XP_050035481.1;XP_050048534.1;XP_050026263.1;XP_050024508.1
Reactome: R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	2	XP_050046838.1;XP_050046837.1
KEGG: 00600+3.2.1.23	Sphingolipid metabolism	20	XP_050039611.1;XP_050038798.1;XP_050042178.1;XP_050042180.1;XP_050042167.1;XP_050042181.1;XP_050039612.1;XP_050042179.1;XP_050042169.1;XP_050042437.1;XP_050042438.1;XP_050042439.1;XP_050040162.1;XP_050042175.1;XP_050038908.1;XP_050042176.1;XP_050045117.1;XP_050042436.1;XP_050042177.1;XP_050040161.1
KEGG: 00562+2.7.1.67	Inositol phosphate metabolism	1	XP_050049284.1
KEGG: 00310+2.1.1.60	Lysine degradation	1	XP_050046958.1
Reactome: R-HSA-1834941	STING mediated induction of host immune responses	3	XP_050028235.1;XP_050028236.1;XP_050028237.1
Reactome: R-HSA-6790901	rRNA modification in the nucleus and cytosol	69	XP_050036543.1;XP_050036830.1;XP_050039886.1;XP_050026185.1;XP_050034770.1;XP_050032347.1;XP_050033847.1;XP_050048805.1;XP_050034620.1;XP_050041314.1;XP_050041310.1;XP_050034757.1;XP_050029294.1;XP_050029851.1;XP_050049769.1;XP_050029364.1;XP_050034659.1;XP_050042954.1;XP_050025176.1;XP_050041143.1;XP_050032353.1;XP_050041312.1;XP_050052060.1;XP_050023588.1;XP_050029850.1;XP_050042950.1;XP_050024361.1;XP_050036431.1;XP_050048853.1;XP_050027513.1;XP_050034633.1;XP_050052269.1;XP_050052202.1;XP_050041315.1;XP_050052201.1;XP_050041311.1;XP_050044114.1;XP_050024740.1;XP_050024370.1;XP_050032331.1;XP_050051569.1;XP_050029316.1;XP_050029607.1;XP_050046746.1;XP_050027512.1;XP_050042306.1;XP_050039582.1;XP_050050067.1;XP_050050490.1;XP_050029380.1;XP_050032634.1;XP_050032840.1;XP_050048049.1;XP_050052268.1;XP_050034721.1;XP_050026793.1;XP_050034745.1;XP_050052267.1;XP_050026008.1;XP_050052296.1;XP_050026792.1;XP_050045601.1;XP_050032330.1;XP_050023381.1;XP_050041313.1;XP_050034567.1;XP_050033723.1;XP_050032602.1;XP_050027514.1
KEGG: 00564+2.7.1.32+2.7.1.82	Glycerophospholipid metabolism	6	XP_050039335.1;XP_050039334.1;XP_050039336.1;XP_050039333.1;XP_050039337.1;XP_050039338.1
Reactome: R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	16	XP_050038989.1;XP_050038767.1;XP_050050057.1;XP_050025018.1;XP_050027715.1;XP_050035481.1;XP_050025017.1;XP_050040730.1;XP_050030675.1;XP_050050066.1;XP_050032654.1;XP_050052234.1;XP_050027404.1;XP_050051774.1;XP_050048534.1;XP_050032655.1
Reactome: R-HSA-977347	Serine biosynthesis	6	XP_050025381.1;XP_050034259.1;XP_050040458.1;XP_050034258.1;XP_050045348.1;XP_050040457.1
MetaCyc: PWY-5530	Sorbitol biosynthesis II	2	XP_050030742.1;XP_050030744.1
KEGG: 00270+3.3.1.1	Cysteine and methionine metabolism	16	XP_050030828.1;XP_050030820.1;XP_050030827.1;XP_050030823.1;XP_050030822.1;XP_050030831.1;XP_050030821.1;XP_050030819.1;XP_050030829.1;XP_050030832.1;XP_050030830.1;XP_050030826.1;XP_050030825.1;XP_050030818.1;XP_050048145.1;XP_050030824.1
Reactome: R-HSA-8941856	RUNX3 regulates NOTCH signaling	4	XP_050038602.1;XP_050050843.1;XP_050038799.1;XP_050045588.1
Reactome: R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	2	XP_050033319.1;XP_050050209.1
Reactome: R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	2	XP_050039212.1;XP_050039213.1
MetaCyc: PWY-6932	Selenate reduction	2	XP_050051798.1;XP_050051797.1
MetaCyc: PWY-5340	Sulfate activation for sulfonation	2	XP_050051798.1;XP_050051797.1
KEGG: 00720+6.4.1.3	Carbon fixation pathways in prokaryotes	1	XP_050049718.1
KEGG: 00260+5.4.2.12	Glycine, serine and threonine metabolism	1	XP_050044976.1
Reactome: R-HSA-8931987	RUNX1 regulates estrogen receptor mediated transcription	1	XP_050047422.1
MetaCyc: PWY-7328	Superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis	3	XP_050031782.1;XP_050042029.1;XP_050031783.1
Reactome: R-HSA-75953	RNA Polymerase II Transcription Initiation	44	XP_050034643.1;XP_050046688.1;XP_050045372.1;XP_050023730.1;XP_050025563.1;XP_050034031.1;XP_050031535.1;XP_050026414.1;XP_050026035.1;XP_050038469.1;XP_050040428.1;XP_050040427.1;XP_050034518.1;XP_050038988.1;XP_050023726.1;XP_050033368.1;XP_050023729.1;XP_050032071.1;XP_050046063.1;XP_050031536.1;XP_050036381.1;XP_050034505.1;XP_050037137.1;XP_050023725.1;XP_050043147.1;XP_050045300.1;XP_050040671.1;XP_050045373.1;XP_050034644.1;XP_050049294.1;XP_050047361.1;XP_050049295.1;XP_050031537.1;XP_050044010.1;XP_050046123.1;XP_050023728.1;XP_050034030.1;XP_050037136.1;XP_050049296.1;XP_050049297.1;XP_050024189.1;XP_050023724.1;XP_050035378.1;XP_050023727.1
KEGG: 00020+6.2.1.5	Citrate cycle (TCA cycle)	8	XP_050026353.1;XP_050049075.1;XP_050042704.1;XP_050026352.1;XP_050049076.1;XP_050042702.1;XP_050042703.1;XP_050043005.1
KEGG: 00480+1.1.1.49	Glutathione metabolism	5	XP_050026012.1;XP_050026015.1;XP_050026014.1;XP_050026016.1;XP_050026013.1
MetaCyc: PWY-6737	Starch degradation V	4	XP_050037069.1;XP_050037070.1;XP_050042052.1;XP_050037071.1
KEGG: 00051+2.7.1.1	Fructose and mannose metabolism	3	XP_050027343.1;XP_050047070.1;XP_050047071.1
MetaCyc: PWY-7442	Drosopterin and aurodrosopterin biosynthesis	4	XP_050045129.1;XP_050048633.1;XP_050048632.1;XP_050048631.1
Reactome: R-HSA-5627123	RHO GTPases activate PAKs	3	XP_050048518.1;XP_050025374.1;XP_050025375.1
MetaCyc: PWY-6642	(R)-cysteate degradation	3	XP_050049202.1;XP_050049203.1;XP_050026413.1
KEGG: 00261+2.7.7.4	Monobactam biosynthesis	2	XP_050051798.1;XP_050051797.1
Reactome: R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	8	XP_050047998.1;XP_050047997.1;XP_050047996.1;XP_050047995.1;XP_050047994.1;XP_050048775.1;XP_050048777.1;XP_050048776.1
MetaCyc: PWY-5076	L-leucine degradation III	4	XP_050052400.1;XP_050039540.1;XP_050052302.1;XP_050052301.1
KEGG: 00720+6.2.1.5	Carbon fixation pathways in prokaryotes	8	XP_050026353.1;XP_050049075.1;XP_050026352.1;XP_050042704.1;XP_050042702.1;XP_050042703.1;XP_050043005.1;XP_050049076.1
Reactome: R-HSA-68689	CDC6 association with the ORC:origin complex	8	XP_050033374.1;XP_050033934.1;XP_050043900.1;XP_050049723.1;XP_050023646.1;XP_050038751.1;XP_050027478.1;XP_050043901.1
Reactome: R-HSA-8939211	ESR-mediated signaling	4	XP_050040551.1;XP_050048821.1;XP_050047598.1;XP_050047606.1
KEGG: 00900+2.7.4.2	Terpenoid backbone biosynthesis	1	XP_050044825.1
MetaCyc: PWY-7782	Plasmalogen biosynthesis	44	XP_050039333.1;XP_050038858.1;XP_050038842.1;XP_050027416.1;XP_050037855.1;XP_050037742.1;XP_050038848.1;XP_050040922.1;XP_050039370.1;XP_050039376.1;XP_050030300.1;XP_050037743.1;XP_050039337.1;XP_050037854.1;XP_050039378.1;XP_050039335.1;XP_050038855.1;XP_050037457.1;XP_050030299.1;XP_050038843.1;XP_050037456.1;XP_050038847.1;XP_050039214.1;XP_050037458.1;XP_050039371.1;XP_050037455.1;XP_050039377.1;XP_050027415.1;XP_050038844.1;XP_050038846.1;XP_050039334.1;XP_050038859.1;XP_050038845.1;XP_050041247.1;XP_050037856.1;XP_050039379.1;XP_050039773.1;XP_050039338.1;XP_050038856.1;XP_050037857.1;XP_050032357.1;XP_050041248.1;XP_050050583.1;XP_050039336.1
Reactome: R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	5	XP_050028323.1;XP_050025697.1;XP_050028292.1;XP_050052094.1;XP_050025696.1
Reactome: R-HSA-8939242	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	1	XP_050047422.1
KEGG: 00630+6.2.1.1	Glyoxylate and dicarboxylate metabolism	3	XP_050040406.1;XP_050044794.1;XP_050030604.1
Reactome: R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	33	XP_050052034.1;XP_050027600.1;XP_050027599.1;XP_050027598.1;XP_050029842.1;XP_050027738.1;XP_050039215.1;XP_050025687.1;XP_050052372.1;XP_050023516.1;XP_050051315.1;XP_050025374.1;XP_050029841.1;XP_050035166.1;XP_050051318.1;XP_050027302.1;XP_050035167.1;XP_050051316.1;XP_050025375.1;XP_050025688.1;XP_050047598.1;XP_050030794.1;XP_050032853.1;XP_050035163.1;XP_050037400.1;XP_050035165.1;XP_050025689.1;XP_050045760.1;XP_050052033.1;XP_050051317.1;XP_050023517.1;XP_050029843.1;XP_050047606.1
Reactome: R-HSA-9028731	Activated NTRK2 signals through FRS2 and FRS3	2	XP_050032853.1;XP_050048507.1
MetaCyc: PWY-5491	Diethylphosphate degradation	8	XP_050045710.1;XP_050041543.1;XP_050042681.1;XP_050042678.1;XP_050042679.1;XP_050047231.1;XP_050041544.1;XP_050041542.1
KEGG: 00250+6.3.4.5	Alanine, aspartate and glutamate metabolism	1	XP_050052351.1
KEGG: 00550+2.7.8.13	Peptidoglycan biosynthesis	1	XP_050034973.1
KEGG: 00760+6.3.5.1	Nicotinate and nicotinamide metabolism	2	XP_050046833.1;XP_050046832.1
KEGG: 00563+2.4.1.198	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	4	XP_050044986.1;XP_050049681.1;XP_050049680.1;XP_050036357.1
KEGG: 00450+2.9.1.2	Selenocompound metabolism	1	XP_050036866.1
Reactome: R-HSA-9027276	Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	2	XP_050052756.1;XP_050028399.1
Reactome: R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	18	XP_050051381.1;XP_050035481.1;XP_050039332.1;XP_050039331.1;XP_050039329.1;XP_050034247.1;XP_050048801.1;XP_050047778.1;XP_050040341.1;XP_050040340.1;XP_050048534.1;XP_050040339.1;XP_050030937.1;XP_050040338.1;XP_050038630.1;XP_050034248.1;XP_050038628.1;XP_050039330.1
KEGG: 00520+2.6.1.16	Amino sugar and nucleotide sugar metabolism	5	XP_050051580.1;XP_050051577.1;XP_050051579.1;XP_050051581.1;XP_050051578.1
Reactome: R-HSA-4043916	Defective MPI causes MPI-CDG (CDG-1b)	1	XP_050044364.1
MetaCyc: PWY-7783	Plasmalogen degradation	27	XP_050035196.1;XP_050037144.1;XP_050035197.1;XP_050035195.1;XP_050037139.1;XP_050037141.1;XP_050037661.1;XP_050025400.1;XP_050037143.1;XP_050025686.1;XP_050037150.1;XP_050050549.1;XP_050035194.1;XP_050035192.1;XP_050037145.1;XP_050030747.1;XP_050031256.1;XP_050037147.1;XP_050035193.1;XP_050035198.1;XP_050033390.1;XP_050037151.1;XP_050037146.1;XP_050037148.1;XP_050037142.1;XP_050035199.1;XP_050037140.1
KEGG: 00920+2.7.1.25	Sulfur metabolism	2	XP_050051797.1;XP_050051798.1
KEGG: 00280+6.4.1.3	Valine, leucine and isoleucine degradation	1	XP_050049718.1
MetaCyc: PWY-5912	2'-deoxymugineic acid phytosiderophore biosynthesis	2	XP_050052168.1;XP_050052167.1
Reactome: R-HSA-180336	SHC1 events in EGFR signaling	1	XP_050032853.1
Reactome: R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	3	XP_050024370.1;XP_050042691.1;XP_050024361.1
MetaCyc: PWY-5663	Erythro-tetrahydrobiopterin biosynthesis I	4	XP_050048631.1;XP_050048633.1;XP_050048632.1;XP_050045129.1
MetaCyc: PWY-6113	Superpathway of mycolate biosynthesis	4	XP_050029751.1;XP_050033008.1;XP_050032773.1;XP_050033009.1
KEGG: 00511+3.2.1.51	Other glycan degradation	8	XP_050040707.1;XP_050041348.1;XP_050051332.1;XP_050040716.1;XP_050033006.1;XP_050041309.1;XP_050040693.1;XP_050043493.1
KEGG: 00513+2.4.1.141	Various types of N-glycan biosynthesis	2	XP_050033583.1;XP_050033584.1
Reactome: R-HSA-210993	Tie2 Signaling	1	XP_050032853.1
Reactome: R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	9	XP_050044528.1;XP_050044532.1;XP_050044525.1;XP_050044524.1;XP_050044531.1;XP_050044527.1;XP_050034639.1;XP_050044530.1;XP_050044529.1
Reactome: R-HSA-2206296	MPS II - Hunter syndrome	1	XP_050040138.1
KEGG: 05235+3.1.3.16	PD-L1 expression and PD-1 checkpoint pathway in cancer	59	XP_050050370.1;XP_050052813.1;XP_050050842.1;XP_050035478.1;XP_050024311.1;XP_050046743.1;XP_050024153.1;XP_050024314.1;XP_050030280.1;XP_050027367.1;XP_050039893.1;XP_050042483.1;XP_050049023.1;XP_050024315.1;XP_050047387.1;XP_050023419.1;XP_050051183.1;XP_050025719.1;XP_050045668.1;XP_050038927.1;XP_050036586.1;XP_050042946.1;XP_050025562.1;XP_050039895.1;XP_050030913.1;XP_050035477.1;XP_050023418.1;XP_050037472.1;XP_050029847.1;XP_050024316.1;XP_050025720.1;XP_050047386.1;XP_050024310.1;XP_050050072.1;XP_050034951.1;XP_050048821.1;XP_050025670.1;XP_050025672.1;XP_050023143.1;XP_050039894.1;XP_050047404.1;XP_050034952.1;XP_050040107.1;XP_050051674.1;XP_050023189.1;XP_050038926.1;XP_050024313.1;XP_050050372.1;XP_050032919.1;XP_050051673.1;XP_050035479.1;XP_050022996.1;XP_050025673.1;XP_050024512.1;XP_050028692.1;XP_050025671.1;XP_050033089.1;XP_050043539.1;XP_050036461.1
KEGG: 00010+1.2.1.12	Glycolysis / Gluconeogenesis	2	XP_050041662.1;XP_050041668.1
MetaCyc: PWY-6536	4-aminobutanoate degradation III	1	XP_050041758.1
Reactome: R-HSA-6804757	Regulation of TP53 Degradation	28	XP_050048620.1;XP_050028323.1;XP_050041412.1;XP_050035481.1;XP_050028292.1;XP_050042304.1;XP_050047375.1;XP_050048619.1;XP_050047371.1;XP_050025347.1;XP_050052241.1;XP_050032510.1;XP_050032512.1;XP_050032511.1;XP_050025348.1;XP_050032514.1;XP_050047372.1;XP_050048534.1;XP_050047374.1;XP_050047373.1;XP_050048621.1;XP_050032509.1;XP_050032516.1;XP_050032515.1;XP_050052242.1;XP_050032513.1;XP_050051690.1;XP_050032548.1
KEGG: 00270+1.13.11.54	Cysteine and methionine metabolism	2	XP_050045631.1;XP_050039079.1
MetaCyc: PWY-5789	3-hydroxypropanoate/4-hydroxybutanate cycle	30	XP_050022903.1;XP_050048466.1;XP_050041635.1;XP_050038033.1;XP_050022906.1;XP_050048458.1;XP_050034249.1;XP_050049116.1;XP_050048461.1;XP_050048467.1;XP_050034236.1;XP_050025446.1;XP_050032010.1;XP_050026422.1;XP_050049115.1;XP_050048463.1;XP_050048460.1;XP_050048459.1;XP_050041643.1;XP_050049114.1;XP_050022895.1;XP_050048465.1;XP_050049718.1;XP_050048456.1;XP_050048468.1;XP_050048462.1;XP_050041651.1;XP_050048457.1;XP_050051194.1;XP_050045094.1
Reactome: R-HSA-3000471	Scavenging by Class B Receptors	13	XP_050042242.1;XP_050042262.1;XP_050042260.1;XP_050042241.1;XP_050023796.1;XP_050023422.1;XP_050042240.1;XP_050038663.1;XP_050023809.1;XP_050023312.1;XP_050023334.1;XP_050042261.1;XP_050042454.1
MetaCyc: PWY-5743	3-hydroxypropanoate cycle	24	XP_050049114.1;XP_050022895.1;XP_050048465.1;XP_050048460.1;XP_050048463.1;XP_050048459.1;XP_050048457.1;XP_050045094.1;XP_050049718.1;XP_050048456.1;XP_050048462.1;XP_050048468.1;XP_050038033.1;XP_050022906.1;XP_050048458.1;XP_050022903.1;XP_050048466.1;XP_050025446.1;XP_050034236.1;XP_050049115.1;XP_050034249.1;XP_050049116.1;XP_050048461.1;XP_050048467.1
Reactome: R-HSA-446199	Synthesis of Dolichyl-phosphate	21	XP_050051831.1;XP_050038667.1;XP_050035210.1;XP_050026424.1;XP_050050944.1;XP_050035212.1;XP_050039374.1;XP_050051832.1;XP_050024031.1;XP_050035209.1;XP_050050945.1;XP_050038737.1;XP_050051593.1;XP_050035211.1;XP_050038668.1;XP_050046583.1;XP_050024028.1;XP_050028887.1;XP_050047428.1;XP_050024030.1;XP_050025956.1
KEGG: 00790+1.5.1.3	Folate biosynthesis	1	XP_050032825.1
KEGG: 00760+6.3.1.5	Nicotinate and nicotinamide metabolism	2	XP_050046832.1;XP_050046833.1
KEGG: 00520+5.3.1.9	Amino sugar and nucleotide sugar metabolism	1	XP_050050068.1
KEGG: 00280+4.1.3.4	Valine, leucine and isoleucine degradation	4	XP_050033709.1;XP_050033707.1;XP_050033827.1;XP_050033708.1
Reactome: R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	5	XP_050048200.1;XP_050048201.1;XP_050032853.1;XP_050048534.1;XP_050035481.1
Reactome: R-HSA-4755579	Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ	2	XP_050050945.1;XP_050050944.1
Reactome: R-HSA-174414	Processive synthesis on the C-strand of the telomere	4	XP_050040824.1;XP_050052687.1;XP_050032670.1;XP_050022594.1
KEGG: 00270+3.1.3.77	Cysteine and methionine metabolism	2	XP_050038461.1;XP_050038462.1
Reactome: R-HSA-5678771	Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1	5	XP_050042719.1;XP_050042828.1;XP_050042723.1;XP_050042721.1;XP_050042722.1
MetaCyc: PWY-7369	Thiamine triphosphate metabolism	1	XP_050030314.1
KEGG: 00510+2.4.1.142	N-Glycan biosynthesis	1	XP_050029793.1
KEGG: 00970+6.1.1.4	Aminoacyl-tRNA biosynthesis	2	XP_050049817.1;XP_050031025.1
Reactome: R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	3	XP_050037178.1;XP_050040343.1;XP_050045005.1
Reactome: R-HSA-1482883	Acyl chain remodeling of DAG and TAG	5	XP_050046980.1;XP_050046979.1;XP_050047472.1;XP_050047470.1;XP_050046981.1
Reactome: R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	7	XP_050033374.1;XP_050023646.1;XP_050033934.1;XP_050043900.1;XP_050038751.1;XP_050027478.1;XP_050043901.1
KEGG: 00983+2.7.4.6	Drug metabolism - other enzymes	6	XP_050029492.1;XP_050031386.1;XP_050031510.1;XP_050038939.1;XP_050029490.1;XP_050043296.1
Reactome: R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	61	XP_050048534.1;XP_050032477.1;XP_050050373.1;XP_050045785.1;XP_050047809.1;XP_050043901.1;XP_050027478.1;XP_050048719.1;XP_050033934.1;XP_050022938.1;XP_050040200.1;XP_050025715.1;XP_050034772.1;XP_050038751.1;XP_050037401.1;XP_050033237.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050050719.1;XP_050045660.1;XP_050044478.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050044469.1;XP_050047181.1;XP_050033318.1;XP_050037398.1;XP_050033374.1;XP_050042788.1;XP_050022518.1;XP_050027134.1;XP_050027657.1;XP_050043900.1;XP_050036156.1;XP_050038140.1;XP_050049723.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050049124.1;XP_050023646.1;XP_050040198.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050052231.1;XP_050044470.1;XP_050029802.1;XP_050050645.1;XP_050048823.1;XP_050040199.1;XP_050033832.1
Reactome: R-HSA-202733	Cell surface interactions at the vascular wall	18	XP_050041374.1;XP_050041376.1;XP_050041373.1;XP_050042242.1;XP_050023809.1;XP_050042240.1;XP_050042454.1;XP_050023334.1;XP_050040600.1;XP_050042260.1;XP_050042262.1;XP_050042241.1;XP_050050313.1;XP_050023796.1;XP_050023422.1;XP_050042261.1;XP_050041375.1;XP_050023312.1
Reactome: R-HSA-5632928	Defective Mismatch Repair Associated With MSH2	4	XP_050041261.1;XP_050027779.1;XP_050042225.1;XP_050036698.1
KEGG: 00970+6.1.1.6	Aminoacyl-tRNA biosynthesis	2	XP_050051668.1;XP_050051666.1
Reactome: R-HSA-373753	Nephrin family interactions	12	XP_050026535.1;XP_050051733.1;XP_050051732.1;XP_050043898.1;XP_050043897.1;XP_050037067.1;XP_050026536.1;XP_050051735.1;XP_050051734.1;XP_050026537.1;XP_050026538.1;XP_050037068.1
Reactome: R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	29	XP_050045760.1;XP_050052033.1;XP_050029841.1;XP_050035166.1;XP_050047606.1;XP_050029843.1;XP_050023517.1;XP_050023516.1;XP_050052372.1;XP_050025687.1;XP_050037400.1;XP_050025374.1;XP_050035165.1;XP_050025689.1;XP_050047598.1;XP_050027738.1;XP_050032853.1;XP_050035163.1;XP_050030794.1;XP_050039215.1;XP_050025375.1;XP_050052034.1;XP_050027600.1;XP_050035167.1;XP_050027302.1;XP_050029842.1;XP_050027599.1;XP_050027598.1;XP_050025688.1
KEGG: 00983+2.5.1.18	Drug metabolism - other enzymes	13	XP_050048233.1;XP_050047905.1;XP_050048256.1;XP_050047704.1;XP_050048247.1;XP_050027833.1;XP_050047714.1;XP_050026762.1;XP_050047698.1;XP_050031855.1;XP_050048220.1;XP_050048267.1;XP_050031872.1
MetaCyc: PWY-6643	Coenzyme M biosynthesis II	3	XP_050049203.1;XP_050049202.1;XP_050026413.1
KEGG: 00910+4.2.1.1	Nitrogen metabolism	8	XP_050049116.1;XP_050025446.1;XP_050049115.1;XP_050022903.1;XP_050038033.1;XP_050049114.1;XP_050022906.1;XP_050022895.1
Reactome: R-HSA-9022537	Loss of MECP2 binding ability to the NCoR/SMRT complex	7	XP_050031707.1;XP_050029499.1;XP_050050589.1;XP_050050590.1;XP_050036728.1;XP_050031742.1;XP_050050591.1
MetaCyc: PWY-6807	Xyloglucan degradation II (exoglucanase)	28	XP_050039612.1;XP_050042169.1;XP_050042179.1;XP_050042437.1;XP_050051332.1;XP_050042438.1;XP_050042439.1;XP_050038798.1;XP_050039611.1;XP_050042180.1;XP_050042167.1;XP_050042178.1;XP_050042181.1;XP_050042176.1;XP_050040716.1;XP_050045117.1;XP_050042436.1;XP_050042177.1;XP_050040161.1;XP_050041348.1;XP_050040707.1;XP_050040162.1;XP_050043493.1;XP_050042175.1;XP_050038908.1;XP_050040693.1;XP_050041309.1;XP_050033006.1
Reactome: R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	1	XP_050023324.1
KEGG: 00562+1.13.99.1	Inositol phosphate metabolism	1	XP_050027273.1
Reactome: R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	1	XP_050032010.1
Reactome: R-HSA-71288	Creatine metabolism	5	XP_050033908.1;XP_050033909.1;XP_050033907.1;XP_050033902.1;XP_050033905.1
MetaCyc: PWY-7533	Gliotoxin biosynthesis	16	XP_050047704.1;XP_050047714.1;XP_050026762.1;XP_050046972.1;XP_050027833.1;XP_050031872.1;XP_050048267.1;XP_050047905.1;XP_050048233.1;XP_050029581.1;XP_050048256.1;XP_050046973.1;XP_050048247.1;XP_050047698.1;XP_050031855.1;XP_050048220.1
Reactome: R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	6	XP_050049052.1;XP_050025576.1;XP_050048361.1;XP_050045189.1;XP_050049051.1;XP_050040012.1
MetaCyc: PWY-5022	4-aminobutanoate degradation V	1	XP_050041758.1
KEGG: 00260+1.8.1.4	Glycine, serine and threonine metabolism	1	XP_050026566.1
Reactome: R-HSA-196819	Vitamin B1 (thiamin) metabolism	6	XP_050034132.1;XP_050041282.1;XP_050041281.1;XP_050041283.1;XP_050030314.1;XP_050047586.1
MetaCyc: PWY-6607	Guanosine nucleotides degradation I	1	XP_050049541.1
KEGG: 00500+2.7.1.1	Starch and sucrose metabolism	3	XP_050047070.1;XP_050027343.1;XP_050047071.1
Reactome: R-HSA-3878781	Glycogen storage disease type IV (GBE1)	1	XP_050042400.1
Reactome: R-HSA-9635644	Inhibition of membrane repair	2	XP_050032655.1;XP_050032654.1
KEGG: 00430+1.13.11.20	Taurine and hypotaurine metabolism	1	XP_050033399.1
Reactome: R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	3	XP_050045005.1;XP_050037178.1;XP_050049284.1
MetaCyc: PWY-6282	Palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)	4	XP_050033009.1;XP_050032773.1;XP_050033008.1;XP_050029751.1
MetaCyc: PWY-8041	Ultra-long-chain fatty acid biosynthesis	78	XP_050051764.1;XP_050027502.1;XP_050036636.1;XP_050039700.1;XP_050051766.1;XP_050039263.1;XP_050042358.1;XP_050025917.1;XP_050036103.1;XP_050045032.1;XP_050039189.1;XP_050039708.1;XP_050042219.1;XP_050033894.1;XP_050041128.1;XP_050033799.1;XP_050039722.1;XP_050039017.1;XP_050039545.1;XP_050039083.1;XP_050026425.1;XP_050039555.1;XP_050039698.1;XP_050027024.1;XP_050039366.1;XP_050039081.1;XP_050026935.1;XP_050039082.1;XP_050025916.1;XP_050039191.1;XP_050039183.1;XP_050048344.1;XP_050039702.1;XP_050033896.1;XP_050039701.1;XP_050036658.1;XP_050039086.1;XP_050036659.1;XP_050039015.1;XP_050041191.1;XP_050039426.1;XP_050039703.1;XP_050039704.1;XP_050039186.1;XP_050027497.1;XP_050026887.1;XP_050039712.1;XP_050039087.1;XP_050027469.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039088.1;XP_050039707.1;XP_050039084.1;XP_050039710.1;XP_050039706.1;XP_050039709.1;XP_050039711.1;XP_050039770.1;XP_050026888.1;XP_050028129.1;XP_050051763.1;XP_050026205.1;XP_050047366.1;XP_050039085.1;XP_050039364.1;XP_050039772.1;XP_050039365.1;XP_050027496.1;XP_050039126.1;XP_050039699.1;XP_050039016.1;XP_050027470.1;XP_050039769.1;XP_050043402.1;XP_050039080.1;XP_050051765.1
Reactome: R-HSA-4551638	SUMOylation of chromatin organization proteins	57	XP_050023475.1;XP_050042392.1;XP_050029891.1;XP_050031628.1;XP_050038199.1;XP_050024263.1;XP_050038865.1;XP_050035770.1;XP_050039855.1;XP_050024250.1;XP_050025243.1;XP_050036268.1;XP_050038864.1;XP_050024518.1;XP_050033146.1;XP_050026810.1;XP_050023718.1;XP_050038862.1;XP_050029516.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050024255.1;XP_050044008.1;XP_050023476.1;XP_050039853.1;XP_050025266.1;XP_050049377.1;XP_050030653.1;XP_050038866.1;XP_050038968.1;XP_050023474.1;XP_050036430.1;XP_050038895.1;XP_050042391.1;XP_050029887.1;XP_050030942.1;XP_050038863.1;XP_050035933.1;XP_050029890.1;XP_050040731.1;XP_050025248.1;XP_050038213.1;XP_050029515.1;XP_050038967.1;XP_050025064.1;XP_050039854.1;XP_050025244.1;XP_050036827.1;XP_050039240.1;XP_050029889.1;XP_050030652.1;XP_050030506.1;XP_050038969.1;XP_050039856.1;XP_050030507.1;XP_050038966.1
MetaCyc: PWY-7559	Glutathione degradation (DUG pathway	42	XP_050025492.1;XP_050030014.1;XP_050025457.1;XP_050025489.1;XP_050036058.1;XP_050030123.1;XP_050023398.1;XP_050025413.1;XP_050029058.1;XP_050028992.1;XP_050024014.1;XP_050029054.1;XP_050031599.1;XP_050043742.1;XP_050024805.1;XP_050029240.1;XP_050030373.1;XP_050029056.1;XP_050025508.1;XP_050029072.1;XP_050043741.1;XP_050029055.1;XP_050027823.1;XP_050022874.1;XP_050025650.1;XP_050029960.1;XP_050029053.1;XP_050029059.1;XP_050025461.1;XP_050025459.1;XP_050024015.1;XP_050031589.1;XP_050029305.1;XP_050025460.1;XP_050025493.1;XP_050025458.1;XP_050029052.1;XP_050031611.1;XP_050025490.1;XP_050029057.1;XP_050025491.1;XP_050029071.1
KEGG: 00230+2.7.4.10	Purine metabolism	1	XP_050039403.1
Reactome: R-HSA-5602680	MyD88 deficiency (TLR5)	1	XP_050024508.1
KEGG: 00930+4.2.1.17	Caprolactam degradation	1	XP_050032010.1
KEGG: 04070+3.1.3.56	Phosphatidylinositol signaling system	5	XP_050050240.1;XP_050050241.1;XP_050050236.1;XP_050050237.1;XP_050050239.1
KEGG: 04150+2.7.11.11	mTOR signaling pathway	8	XP_050042112.1;XP_050042111.1;XP_050042105.1;XP_050042109.1;XP_050042106.1;XP_050042107.1;XP_050042108.1;XP_050042110.1
Reactome: R-HSA-5632927	Defective Mismatch Repair Associated With MSH3	1	XP_050027779.1
KEGG: 00970+6.1.1.22	Aminoacyl-tRNA biosynthesis	2	XP_050040006.1;XP_050044710.1
Reactome: R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	45	XP_050047769.1;XP_050023922.1;XP_050039261.1;XP_050024782.1;XP_050035880.1;XP_050049353.1;XP_050036465.1;XP_050025351.1;XP_050028813.1;XP_050040623.1;XP_050048534.1;XP_050030429.1;XP_050043820.1;XP_050030428.1;XP_050038645.1;XP_050038560.1;XP_050030430.1;XP_050030424.1;XP_050038642.1;XP_050047670.1;XP_050035119.1;XP_050044095.1;XP_050044093.1;XP_050030426.1;XP_050030425.1;XP_050025352.1;XP_050045039.1;XP_050043821.1;XP_050043899.1;XP_050038643.1;XP_050038648.1;XP_050035114.1;XP_050025353.1;XP_050034759.1;XP_050035116.1;XP_050044094.1;XP_050040624.1;XP_050038561.1;XP_050045165.1;XP_050044096.1;XP_050045038.1;XP_050038644.1;XP_050038647.1;XP_050038646.1;XP_050035481.1
KEGG: 00401+2.6.1.5	Novobiocin biosynthesis	3	XP_050049181.1;XP_050049182.1;XP_050031962.1
Reactome: R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	21	XP_050050532.1;XP_050022594.1;XP_050028231.1;XP_050042755.1;XP_050029505.1;XP_050048534.1;XP_050045558.1;XP_050042972.1;XP_050040824.1;XP_050049952.1;XP_050045557.1;XP_050025144.1;XP_050029852.1;XP_050034506.1;XP_050022980.1;XP_050051397.1;XP_050032670.1;XP_050052687.1;XP_050035481.1;XP_050029342.1;XP_050046062.1
MetaCyc: PWY-7574	Propanoyl-coa degradation II	2	XP_050026060.1;XP_050023456.1
Reactome: R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	34	XP_050024178.1;XP_050050683.1;XP_050050679.1;XP_050023932.1;XP_050050701.1;XP_050050690.1;XP_050050686.1;XP_050050700.1;XP_050024179.1;XP_050024175.1;XP_050050697.1;XP_050050696.1;XP_050050685.1;XP_050050698.1;XP_050050687.1;XP_050050684.1;XP_050050681.1;XP_050024177.1;XP_050050695.1;XP_050039818.1;XP_050050682.1;XP_050047598.1;XP_050050693.1;XP_050050692.1;XP_050024180.1;XP_050050688.1;XP_050050689.1;XP_050050694.1;XP_050050691.1;XP_050024176.1;XP_050050680.1;XP_050047606.1;XP_050050702.1;XP_050050699.1
Reactome: R-HSA-947581	Molybdenum cofactor biosynthesis	12	XP_050025637.1;XP_050038900.1;XP_050036161.1;XP_050027387.1;XP_050048625.1;XP_050027385.1;XP_050025634.1;XP_050027388.1;XP_050048624.1;XP_050041676.1;XP_050050274.1;XP_050027386.1
MetaCyc: PWY-6987	Lipoate biosynthesis and incorporation III (Bacillus)	4	XP_050039804.1;XP_050045962.1;XP_050048152.1;XP_050036621.1
Reactome: R-HSA-442742	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	1	XP_050026027.1
Reactome: R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	45	XP_050042366.1;XP_050052763.1;XP_050037414.1;XP_050046840.1;XP_050042363.1;XP_050022603.1;XP_050042989.1;XP_050038602.1;XP_050042364.1;XP_050052258.1;XP_050042988.1;XP_050022604.1;XP_050022605.1;XP_050025215.1;XP_050025220.1;XP_050025266.1;XP_050052764.1;XP_050023898.1;XP_050046898.1;XP_050042367.1;XP_050042990.1;XP_050025227.1;XP_050022602.1;XP_050038199.1;XP_050025243.1;XP_050025229.1;XP_050025217.1;XP_050025230.1;XP_050036268.1;XP_050025223.1;XP_050034171.1;XP_050035110.1;XP_050025244.1;XP_050023897.1;XP_050052762.1;XP_050046839.1;XP_050025231.1;XP_050023896.1;XP_050022472.1;XP_050022606.1;XP_050027729.1;XP_050025232.1;XP_050025236.1;XP_050025248.1;XP_050038213.1
KEGG: 00790+4.2.3.12	Folate biosynthesis	1	XP_050045129.1
Reactome: R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	55	XP_050025848.1;XP_050048721.1;XP_050044476.1;XP_050031479.1;XP_050044478.1;XP_050045660.1;XP_050034772.1;XP_050025715.1;XP_050047670.1;XP_050033237.1;XP_050037401.1;XP_050022938.1;XP_050040200.1;XP_050050373.1;XP_050045785.1;XP_050040623.1;XP_050048534.1;XP_050032477.1;XP_050048719.1;XP_050047809.1;XP_050033331.1;XP_050036567.1;XP_050040624.1;XP_050051964.1;XP_050035472.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050052231.1;XP_050044470.1;XP_050029802.1;XP_050050645.1;XP_050040198.1;XP_050035481.1;XP_050042025.1;XP_050048720.1;XP_050049124.1;XP_050024749.1;XP_050044475.1;XP_050037397.1;XP_050027118.1;XP_050031786.1;XP_050042788.1;XP_050027134.1;XP_050022518.1;XP_050037398.1;XP_050033318.1;XP_050038140.1;XP_050036156.1;XP_050027657.1;XP_050037399.1;XP_050048824.1;XP_050033833.1;XP_050044469.1;XP_050047181.1
Reactome: R-HSA-110312	Translesion synthesis by REV1	17	XP_050050532.1;XP_050048534.1;XP_050042755.1;XP_050022795.1;XP_050027026.1;XP_050027028.1;XP_050042972.1;XP_050049952.1;XP_050025144.1;XP_050029852.1;XP_050027029.1;XP_050052687.1;XP_050051397.1;XP_050035481.1;XP_050022980.1;XP_050046062.1;XP_050029342.1
Reactome: R-HSA-9640463	Wax biosynthesis	24	XP_050039377.1;XP_050039371.1;XP_050039214.1;XP_050038842.1;XP_050038858.1;XP_050038847.1;XP_050040922.1;XP_050038844.1;XP_050038848.1;XP_050037742.1;XP_050037743.1;XP_050039376.1;XP_050038846.1;XP_050039370.1;XP_050041247.1;XP_050038845.1;XP_050038859.1;XP_050039773.1;XP_050039379.1;XP_050039378.1;XP_050038855.1;XP_050038856.1;XP_050041248.1;XP_050038843.1
KEGG: 00240+2.7.4.6	Pyrimidine metabolism	6	XP_050029492.1;XP_050031386.1;XP_050031510.1;XP_050038939.1;XP_050029490.1;XP_050043296.1
MetaCyc: PWY-7226	Guanosine deoxyribonucleotides de novo biosynthesis I	8	XP_050038800.1;XP_050043296.1;XP_050038939.1;XP_050029490.1;XP_050031386.1;XP_050031510.1;XP_050030600.1;XP_050029492.1
MetaCyc: PWY-7728	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)	2	XP_050042358.1;XP_050045032.1
Reactome: R-HSA-1483115	Hydrolysis of LPC	1	XP_050022770.1
Reactome: R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	69	XP_050032477.1;XP_050040340.1;XP_050048534.1;XP_050040339.1;XP_050047809.1;XP_050039330.1;XP_050022938.1;XP_050051381.1;XP_050033237.1;XP_050044476.1;XP_050045660.1;XP_050048824.1;XP_050037399.1;XP_050038630.1;XP_050044469.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050034248.1;XP_050038628.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050049723.1;XP_050049124.1;XP_050048720.1;XP_050044475.1;XP_050036567.1;XP_050039329.1;XP_050034247.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050048823.1;XP_050033832.1;XP_050045785.1;XP_050050373.1;XP_050048719.1;XP_050040200.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050039332.1;XP_050039331.1;XP_050031479.1;XP_050048721.1;XP_050025848.1;XP_050044478.1;XP_050048801.1;XP_050047778.1;XP_050040341.1;XP_050033833.1;XP_050030937.1;XP_050040338.1;XP_050047181.1;XP_050033318.1;XP_050022518.1;XP_050042025.1;XP_050035481.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050035472.1;XP_050051964.1;XP_050033331.1;XP_050044470.1;XP_050040199.1
MetaCyc: PWY-6117	Spermine and spermidine degradation I	5	XP_050045770.1;XP_050050999.1;XP_050045759.1;XP_050051327.1;XP_050046955.1
Reactome: R-HSA-9010642	ROBO receptors bind AKAP5	8	XP_050042112.1;XP_050042111.1;XP_050042105.1;XP_050042109.1;XP_050042108.1;XP_050042107.1;XP_050042106.1;XP_050042110.1
Reactome: R-HSA-74217	Purine salvage	23	XP_050039089.1;XP_050035322.1;XP_050035321.1;XP_050039203.1;XP_050041708.1;XP_050035320.1;XP_050046554.1;XP_050039253.1;XP_050050828.1;XP_050049687.1;XP_050039246.1;XP_050051074.1;XP_050051072.1;XP_050035323.1;XP_050041707.1;XP_050046556.1;XP_050035325.1;XP_050035327.1;XP_050035324.1;XP_050039202.1;XP_050050829.1;XP_050035326.1;XP_050035328.1
Reactome: R-HSA-427975	Proton/oligopeptide cotransporters	1	XP_050049507.1
Reactome: R-HSA-1250342	PI3K events in ERBB4 signaling	4	XP_050051864.1;XP_050051865.1;XP_050051866.1;XP_050051868.1
KEGG: 00380+4.2.1.17	Tryptophan metabolism	1	XP_050032010.1
KEGG: 00380+1.14.13.9	Tryptophan metabolism	1	XP_050048623.1
Reactome: R-HSA-198693	AKT phosphorylates targets in the nucleus	4	XP_050048620.1;XP_050048619.1;XP_050048621.1;XP_050026421.1
Reactome: R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	16	XP_050050240.1;XP_050052037.1;XP_050052036.1;XP_050050237.1;XP_050050239.1;XP_050040160.1;XP_050040158.1;XP_050040157.1;XP_050040343.1;XP_050050236.1;XP_050023808.1;XP_050050241.1;XP_050040159.1;XP_050048146.1;XP_050027273.1;XP_050025862.1
MetaCyc: PWY-7285	Methylwyosine biosynthesis	8	XP_050047573.1;XP_050050267.1;XP_050050266.1;XP_050024735.1;XP_050030696.1;XP_050046343.1;XP_050050265.1;XP_050022865.1
Reactome: R-HSA-8941284	RUNX2 regulates chondrocyte maturation	2	XP_050033319.1;XP_050047422.1
Reactome: R-HSA-112308	Presynaptic depolarization and calcium channel opening	7	XP_050045824.1;XP_050045825.1;XP_050045828.1;XP_050045823.1;XP_050051473.1;XP_050045826.1;XP_050045827.1
Reactome: R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	132	XP_050033573.1;XP_050029850.1;XP_050052753.1;XP_050035484.1;XP_050025202.1;XP_050043804.1;XP_050044122.1;XP_050043802.1;XP_050028344.1;XP_050023059.1;XP_050028318.1;XP_050036006.1;XP_050049522.1;XP_050023818.1;XP_050044983.1;XP_050052117.1;XP_050045189.1;XP_050048061.1;XP_050027435.1;XP_050048060.1;XP_050049523.1;XP_050044982.1;XP_050039882.1;XP_050051109.1;XP_050035483.1;XP_050029294.1;XP_050051067.1;XP_050041744.1;XP_050048534.1;XP_050041753.1;XP_050035149.1;XP_050023811.1;XP_050029924.1;XP_050026018.1;XP_050039340.1;XP_050023058.1;XP_050045969.1;XP_050032598.1;XP_050050940.1;XP_050030410.1;XP_050027305.1;XP_050029925.1;XP_050052131.1;XP_050025320.1;XP_050023742.1;XP_050031230.1;XP_050047002.1;XP_050043917.1;XP_050049519.1;XP_050032330.1;XP_050039286.1;XP_050026722.1;XP_050032528.1;XP_050045970.1;XP_050034868.1;XP_050022748.1;XP_050032936.1;XP_050031861.1;XP_050044355.1;XP_050029923.1;XP_050032331.1;XP_050032921.1;XP_050039285.1;XP_050051073.1;XP_050051569.1;XP_050044445.1;XP_050049776.1;XP_050043803.1;XP_050032267.1;XP_050049896.1;XP_050050516.1;XP_050025636.1;XP_050052130.1;XP_050042319.1;XP_050027477.1;XP_050044356.1;XP_050034325.1;XP_050043916.1;XP_050051087.1;XP_050028191.1;XP_050039997.1;XP_050038626.1;XP_050044358.1;XP_050029851.1;XP_050038550.1;XP_050026723.1;XP_050044593.1;XP_050049373.1;XP_050046933.1;XP_050048062.1;XP_050051080.1;XP_050032688.1;XP_050043919.1;XP_050052750.1;XP_050031153.1;XP_050044680.1;XP_050044359.1;XP_050042714.1;XP_050033913.1;XP_050040632.1;XP_050041323.1;XP_050052195.1;XP_050044357.1;XP_050026721.1;XP_050052752.1;XP_050027304.1;XP_050043918.1;XP_050026674.1;XP_050049831.1;XP_050035481.1;XP_050032927.1;XP_050052751.1;XP_050028604.1;XP_050032599.1;XP_050022853.1;XP_050032793.1;XP_050040677.1;XP_050026675.1;XP_050051098.1;XP_050026103.1;XP_050023492.1;XP_050049170.1;XP_050049521.1;XP_050024740.1;XP_050032928.1;XP_050045196.1;XP_050029380.1;XP_050044360.1;XP_050049830.1;XP_050049520.1;XP_050046934.1;XP_050036005.1
Reactome: R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	3	XP_050052764.1;XP_050052762.1;XP_050052763.1
Reactome: R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	37	XP_050028292.1;XP_050022603.1;XP_050037414.1;XP_050022605.1;XP_050022604.1;XP_050029852.1;XP_050034960.1;XP_050025144.1;XP_050035537.1;XP_050032647.1;XP_050022602.1;XP_050033904.1;XP_050042401.1;XP_050033903.1;XP_050039624.1;XP_050029342.1;XP_050038612.1;XP_050048499.1;XP_050046062.1;XP_050022980.1;XP_050028323.1;XP_050022581.1;XP_050051397.1;XP_050044213.1;XP_050046064.1;XP_050047551.1;XP_050048786.1;XP_050023494.1;XP_050044695.1;XP_050032478.1;XP_050044807.1;XP_050048896.1;XP_050042755.1;XP_050022606.1;XP_050034961.1;XP_050045930.1;XP_050050532.1
Reactome: R-HSA-5617833	Cilium Assembly	21	XP_050046734.1;XP_050051355.1;XP_050052055.1;XP_050052420.1;XP_050049762.1;XP_050049759.1;XP_050052605.1;XP_050024841.1;XP_050049761.1;XP_050039381.1;XP_050047338.1;XP_050046735.1;XP_050043181.1;XP_050049758.1;XP_050039380.1;XP_050051356.1;XP_050024840.1;XP_050051357.1;XP_050052603.1;XP_050052606.1;XP_050049757.1
Reactome: R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	2	XP_050038736.1;XP_050026533.1
KEGG: 00640+6.2.1.5	Propanoate metabolism	8	XP_050049076.1;XP_050042702.1;XP_050042703.1;XP_050043005.1;XP_050026353.1;XP_050049075.1;XP_050042704.1;XP_050026352.1
Reactome: R-HSA-5610787	Hedgehog 'off' state	36	XP_050042105.1;XP_050030923.1;XP_050042109.1;XP_050030922.1;XP_050045739.1;XP_050029917.1;XP_050045224.1;XP_050030924.1;XP_050041325.1;XP_050045741.1;XP_050045740.1;XP_050042112.1;XP_050045225.1;XP_050029919.1;XP_050029918.1;XP_050050657.1;XP_050035319.1;XP_050052227.1;XP_050041328.1;XP_050042111.1;XP_050051299.1;XP_050042108.1;XP_050040744.1;XP_050039902.1;XP_050032121.1;XP_050040396.1;XP_050032233.1;XP_050032122.1;XP_050048963.1;XP_050041327.1;XP_050048935.1;XP_050050659.1;XP_050042110.1;XP_050050658.1;XP_050042106.1;XP_050042107.1
KEGG: 00240+2.1.3.2	Pyrimidine metabolism	1	XP_050032255.1
MetaCyc: PWY-5892	Menaquinol-12 biosynthesis	1	XP_050045574.1
MetaCyc: PWY-7233	Ubiquinol-6 bypass biosynthesis (eukaryotic)	3	XP_050033250.1;XP_050025938.1;XP_050025937.1
KEGG: 00190+1.3.5.1	Oxidative phosphorylation	4	XP_050033843.1;XP_050033718.1;XP_050033719.1;XP_050038590.1
KEGG: 00500+3.2.1.1	Starch and sucrose metabolism	4	XP_050028738.1;XP_050025609.1;XP_050025610.1;XP_050028469.1
Reactome: R-HSA-9646399	Aggrephagy	47	XP_050039380.1;XP_050029897.1;XP_050024840.1;XP_050051356.1;XP_050045597.1;XP_050035992.1;XP_050035481.1;XP_050035989.1;XP_050023674.1;XP_050024240.1;XP_050035983.1;XP_050035974.1;XP_050035987.1;XP_050043181.1;XP_050026883.1;XP_050047338.1;XP_050035978.1;XP_050035986.1;XP_050051355.1;XP_050052055.1;XP_050035991.1;XP_050035973.1;XP_050035977.1;XP_050023192.1;XP_050035984.1;XP_050035982.1;XP_050035979.1;XP_050051357.1;XP_050035993.1;XP_050049757.1;XP_050035975.1;XP_050046735.1;XP_050035976.1;XP_050035981.1;XP_050035980.1;XP_050049758.1;XP_050049761.1;XP_050024841.1;XP_050049759.1;XP_050039381.1;XP_050035990.1;XP_050048534.1;XP_050046734.1;XP_050035985.1;XP_050035988.1;XP_050049762.1;XP_050052420.1
Reactome: R-HSA-9665251	Resistance of ERBB2 KD mutants to lapatinib	2	XP_050048201.1;XP_050048200.1
Reactome: R-HSA-909733	Interferon alpha/beta signaling	10	XP_050023331.1;XP_050050324.1;XP_050050323.1;XP_050039986.1;XP_050031956.1;XP_050031398.1;XP_050025376.1;XP_050024450.1;XP_050046345.1;XP_050031957.1
MetaCyc: PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	24	XP_050026084.1;XP_050040580.1;XP_050050544.1;XP_050025836.1;XP_050040583.1;XP_050040415.1;XP_050040418.1;XP_050040584.1;XP_050040577.1;XP_050052719.1;XP_050035077.1;XP_050050545.1;XP_050040416.1;XP_050045561.1;XP_050040419.1;XP_050052721.1;XP_050025837.1;XP_050025835.1;XP_050040417.1;XP_050052716.1;XP_050048623.1;XP_050052715.1;XP_050025834.1;XP_050040581.1
KEGG: 00510+2.4.1.143	N-Glycan biosynthesis	3	XP_050036462.1;XP_050030754.1;XP_050030755.1
MetaCyc: PWY-7888	Trna-uridine 2-thiolation (cytoplasmic)	1	XP_050029894.1
Reactome: R-HSA-9636467	Blockage of phagosome acidification	4	XP_050045458.1;XP_050045459.1;XP_050045457.1;XP_050049787.1
MetaCyc: PWY-7375	Mrna capping I	2	XP_050041013.1;XP_050033935.1
KEGG: 00380+1.2.4.2	Tryptophan metabolism	2	XP_050036622.1;XP_050022550.1
Reactome: R-HSA-450321	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	5	XP_050051597.1;XP_050028061.1;XP_050048534.1;XP_050035481.1;XP_050028062.1
KEGG: 00592+4.2.1.17	alpha-Linolenic acid metabolism	6	XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1;XP_050041643.1
KEGG: 00360+2.6.1.1	Phenylalanine metabolism	3	XP_050049202.1;XP_050049203.1;XP_050026413.1
MetaCyc: PWY-6519	8-amino-7-oxononanoate biosynthesis I	4	XP_050029751.1;XP_050033009.1;XP_050032773.1;XP_050033008.1
Reactome: R-HSA-174577	Activation of C3 and C5	6	XP_050031301.1;XP_050044540.1;XP_050046184.1;XP_050031300.1;XP_050028047.1;XP_050030876.1
Reactome: R-HSA-400206	Regulation of lipid metabolism by PPARalpha	11	XP_050042080.1;XP_050035889.1;XP_050042079.1;XP_050042082.1;XP_050042081.1;XP_050043924.1;XP_050031330.1;XP_050042083.1;XP_050031490.1;XP_050035890.1;XP_050031529.1
Reactome: R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	57	XP_050025715.1;XP_050028292.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050031479.1;XP_050044476.1;XP_050048721.1;XP_050050553.1;XP_050025848.1;XP_050045660.1;XP_050044478.1;XP_050032477.1;XP_050048534.1;XP_050045785.1;XP_050050373.1;XP_050047809.1;XP_050048719.1;XP_050050552.1;XP_050040200.1;XP_050022938.1;XP_050049124.1;XP_050035481.1;XP_050048720.1;XP_050042025.1;XP_050040198.1;XP_050028323.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050044475.1;XP_050024749.1;XP_050035472.1;XP_050051964.1;XP_050033331.1;XP_050036567.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050044470.1;XP_050040199.1;XP_050048823.1;XP_050033832.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050047181.1;XP_050044469.1;XP_050037398.1;XP_050033318.1;XP_050027134.1;XP_050022518.1;XP_050042788.1;XP_050027657.1;XP_050050551.1;XP_050038140.1;XP_050036156.1
MetaCyc: PWY-181	Photorespiration 	3	XP_050032637.1;XP_050034367.1;XP_050032636.1
MetaCyc: PWY-6111	Mitochondrial L-carnitine shuttle	3	XP_050048736.1;XP_050048737.1;XP_050048738.1
Reactome: R-HSA-202433	Generation of second messenger molecules	7	XP_050037484.1;XP_050037481.1;XP_050037483.1;XP_050048140.1;XP_050048141.1;XP_050037480.1;XP_050037482.1
MetaCyc: PWY-7602	Icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)	78	XP_050039017.1;XP_050039545.1;XP_050041128.1;XP_050033894.1;XP_050039722.1;XP_050033799.1;XP_050039698.1;XP_050039366.1;XP_050027024.1;XP_050039083.1;XP_050039555.1;XP_050026425.1;XP_050039700.1;XP_050027502.1;XP_050051764.1;XP_050036636.1;XP_050042219.1;XP_050036103.1;XP_050039263.1;XP_050042358.1;XP_050025917.1;XP_050051766.1;XP_050045032.1;XP_050039189.1;XP_050039708.1;XP_050039426.1;XP_050041191.1;XP_050039015.1;XP_050036658.1;XP_050039701.1;XP_050039086.1;XP_050036659.1;XP_050026887.1;XP_050027497.1;XP_050039186.1;XP_050039703.1;XP_050039704.1;XP_050026935.1;XP_050039082.1;XP_050039081.1;XP_050039702.1;XP_050048344.1;XP_050033896.1;XP_050039191.1;XP_050025916.1;XP_050039183.1;XP_050026888.1;XP_050039710.1;XP_050039711.1;XP_050039770.1;XP_050039709.1;XP_050039706.1;XP_050026205.1;XP_050028129.1;XP_050051763.1;XP_050039705.1;XP_050026206.1;XP_050041192.1;XP_050039087.1;XP_050027469.1;XP_050039712.1;XP_050039084.1;XP_050039088.1;XP_050039707.1;XP_050039016.1;XP_050051765.1;XP_050043402.1;XP_050039080.1;XP_050039769.1;XP_050027470.1;XP_050039364.1;XP_050047366.1;XP_050039085.1;XP_050027496.1;XP_050039699.1;XP_050039126.1;XP_050039772.1;XP_050039365.1
Reactome: R-HSA-5659996	RPIA deficiency: failed conversion of R5P to RU5P	1	XP_050049438.1
KEGG: 00130+2.5.1.39	Ubiquinone and other terpenoid-quinone biosynthesis	1	XP_050040261.1
KEGG: 00230+3.5.4.10+2.1.2.3	Purine metabolism	1	XP_050034170.1
Reactome: R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	15	XP_050035858.1;XP_050043147.1;XP_050050408.1;XP_050033563.1;XP_050024189.1;XP_050034644.1;XP_050035556.1;XP_050046123.1;XP_050035555.1;XP_050038469.1;XP_050051043.1;XP_050042137.1;XP_050042138.1;XP_050034643.1;XP_050042139.1
KEGG: 00051+2.7.1.11	Fructose and mannose metabolism	4	XP_050040645.1;XP_050040641.1;XP_050040643.1;XP_050040644.1
Reactome: R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	1	XP_050023744.1
KEGG: 00010+5.3.1.9	Glycolysis / Gluconeogenesis	1	XP_050050068.1
KEGG: 00720+6.3.4.3	Carbon fixation pathways in prokaryotes	1	XP_050048637.1
KEGG: 00220+3.5.1.5	Arginine biosynthesis	2	XP_050024271.1;XP_050024276.1
Reactome: R-HSA-5218921	VEGFR2 mediated cell proliferation	3	XP_050045552.1;XP_050032548.1;XP_050025879.1
KEGG: 00970+6.1.1.20	Aminoacyl-tRNA biosynthesis	6	XP_050024514.1;XP_050042092.1;XP_050033225.1;XP_050033226.1;XP_050051222.1;XP_050022958.1
KEGG: 00520+2.7.7.12	Amino sugar and nucleotide sugar metabolism	1	XP_050045037.1
MetaCyc: PWY-6369	Inositol diphosphates biosynthesis	20	XP_050034740.1;XP_050034723.1;XP_050034732.1;XP_050034729.1;XP_050034728.1;XP_050034736.1;XP_050026059.1;XP_050034727.1;XP_050034725.1;XP_050034733.1;XP_050034737.1;XP_050034730.1;XP_050034734.1;XP_050034726.1;XP_050034739.1;XP_050034731.1;XP_050034724.1;XP_050034722.1;XP_050034735.1;XP_050034738.1
MetaCyc: PWY-6012-1	Acyl carrier protein activation	1	XP_050040326.1
KEGG: 00280+1.8.1.4	Valine, leucine and isoleucine degradation	1	XP_050026566.1
Reactome: R-HSA-389359	CD28 dependent Vav1 pathway	3	XP_050025375.1;XP_050025374.1;XP_050032853.1
KEGG: 00720+5.1.99.1	Carbon fixation pathways in prokaryotes	1	XP_050034236.1
MetaCyc: PWY-6823	Molybdenum cofactor biosynthesis	8	XP_050050274.1;XP_050027386.1;XP_050038900.1;XP_050036161.1;XP_050027387.1;XP_050025634.1;XP_050027385.1;XP_050027388.1
MetaCyc: PWY-6118	Glycerol-3-phosphate shuttle	4	XP_050034934.1;XP_050034933.1;XP_050040576.1;XP_050034614.1
KEGG: 00230+4.3.2.2	Purine metabolism	1	XP_050030286.1
Reactome: R-HSA-5610780	Degradation of GLI1 by the proteasome	64	XP_050040200.1;XP_050042109.1;XP_050048719.1;XP_050042105.1;XP_050045785.1;XP_050050373.1;XP_050044478.1;XP_050031479.1;XP_050048721.1;XP_050025848.1;XP_050037401.1;XP_050047670.1;XP_050025715.1;XP_050034772.1;XP_050033318.1;XP_050042108.1;XP_050022518.1;XP_050047181.1;XP_050033833.1;XP_050042111.1;XP_050044470.1;XP_050042110.1;XP_050040199.1;XP_050051964.1;XP_050035472.1;XP_050042106.1;XP_050033331.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050042025.1;XP_050035481.1;XP_050040198.1;XP_050048935.1;XP_050022938.1;XP_050047809.1;XP_050032477.1;XP_050048534.1;XP_050040623.1;XP_050045660.1;XP_050044476.1;XP_050033237.1;XP_050042112.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050044469.1;XP_050048824.1;XP_050037399.1;XP_050050645.1;XP_050029802.1;XP_050052231.1;XP_050048823.1;XP_050033832.1;XP_050042107.1;XP_050040624.1;XP_050036567.1;XP_050044475.1;XP_050049124.1;XP_050048720.1
KEGG: 00051+3.1.3.11	Fructose and mannose metabolism	2	XP_050044414.1;XP_050038404.1
Reactome: R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	3	XP_050042668.1;XP_050042670.1;XP_050042669.1
Reactome: R-HSA-4724289	Defective ALG6 causes ALG6-CDG (CDG-1c)	1	XP_050023594.1
Reactome: R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	16	XP_050037004.1;XP_050042417.1;XP_050023789.1;XP_050035381.1;XP_050049123.1;XP_050044765.1;XP_050049441.1;XP_050041682.1;XP_050049165.1;XP_050049167.1;XP_050051195.1;XP_050049122.1;XP_050040640.1;XP_050041683.1;XP_050039289.1;XP_050041684.1
KEGG: 00052+3.1.3.9	Galactose metabolism	2	XP_050034452.1;XP_050036456.1
KEGG: 04150+2.7.1.153	mTOR signaling pathway	2	XP_050052756.1;XP_050028399.1
Reactome: R-HSA-77387	Insulin receptor recycling	26	XP_050032732.1;XP_050045459.1;XP_050042150.1;XP_050032728.1;XP_050044696.1;XP_050034125.1;XP_050034072.1;XP_050048793.1;XP_050037617.1;XP_050034615.1;XP_050034127.1;XP_050049787.1;XP_050045457.1;XP_050037618.1;XP_050044697.1;XP_050038826.1;XP_050049937.1;XP_050034126.1;XP_050049586.1;XP_050044699.1;XP_050045458.1;XP_050049057.1;XP_050050217.1;XP_050041945.1;XP_050041324.1;XP_050023172.1
MetaCyc: PWY-7007	Methyl ketone biosynthesis (engineered)	8	XP_050051194.1;XP_050023456.1;XP_050041651.1;XP_050026422.1;XP_050032010.1;XP_050041635.1;XP_050026060.1;XP_050041643.1
Reactome: R-HSA-173623	Classical antibody-mediated complement activation	1	XP_050045926.1
MetaCyc: PWY-6853	Ethylene biosynthesis II (microbes)	1	XP_050029177.1
Reactome: R-HSA-170660	Adenylate cyclase activating pathway	8	XP_050045741.1;XP_050045740.1;XP_050045225.1;XP_050045739.1;XP_050051299.1;XP_050045224.1;XP_050041325.1;XP_050040744.1
Reactome: R-HSA-69202	Cyclin E associated events during G1/S transition	24	XP_050036138.1;XP_050026017.1;XP_050035378.1;XP_050050601.1;XP_050046148.1;XP_050024395.1;XP_050033368.1;XP_050037098.1;XP_050048621.1;XP_050031701.1;XP_050046150.1;XP_050037097.1;XP_050033968.1;XP_050046147.1;XP_050039527.1;XP_050037096.1;XP_050046149.1;XP_050037094.1;XP_050045300.1;XP_050039528.1;XP_050031698.1;XP_050048620.1;XP_050048619.1;XP_050037095.1
KEGG: 00561+2.7.1.30	Glycerolipid metabolism	6	XP_050023583.1;XP_050044168.1;XP_050023601.1;XP_050034558.1;XP_050034559.1;XP_050043007.1
MetaCyc: PWY-6978	Plastoquinol-9 biosynthesis II	1	XP_050040261.1
MetaCyc: PWY-6992	1,5-anhydrofructose degradation	2	XP_050044364.1;XP_050050068.1
Reactome: R-HSA-5655253	Signaling by FGFR2 in disease	1	XP_050032853.1
Reactome: R-HSA-2465910	MASTL Facilitates Mitotic Progression	4	XP_050052056.1;XP_050045478.1;XP_050045477.1;XP_050042629.1
Reactome: R-HSA-211897	Cytochrome P450 - arranged by substrate type	2	XP_050023018.1;XP_050023019.1
Reactome: R-HSA-2022928	HS-GAG biosynthesis	15	XP_050050426.1;XP_050041512.1;XP_050031244.1;XP_050042777.1;XP_050025614.1;XP_050039341.1;XP_050042776.1;XP_050025613.1;XP_050032842.1;XP_050040600.1;XP_050036614.1;XP_050052149.1;XP_050043294.1;XP_050043439.1;XP_050045389.1
KEGG: 00564+3.1.3.27	Glycerophospholipid metabolism	2	XP_050034952.1;XP_050034951.1
MetaCyc: PWY-7767	L-leucine degradation IV (Stickland reaction)	1	XP_050039540.1
KEGG: 00561+3.1.3.4	Glycerolipid metabolism	4	XP_050037456.1;XP_050037457.1;XP_050037458.1;XP_050037455.1
KEGG: 04070+2.7.7.41	Phosphatidylinositol signaling system	3	XP_050052679.1;XP_050031896.1;XP_050031895.1
Reactome: R-HSA-432047	Passive transport by Aquaporins	19	XP_050044620.1;XP_050044625.1;XP_050044622.1;XP_050044614.1;XP_050047265.1;XP_050049588.1;XP_050044621.1;XP_050050937.1;XP_050044613.1;XP_050044617.1;XP_050044618.1;XP_050045957.1;XP_050044626.1;XP_050044624.1;XP_050044623.1;XP_050044612.1;XP_050044616.1;XP_050027417.1;XP_050026463.1
Reactome: R-HSA-6807878	COPI-mediated anterograde transport	133	XP_050049353.1;XP_050051733.1;XP_050049762.1;XP_050035985.1;XP_050035988.1;XP_050048810.1;XP_050051735.1;XP_050030784.1;XP_050052544.1;XP_050046735.1;XP_050032742.1;XP_050047797.1;XP_050052563.1;XP_050049757.1;XP_050052547.1;XP_050035984.1;XP_050035982.1;XP_050035977.1;XP_050042243.1;XP_050052580.1;XP_050052560.1;XP_050052562.1;XP_050051139.1;XP_050052055.1;XP_050047338.1;XP_050036184.1;XP_050026883.1;XP_050048257.1;XP_050052551.1;XP_050036850.1;XP_050052573.1;XP_050052559.1;XP_050022514.1;XP_050035989.1;XP_050039380.1;XP_050046113.1;XP_050051356.1;XP_050052574.1;XP_050052420.1;XP_050036848.1;XP_050051141.1;XP_050039381.1;XP_050038325.1;XP_050052552.1;XP_050024841.1;XP_050052554.1;XP_050036851.1;XP_050052558.1;XP_050030786.1;XP_050052586.1;XP_050031039.1;XP_050052568.1;XP_050052569.1;XP_050035979.1;XP_050034917.1;XP_050031520.1;XP_050052583.1;XP_050051357.1;XP_050034982.1;XP_050051355.1;XP_050052576.1;XP_050035978.1;XP_050035986.1;XP_050043899.1;XP_050035974.1;XP_050052567.1;XP_050041981.1;XP_050045597.1;XP_050052565.1;XP_050035540.1;XP_050052587.1;XP_050049233.1;XP_050052549.1;XP_050028330.1;XP_050052570.1;XP_050035980.1;XP_050035981.1;XP_050035976.1;XP_050032270.1;XP_050037041.1;XP_050052584.1;XP_050052578.1;XP_050052550.1;XP_050050989.1;XP_050044767.1;XP_050041757.1;XP_050035973.1;XP_050051138.1;XP_050052546.1;XP_050043181.1;XP_050051732.1;XP_050030783.1;XP_050035992.1;XP_050047207.1;XP_050034282.1;XP_050029897.1;XP_050046734.1;XP_050052572.1;XP_050052582.1;XP_050052553.1;XP_050051406.1;XP_050052571.1;XP_050052545.1;XP_050051734.1;XP_050035990.1;XP_050052566.1;XP_050049759.1;XP_050049761.1;XP_050030787.1;XP_050052579.1;XP_050049758.1;XP_050052555.1;XP_050035975.1;XP_050034918.1;XP_050030785.1;XP_050049232.1;XP_050035993.1;XP_050046002.1;XP_050035991.1;XP_050052556.1;XP_050052557.1;XP_050043547.1;XP_050032743.1;XP_050051140.1;XP_050035987.1;XP_050052585.1;XP_050046114.1;XP_050035983.1;XP_050052561.1;XP_050036849.1;XP_050052577.1;XP_050024840.1;XP_050045165.1
MetaCyc: PWY-5839	Menaquinol-7 biosynthesis	1	XP_050045574.1
Reactome: R-HSA-2206305	MPS IIID - Sanfilippo syndrome D	2	XP_050027139.1;XP_050027140.1
KEGG: 00330+2.6.1.13	Arginine and proline metabolism	1	XP_050048960.1
MetaCyc: PWY-7053	Docosahexaenoate biosynthesis I (lower eukaryotes)	2	XP_050042358.1;XP_050045032.1
MetaCyc: PWY-6517	N-acetylglucosamine degradation II	1	XP_050049157.1
Reactome: R-HSA-9022692	Regulation of MECP2 expression and activity	66	XP_050039235.1;XP_050052226.1;XP_050049404.1;XP_050050682.1;XP_050050680.1;XP_050050702.1;XP_050050689.1;XP_050045362.1;XP_050050694.1;XP_050029824.1;XP_050050679.1;XP_050052225.1;XP_050035890.1;XP_050050700.1;XP_050050690.1;XP_050049406.1;XP_050035889.1;XP_050050590.1;XP_050050685.1;XP_050031742.1;XP_050051917.1;XP_050050687.1;XP_050050698.1;XP_050026047.1;XP_050029825.1;XP_050029859.1;XP_050050693.1;XP_050050692.1;XP_050036728.1;XP_050045364.1;XP_050032553.1;XP_050029337.1;XP_050050688.1;XP_050029861.1;XP_050026046.1;XP_050026223.1;XP_050051916.1;XP_050050695.1;XP_050028353.1;XP_050050589.1;XP_050045365.1;XP_050029336.1;XP_050050699.1;XP_050029862.1;XP_050050591.1;XP_050050691.1;XP_050029827.1;XP_050029499.1;XP_050031707.1;XP_050050701.1;XP_050052512.1;XP_050050686.1;XP_050051915.1;XP_050023605.1;XP_050045363.1;XP_050029826.1;XP_050050683.1;XP_050029338.1;XP_050050684.1;XP_050050681.1;XP_050039236.1;XP_050049405.1;XP_050029858.1;XP_050050697.1;XP_050029860.1;XP_050050696.1
Reactome: R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	2	XP_050048534.1;XP_050035481.1
Reactome: R-HSA-1266695	Interleukin-7 signaling	3	XP_050023897.1;XP_050023896.1;XP_050023898.1
Reactome: R-HSA-375281	Hormone ligand-binding receptors	15	XP_050049308.1;XP_050049286.1;XP_050049293.1;XP_050049211.1;XP_050049205.1;XP_050049256.1;XP_050049301.1;XP_050049292.1;XP_050049264.1;XP_050049278.1;XP_050049248.1;XP_050049270.1;XP_050049220.1;XP_050049239.1;XP_050049231.1
Reactome: R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	1	XP_050050758.1
Reactome: R-HSA-5654719	SHC-mediated cascade:FGFR4	1	XP_050032853.1
KEGG: 00240+3.5.4.12	Pyrimidine metabolism	1	XP_050029488.1
MetaCyc: PWY-7573	GDP-mycosamine biosynthesis	3	XP_050047839.1;XP_050047837.1;XP_050047838.1
KEGG: 00600+3.2.1.22	Sphingolipid metabolism	8	XP_050038832.1;XP_050038833.1;XP_050038829.1;XP_050039867.1;XP_050038635.1;XP_050038831.1;XP_050038830.1;XP_050038834.1
KEGG: 00480+1.11.1.15	Glutathione metabolism	14	XP_050047042.1;XP_050042018.1;XP_050047038.1;XP_050047034.1;XP_050047039.1;XP_050052142.1;XP_050047041.1;XP_050047040.1;XP_050034716.1;XP_050027433.1;XP_050047036.1;XP_050047035.1;XP_050047037.1;XP_050052141.1
KEGG: 00362+4.2.1.17+1.1.1.35	Benzoate degradation	6	XP_050041651.1;XP_050051194.1;XP_050041635.1;XP_050032010.1;XP_050026422.1;XP_050041643.1
Reactome: R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	57	XP_050048534.1;XP_050032514.1;XP_050044010.1;XP_050044656.1;XP_050029645.1;XP_050046123.1;XP_050023148.1;XP_050029647.1;XP_050045758.1;XP_050037136.1;XP_050031823.1;XP_050032509.1;XP_050049362.1;XP_050024189.1;XP_050044609.1;XP_050023824.1;XP_050046028.1;XP_050032513.1;XP_050035378.1;XP_050029320.1;XP_050026755.1;XP_050023147.1;XP_050034094.1;XP_050045300.1;XP_050026756.1;XP_050029649.1;XP_050029087.1;XP_050029644.1;XP_050050819.1;XP_050050506.1;XP_050050029.1;XP_050034644.1;XP_050029648.1;XP_050032511.1;XP_050049363.1;XP_050032510.1;XP_050047361.1;XP_050033368.1;XP_050050820.1;XP_050032515.1;XP_050032516.1;XP_050029646.1;XP_050051314.1;XP_050034093.1;XP_050029370.1;XP_050043147.1;XP_050037137.1;XP_050035481.1;XP_050034643.1;XP_050025563.1;XP_050038469.1;XP_050049837.1;XP_050039454.1;XP_050040428.1;XP_050040427.1;XP_050032512.1;XP_050046029.1
KEGG: 00380+1.11.1.6	Tryptophan metabolism	6	XP_050038505.1;XP_050038506.1;XP_050029373.1;XP_050029938.1;XP_050048386.1;XP_050048385.1
Reactome: R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	26	XP_050052225.1;XP_050032553.1;XP_050052512.1;XP_050029337.1;XP_050039235.1;XP_050026223.1;XP_050026046.1;XP_050029861.1;XP_050023605.1;XP_050051915.1;XP_050029826.1;XP_050052226.1;XP_050051916.1;XP_050028353.1;XP_050029338.1;XP_050051917.1;XP_050039236.1;XP_050029862.1;XP_050029336.1;XP_050026047.1;XP_050029827.1;XP_050029858.1;XP_050029824.1;XP_050029860.1;XP_050029825.1;XP_050029859.1
Reactome: R-HSA-418597	G alpha (z) signalling events	18	XP_050025622.1;XP_050040744.1;XP_050041325.1;XP_050044424.1;XP_050023177.1;XP_050045224.1;XP_050051299.1;XP_050045739.1;XP_050036247.1;XP_050030242.1;XP_050033083.1;XP_050030241.1;XP_050036246.1;XP_050045225.1;XP_050045741.1;XP_050045740.1;XP_050033084.1;XP_050025623.1
Reactome: R-HSA-3928665	EPH-ephrin mediated repulsion of cells	27	XP_050023786.1;XP_050028849.1;XP_050026843.1;XP_050043649.1;XP_050048893.1;XP_050040246.1;XP_050028745.1;XP_050039071.1;XP_050037415.1;XP_050034653.1;XP_050039072.1;XP_050037100.1;XP_050037416.1;XP_050027801.1;XP_050023628.1;XP_050034595.1;XP_050039510.1;XP_050048294.1;XP_050023769.1;XP_050026914.1;XP_050035872.1;XP_050023761.1;XP_050041704.1;XP_050028603.1;XP_050031262.1;XP_050043659.1;XP_050023778.1
MetaCyc: PWY-6824	Justicidin B biosynthesis	18	XP_050031263.1;XP_050052157.1;XP_050030590.1;XP_050052159.1;XP_050022517.1;XP_050033134.1;XP_050037572.1;XP_050032263.1;XP_050022520.1;XP_050037574.1;XP_050031815.1;XP_050030591.1;XP_050037573.1;XP_050037575.1;XP_050022911.1;XP_050031834.1;XP_050052158.1;XP_050037576.1
Reactome: R-HSA-1538133	G0 and Early G1	9	XP_050039527.1;XP_050046147.1;XP_050026017.1;XP_050036138.1;XP_050046150.1;XP_050049483.1;XP_050046149.1;XP_050046148.1;XP_050039528.1
KEGG: 00643+1.13.11.5	Styrene degradation	1	XP_050027257.1
KEGG: 00010+1.1.1.1	Glycolysis / Gluconeogenesis	3	XP_050052301.1;XP_050052302.1;XP_050052400.1
Reactome: R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	70	XP_050037401.1;XP_050025715.1;XP_050046735.1;XP_050034772.1;XP_050049757.1;XP_050044478.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050049762.1;XP_050048719.1;XP_050050373.1;XP_050045785.1;XP_050040200.1;XP_050027118.1;XP_050031786.1;XP_050024749.1;XP_050043181.1;XP_050037397.1;XP_050042025.1;XP_050035481.1;XP_050040198.1;XP_050044470.1;XP_050040199.1;XP_050035472.1;XP_050051964.1;XP_050039380.1;XP_050033331.1;XP_050051356.1;XP_050047181.1;XP_050033833.1;XP_050052055.1;XP_050047338.1;XP_050033318.1;XP_050022518.1;XP_050033237.1;XP_050049758.1;XP_050045660.1;XP_050044476.1;XP_050051357.1;XP_050047809.1;XP_050052420.1;XP_050048534.1;XP_050032477.1;XP_050046734.1;XP_050039381.1;XP_050022938.1;XP_050049761.1;XP_050024841.1;XP_050049759.1;XP_050044475.1;XP_050048720.1;XP_050049124.1;XP_050052231.1;XP_050050645.1;XP_050029802.1;XP_050048823.1;XP_050033832.1;XP_050036567.1;XP_050024840.1;XP_050044469.1;XP_050051355.1;XP_050037399.1;XP_050048824.1;XP_050027657.1;XP_050036156.1;XP_050038140.1;XP_050037398.1;XP_050042788.1;XP_050027134.1
Reactome: R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	15	XP_050046963.1;XP_050038213.1;XP_050025248.1;XP_050025266.1;XP_050036268.1;XP_050025243.1;XP_050044957.1;XP_050046119.1;XP_050044956.1;XP_050044958.1;XP_050044955.1;XP_050048804.1;XP_050046120.1;XP_050038199.1;XP_050025244.1
MetaCyc: PWY-8060	2-deoxy-D-ribose degradation I	1	XP_050048410.1
Reactome: R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	13	XP_050029342.1;XP_050048896.1;XP_050042755.1;XP_050022980.1;XP_050052687.1;XP_050032670.1;XP_050031345.1;XP_050027779.1;XP_050022594.1;XP_050031446.1;XP_050029852.1;XP_050040824.1;XP_050050532.1
MetaCyc: PWY-6147	6-hydroxymethyl-dihydropterin diphosphate biosynthesis I	3	XP_050048633.1;XP_050048632.1;XP_050048631.1
KEGG: 00561+2.3.1.51	Glycerolipid metabolism	8	XP_050037854.1;XP_050027416.1;XP_050037855.1;XP_050027415.1;XP_050037857.1;XP_050032357.1;XP_050050583.1;XP_050037856.1
KEGG: 00680+1.1.1.37	Methane metabolism	11	XP_050037925.1;XP_050045192.1;XP_050037167.1;XP_050035735.1;XP_050037166.1;XP_050037172.1;XP_050037164.1;XP_050037165.1;XP_050037926.1;XP_050037169.1;XP_050037168.1
KEGG: 00240+2.4.2.3	Pyrimidine metabolism	3	XP_050032573.1;XP_050035831.1;XP_050036028.1
KEGG: 04070+2.7.1.159	Phosphatidylinositol signaling system	1	XP_050048806.1
MetaCyc: PWY-7181	Pyrimidine deoxyribonucleosides degradation	2	XP_050025364.1;XP_050025363.1
Reactome: R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	4	XP_050031012.1;XP_050031013.1;XP_050031011.1;XP_050038602.1
Reactome: R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	9	XP_050024178.1;XP_050024177.1;XP_050024175.1;XP_050024179.1;XP_050047606.1;XP_050024180.1;XP_050023932.1;XP_050024176.1;XP_050047598.1
Reactome: R-HSA-975577	N-Glycan antennae elongation	16	XP_050027346.1;XP_050030575.1;XP_050045709.1;XP_050040302.1;XP_050049401.1;XP_050040309.1;XP_050027345.1;XP_050046537.1;XP_050040307.1;XP_050040306.1;XP_050027344.1;XP_050027354.1;XP_050049413.1;XP_050040303.1;XP_050040304.1;XP_050041857.1
MetaCyc: PWY-8004	Entner-Doudoroff pathway I	14	XP_050026015.1;XP_050051894.1;XP_050049839.1;XP_050034254.1;XP_050034253.1;XP_050041662.1;XP_050026014.1;XP_050026012.1;XP_050034255.1;XP_050041668.1;XP_050038972.1;XP_050026013.1;XP_050038973.1;XP_050026016.1
Reactome: R-HSA-9634600	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	19	XP_050030805.1;XP_050042110.1;XP_050042107.1;XP_050042106.1;XP_050030800.1;XP_050030797.1;XP_050030798.1;XP_050030803.1;XP_050042112.1;XP_050030795.1;XP_050042108.1;XP_050030804.1;XP_050030796.1;XP_050042109.1;XP_050042105.1;XP_050030799.1;XP_050042111.1;XP_050030802.1;XP_050030801.1
Reactome: R-HSA-69052	Switching of origins to a post-replicative state	10	XP_050031078.1;XP_050031079.1;XP_050045792.1;XP_050049555.1;XP_050046049.1;XP_050035183.1;XP_050036167.1;XP_050040739.1;XP_050049556.1;XP_050049554.1
MetaCyc: PWY-7198	Pyrimidine deoxyribonucleotides de novo biosynthesis IV	12	XP_050029492.1;XP_050034794.1;XP_050031510.1;XP_050030600.1;XP_050031386.1;XP_050051386.1;XP_050038939.1;XP_050027283.1;XP_050027282.1;XP_050029490.1;XP_050038800.1;XP_050043296.1
Reactome: R-HSA-5576893	Phase 2 - plateau phase	11	XP_050045827.1;XP_050032079.1;XP_050045823.1;XP_050041731.1;XP_050045824.1;XP_050045825.1;XP_050026855.1;XP_050045826.1;XP_050033136.1;XP_050026451.1;XP_050045828.1
Reactome: R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	51	XP_050026551.1;XP_050049340.1;XP_050043659.1;XP_050044795.1;XP_050045588.1;XP_050048534.1;XP_050040623.1;XP_050037416.1;XP_050023569.1;XP_050031360.1;XP_050032607.1;XP_050049030.1;XP_050048893.1;XP_050046640.1;XP_050047965.1;XP_050049349.1;XP_050047670.1;XP_050050621.1;XP_050038799.1;XP_050034209.1;XP_050036365.1;XP_050043649.1;XP_050048137.1;XP_050027119.1;XP_050031442.1;XP_050038602.1;XP_050026914.1;XP_050023568.1;XP_050036502.1;XP_050031594.1;XP_050045648.1;XP_050031262.1;XP_050044797.1;XP_050035872.1;XP_050034653.1;XP_050037415.1;XP_050049355.1;XP_050027121.1;XP_050034595.1;XP_050027801.1;XP_050023628.1;XP_050036373.1;XP_050040624.1;XP_050047955.1;XP_050048132.1;XP_050026843.1;XP_050031443.1;XP_050035481.1;XP_050050843.1;XP_050027120.1;XP_050044796.1
MetaCyc: PWY-5269	Cardiolipin biosynthesis II	4	XP_050034952.1;XP_050029507.1;XP_050029506.1;XP_050034951.1
Reactome: R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	2	XP_050036189.1;XP_050036188.1
KEGG: 00500+2.7.7.9	Starch and sucrose metabolism	4	XP_050037409.1;XP_050037410.1;XP_050037411.1;XP_050037412.1
Reactome: R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	1	XP_050047422.1
Reactome: R-HSA-5654727	Negative regulation of FGFR2 signaling	5	XP_050048534.1;XP_050035481.1;XP_050047606.1;XP_050032853.1;XP_050047598.1
Reactome: R-HSA-72187	mRNA 3'-end processing	55	XP_050023742.1;XP_050029909.1;XP_050047731.1;XP_050047730.1;XP_050032814.1;XP_050047733.1;XP_050045659.1;XP_050029925.1;XP_050052839.1;XP_050047729.1;XP_050044983.1;XP_050023014.1;XP_050047758.1;XP_050040680.1;XP_050049519.1;XP_050036485.1;XP_050049522.1;XP_050029632.1;XP_050032815.1;XP_050047732.1;XP_050038928.1;XP_050048350.1;XP_050027597.1;XP_050029924.1;XP_050048613.1;XP_050052835.1;XP_050030410.1;XP_050032813.1;XP_050041352.1;XP_050049411.1;XP_050039198.1;XP_050038682.1;XP_050049520.1;XP_050040805.1;XP_050030603.1;XP_050026402.1;XP_050038681.1;XP_050045424.1;XP_050036363.1;XP_050049410.1;XP_050029351.1;XP_050048351.1;XP_050049521.1;XP_050029923.1;XP_050029327.1;XP_050049523.1;XP_050036364.1;XP_050035496.1;XP_050035497.1;XP_050038680.1;XP_050045189.1;XP_050029910.1;XP_050032816.1;XP_050049409.1;XP_050044982.1
MetaCyc: PWY-6936	Seleno-amino acid biosynthesis (plants)	6	XP_050050545.1;XP_050052719.1;XP_050052721.1;XP_050050544.1;XP_050052716.1;XP_050052715.1
Reactome: R-HSA-2161541	Abacavir metabolism	6	XP_050050199.1;XP_050050200.1;XP_050050201.1;XP_050050203.1;XP_050050204.1;XP_050050202.1
Reactome: R-HSA-428543	Inactivation of CDC42 and RAC1	2	XP_050025375.1;XP_050025374.1
KEGG: 00052+2.7.1.1	Galactose metabolism	3	XP_050027343.1;XP_050047070.1;XP_050047071.1
Reactome: R-HSA-112382	Formation of RNA Pol II elongation complex	55	XP_050043138.1;XP_050040428.1;XP_050030634.1;XP_050048255.1;XP_050040427.1;XP_050022472.1;XP_050039484.1;XP_050039068.1;XP_050044472.1;XP_050038469.1;XP_050034643.1;XP_050023730.1;XP_050025563.1;XP_050037137.1;XP_050048717.1;XP_050023725.1;XP_050043147.1;XP_050044597.1;XP_050023576.1;XP_050025635.1;XP_050023714.1;XP_050023726.1;XP_050033368.1;XP_050023729.1;XP_050046063.1;XP_050045190.1;XP_050048718.1;XP_050023779.1;XP_050047361.1;XP_050042077.1;XP_050023776.1;XP_050045189.1;XP_050034644.1;XP_050045027.1;XP_050051336.1;XP_050030810.1;XP_050051335.1;XP_050045300.1;XP_050030280.1;XP_050023724.1;XP_050023727.1;XP_050023777.1;XP_050035378.1;XP_050034171.1;XP_050030811.1;XP_050024189.1;XP_050046123.1;XP_050044473.1;XP_050023728.1;XP_050047588.1;XP_050037136.1;XP_050023577.1;XP_050044010.1;XP_050045052.1;XP_050039485.1
Reactome: R-HSA-1222556	ROS and RNS production in phagocytes	32	XP_050048936.1;XP_050034072.1;XP_050048952.1;XP_050045457.1;XP_050034127.1;XP_050048793.1;XP_050050217.1;XP_050024661.1;XP_050044699.1;XP_050045458.1;XP_050034126.1;XP_050044697.1;XP_050049937.1;XP_050048943.1;XP_050044865.1;XP_050049787.1;XP_050037617.1;XP_050034615.1;XP_050042150.1;XP_050032732.1;XP_050045459.1;XP_050044696.1;XP_050034125.1;XP_050032728.1;XP_050049057.1;XP_050049586.1;XP_050023172.1;XP_050041324.1;XP_050024666.1;XP_050041945.1;XP_050037618.1;XP_050038826.1
Reactome: R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	52	XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050033237.1;XP_050044476.1;XP_050031479.1;XP_050025848.1;XP_050048721.1;XP_050045660.1;XP_050044478.1;XP_050032477.1;XP_050050373.1;XP_050045785.1;XP_050047809.1;XP_050048719.1;XP_050022938.1;XP_050040200.1;XP_050033491.1;XP_050042025.1;XP_050048720.1;XP_050049124.1;XP_050040198.1;XP_050027118.1;XP_050031786.1;XP_050044475.1;XP_050024749.1;XP_050037397.1;XP_050051964.1;XP_050035472.1;XP_050036567.1;XP_050033331.1;XP_050052231.1;XP_050044470.1;XP_050029802.1;XP_050050645.1;XP_050033832.1;XP_050048823.1;XP_050040199.1;XP_050033833.1;XP_050048824.1;XP_050037399.1;XP_050044469.1;XP_050033504.1;XP_050047181.1;XP_050037398.1;XP_050033318.1;XP_050042788.1;XP_050022518.1;XP_050027134.1;XP_050027657.1;XP_050038140.1;XP_050036156.1
KEGG: 00531+3.2.1.23	Glycosaminoglycan degradation	20	XP_050039612.1;XP_050042169.1;XP_050042179.1;XP_050042437.1;XP_050042439.1;XP_050042438.1;XP_050038798.1;XP_050039611.1;XP_050042167.1;XP_050042180.1;XP_050042178.1;XP_050042181.1;XP_050042176.1;XP_050045117.1;XP_050042436.1;XP_050042177.1;XP_050040161.1;XP_050040162.1;XP_050042175.1;XP_050038908.1
Reactome: R-HSA-5686938	Regulation of TLR by endogenous ligand	12	XP_050042242.1;XP_050042260.1;XP_050042262.1;XP_050042241.1;XP_050023312.1;XP_050042261.1;XP_050023334.1;XP_050042454.1;XP_050023796.1;XP_050023422.1;XP_050042240.1;XP_050023809.1
KEGG: 00350+1.13.11.5	Tyrosine metabolism	1	XP_050027257.1
MetaCyc: PWY-7003	Glycerol degradation to butanol	10	XP_050034253.1;XP_050041662.1;XP_050034254.1;XP_050051894.1;XP_050044976.1;XP_050038973.1;XP_050045451.1;XP_050041668.1;XP_050038972.1;XP_050034255.1
MetaCyc: PWY-6344	L-ornithine degradation II (Stickland reaction)	3	XP_050048960.1;XP_050039554.1;XP_050040888.1
KEGG: 00564+1.1.5.3	Glycerophospholipid metabolism	3	XP_050040576.1;XP_050034934.1;XP_050034933.1
Reactome: R-HSA-4090294	SUMOylation of intracellular receptors	33	XP_050049221.1;XP_050051155.1;XP_050051156.1;XP_050049222.1;XP_050044404.1;XP_050044407.1;XP_050034257.1;XP_050044398.1;XP_050044396.1;XP_050044402.1;XP_050044394.1;XP_050049223.1;XP_050049218.1;XP_050049219.1;XP_050044408.1;XP_050049225.1;XP_050049217.1;XP_050049229.1;XP_050044405.1;XP_050044401.1;XP_050049228.1;XP_050049224.1;XP_050044403.1;XP_050049227.1;XP_050034256.1;XP_050044395.1;XP_050044406.1;XP_050049230.1;XP_050044397.1;XP_050049226.1;XP_050044400.1;XP_050049673.1;XP_050049216.1
MetaCyc: PWY-6613	Tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	4	XP_050048865.1;XP_050052683.1;XP_050052682.1;XP_050048637.1
KEGG: 00230+6.3.2.6	Purine metabolism	2	XP_050039992.1;XP_050039993.1
Reactome: R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	2	XP_050023802.1;XP_050037114.1
KEGG: 00510+2.4.1.68	N-Glycan biosynthesis	1	XP_050036571.1
MetaCyc: PWY-5129	Sphingolipid biosynthesis (plants)	2	XP_050037297.1;XP_050023783.1
MetaCyc: PWY-8099	Tetrahydropteridine recycling	1	XP_050034971.1
MetaCyc: PWY-6983	Threo-tetrahydrobiopterin biosynthesis	4	XP_050045129.1;XP_050048633.1;XP_050048632.1;XP_050048631.1
Reactome: R-HSA-2173789	TGF-beta receptor signaling activates SMADs	3	XP_050049690.1;XP_050023721.1;XP_050049691.1
Reactome: R-HSA-5656169	Termination of translesion DNA synthesis	23	XP_050022594.1;XP_050045599.1;XP_050050532.1;XP_050042972.1;XP_050042755.1;XP_050028231.1;XP_050022795.1;XP_050045558.1;XP_050048534.1;XP_050023241.1;XP_050029852.1;XP_050034506.1;XP_050040824.1;XP_050045557.1;XP_050025144.1;XP_050049952.1;XP_050029342.1;XP_050046062.1;XP_050022980.1;XP_050051397.1;XP_050032670.1;XP_050052687.1;XP_050035481.1
KEGG: 00260+1.1.1.95	Glycine, serine and threonine metabolism	1	XP_050045348.1
Reactome: R-HSA-6811438	Intra-Golgi traffic	31	XP_050025702.1;XP_050025708.1;XP_050022514.1;XP_050050875.1;XP_050052115.1;XP_050025705.1;XP_050026124.1;XP_050046114.1;XP_050034917.1;XP_050046113.1;XP_050048230.1;XP_050047207.1;XP_050046002.1;XP_050032270.1;XP_050049232.1;XP_050045031.1;XP_050025706.1;XP_050045030.1;XP_050025704.1;XP_050045029.1;XP_050051406.1;XP_050052114.1;XP_050049233.1;XP_050048257.1;XP_050025703.1;XP_050040144.1;XP_050023720.1;XP_050025707.1;XP_050043547.1;XP_050036184.1;XP_050038325.1
KEGG: 00650+4.2.1.17+1.1.1.35	Butanoate metabolism	6	XP_050041643.1;XP_050041635.1;XP_050051194.1;XP_050041651.1;XP_050026422.1;XP_050032010.1
KEGG: 00230+3.6.1.9	Purine metabolism	3	XP_050045218.1;XP_050025198.1;XP_050041566.1
Reactome: R-HSA-176034	Interactions of Tat with host cellular proteins	2	XP_050048718.1;XP_050048717.1
Reactome: R-HSA-912526	Interleukin receptor SHC signaling	1	XP_050032853.1
Reactome: R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	50	XP_050030572.1;XP_050038561.1;XP_050045165.1;XP_050044094.1;XP_050038647.1;XP_050038646.1;XP_050044571.1;XP_050043181.1;XP_050030568.1;XP_050044096.1;XP_050038644.1;XP_050045038.1;XP_050045039.1;XP_050043821.1;XP_050043899.1;XP_050038643.1;XP_050025352.1;XP_050030425.1;XP_050030426.1;XP_050035116.1;XP_050034759.1;XP_050047679.1;XP_050035114.1;XP_050038648.1;XP_050025353.1;XP_050038560.1;XP_050030430.1;XP_050026098.1;XP_050030429.1;XP_050043820.1;XP_050030428.1;XP_050043296.1;XP_050038645.1;XP_050023810.1;XP_050030570.1;XP_050030569.1;XP_050044095.1;XP_050044093.1;XP_050030424.1;XP_050045471.1;XP_050038642.1;XP_050030571.1;XP_050035119.1;XP_050039261.1;XP_050024782.1;XP_050049353.1;XP_050035880.1;XP_050036465.1;XP_050025351.1;XP_050028813.1
Reactome: R-HSA-210991	Basigin interactions	1	XP_050036619.1
KEGG: 00270+2.5.1.16	Cysteine and methionine metabolism	4	XP_050041583.1;XP_050027526.1;XP_050027527.1;XP_050041589.1
MetaCyc: PWY-5132	Lupulone and humulone biosynthesis	3	XP_050044794.1;XP_050040406.1;XP_050030604.1
Reactome: R-HSA-1433557	Signaling by SCF-KIT	6	XP_050032853.1;XP_050034361.1;XP_050034961.1;XP_050034960.1;XP_050034359.1;XP_050034360.1
KEGG: 00660+6.2.1.5	C5-Branched dibasic acid metabolism	8	XP_050049076.1;XP_050042702.1;XP_050043005.1;XP_050042703.1;XP_050026353.1;XP_050049075.1;XP_050042704.1;XP_050026352.1
KEGG: 00983+2.7.1.21	Drug metabolism - other enzymes	1	XP_050032909.1
Reactome: R-HSA-8853884	Transcriptional Regulation by VENTX	28	XP_050039331.1;XP_050039332.1;XP_050052225.1;XP_050039235.1;XP_050051381.1;XP_050048801.1;XP_050052226.1;XP_050051916.1;XP_050051915.1;XP_050029861.1;XP_050039329.1;XP_050034247.1;XP_050038630.1;XP_050040338.1;XP_050030937.1;XP_050040339.1;XP_050029862.1;XP_050051917.1;XP_050039236.1;XP_050040340.1;XP_050040341.1;XP_050047778.1;XP_050029858.1;XP_050039330.1;XP_050034248.1;XP_050038628.1;XP_050029859.1;XP_050029860.1
Reactome: R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1	XP_050032010.1
Reactome: R-HSA-983712	Ion channel transport	26	XP_050049057.1;XP_050050217.1;XP_050034126.1;XP_050049586.1;XP_050045458.1;XP_050044699.1;XP_050041324.1;XP_050023172.1;XP_050041945.1;XP_050044697.1;XP_050037618.1;XP_050049937.1;XP_050038826.1;XP_050034072.1;XP_050049787.1;XP_050045457.1;XP_050034127.1;XP_050048793.1;XP_050037617.1;XP_050034615.1;XP_050042150.1;XP_050032732.1;XP_050045459.1;XP_050034125.1;XP_050044696.1;XP_050032728.1
Reactome: R-HSA-1912408	Pre-NOTCH Transcription and Translation	47	XP_050050843.1;XP_050032553.1;XP_050046149.1;XP_050029337.1;XP_050039235.1;XP_050025244.1;XP_050041140.1;XP_050028353.1;XP_050046147.1;XP_050026046.1;XP_050026223.1;XP_050029861.1;XP_050051916.1;XP_050052226.1;XP_050041139.1;XP_050029862.1;XP_050023625.1;XP_050029336.1;XP_050046150.1;XP_050029824.1;XP_050025248.1;XP_050038213.1;XP_050029827.1;XP_050051590.1;XP_050052512.1;XP_050038602.1;XP_050052225.1;XP_050038799.1;XP_050025266.1;XP_050023605.1;XP_050051915.1;XP_050029826.1;XP_050039236.1;XP_050051917.1;XP_050046148.1;XP_050038199.1;XP_050029338.1;XP_050045588.1;XP_050029860.1;XP_050029825.1;XP_050029859.1;XP_050051588.1;XP_050025243.1;XP_050041141.1;XP_050026047.1;XP_050036268.1;XP_050029858.1
MetaCyc: PWY-7383	Anaerobic energy metabolism (invertebrates, cytosol)	29	XP_050049203.1;XP_050034254.1;XP_050038121.1;XP_050037164.1;XP_050034972.1;XP_050034554.1;XP_050037166.1;XP_050038117.1;XP_050037167.1;XP_050038118.1;XP_050038127.1;XP_050049202.1;XP_050034253.1;XP_050038132.1;XP_050037168.1;XP_050037926.1;XP_050026413.1;XP_050037169.1;XP_050038116.1;XP_050037165.1;XP_050031435.1;XP_050037172.1;XP_050026567.1;XP_050035735.1;XP_050045192.1;XP_050037925.1;XP_050034255.1;XP_050038119.1;XP_050034437.1
KEGG: 05165+2.7.11.1	Human papillomavirus infection	141	XP_050041922.1;XP_050037630.1;XP_050042989.1;XP_050036226.1;XP_050029303.1;XP_050048619.1;XP_050031198.1;XP_050036224.1;XP_050034960.1;XP_050051647.1;XP_050037625.1;XP_050031200.1;XP_050026053.1;XP_050031206.1;XP_050048905.1;XP_050050723.1;XP_050026954.1;XP_050043308.1;XP_050034932.1;XP_050031194.1;XP_050027320.1;XP_050026027.1;XP_050036232.1;XP_050036237.1;XP_050044446.1;XP_050026955.1;XP_050028233.1;XP_050036225.1;XP_050032708.1;XP_050045593.1;XP_050028292.1;XP_050031207.1;XP_050051059.1;XP_050036131.1;XP_050037629.1;XP_050050709.1;XP_050050734.1;XP_050037623.1;XP_050041921.1;XP_050048621.1;XP_050028166.1;XP_050043849.1;XP_050050310.1;XP_050032548.1;XP_050050715.1;XP_050031209.1;XP_050029160.1;XP_050026977.1;XP_050043304.1;XP_050032707.1;XP_050026695.1;XP_050022875.1;XP_050042307.1;XP_050037622.1;XP_050049192.1;XP_050036239.1;XP_050048906.1;XP_050026555.1;XP_050036230.1;XP_050037627.1;XP_050043130.1;XP_050036231.1;XP_050032586.1;XP_050026976.1;XP_050032928.1;XP_050043302.1;XP_050033844.1;XP_050023932.1;XP_050028165.1;XP_050031197.1;XP_050037624.1;XP_050042988.1;XP_050032102.1;XP_050036238.1;XP_050041923.1;XP_050042990.1;XP_050025348.1;XP_050031202.1;XP_050049350.1;XP_050043303.1;XP_050043305.1;XP_050031205.1;XP_050031203.1;XP_050031201.1;XP_050048620.1;XP_050035999.1;XP_050037621.1;XP_050036129.1;XP_050043301.1;XP_050025347.1;XP_050030586.1;XP_050036236.1;XP_050026974.1;XP_050036240.1;XP_050044807.1;XP_050031195.1;XP_050050041.1;XP_050036228.1;XP_050032927.1;XP_050034961.1;XP_050043306.1;XP_050036235.1;XP_050036234.1;XP_050029381.1;XP_050037628.1;XP_050036223.1;XP_050036613.1;XP_050042629.1;XP_050043307.1;XP_050037631.1;XP_050049191.1;XP_050036227.1;XP_050033720.1;XP_050033021.1;XP_050031204.1;XP_050035462.1;XP_050026975.1;XP_050045265.1;XP_050046724.1;XP_050036142.1;XP_050031196.1;XP_050031199.1;XP_050041948.1;XP_050036233.1;XP_050028323.1;XP_050031208.1;XP_050037626.1;XP_050041924.1;XP_050039865.1;XP_050043129.1;XP_050043309.1;XP_050036229.1;XP_050036130.1;XP_050045266.1;XP_050050042.1;XP_050026054.1;XP_050034828.1;XP_050034829.1;XP_050044080.1;XP_050036241.1;XP_050028687.1
MetaCyc: PWY-7587	Oleate biosynthesis III (cyanobacteria)	11	XP_050037855.1;XP_050027416.1;XP_050037854.1;XP_050027415.1;XP_050032357.1;XP_050037857.1;XP_050047027.1;XP_050037775.1;XP_050050583.1;XP_050047026.1;XP_050037856.1
Reactome: R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	12	XP_050037100.1;XP_050041375.1;XP_050049233.1;XP_050030242.1;XP_050041373.1;XP_050040246.1;XP_050028603.1;XP_050030241.1;XP_050049232.1;XP_050048294.1;XP_050041374.1;XP_050041376.1
KEGG: 00230+3.6.1.66	Purine metabolism	5	XP_050030111.1;XP_050038111.1;XP_050038110.1;XP_050025198.1;XP_050041566.1
Reactome: R-HSA-114516	Disinhibition of SNARE formation	2	XP_050030242.1;XP_050030241.1
Reactome: R-HSA-379726	Mitochondrial tRNA aminoacylation	15	XP_050044097.1;XP_050051666.1;XP_050044543.1;XP_050051222.1;XP_050024345.1;XP_050049817.1;XP_050051668.1;XP_050026443.1;XP_050036769.1;XP_050048047.1;XP_050031591.1;XP_050024346.1;XP_050032528.1;XP_050031592.1;XP_050036768.1
Reactome: R-HSA-5578749	Transcriptional regulation by small RNAs	51	XP_050034643.1;XP_050025064.1;XP_050025244.1;XP_050036827.1;XP_050039240.1;XP_050038469.1;XP_050038967.1;XP_050030507.1;XP_050038966.1;XP_050030652.1;XP_050030506.1;XP_050038969.1;XP_050030942.1;XP_050038863.1;XP_050038895.1;XP_050042391.1;XP_050036430.1;XP_050023474.1;XP_050029515.1;XP_050025248.1;XP_050038213.1;XP_050035933.1;XP_050043147.1;XP_050035932.1;XP_050046156.1;XP_050026809.1;XP_050023718.1;XP_050029516.1;XP_050038862.1;XP_050026810.1;XP_050033146.1;XP_050038866.1;XP_050038968.1;XP_050034644.1;XP_050025266.1;XP_050049377.1;XP_050030653.1;XP_050044008.1;XP_050023476.1;XP_050047656.1;XP_050038199.1;XP_050046123.1;XP_050042392.1;XP_050023475.1;XP_050024518.1;XP_050024189.1;XP_050038864.1;XP_050025243.1;XP_050036268.1;XP_050038865.1;XP_050035770.1
KEGG: 00680+3.1.2.12	Methane metabolism	1	XP_050049682.1
MetaCyc: PWY-6289	Petrobactin biosynthesis	1	XP_050040326.1
Reactome: R-HSA-5689877	Josephin domain DUBs	10	XP_050032943.1;XP_050036377.1;XP_050048534.1;XP_050035481.1;XP_050032942.1;XP_050032945.1;XP_050023321.1;XP_050024240.1;XP_050032944.1;XP_050023192.1
Reactome: R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	28	XP_050024189.1;XP_050025635.1;XP_050023576.1;XP_050030811.1;XP_050023777.1;XP_050043147.1;XP_050023727.1;XP_050023725.1;XP_050023724.1;XP_050030280.1;XP_050039485.1;XP_050023779.1;XP_050023577.1;XP_050047588.1;XP_050046063.1;XP_050023729.1;XP_050023728.1;XP_050023726.1;XP_050046123.1;XP_050034644.1;XP_050039484.1;XP_050045189.1;XP_050023776.1;XP_050043138.1;XP_050023730.1;XP_050030810.1;XP_050034643.1;XP_050038469.1
KEGG: 00630+5.1.99.1	Glyoxylate and dicarboxylate metabolism	1	XP_050034236.1
Reactome: R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	2	XP_050039213.1;XP_050039212.1
Reactome: R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	68	XP_050035472.1;XP_050051964.1;XP_050033331.1;XP_050044470.1;XP_050040199.1;XP_050035481.1;XP_050042025.1;XP_050040198.1;XP_050031786.1;XP_050027118.1;XP_050037397.1;XP_050024749.1;XP_050033318.1;XP_050022518.1;XP_050047778.1;XP_050040341.1;XP_050033833.1;XP_050030937.1;XP_050047181.1;XP_050040338.1;XP_050031479.1;XP_050048721.1;XP_050025848.1;XP_050044478.1;XP_050048801.1;XP_050025715.1;XP_050034772.1;XP_050037401.1;XP_050039332.1;XP_050039331.1;XP_050040200.1;XP_050045785.1;XP_050050373.1;XP_050048719.1;XP_050039329.1;XP_050034247.1;XP_050036567.1;XP_050029802.1;XP_050050645.1;XP_050052231.1;XP_050048823.1;XP_050033832.1;XP_050049124.1;XP_050048720.1;XP_050044475.1;XP_050037398.1;XP_050027134.1;XP_050042788.1;XP_050034248.1;XP_050038628.1;XP_050027657.1;XP_050038140.1;XP_050036156.1;XP_050037399.1;XP_050048824.1;XP_050038630.1;XP_050044469.1;XP_050044476.1;XP_050045660.1;XP_050051381.1;XP_050033237.1;XP_050039330.1;XP_050022938.1;XP_050032477.1;XP_050048534.1;XP_050040340.1;XP_050040339.1;XP_050047809.1
KEGG: 00510+3.2.1.106	N-Glycan biosynthesis	3	XP_050050232.1;XP_050050233.1;XP_050050234.1
KEGG: 00130+4.1.1.90	Ubiquinone and other terpenoid-quinone biosynthesis	1	XP_050052424.1
MetaCyc: PWY-6944	Androstenedione degradation	6	XP_050032010.1;XP_050026422.1;XP_050041651.1;XP_050041635.1;XP_050051194.1;XP_050041643.1
Reactome: R-HSA-109704	PI3K Cascade	3	XP_050032853.1;XP_050047065.1;XP_050045005.1
Reactome: R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	1	XP_050027890.1
MetaCyc: PWY-5082	L-methionine degradation III	3	XP_050052302.1;XP_050052400.1;XP_050052301.1
Reactome: R-HSA-6787450	tRNA modification in the mitochondrion	11	XP_050036852.1;XP_050049014.1;XP_050033201.1;XP_050036853.1;XP_050033200.1;XP_050045564.1;XP_050046343.1;XP_050030696.1;XP_050033199.1;XP_050031168.1;XP_050045062.1
Reactome: R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	70	XP_050049353.1;XP_050024782.1;XP_050049762.1;XP_050043820.1;XP_050030429.1;XP_050038645.1;XP_050030570.1;XP_050049757.1;XP_050043296.1;XP_050045471.1;XP_050046735.1;XP_050030426.1;XP_050025352.1;XP_050047338.1;XP_050045039.1;XP_050038643.1;XP_050047679.1;XP_050035114.1;XP_050038648.1;XP_050025353.1;XP_050034759.1;XP_050035116.1;XP_050052055.1;XP_050045474.1;XP_050030572.1;XP_050039380.1;XP_050051356.1;XP_050030568.1;XP_050043181.1;XP_050044096.1;XP_050038646.1;XP_050044571.1;XP_050039381.1;XP_050024841.1;XP_050049759.1;XP_050039261.1;XP_050049761.1;XP_050035880.1;XP_050052420.1;XP_050028813.1;XP_050036465.1;XP_050025351.1;XP_050046734.1;XP_050026098.1;XP_050023810.1;XP_050030428.1;XP_050038560.1;XP_050051357.1;XP_050030430.1;XP_050038642.1;XP_050030424.1;XP_050049758.1;XP_050035119.1;XP_050030571.1;XP_050044095.1;XP_050030569.1;XP_050044093.1;XP_050030425.1;XP_050043899.1;XP_050043821.1;XP_050025026.1;XP_050051355.1;XP_050044094.1;XP_050024840.1;XP_050038561.1;XP_050045165.1;XP_050045038.1;XP_050038644.1;XP_050045473.1;XP_050038647.1
MetaCyc: PWY-7409	Phospholipid remodeling (phosphatidylethanolamine, yeast)	27	XP_050050549.1;XP_050035194.1;XP_050037150.1;XP_050025686.1;XP_050025400.1;XP_050037661.1;XP_050037143.1;XP_050037141.1;XP_050035197.1;XP_050037139.1;XP_050035195.1;XP_050035196.1;XP_050037144.1;XP_050037140.1;XP_050037148.1;XP_050037146.1;XP_050037142.1;XP_050035199.1;XP_050033390.1;XP_050037151.1;XP_050035198.1;XP_050037147.1;XP_050031256.1;XP_050035193.1;XP_050030747.1;XP_050037145.1;XP_050035192.1
KEGG: 00791+3.5.1.5	Atrazine degradation	2	XP_050024276.1;XP_050024271.1
KEGG: 00960+2.6.1.5	Tropane, piperidine and pyridine alkaloid biosynthesis	3	XP_050049182.1;XP_050049181.1;XP_050031962.1
MetaCyc: PWY-7338	10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)	2	XP_050023456.1;XP_050026060.1
Reactome: R-HSA-111957	Cam-PDE 1 activation	5	XP_050050019.1;XP_050050016.1;XP_050050015.1;XP_050050018.1;XP_050050017.1
Reactome: R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	3	XP_050026420.1;XP_050039873.1;XP_050044537.1
Reactome: R-HSA-111447	Activation of BAD and translocation to mitochondria	7	XP_050025568.1;XP_050048620.1;XP_050033750.1;XP_050048621.1;XP_050033752.1;XP_050048619.1;XP_050033751.1
Reactome: R-HSA-5632681	Ligand-receptor interactions	5	XP_050044749.1;XP_050044750.1;XP_050050209.1;XP_050033319.1;XP_050037704.1
Reactome: R-HSA-8876725	Protein methylation	10	XP_050029294.1;XP_050027475.1;XP_050046958.1;XP_050031227.1;XP_050029380.1;XP_050034948.1;XP_050032120.1;XP_050023192.1;XP_050032118.1;XP_050029596.1
Reactome: R-HSA-9614399	Regulation of localization of FOXO transcription factors	4	XP_050048620.1;XP_050048621.1;XP_050048619.1;XP_050026421.1
KEGG: 00340+4.2.1.49	Histidine metabolism	2	XP_050027712.1;XP_050027711.1
Reactome: R-HSA-389977	Post-chaperonin tubulin folding pathway	9	XP_050045511.1;XP_050033998.1;XP_050051356.1;XP_050051357.1;XP_050047338.1;XP_050049757.1;XP_050051355.1;XP_050052055.1;XP_050052420.1
KEGG: 00010+2.7.2.3	Glycolysis / Gluconeogenesis	2	XP_050038972.1;XP_050038973.1
KEGG: 00565+3.1.3.4	Ether lipid metabolism	4	XP_050037456.1;XP_050037457.1;XP_050037455.1;XP_050037458.1
Reactome: R-HSA-156584	Cytosolic sulfonation of small molecules	5	XP_050045134.1;XP_050045127.1;XP_050045141.1;XP_050045158.1;XP_050045150.1
Reactome: R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	93	XP_050024748.1;XP_050046803.1;XP_050035956.1;XP_050035847.1;XP_050024746.1;XP_050035952.1;XP_050035948.1;XP_050043638.1;XP_050027888.1;XP_050035217.1;XP_050024898.1;XP_050035213.1;XP_050031349.1;XP_050024880.1;XP_050035553.1;XP_050035848.1;XP_050035966.1;XP_050043179.1;XP_050035763.1;XP_050036094.1;XP_050035829.1;XP_050046242.1;XP_050031346.1;XP_050035762.1;XP_050024784.1;XP_050024741.1;XP_050043177.1;XP_050035955.1;XP_050035958.1;XP_050024721.1;XP_050035823.1;XP_050035826.1;XP_050035967.1;XP_050035951.1;XP_050024723.1;XP_050035705.1;XP_050031348.1;XP_050034860.1;XP_050044875.1;XP_050031482.1;XP_050044647.1;XP_050035791.1;XP_050031477.1;XP_050045695.1;XP_050045420.1;XP_050034469.1;XP_050034468.1;XP_050035314.1;XP_050041659.1;XP_050040139.1;XP_050031480.1;XP_050034533.1;XP_050023509.1;XP_050024747.1;XP_050024879.1;XP_050035552.1;XP_050046806.1;XP_050024743.1;XP_050043180.1;XP_050035954.1;XP_050024745.1;XP_050024724.1;XP_050034967.1;XP_050041992.1;XP_050046804.1;XP_050035845.1;XP_050031347.1;XP_050025319.1;XP_050038747.1;XP_050035554.1;XP_050031478.1;XP_050024865.1;XP_050034395.1;XP_050034768.1;XP_050046807.1;XP_050031481.1;XP_050034532.1;XP_050031476.1;XP_050024742.1;XP_050024744.1;XP_050034984.1;XP_050035403.1;XP_050022871.1;XP_050034966.1;XP_050029239.1;XP_050025028.1;XP_050024504.1;XP_050034983.1;XP_050034396.1;XP_050035422.1;XP_050034433.1;XP_050031483.1;XP_050024720.1
KEGG: 00790+4.6.1.17	Folate biosynthesis	1	XP_050038900.1
KEGG: 00250+6.3.1.2	Alanine, aspartate and glutamate metabolism	11	XP_050038621.1;XP_050033588.1;XP_050051950.1;XP_050028873.1;XP_050038622.1;XP_050038620.1;XP_050038619.1;XP_050028876.1;XP_050038618.1;XP_050028874.1;XP_050033589.1
KEGG: 00982+1.14.13.8	Drug metabolism - cytochrome P450	11	XP_050040206.1;XP_050040208.1;XP_050042195.1;XP_050039445.1;XP_050026390.1;XP_050039447.1;XP_050042199.1;XP_050040207.1;XP_050042198.1;XP_050039444.1;XP_050039651.1
Reactome: R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	37	XP_050034061.1;XP_050039235.1;XP_050051294.1;XP_050034062.1;XP_050025244.1;XP_050045285.1;XP_050034066.1;XP_050029861.1;XP_050051916.1;XP_050034681.1;XP_050052226.1;XP_050034060.1;XP_050029862.1;XP_050036655.1;XP_050045294.1;XP_050038213.1;XP_050047422.1;XP_050025248.1;XP_050035890.1;XP_050052225.1;XP_050035889.1;XP_050034064.1;XP_050034065.1;XP_050045301.1;XP_050025266.1;XP_050051915.1;XP_050052258.1;XP_050039236.1;XP_050051917.1;XP_050038199.1;XP_050029860.1;XP_050029859.1;XP_050035110.1;XP_050034063.1;XP_050036268.1;XP_050025243.1;XP_050029858.1
Reactome: R-HSA-428540	Activation of RAC1	7	XP_050036142.1;XP_050026054.1;XP_050043898.1;XP_050043130.1;XP_050026053.1;XP_050043897.1;XP_050043129.1
Reactome: R-HSA-5655291	Signaling by FGFR4 in disease	1	XP_050032853.1
Reactome: R-HSA-5689901	Metalloprotease DUBs	12	XP_050047074.1;XP_050040200.1;XP_050036675.1;XP_050040199.1;XP_050035481.1;XP_050036207.1;XP_050048534.1;XP_050040198.1;XP_050023798.1;XP_050024165.1;XP_050023797.1;XP_050036676.1
Reactome: R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	93	XP_050041595.1;XP_050046689.1;XP_050027095.1;XP_050041237.1;XP_050038732.1;XP_050035489.1;XP_050036610.1;XP_050033197.1;XP_050039343.1;XP_050047121.1;XP_050044704.1;XP_050041239.1;XP_050039342.1;XP_050026287.1;XP_050036813.1;XP_050027659.1;XP_050023187.1;XP_050041610.1;XP_050050923.1;XP_050050792.1;XP_050041243.1;XP_050026286.1;XP_050044702.1;XP_050035559.1;XP_050041241.1;XP_050039208.1;XP_050050791.1;XP_050051980.1;XP_050041602.1;XP_050039210.1;XP_050044700.1;XP_050046966.1;XP_050049078.1;XP_050050924.1;XP_050045030.1;XP_050041236.1;XP_050036612.1;XP_050048621.1;XP_050030169.1;XP_050023720.1;XP_050049317.1;XP_050039211.1;XP_050051981.1;XP_050024480.1;XP_050025080.1;XP_050048620.1;XP_050038349.1;XP_050048473.1;XP_050048470.1;XP_050023860.1;XP_050024131.1;XP_050049903.1;XP_050049316.1;XP_050045031.1;XP_050038348.1;XP_050039344.1;XP_050045029.1;XP_050039209.1;XP_050049910.1;XP_050044705.1;XP_050038347.1;XP_050047806.1;XP_050041242.1;XP_050041240.1;XP_050027094.1;XP_050046821.1;XP_050041624.1;XP_050046967.1;XP_050047419.1;XP_050039345.1;XP_050047671.1;XP_050023186.1;XP_050051989.1;XP_050044703.1;XP_050048619.1;XP_050046822.1;XP_050041618.1;XP_050026289.1;XP_050028703.1;XP_050038731.1;XP_050026288.1;XP_050036611.1;XP_050026966.1;XP_050051990.1;XP_050045632.1;XP_050044701.1;XP_050028561.1;XP_050048471.1;XP_050048472.1;XP_050049318.1;XP_050028704.1;XP_050046001.1;XP_050036814.1
Reactome: R-HSA-8964038	LDL clearance	40	XP_050042812.1;XP_050049658.1;XP_050042240.1;XP_050023809.1;XP_050030101.1;XP_050042454.1;XP_050049725.1;XP_050040836.1;XP_050028603.1;XP_050023796.1;XP_050049676.1;XP_050023422.1;XP_050040436.1;XP_050049713.1;XP_050045786.1;XP_050049651.1;XP_050042344.1;XP_050042260.1;XP_050042241.1;XP_050052836.1;XP_050040246.1;XP_050026657.1;XP_050049667.1;XP_050023334.1;XP_050037100.1;XP_050049738.1;XP_050048294.1;XP_050042242.1;XP_050043166.1;XP_050049760.1;XP_050040835.1;XP_050049771.1;XP_050034717.1;XP_050036812.1;XP_050023312.1;XP_050042261.1;XP_050049747.1;XP_050034867.1;XP_050049261.1;XP_050042262.1
Reactome: R-HSA-4420097	VEGFA-VEGFR2 Pathway	40	XP_050031019.1;XP_050023516.1;XP_050051315.1;XP_050025374.1;XP_050042105.1;XP_050035166.1;XP_050042109.1;XP_050031023.1;XP_050033239.1;XP_050033240.1;XP_050051318.1;XP_050027600.1;XP_050032102.1;XP_050027598.1;XP_050027599.1;XP_050027738.1;XP_050031020.1;XP_050042112.1;XP_050039215.1;XP_050043898.1;XP_050033242.1;XP_050042108.1;XP_050035165.1;XP_050028233.1;XP_050051317.1;XP_050031021.1;XP_050023517.1;XP_050042111.1;XP_050035167.1;XP_050042110.1;XP_050051316.1;XP_050025375.1;XP_050042107.1;XP_050042106.1;XP_050033244.1;XP_050031022.1;XP_050033243.1;XP_050033241.1;XP_050043897.1;XP_050035163.1
MetaCyc: PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	3	XP_050025344.1;XP_050025345.1;XP_050041676.1
MetaCyc: PWY-7857	Adlupulone and adhumulone biosynthesis	3	XP_050040406.1;XP_050044794.1;XP_050030604.1
KEGG: 00600+3.5.1.23	Sphingolipid metabolism	1	XP_050048005.1
Reactome: R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	3	XP_050025361.1;XP_050042866.1;XP_050042873.1
Reactome: R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	35	XP_050023727.1;XP_050023777.1;XP_050023724.1;XP_050030280.1;XP_050024189.1;XP_050030811.1;XP_050047588.1;XP_050023728.1;XP_050046123.1;XP_050039485.1;XP_050045052.1;XP_050023577.1;XP_050034644.1;XP_050023776.1;XP_050051335.1;XP_050030810.1;XP_050051336.1;XP_050023725.1;XP_050043147.1;XP_050048717.1;XP_050025635.1;XP_050023576.1;XP_050046063.1;XP_050023729.1;XP_050023726.1;XP_050023714.1;XP_050023779.1;XP_050048718.1;XP_050030634.1;XP_050043138.1;XP_050039068.1;XP_050039484.1;XP_050038469.1;XP_050023730.1;XP_050034643.1
Reactome: R-HSA-5578999	Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)	3	XP_050051979.1;XP_050026350.1;XP_050027889.1
KEGG: 00650+1.3.5.1	Butanoate metabolism	4	XP_050038590.1;XP_050033719.1;XP_050033718.1;XP_050033843.1
Reactome: R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	8	XP_050048534.1;XP_050035481.1;XP_050028061.1;XP_050049501.1;XP_050049499.1;XP_050049500.1;XP_050050758.1;XP_050028062.1
MetaCyc: PWY-8001	Felinine and 3-methyl-3-sulfanylbutan-1-ol biosynthesis	42	XP_050024014.1;XP_050029054.1;XP_050024805.1;XP_050043742.1;XP_050029240.1;XP_050031599.1;XP_050030373.1;XP_050029056.1;XP_050025508.1;XP_050025492.1;XP_050030014.1;XP_050025457.1;XP_050025489.1;XP_050036058.1;XP_050030123.1;XP_050023398.1;XP_050025413.1;XP_050029058.1;XP_050028992.1;XP_050025459.1;XP_050024015.1;XP_050031589.1;XP_050025460.1;XP_050029305.1;XP_050025493.1;XP_050025458.1;XP_050029052.1;XP_050025490.1;XP_050031611.1;XP_050029057.1;XP_050025491.1;XP_050029071.1;XP_050029072.1;XP_050043741.1;XP_050029055.1;XP_050027823.1;XP_050022874.1;XP_050025650.1;XP_050029960.1;XP_050029059.1;XP_050029053.1;XP_050025461.1
Reactome: R-HSA-3232118	SUMOylation of transcription factors	16	XP_050044397.1;XP_050044406.1;XP_050044395.1;XP_050044398.1;XP_050044402.1;XP_050044396.1;XP_050044400.1;XP_050044394.1;XP_050044408.1;XP_050044405.1;XP_050044401.1;XP_050044403.1;XP_050034256.1;XP_050034257.1;XP_050044407.1;XP_050044404.1
KEGG: 00230+3.1.4.53	Purine metabolism	10	XP_050042037.1;XP_050042043.1;XP_050042042.1;XP_050042035.1;XP_050042045.1;XP_050042041.1;XP_050042036.1;XP_050042039.1;XP_050042044.1;XP_050042038.1
Reactome: R-HSA-175474	Assembly Of The HIV Virion	2	XP_050048534.1;XP_050035481.1
KEGG: 00350+1.1.1.1	Tyrosine metabolism	3	XP_050052400.1;XP_050052302.1;XP_050052301.1
MetaCyc: PWY-7379	Mrna capping II	2	XP_050037264.1;XP_050037263.1
Reactome: R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	57	XP_050045300.1;XP_050051335.1;XP_050030810.1;XP_050028292.1;XP_050051336.1;XP_050034644.1;XP_050043463.1;XP_050023776.1;XP_050047361.1;XP_050034960.1;XP_050039485.1;XP_050044010.1;XP_050045052.1;XP_050023577.1;XP_050037136.1;XP_050047588.1;XP_050023728.1;XP_050046123.1;XP_050024189.1;XP_050030811.1;XP_050023777.1;XP_050035378.1;XP_050023727.1;XP_050023724.1;XP_050030280.1;XP_050028323.1;XP_050023730.1;XP_050025563.1;XP_050027779.1;XP_050031345.1;XP_050034643.1;XP_050038469.1;XP_050039068.1;XP_050039484.1;XP_050040427.1;XP_050030634.1;XP_050040428.1;XP_050043138.1;XP_050047064.1;XP_050023625.1;XP_050023779.1;XP_050048718.1;XP_050024696.1;XP_050046063.1;XP_050044807.1;XP_050023729.1;XP_050033368.1;XP_050023714.1;XP_050023726.1;XP_050025635.1;XP_050023576.1;XP_050043147.1;XP_050023725.1;XP_050031446.1;XP_050034961.1;XP_050037137.1;XP_050048717.1
KEGG: 04150+2.7.11.1	mTOR signaling pathway	141	XP_050028165.1;XP_050036238.1;XP_050042988.1;XP_050032102.1;XP_050037624.1;XP_050031197.1;XP_050033844.1;XP_050032928.1;XP_050043302.1;XP_050023932.1;XP_050043305.1;XP_050043303.1;XP_050031203.1;XP_050031205.1;XP_050042990.1;XP_050025348.1;XP_050041923.1;XP_050031202.1;XP_050049350.1;XP_050043301.1;XP_050025347.1;XP_050030586.1;XP_050036236.1;XP_050035999.1;XP_050031201.1;XP_050048620.1;XP_050037621.1;XP_050036129.1;XP_050032927.1;XP_050036228.1;XP_050050041.1;XP_050043306.1;XP_050034961.1;XP_050036240.1;XP_050026974.1;XP_050031195.1;XP_050044807.1;XP_050037631.1;XP_050043307.1;XP_050042629.1;XP_050033720.1;XP_050033021.1;XP_050036227.1;XP_050049191.1;XP_050029381.1;XP_050036234.1;XP_050036235.1;XP_050036223.1;XP_050036613.1;XP_050037628.1;XP_050041948.1;XP_050031199.1;XP_050036233.1;XP_050035462.1;XP_050046724.1;XP_050045265.1;XP_050026975.1;XP_050031204.1;XP_050031196.1;XP_050036142.1;XP_050041924.1;XP_050039865.1;XP_050028323.1;XP_050037626.1;XP_050031208.1;XP_050044080.1;XP_050026054.1;XP_050034828.1;XP_050034829.1;XP_050028687.1;XP_050036241.1;XP_050036229.1;XP_050043129.1;XP_050043309.1;XP_050045266.1;XP_050050042.1;XP_050036130.1;XP_050036224.1;XP_050031198.1;XP_050034960.1;XP_050051647.1;XP_050041922.1;XP_050037630.1;XP_050042989.1;XP_050029303.1;XP_050048619.1;XP_050036226.1;XP_050031206.1;XP_050026053.1;XP_050048905.1;XP_050050723.1;XP_050026954.1;XP_050037625.1;XP_050031200.1;XP_050026027.1;XP_050036237.1;XP_050036232.1;XP_050034932.1;XP_050031194.1;XP_050043308.1;XP_050027320.1;XP_050028233.1;XP_050032708.1;XP_050036225.1;XP_050026955.1;XP_050044446.1;XP_050037629.1;XP_050051059.1;XP_050036131.1;XP_050050709.1;XP_050028292.1;XP_050045593.1;XP_050031207.1;XP_050043849.1;XP_050032548.1;XP_050050310.1;XP_050050734.1;XP_050037623.1;XP_050048621.1;XP_050028166.1;XP_050041921.1;XP_050032707.1;XP_050043304.1;XP_050022875.1;XP_050026695.1;XP_050049192.1;XP_050037622.1;XP_050042307.1;XP_050050715.1;XP_050031209.1;XP_050026977.1;XP_050029160.1;XP_050036231.1;XP_050043130.1;XP_050032586.1;XP_050026976.1;XP_050048906.1;XP_050036239.1;XP_050037627.1;XP_050026555.1;XP_050036230.1
Reactome: R-HSA-203615	eNOS activation	3	XP_050045374.1;XP_050052052.1;XP_050052051.1
KEGG: 00710+2.7.1.14	Carbon fixation in photosynthetic organisms	1	XP_050028579.1
Reactome: R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	101	XP_050043804.1;XP_050038626.1;XP_050029851.1;XP_050043802.1;XP_050044122.1;XP_050028344.1;XP_050038550.1;XP_050039997.1;XP_050028191.1;XP_050051087.1;XP_050029850.1;XP_050033573.1;XP_050035484.1;XP_050048062.1;XP_050036006.1;XP_050032688.1;XP_050051080.1;XP_050031153.1;XP_050043919.1;XP_050044593.1;XP_050026723.1;XP_050023059.1;XP_050028318.1;XP_050046933.1;XP_050049373.1;XP_050042714.1;XP_050039882.1;XP_050040632.1;XP_050033913.1;XP_050045189.1;XP_050052117.1;XP_050048061.1;XP_050027435.1;XP_050048060.1;XP_050044680.1;XP_050041744.1;XP_050026721.1;XP_050048534.1;XP_050035149.1;XP_050041753.1;XP_050051109.1;XP_050041323.1;XP_050052195.1;XP_050035483.1;XP_050051067.1;XP_050029294.1;XP_050035481.1;XP_050049831.1;XP_050023058.1;XP_050039340.1;XP_050032598.1;XP_050045969.1;XP_050050940.1;XP_050027304.1;XP_050043918.1;XP_050026018.1;XP_050043917.1;XP_050022853.1;XP_050032793.1;XP_050032330.1;XP_050051098.1;XP_050040677.1;XP_050052131.1;XP_050028604.1;XP_050027305.1;XP_050032599.1;XP_050025320.1;XP_050047002.1;XP_050031230.1;XP_050024740.1;XP_050032331.1;XP_050039285.1;XP_050032921.1;XP_050045196.1;XP_050051073.1;XP_050044445.1;XP_050051569.1;XP_050026722.1;XP_050032528.1;XP_050039286.1;XP_050034868.1;XP_050045970.1;XP_050026103.1;XP_050032936.1;XP_050049170.1;XP_050031861.1;XP_050022748.1;XP_050023492.1;XP_050050516.1;XP_050025636.1;XP_050036005.1;XP_050043916.1;XP_050046934.1;XP_050027477.1;XP_050052130.1;XP_050042319.1;XP_050029380.1;XP_050049776.1;XP_050049830.1;XP_050043803.1;XP_050032267.1
KEGG: 00020+4.2.1.2	Citrate cycle (TCA cycle)	1	XP_050037417.1
KEGG: 00010+5.3.1.1	Glycolysis / Gluconeogenesis	1	XP_050045451.1
Reactome: R-HSA-196025	Formation of annular gap junctions	6	XP_050028849.1;XP_050039510.1;XP_050039072.1;XP_050028745.1;XP_050028603.1;XP_050039071.1
Reactome: R-HSA-8949664	Processing of SMDT1	26	XP_050050909.1;XP_050025944.1;XP_050038351.1;XP_050036033.1;XP_050049300.1;XP_050024917.1;XP_050025946.1;XP_050047407.1;XP_050036030.1;XP_050036029.1;XP_050025949.1;XP_050050911.1;XP_050050055.1;XP_050047406.1;XP_050036031.1;XP_050036034.1;XP_050025948.1;XP_050050910.1;XP_050029787.1;XP_050024186.1;XP_050036032.1;XP_050049299.1;XP_050022864.1;XP_050025945.1;XP_050038350.1;XP_050025947.1
KEGG: 00240+3.6.1.9	Pyrimidine metabolism	3	XP_050041566.1;XP_050025198.1;XP_050045218.1
MetaCyc: PWY-7836	Ganglio-series glycosphingolipids biosynthesis	1	XP_050023783.1
Reactome: R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	1	XP_050049277.1
KEGG: 00480+6.3.2.2	Glutathione metabolism	2	XP_050026350.1;XP_050027889.1
Reactome: R-HSA-5339700	TCF7L2 mutants don't bind CTBP	4	XP_050049378.1;XP_050049376.1;XP_050049374.1;XP_050049375.1
KEGG: 00030+2.7.1.15	Pentose phosphate pathway	2	XP_050048528.1;XP_050048527.1
MetaCyc: PWY-7724	Icosapentaenoate biosynthesis III (8-desaturase, mammals)	78	XP_050039365.1;XP_050039772.1;XP_050039126.1;XP_050039699.1;XP_050027496.1;XP_050039085.1;XP_050047366.1;XP_050039364.1;XP_050039769.1;XP_050027470.1;XP_050043402.1;XP_050039080.1;XP_050051765.1;XP_050039016.1;XP_050039707.1;XP_050039088.1;XP_050039084.1;XP_050039712.1;XP_050027469.1;XP_050039087.1;XP_050026206.1;XP_050041192.1;XP_050039705.1;XP_050051763.1;XP_050028129.1;XP_050026205.1;XP_050039706.1;XP_050039709.1;XP_050039711.1;XP_050039770.1;XP_050039710.1;XP_050026888.1;XP_050039183.1;XP_050025916.1;XP_050039191.1;XP_050033896.1;XP_050048344.1;XP_050039702.1;XP_050039081.1;XP_050039082.1;XP_050026935.1;XP_050039703.1;XP_050039704.1;XP_050039186.1;XP_050027497.1;XP_050026887.1;XP_050036659.1;XP_050039086.1;XP_050039701.1;XP_050036658.1;XP_050039015.1;XP_050039426.1;XP_050041191.1;XP_050039708.1;XP_050045032.1;XP_050039189.1;XP_050039263.1;XP_050042358.1;XP_050051766.1;XP_050025917.1;XP_050036103.1;XP_050042219.1;XP_050036636.1;XP_050051764.1;XP_050027502.1;XP_050039700.1;XP_050026425.1;XP_050039555.1;XP_050039083.1;XP_050027024.1;XP_050039366.1;XP_050039698.1;XP_050033799.1;XP_050039722.1;XP_050033894.1;XP_050041128.1;XP_050039545.1;XP_050039017.1
MetaCyc: PWY-3881	Mannitol biosynthesis	1	XP_050044364.1
Reactome: R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	24	XP_050050679.1;XP_050050693.1;XP_050050692.1;XP_050050701.1;XP_050050688.1;XP_050050686.1;XP_050050690.1;XP_050050700.1;XP_050050695.1;XP_050050683.1;XP_050050682.1;XP_050050685.1;XP_050050684.1;XP_050050681.1;XP_050050687.1;XP_050050680.1;XP_050050698.1;XP_050050699.1;XP_050050702.1;XP_050050689.1;XP_050050694.1;XP_050050697.1;XP_050050691.1;XP_050050696.1
KEGG: 00332+1.2.1.41	Carbapenem biosynthesis	1	XP_050049134.1
Reactome: R-HSA-4720475	Defective ALG3 causes ALG3-CDG (CDG-1d)	1	XP_050025367.1
Reactome: R-HSA-1855191	Synthesis of IPs in the nucleus	1	XP_050026059.1